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Metallo-beta-lactamases and resistance to carbapenems
P408
First isolated of Vim-1 in Enterobacteriaceae
in Spain
S. Lavilla, M.T. To´rtola, J.J. Gonza´lez, N. Larrosa, E. Miro´,
G. Prats (Barcelona, E)
Objective: During the year 2003 we have investigated the
carbapenem resistance in enterobacteriaceae from fecal carriers
and other clinical samples.
Methods: All stool specimens submitted for bacterial culture
were inoculated onto MacConkey agar supplemented with
2 mg/L of imipenem (IMAC). These IMAC plates were
incubated overnight. The enterobacteriaceae strains suspected
to be carrier of MBLs were identiﬁed by API 20E system
(bioMe´rieux, Marcy l’Etoile, France). In vitro susceptibility
testing were determined by the standard disk diffusion method
and it was conﬁrmed by Etest. To detect MBLs production a
synergy test using disks or an Etest strip containing imipenem
plus EDTA were employed. The detection of the gene blaVIM-1
and class 1 integrons was performed by PCR ampliﬁcation.
Nucleotide sequences of the PCR products were determined
with a Beckmann 8000 sequencer. Conjugation and transforma-
tion experiments were conducted by the ﬁlter mating method
and following Bio-Rad recommendations (Bio-Rad, Laborator-
ies) respectively.
Results: Of 1043 stools studied and 4345 susceptibility tests
determined in clinical samples during the year 2003 we
obtained two strains, Klebsiella penumoniae from stool and
Escherichia coli from urine sample, suspected to be carrier of
MBLs. These strains were obtained from two patients. The
in vitro susceptibility testing showed that both strains were
resistant to all b-lactamics but were sensitive to aztreonam.
Although imipenem was sensitive its diameter was low
(22 mm). MIC to imipenem was 4–6 mg/L and 0.75 mg/L
for K. pneumoniae and E. coli respectively. The synergy test
using disks showed a positive result. The PCR ampliﬁcation of
blaVIM-1 was positive and direct sequencing of this ampliﬁ-
cation product showed 100% homology for the gen blaVIM-1
in both strains. PCR of class 1 integron yielded a 4 kb
ampliﬁcation product from K. pneumoniae and E. coli. The
conjugal transfer of the resistance was managed with
K. pneumoniae and E. coli, but in E. coli a previous transforma-
tion was needed.
Conclusion: The prevalence of carbapenemases in enterobacte-
riaceae strains is low. To our knowledge, these isolates of
K. pneumoniae and E. coli are the ﬁrst enterobacteriaceae species
producing VIM-1 in Spain. The MBLs production should be
studied when the strain showed a proﬁle of resistance to
cefotaxime, ceftazidime and cefepime but sensitive to aztreonam
and imipenem.
P409
Metallo-beta-lactamase in clinical Pseudomonas
aeruginosa isolate in a Portuguese hospital and
identiﬁcation of a new VIM-2 like enzyme
M.J. Carvalho, M.J. Saavedra, A. Correia, A.P. Castro,
A. Duarte (Aveiro, Vila Real, Lisbon, P)
Objectives: Metallo-beta-lactamases are responsible for carbap-
enems-resistant Pseudomonas aeruginosa . The spread of genes
enconding for these enzymes among gram-negative bacteria has
been described in different countries as well as in different
species and is a threat to public health.The aim of this work was
to identify metallo-beta-lactamases in Pseudomonas aeruginosa
clinical isolates.
Methods: A total of 27 clinical isolates of Pseudomonas aeruginosa
collected from February to October 2004 at an hospital in north
of Portugal were found to be resistant to Imipenem. Antibiotic
susceptibilities were determined by the agar disk diffusion
according to the protocol recommended by NCCLS. Detection of
metallo-beta-lactamases was performed by using the Imipenem-
EDTA disk method and conﬁrmed by the MBL E-test. The
isolates were subjected to PCR assays with speciﬁc primers for
blaIMP and blaVIM and sequence analysis were made to
identify the metallo-beta-lactamase. Epidemiological typing
was performed by M13 ﬁngerprinting.
Results: Antibiotic susceptibility tests revealed high percentage
of resistance to most antibiotics tested: Imipenem (96.3%),
Meropenem (84%), Ciproﬂoxacin (74.1%), Piperacillin-tazobac-
tam (34.6%), Ceftazidime (34.6%), Gentamicin (25.9%), Amikacin
(14.8%) and Tobramicin (7.7%). In the Imipenem-EDTA test only
one strain (Ps10VR) demonstrated a growth-inhibitory zone
with 16 mm of diameter, suggesting production of metallo-beta-
lactamases, while no remarkable distinct change was noticed in
the others isolates. The MBL E-test was realized for this strain
and Imipenem MIC has decreased from 16 to <1 mg/l.In PCR
experiments using speciﬁc primers for blaIMP the results were
negative among all strains, while in those using speciﬁc primers
for blaVIM one strain generated a positive result, the same that
was positive to Imipenem-EDTA test and MBL E-test (Ps10VR).
The sequence analysis revealed that this strain was carrying a
variant blaVIM-2 that encodes a VIM-2 like enzyme. The novel
gene differs from blaVIM-2 by replacement of a G with a A at
nucleotide 443 of structural gene, which results in Ser-to- Asp
change at amino acid positions 136.M13 ﬁngerprinting revealed
that six clinical isolates were closely or possibly genetically
related and that one VIM-2 like producing Ps.aeruginosa Ps10VR
isolate was genetically indistinguishable.
Conclusion: The results showed a new VIM-2 like enzyme in
Pseudomonas aeruginosa.
P410
Detection of a new VIM-type metallo-beta-
lactamase (VIM-11) in a Pseudomonas aeruginosa
clinical isolate from Italy
A. Mazzariol, C. Mammina, R. Konkan, V. Di Gaetano, P. Di
Carlo, D. Cipolla, G. Corsello, G. Cornaglia (Verona, Palermo, I)
Objectives: A one-year prospective study of multidrug-resist-
ant Gram-negative microorganisms was carried out in a
neonatal intensive care unit (NICU) in Palermo, Italy, within
the framework of an infection control programme. All the
newborns that were admitted to the NICU for at least 24 h –
namely 211 cases – were enrolled in the study. All the
imipenem-resistant Pseudomonas aeruginosa isolates from all
kinds of specimens were tested for metallo-beta-lactamase
(MBL) production.
Methods: Antimicrobial susceptibility testing was performed
by both diffusion and microdilution and interpreted according
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to the latest NCCLS documents. The presence of carbapenemase
was screened by means of the MBL-etest, and further investi-
gated by following carbapenem hydrolysis and its inhibition by
EDTA. PCR and sequencing were carried out by standard
procedures. An enzyme endowed with carbapenemase activity
was cloned on a phagemid vector pPCR script Cam SK+ and
transformed in Escherichia coli XL10 ultracompetent cells using
the ligation kit polishing protocol.
Results and Conclusions: 54.5% (115/211) of newborns were
colonised by MDR Gram-negatives. 16.1% (34/211) were colo-
nised by an imipenem-resistant strain of P. aeruginosa. Twenty-
one of these latter strains shared the same PFGE proﬁle and all
showed clear positivity with the MBL etest. Imipenem hydro-
lysis by spectrophotometric analysis of crude sonic extracts
conﬁrmed that imipenem was hydrolysed at a rate of
5 · 10)8 mol/min/mg, whereas on adding EDTA 2 mM the
kinetics was 7.2 · 10)10 mol/min/mg.A polymerase chain reac-
tion (PCR) performed with either bla(VIM) or bla(IMP) primers
yielded positive results only with the bla(VIM) primers; a
speciﬁc PCR yielded a product of about 800 bp that - after
sequencing - was found to code for a polypeptide differing from
VIM-4 in one amino acid, namely G31S. The new enzyme was
named VIM-11 at the www.lahey.org site and received the
accession number AY635904.
P411
JAP-1, a new member of subclass B3 metallo-beta-
lactamase from Bradyrhizobium japonicum
M. Stoczko, J.M. Frere, G.M. Rossolini, J.D. Docquier (Siena, I;
Lie`ge, B)
Objectives: The most common cause of bacterial resistance to
beta-lactam antibiotics is the production of beta-lactamase.
Among these, metallo-beta-lactamases (MBLs) are zinc-depend-
ent enzymes that have been the focus of increasing attention
because of their ability to hydrolyze nearly all known beta-
lactams and of the lack of clinically-useful inhibitors. However,
several MBLs have been reported also from bacterial species that
are primarily members of the environmental microbiota (e.g.
CAU-1 from Caulobacter crescentus and THIN-B from Janthino-
bacterium lividum). In the genome of Bradyrhizobium japonicum
USDA 110, a nitrogen-ﬁxing symbiont of legumes among the
most important in agriculture and plant biotechnology, an open
reading frame was found (ORF blr 6230) that encodes a protein
sharing 28–40% sequence identity with subclass B3 MBLs. The
functional properties of the enzyme, named JAP-1, were
investigated.
Methods: ORF blr 6230 was ampliﬁed from Bradyrhizobium
japonicum USDA110 by PCR using custom primers, and the
ampliﬁcation product was cloned into the T7-based expression
vector pET-9a to yield the recombinant plasmid pET-JAP-1.
E. coli BL21(DE3)[pET-JAP-1] strain was used for protein produc-
tion. The enzyme was subjected to biochemical characterization
and the kinetic properties investigated by spectrophotometry.
Results: ORF blr 6230 encodes a putative protein of 294
residues and a predicted molecular mass of 32 kDa. JAP-1
exhibits the highest sequence identity with CAU-1 and FEZ-1
(from Legionella gormanii) enzymes (40 and 34% respectively).
E. coli BL21(DE3)[pET-JAP-1] produced a imipenemase activity
(sp. act. 155 nmol/min.mg of protein) that was inhibited >95%
after incubation in presence of 5 mM EDTA. The puriﬁed JAP-1
enzyme efﬁciently hydrolyzed penicillins, cephalosporins and
carbapenems.
Conclusion: The MBL homologue encoded by the B. japonicum
USDA 110 chromosome is a functional MBL of subclass B3 that
exhibits a broad substrate proﬁle. This is the ﬁrst example of a
MBL found in the bacterial species belonging to the Rhizobiales
order.
P412
The diverse integron structures disseminating
VIM genes in Poland
J.A. Patzer, M.A. Toleman, A. Grzesik, D. Dzierzanowska,
T.R. Walsh (Warsaw, PL; Bristol, UK)
Objectives: Recently we have characterized a novel blaVIM-4
metallo-beta-lactamase (MBL) gene cassette from clinical strains
isolated from hospitalized children in Warsaw, Poland. This
novel gene cassette was harboured on class 1 integron and
found in 11 strains of Pseudomonas aeruginosa with various PFGE
patterns. The aim of this study was to genetically examine other
carbapenem-resistant P. aeruginosa and P. putida clinical strains
for similar integrons.
Methods: Phenotypic screening involved the MBL Etest strip
(AB BIODISK). Biochemical analysis used crude extrats exam-
ining imipenem (IMP) and meropenem (MEM) hydrolysis
preincubated with 20 mM EDTA. PCR analysis was performed
using primers speciﬁc for blaIMP and blaVIM genes and class 1
integrons. Sequencing was carried out using Perkin-Elmer
Biosystems 377 DNA sequencer and analysed using DNAstar.
Results: The Etest produced for the majority of isolates a
positive phenotypic test for MBL: IMP MIC > 256 mg/l; IMP/
EDTA 1–8 mg/L. Isolates were resistant to all beta-lactams, and
some additionally to aminoglycosides. The crude extracts of
isolates showed hydrolysis of IMP and MEM, which were
inhibited over 90% with EDTA. Screening for MBL using PCR
analysis gave a positive result for the presence of the blaVIM
gene. Two isolates of P. putida had an integron containing MBL
gene blaVIM-4/blaVIM-4 partial repeat, then aacA4 (or aadB),
OXA-2, orfD followed by qacEdelta1. P. aeruginosa isolate 266/
03 had restriction pattern of blaVIM-4 as previously isolated in
our hospital. Two P. aeruginosa isolates: 414/03 from our
hospital and 303/03 from other hospital in Warsaw, had MBL
gene blaVIM-2 as isolated previously in Warsaw. However, they
had different additional genes within the class 1 integron.
Conclusions: Since 1998, P. aeruginosa strains with blaVIM-4
MBL genes have become endemic in children hospitalized in our
institute. The source of blaVIM-4 gene cassette are probably the
P. putida strains. Diverse integrons found in P. putida and
P. aeruginosa isolates are responsible for the spread blaVIM
genes in Poland.
P413
Diverse transposons are responsible for the
dissemination of Japanese metallo-beta-lactamase
alleles: Report from the SENTRY Surveillance
Programme
M.A. Toleman, D.M.C. Bennett, R.N. Jones, T.R. Walsh (Bristol,
UK; Iowa, USA)
Objectives: MBL’s were initially characterised in Japan, usually
of the IMP type and found in Pseudomonas aeruginosa , Acinetob-
acter or Serratia marcescens and have been endemic in Japan for
the last decade. However, little work has been done to
characterize the integron structures or classify the mobile
Abstracts
100
genetic elements associated with them. Here we have sequenced
upstream of the integrons harbouring MBL genes in ﬁve isolates
to identify genes responsible for dissemination.
Methods: Integron structures were determined by sequencing
PCR products ampliﬁed with 5’ and 3’ conserved sequence
primers. Adjacent sequences to the Class 1 integron were
ampliﬁed by PCR with nested primers anchored to the 5’ end of
the Class 1 integron and degenerate primers designed to
randomly hybridize to upstream sequences. Sequencing was
performed on both strands.
Results: S. marcescens isolates 206-3105 and 205-3106 were of
an identical integron structure with blaIMP-1 in the ﬁrst gene
cassette position followed by an OXA-1 gene cassette, both
integrons were inserted into a Tn21 transposon in an identical
position to the integron previously found in Tn21. The S.
marcescens isolate 206-825 harboured a blaIMP-1 containing
integron which was inserted into a resolvase gene of a
Tn5044-like transposon. Isolate 205-1297 harboured a novel
blaIMP-11 integron which was inserted into a sequence which
displayed high identities to a Tn5053 transposon recently
identiﬁed from Russian permafrost. Isolate 205-5353 har-
boured an blaIMP-1 containing integron which was inserted
into a sequence of plasmid origin not linked to any transpo-
son genes.
Conclusions: Analysis of the genetic elements ﬂanking the
blaIMP containing integrons revealed a surprising degree of
diversity of genetic elements associated with these structures.
The integrons harboured by Tn21 would be expected to be very
mobile. However integrons inserted into functional transposase
genes such as in isolates 206-825 and 205-1297 would be
expected to be less mobile.
P414
Genetic characterisation of the IMP-1 metallo-
beta-lactamase gene in Enterobacter cloacae
strains from Turkey
M.A. Toleman, D.M.C. Bennett, H. Sader, T.R. Walsh (Bristol,
UK; Iowa, USA)
Objectives: The occurrence of metallo-beta-lactamase (MBL)
genes in clinical strains of Enterobacteriaceae is worrisome since
carbapenems have been used clinically to counteract AmpC
producing pathogens. Herein, we describe the genetic context of
MBL genes from clinical isolates of E. cloacae isolated from two
medical centres in Turkey.
Methods: 6 strains of E. cloacae had imipenemMICs of 2–4mg/l.
Genetic screening for blaIMP, blaVIM, blaSPM, blaGIM MBL
genes and the NmcA gene was performed by PCR. The genetic
context of MBL genes was also investigated by PCR with
primers designed to amplify Class 1 and Class 3 integrons which
have been implicated in the transfer of antimicrobial resistant
genes and also primers designed to common regions known to
be associated with numerous lactamase genes, such as the
blaSPM. MBL genes were also examined to ascertain whether
they were plasmid or chromosomally mediated. Plasmids were
electroporated into Escherichia coli. The isolates were molecular
typed by automated ribotyping and PFGE.
Results: The MBL gene blaIMP-1 was detected in all six strains
of E. cloacae but PCR was negative for all other beta-lactamase
genes. Plasmids were detected in all strains of E. cloacae with
three different agarose gel proﬁles. Two different plasmid
proﬁles were detected at site 69 and a third proﬁle at site 68.
blaIMP-1 PCR of plasmids indicated that blaIMP-1 was plasmid
located in the E. cloacae strains from site 69 but probably
chromosomally located in the strain from site 68. These results
were further conﬁrmed by electroporation of E. coli with
plasmids isolated from each strain, followed by blaIMP-1 PCR
using the E. coli host as template. No Class 1 integrons were
detected by PCR. Although products were produced by PCR
using Class 3 integron primers, subsequent PCR did not detect
blaIMP-1 on this product. Common region (CR) PCR detected
putative CRs in 5 of 6 isolates. 4 isolates from site 69 showed
identical ribotype and PFGE pattern, while the other 2 strains
showed unique ribotypes.
Conclusions: blaIMP-1, was detected in E. cloacae isolated at
two different institutions within Turkey. The blaIMP-1 gene was
found on different plasmid backgrounds and also on the
chromosome in one isolate demonstrating mobility. However,
in all cases the MBL gene did not appear to be associated with
an integron. Putative common regions were detected in these
isolates but any genetic linkage with blaIMP-1 has yet to be
conﬁrmed.
P415
In vitro activity of beta-lactam antimicrobial
agent combinations with aztreonam when testing
metallo-beta-lactamase-producing Pseudomonas
aeruginosa and Acinetobacter spp.
H. Sader, P. Rhomberg, L. Deshpande, R. Jones (North Liberty,
USA)
Objectives: To evaluate the interactions between aztreonam
(AZT) and selected beta-lactams (BL) when tested against
metallo-beta-lactamase (MBL)-producing P. aeruginosa (PSA)
and Acinetobacter spp. (ASP) strains. AZT often displays
on-scale MIC results tested against MBL-producing strains.
Methods: Ten PSA strains, including 9 well-characterized MBL-
producers (IMP-1, -2, -13, -16, VIM-1, -2, -7, SPM-1 and GIM-1)
and 5 ASP strains, including 3 MBL-producers (IMP-1 and -2)
were tested using time kill/bactericidal activity methods. AZT
at 4, 8 and 16 mg/L was combined with 4 BLs (cefepime [CPM],
ceftazidime [CAZ], meropenem [MEM] and piperacillin/tazo-
bactam [P/T] for PSA or ampicillin/sulbactam [A/S] for ASP),
which were tested at the NCCLS susceptible (S) breakpoint
concentration. Bacterial counts were determined at time 0, 4, 8
and 24 hours. Enhanced activity was deﬁned as a ‡ 1 and
synergy (SYN) as ‡2 log10 reduction in the CFU/ml compared to
the result of the most active antimicrobial tested alone. Antag-
onism (ANT) was deﬁned as a ‡ 2 log10 increase in CFU/ml
compared to the most active drug.
Results: All MBL-producing PSA were resistant (R) to tested
BLs, except for AZT on IMP-16 (MIC, 1 mg/L), SPM-1 (8 mg/L)
and GIM-1 (16 mg/L), and for P/T on IMP-16 (4/4 mg/L),
VIM-2 (16/4 mg/L) and IMP-2 (32/4 mg/L). Enhanced activity
was observed with 4 PSA strains (IMP-16, VIM-2, SPM-1 and
GIM-1) and 4 ASP, while ANT was observed with 1 PSA (IMP-
16) with MEM and 1 ASP (non-MBL-producing). All other
strains showed indifferent interactions (CFU/ml variation of
±1 log10) with any combination evaluated. Results of CFU/ml
variation observed when AZT at 8 mg/L was combined with
the BLs are listed in the Table: Enhanced activity was also
observed when AZT at 4 mg/L was combined with P/T (PSA
IMP16, VIM-2 and SPM-1), MEM (PSA SPM-1), CPM (PSA GIM-
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1) or A/S (ASP IMP-1 and non-MBL) and when AZT at 16 mg/L
was combined with CPM, MEM and P/T (PSA GIM-1), CAZ
(ASP IMP-1) or A/S (ASP non-MBL). Among PSA strains, ANT
was observed only with the IMP-16 strain when AZT at 4 and
8 mg/L was combined with MEM or when AZT at 4 mg/L was
combined with CAZ, while among ASP ANT was observed
when AZT at 4 mg/L was combined with CPM.
Conclusions: MBL-producing PSA and ASP strains are usually
R to most BLs except AZT. AZT can favorably interact with
other BL agents against some multi-drug resistant isolates for
possible chemotherapy.
P416
Transfer and carriage of naturally occurring
Pseudomonas aeruginosa plasmids harbouring
metallo-beta-lactamase to Enterobacteriaceae
strains
M. Castanheira, R.E Mendes, M.A Toleman, R.N Jones,
T.R. Walsh (Bristol, UK; North Liberty, USA)
Background: The presence of metallo-beta-lactamase (MBL)
genes in clinical strains of some Enterobacteriaceae is worrisome
since carbapenems have been used clinically to counteract
extended-spectrum beta-lactamase producing pathogens.
Herein, we assessed the frequency and the viability of plasmids
carrying MBL genes transferred into Enterobacteriaceae.
Methods: Twenty-one carbapenem-susceptible and intermedi-
ate resistant Enterobacteriaceae (Escherichia coli, Enterobacter
cloacae, Klebsiella pneumoniae and Citrobacter freundii) clinical
isolates from different genotypes were screened for absence of
plasmids and activity against carbapenems. The isolates were
transformed with wild-type plasmids (24 kb–400 kb) harbour-
ing the MBL genes blaIMP-1, blaVIM-7, blaSPM-1 and blaGIM-1
by electroporation and conjugation. Plasmids were isolated
using Qiagen commercial kits. Selection was performed with a
range of ceftazidime (20–100 lg/ml) or imipenem (10–50 lg/
ml) incorporated into the medium. The plasmids RSF1010 and
pK18 were used as controls during the transformation experi-
ments. PCR reactions for the internal regions of the MBL genes
and activity assays against imipenem were performed to
conﬁrm the transfer of the gene.
Results: Twelve isolates containing no plasmids and showing
high-level of sensibility to carbapenems were transformed with
the four MBL harbouring plasmids. Transformants could not be
recovered in 11 from the 12 isolates, although the controls
demonstrated positive transfer at high frequencies. Evidence of
transfer was obtained in plates containing 20, 30 and 40 lg/ml
of imipenem with an imipenem intermediate-resistant C. freundii
isolate (MIC 8 lg/ml) transformed with blaVIM-7 plasmid. The
presence of the MBL gene in the transformants was conﬁrmed
by PCR and sequencing; however, no activity against imipenem
could be observed.
Conclusions: The spread of the MBL genes in Enterobacteria-
ceae is a great concern. However, data from this pilot study
indicates that in-vitro transfer does not happen at a high
frequency and may be strain dependent.
P417
Silencing of a Pseudomonas aeruginosa metallo-
beta-lactamase gene in Enterobacteriaceae isolate:
evidence of post-transcriptional modiﬁcations
T.R. Walsh, M. Castanheira, P.M. Bennett,
A. Sundsfjord (Bristol, UK; Tromso, N)
Background: Gene silencing represents a cellular defense
system for controlling foreign gene expression. As metallo-
beta-lactamase genes are becoming more spread, it is important
to evaluate the ability of Enterobacteriaceae to express Pseudo-
monas metallo-beta-lactamase genes carried on native plasmids.
Methods: Plasmids harbouring metallo-beta-lactamase genes
were transformed in K2-23, a Citrobacter freundii strain with
intermediate resistance to imipenem and meropenem due to
decreased expression of 42 kDa outer membrane protein.
Selection was performed with imipenem (10–50 mg/L). PCR
reactions and sequencing of the metallo-beta-lactamases gene
and surrounding regions were carried out to conﬁrm integrity of
the structural gene and promoter regions. Activity assays
against imipenem, meropenem and ceftazidime were performed
to the original strain and transformants. Gene expression was
analysed by RT-PCR with blaVIM-7 primers using housekeep-
ing genes as controls.
Results: Colonies were recovered from transformation with
blaVIM-7 in imipenem concentrations of 20, 30 and 40 mg/L.
PCR reactions showed the presence of blaVIM-7 in different
colonies, showing increased imipenem MICs (>32 mg/L). Gene
sequencing results conﬁrmed the presence of blaVIM-7 in the
transformants. However, detectable activity against imipenem
and meropenem could not be demonstrated in any of the
transformant colonies. Sequencing results conﬁrmed the integ-
rity of the blaVIM-7 gene and no alterations could be observed
in the upstream (including the integron promoter) and down-
stream regions of the gene cassette. RT-PCR demonstrated the
presence of mRNA of blaVIM-7, showing that the gene has been
transcribed.
Conclusions: Silencing of genes occurs at the transcriptional
level, whereas in other cases, silencing is due to a postranscrip-
tional process. The results of this study indicate the occurrence
of postranscriptional modiﬁcations.
P418
Phenotypic detection of Pseudomonas aeruginosa
producing metallo-beta-lactamases
A. Bisiklis, E. Tsiakiri, S. Alexiou-Daniel (Thessaloniki, GR)
Objectives: The purpose of our study was to determinate the
proportion of Pseudomonas aeruginosa producing metallo-beta-
lactamases.
Methods: We have studied a random sample of 44 Pseudomonas
aeruginosa strains. 34 of these strains were Imipenem resistance
and 10 were Imipenem sensitive. Strains were isolated by
clinical sample cultures. The samples were collected during 2003
from Intensive Care Units (52%), Surgical wings (25%) and
Pathological wings (23%) of the university hospital AHEPA. The
cultures became in common nutrient substrates. The identiﬁca-
tion and determination of antibiotic sensitivity was performed
by Vitek 2 system (BioMe´rieux). The identiﬁcation was con-
ﬁrmed by API 20NE system. The Imipenem resistance was
CFU/ml variation (log10) +AZT
Organism
CPM
(8 mg/L)
CAZ
(8 mg/L)
MEM
(4 mg/L)
P/T
(64/4 mg/L)
A/S
(8/4 mg/L)
PSA IMP-16 -3.8a -2.6 +2.5 -3.8 -
PSA VIM-2 +0.3 -1.0 -0.6 -2.7 -
PSA SPM-1 -0.4 +1.4 +0.8 -1.2 -
PSA GIM-1 -1.6 +0.1 0.0 +0.1 -
ACB IMP-2 +0.1 +0.2 0.0 - -2.2
ACB 4-575
(non-MBL)
+0.3 +0.4 0.0 - -2.7
a. underline values indicate SYN.
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conﬁrmed by E-test (AB Biodisk). The phenotypic detection of
producing of metallo-beta-lactamases was performed by E-test
MBL (Imipenem (IP) / Imipenem+EDTA (IPI)) of AB Biodisk.
Results: We found 8 negative and 2 undetermined results for
producing metallo-beta-lactamases during phenotypic control of
Imipenem sensitive strains. Strains with undetermined results
had borderline Imipenem MIC (4 lg/ml). Also, we found 23
positive (67%), 8 negative (24%) and 3 undetermined (9%)
results during phenotypic control of Imipenem resistance
strains. Strains produced metallo-beta-lactamases had resistance
phenotype as follows: 100% resistance to Ampicillin, Ampicil-
lin/Sulbactam, Ceﬁxime, Cefotaxime and Meropenem, 90% to
Ceftazidime, Cefepime and Ciproﬂoxacine, 86% to Gentamicin
and Tobramycin, 78% to Piperacillin and 26% to Piperacillin/
Tazobactam. The positive strains were isolated from bronchial
excretions (11), pus (3), blood (2), urine (2) venous catheters (2)
ear excretions (2) and CSF (1). Also, positive strains were
collected from Intensive Cure Units (61%), Surgical wings (26%)
and Pathological wings (13%).
Conclusions: a)A high proportion of strains produced metallo-
beta-lactamases was found. b) The biggest proportion of
positive strains was collected from Intensive care Units. c) The
detection of producing metallo-beta-lactamases was observed in
multi-resistant Pseudomonas aeruginosa. d) All positive strains
were Imipenem-resistant. e) It was remarkable that while
Tazobactam does not inhibit metallo-beta-lactamases, it was
found a particularly low resistance proportion to Piperacillin/
Tazobactam.
P419
Metallo-beta-lactamase production and
susceptibility to antibiotics of Pseudomonas
aeruginosa isolates from Zagreb, Croatia
B. Bedenic, M. Bubonja, S. Suto, A. Budimir, V. Plecko,
N. Jarza-Davila (Zagreb, Rijeka, Livno, HR)
Objectives: The aim of this study was to determine the
susceptibilities to wide range of antibiotics of P. aeruginosa
isolates with reduced susceptibility to either imipenem or
meropenem and the prevalence of metallo-b-lactamases
(MBLs) produced by these isolates.
Methods: 100 P. aeruginosa isolates with reduced susceptibility
to carbapenems were collected in three hospitals in Zagreb
during 2002–2004. The antibiotic susceptibilities were deter-
mined by broth microdilution method. MBLs were detected
with three different phenotypic methods: EDTA double-disk
potentiation test using ceftazidime disk, combined disk test and
E test. The sensitivity and speciﬁcity of these methods were
compared. Positive and negative control strains were included
in the tests.
Results: Antibiotic susceptibilities The concentration of anti-
biotic necessary to inhibit 90% of the strains was 16 mg/L for
meropenem, 32 mg/L for imipenem and ciproﬂoxacin, 128 mg/
L for ceftazidime alone and combined with clavulanate and
cefepime, and 256 mg/L for piperacillin alone and combined
with tazobactam, cefoperazone, cefotaxime and gentamicin. 33%
of the strains were resistant to piperacillin/tazobactam, 36% to
imipenem, 40% to ceftazidime, 41% to piperacillin and ceftaz-
idime/clavulanate, 42% to meropenem, 49% to cefoperazone,
55% to cefepime, 56% to cefotaxime, 70% to ciproﬂoxacin and
75% to gentamicin. Detection of MBLs Combined disk test
detected MBLs in 51 strains, double-disk test in 40 and E test in 7
strains. Detection of MBLs was not determinable by E test in 8
strain because of the off-scale MIC values.
Conclusions: None of the antibiotics tested in this study should
be recommended as the antibiotic of choice for the treatment of
P. aeruginosa strains with reduced susceptibility to carbapenems
due to high percentage of resistance.Combined-disk test has
shown to be the most sensitive in detection of MBLs, followed
double-disk test. E-test gave the lowest rate of positive results.
Speciﬁcity of all three test was 100%. As previously observed by
other authors E test detects MBLs only in strains with high level
enzyme production and this can be an explanation for imperfect
correlation between phenotypic tests for MBLs.With increasing
incidences of MBLs among P. aeruginosa isolates, it would be
important that screening to detect them is incorporated in
routine diagnostic testing.
P420
Spread of highly carbapenem-resistant
Acinetobacter baumannii in an intensive care unit
of a tertiary hospital: the role of AmpC
overproduction in this resistance
A. Tsakris, S. Pournaras, A. Markogiannakis, A. Ikonomidis,
G. Bethymoutis, M. Mouroutsou, A.N. Maniatis (Athens, Larissa,
GR)
Objectives: To investigate the resistance mechanisms of highly
imipenem- and meropenem-resistant P. aeruginosa in an inten-
sive-care unit (ICU) of a large tertiary hospital.
Methods: A total of 17 non-repetitive Acinetobacter baumannii
strains were collected from hospital infection samples as well as
environmental sources in the ICU of Red Cross General
Hospital, Athens, Greece. Identiﬁcation and susceptibility test-
ing were performed by using the Vitek 2 Automated System
(Biomerieux, Marcy l’ Etoile, France). Imipenem and merope-
nem MICs were determined using E-test. The isolates were
tested by E-test MBL for a possible metallo-beta-lactamase
production, PCR for the presence of carbapenemase-encoding
genes blaIMP, blaVIM and blaOXA, and synergy experiments
using meropenem and the efﬂux pump-inhibitor carbonyl-
cyanide-chloro-phenylhydrazone (CCCP). Also, RT-PCR for
ampC gene was performed to test for a possible contribution
of AmpC overexpression to the carbapenem resistance.
Results: During the study period, 17 carbapenem-resistant
A. baumannii isolates were recovered from clinical infections
and environmental samples. MICs of imipenem and meropenem
ranged from 8 to >256 mg/L. All the isolates except two were
negative by the E-test MBL, while all were negative by PCR for
genes encoding known carbapenemases. No isolate exhibited
signiﬁcant synergy between meropenem and CCCP, indicating
that over-expression of proton-gradient dependent efﬂux
pumps did not contribute to the meropenem resistance. AmpC
overexpression was demonstrated in seven isolates. In these
isolates, inhibition of AmpC by cloxacillin, reduced MICs for
several cephalosporins and carbapenems.
Conclusions: The aetiology of resistance phenotype of these
isolates is still unclear. The overexpressed AmpC only in part
contributes to the carbapenem resistance. The possible presence
of an unknown carbapenemase needs further investigation.
P421
Development of phenotypic and genotypic
methods for the detection of carbapenemases in
clinical isolates of A. baumannii resistant to
imipenem
C. Valderrey, E. Sevillano, M. Canduela, E. Ferna´ndez,
P. del Rio, F. Calvo, L. Gallego (Bilbao, E)
Objectives: The aim of this study was to develop different
techniques to detect and identify the presence of
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carbapenemases in clinical isolates of Acinetobacter baumannii
resistant to imipenem.
Methods: The study included 58 resistant isolates obtained at
Hospital de Santa Marina (Bilbao,Northern Spain) during 2002
belonging to previously identiﬁed clone I (19 isolates), II (13), III
(3) and IV (1). Phenotypic detection was done using the
following methods: Hodge test, Hodge test plus zinc sulphate,
EDTA test, and two variants of DDST test (one disk containing
EDTA+SMA and double disk EDTA/SMA). Genetic experi-
ments to detect bla-OXA 40, bla-IMP and bla-VIM genes
were performed by DNA ampliﬁcation with the primers P1/
OXA-24: 5’-GTACTAATCAAAGTTGTGAA-3’ and P2/OXA-24:
5’-TTCCCCTAACATGAATTTGT-3’), BLAIMPF: 5’-CTACCG-
CAGCAGAGTCTTTG-3’ and BLAIMPR 5’-AACCAGTTTTGCC-
TTACCAT-3’); VIM-DIA/r 5’-AGGTGGGCCATTCAGCCAGA-
3’; VIM1-upv 5’-GTCGCAAGTCCGTTAGCCCAT-3’ and VIM
2-upv 5’-GATTCTAGCGGTGAGTATCCG-3’.
Results: The results obtained are sumarized in the following
table:
Conclusions: Phenotypic tests were easy to perform but,
specially with metallobetalactamase tests the interpretation
was rather difﬁcult. The majority of isolates showed carbapen-
emase activity which was correspondent with the detection of
the OXA-40 gene. Some metallobetalactamase tests were posit-
ive but no genetic correspondence was observed; moreover, the
VIM-2 and IMP positive isolates found were all negative in the
phenotypic tests. This is the ﬁrst time we detect VIM and IMP
enzymes in our envirorment.
P422
Genetic analysis of imipenem-resistant
Pseudomonas aeruginosa oprD gene from clinical
isolates in Korea
J.K. Lee, E.S. Sohn, Y.S. Yoo, Y.S. Lee, J.I. Yoo, B.S. Kim (Seoul,
KOR)
Objectives: The emergence of multidrug-resistant strains in
Pseudomonas aeruginosa isolates has increased worldwide. Imi-
penem (IPM) is the most potent agent for treatment of multidrug
resistant P. aeruginosa infection but a number of clinical
P. aeruginosa isolates have shown reduced susceptibility or
resistance to IPM. IPM-resistant strains have either lost OprD or
have strongly reduced OprD levels, and loss of OprD has been
reported to occur in isolates with mutation, base transitions or
deletions, in the oprD structural gene. In recent years, IPM-
resistant P. aeruginosa isolates have emerged rapidly in South
Korea. The objective of this study was to evaluate the association
between mutations in oprD gene and IPM resistance.
Methods: Fifteen IPM-resistant and 3 IPM-susceptible P. aeru-
ginosa evaluated in this study were isolated from non-tertiary
hospitals in Korea during 2003. MICs of imipenem and
meropenem were determined according to the criteria of
NCCLS. The oprD gene was ampliﬁed by PCR using speciﬁc
primers and sequencing was performed by the dideoxy-chain
termination method. The amino acid alterations in the oprD
gene of IPM-resistant isolates were compared with the corres-
ponding sequence of P. aeruginosa PAO1 and IPM-susceptible
isolates. The mRNA levels from oprD gene of P. aeruginosa
isolates obtained by real-time quantitative PCR.
Results: All of IPM-resistant isolates produced metallo-beta-
lactamase, VIM-2, and the MICs of IPM for these isolates were
16 to 512 mg/L. All oprD sequences from P. aeruginosa isolates
were divided into three distinct groups (A, B and C), with
identities ranging from 91.1% to 100% for amino acids. In these
isolates, amino acid variations among oprD groups were
observed mainly at the external loops. We did not ﬁnd the
direct correlation between the oprD group and imipenem
resistance. However, IPM-resistant isolates in each oprD group
had amino acid substitutions in the external loops (loop 2, 3, 5, 6,
7 or 8). The level of oprD mRNA in IPM-resistant isolates was
down-regulated, compared with IPM-susceptible isolates.
Conclusion: These results suggested that amino acid alterations
in external loops of oprD gene from P. aeruginosa isolates was
associated with the down-regulation of oprD transcription and
IPM resistance.
P423
Resistance to carbapenems in Pseudomonas
aeruginosa clinical isolates
A. Sanchez Garcia, I. Gestoso , S. Solis del Ban˜o, A. San Pedro
Garrido, J.J. Picazo (Madrid, E)
Objective: Study of sensitivity to antibiotics of clinical isolates
of carbapenem-resistant P. aeruginosa,and determination of the
presence of metallo-betalactamases(MBL).
Methods: We selected 133 strains of P. aeruginosa with MIC ‡ 4
to imipenem and/or meropenem from August-02 to August-03.
Sensitivity to antibiotics was determined by automated
systems for piperacillin (PIP), piperacillin-tazobactam (PT),
imipenem (IP), meropenem (MER), ceftazidime (CTZ), gen-
tamicin(GE), tobramycin(TO), ciproﬂoxacin (CIP) and levoﬂ-
oxacin(LEV, and E-test for aztreonam(AZ) and colistin(CO). To
determine the presence of MBL, we used the E-test with
imipenem (IP) / imipenem plus EDTA (IPI). With strains
which proved positive with this screening test, we carried out
a PCR with the primers described by Nordmann and Poirel for
VIM type genes.
Results: Of the 133 strains selected, 109 (82%) had MIC ‡ 4 to
both carbapenems, 23 (17.3 %) only to IP, and only 1 strain
(0.75%) had MIC ‡ 4 for MER, and was sensitive to IM. The
most active antibiotics against these carbapenem-resistant
strains were the aminoglycosides, especially TO(73.7% sensitive
strains), and COL(82.7%). The least active antibiotics were
CIP(33.8%), CTZ(41.35%) and AZ(52.6%). The most active
betalactam antibiotic in vitro was the combination PT. Of the
67 strains resistant to PIP(1.2%), they become sensitive with the
introduction of tazobactam. As a result of the screening test to
evaluate the presence of MBL,we obtained 4/133 strains as
probable producers of metalloenzyme. We selected strains with
MIC IP/MIC IPI ‡ 5 due to previous experience in our hospital.
The MIC of these 4 strains to IP and MER were, respectively: 4–
4, 4–4, 8–8 and>16–2. Of these 4 strains, two were resistant to
GE, and one to TO (sensitive to GE); all were sensitive to the
betalactams, quinolones and to AZ. The MIC for colistin were
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0.5,6,6 and 12. With these 4 strains a PCR was carried out with
primers for VIM-type genes, and we obtained a 676 bp band for
each of the strains.
Conclusions: The most active antibiotics in vitro against
P. aeruginosa with an MIC ‡ 4 to carbapenems are TO and
COL.AZ is active against 52.6% of the betalactams. The four
strains carrying VIM-like MBL were sensitive in vitro to
betalactams, and two of these had an MIC = 4 for IP and MER.
Carbapenemases are enzymes capable of hydrolyzing all the
betalactam antibiotics. Therefore,laboratory detection of these
enzymes is important, since it can predict therapeutic failure.
P424
Spread of OXA-58-producing carbapenem-
resistant Acinetobacter baumannii isolates in Iasi,
Romania
L. Poirel, R. Filip, G. Coman, P. Nordmann (Le Kremlin Bicetre, F;
Iasi, RO)
Purpose: To characterize the clonal relationship and the beta-
lactamase content of carbapenem-resistant Acinetobacter bauman-
nii isolates recovered in a Pediatric Hospital in Iasi, Romania.
Material and methods: Fifteen carbapenem-resistant Acineto-
bacter sp. isolates were recovered during the 1999–2003 period at
the St.-Maria Pediatric Hospital of Iasi. Species identiﬁcation
was done by the biochemical API32 GN test (bio-Me´rieux,
France) and by 16S rRNA sequencing. Sensitivity testing was
done by disk diffusion method and Minimum Inhibitory
Concentration (MICs) were determined by agar dilution. The
presence of oxacillinase or metallo beta-lactamase genes was
performed by PCR. In particular, genes coding for the carbape-
nem-hydrolyzing OXA-23, OXA-40 and OXA-58 subgroups
were searched. Genotyping was done by pulsed ﬁeld gel
electrophoresis (PFGE) after digestion by ApaI.
Results: All isolates but one were identiﬁed as A. baumannii. A
single isolate was A. junii. The majority of strains (n = 11),
including the A. junii strain, possessed the blaOXA-58 gene,
whereas three isolates were blaOXA-23 positive and one was
blaOXA-40 positive. Genotyping revealed that eight out of ten
OXA-58-positive A. baumannii isolates corresponded to a single
clone. The blaOXA-58 gene was plasmid-located in all cases.
Conclusion: As observed in other European countries, increas-
ing prevalence of carbapenem resistance in Acinetobacter sp. may
be explained by the presence of carbapenem-hydrolyzing
oxacillinases.
P425
Analysis of the genetic structures at the origin of
acquisition and expression of the blaOXA-58
carbapenem-hydrolysing oxacillinase gene of
Acinetobacter baumannii
L. Poirel, S. Marque´, C. He´ritier, P. Nordmann (Le Kremlin
Bicetre, F)
Objectives: Oxacillinase-mediated resistance to carbapenems in
Acinetobacter baumannii is increasingly reported worldwide.
Three clusters of carbapenem-hydrolyzing Ambler class D
beta-lactamases (OXA-23, OXA-40 and OXA-58) are known in
that species. The blaOXA-23 gene was plasmid-located in
several isolates and associated to the ISAba1 insertion sequence
(IS). The blaOXA-40 gene was chromosomally-located in differ-
ent clones and not associated to integron or transposon
structures. The aim of this work was to characterize the genetic
structure surrounding the blaOXA-58 gene and involved in its
expression.
Methods: A. baumannii MAD strain isolated in Toulouse,
France, was used as OXA-58-positive reference strain. Cloning
and PCR experiments were performed to identify the upstream-
and downstream-located regions of blaOXA-58 gene in isolates
from different geographical origins. Primer extension experi-
ments identiﬁed the promoter sequences responsible for its
expression in several genetic structures.
Results: The blaOXA-58 gene was located on a 30-kb plasmid in
A. baumannii MAD. An ISAba3 element was identiﬁed down-
stream of blaOXA-58 and an isoform of ISAba3 was present
upstream of it. ISAba2 (weakly related) was inserted in the
upstream-located ISAba3 sequence. This structure was con-
served in blaOXA-58-positive isolates from various European
origins even if ISAba2 was not always detected. This genetic
structure was bracketed by two 27-bp long repeated sequences
that were likely the signature of an illegitimate recombination
event at the origin of the blaOXA-58 gene acquisition. This
hypothesis was reinforced by the analysis of a plasmid present
in a clonally-related but carbapenem-susceptible A. baumannii
isolate recovered in the environment from the same hospital in
Toulouse. In that isolate, the ISAba2/ISAba3/blaOXA-58-con-
taining structure was lost and only one out of the two 27 bp
sequences was conserved.The sequences involved in the
blaOXA-58 expression were made of a -35 promoter region
located in ISAba2 and a -10 promoter region located in ISAba3,
thus constituting an hybrid promoter. Analysis of several
isolates in which ISAba2 was absent revealed that ISAba3 may
provide both )35 and )10 promoter sequences.
Conclusion: This works described novel structures at the origin
of acquisition of a carbapenem-hydrolyzing beta-lactamase
identiﬁed in A. baumannii isolates from several European
countries.
P426
Occurrence of carbapenem-resistant Bacteroides
fragilis strains in Sweden during a relatively long
period (1990–2004) and analysis of the resistance
mechanisms
J. So´ki, M. Hedberg, H. Fang, S. Lo¨fmark, E. Nagy,
C.E. Nord (Szeged, HUN; Stockholm, S)
Objectives: The aim was to study the resistance mechanisms of
identiﬁed carbapenem-resistant B. fragilis isolates from different
Swedish hospitals and the trend in their appearance frequency
was also followed.
Methods: Agar dilution and Etests were applied for antimicro-
bial susceptibility measurements; PCR was used to detect the
cﬁA genes and activating insertion sequence (IS) elements, and
ﬁnally the IS elements were sequenced.
Results: The investigated strains were isolated during the
period from 1990 to 2004. Eight B. fragilis strains were studied,
all of which had previously been identiﬁed as imipenem-
resistant at various Swedish hospitals. Six of these isolates
originated from clinical samples and the remaining two were
from diarrhoeal faeces. The occurrence of these strains could be
regarded as sporadic as no signiﬁcant increase was observed
during time. All were cﬁA-positive and the insertion of IS1186
(three strains), IS614B (two), IS1187 (one) and IS942 (one)
elements were detected in the upstream regions of the resistance
genes. In one isolate, B. fragilis 1619, the upstream region was
altered in such a way that no IS element could be found by the
method employed in the present study. The three IS1186-
bearing strains also carried IS4351 in the genome and were nimB
gene-positive. The insertion sequence IS1186 was inserted at
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different positions in the conserved upstream region of the cﬁA
genes. Such a conﬁguration or coincidence of these genetic
elements implies a common origin. IS elements similar to those
that activated the cﬁA genes in the present study have been
detected in B. fragilis isolates from the USA and the UK.
Conclusion: The presence of IS elements upstream of cﬁA
might activate the expression of carbapenem resistance. How-
ever, further investigations are needed to elucidate the resist-
ance mechanisms in B. fragilis. For some carbapenem-resistant
isolates, a prevailing and prevalent pre-carbapenem-resistant
strain is probably the predecessor for such strains, before IS
insertion occurs.
P427
Novel class A carbapenemase, KPC-4, in an
Enterobacter isolate from Scotland
M.-F.I. Palepou, N. Woodford, R. Hope, M. Colman, J. Glover,
M.E. Kaufmann, C. Lafong, R. Reynolds, D.M.
Livermore (London, Fife, Bristol, UK)
Objectives: The BSAC Bacteraemia Resistance Surveillance
Programme began in 2001. It aims to allow long-term monitor-
ing of resistance trends and the emergence of new resistance
mechanisms. A carbapenem-resistant isolate of Enterobacter sp.
(E624) was identiﬁed in 2003. Two further Enterobacter isolates
from the same patient varied in their degrees of carbapenem
susceptibility. We sought to determine their mechanism(s) of
carbapenem resistance.
Methods: Isolates were typed by PFGE of XbaI-digested
genomic DNA and analysed with BioNumerics software. MICs
were determined and interpreted using to BSAC guidelines.
Isolates were screened by PCR for genes encoding known
carbapenemases; amplicons were sequenced using dye-termi-
nator chemistry. Imipenem (IPM) hydrolysis was investigated
by spectrophotometry. Iso-electric focusing (IEF) was performed
to visualise beta-lactamases. Outer membrane proﬁles were
examined by SDS-PAGE analysis.
Results: The three Enterobacter isolates were highly-related by
PFGE and represented a single strain. Despite this, one isolate
was susceptible to carbapenems (MICs of ertapenem [ETP], IPM
and meropenem [MEM] 2 mg/L, 0.5 mg/L and 0.25 mg/L,
respectively), whereas E624 was highly-resistant (MICs >16
mg/L). Carbapenemase activity was detected in these 2 isolates
by spectrophotometry, and a blaKPC allele was identiﬁed. This
allele encoded a novel KPC variant, designated KPC-4 (GenBank
AY700571), with 3 amino acid substitutions, Pro(103)Arg,
Ser(174)Gly, and Val(239)Gly, in comparison with KPC-1. Two
beta-lactamases were apparent by IEF, and were consistent with
KPC and an AmpC enzyme. The third isolate was resistant to
ETP (MIC > 16 mg/L), but less so to MEM (MIC 8 mg/L) and
IPM (MIC 4 mg/L); it lacked a blaKPC allele, carbapenemase
activity was not detected by spectrophotometry, and its
susceptibility to carbapenems was restored in the presence of
100 mg/L cloxacillin. The two carbapenem-resistant isolates
lacked a major outer membrane protein (OMP) present in the
susceptible isolate.
Conclusions: Enterobacter E624 produced a novel carbapene-
mase, KPC-4. To our knowledge this is the ﬁrst KPC enzyme
detected outside of the United States. Production of KPC-4 alone
did not confer high-level resistance to IPM, MEM and ETP;
rather resistance needed concomitant OMP loss. In the absence
of KPC-4, high-level resistance to ETP and moderate levels of
resistance to IPM and MEM was associated with a combination
of AmpC activity plus OMP loss.
Epidemiology of ESBL and MBL – I
P428
Enterobacter aerogenes and extended-spectrum
beta-lactamases: prevalence and development of a
routine ESBL testing protocol in a Belgian
hospital
A. Brouwers, G. Huysmans, C. Bonroy, A. Boel, W. De Brauw,
H. De Beenhouwer (Aalst, B)
Objectives: Extended-spectrum beta-lactamase (ESBL) produ-
cing strains of Enterobacteriaceae other than E. coli and Klebsiella
spp. are a cause of increasing concern in Belgium. No NCCLS
guidelines are available for ESBL detection in these species. The
presence of membrane permeability alterations, high-level
AmpC beta-lactamases and other beta-lactamases, often in
combination, makes testing of beta-lactam antibiotics a compli-
cated matter. Aim of our study was to establish the prevalence
of ESBL producing strains of Enterobacter aerogenes in our
hospital and to develop an optimal routine ESBL testing
protocol.
Methods: A total of 97 nonrepetitive isolates of Enterobacter
aerogenes were obtained from clinical specimens between
November 2003 and July 2004. Identiﬁcation and antimicrobial
susceptibility testing were performed by Phoenix (BD). All
strains were tested for ESBL production using a modiﬁed
double-disk synergy test (MDDST) with three 3rd generation
cefalosporines, aztreonam and cefepime.
Results: Of the 97 isolates, 67 (=69%) were ﬂagged for ESBL by
BDXpert. Only 26 of them could be conﬁrmed as ESBL producer
by MDDST. In the subgroup without BDXpert ﬂagging (n = 30),
11 strains were also ESBL positive. In order to develop a reliable,
cost-effective screening protocol, MIC values of cefotaxime,
ceftazidime, aztreonam, cefepime, ciproﬂoxacin, co-trimoxazol
and amikacin/gentamicin ratio were compared between ESBL
positive and negative group.None of the isolates with a MIC for
cefotaxime, ceftazidime and aztreonam £2 (group A, n = 12)
harboured an ESBL. Isolates with a MIC for cefotaxime,
ceftazidime or aztreonam >2 and cefepime >2 (group B1,
n = 26), were all ESBL positive except four. In the subgroup
with a MIC for cefepime £2 (group B2, n = 59), 44 strains were
ESBL negative and 15 positive. The following protocol was
worked out: group A = ESBL negative, group B1 = ESBL pos-
itive and group B2 = ESBL conﬁrmation with MDDST. After
application of this protocol, 59 strains (61%) remained to be
tested.
Conclusion: EBSL ﬂagging by BDXpert proved to be not very
sensitive nor speciﬁc for Enterobacter aerogenes. By developing a
screening protocol, the number strains requiring conﬁrmation
for ESBL could be safely reduced.
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P429
Community-associated emergence of CTX-M and
TEM extended spectrum beta-lactamase (ESBL)-
producing Escherichia coli in Belgium
H. Rodriguez-Villalobos, S. Cuvelier, I. Dom, J. Frankard,
V. Malaviolle, A. Deplano, C. Nonhoff, R. De Mendonc¸a, B. Byl,
M.J. Struelens (Brussels, B)
Objectives: Recent reports indicate that CTX-M-producing
Enterobacteriaceae are emerging in Europe and threaten current
treatment strategies. We study the molecular epidemiology of
ESBL-producing E. coli (ESBL-EC) over the last 4 years in a
University hospital in Brussels, Belgium.
Methods: In 2000–2003, 10,281 E. coli clinical isolates were
tested by disk diffusion and screened for ESBL production by
double-disk synergy test. ESBL were characterized by Iso-
electric focusing, multiplex PCR for bla genes of the SHV, TEM
and CTX-M family and DNA sequencing. ESBL-EC strains were
tested for MIC of 12 antimicrobials by agar dilution, genotyped
by pulsed-ﬁeld gel electrophoresis (PFGE) and screened for class
I and II integrase by PCR.
Results: The proportion of ESBL-EC increased from 21(0.92%)
in 2000, 33 (1.25%) in 2001, 48 (1.85%) in 2002 to 64 (2.34%) in
2003 (p < 0.001). Strains were isolated from 79 male and 86
female with a mean age of 63 years (0–94). Cases were
community-associated (i.e. <48 hours after admission) in 41%,
of whom 11% had previous contact with our institution. ESBL-
EC isolates harboured CTX-M+TEM (35%), TEM alone (44%),
CTX-M alone (6%), CTX-M+SHV (2%) or other ESBL combina-
tion (10%). DNA sequencing revealed CTX-M1 or CTX-M2.
Class I integrase was detected in 71% of strains. Isolates
included screening isolates from rectal swabs (37%), clinical
isolates from urinary tract (38%), respiratory tract (10%), blood
(2%) or other sites (13%). Nosocomial isolates (59%) originated
from all hospital wards. PFGE typing showed polyclonality with
a majority of sporadic cases with unique genotypes and a few
clusters of 2 to 6 patients sharing the same genotype without
direct contact during hospital stay. ESBL-EC showed high
frequency of co-resistance to ciproﬂoxacin (61%), cotrimoxazole
(62%), gentamicin (37%) and tobramycin (55%). Only merope-
nem and amikacin remained active on >95% of these isolates.
Strains harbouring CTX-M enzymes showed signiﬁcantly higher
MICs to ceftriaxone, cefepime, amikacin and tobramicin, com-
pared to those with other enzymes.
Conclusion: Although not previously reported in Belgium,
multiresistant CTX-M and/or TEM ESBL-EC were detected
with increasing frequency at this tertiary care centre. ESBL-EC
appeared present on admission in a third of cases and was
typically associated with urinary tract infection in elderly
patients. Further analysis of clinical presentation and risk factors
for infections with ESBL-EC is needed.
P430
Dissemination of CTX-M-type beta-lactamases
among clinical isolates of E. coli from geriatric
long-term care and rehabilitation facilities in
northern Italy
R. Migliavacca, M. Balzaretti, M. Spalla, C. Terulla, E. Nucleo,
M. Quatela, D. Taccani, L. Pagani (Pavia, Milan, I)
Objectives: To investigate the presence of CTX-M type
enzymes in extended-spectrum beta-lactamases (ESBLs) produ-
cing E.coli isolates from patients at different geriatric long-term
care and rehabilitation facilities (LTCFs) in Northern Italy,
where CTX-M producers were ﬁrst detected in 2001.
Methods: 77 consecutive nonreplicate isolates of E. coli with an
ESBL-positive phenotype were obtained from inpatients at
different LCTFs in Northern Italy. ESBL production was
screened by VITEK system (BioMe´rieux) and was conﬁrmed
by double-disk synergy test between tazobactam and oxyimino
cephalosporins or aztreonam (ATM). Beta-lactamase production
was investigated by analytical isoelectric focusing (IEF) coupled
with a bioassay. The presence of beta-lactamase genes was
investigated by colony blot hybridization. PCR ampliﬁcation of
blaTEM, blaSHV, blaCTX-M alleles was carried out with
primers designed on highly conserved gene regions. Direct
sequencing of PCR products was carried out. Conjugation
experiments were performed in liquid medium. Pulsed-ﬁeld gel
electrophoresis (PFGE) proﬁles of genomic DNA digested with
NotI were analysed by using the Bio-Rad Gene Path procedure.
Results: During the period March 2003–May 2004 at the
Laboratory of Clinical Microbiology of ‘Redaelli’ LCTF in
Milan, Italy, a total of 529 samples positive for E.coli were
processed and 77 nonreplicate ESBL producers were identiﬁed
by Vitek System. 61/77 isolates were characterized by higher
levels of resistance to cefotaxime (CTX) than to ceftazidime
(CAZ). IEF revealed multiple beta-lactamase bands including
one enzyme with pI 8.4 that, in a bioassay, was more active on
CTX, ATM than on CAZ. 43 isolates produced both TEM-1 and
CTX-M-type enzymes, 14 strains expressed only CTX-M-type
beta-lactamase while in 4 cases were found blaCTX-M with
blaTEM and blaSHV genes.The remainders (n = 16), character-
ized by high levels of resistance to both CTX and CAZ,
produced TEM-1 and SHV-5 enzymes (n = 1) and TEM type
ESBLs (n = 15).All ESBLs producers retained susceptibility to
piperacillin-tazobactam. The ESBL determinants were transfer-
able by conjugation. Comparison of PFGE proﬁles of ESBL
producers revealed clonal heterogeneity.
Conclusions: Our work conﬁrms the emergence of CTX-M-type
enzymes and their spread in Northern Italy also in long-term
care and rehabilitation facilities that may be an important
reservoir of ESBL producing E.coli.
P431
Occurrence of metallo-beta-lactamase VIM-2 in
Pseudomonas aeruginosa clinical isolates resistant
to carbapenems in a hospital in central Portugal
A. Pena, J. Martins, A. Donato, R. Leita˜o, O. Cardoso
(Coimbra, P)
Objectives: The worldwide spread of acquired metallo-beta-
lactamases (MBLs) in Gram negative bacilli has become a great
concern. Based on amino acid sequence homology, these MBLs
have been classiﬁed into three major types: IMP, VIM and SPM
enzymes. The two ﬁrst subtypes have been identiﬁed in clinical
isolates of Pseudomonas aeruginosa (PA) in many parts of the
world, especially Asia and Europe, whereas SPM has been
reported only in Brazil.The aim of this study was to determine
the occurrence of these enzymes in Portuguese clinical isolates
of PA imipenem (IP) resistant.
Methods: Nonduplicate isolates of PA (n = 273) were collected
from hospitalized patients in Centro Hospitalar de Coimbra, a
central hospital from the Centre of Portugal during one year
(April 2003–April 2004). Bacterial identiﬁcation and susceptibil-
ity were performed by MicroScan WalkAway (Dadebehering)
system. In selected isolates, susceptibilities were also deter-
mined by disk diffusion method on Mueller–Hinton agar, and
susceptibilities to Piperacillin, Piperacillin plus Tazobactam,
Aztreonam (AZT), Ceftazidime (CAZ), IP, Meropenem (MP),
Amikacin, Tobramicin, Gentamicin, and Ciproﬂoxacin were
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guideline by NCCLS. Double-disk synergy test was used for
screening MBLs, and they were analysed by PCR for blaIMP,
blaVIM and blaSPM using primers speciﬁcs for IMP, VIM, and
SPM-1 enzymes, and DNA sequencing.
Results: Among the 273 nosocomial isolates, ﬁfty three were
resistant to IP (19.4%) and thirty two to MP (11.7%). These
isolates resistant to carbapenems were selected for this study.
Twenty eight carbapenem resistant were double disk synergy
test positive (52.8%). Among these, PCR experiments and DNA
sequencing revealed that the VIM-2 determinant was present in
seventeen strains, but none of them presented blaIMP or
blaSPM. The majority of these isolates were susceptible to
AZT (94.1%), resistance to CAZ was 35.3%, and the aminogly-
cosides and CIP presented the same resistance (52.9%).
Conclusions: The emergence of MBLs producing bacilli that are
resistant to carbapenems is becoming a severe therapeutic
problem. In general, they have a common multidrug-resistant
phenotype that not only included carbapenems, but also last
generation cephalosporins, aminoglycosides and ﬂuoroquinolo-
nes. Appropriate therapeutic protocols and a regular screening/
monitoring system should be established to prevent the wider
spread of this worrisome resistance determinant.
P432
Prevalence and characterisation of extended-
spectrum beta-lactamases produced in
Enterobacteriaceae isolated from patients
hospitalised in a Belgian hospital
Y. De Gheldre, C. Bauraing, C. Berhin, V. Avesani, M. Delme´e,
Y. Glupczynski (Yvoir, Woluwe´, B)
Objectives: To determine the prevalence and charcterize ESBLs
produced in Enterobacteriaceae isolated from patients hospital-
ized in our institution.
Methods: All Enterobacteriaceae strains were screened pro-
spectively between January 2003 and September 2004 for ESBL
production, on the basis of a positive double-disk synergy test or
positive ceftazidime and cefotaxime clavulanic combination
discs tests. Only one strain of each species was evaluated per
patient. Isoelectrofocusing (IEF) and PCR for blaTEM, blaSHV
and blaCTX-M genes were used to conﬁrm ESBL-production.
When IEF and PCR indicated concordant results, ﬁnal identiﬁ-
cation of ESBLs was obtained by sequence analysis of PCR
products. Pulsed Field Gel Electrophoresis (PFGE) was used to
delineate clonal relationships between strains of the same
species recovered from different patients and showing identical
ESBL proﬁles.
Results: Among the 1737 Enterobacteriaceae isolated during the
study period, 80 (7%) were detected as ESBL-producers [Ente-
robacter aerogenes (n = 51), Escherichia coli (n = 16), Citrobacter
freundii (n = 5), Klebsiella pneumoniae (n = 4), Klebsiella oxytoca
(n = 2), Enterobacter cloacae, Proteus mirabilis (n = 1 each)].
E. aerogenes and E. coli represented 64% and 20% of ESBL-
producing strains, respectively. Thirty-nine Enterobacter aero-
genes strains which had been previously characterized as TEM-
24 producers during a national surveillance study performed in
2003 were not analysed. IEF and PCR conﬁrmed the presence of
ESBLs in 37 (90%) of the remaining 41 strains, which were
identiﬁed based on their pI as TEM-24 (n = 21), TEM-3 (n = 5),
CTX-M-9 group (n = 4), TEM-4 (n = 3), SHV-4, CTX-M-1 and
CTX-M-2 groups (n = 2 each), TEM-12 and TEM-21 (n = 1 each).
PCR-sequencing analysis is ongoing and already conﬁrmed
CTX-M-15, -2 and -9 ESBLs. Four strains produced more than
one ESBL. PFGE analysis revealed the dissemination of 2
K. oxytoca, K. pneumoniae and E. cloacae strains between 5
patients and the absence of any clonal relationship between
strains of other species.
Conclusions: This study illustrates the diversity of type of
ESBLs produced by a wide range of species among Enterobac-
teriaceae in our institution, including the emergence of CTX-M
group beta-lactamases and the rising proportion of ESBL-
producing E. coli strains. The large clonal variability between
the majority of strains was also delineated.
P433
The early phase epidemiology of CTX-M type
extended spectrum beta lactamase-producing
Escherichia coli among hospitalised patients in
Belfast
R. McMullan, A. Loughrey, M. McCalmont, P. Rooney
(Belfast, UK)
Objective: To describe the demographics, prevalence of risk
factors and outcomes among the ﬁrst adult hospitalised patients
who had colonisation or infection and with ESBL-producing
E. coli in a university hospital in Belfast.
Methods: Retrospective casenote review of patients who were
culture-positive between 1st January 2004 and 31st May 2004.
Results: Of 53 patients identiﬁed, 45 casenotes were available
for review. The mean age was 73.1 (+14.6) years and 67% of
patients were female. Most (56%) patients were in a medicine or
elderly care unit at the time of the positive culture. The most
frequently recorded comorbidity was haemodialysis-depend-
ence. Many (51%) patients had an indwelling urinary catheter
and prior to isolation of the ESBL-producing E. coli, 24.4% of
patients had a positive culture for MRSA.The majority (57.8%) of
patients had an isolate from urine only; 17.8% had positive
blood cultures. The organism had been acquired in hospital in
69% of instances; of these, the mean duration of inpatient stay
prior to onset of infection was 45.2 (+52.9) days. Overall, 81% of
evaluable patients had received antibiotic therapy within
30 days prior to the ﬁrst isolate; the mean number of antibi-
otic-days per patient in this time was 13.9 (range 0–48). The most
frequently consumed class of antibiotic was b-lactam/b-lacta-
mase inhibitor combinations.Of the 45 episodes, 35 (77.8%) were
associated with clinically determined infections; of these, 74.2%
were successfully treated. Overall, the crude 30-day mortality
among patients with such infection was 34.3%; the attributable
mortality was estimated at 20%. Among patients with bacterae-
mia, the attributable mortality was 25%.
P434
Extended spectrum beta-lactamase production of
enteroaggregative Escherichia coli strains isolated
in the United Arab Emirates
T. Pa´l, A´. Sonnevend, K. Al-Dhaheri, M. Herpay, N. Nowotny,
A. Usmani (Al Ain, UAE; Budapest, HUN)
Objectives: Extended spectrum beta-lactamase (ESBL) produc-
tion was investigated among enteroaggregative Escherichia coli
(EAEC) strains isolated in the United Arab Emirates.
Methods: Thirty six strains randomly selected from isolates
identiﬁed as EAEC by a pCVD432 speciﬁc PCR in diarrhoeal
stool samples of children (24 isolates), and those of adults (12
strains) were studied. The isolates were serotyped and their
antibiotic sensitivity was tested by disc diffusion. Strains non-
susceptible to ceftazidime and/or ceftriaxone were selected for
MIC determination of ceftriaxone, ceftazidime, cefotaxime,
cefepime and aztreonam by E-test. ESBL-production was
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proven by ceftazidime and cefotaxime E-test with and without
clavulanic acid. The type of beta-lactamase gene present was
tested with TEM-, CTX-M-, and SHV-speciﬁc PCRs. The cefo-
taxim resistant phenotype was transferred to E. coli J53 by
conjugation. The similarity between ESBL producing strains was
determined by pulsed ﬁeld gel electrophoresis (PFGE) following
XbaI digestion of the genomic DNA.
Results: Of the 36 isolates tested 5 exhibited non-susceptibility
to 3rd generation cephalosporins and were shown to produce
ESBL, indeed by having an over 8 times higher MIC value
against ceftazidime and cefotaxime without, than with clavul-
anic acid. From one isolate the resistance to cefotaxime was
successfully transferred by conjugation to E. coli J53. In all the
ﬁve wild type isolates, as well as in the transconjugant the MIC
of cefotaxime and ceftriaxone exceeded that of ceftazidime. All
the ﬁve isolates and the transconjugant gave a positive PCR
reaction with the CTX-M -, as well as with the TEM -speciﬁc
primers. Beyond beta-lactams, all the 5 isolates were non-
susceptible to chloramphenicol, 4 to tetracycline, trimethoprim-
sulphamethoxasole, and nalidixic acid, 2 to ciproﬂoxacin and
one to gentamicin, respectively. The conjugal transfer of cefo-
taxime resistance was not accompanied by the co-transfer of
resistance to any other antibiotics tested but the beta-lactams.
Two of the 5 ESBL producing strains exhibited the same
serotype (O153:HNT), while the others were ONT:H21,
O90:HNT, O25:H4. Macrorestriction analysis by PFGE revealed
that the similarity coefﬁcient never exceeded 75% when com-
paring the isolates.
Conclusion: Multiresistant EAEC producing plasmid coded
ESBL, most likely cefotaximase, are common among strains
isolated in the Middle East.
P435
Diverse extended spectrum beta-lactamases in
minor serotypes of foodborne Salmonella enterica
subsp. enterica from Greece
L. Politi, P.T. Tassios, M. Lambiri, A. Kansouzidou, M. Pasiotou,
A.C. Vatopoulos, N.J. Legakis, L.S. Tzouvelekis (Athens,
Thessaloniki, Halkida, GR)
Objectives: Sporadic foodborne salmonellae with extended-
spectrum beta-lactamases (ESBLs), causing resistance to ‘third
generation’ cephalosporins, were ﬁrst isolated in Greece from
human isolates in 1998–99. The present study aimed to examine
the extent of the phenomenon amongst both human and animal
isolates during 2000–02, and investigate the plasmid vectors as
well as the chromosomal background of the isolates harbouring
ESBL-encoding genes.
Methods: The antimicrobial susceptibility of 727 (23% of the
total 3142) randomly selected human isolates from 2000–02 and
94 (8% of the total 1148) food, animal, and animal feed isolates
from 2000–01 was assessed by disk diffusion and interpreted
according to NCLLS recommendations. Chromosomal ﬁnger-
prints of representative isolates were obtained by pulsed ﬁeld
gel electrophoresis (PFGE) after XbaI digestion of genomic DNA
and compared using the GelCompar software; patterns differing
by up to four DNA fragments were assigned to (subtypes of) the
same type. Plasmid transfer was tested by conjugation. ESBLs
were characterised by isoelectric focusing, and the correspond-
ing genes identiﬁed by PCR and nucleotide sequencing.
Results: Three ESBL-producing non-typhoid salmonella strains
of serotypes Brandenburg, Blockley, and Hadar were isolated
from humans in Greece during 2000–2002. Salmonella Branden-
burg harboured an SHV-5-encoding plasmid similar to those
found in nosocomial enterobacteria. S. Blockley and S. Hadar both
produced TEM-52 encoded by an identical plasmid. An addi-
tional S. Virchow strain producing a plasmid-mediated CTX-M-
32 was isolated from two chicken meat isolates from a
production unit. All ESBL-encoding plasmids were multidrug-
resistant and self-transferable. With the exception of Blockley,
PFGE typing showed that these ESBL genes had been acquired
by Salmonella enterica clones currently common in Greece.
Conclusions: While still sporadic, ESBL enzymes are neverthe-
less found amongst foodborne salmonellae from both humans
and animals in Greece. The identity of responsible genes and
plasmids highlights the intricate interplay between gene ‘abduc-
tion’ from the environment (for example, by food animals), gene
incorporation into multidrug-resistant ‘nosocomial’ plasmids,
and transmission via dominant bacterial clones.
P436
Evaluation of antibiotic containing agars for
screening patients for ESBL carriage in an ITU
unit of a Scottish hospital
D. McCabe, G. Wilson (Stirling, UK)
Objectives: The detection of ESBL producing organisms is
important because conventional antimicrobial susceptibility
testing can often miss them. This is important in ITU units
where it is essential that patients receive the correct antimicro-
bial regime. This study evaluated the use of two screening agars
to facilitate the detection of ESBL producing organisms in the
ITU unit of our hospital.
Methods: The antibiotics Cefotaxime (CTX) and Ceftazidine
(CAZ) were separately added to MacConkey agar (Oxoid,
England) at concentrations of 0.5 and 1.0 mg/l. A total of 39
known positive ESBL producers and 50 known negative organ-
isms were used as positive and negative controls. Over a
6-month period 630 patient samples were tested. The samples
consisted of 200 groin swabs, 192 urines, 122 endotracheal
aspirates, 106 wound swabs and 10 faeces. These were tested
against the different concentrations of CTX and CAZ along with
a MacConkey containing no antibiotics to act as a control plate.
Any growth was identiﬁed and antimicrobial sensitivities were
carried out using the Vitek 2 automated system (bioMerieux,
France). The detection of ESBL production was carried out by
double disc synergy (DDS) and both CTX and CAZ combination
disc methods (Oxoid, England). AMP C production was also
looked for by Cefoxitin/CTX disc antagonism and the modiﬁed
Hodge test.
Results: Negative controls did not grow on the screening agars.
For the positive controls 100% were conﬁrmed by DDS and 72%
by combination disc methods. A total of 14 ESBLs were detected
from the clinical samples with 12 conﬁrmed by DDS and 14 by
CAZ combination discs, 2 were negative with CTX combination
discs. There was no difference between the two antibiotics or the
two concentrations tested. The screening agars had a sensitivity
of 100% (CI 78.5–100) and a speciﬁcity of 82.8% (CI 79.6–85.6) for
the isolation of ESBL producers. 50% of the clinical ESBLs were
isolated from groin swabs. In addition 3 AMP C isolates were
detected by the modiﬁed Hodge test but only two by Cefoxitin/
CTX disc antagonism.
Conclusions: In order to detect ESBL producing organisms the
combined use of CTX and CAZ screening agars are suggested.
This would also allow the detection of CTX-M enzyme produc-
ers. MRSA screens are a natural regime in ICUs and usually
include a groin swab, which could easily be used with the 2
ESBL screening plates. This could form an adjunct to hospital
infection control measures.
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P437
Impact of extended-spectrum beta-lactamases
produced by Gram-negative bacteria on efﬁcacy
of cephalosporins and quinolones
S. Yakovlev, O. Romashov, S.V. Sidorenko,
L. Eryomina (Moscow, RUS)
Objective: Assessment of efﬁcacy of 3rd and 4th generation
cephalosporins and quinolones in nosocomial pneumonia
caused by gram-negative bacteria resistant to multiple antibiot-
ics depending on their capacity to produce extended-spectrum
beta-lactamases (ESBL).
Methods: We studied the cases of nosocomial pneumonia
caused by gram-negative micro-organisms at an emergency
hospital. The patients included in the study were on 3rd or 4th
generation cephalosporins or quinolones therapy as a initial
empiric therapy for nosocomial pneumonia. The strains which
supposedly produced ESBL were tested for ESBL production in
compliance of NCCLS criteria. To identify the type of ESBL, PCR
and sequencing techniques were used.
Results: During the period of 2001–2003, sixty-two cases of
nosocomial pneumonia were diag-nosed, resulting from infec-
tion with Enterobacteriaceae strains or non-fermenting micro-
organisms suspicious of producing ESBL. As the initial
monotherapy, 25 patients were taking cefepime, 13 individuals
– 3rd generation cephalosporins, while 20 patients were on
quinolones. The etiologic factors of pneumonia were Klebsiella
spp. (22 strains), E.coli (14), P. aeruginosa (15), Acinetobacter spp.
(11). The ESBL-producing capacity has been conﬁrmed in
twenty-ﬁve Enterobacteriaceae strains by eighteen Klebsiella
spp. strains and seven E. coli strains that produced ESBL. In
contrast, none of non-fermenting microorganisms demonstrated
the capacity to produce ESBL. The testing of strains that
produced ESBL helped ﬁnd the prevalence of ESBL types as
follows (totally 30 types): TEM-3, SHV-15, CTX-UNI-6, CTX-A-3,
CTX-C-3. The clinical efﬁcacy of the antibiotics under investi-
gation against the microorganisms, both with and without the
ESBL-producing capacity, is shown in the Figure. The eradica-
tion rate of ESBL-producers was twice as higher in patients who
were on cefepime as compared with those in patients taking 3rd
generation cephalosporins or quinolones, 88.4 and 43.0%,
respectively.
Conclusions: The efﬁcacy of cefepime in nosocomial pneu-
monia is high and does not depend on the microorganism’s
ESBL-producing capacity. The effectiveness of 3rd generation
cephalosporins proved satisfactory in case of lack of the bacterial
ESBL-producing capacity, but it tended to be 1.5-fold lower if it
was due to a ESBL-producer. The same was true in individuals
on quinolones. Thus, the empiric therapy of nosocomial pneu-
monia was the most effective with cefepime.
P438
Prevalence of extend-spectrum beta-lactamase
producing enterobacteria in different samples of
patients hospitalised in a Serbian clinical centre
S. Jovanovic, V. Mioljevic, B. Jovanovic, N. Mazic, J. Obrenovic,
M. Prica, Z. Stojanovic-Varagic (Belgrade, CS)
Objective: It has been observed that Enterobacteriaceae produ-
cing ESBL are becoming increasingly widespread as the result of
use of cefalosorins. ESBL producers provide a therapeutic
chelange. The objective of the study was to establish the
prevalence as well as in vitro sensitivity of ESBL-producing
Enterobacteriaceae isolated from different clinical samples to
antimicrobial drugs.
Methods: In the period January–June 2004, 1974 strains of gram
negative bacilles were isolated from different clinical samples
(wound swabs, blood cultures, urine, liquor) obtained from
patients hospitalized in several CCS institutes. Identiﬁcation and
sensitivity to antibiotics were carried out by standard microbio-
logical methods (Kirby–Bauer disc-diffusion). ESBL positive
strains were detected by double disc synergy test by Jarlier and
all.
Results: During the observation period, 1026 strains of entero-
bacteria (51.9%) and 948 (48.1%) of non-fermentative bacilles
were isolated. A total of 428 ESBL positive strains (21.6%) were
detected, out of which: E. coli – 98 (22.9%), Klebsiella spp. – 90
(21%), Enterobacter spp. – 78 (18.2%), Proteus mirabilis – 88
(20.6%), Serratia spp. – 53 (12.4%), Rettgerela rettgeri – 7 (1.6%),
Proteus vulgaris - 3 (0.7%), Citrobacter freundii – 2 (0.5%), as well
as 9 (2.1%) strains of non-fermentative ESBL positive bacilles.
These strains were isolated from wounds – soft tissues (77.8%),
urine (17.2%), blood cultures (2.6%), liquor (0.2%) and respir-
atory tract (2.2%). All tested ESBL positive strains of enterobac-
teria were sensitive to meropenem, while 0.7% of strains were
resistant to imipenem (3 strains of Serratia spp.). Co-resistance of
isolated ESBL positive strains to aminoglycosides and ﬂuoro-
quinolones was frequent (89% of them were resistant to
gentamicin, 58% to amikacin and 56.8% to ciproﬂoxacin).
Conclusion: All strains were sensitive to meropenem and
exhibited varying degree of resistance to aminoglycosides and
ﬂuoroquinolones. High percentage of ESBL-producing strains of
enterobacteria suggests the need of introduction of ESBL
screening on regular basis. Further studies related to typing
and epidemiology of ESBL strains are necessary.
P439
Epidemiology and infection control of ESBL-
producing Klebsiella pneumoniae strains caused 5
outbreaks in a Hungarian neonatal intensive care
unit during the years 2001–2004
I. Damjanova, Z. Ozsva´r, A´. To´th, I. Csana´dine´ dr. Petro´,
L. Szikra, J. Pa´szti, G. Simon (Budapest, Sze´kesfehe´rva´r, HUN)
Objectives: The aim of this study was to perform a prospective
survey on prevalence and epidemiological relatedness among
ESBL KP strains isolated in a Hungarian NICU during a four-
year period.
Methods: All patients admitted to NICU during the four-year
period were screened for colonisation with ESBL-producing
K. pneumoniae. Conﬁrmation of ESBL production was done by
Etest, double-disc diffusion and agar dilution methods accord-
ing to NCCLS. We performed PCR analysis for beta-lactamase
detection using speciﬁc primers, phage typing, resistance
transfer, plasmid proﬁle analysis and plasmid REA, genomic
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ﬁngerprinting by ERIC-PCR and PFGE to determine the genetic
relatedness of strains.
Results: Among 210 K. pneumoniae isolates recovered from
NICU between 2001–2004, 119 were ESBL-producers, but none
of these were isolated in 2004. 107 ESBL isolates were recovered
from ﬁve outbreak periods. The outbreak strains showed
multidrug-resistance with similar antibiotypes. 87 of 107 isolates
belonged to six different phage types, but 20 were non typable.
PFGE analysis revealed six different genetic clones at 90%
similarity level. All isolates harboured plasmids ranging from
2,6 to 203 kb: 14 different plasmid proﬁles were identiﬁed. The
same plasmid of 94 kb was obtained from the transconjugants of
six outbreak clones by plasmid restriction analysis. The
sequence analysis of the SHV PCR products showed that SHV-
5 was presented in all outbreak clones and their transconjugants.
Conclusions: This prospective study conﬁrms that the same
ESBL coding plasmid persisted from 2001–2003 in this hospital
ward, while six different outbreak clones were revealed during
the given period. After the change of the antibiotic treatment
regiment at the beginning of 2004 there were no more ESBL-
producers isolated.
P440
A nosocomial outbreak of CTX-M-15 producing
E. coli in Norway
B. Haldorsen, O. Nata˚s, H. Grundt, B. Bue, U. Naseer,
T.R. Walsh, A. Sundsfjord (Tromsø, Stavanger, N; Bristol, UK)
Objective: The ﬁrst nosocomial outbreak of ESBL-producing
E. coli in Norway involving 8 elderly patients is described.
Material and methods: Four ESBL-producing E. coli strains
were isolated from different patients at the Department of
Pulmonary Medicine, Regional Hospital of Rogaland august
2004. Additional 4 urinary tract E. coli isolates with an ESBL
production phenotype were detected during the following
month from out-patients that had been hospitalised in the
same department in august 2004. The patients were between 66
and 93 years; 6 men and 2 women. The 8 isolates were recovered
from urine samples (N = 5), blood, sputum, lung and kidney
tissue at autopsy. Antimicrobial susceptibilities were tested by
Etest and agar disk diffusion and interpretation was according
to the Norwegian Working Group for Antibiotics. Molecular
typing was performed by TEM-, SHV, CTX-M, and ISEcp1
PCRs, sequence analysis of PCR amplicons and XbaI-PFGE.
Results: All strains expressed a typical ESBL-cefotaximase
proﬁle (cefotaxime MIC > ceftazidime MIC) and clavulanic
acid synergy. Seven strains displayed high-level resistance
towards all penicillins and cephalosporines, while one strain
were susceptible to ceftazidime. Multiple resistances to other
antimicrobial agents including gentamicin, nitrofurantoin, trim-
ethoprim-sulfamethoxazole, ciproﬂoxacin and piperacillin-tazo-
bactam were detected. All strains were susceptible to
carbapenems. Molecular characterization revealed a CTX-M-15
in 6 strains, CTX-M-3 in one strain, and one strain to be
analysed. The six CTX-M-15 strains had indistinguishable XbaI-
PFGE patterns and positive ISEcp1-element PCRs consistent
with a clonal relationship. Three of the patients died during this
period and the potential impact of the actual infection is
currently being assessed. Infection control measurements were
implemented and additional ESBL-producing E. coli has not
been recovered. Preliminary environmental samples and addi-
tional investigations have not discerned any apparent source for
this outbreak
Conclusions: (i) The outbreak illustrates the epidemic potential
of this particular multiple-antibiotic resistant CTX-M-15 produ-
cing E. coli strain also in a country with a low prevalence of
antimicrobial resistance. (ii) The clonal relationship to epidemic
CTX-M-15 producing E. coli strains in other countries has to be
investigated to identify potential common reservoirs and lines of
resistance transmission as a basis for intervention.
P441
Escherichia coli and Klebsiella pneumoniae
clinical isolates from intensive care unit bearing
CTX-M-15 extended-spectrum beta-lactamase
A. Mazzariol, G. Lo Cascio, R. Fontana, G. Cornaglia (Verona, I)
Objectives: Five strains of Escherichia coli and one of Klebsiella
pneumoniae with a phenotype suggestive of an ESBL and more
resistant to cefotaxime than to ceftazidime were isolated from
bronchial aspirates of six different patients admitted to the
intensive care unit of the Verona University Hospital between 13
April and 15 July 2004. The strains were investigated for the
presence of CTX-M-type enzymes.
Methods: Antimicrobial susceptibility testing was performed
by both diffusion and microdilution and interpreted according
to the latest NCCLS documents. The presence of an ESBL was
preliminarily investigated by means of a double-disk synergy
test. Isoelectrofocusing (IEF), PCR and sequencing were carried
out according to standard procedures. Plasmid extraction was
performed by alkaline lysis. Conjugation was used to ascertain
whether the CTX-M enzyme was transferable.
Results: MICs were >128 mg/L for both aztreonam and cefo-
taxime and 64 mg/L for ceftazidime. The presence of an ESBL
was suggested by the synergies detected between clavulanic
acid and third-generation cephalosporins (3-GCs) in the disk-
diffusion assay. Spectrophotometric analysis of crude sonic
extracts conﬁrmed that 3-GCs were hydrolysed with fast
kinetics. IEF visualised two beta-lactamases in all E. coli strains
with isoelectric points (pI) of 7.4 and 8.9, respectively. The latter
value matched that previously reported for CTX-M-15. Two
bands (namely 7.6 and 8.9) were also visualised in the
K. pneumoniae strain. The 8.9 band of E.coli and both bands of
K.pneumoniae were inhibited by clavulanic acid.A polymerase
chain reaction (PCR) was performed using primers speciﬁc for
the bla(SHV), bla (TEM) and bla (CTX-M) genes. For the E. coli
strains we obtained PCR products of about 950 bp only with the
bla (CTX-M) primers, which - after sequencing - were found to
code for CTX-M-15. CTX-M-15 was indeed the only enzyme
transferred to E. coli J53 by conjugation. Besides amplifying for
CTX-M-15, the K.pneumoniae strain also ampliﬁed for an SHV
enzyme that – after sequencing – was found to be SHV-1. Only
CTX-M-15 was transferable by conjugation to E. coli J53.
Conclusions: is responsible for 3-GC-resistant Enterobacteria-
ceae outbreaks throughout Europe and also made its appearance
in Italy. The ﬁnding of CTX-M-15 in the ICU of the Verona
Hospital is a disquieting addition to this picture.
P442
Detection of extended-spectrum beta-lactamases,
including the CTX-M-type enzymes, in
Escherichia coli and Klebsiella pneumoniae using
VITEK 2 System and the Advanced Expert
System
G.J. Da Silva, L. Boaventura, C. Vital, A. Simo˜es, C. Oliveira,
O. Santos, C. Vieira, F. Cardoso, G. Ribeiro (Coimbra, P)
From November 2003 until February 2004, 42 isolates of
Escherichia coli and Klebsiella pneumoniae were recovered from
45 inpatients of different wards of the University Hospitals of
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Coimbra, Portugal, identiﬁed as extended-spectrum beta-lacta-
mases (ESBL) producers by the automatic VITEK 2 System and
the Advanced Expert System (VITEK 2 AES) (BioMe´rieux,
Marcy L’E´toile, France).
Objective: The main objective of this study was to investigate if
the VITEK 2 ASE could accurately detect ESBL in those species,
comparing the ﬁnal data report with the results of phenotypic
and genotypic based methods. A special approach was given to
the new emergent CTX-M-type ESBL.
Methods: The antibiotic susceptibilities were determined by
VITEK 2 and the susceptibility reports were edited after
interpretation by AES of the inferred resistance phenotype.
ESBL were also detected by Etest ESBL with Ceftazidime/
Ceftazidime + Clavulanic ac. and Cefotaxime/Cefotaxi-
me + Clavulanic ac. strips, according manufacturer’s instruc-
tions, and by using the double-disc diffusion method (DDM)
with amoxicillin/clavulunate, aztreonam, cefepime, CAZ and
CTX. PCR was used to screen for CTX-M-type enzymes with
speciﬁc primers in isolates resistant to CTX.
Results: VITEK 2 determined that: for CAZ, 35 isolates were
resistant, 5 were intermediate and 2 isolates were susceptible;
while for CTX, 23 isolates were resistant, 2 were classiﬁed as
intermediate and 17 isolates were susceptible. AES edited these
data as resistance phenotypes, suggesting the production of
ESBL. Using the Etest, 39 isolates produced ESBL. The results for
3 isolates were indeterminate, according the manufacturer’s
guidelines. However, two of them showed synergism by the
DDM suggestive of the presence of an ESBL. The other isolate
showed a band of ca550 bp with speciﬁc primers for CTX-
M-type enzyme, after PCR. CTX-M-type enzymes were detected
in 24 E. coli and 6 K. pneumoniae. It is noteworthy that VITEK 2
classiﬁed 6 K. pneumonia and 2 E. coli isolates as susceptible to
CTX, but AES interpreted as being resistant, which is in
accordance with the PCR results.
Conclusion: This study demonstrated the capacity of VITEK 2
AES to detected and interpreted resistance mechanisms, infer-
ring with good accuracy the production of ESBL in E. coli and
K. pneumoniae, and including the most recent emergent CTX-
M-enzymes, even when the VITEK 2 shows a susceptible MIC
for CTX.
P443
Outbreak of Klebsiella pneumoniae producing
SHV-12 and CMY-2 in NICU of a Korean tertiary
care hospital
K. Lee, D.-Y. Park, Y.S. Choi, D. Yong, S. Kim, H. Lee, J.H. Yum,
Y. Chong (Seoul, KOR)
Objectives: Extended-spectrum beta-lactamases (ESBLs)-pro-
ducing Gram-negative bacilli are usually resistant to the 3rd
and 4th cephalosporins, but susceptible to cephamycins.
Recently, simultaneous ESBL- and plasmid-mediated AmpC
beta-lactamase (PABL)-producing strains, which were also
resistant to cefoxitin, were reported. We report the outbreak of
SHV-12- and CMY-2-producing K. pneumoniae in neurological
intensive care unit (NICU) patients.
Methods: K. pneumoniae were isolated from patients at a Korean
tertiary-care hospital between March to June, 2003. Detection for
ESBL-producing strains was performed using double disk
synergy test (DDST) with cefotaxime, ceftazidime, aztreonam,
cefepime and amoxicillin-clavulanic disk. The PABL genes were
detected by multiplex PCR designed by Perez–Perez and
Hanson. The transferability of resistance was tested by the
agar mating method using a sodium azide-resistant E. coli J53
recipient. The isoelectric points of beta-lactamases were
determined. Nucleotide sequencings were carried out by the
dideoxy-chain termination method with an automatic DNA
sequencer (ABI 3700, Perkin-Elmer, Foster City, Ca., USA). Xba
I-digested genomic DNA bands of the isolates were separated
by PFGE.
Results: Among the 114 ESBL-producing K. pneumoniae,
9 isolates showed indistinct results of DDST. However,
blaCMY-2 and blaSHV-12 alleles were detected simultaneously
by PCR. The resistance was transferred in all 9 strains. The pIs of
beta-lactamase were 5.4 and >8.0. The PFGE band patterns of
9 isolates were identical. All of them were isolated from patients,
who were admitted in NICU.
Conclusion: It is worrisome that the emergence and spread of
simultaneous ESBL- and PABL-producing K. pneumoniae iso-
lates. Further modiﬁcations of method to detect them would be
required, because of the false-negative results in DDST. More
effective infection control measures would be required to control
the spread of the resistant isolates.
P444
An outbreak of ESBL producing Klebsiella
pneumoniae in neonatal intensive care unit of a
university hospital: the long-term gut carriage
among infection-free patients
S. Gundes, A.E. Arisoy, F. Kolayli, E. Karaali, G. Turker,
A. Sanic, E.A. Arisoy, H. Vahaboglu (Kocaeli, TR)
Objectives: An outbreak of ESBL producing K. pneumoniae was
investigated.
Methods: An outbreak of ESBL producing Klebsiella was detec-
ted in a neonatal intensive care unit between 12th of September
and 6th of October. Surveillance was carried out by obtaining
twice a week of stool cultures from the neonates hospitalized in
the ICU up to 7 weeks after the ﬁrst case. The DNA relatedness
of the strains was investigated by ERIC-PCR patterns. ESBL was
detected by double-disk synergy test. Later the existence of
TEM, CTXM and SHV-type beta-lactamases were investigated
by PCR tests.
Results: During the ﬁrst 25 days period of the investigation,
ﬁve neonates were infected with an ESBL producing
K. pneumoniae. Among these two were died. The last isolate
from an infected patient was on the 6th of October. However,
during the following 22 days neonates those were hospitalized
in the same unit were continued to excrete an ESBL producing
K. pneumoniae by their stools. A total of 24 K. pneumonia have
been isolated from clinical materials and the stool samples of
ﬁve infected and ﬁve non-infected patients. ERIC-PCR con-
ﬁrmed the clonal relatedness of these strains. SHV 5 gene was
detected by PCR.
Conclusion: This study showed that outbreak strains may
continue to be excreted by the stool of non-infected neonates
even after the outbreak itself. This data reminds the signiﬁcance
of surveillance for resistant bacteria in stool samples in ICUs.
P445
Persistent import and transient nosocomial
establishment of ESBL-producing Klebsiella
pneumoniae causing bloodstream infection in a
neonatal intensive care unit
E. Lebessi, H. Dellagrammaticas, L.S. Tzouvelekis,
M. Foustoukou, N.J. Legakis, P.T. Tassios (Athens, GR)
Methods: We conducted a 6-year prospective study of bacte-
remic episodes from ESBL-KP in neonates hospitalized in NICU
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(30 beds) from Jan 1999 through Nov 2004, as part of a hospital
infection control programme. An epidemiological questionnaire
was completed for each patient with ESBL-KP bacteraemia.
Blood specimens were incubated in the automated system
BacT/Alert (bioMerieux), identiﬁcation of microorganisms was
performed by the API system, susceptibility to antimicrobials by
a disc-diffusion method and extended-spectrum b-lactamase
expression were detected according to NCCLS criteria. Molecu-
lar typing of isolates was performed using PFGE.
Results: A total of 17 episodes of ESBL-KP bacteraemia
occurred in 16 patients (male/female ratio:1). The distribution
of cases for the years 1999 through 2004 was: 0, 2, 3, 9, 3, 0,
respectively. Mean gestational age was 34 weeks (range: 25–40)
and mean birth weight was 2063 g (range: 600–4030). The
following risk factors were identiﬁed: total parenteral nutrition
94%, mechanical ventilation 69% and central venus catheter
37%. All babies had severe underlying disease. Seven out of 17
bacteremic episodes were due to ESBL-KP isolates which had
colonized the neonates during their stay in the referring
maternity hospitals (MH-1, MH-2), while the remaining ten
were NICU-acquired. Mean hospital stay before the bacteremic
episode was 40 days (range: 6–218) for NICU-acquired cases. All
cases were treated with imipenem. Two patients died of septic
shock, while in four, death was probably due to the underlying
disease. PFGE analysis revealed three clones: A from MH-I, B
from MH-II and C responsible for two NICU-acquired blood-
stream infections. Five NICU-acquired infections that occurred
from Sep 2001 to Dec 2002 were due to the imported clone A.
This clone has persisted in MH-I since 1997 (previous published
data). No case was referred from general or maternity hospitals
outside of Athens.
Conclusions: We detected sporadic cases as well as an outbreak
of ESBL-KP bacteraemia in our NICU. Most cases occurred in
neonates with severe underlying disease and risk factors.
Maternity hospitals MH-1 and MH-2 were the sources of two
ESBL-KP clones, one of which was transiently established as a
nosocomial pathogen in our NICU. Reinforcement of infection
control measures, especially handwashing stopped the out-
break. No case was detected during 2004.
P446
A new outbreak of VIM-1-producing
Pseudomonas aeruginosa in the same site as the
ﬁrst VIM description
A. Mazzariol, G. Bahar, R. Konkan, R. Fontana,
G. Cornaglia (Verona, I; Ankara, TR)
Objectives: Pseudomonas aeruginosa strain PSE VR143/97 was
responsible for an outbreak in the Verona University Hospital in
1997, this being the ﬁrst world occurrence of a VIM-type
enzyme. Between February 2003 and July 2004, 14 strains of
P. aeruginosa highly resistant to carbapenems, 12 from the ICU
and two from the hematology unit, were isolated from the same
hospital. All strains were investigated for their possible pro-
duction of metallo-beta-lactamase.
Methods: Antimicrobial susceptibility testing was performed
by both diffusion and microdilution and interpreted according
to the latest NCCLS documents. The presence of carbapenemase
was screened by means of the MBL-etest, and further investi-
gated spectrophotometrically by following the crude sonic
extract hydrolysis of imipenem and its inhibition by EDTA.
PCRs were performed with either bla(VIM) or bla(IMP) primers.
PFGE, isoelectrofocusing, and sequencing were carried out
according to standard procedures. The integron carrying the
bla gene was also studied by both PCR and sequencing.
Results: All strains proved resistant to all beta-lactams tested,
with the sole exception of aztreonam, as well as to ciproﬂoxacin,
gentamicin, amikacin, and tobramycin. The MBL-etest was
suggestive of an MBL in all cases. Imipenem hydrolysis
conﬁrmed that imipenem was hydrolysed at a rate of
1 · 10)8 mol/min/mg, whereas in the presence of EDTA
2 mM the kinetics was 1 · 10)9 mol/min/mg. The isoelectrofo-
cusing showed a band at 5.3, i.e. the same level as VIM-1 from
the index strain PSE VR143/97. PCRs performed with either
bla(VIM) or bla(IMP) primers yielded positive results only with
the bla(VIM) primers; a speciﬁc PCR performed with the
bla(VIM-1) primers yielded a product of about 800 bp which,
after sequencing, was found to code for VIM-1. The strains
showed PFGE patterns that were either identical or correlated to
one another but were different from the pattern of index strain
PSE VR143/97 which was responsible for the outbreak in 1997 in
the same hospital.
Conclusions: All strains carried a VIM-1 enzyme, and seemed
to be derived from the same clone. They sharply differed from
the index strain responsible for the 1997 outbreak. These results
enabled us to exclude the persistence of PSE VR143/97 in the
two wards of the Verona University Hospital, but showed that
the existing infection control procedures were not sufﬁcient to
avoid the diffusion and long-term persistence of a new VIM-
1-bearing P. aeruginosa.
P447
The antimicrobial susceptibility pattern of
extended-spectrum beta-lactamase producing
Escherichia coli in Surabaya, Indonesia
K. Kuntaman, N.M. Mertaniasih, M. Purwanta, U. Hadi,
H.A. Verbrugh On behalf of the AMRIN (Antimicrobial Resistance
in Indonesia: Prevalence and Prevention) Study Group
Objectives: To study the susceptibility pattern of ESBL (Exten-
ded spectrum beta lactamase) producing Escherichia coli from
clinical isolates against commonly used antimicrobial agents.
Methods: The study was conducted in Dr. Soetomo Hospital
with 1500 beds capacity in Surabaya, Indonesia. All clinical
isolates Escherichia coli resistant to third generation cephalosp-
orine in the routine examination were included in this study.
The susceptibility test was performed by disk diffusion test
(NCCLS, 2002). The phenotypic conﬁrmatory test for ESBL was
performed by disk diffusion test using ceftazidime disk (CAZ)
and combination ceftazidime plus clavulanic acid (CD). A
5 millimeter in zone around CD compare to CAZ, was used to
identify ESBL producer. These isolates were further tested
against Ceftazidime (CAZ), Cefotaxim (CTX), Ceftriaxone
(CRO), Ciproﬂoxacin (CIP), Ceﬁxim (CFM), Cefepim (FEP),
Meropenem (MEM) and Cefoperazone-sulbactam (SCF).
Results: During January to September 2004, 435 clinical strains
of E. coli, including 358 strains (82.3%) from urine specimens
were included. 57 strains (10.8%) were conﬁrmed as ESBL
producers. The antimicrobial susceptibility pattern (in % of
S = Susceptible, I = Intermediate, R = Resistance) against the
tested antimicrobials were as follow: S, I, R (%) against CAZ
19.3, 28.1, 52.6; CTX 0, 7, 93; CRO 8.8, 17.5, 73.7; CIP 19.3, 3.5,
77.2; CFM 5.3, 5.3, 89.5; FEP 43.9, 26.3, 29.8; MEM 94.7, 0, 5.3;
SCF 78.9, 17.5, 3.5.
Conclusions: ESBL producing Escherichia coli were frequently
isolated in this region of the world, they mostly resistant to
ceftazidime (52.6%), cefotaxime (93%), ceftriaxone (73.7%) and
ciproﬂoxacine (77.2%), and on the lesser extend to cefepime
(29.8%). The resistance rate to the second tier agents meropenem
and the combination of cefoperazone-sulbactam, was very low,
5.5% and 3.3% respectively.
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P448
The use of cefadroxil in primary susceptibility
testing to screen for cephalosporin resistance in
Enterobacteriaceae, including ESBLs
R.W. Smyth, C. Bore´n, G Kahlmeter (Va¨xjo¨, S)
Objectives: Bacterial resistance to second and third generation
cephalosporins, including ESBLs, is an increasing problem even
in the community. Within Enterobacteriaceae a number of
different betalactam resistance mechanisms have evolved over
recent years. TEM and SHV mutants, and CTX-M types,
collectively known as ESBLs, have emerged. A low strength
cefpodoxime disc is probably the best method for sensitive (but
non-speciﬁc) detection of strains with these mechanisms. The
alternative would be to use both cefotaxime and ceftazidime.
However, either strategy would for most laboratories require the
use of an extra plate in Enterobacteriaceae from community
acquired urinary tract infections (CA-UTI) and most laboratories
have not considered this to be worthwhile. Recent epidemics
with CTX-M:s in the community emphasise the need for this
procedure. We describe the use of a ﬁrst generation cephalosp-
orin as a surrogate sensitive but non-speciﬁc screen method for
ESBLs. This has the advantage of being a valid alternative in the
treatment of uncomplicated CA-UTI.
Methods: Disc diffusion with antibiotic discs from Oxoid UK,
semi-conﬂuent inoculum and overnight incubation at 35–37 C
on IsoSensitest Agar (Oxoid, UK). Antibiotics, zone breakpoints
and disc strengths are given in the Table. 52 strains (E. coli,
Klebsiellae, C. freundii and E. cloacae), each showing one or more
resistance mechanism, were tested. 33 strains were ESBL
producers of which 21 of type CTX-M, nine of SHV type, two
of TEM type and one with an unidentiﬁed ESBL. The remaining
strains consisted of ten with AmpC, three K1 hyperproducers,
three showing cefuroxime resistance and three of Imp+ type.
Results:
Conclusion: Cefpodoxime identiﬁed 49 of 52 Enterobacteria-
ceae with cephalosporin resistance, including all ESBL strains.
Cefadroxil detected 45 of 52 Enterobacteriaceae with cephalosp-
orin resistance including all 21 of the ESBL producers of CTX-M
type. A low content cefotaxime disc detected 92.3% of all
resistant strains including 96.9% of ESBL producers. Ceftazi-
dime 10 mcg disc detected only 67.3% overall and was not
helpful in detection of CTX-M resistance. However, a combina-
tion of cefadroxil and ceftazidime would have identiﬁed all 33
ESBL producers in this collection.
P449
Detection of ESBL in Enterobacter cloacae
S.G. Gatermann, B. Hurm, S. Friedrich (Bochum, D)
Objectives: Extended-spectrum b-lactamases (ESBL) are
increasingly prevalent in E. coli and Klebsiella spp. Consequently,
detection of ESBL focuses on these two species. However, ESBL
have been described in various Enterobacteriaceae, including
Citrobacter and Enterobacter. Detection is difﬁcult in these two
genera because constitutive expression of their chromosomal
AmpC b-lactamase interferes with or obscures the actions of
concomitant ESBL. We wanted to assess the frequency of ESBL
in clinical strains of Enterobacter cloacae.
Methods: To detect ESBL in species producing a chromosomal
AmpC b-lactamase a modiﬁed double disk diffusion test
(MDDT) described by Pitout et al. was used. 240 non-copy
strains of Enterobacter cloacae were tested with the MDDT and
equivocal results were resolved by E-test, or by testing combi-
nations of clavulanic acid and cephalosporins.
Result: We that 20% showed a deformation of inhibition zones
typically observed in Enterobacteriaceae expressing ESBL. A
plasmid preparation of one of these isolates was transformed
into E. coli and the transformand expressed a b-lactamase that
was active against third generation cephalosporins but not
against cefoxitin.
Conclusions: The results show that strains of Enterobacacter
cloacae may express ESBL. While this observation is probably of
little therapeutic importance, it may be epidemiologically
relevant since Enterobacter and Citrobacter may function an a
reservoir for plasmids carrying ESBL-encoding genes.
Extended-spectrum beta-lactamase and other beta-lactamases
P450
Cloning and characterisation of chromosomal
class C b-lactamase and its regulatory gene in
Laribacter hongkongensis
S.K.P. Lau, P.L. Ho, M. Li, H.-W. Tsoi, R.W.H. Yung,
P.C.Y. Woo, K.-Y. Yuen (Hong Kong, HK)
Objective: To clone and characterize a chromosomal class C
b-lactamase and its regulatory gene in Laribacter hongkongensis, a
newly discovered bacterium associated with gastroenteritis.
Methods: The b-lactam susceptibility proﬁle of 7 strains of
L. hongkongensis was studied. A genomic DNA library of strain
HLHK5 was constructed and antibiotic-resistant clones were
selected on LB plates containing cefoperazone with their inserts
sequenced. The identiﬁed b-lactamase gene sequenced was
analysed and the prevalence of the gene in L. hongkongensis
studied. Southern hybridization of the identiﬁed b-lactamase
gene was performed on strain HLHK5. The cloned b-lactamase
was also studied by b-lactamase assays and isoelectric focusing
analysis.
Results: Among seven clinical isolates of L. hongkongensis
tested, the MICs of ampicillin were 32 to 256 lg/ml and those
of third generation cephalosporins, were 64 to >256 lg/ml.
Clavulanic acid and sulbactam were ineffective in restoring
susceptibility to ampicillin and/or cefoperazone. Two genes,
ampC and ampR, were cloned by inserting restriction fragments
of genomic DNA from L. hongkongensis strain HLHK5 into pBK-
CMV to give the recombinant plasmid pBK-LHK-5. The ampR
and ampC genes and their promoters were divergently oriented,
with the ampR gene immediately upstream to the ampC gene
Number of strains correctly identiﬁed by
n
CDR 30 mcg
<14 mm
CAZ 10 mcg
<23 mm
CTX 5 mcg
<24 mm
CPO 10 mcg
<21 mm
All strains 52 45 35 48 49
ESBL strains 33 29 23 32 33
ESBL of CTX-M type 21 21 11 21 21
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and an intercistronic Lys-R motif, typical of inducible ampC–
ampR regulatory systems. The deduced amino acid sequence of
the cloned AmpC b-lactamase (pI, 8.1) contained consensus
motifs characteristic of class C b-lactamases, but had no greater
than 48% identities to known class C b-lactamases. When
expressed in E. coli, the AmpC conferred resistance to ampicillin,
ampicillin/clavulanic acid, ampicillin/sulbactam, cefuroxime,
ceftazidime, cefoperazone and cefoperazone/sulbactam. The
kinetic properties of this AmpC were also compatible with class
C b-lactamase. The expression of the ampC gene was inducible,
which required the presence of ampR. PCR of 20 clinical isolates
of L. hongkongensis, including HLHK5, showed the presence of
both ampC and ampR genes in all isolates. Southern hybridiza-
tion suggested that the ampC gene of HLHK5 was chromoso-
mally encoded.
Conclusion: A novel chromosomal class C b-lactamase was
identiﬁed in L. hognkongensis. The b-lactamase characterized
from strain HLHK5 was named LHK-5 (gene, blaLHK-5) and
represented the ﬁrst example of AmpC b-lactamase in the
b-subdivision of proteobacteria.
P451
Prevalence and characteristics of plasmid-
mediated AmpC beta-lactamase in Escherichia
coli and Klebsiella pneumoniae isolates in a
Korean hospital
D. Yong, Y.S. Choi, D.-Y. Park, S. Kim, H. Lee, J.H. Yum, K. Lee,
Y. Chong (Seoul, KOR)
Objectives: Various plasmid-mediated AmpC beta-lactamases
(PABL) have been found, particularly in Klebsiella spp. and
Escherichia coli. AmpC beta-lactamase provided resistance to 3rd
generation cephalosporins and cephamycins Because of the
transferability of their resistance gene to other strains, PABL
have been considered to be clinically important. The aims of this
study were to determine the prevalence of PABL-producing
E. coli and K. pneumoniae isolates in a Korean University
Hospital, and the genetic characteristics of their PABL.
Methods: Cefoxitin-nonsusceptible E. coli and K. pneumoniae
were isolated in patients at a Korean University hospital
between March to June, 2003. PABL-producing isolates were
screened by the Modiﬁed Hodge test, and the genes were
detected by multiplex PCR designed by Perez–Perez and
Hanson. Some of the PCR-generated amplicons were puriﬁed
by agarose gel electrophoresis and using a DNA extraction kit
(Quiagen, Hiden, Germany). Nucleotide sequencing were
carried out by the dideoxy-chain termination method with an
automatic DNA sequencer (ABI 3700, Perkin–Elmer, Foster
City, Ca., USA). To determine the genetic characteristics of
blaDHA, PCR using allele-speciﬁc primers were performed
additionally.
Results: Among the 56 E. coli and 71 K. pneumoniae, PABL genes
were detected by multiplex PCR in 41 (73%) and 55 (77%)
isolates, respectively. PABL genes of CIT, DHA, and MOX
group were detected in 32, 7, and 2 E. coli isolates, and 14, 38,
and 3 K. pneumoniae isolates, respectively. All were found to be
identical to blaCMY-1 and blaCMY-2. All of the isolates with
blaDHA alleles showed positive PCR reaction with blaDHA-1
allele-speciﬁc primers, but did not with blaDHA-2 allele-speciﬁc
primers.
Conclusion: Among the cefoxitin-nonsusceptible E. coli and
K. pneumoniae isolates, PABL-producing strains were very
prevalent. AmpC beta-lactamases of CIT group were most
prevalent in E. coli, DHA group in K. pneumoniae isolates.
P452
Characterisation of clinical isolates of Klebsiella
oxytoca susceptible to ampicillin
L. Lopez, C. Velasco, S. Granier, L. Martinez-Martinez,
A. Pascual (Seville, E; Paris, F)
Objective: Klebsiella oxytoca expresses class A chromosomal
beta-lactamases (K1 or KOXY) and is generally resistant to
Ampicillin and Piperacilin at high inoculum size. Betalactamase-
negative strains are extremely uncommon. The aim of this study
was to analyse two clinical isolates of K. oxytoca fully susceptible
to Ampicillin.
Material and Methods: The two isolates (HUS-837 and HUS-
610) belonged to a collection of 154 K. oxytoca isolates recovered
from clinical samples during a 4-year period. Identiﬁcation was
performed by reference biochemical tests, VITEK 2 system, API
20 E and then by sequence analysis of the 387-bp fragment of the
16S and the 512-bp fragments of the rpoB genes respectively.
Susceptibility to Ampicillin (range 0.5–64 mg/L) and Ampicillin
plus Clavulanic acid (ﬁxed concentration of 4 mg/L) was
determined by microdilution using three different inocula of
5 · 105, 5 · 106 and 5 · 107 CFU/ml. Sonicated crude beta-
lactamase extracts were studied using cephaloridine. The
bla-OXY gene was ampliﬁed and sequenced. Southern hybrid-
izations, using bla-OXY-1 and bla-OXY-2 genes as probes, were
also carried out.
Results: The two clinical K. oxytoca strains showed Ampicillin
MIC 0.5 mg/L irrespective of inoculum size tested and this
value did not change with clavulanic acid. No beta-lactamase
activity was detected in any strain. Analysis of the 16S and rpoB
sequences placed both strains within the oxy-1 genetic group
and DNA from both of them strongly hybridized with the bla-
OXY-1 probe. The sequence of bla-OXY of HUS-837 strain
revealed the presence of three amino-acid substitutions within
the coding region and the promoter region was 100% identical to
that of bla-OXY1 gene. Bla-OXY gene of HUS-610 strain could
not be ampliﬁed by standard PCR. Southern hybridisation
patterns suggest that bla-OXY genes from both mutant strains
are located in a different genetic environment to that bla-OXY-1
and bla-OXY-2.
Conclusion: The occurrence of Ampicillin susceptible K. oxytoca
is rare (1.3%) and could be caused by different genetic events.
The presence of three amino-acid substitution in the coding
region of the bla-OXY gene of HUS-837 might be sufﬁcient to
modify the conformation and in turn the functional properties of
this mutant beta-lactamase. Further analyses are currently
carried out to characterize the HUS-610 strain and also the
transcription of both bla-OXY genes.
P453
Genetic analysis of CMY-2 beta-lactamase genes
and class 1 integrons in Escherichia coli and
Enterobacter cloacae from Norway
T.R. Walsh, M.A. Toleman, D.M.C. Bennett, B. Haldorsen,
A. Sundsfjord (Bristol, UK; Tromso, N)
Objectives: As part of the Norwegian reference laboratory
screening programme E. coli and E. cloacae exhibiting high-level
resistance to extended spectrum cephalosporins were forwarded
for molecular analysis. Therefore, we molecularly investigated
the mechanism of this broad-spectrum beta-lactam resistance in
ﬁve strains: two E. coli (K4-14, K5-63) and three E. cloacae (K2-38,
K2-41 and K2-49).
Methods: Genetically screening for Eextended-Spectrum beta-
lactamase genes (TEM, SHV, CTX-M and OXA-type) and
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CMY-type beta-lactamase (BL) genes involved PCR. Degenerate
primers used were designed on the conserved regions of the
genes and often more than one primer set was required. To
examine the genetic context of BL genes, primers were designed
to amplify class 1 integrons and common regions implicated in
the transfer of antibiotic resistant genes. BL genes were also
examined to ascertain whether they were plasmid or chromos-
omally mediated. PCR amplicons of the desired size were
sequenced by an AB sequencer.
Results: CMY-2 was found in all strains except for K2-41 and
CTX-M-1 was found in K2-38 and K2-41. Plasmids were isolated
from all strains and CMY-2 was found on plasmids from strain
K4-14. Class 1 integrons were ampliﬁed only from E. coli K4-14
and K5-63. Sequence analysis determined both integrons were
identical and contained the gene cassettes dhfrVII and aadA4 in
the variable region. Positive amplicons for common regions
were found in both E. coli strains but none of the E. cloacae
strains. Flanking PCR approach to determine the genetic context
of CMY-2 gave a product of 300 bp which is being analysed.
Conclusion: The data arising from these studies would indicate
that the CMY-2 BL has arisen from different sources in E. coli and
E. cloacae. The E. coli CMY-2 gene is probably associated with
common regions. The E. cloacae CMY-2 gene is neither associated
with common regions, integrons or plasmid mediated.
P454
Study of beta-lactamases and outer membrane
proteins in clinical isolates of the genus
Klebsiella
M. Vrabelova-Poczova, D. Michalkova-Papajova, E. Sodomova,
D. Rovna, M. Kettner (Bratislava, SVK)
Objectives: To study occurrence of extended-spectrum beta-
lactamases (ESBLs) and porin expression (OmpK35, OmpK36) in
clinical isolates of the genus Klebsiella obtained from Hospital
Ruzinov, Bratislava (Slovakia) during the years 2002–2003.
Methods: Clinical isolates were selected as ESBL-producers and
identiﬁed by ENTEROtest24 (Pliva–Lachema, Czech Republic).
Minimal inhibitory concentrations (MICs) of beta-lactam antibi-
otics were determined by standard agar dilution method
according to the NCCLS guidelines. The following antibiotics
were tested: ampicillin (AMPI), cefoxitin (CFOX), cefotaxime
(CTAX), ceftazidime (CTAZ), ceftriaxone (CIAX), cefepime
(CEPI), azthreonam (AZTR), meropenem (MERP). Transferabil-
ity of resistance to beta-lactam antibiotics from clinical isolates to
Escherichia coli K-12 3110 was carried out by bacterial conjuga-
tion. Transconjugants were selected as resistant to ampicillin.
ESBL production was detected by combination disk method
(NCCLS). PCR was used to determine the presence of blaTEM,
blaSHV and blaCTX-M genes. Outer membrane protein (OMP)
proﬁles were determined by SDS-PAGE.
Results: In the set of 43 clinical isolates 42 were identiﬁend as
Klebsiella pneumoniae and one as Klebsiella oxytoca. All clinical
isolates tested were resistant to AMPI and none of them was
resistant to MERP. 54% of clinical isolates were resistant to
CFOX, 84% to CTAX, 95% to CTAZ, 86% to CIAX, 43% to CEPI
and 86% to AZTR. ESBL production was detected by combina-
tion disk method in all clinical isolates and in 71% of transcon-
jugants. The presence of blaTEM , blaSHV and blaCTX-M genes
was detected in 44%, 95% and 5% of clinical isolates, respect-
ively. The same genes were detected in 5%, 54% and 0% of
transconjugants, respectively. In the selected clinical isolates the
presence of 32 kDa OmpA-like protein and 35–37 kDa OMPs
(OmpK35, OmpK36) was observed. In Klebsiella oxytoca clinical
isolate, which was resistant to CFOX (MIC 64 mg/l) the loss of
35–37 kDa OMPs was detected.
Conclusions: Nosocomial outbreaks due to ESBL-producing
Enterobacteriaceae have become a serious problem worldwide.
Treatment of infections caused by these microorganisms is a
difﬁcult task because beta-lactamase production inactivates
most of the beta-lactam antibiotics. Cephamycins such as
cefoxitin are active in vitro against these strains, but this agent
can select porin-deﬁcient mutants with increased levels of
resistance to cefoxitin and other cephalosporins.
P455
In vitro activity of beta-lactams against clinical
isolates of Escherichia coli with
AmpC-hyperproduction phenotype
M.C. Conejo, G. Amblar, J.W. Huizing, A. Pascual, L. Martı´nez-
Martı´nez (Seville, Santander, E)
Objective: To study the in-vitro activity of beta-lactams against
clinical isolates of Escherichia coli with a phenotype compatible
with AmpC-hyperproduction, to characterize beta-lactamases
(BLs) produced in these organisms and to determine the clonal
relationship of the isolates.
Methods: E. coli from clinical samples obtained at the Service of
Microbiology, Univ. H. Virgen Macarena, Seville, Spain during
1999–2001 were evaluated. Identiﬁcation and preliminary sus-
ceptibility testing were performed with Vitek-2. Reference
susceptibility testing was performed by microdilution (NCCLS
guidelines). Eighty organisms resistant to ampicillin, amoxicillin
plus clavulanate (CLV), cephalothin and cefoxitin and lacking
extended-spectrum BLs [no synergy of cefotaxime (CTX) or
ceftazidime (CAZ) with CLV] were selected. The following
agents were additionally tested: ampicillin-sulbactam (ASB),
piperacillin (PIP), PIP-tazobactam (PTZ), carbenicillin (CAR),
temocillin (TEM), cefotetan (CTT), cefpodoxime (POD), cefepi-
me (FEP), imipenem (IMP) and meropenem (MPM). Clonal
relationship was determined by REP-PCR, with primer 5¢-III
GCG CCG ICA TCA GGC-3¢. Isoelectric focusing (PhastGel, IEF
range 3–9) was performed to identify the numbers and isoelec-
tric points (pIs) of the BLs present. In-situ inhibition of BL with
cloxacillin (CLX) or CLV was also assessed.
Results: Sixty REP-PCR proﬁles were observed. Forty-two
(52.5%) isolates produced two BL with a pI of ‡9 (inhibited by
CLX but not by CLV, compatible with AmpC) and 5.4 (inhibited
by CLV but not by CLX, compatible with TEM-1), respectively,
35 strains (43.8%) only produced the BLs of pI ‡9, and 3 (3.7%)
strains a BLs of pI 8.0 All 80 isolates were susceptible to IMP,
MPM and FEP. The percentages of strains susceptible to the
tested agents were: TEM: 95, CTX: 91, PTZ: 84, CTT: 74, CAZ: 48,
PIP: 29, POD: 7, CAR: 4 and AMS: 1. Resistance to CAR and to
PIP but not to other agents was associated with production of
the pI 5.4 BL.
Conclusions: There is considerable clonal variability among
Escherichia coli isolates with an AmpC-hyperproduction pheno-
type. Carbapenems and cefepime showed an excellent activity
against these isolates. Marked differences in the activities of
cefoxitin and cefotetan against the isolates were observed.
P456
Beta-lactamases and antibiotic susceptibilities of
Moraxella catarrhalis isolates from Zagreb,
Croatia
B. Bedenic, J. Vranes (Zagreb, HR)
Background and objectives: The b-lactamase production in
M. catarrhalis ﬁrst described in 1977 has been reported with
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increasing frequency in many countries of the world. However
there were no reports from Croatia so far.The aim of this study
was to investigate antibiotic susceptibilities and b-lactamase
production in M. catarrhalis isolates from Croatia.
Methods: Fifty M. catarrhalis strains were collected in Univer-
sity Children’s Hospital in Zagreb. Suceptibilities to wide range
of antibiotics were determined by broth microdilution method.
b-lactamases were detected with commercially available chrom-
ogenic cephalosporin disk b-lactamase test containing nitroceﬁn.
The substrate proﬁle of the enzymes was determined by
biological assay.
Results: b-lactamases were detected by disk chromogenic sub-
strate (nitrocephin) test in all strains. Prevalence of b-lactamase
positive strains in the study period was 100%. Eighty% of the
strains were resistant to amoxycillin, 4% to cefadroxil and 2% to
cefuroxime and cefprozil. No resistance to cephalexin, ceftib-
uten, tetracycline, erythromycine, azithromycine and chloram-
phenicol was observed. The activity of amoxycillin was strongly
enhanced in the presence of clavulanic acid in all strains. Older
cephalosporins were equally active but third generation cepha-
losporin ceftibuten displayed signiﬁcantly lower MICs com-
pared to older compounds. Among non b-lactam antibiotics
tetracycline and erythromycine showed similar activity. Azith-
romycine had markedly stronger inhibitory activity in compar-
ison with erythromycine and tetracycline. Crude b-lactamases
extracts from M. catarrhalis strains antagonized the activities of
disks containing ampicillin. Enzymes did not affect the inhibi-
tion zones around cephalosporin disks.
Conclusions: Prevalence of b-lactamase producingM. catarrhalis
strains is higher in Croatia than in other countries of the world
except of Japan.The results of the susceptibility tests were in
concordance with the results reported by other investigators.
Wide range of MICs for amoxycillin alone and combined with
clavulante could be attributed to various level of enzyme
production by M. catarrhalis strains According to our results
amoxycillin combined with clavulanic acid should be the antibi-
otic of choice for the treatment of infections caused with
b-lactamasepositive isolatesofM.catarrhalis.Oralcephalosporins,
tetracycline, macrolides or azithromycine could be an option too.
P457
Detection of extended-spectrum beta-lactamase
producers with four variants of the Oxoid
combination disc method
A. Rokosz, A. Sawicka-Grzelak, M. Wroblewska, E. Swoboda-
Kopec, M. Luczak (Warsaw, PL)
Objectives: To evaluate the usefulness of four variants of the
Oxoid combination disc method to detect ESBLs in nosocomial
strains of Gram-negative rods. To compare the Oxoid test with
the double disc synergy test (DDST) for ESBLs detection.
Methods: A total number of 110 ESBL-positive (DDST-positive)
nosocomial isolates cultured in 2004 were investigated. Ninety
nine strains (90%) of enteric rods and eleven strains (10%) of
nonfermentative rods were examined. Two control strains were
included in the study. Four variants of the Oxoid combination
disc method: CPD/CD 01, CAZ/CD 02, CTX/CD 03 and CPO/
CD 04 were applied for ESBLs detection.
Results: All examined strains were DDST-positive. Positive
results in the Oxoid combination disc method were as follows:
CPD/CD 01–59 strains (53.6%),CAZ/CD 02–79 strains (71.8%),
CTX/CD 03–91 strains (82.7%) and CPO/CD 04–109 strains
(99.1%).
Conclusions: CPO/CD 04 discs were the best combination for
detection of ESBLs in clinical strains of Gram-negative rods
collected in our laboratory. Application of several methods to
detect ESBL producers increases the probability of their proper
identiﬁcation.
P458
Epidemiology of CTX-M beta-lactamases in
Spain
E. Valverde Romero, M.I. Garcı´a Garcı´a, T. Parras Padilla,
A. Herrero Herna´ndez, M. Ferna´ndez Va´zquez, R. Pe´rez Grande,
J.A. Garcı´a-Rodrı´guez, J.L. Mun˜oz Bellido (Salamanca, E)
Objectives: Extended spectrum beta-lactamases (ESBL) are one
of the main resistance problems affecting beta-lactams now. In
Spain, recent study suggest CTX-M group ESBLs are becoming
the most frequent ESBL group, and their frequency is increasing
in the community setting. We have identiﬁed the ESBLs-
producing isolates and characterized the enzymes found in the
Hospital Universitario de Salamanca during 2004.
Methods: Presumptive detection was done by double disc
diffusion method or MIC by the microdilution method. ESBLs
were studied by isoelectric focusing and PCR and sequencing.
Results: We have detected phenotypically 125 isolates suspi-
cious of being ESBL-producers. ESBLs belonging to the CTX-M
group were detected in 80 isolates (64%). The most frequent
CTX-9 enzyme was CTX-M 14 (55 isolates, 68.8%), followed by
CTX-M 9 and CTX-M 15(11 isolates, 13.8% each). SHV and TEM
ESBLs were isolated in 41 (32.8%) and 39 (31.2%) isolates
respectively. CTX-M were mainly found in E. coli, K. pneumoniae
and K. oxytoca isolates, excepting 4 CTX-M which were found in
Salmonella. 19 CTX-M-producing isolates (23.8%) produced two
or more different ESBL enzymes. The presence of two or more
ESBLs was found in 14 E. coli and 5 K. pneumoniae isolates
producing CTX-M 9, CTX-M 14 or CTX-m 15 enzymes. No
K. oxytoca isolates producing more than one ESBL were found.
The most frequent ESBL combination was CTX-M 14 + TEM-
116, found in 8 E. coli and 1 K. pneumoniae isolates, followed by
CTX-M 14 + TEM-116 + SHV-5, found in 3 K. pneumoniae
isolates. Most CTX-M-producing isolates were obtained from
UTIs and from community patients.
Comments: CTX-M are becoming the most frequent ESBLs
group in our area. As in other studies in Spain CTX-M 14 is, by
far, the most frequent ESBL. The ﬁnding of isolates producing
more than one ESBL, formerly very infrequent, is becoming
much more usual. Most ESBL-producing isolates are obtained
from UTIs, and frequently in community patients.
P459
An ESBL-producing Klebsiella pneumoniae strain
isolated from a nosocomial outbreak becomes
resistant to all clinically available antibiotics by
acquisition of a plasmid-mediated AmpC
beta-lactamase
S. Burak, B. Wiedemann, I. Wiegand (Bonn, D)
Objectives: Outbreaks caused by multiresistant Klebsiella pneu-
moniae strains, especially extended-spectrum beta-lactamase
(ESBL)-producing strains, are an increasing serious problem.
Carbapenems are valuable therapeutic options against those
strains, as, even with a porin loss, ESBL-producing K. pneumo-
niae remain susceptible to carbapenems. But they may become
carbapenem-resistant because of porin loss in combination with
plasmid-mediated AmpC beta-lactamase production.In this
work, we analysed the molecular background of a multiresistant
clinical ESBL-producing K. pneumoniae isolate. We wanted to
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examine its ability to become carbapenem-resistant by acquisi-
tion of a plasmid-mediated AmpC enzyme.
Methods: K. pneumoniae 5111 was isolated during an outbreak
of multiresistant ESBL-producing K. pneumoniae in the surgical
ICU of a german university hospital in April 2002. MIC values
were determined by broth microdilution according to NCCLS.
Resistance genes were detected by PCR and sequencing.
Conjugation experiments were performed by ﬁltermating
using two different clinical E. coli and one K. pneumoniae isolate
harbouring the AmpC beta-lactamase CMY-2 on different
plasmids as donor strains and K. pneumoniae 5111 as the
recipient.
Results: Strain 5111 was resistant to all tested beta-lactams
except carbapenems and also resistant to aminoglycosides,
quinolones, tetracyclines, cotrimoxazol and chloramphenicol.
The beta-lactam resistance is caused by production of the ESBL
SHV-12. Cefoxitin resistance indicates a porin loss. Two chro-
mosomal mutations in gyrA and one in parC are responsible for
the quinolone resistance. The strain carries at least six genes for
aminoglycoside-modifying enzymes and four additional resist-
ance genes.Conjugation experiments were successful with one
E. coli donor strain with a conjugation frequency of 1.7 · 10)8.
The transconjugant had acquired the AmpC CMY-2 and was
resistant to carbapenems.
Conclusion: The examined strain becomes completely resistant
to all clinically available antibiotics by acquisition of a plasmid-
mediated AmpC beta-lactamase by conjugation. Conjugation
events can also occur in vivo in the gastrointestinal tract of
colonized patients. Appropriate surveillance is therefore neces-
sary for early identiﬁcation of such strains and prevention of
their spread.
P460
Detection of ESBL in Enterobacteriaceae in the
Polish National External Quality Assesment
scheme – POLMICRO 2004
B. Chmylak, E. Mlodzinska, E. Stefaniuk, K. Szczypa, J. Fiett,
M. Gniadkowski, W. Hryniewicz (Warsaw, PL)
Objectives: The objective was to analyse the results of proﬁ-
ciency testing obtained by Polish microbiology laboratories
participating in POLMICRO.
Materials and methods: Gram-negative rods belonging to the
family Enterobacteriaceae were distributed among 480 laborat-
ories all over the country. The following organisms were
included in the edition; four ESBL - positive strains: Escherichia
coli, Proteus mirabilis, Serratia marcescens, Citrobacter freundii and
two ESBL – negative strains: Klebsiella pneumoniae, Enterobacter
cloacae (AmpC) however each laboratory obtained three organ-
isms selected from the set. The laboratories were asked to
provide identiﬁcation to the species level and susceptibility
results and interpretation. One of the main tasks was to detect
ESBL production and correctness of clinical interpretation of the
susceptibility test results.
Results: Most of the laboratories reported correct identiﬁcation
of the species, however, 10.2% of them misidentiﬁed the
E. cloacae strain. Approximately 93% laboratories correctly
identiﬁed ESBL production. Thus, 31 laboratories (12.6%) did
not detect ESBL in the E. coli strain. In the case of P. mirabillis 26
laboratories (11.1%) did not identify ESBL activity. More than
90% of the laboratories which tested K. pneumoniae obtained
acceptable antimicrobial susceptibility results. About 60% labor-
atories were not able to detect correctly susceptibility of
S. marcescens and E. coli to piperacillin/tazobactam. No single
very major error was produced by 336 laboratories (70%).
However, one very major error was made by 48 (10%)
laboratories in susceptibility testing. Total of 326 laboratories
reached accurate results of the proﬁciency testing performance.
Conclusions: Over 90% laboratories correctly identiﬁed and
interpreted ESBL production in the strains of the family
Enterobacteriaceae.
P461
ESBL in Escherichia coli: increase in prevalence
and diversity
E. Miro´, B. Mirelis, F. Navarro, C. Roig, A. Ribera, R.-J. Mesa,
L. Go´mez, P. Coll (Barcelona, E)
Objectives: To evaluate the prevalence and diversity of exten-
ded-spectrum beta-lactamases (ESBLs) in Escherichia coli infec-
tions from 1994 to 2003.
Methods: All non-duplicate isolates of E. coli resistant or with
reduced susceptibility to third generation cephalosporins and
with synergistic effect to clavulanic acid were collected. ESBLs
isoelectric points were determined. bla genes for TEM-type,
SHV-type, CTX-M-1, CTX-M-5 and CTX-M-9 related enzymes
were ampliﬁed by PCR and most were sequenced. To differen-
tiate CTX-M-9 from other CTX-M-9-related enzymes, the pres-
ence of the orf513 and orf1005 surrounding sequences described
in integron In60 were veriﬁed by PCR.
Results: The prevalence of ESBLs increased from 0.08% in 1994
to 2.6% in 2003. A total of 209 ESBLs-producing strains from
23,818 E. coli strains were collected.The presence of TEM-type
ESBLs was sporadic, with 7 strains (3 blaTEM-12, 1 blaTEM-10,1
blaTEM-19 and 1 blaTEM-104), representing 3.3% of all ESBLs
isolates. SHV-type ESBLs were present throughout the study
period (20.6% of ESBLs isolates; 46 strains), with a steady
increase in the last three years. Of 39 sequenced amplicons 12
were blaSHV-2 and 27 blaSHV-12 genes. SHV-2 was present
from 1994 to 2001. SHV-12 appeared in 2000 and was the only
enzyme detected in 2002. All strains with SHV-12 isolated in
2001 and 2002 also produced CTX-M-9. The CTX-M-types were
the most frequent ESBLs found (76.2% of ESBLs isolates; 170
strains). Among them, 55.9% (95 strains) were CTX-M-9 and
their prevalence increased from 1996 to 2002. The ﬁrst CTX-M-9-
related enzymes appeared in 1999 and is now the most frequent
(58 strains; 34.1%). The presence of CTX-M-14 enzymes was
documented in all thirty sequenced strains. After 2001, we also
observed an increase in the CTX-M-1-group (16 strains; 9.4%).
There were four CTX-M-1, two CTX-M-15 and one CTX-M-32.
Only one CTX-M-5 type (CTX-M-2) was observed.
Conclusions: Although the incidence of ESBLs in our hospital
remains low, we observed an increase over the study period
from 0.08% to 2.6%. The prevalence of SHV and CTX-M-related
enzymes rose from 0.04% to 0.6% and from 0% to 2%,
respectively. A major range of diversity of the ESBLs involved
accompanied this increase, mainly due to CTX-M-type enzymes
(CTX-M-1, CTX-M-2, CTX-M-9, CTX-M-14, CTX-M-15 and CTX-
M-32).
P462
Molecular genetics of extended-spectrum beta-
lactamase among Escherichia coli and Klebsiella
spp. isolates in Finland
S.D. Nyberg, M. O¨sterblad, A.J. Hakanen, P. Huovinen, J. Jalava
and The Finnish Study Group for Antimicrobial Resistance
Objectives: Extended-spectrum beta-lactamase (ESBL) produ-
cing Escherichia coli and Klebsiella spp. isolates are spreading and
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becoming an increasing problem, especially, concerning treat-
ment, diagnostics and hospital hygiene. The prevalence of ESBL-
producers in Finland was studied in the 1990s, but only a few
strains were found. This work was done to ﬁnd out the
molecular genetics of ESBL-enzymes among cefuroxime resist-
ant E. coli and Klebsiella spp isolates in Finland.
Methods: From January 2002 until October 2004 cefuroxime
resistant E. coli and Klebsiella spp. isolates were collected from 26
laboratories included in the Finnish Study Group for Antimi-
crobial Resistance (FiRe). MICs were determined by the agar
dilution method on Mueller–Hinton II medium for 22 antimi-
crobial agents representing penicillin, carbapenem and cepha-
losporin derivatives. Part of the isolates representing different
phenotypes and laboratories were chosen for further studies.
These isolates were screened for resistance genes by PCR with
speciﬁc TEM, SHV and CTX-M primers and then sequenced
with an Applied Biosystems 3730 DNA Analyzer.
Results: A total of 460 isolates were collected. Screening for
blaTEM, blaSHV and blaCTX-M were done for 160 isolates (54%
E. coli and 46% Klebsiella spp.). The presence of a gene coding for
ESBL-enzymes was conﬁrmed in 79% of the strains. TEM-1 was
represented in 62.5% of the isolates. Only two isolates had an
ESBL variant of TEM (TEM-2 and TEM-52). Different kinds of
SHV-enzymes were present in 37% and CTX-M in 73% of the
isolates. The most common mutations in SHV were the ones
representing SHV-12 which was seen among 6% of the isolates.
4% of the isolates produced two different ESBL-enzymes
(TEM + SHV or SHV + CTX-M).
Conclusion: blaCTX-M alone was the most common ESBL-
gene. Isolates with TEM-1 and an ESBL-gene were very common
in the studied Finnish material.
P463
Molecular characterisation of TEM-123 and
TEM-124 extended-spectrum beta-lactamases
from clinical isolates of Enterobacteriaceae
M. Perilli, C. Pellegrini, B. Segatore, G.M. Rossolini, B. Caporale,
F. De Santis, M. Fiore, F. Luzzaro, A. Toniolo,
G. Amicosante (L’Aquila, Siena, Varese, I)
Objectives: Enterobacteriaceae are the major recipients of
extended-spectrum beta-lactamases (ESBLs). A number of
these ESBLs are variants of TEM-1 or TEM-2 which have
modiﬁed substrate speciﬁcity due to the presence of one or more
amino acid substitutions. Diffusion of these enzymes constitute
a relevant emerging problem for antimicrobial chemotherapy.
The aim of this work was that to characterize the TEM-123 and
TEM-124 TEM-type ESBLs produced by Proteus mirabilis and
Morganella morganii respectively.
Methods: The nature of blaTEM gene was determined by PCR
and direct sequencing. Sequence was determined on two
independent ampliﬁcation products for each isolate. The
deduced amino acid sequences were compared to those of
known TEM variants. The amplicons were cloned in pBC-SK
and transformation of recombinants plasmids was performed
using E. coli HB-101 competent cells. TEM-123 and TEM-124
were puriﬁed from E. coli HB-101 (pBC-SK-TEM-123) and E. coli
HB-101 (pBC-SK-TEM-124), respectively, by two chromato-
graphic steps using Sepharose S and Superdex G-75.
Results: Sequence analysis of amplicons revealed the presence
of two novel TEM-type variants: TEM-123 and TEM-124. TEM-
123 was detected in Proteus mirabilis and carried the following
mutations compared to TEM-1: Q6K, E104K andG238S; TEM-124
was found in Morganella morganii and carried the following
mutations compared to TEM-1: Q6K, E104K and M182T. The
kinetic parameters of the puriﬁed b-lactamases showed that
TEM-123 and TEM-124 were able to hydrolyze several b-lactams
including oxyiminocephalosporins. The highest hydrolytic efﬁ-
ciencies were observedwith cefotaxime (kcat/Km, 1.05 lM-1 s)1)
for TEM-123 and with penicillin G (kcat/Km, 1.2 lM)1 s)1) for
TEM-124. The kcat/Km value of cefotaxime for TEM-124 was
0.15 lM)1 s)1. No hydrolysis of aztreonam was observed for
TEM-123 and TEM-124 enzymes. Both clavulanic acid and
tazobactam behaved as good competitive inhibitors: Ki value of
2.8 lM and 0.065 lM, respectively for TEM-123; Ki value of
0.63 lM and 0.003 lM, respectively for TEM-124.
Conclusions: TEM-123 and TEM-124 are natural TEM-type
ESBLs that differ from TEM-15 and TEM-106, respectively, in
one amino acid substitution in the signal peptide sequence
(Q6K). This position apparently plays an important role in
efﬁcient protein secretion across the membrane.
P464
Characterisation of Escherichia coli producing
CTX-M-9-like beta-lactamases in the UK
E.J. Fagan, M. Warner, R. Pike, J. Turton, M.E. Kaufmann,
D.M. Livermore, N. Woodford (London, UK)
Objectives: Approximately 5% of CTX-M beta-lactamase-pro-
ducing E. coli isolates from the UK produce group 9 CTX-M
enzymes and, between August 2003 and October 2004, the
national reference laboratory received 30 such isolates from 22
centres. The aimof this studywas to characterise these organisms.
Methods: Isolates were compared by PFGE of XbaI-digested
genomic DNA; data were analysed with BioNumerics software.
MICs were determined and interpreted according to BSAC
guidelines. The genes for CTX-M group 9 enzymes were
detected by PCR with primers speciﬁc for blaCTX-M-9; selected
alleles were sequenced directly.
Results: The PFGE proﬁles for 18 of 30 isolates were each
unique; those of 11 isolates separated into ﬁve clusters with
>85% similarity (one cluster comprised 3 isolates from the same
centre with 100% similarity, whilst another comprised 2 iden-
tical isolates from a different centre); DNA from one isolate
autodigested. The isolates were resistant to cefotaxime (MIC 16–
256 mg/L), whilst the majority (n = 24) lacked obvious resist-
ance to ceftazidime (MIC £ 2 mg/L). MICs of CTZ-R isolates
(n = 6) were 8–16 mg/L. All the isolates (n = 30) were suscept-
ible to carbapenems. Alleles from ten isolates from different
hospitals were sequenced: 6 isolates produced CTX-M-14-like
enzymes; 4 produced CTX-M-9-like enzymes. One of the latter
had a novel variant, which differed from CTX-M-9 by an
Ala234Val substitution.
Conclusions: We found multiple different strains of E. coli with
group 9CTX-Menzymes (CTX-M-9 or 14-like) at 22 centres across
the UK. There appeared to be local spread of some strains, but
there was no evidence of ‘epidemic’ strains, in contrast to the
situationwith UK producers of group 1 enzymes, wheremultiple
serotypeO25 strains have spread among sites andwhere one such
strain is widespread in geographically remote parts of the UK.
P465
Association of plasmid-mediated QnrA-like
determinant and gene coding for extended-
spectrum beta-lactamase VEB-1
H. Mammeri, L. Poirel, M. Van de Loo, P. Nordmann
(Le Kremlin Bicetre, F)
Objectives: A plasmid mediated QnrA determinant had been
identiﬁed in Escherichia coli at the Bicetre hospital (France) in
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2003. It was associated with a gene coding for the expanded-
spectrum beta-lactamase (ESBL) VEB-1. Thus, an investigation
was performed for analyzing the prevalence of qnrA-like genes
among nalidixic-acid resistant enterobacterial isolates (exclu-
ding E. coli) from the same French hospital and in a series of
blaVEB-1-positive Gram negative rods.
Methods: One hundred thirty nalidixic-acid resistant enterobac-
terial clinical isolates thatwere recovered at the Bicetre hospital in
2003 were screened for qnrA-like gene by PCR. A second
collection of 92 strains isolated in Thailand during a previous
studyand including37 blaVEB-1-positive enterobacterial isolates,
22 blaVEB-1-negative enterobacterial isolates, and 33 blaVEB-1-
positive Pseudomonas aeruginosa, was also tested. Mapping and
sequencing of the sul1-type integrons were also performed.
Results: Among the nalidixic-acid resistant enterobacterial
strains isolated at the Bicetre hospital, a single Enterobacter cloacae
that was blaVEB-1-positive harboured a qnrA-like gene whereas
eleven blaVEB-1-positive enterobacterial isolates from Thailand
were positive. However, qnr-like gene was not identiﬁed from
the blaVEB-1-negative enterobacterial isolates from Thailand and
not from blaVEB-1-positive Pseudomonas aeruginosa isolates. In all
isolates, the qnrA-like gene was identical and differed from the
original qnrA gene reported by an asparagine to aspartate
substitution at position 178 that did not lead to change in the
quinolone resistance proﬁle. The qnrA-like genes were located in
sul1-type integrons that differed in structure.
Conclusion: This study indicated a furtherdissemination ofQnr-
like determinants among European and South-East Asian isolates
and identiﬁed a frequent association between this resistance
determinant and the gene coding for the ESBL VEB-1.
P466
Prevalence of Ambler class A extended-spectrum
b-lactamase-producing Escherichia coli and
Klebsiella pneumoniae in Korean hospitals
S.H. Jeong, J. Lee, W.G. Lee, J.O. Kang, S.G. Hong, J.H. Shin,
Y. Uh, Y.J. Park, E.-C. Kim, K. Lee, D. Yong (Busan, Daejeon,
Suwon, Guri, Bundang, Kwangju, Wonju, Seoul, KOR)
Objectives: Prevalences of TEM-, SHV-, and CTX-M-type
extended-spectrum b-lactamases(ESBLs) in Korea are investi-
gated repeatedly, but those of PER-, VEB-, GES-, IBC-, and TLS-
type ESBLs are rarely studied. The aim of this study was to
determine the nationwide prevalence of Ambler class A ESBL-
producing Escherichia coli and Klebsiella pneumoniae and to
characterize genotypes of ESBLs including rarely studied ones.
Methods: During the period of February to July, 2003, E. coli
and K. pneumoniae isolates were collected from 12 hospitals in
Korea. Antimicrobial susceptibilities were tested by disk diffu-
sion method, and ESBL-production was determined by the
double disk synergy test. MICs of b-lactam antibiotics were
tested by agar dilution method. Transferabilities of ceftazidime-
resistance of ESBL-producers were tested by conjugation.
Isoelectric focusing was performed to determine the pIs of
ESBLs. Searches for blaTEM, blaSHV, blaCTX-M, blaPER-1,
blaVEB, blaIBC, blaGES and blaTLA genes were performed by
PCR ampliﬁcation, and the genotypes of ESBLs were deter-
mined by direct nucleotide sequence analysis of ampliﬁcation
products.
Results: Resistance ratios of E. coli (n = 246) and K. pneumoniae
(n = 239) isolates to ceftazidime were 8.5% and 20.1%, respect-
ively. Twenty-three isolates (9.3%) of E. coli and 55 (23.0%)
K. pneumoniae isolates showed positive results in the double disk
synergy test. Most prevalent Ambler class A ESBL genotypes in
E. coli isolates were blaCTX-M-15 (n = 4) and blaCTX-M-3
(n = 3), and each of blaCTX-M-14, blaSHV-12, and blaTEM-52
gene was also found in one isolate. One E. coli isolate contained
blaCTX-M-15 and blaSHV-12 genes, simultaneously. Most pre-
valent ESBL genotypes in K. pneumoniae were blaSHV-12
(n = 30) and blaCTX-M-3 (n = 13), and blaCTX-M-14 (n = 5),
blaSHV-2a (n = 3), blaSHV-5 (n = 2), blaTEM-52 (n = 1), blaGES
(n = 2) genes were also found in K. pneumoniae isolates. Some of
K. pneumoniae isolates contained more than 2 ESBL genes,
simultaneously; blaSHV-12 plus blaCTX-M-3 (n = 1), blaSHV-12
plus blaCTX-M-14 (n = 2), blaSHV-12 plus blaGES (n = 2), and
blaTEM-52 plus blaSHV-12 plus blaCTX-M-3 genes (n = 1).
Nucleotide sequence of blaGES genes from 2 K. pneumoniae
isolates were different from those of other ESBL genes.
Conclusion: It is concluded that CTX-M-type ESBL-producing
E. coli and K. pneumoniae isolates are spreading, and a new GES-
type ESBL has emerged in Korea. Periodical survey for inspect-
ing spread of ESBLs are needed.
P467
CTX-m type A-lactamases among ESBL
producing Escherichia coli in a tertiary care Greek
hospital
P. Sikalidou, D. Soﬁanou (Thessaloniki, GR)
Objectives: The CTX-M- type enzymes are a group of molecu-
lar class A extended-spectrum b-lactamases (ESBLs) that exhibit
an overall preference for cefotaxime rather than ceftazidime and
higher susceptibility to tazobactam than to clavulanate. The aim
of this study was to investigate the presence of CTX M type
enzymes among ESBL producing Escherichia coli.
Methods: A total of 150 non duplicate E.coli were recovered as
ESBL producers All strains were isolated from clinical speci-
mens. Identiﬁcation and susceptibility testing was performed
using VITEK 2 automated system(bioMerieux, France). All
isolates were screened for ESBL production by the double–
disk–synergy–test(DDST). The presence of bla CTX-M alleles
was evaluated by PCR, initially with universal primers and then
with primers speciﬁc for CTX-M-3. The PCR products were
separated in 1.5% agarose gels and were visualized under UV
light after staining with ethidium bromide.
Results: Among 150 ESBL positive strains studied 68 (44%) were
CTX-M producers. Most isolates showed high MIC values for
Cefotaxime (8–64 mg/l) and bordline values for ceftazidime.
Most of isolates were sensitive to cefoxitin (except six isolates that
were resistant to cefoxitin) and all were sensitive to piperacillin/
tazobactam. The majority of CTX-M positive isolates belongs to
CTX-M-3. The CTX-M positive isolates were recovered from
hospitalized patients and from outpatients though at lower rates.
Epidemiological analysis showed that forty eight (73%) CTX-M
positive isolates were identiﬁed in urine sample, followed by
those recovered from wounds (12 isolates; 18%), blood (3isolates;
4.5%) and bronchial exudates (3 isolates; 4.5%).
Conclusion: CTX-M type enzymes appear to be emerging
among E.coli isolates in both the hospital and community
environment. This study provides further evidence of the global
dissemination of CTX-M type ESBLs and emphasizes the need
for their epidemiological monitoring.
P468
Functional characterisation of IS1999, an
IS4-family member involved in beta-lactam
resistance gene mobilisation
D. Aubert, T. Naas , C. Heritier, L. Poirel,
P. Nordmann (Kremlin-Bicetre, F)
Objectives: The insertion sequence IS1999 is widespread
among Pseudomonas aeruginosa isolates where it is inserted
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inside a class 1 integron upstream of the veb1 gene cassette
encoding an extended-spectrum beta-lactamase. Recently, an
iso-IS1999 (ﬁve silent nucleotide substitutions as compared to
IS1999) has been detected in Klebsiella pneumoniae upstream of
another beta-lactam resistance gene, blaOXA-48, which posses-
ses a signiﬁcant carbapenemase activity. An outward directed
promoter, pOUT located close to the left inverted repeat of
IS1999 was shown to be responsible for enhancing the blaVEB-1
gene expression in P. aeruginosa. The aim of this work was to
study the role of IS1999 in expression and mobilization of
medically relevant antibiotic resistance genes.
Methods: Transposition experiments combined with a mating-
out assay system have been undertaken using single IS1999
elements or composite transposons tagged with a kanamycin
resistance gene. 5¢RACE was used to map the promoter of
blaOXA-48 gene expression.
Results: The upstream located iso-IS1999 element provided
blaOXA-48 with the outward-directed promoter, pOUT, respon-
sible for its expression. Further analysis of the genetic environ-
ment of blaOXA-48 identiﬁed a second identical copy of iso-
IS1999, thus deﬁning a novel composite transposon, named
Tn1999. On both sides of Tn1999 a 9-bp target site was found
which is the signature of a transposition event.This insertion
sequence was capable of transposing onto the conjugative
plasmid pOX38-Gen either as a single element or as various
composite transposons. Sequence analysis of the insertion sites
revealed that IS1999 inserted preferentially into DNA targets
containing the consensus sequence 5¢-NGCNNNGCN-3¢. The
transposition frequencies of the iso-IS1999 element was 10 fold
lower as compared to IS1999, thus suggesting that these ﬁve
nucleotide substitutions, even though silent, may play a role in
the transposition process.
Conclusions: This study characterized an actively transposing
insertion sequence, IS1999 capable of mobilization and activa-
tion of another expanded spectrum b-lactamase gene.
P469
Integrase-mediated veb1 gene cassette
mobilization
T. Naas, D. Aubert, P. Nordmann (Kremlin-Bicetre, F)
Objectives: The veb1 gene cassette that encodes the extended
spectrum beta-lactamase, VEB-1 is increasingly isolated from
Gram-negative rods,where it is inserted into thevariable regionof
class 1 integrons varying in size and composition. However in all
these integrons, theveb1gene cassettewas alwaysassociatedwith
the aadB gene cassette encoding an aminoglycoside adenylyl-
transferase and in Pseudomonas aeruginosa, in addition to aadB, an
insertion sequence, IS1999, was inserted upstream of the veb1
gene cassettewithin the integron speciﬁc recombination site, attI1.
Methods: Naturally encountered integron-structures either
with or without aadB and/or IS1999 were investigated in
respect to cassette excision and excision/integration into the
recipient integron In3 located onto the conjugative plasmid R388
and in presence of over-expressed integrase gene.
Results: The co-excision of both veb1/aadB gene cassettes was
more efﬁcient than excision of veb1 alone and the frequency of
veb1/aadB excision/integration frequency was 50 fold higher
than veb1 alone. Replacement of attC site of veb1 with that of
aadB gene cassette, restored a recombination frequency for veb1
gene cassette similar to that of aadB. Furthermore, the insertion
of IS1999 within the attI1 recombination site reduced signiﬁ-
cantly the recombination frequency and only co-excised veb1/
aadB gene cassettes could be detected.
Conclusions: Besides gene activation and mobilization, ISs are
usually capable of inactivating functional DNA sequences. This
is the case for IS1999 which insertion into attI1 site, reduced
signiﬁcantly recombinational properties of attI1, thus maintain-
ing the veb1 gene cassette in the ﬁrst position of the integron
and thus ensuring optimal gene expression. The higher excision
rates of veb1/aadB gene cassettes together may explain the
frequent association between these two gene cassettes and
suggests that the attC site of veb1 gene cassette is not efﬁcient
for speciﬁc recombination.
P470
Development of a multiplex PCR assay for genes
encoding CTX-M extended-spectrum
beta-lactamases
N. Woodford, E.J. Fagan, M.J. Ellington (London, UK)
Objectives: CTX-M extended-spectrum beta-lactamases
(ESBLs) are increasingly prevalent worldwide, including in the
UK where nearly one half of all microbiology laboratories have
encountered producers. More than 30 CTX-M beta-lactamases
have been described and are divided into ﬁve phylogenetic
groups. Characterisation of the blaCTX-M alleles present in
clinical isolates is time-consuming, typically requiring multiple
PCRs with universal and then group-speciﬁc primers. We
sought to develop a multiplex assay that could differentiate
alleles encoding CTX-M enzymes belonging to the ﬁve major
phylogenetic groups.
Methods: The sequences of reference blaCTX-M alleles were
aligned and group-speciﬁc regions were identiﬁed. Primers
speciﬁc for alleles encoding enzymes belonging to groups 1, 2
and 9 were designed in silico; those for blaCTX-M-25/-26 and for
blaCTX-M-8 were developed and optimised empirically. Predic-
ted amplicon sizes for blaCTX-M alleles were: group 1, 415 bp;
group 2, 552 bp; group 9, 205 bp; group 25/26, 327 bp; and CTX-
M-8, 677 bp. The primers were evaluated separately and in a
multiplex. One hundred and forty-two referred isolates of
Enterobacteriaceae were used as test samples. As controls, we
included 6 isolates known to produceCTX-M-15 enzyme, and one
producer each of CTX-M-2, -9, -14, -25 and -26. No CTX-M-8
producer was available.
Results: A multiplex assay was designed that incorporated 9
primers. The phylogenetic groups assigned by this assay to the 11
control isolates were consistent with the blaCTX-M allele present,
and amplicons matched the predicted sizes. Among the referred
isolates, 113 (79.5%; 88 E. coli, 24 Klebsiella spp., 1 Morganella sp.)
contained alleles encoding group 1 enzymes, 28 (19.7%; 26 E. coli,
2 Klebsiella spp.) produced group 9 enzymes, and 1 isolate of
E. coli produced CTX-M-2. The inferred producers of group 1
enzymes included 17 prospectively-tested members of a UK
epidemic CTX-M-15-producing E. coli strain.
Conclusions: We have developed a multiplex PCR that can
detect and distinguish alleles encoding CTX-M enzymes of
groups 1, 2, 9 and 25/26. Its ability to detect blaCTX-M-8 has not
been proven, but it includes primers that should detect this rare
variant. CTX-M ESBLs are recognized worldwide as a increas-
ingly-serious public health concern. This simple assay will assist
in monitoring their emergence and dissemination.
P471
Molecular characterisation of plasmids from
CTX-M-15-producing Escherichia coli strains
responsible for outbreaks in the United Kingdom
E. Karisik, M.J. Ellington, R. Pike, M.E. Ward, E.J. Fagan,
D.M. Livermore, N. Woodford (London, UK)
Objectives: Since 2003, E. coli with CTX-M ESBLs have spread
widely in the UK. The epidemiology is partly clonal, including
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ﬁve major strains (A-E), as well as many diverse producers.
Strains A (the most prevalent type) and D are the most clearly-
distinct of the major lineages, and this study aimed to charac-
terise the plasmids responsible for their multi-drug resistance.
Methods: Plasmids were extracted by alkaline lysis and blotted
onto nylon membranes for hybridisation. Antibiotic resistance
was transferred into E. coli DH5-alpha by electroporation. MICs
for clinical isolates and transformants were determined and
interpreted according to BSAC guidelines. Isoelectric focusing
(IEF) was used to detect beta-lactamases; bla genes were
identiﬁed by PCR and sequencing.
Results: Eleven isolates of strain A and 3 of strain D showed
various combinations of beta-lactamase expression, with pI
values of 5.4, 7.5 and 8.6, corresponding respectively to the
blaTEM-1, blaOXA-1-like and blaCTX-M-15 genes detected by
PCR. Strain D isolates consistently expressed all three enzymes.
All strain A isolates expressed OXA-1-like and CTX-M-15,
though the latter was difﬁcult to detect by IEF, apparently owing
to low expression associated with an IS26 insertion element
between blaCTX-M-15 and its normal promoter. Only 6 of the 11
strain A isolates produced TEM-1. Hybridization studies
showed blaCTX-M was located on plasmids of 150 kb and
70 kb in strains A and D, respectively. blaTEM-1 and/or
blaOXA-1-like genes were also located on these plasmids.
MICs for transformants revealed these plasmids also mediated
resistance to tetracyclines, tobramycin, amikacin (low level),
gentamicin (plasmid from strain D only), and trimethoprim
(plasmid from strain A only). The original clinical isolates were
also resistant to ciproﬂoxacin.
Conclusions: blaCTX-M-15 was plasmid-mediated in both
major E. coli strains and was linked with blaTEM-1 and/or
blaOXA-1-like on large plasmids, which also conferred resist-
ance to several aminoglycosides, tetracyclines and trimetho-
prim. This multi-resistance left only carbapenems as possible
treatments for severe infections.
P472
Salmonella enterica serovar Virchow with
TEM-52 ESBL in Greece
S. Maraki, I. Neonakis, E. Scoulica, Y. Tselentis (Heraklion,
Crete, GR)
Introduction: Salmonella enterica serovar Virchow, is one of the
non-typhoidal Salmonella species (NTS) that infect humans. Due
to it’s potency to cause invasive diseases, isolation of this
serovar and specially isolation of strains with acquired resist-
ance mechanisms is of great concern. TEM-52 is an extended
spectrum beta-lactamase (ESBL), well established in many
countries. Here we report on the ﬁrst detection of TEM-52 in
S. enterica serovar Virchow.
Case summary – ESBL analysis: The strain was isolated from
the stools of an adult patient with a 7-day history of
gastroenteritis. On admission he was afebrile and dehydrated.
Physical examination was otherwise normal. Biochemistry
revealed mildly elevated urea levels. Identiﬁcation was made
with the API 20E system and serotyping was performed by the
slide agglutination method with commercial antisera. Disk
diffusion and E-test method were used to determine suscep-
tibilities and MICs to antimicrobials. Among others the strain
was susceptible to aminoglycosides and newer quinolones, but
resistant to ampicillin, ticarcillin, piperacillin and intermedi-
ately resistant to third generation cephalosporins.A positive
double-disk synergy test, indicative of an ESBL production led
us to further in-depth investigation with analytical isoelectric
focusing (IEF), PCR with speciﬁc SHV- and TEM-type primers
and sequencing. Only TEM-speciﬁc primers gave a positive
signal, which upon sequencing, revealed to match totally with
the TEM-52 sequence determinant. This is in accordance with
the result of the IEF that showed one beta-lactamase band of
isoelectric point (pI) 6.
Conclusion: Extended-spectrum beta-lactamases (ESBLs) are
rarely found among Salmonella strains, compared with other
members of Enterobacteriaceae. Sporadic cases or even out-
breaks caused by ESBL-producing Salmonella strains have
already been described. To our knowledge, this is the ﬁrst
time that TEM-52 is being detected in S. enterica serovar
Virchow. The emergence of ESBLs in NTS represents a serious
problem, as treatment alternatives are limited especially in
children.
P473
Effect of inoculum size on the activity of
betalactams and betalactam-inhibitors against
SHV-, TEM- and CTX-M-producing
Enterobacteriaceae
L. Romero Perez, L. Lopez, J. Rodriguez-Bano,
A. Pascual (Seville, E)
Objective: To investigate the effect of inoculum size on the
activity of imipenem (IMP), amoxicillin-clavulanate (AMC) and
piperacillin-tazobactam (PTZ) against well-characterized and
clinically isolated ESBL-producers strains and their respective
transconjugants.
Material and methods: A total of 16 E. coli and 6 K. pneumoniae
isolates producing only one ESBL were selected. The character-
ization of beta-lactamases was realized by Isoelectric focusing
(IEF) and then by ampliﬁcation and sequencing of the respective
bla genes. Thirteen expressed CTX-M-14, one CTX-M-9, ﬁve
SHV-12, two SHV-4 and one TEM-4. MICs were determined by
NCCLS broth microdilution method using as inocula: 5 · 105
(NCCLS standard inoculum), 5 · 106 and 5 · 107 CFU/ml.
Results: When the standard inoculum was used, all the strains
were found to be susceptible to IMP, 20 (91%) to AMC and 20
(91%) to PTZ. When the inoculum size was increased to
5 · 106 CFU/ml, the MICs values increased 1–2 dilutions with
the three antibiotics in all the cases. At an inoculum of
5 · 107 CFU/ml, a 2–4-fold increase in the MICs values were
observed with IMP, but all the strains showed low MICs values
£0.5 mg/L. For AMC, the increase observed with 5 · 107 CFU/
ml were of 1–2 dilutions (21 strains) and 3 dilutions in one
strain. Forteen (64%) strains remained susceptible to AMC with
the highest inoculum, 5 (23%) strains became intermediate and 3
(14%) became resistants. The change to resistant category in
AMC was only observed in CTX-M-producing isolates. At an
inoculum of 5 · 107 CFU/ml, the PTZ MICs values increased
dramatically to 256 mg/L (5–9 dilutions). With this inoculum,
all the strains became resistants to PTZ regardless the ESBL-type
produced.
Conclusions: At a high inoculum of 5 · 107 CFU/ml, signiﬁ-
cant differences were found between AMC and PTZ against the
ESBL-producing strains. While 64% of strains remained sus-
ceptible to AMC when the inoculum rose, all the strains became
resistant to PTZ with very high MICs values. All the strains
remained susceptible to IMP irrespective of the inoculum tested.
These data suggest that AMC should be evaluated in clinical
studies as an alternative to IMP for the treatment of susceptible
strains even when causing infections with a high bacterial
charge.
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Elevated frequency of second-step ceftazidime
resistance in hypermutable mutS negative
Escherichia coli harbouring an extended spectrum
beta-lactamase
M.J. Ellington, D.M. Livermore, T.L. Pitt, L.M.C. Hall,
N. Woodford (London, UK)
Objectives: Hypermutability in E. coli can result from lesions in
the DNA-repair pathway gene mutS. The rate of ESBL devel-
opment has been shown to be elevated in a mutS-negative strain
carrying the pUC19-TEM or TEM-1 beta-lactamases. To examine
the effect of hypermutability on the emergence of second-step
ceftazidime (CTZ) resistance, we tested the rate of mutation to
resistance at up to 16 · CTZ MIC in wild-type and mutS-
negative E. coli each harbouring a ﬁrst-step TEM extended-
spectrum beta-lactamase (ESBL) mutant encoded on pUC19.
Methods: Etest was used to determine the CTZ MICs for wild-
type and mutS negative E. coli harbouring an Arg164His
substituted ﬁrst-step TEM mutant on pUC19. Mutants resistant
to 32, 64 and 128 ug/ml CTZ were selected in triplicate
experiments on agar, and the frequency of mutation to each
level of resistance was calculated. MICs were determined, and
beta-lactamase gene sequencing was performed.
Results: MICs of CTZ for both mutS-negative E. coli and the
corresponding wild-type parent with the ﬁrst-step ceftazidimase
mutant of the TEM-pUC19 beta-lactamase were 8 ug/ml. The
emergence of mutants resistant to 32, 64 and 128 ug/ml CTZ
was 10–15 fold higher for the mutS-negative strain (e.g.
1.82 · 10)5, SE 9.89 · 10)6 at 32 ug/ml CTZ) than the wild-
type (e.g. 1.33 · 10)6, SE 9.15 · 10)7 at 32 ug/ml CTZ). MICs of
CTZ for mutants from the mutS-negative and wild-type host
ranged from 8–64 lg/ml. MICs of non-ESBL substrates such as
cefoxitin and ciproﬂoxacin were also raised. DNA sequencing of
8 selected mutants from each parent showed no additional
changes beyond the ﬁrst-step Arg164His substitution. Thus, the
selection of second-step resistance was not contingent upon
additional mutations in the beta-lactamase gene.
Conclusion: Second-step CTZ resistance was readily selected in
both wild-type and mutS hosts harbouring a TEM-ESBL, but the
mutS host gave rise to second-step resistance more readily. The
mechanism of these additional resistances may entail permeab-
ility and/or efﬂux changes; the beta-lactamase gene was
unaltered.
P475
Accelerated development of TEM-29 extended-
spectrum beta-lactamase from TEM-1 in
hypermutable, mutS, Escherichia coli
M.J. Ellington, D.M. Livermore, T.L. Pitt, L.M.C. Hall,
N. Woodford (London, UK)
Objectives: Lesions in the DNA-repair pathway gene mutS can
result in a hypermutable phenotype in E. coli, and this may
expedite the diversiﬁcation of beta-lactamases. To gain signiﬁ-
cant activity against ceftazidime (CTZ), at least one amino acid
substitution must occur in the TEM-1 beta-lactamase. In order to
examine the effect of hypermutability on extended-spectrum
beta-lactamase (ESBL) development from TEM-1, we compared
the rate of CTZ resistance development from blaTEM-1 in wild-
type and mutS-negative E. coli.
Methods: The XmnI and BsrFI fragment of pBR322 replaced the
corresponding fragment of pUC19, creating a pUC19-based
vector encoding classical TEM-1; designated pTEM-1. CTZMICs
for isogenic wild-type and mutS-negative E. coli harbouring
pTEM-1 were determined by Etest. Selection of mutants resist-
ant to 4 · MIC CTZ was performed in triplicate experiments
from 3 independent cultures on agar, and the frequency of CTZ
resistance was calculated. MICs for randomly-selected colonies
were determined. Mutations in blaTEM-1 were identiﬁed by
sequencing.
Results: MICs of CTZ for the wild-type and mutS-negative
parent strains harbouring pTEM-1 were 0.25 lg/ml. The emer-
gence rate of CTZ-resistant mutants was >300-fold higher for the
mutS-negative strain (1.58 · 10)6, SE 8.55 · 10)7) than for the
wild-type (4.14 · 10)9, SE 8.43 · 10)10). Thirteen of 19 mutants
from the mutS-negative host were CTZ resistant at the British
Society for Antimicrobial Chemotherapy breakpoint of >2 lg/
ml (range 4–16 lg/ml). DNA sequencing showed an Arg164His
substitution in all of 4 sequenced mutants. This mutation
changes TEM-1 into the ESBL TEM-29. All of 20 mutants
selected from the wild-type host were susceptible to <2 lg/ml
CTZ, and, none of these had mutations in the blaTEM-1 gene.
Conclusions: Resistance-conferring point mutations occurred
readily within blaTEM-1 in a mutS background but did not
occur at a detectable frequency in a wild-type background.
Whilst the role of hypermutators in ESBL evolution is uncertain,
these experiments indicate its potential.
Various antimicrobial agents including disinfectants
P476
Antimicrobial effect of allicin on
intramacrophages Brucella spp.
R. Shapouri, M. Sattari, Z.M. Hassan (Tehran, IR)
Objectives: Investigation the effect of Allicin as a antimicrobial
agent on intramacrophage brucellae.
Methods: In this study, garlic choloroformic extract prepared
and choloroform separated from garlic extract in vacuum pump.
The purity and concentration of the allicin in the extract was
determined by high performance liquid chromatography
(HPLC) based on a previously published method. Then effect
of extract on mouse peritoneal macrophages (6–8 weeks old
female BALB/c mice) and on intramacrophage survival of
B.melitensis Rev.1 & B.abortus S19 on cell culture of mouse
peritoneal macrophages studied.
Results: Results indicated that dilution 1:20 of extract (1071 mi-
crogr/ml allicin) shown inhibitory effect on peritoneal macro-
phages while this effect were not seen by other dilutions. At the
second stage number of CFU of Rev.1 & S19 in lysates for each
treatment group shown signiﬁcance differences with control
group. We have shown, dilutions 1:40 (439 microgr/ml allicin),
1:80 (218 microgr/ml allicin)and 1:160 (128 microgr/ml alli-
cin)causes complete elimination of intracellular brucellae
(5,00,000 organism) at 24 hr.
Conclusion: Data clearly show that garlic extract was effective
on intramacrophages Brucella in vitro. Also other investigators
shown the immune enhancing effects of garlic extract such as
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activation of macrophages and T-cells. We suggest using of
garlic and its compounds in treatment of brucellosis, especially
for animal brucellosis, there is no effective antibiotic therapy.
P477
Bactericidal and anti-adhesive properties of
culinary and medicinal plants against
Helicobacter pylori
R. O’Mahony, H. Al-Khtheeri, A. Bogahawata, D. Weerasekera,
D. Vaira, M. Avedian, N. Fernando, J. Holton, C. Basset (London,
UK; Colombo, LK; Bologna, I; Lille, F)
Objectives: H. pylori colonises the stomach of over half the
human population and in 5–20% of those infected, causes severe
gastroduodenal diseases, including adenocarcinomas. Signiﬁ-
cant resistance of H. pylori to current antibiotic treatment is
being reported, resulting in failure to eradicate the organism.
Alternative approaches are needed and we therefore investi-
gated both the bactericidal and anti-adhesive properties of a
number of plants that are frequently used in cooking as well as
plants which are used medicinally in Sri Lanka, Iran and the
Middle East.
Methods: We have used H. pylori NCTC Type I (11637) as well
as 6 fresh clinical isolates of H. pylori. 18 plants were tested, of
which 14 have never before been tested against H. pylori: Aegle
marmelos, Coscinium fenestratum, Solanum xanthocarpum, Mollugo
cerviana, Solanum surattense, Piper longum, Glycrrhiza glabra,
Allium sativum, Petroselinum crispum, Anethum graveolens, Salvia
ofﬁcinalis, Oreganum vulgare, Artemisia dracunculus, Myristica
fragrans, Piper nigrum, Cinnamomum verum, Nigella sativa and
Borago ofﬁcinalis. Plants were boiled in water to make extracts
and simulate effects of cooking. The bactericidal activity of the
extracts (0.1 g/ml) was assessed by a standard kill-curve with a
ﬁnal inoculum of 1 · 107 organisms per ml over a time course of
60 minutes. The anti-adhesive property was assessed by inhibi-
tion of binding of FITC-labelled H. pylori to stomach sections
using confocal microscopy and quantiﬁed with the aid of a
software package (Metamorph).
Results: 5 of the plants had no bactericidal effect on any of the
isolates: Aegle, Piper nigrum, Anethum, Solanum surattense and
Allium. A weak effect (approx. 30% of bacteria killed) was seen
with Solanum xanthocarpum, Myristica, Petroselinum, Mollugo,
Piper longum and Coscinium. Successful killing of H. pylori was
demonstrated with Borago, Nigella, Cinnamomum, Origanum,
Salvia, Artemisia and Glycrrhiza, (100% of bacteria killed within
15–60 mins. Borago and Petroselinum also inhibited the adhesion
of H. pylori to stomach sections. Mean inhibition of the 4 strains
to stomach sections expressing the Lewis a antigen was 61% and
34% (for Borago and Petroselinium respectively) and for sections
expressing the Lewis b antigen, inhibition was 60% and 49%.
Conclusion: We have demonstrated both bactericidal and anti-
adhesive properties of a range of plants against H. pylori, which
could represent an alternative to failed antibiotic therapy.
P478
The investigation of antimicrobial impact of Thai
medicinal plant extracts against Escherichia coli
strains
S.P. Voravuthikunchai, S. Limsuwan, S. Wanmanee (Hatyai, TH)
Objectives: The effect of medicinal plant extracts on cell surface
hydrophobicity has been claimed to be one important antimi-
crobial mechanism. The aim of our study was to closely
investigate the effect of aqueous extracts of medicinal plants,
widely used in Thai traditional medicine for the treatment of
diarrhoea, on Escherichia coli surface properties and to correlate
this mechanism with their antimicrobial activity.
Methods: The effects of aqueous and ethanolic extracts of ten
medicinal plant species including Punica granatum Acacia cate-
chu, Andrographis paniculata, Holarrhena antidysenterica, Peltopho-
rum pterocarpum, Piper sarmentosum, Pluchea indica, Psidium
guajava, Punica granatum, Tamarindus indica, and Walsura robusta
were used against 15 different strains of E. coli. Salt aggregation
test to study their cell surface hydrophobicity, agar diffusion
assay, and agar microdilution method for detection of antimi-
crobial activity were studied.
Results: Acacia catechu and Punica granatum increased hydro-
phobicity of all bacterial strains tested 3 strains of E. coli O157:
H7 isolated from outbreak in Japan 1997, E. coli O26: H11, E. coli
O111: NM, E. coli O22, 3 strains of E. coli O157 O157: H7 isolated
from food, 5 strains of E. coli isolated from bovine, and E. coli
ATCC 25922. The hydrophobicity of bacterial strains increased
depending on the concentration of medicinal plants tested.
There was no correlation between aggregation property and
antimicrobial activity.
Conclusions: The activity of medicinal plants on hydrophobic-
ity of the E. coli cells showed no correlaton with the antibacterial
activity.
Acknowledgement: This work was supported by a fund from
Thailand-Tropical Diseases Research Programme. National
Center for Genetic Engineering and Biotechnology, Fiscal year
2004.
P479
Antimicrobial activity of chemical constituents
from Inula pseudolimonella (Asteraceae) growing
in Greece
G. Panoutsopoulos, N. Aligiannis, E. Chinou, I. Chinou
(Athens, GR)
Objectives: The aerial parts of Inula pseudolimonella yielded
9aˆ-hydroxyparthenolide 1, a new sesquiterpenic lactone 2,
together with the known sesquiterpenic lactones inusoniolide 3,
tomentosine 4, as well as the triterpenoid dammara-20,24-dien-
3aˆ-yl-acetate 5. All isolated compounds were identiﬁed bymeans
of spectral data (IR, 1HNMR 13CNMR,HRFABMS andCIDMS).
Methods: The in vitro antimicrobial activities of the extract as
well as from the pure isolated compounds were determined,
using the dilution technique, by measuring the MIC of them
against two Gram positive bacteria: S. aureus (25923) and
S. epidermidis (2228), and four Gram negative: P. aeruginosa
(27853), E. coli (25922), E. cloacae (13047), K. pneumoniae (13883), as
well as against three pathogenic fungi, Candida albicans (10231),
C. tropicalis (13801) and C. glabrata (28838). Standard antibiotics
were used in order to control the sensitivity of the tested bacteria
and fungi. The assayed strains were standards, from ATCC.
Results: Through the antimicrobial screening, the extract proved
tobeactive against all six testedbacteria aswell as the tested fungi,
while the pure isolated compounds 1–5, which were also assayed
against the same microorganisms, showed an interesting proﬁle
mostly againstGram (+) bacteria. Compounds 1, 2 and 4 exhibited
the strongest antibacterial activity (MIC values 0.03–0.5 mg/ml)
and 2,4 the strongest antifungal one (MIC values 0.025–
0.07 mg/ml). All the rest of the tested compounds, showed
moderate to strong activities against all the abovemicroorganisms.
Conclusions: The results of the assays suggest that Inula
pseudolimonella, possesses strong antimicrobial activities. These
activities can be attributed, mostly, to the existence of sesquit-
erpenes (such as 2–4), which appeared to possess strong
activities against all tested microbia.
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Antimicrobial activity of Greek royal jelly and
chemical constituents
E. Meliou, I. Chinou, E. Chinou (Athens, GR)
Objectives: As a part of a systematic research on the chemical
composition and antimicrobial activities of Greek Bee-hive
products, we report in this study the antimicrobial activities of
Royal Jelly (extracts and pure isolated compounds), which, to
our knowledge, have never been studied before. Royal Jelly, so
called because it is the exclusive food of the Queen-bees.
Methods: The in vitro antimicrobial activities of Greek Royal
Jelly and of pure isolated compounds were determined, using
the disk diffusion technique, by measuring the zones of
inhibition of them against two Gram positive bacteria: S.
aureus and S. epidermidis, and four Gram negative: P. aeruginosa,
E. coli, E. cloacae, K. pneumoniae, as well as against three
pathogenic fungi, Candida albicans, C. tropicalis and C. glabrata.
The assayed strains were standards from ATCC. Besides, the
antimicrobial activities of all the above referred compounds
were tested against 11 clinical isolated microbial strains (of
S. aureus, S. epidermides, E. faecalis, Streptococcus haemoliticus,
P. aeruginosa, K. pneumonia, Salmonella enteritides, E. coli,
C. albicans, C. crusei, and C. tropicalis).
Results: Through the antimicrobial screening, the extracts
proved to be active against all six tested bacteria as well as the
tested fungi (zones of inhibition 12–16 mm). The chemical
composition of the extracts has been further studied and from
the 10 identiﬁed constituents, the major compounds (sembacic
acid, paraben, decanoic acid, 10-hydroxy-2-decenoic acid, 3,10
dihydroxy decanoic acid, 3,9 dihydroxy decanoic acid and 8,9
dihydroxy-decanoic acid) have been isolated and were also
tested, showing moderate to strong activities against all the
above referred microorganisms.
Conclusions: The results of the assays suggest that, Greek
Royal Jelly, possess strong antimicrobial activities. These activ-
ities can be attributed, to a considerable degree, to the existence
of decanoic acids derivatives (compounds with unique chem-
istry existing exclusively in Royal Jelly, among which two are
new natural products) which appeared to possess strong
activities against all tested microbia.
P481
In vitro hexetidine effect on bacterial adherence
to restorative materials used in dentistry
S. Alecu, G. Bancescu, S. Dumitriu (Bucharest, RO)
Adhesion of oral bacteria to restorative materials plays an
important role in the pathogenesis of oral diseases especially in
secondary caries onset. This study investigated the effect of a
hexetidine commercially available oral rinse on initial adhesion
of Streptococcus mutans to restorative materials in vitro. Three
types of biomaterials: glass ionomer, composite resin and
amalgam were included in this study. For standardization,
from each of these materials were prepared 1 cm2 square shape
pieces, with the surfaces polished as in routine dental ofﬁce
practice. The biomaterials were incubated 2 hours at 37C,
together with an inoculum of Streptococcus mutans in Bioﬁlm
Study Broth in two different conditions with and without
hexetidine. The Hexetidine was added to the medium in a
subminimal inhibitory concentration. The bacterial adherence
was evaluated by ﬁngerprinting a solid medium (Columbia agar
supplemented with 5% sheep blood) with the pieces of bioma-
terials after washing with phosphate buffer saline solution and
the colony counting per 1 cm2 was carried out after 24 h
incubation at 37C. In hexetidine free conditions, glass ionomer
was highly colonised and the lowest colonised was the amalgam
square piece. The presence of hexetidine in subminimal con-
centration decrease the adherence with almost 30% for all three
biomaterials tested, with no relationship with the material type.
P482
Antimicrobial effects of nonantibiotics – reversal
of resistance in Gram-positive bacteria
O. Hendricks, L. Aagaard, J.B. Christensen, M.N. Skov,
H.J. Kolmos, J.E. Kristiansen (Sønderborg, Copenhagen,
Odense, DK)
Objectives: The project investigates the antimicrobial activity of
deﬁned non-antibiotics against clinically relevant gram positive
bacteria and the interaction of these compounds with antibiot-
ics.Growing problems with antibiotic resistance have increased
the need for alternative antimicrobial treatment strategies.
Psychotropic therapeutics, especially the phenothiazines,have
antimicrobial activities and may reverse antibiotic resistance in
vitro (1). Such agents could be used as helper-compounds to
antibiotics.
Methods: The Minimum Inhibitory Concentration (MIC) of
each antibiotic against various strains employed in this study
was determined by the E-test system and checkerboard micro-
dilution techniques. MICs for all non-antibiotic test substances
were determined by agar- dilution. The interaction of each
antibiotic with the test substances was determined by the
checkerboard method and interpretation of synergy, additive or
interference effects was recorded.
Results: We found that all Gram-positive bacterial strains,
regardless of their susceptibility to regularly used antibiotics,
were inhibited by the test substances at concentrations of
8–128 mg/ ml. In case of sertraline, racemic and stero-isomeric
forms of thioridazine MIC levels at 8–32 mg/ ml were deﬁned.
Furthermore, racemic and stereo-isomeric forms of thioridazine
are characterized by resistance modifying abilities at subinhib-
itory concentrations. The study showed up to 256- fold reduc-
tion of primarily deﬁned MIC values of different antibiotics such
as oxacillin, erytromycin, vancomycin and ampicillin for differ-
ent Gram positive species (2). The concentrations used in
synergy studies are comparable to those found in body tissues
after therapeutically application of chlorpromazine.
Conclusion: Since many of the classical narcoleptics are known
to be mixtures of stereoisomers, the challenge for the future is
screening the pure isomers for reduced central nervous system
activity and maintained antibiotic potential and especially use
the CNS inactive stereoisomeres as ’’helper-compounds’’ util-
izing their potentials as antimicrobial resistant reversal agents of
Gram positive organisms.
Literature 1. Kristiansen JE. The antimicrobial activity of psych-
otropic drugs and stereo isomeric-analogues (disp)Dan Med
Bull 1990; 37:165–82.
2. Hendricks O et al. Antibakterielle Eigenschaften der Pheno-
thiazine–eine Behandlungoption fu¨r die Zukunft? Chemother J
2004; 13: 203–205.
P483
The antibacterial properties of EMLA-cream. An
in vitro study on common pathogenic bacteria
J.O. Berg, B.K. Mo¨ssner, M.N. Skov, F. Gottrup, H.J.
Kolmos (Odense, DK)
Objective: The purpose of this study was to investigate the
antibacterial properties of EMLA-cream on common wound
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pathogenic bacteria compared to lidocaine (lignocaine). Many
local anesthetic drugs have antibacterial properties. EMLA-
cream contain two anaesthetic drugs, lignocaine (25 mg/g) and
prilocaine (25 mg/g). Little is known of the antimicrobial
activity of this combination of compounds.
Method: An in vitro study was performed on 5 ATCC strains
and 5 clinical isolates of each of the following species: Staphy-
lococcus aureus, mehticillin resistant Staphylococcus aureus
(MRSA), Eschericia coli, Pseudomonas aeruginosa and Streptococcus
pyogenes. The test organisms were exposed to a pure solution of
EMLA-cream and a commercially available pure solution of
lidocaine 1% over a 24-hour period and time-kill-curves were
recorded.
Results: The anaesthetic cream was forund to have a substantial
antibacterial effect compared to growth controls. Lidocaine had
antibacterial effects to a lesser extent. With the anaesthetic cream
there was a rapid and signiﬁcant kill of all the tested strains
within two hours. Pseudomonas aeruginosa and Eschericia coli
were almost immediately killed.
Conclusion: EMLA-cream is an easily applicable and non-
painful way of topical anaesthesia. It can be used for example
prior to bedside debridement of a chronic wound. The cream
has signiﬁcant antibacterial properties on common wound
pathogenic bacteria in vitro. In the clinical setting, as a positive
side effect to the anaesthetic effect, EMLA-cream may minimise
the risk of iatrogenic bacterial spread and transient bacteraemia
during wound debridement.
P484
Comparative assessment of chloramine T
trihydrate against suspension and attachment
status of Legionella pneumophila strains
A. Kimiran Erdem, N. Sanli Yurudu, A. Cotuk, H. Kasgar
Ataer (Istanbul, TR)
Objectives: Legionella pneumophila has frequently been isolated
from man-made recirculating water systems, such as humidiﬁ-
ers, hot water systems and cooling towers. Several outbreaks of
Legionnaires’ Disease have been directly linked with contamin-
ated recirculating water systems. In order to prevent these
outbreaks, before practical usage, activity of a water treatment
biocide needs to be evaluated in laboratory conditions for both
attachment and suspension bacteria.The aim of this study was to
investigate the fatal activity of various concentrations of
monochloramine compound (Chloramine T trihydrate), which
is potential alternative to chlorine, at different contact times
against different Legionella strains [C1 isolated from a cooling
tower, C2 isolated from water and standard strain L. pneumophila
serogrup1 ATCC 33152, which was obtained from Hertfordshire
University Biodeterioration Center]. The susceptibility of envi-
ronmental isolates and standard strain,in different physiological
status (suspension and attachment) against biocide sensitivity
was investigated.
Methods: In this study, Skaliy and other’s qualitative suspension
test method which was modiﬁed based on ASTM (The American
Society for Testing Materials) E645-91 standard test method for
efﬁcacy of biocides prepared in cooling systems was used.
Results: In suspension status, it was found that in 100 mg/L
biocide killed all strains at zero time. 10 mg/L biocide killed C1
and standard strain in 3 hours contact time, and C2 strain in
6 hours contact time. 1 mg/L biocide killed all strains in
24 hours contact time. It was found that C2 strain is the most
resistant to biocides. The susceptibility of standard and C1 strain
was found to be similar against Chloramine.In attachment
status, it was determined that 15000 mg/L Chloramine killed C1
strain in 24 hours contact time, there was >1 log reduction for C2
strain and >2 log reduction for standard strain. 10000 mg/L
biocide dosage was found to have no effect within 24 hours
contact time for all strains. In attachment status, the sensivity of
strains was in order of C1, standard and C2 strain.
Conclusions: Attachment bacteria was found to be more resist-
ant than in suspension status bacteria. When a sample is
undertaken for evaulation of bacterial counts or the efﬁcacy of
biocide, samples must be taken from the both bulk water and
attachment and according to these results the effective biocide
dosage must be detected.
P485
Efﬁcacy of various biocides against
L. pneumophila depending on the contact time
A. Soler-Membrives, M. Garcı´a-Nun˜ez, S. Ragull, N. Sopena,
M.L. Pedro-Botet, M. Sabria` (Badalona, E)
Background: Cooling towers have been related to community-
acquired legionellosis outbreaks. Thus, the proper maintenance
and choice of biocides is important to maintain Legionella counts
at undetectable levels.
Aims: The aim of this study was to compare the antimicrobial
activity of four commercial cooling tower microbicides against
Legionella pneumophila, and to determine whether the contact
time was an important factor in the application of the correct
biocidal concentration.
Material and methods: Four cooling tower biocides were tested
against Legionella pneumophila (ATCC 33152): 2,2-dibromo-
3-nitrilepropionamide (biocide 1), a dilution of biocide 1 (biocide
2), bromo-chloro-5,5-dimethylhydantoin (biodide 3) and 1,3,5-
trichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione (biocide 4). And
in vitro test was performed following the prEN 13623 test
method (Chemical desinfectants and antiseptics- Bactericidal
activity of products against L.pneumophila- Test method require-
ments (phase2/step1)).
Results: Biocide 1 was found to be the best disinfectant
(effective at lower concentrations, 0.005 ppm). Biocide 2 was
active at concentrations 20-fold higher than biocide 1 (0.1 ppm),
followed by biocide 3, which was active at 5–10 ppm. The data
obtained indicated that biocide 4 also had bactericidal activity at
concentrations higher than 5ppm. No differences were found
when L. pneumophila was exposed to biocide 1, 2 and 4, at
different contact times (60 minutes or 24 hours). However,
biocide 3 presented a slow bactericidal activity; at least twice
the concentration of biocide 3 was needed at short contact times
(60 minutes), in contrast to prolonged contact times (24 hours).
Conclusions: Of the biocides tested we found 2,2-dibromo-
3-nitrilepropionamide (biocide 1) to be themost effective, because
it is active at very low concentrations, and its activity is long-
lasting.
P486
Effect of Thymbra capitata on Aspergillus: a
cytometric approach
S. Costa-de-Oliveira, G. Gonc¸alves, C. Pina-Vaz, A. Gonc¸alves-
Rodrigues, M. Gonc¸alves, L. Salgueiro, C. Cavaleiro, E. Pinto,
J. Martinez-de-Oliveira (Porto, Coimbra, P)
Essential oils have been empirically used as antimicrobial
agents, but its mechanisms of action are still unknown. The
increased incidence of aspergilosis, particularly in patients with
impaired immunity, justiﬁes the search of alternatives to
classical antifungal therapy. Thymbra capitata is a widespread
plant in southern Portugal (Algarve), traditionally used due to
its anticrobial proprieties, with great activity against Aspergillus
(1).
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Objective: To clarify the mechanism of action of T. capitata and
of their main active components (carvacrol and p-cymene) on
clinical species of Aspergillus.
Methods: Four strains of A. fumigatus (3 clinical isolates and 1
American Type Culture Collection strain), 2 clinical isolates of A.
niger and 1 of A. ﬂavus were studied. The Minimal Inhibitory
Concentration (MIC) and Minimal Lethal Concentration (MLC)
were determined using NCCLS M38-A protocol. To clarify the
mechanism of action a ﬂow cytometry assay using propidium
iodide (PI; Sigma) was used (2). 106 conidia/ml were incubated
with MIC and MLC of T. capitata and their main components
during 1, 3, 5 and 7 hours at 37C, following staining with 1 lg/
ml of PI during 15 minutes, and the percentage of stained
conidia evaluated by ﬂow cytometry (Beckman Coulter XL-
MCL) . PI only penetrates cells with a severe impairment of the
cell membrane, i.e. dead cells.
Results: The MIC and MLC values were similar, ranging
between different strains from 0.16 to 0.64 ll/ml(V/V), accord-
ing the different strains. The percentage of dead conidia
increased with the incubation time. Seven hours after incubation
with MLC values over than 90% of the cells dead.
Conclusions: This study clearly shows that T. capitata and its
main components are fungicidal by producing severe lesion on
fungal membrane, an effect that deserves evaluation in future
clinical trials.
(1) Salgueiro LR, et al. Planta Med 2004; 70(6):572–5.
(2) Pina-Vaz C, et al. J Med Microb 2000; 49: 831–840.
Financial support: FCT, POCTI and FEDER (POCTI/40167/
ESP/2001).
P487
Aspects of the mode of action of the novel biocide
Akacid Forte on E. coli
H. Kerschner, A. Georgopoulos, J. Wernisch, W. Binder (Vienna,
A)
Objective: Akacid Forte (Poly-oxyalkylenebiguanide) is a novel
biguanidic biocide intended for use as a disinfectant. The aim of
this work was to investigate the mechanism of action of this
biocide on E. coli using a variety of techniques.
Methods: Initially the rapid bactericidal effect of the substance
was demonstrated and quantiﬁed by MIC and MBC testing as
well as in killing curve experiments. Potassium efﬂux from
E. coli was evaluated using atomic absorption spectroscopy. The
uptake of the hydrophobic probe NPN by E. coli was measured.
Membrane disruption was assessed with carboxyﬂuorescein
containing phospholipid vesicles and with E. coli spheroplasts.
Photomicrographies of bacteria and vesicles were taken.
Results: The MIC and MBC of Akacid Forte for E. coli was
1 lg/ml. Akacid Forte induced rapid efﬂux of potassium ions
from E. coli cells. Also, NPN uptake was enhanced by the
substance. Vesicle and spheroplast membranes were disrupted
by Akacid Forte.
Conclusion: The experiments show that Akacid Forte has
distinct membrane damaging properties. Given the fact that an
intact membrane function is essential for the survival of any cell,
these results provide evidence that damage to the membrane is
an important contribution to the mode of action of Akacid Forte
against E. coli.
P488
The role of iodine in ampicillin and tetracycline
antibiotic resistance transfer
Q. Behzadiyan-Nejad, S.D. Siadat, S. Najar Peerayeh,
B. Tabaraie, H. Ahmadi, M. Nejati (Tehran, IR)
Disinfectants or chemical biocides are widely used to remove
infectious agents, but resistance to the agents is observed among
some bacteria. A number of research reports have expressed
concern that the use of biocides may contribute to the develop-
ment of antibiotic resistance. Therefor we studied the effects of
different concentration of iodine on antibiotic resistance transfer
toSalmonella typhimurium.Salmonella typhimuriumwas considered
as recipient species and E.coli strains was selected as donor of
antibiotic resistance. The bacterial antibiotic susceptibility was
accomplished by Disk diffusion method, and MIC was also
determined. Then the Salmonella strains (recipient) was treated
with sub MIC of iodine, and Salmonella and E. coli(donor) were
mixed in TSB broth. Antibiotic resistance transfer was studied in
the Bismuth sulfate agar containing antibiotics. The results
indicated that the treatment of Salmonella strains with %0.1–
%0.3 iodine, causes an increase in resistance transfer rate to
Ampicillin and Tetracycline, but it was decreased when the
concentration increased. This ﬁndingwas signiﬁcant, and empha-
sizes the important role of the special concentrationof disinfectant
substances like iodine on antibiotic resistance transfer.
Urinary tract infections
P489
Pathogenicity and susceptibility to antibiotics of
Proteus mirabilis strains isolated from urinary
catheters
A. Torzewska, M. Baranowska, A. Blaszczyk, A. Rozalski
(Lodz, PL)
Objectives: Proteus mirabilis is common microorganism isolated
from catheterized patients. P. mirabilismay persist in the urinary
tract despite many changes of catheter and antibiotic therapy. It
blocks urinary catheters through the formation of extensive
crystalline bioﬁlms. The obstruction of urine ﬂow can induce
episodes of pyelonephritis, septicemia and urinary calculi. The
goal of this study was to determine important virulence factors
of P. mirabilis strains recovered from catheter of long-term
catheterized patients, as well as their resistance to antibiotics.
Methods: Collection of 22 P. mirabilis strains was obtained from
88 Foley catheters. We analysed the following virulence factors:
type of ﬁmbriae by hemagglutination test, activity of urease
using method of Weatherburn and ability of these bacteria to
swarm over the surface of agar media. Invasiveness and
adherence of selected strains to Hu 609 line (normal human
bladder urothelium) were also determined. Urifast Twin 1C xp
test was used to study the susceptibility of the P. mirabilis. The
antibiotics included in this test were tested at one concentration,
the low breakpoint according to the NCCLS standard.
Results: It was found that all of tested P. mirabilis strains
indicated urease activity and it was ranged from 217 to 95 U (1
U is a number of micrograms ammonium released per min per
milligram protein of bacteria). Among of all strains 13 (49%)
were able to swarm over solid surface. Fimbriae were observed
in most strains, both MR/P and MR/K (72%, 59% strains,
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respectively). It was also found that P.mirabilis isolated from
urinary catheter demonstrated a signiﬁcant ability to adhere and
penetrate normal urothelium. Resistance rate of P.mirabilis was
as follows: ciproﬂoxacin, 91%, gentamicin, 86%, amoxicillin 76%,
trimethoprim/sulfamethoxazole, 67%, norﬂoxacin, 52%, amox-
icillin/clavulanic acid, 33% and cephalothin, 33%. Ceftriaxone
and amikacin were the most active antimicrobials.
Conclusion: Our results showed that P.mirabilis colonizing
urinary catheter were drug resistant as well as had virulence
factors enable them to invade the kidney and induce infection,
usually chronic commonly results in the formation of bladder
and kidney stones.
P490
Comparison of two closed urinary catheter
system bags with single and double non-return
valve using a laboratory model
S. Wenzler-Ro¨ttele, E. Schmidt-Eisenlohr, A. Bogdan,
D. Mlangeni, M. Dettenkofer (Freiburg, D)
Objectives: Comparison in the laboratory of two urinary closed
system bags (CSB), one with single the other with double non-
return valve (NRV) with regard to bacterial ascension from the
drainage bag to the bladder.
Methods: The test was performed in a microbiological laborat-
ory using a urinary tract model: 10 drainage bags with a single
NRV, (CSB A) and another 10 with the double NRV (CSB B)
were inoculated with E. coli (ATCC 25922). Daily samples were
taken from two drainage ports of each catheter system - one at
the connection between the catheter and the drainage tube (Port
I), and one above the top of the bladder (between the peristaltic
pump and the bladder, Port II) -Time till the E. coli reached the
drainage ports (time to positivity) was measured.
Results: No great differences were observed between the two
systems in time to positivity at Port I (mean: 9.2 (CSB A) vs
9.5 days (CSB B), range: 6–12 days each). However, substantial
differences were observed between the two systems in time to
positivity at Port II. Port II in the bladder model using CSB A
became positive after a mean of 13.9 days (range: 12–17 days),
whereas Port II of the model using CSB B became positive after
19.2 days (range: 15–20 days). This amounts to a difference of
5.3 days.
Conclusions: Under laboratory conditions, colonization of the
bladder (time to positivity at Port II) was clearly delayed using
the double NRV in comparison to using the single NRV-system.
Clinical trials should be conducted to investigate whether the
CSB with the double NRV-system really has the ability to delay
infection in vivo.
P491
Antimicrobial resistance rates in nosocomial
catheter-associated urinary tract infections
M. Kompoti, S. Drimis, K. Kontos, A. Georgopali, O. Zarkotou,
K. Tryﬁnopoulou, C. Nikolopoulou, D. Voutsinas (Athens, GR)
Object: To assess the incidence of urinary tract infections (UTI)
and antimicrobial resistance rates of the isolated microorgan-
isms following indwelling urethral catheterization among hos-
pitalized patients.
Methods: We studied prospectively all patients admitted to our
medical department during a one-year period, provided that
they had been newly catheterized upon admission and that the
urine culture obtained within the ﬁrst 24 h of hospitalization
was sterile. A urine specimen was obtained everyday for culture
and microscopic examination.
Results: One hundred consecutive patients were enrolled in the
study, 24 males (24%) and 76 females (74%). Mean age was
73.0 ± 15.9 years for males and 76.3 ± 10.6 years for females.
Bacteriuria was detected in 44 patients, 39 females and 5 males.
Median duration of hospitalization before detection of catheter
colonization was 5.6 ± 3.5 days. Mean duration of hospitaliza-
tion was 11.1 ± 6.7 days. Risk factors for catheter-related bacte-
riuria were female gender [odds ratio (OR) = 4.0, 95%
conﬁdence intervals (CI) 1.3–11.8] and previous UTI history
(OR=5.7, 95% CI 1.1–29.4). Isolated microorganisms were
Eschericia coli (54.5%), other Enterobacteriacae (11.3%), Candida
albicans (11.3%), Enterococcus sp. (9.0%), Pseudomonas sp. (6.8%),
Acinetobacter sp. (4.5%) and coagulase-negative staphylococci
(2.2%). Antimicrobial resistance rates of the isolated Enterobac-
teriacae strains were: ampicillin 61.5%, coamoxiclav 7.7%,
cefalothin 34.6%, cefuroxime 3.8%, cefotaxime 16%, cotrimoxaz-
ole 34.6%, ﬂuoroquinolones 7.6%, piperacillin 32.0%, piperacil-
lin/tazobactam 4.0%, aminoglycosides 3.8%. In 16 patients
(36.3%), the isolated microorganism accounted for cystitis,
while in the rest 28 (63.6%) it accounted for asymptomatic
bacteriuria. Cystitis was treated with the appropriate antimicro-
bials according to susceptibility tests.
Conclusions: Urinary bladder catheterization is frequently fol-
lowed by bacterial and/or fungal catheter colonization. In our
series, female gender and previous UTI history were the main
risk factors for urinary catheter-associated UTI. In most cases,
E. coli was the isolated microorganism. Antimicrobial resistance
rates of the isolated Enterobacteriacae were high for ampicillin
but low or intermediate for other antimicrobial agents.
P492
Comparison of ﬂow cytometry with urine culture
and Gram stain in a routine microbiology
laboratory
H. von Wulffen (Hamburg, D)
Objectives: In an attempt to lower the workload in a bacterio-
logy laboratory providing services for seven general hospitals
we wanted to ﬁnd out if we could eliminate unnecessary urine
cultures using ﬂow cytometry as screening method and also to
replace microscopy.
Methods: Over a period of two weeks 673 urine specimens send
in with a request for urine culture were processed using the
Sysmex UF-100 automated urine cell analyzer in parallel with
Gram stain and culturing overnight of 0.01 ml concentrated
urine and 0.01 ml of a 1:500 dilution onto Columbia sheep blood
agar and C.L.E.D. agar using calibrated loops. Specimens were
also tested for inhibitory activity using spore plates.
Results: 659 specimens were left for evaluation as the UF-100
rejected 14 (2%) of the specimens for various reasons. UF-100
results were considered to be in full agreement with culture
results when urinary tract infection (UTI) ﬂags were either
positive (on the basis of the cut-offs suggested by the manufac-
turer) and culture yielded relevant organisms at 100,000 colony
forming units (CFU)/ml or higher or UTI ﬂags were negative
and culture yielded no growth or low counts or contaminants.
On this basis 31% of the UF-100 results were true positive, 30%
true negative, 11% showed partial agreement, 25% were false
positive and 3% were false negative. 66% of the specimens with
false positive results showed inhibitory activity vs. 41% of the
other specimens. Out of the 18 false negative results a closer look
revealed that only three of them, i.e. 0.5% of all specimens
evaluated, came from same day specimens and yielded a single
relevant organism (two with E. coli and one with enterococci).
UF-100 results were clearly superior to Gram stain regarding
leukocytes and comparable regarding quantiﬁcation of bacteria.
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Conclusions: Using the UF-100 we would only have to culture
about 70% of the urine specimens. The UF-100 could also replace
time-consuming microscopy for our purposes. The low rate of
truly false negative results around 0.5% appears to be tolerable.
Specimens from certain patients (e.g. haematology patients with
cytopenia) or certain materials (e.g. suprapubic bladder aspir-
ates) should be cultured in any case.
P493
Escherichia coli causing recurrent urinary tract
infections belong mainly to the phylogenetic
group B2
K. Ejrnaes, D. Sandvang, B. Lundgren, S. Ferry, T. Monsen,
S. Holm, R. Lundholm, N. Frimodt-Moller (Copenhagen, DK;
Umea, S)
Objectives: Escherichia coli (E. coli) is divided into four main
phylogenetic groups (PGs), designated A, B1, B2 and D. Most
E. coli strains causing urinary tract infections (UTI) and other
extraintestinal infections have been shown to belong to group B2
or, to a lesser extent, to group D. Overall strains belonging to B2
and D have virulence factors (VF) lacking in group A and B1.
The aim of this study was to determine the PG in relation to the
ability to cause recurrent urinary tract infections (RUTI).
Methods: A multicentre, double-blind, placebo-controlled com-
parative study of different dosing regimens of pivmecillinam of
1143 women with community acquired lower UTI. Clinical/
bacteriological evaluation was done at day 1, day 8–10 and day
35–49. 156 women with E. coli at the index episode and at follow-
up and 90 women with E. coli at the index episode and negative
urine culture at follow-up were randomly selected and the E. coli
strain studied with respect to phylogenetic grouping in relation
to the ability to cause recurrence. Phylogenetic grouping was
done by the triplex PCR of the genes chuA, yjaA and the DNA
fragment TSPE4.C2 (Clermont O. et al, 2000). PFGE with XbaI
was performed and interpreted with BioNumerics.
Results: E. coli index strains followed by bacterial persistence or
reinfection with the same strain (100% identical PFGE proﬁles) at
follow-up showed the following distribution of the PGs: A: 10%,
B1: 4%, B2: 71%, D: 15%. E. coli index strains followed by
persistence/reinfection with a new strain (PFGE proﬁles not
100% identical) or a negative urine culture at follow-up showed
followingdistribution of the PGs:A: 22%, B1: 4%, B2: 54%,D: 20%.
The differences between the two groups for the PG B2 (p = 0.008)
and for PG A (p = 0.01) were highly signiﬁcant. The difference
between the two groups for the PG B1 and Dwas not signiﬁcant.
Conclusion: E. coli strains causing RUTI with the same strain
belong mainly to the PG B2 (71%), which is signiﬁcantly higher
than for E. coli not capable of causing RUTI. This is in
accordance with studies showing B2 to be associated with at
higher number of VF and warrant further research into VF
related to strains causing RUTI.
P494
Comparison of intravenous ceftriaxone and
switch therapy to oral oﬂoxacin versus the oral
oﬂoxacin alone in patients with UTIs
F. Masjedian, F. Alinejad, A. Rastegar Lari, M. Habibi,
H. Mostafavi (Tehran, IR)
Introduction: Urinary tract infections (UTIs) are one of the most
important causes of hospitalization patients in Iran. An intra-
venous antibiotic therapy is associated with side effects, toxicity,
high cost, and long period of hospitalization in treatment of
UTIs, "switch" therapy (intravenous-to-oral antibiotic) has been
considered. The aim of this study was to compare the efﬁcacy of
intravenous Ceftriaxone and switch therapy to oral Oﬂoxacin
versus the oral Oﬂoxacin alone in patients with UTIs.
Materials and Methods: In this randomized clinical trial, 53
patients (30% aged <25 years) with complicated urinary tract
infections, who were determined by positive urine analysis and
culture, were enrolled and divided in two groups of A and B.
Patients in group A (n = 24) treated with intravenous Ceftriaxone
(1 g/daily) for the ﬁrst 2 days and then switch to Oﬂoxacin
(400 mg/daily) for 8 days. Patients in groupB (n = 29) treatedwith
oral Oﬂoxacin (400 mg/daily) for 10 days. One week after
treatment, patients were evaluated clinically andmicrobiologically
Results: Causative agents were isolated: E. coli (79%), Klebsiella
sp (11%), Proteus sp (6%) and others microorganisms (4%).
Ninety per cent of strains were susceptible to Amikacin,
Cefotaxime, Ceftazidime, Amoxi-clave, Ceﬁxime, Ciproﬂoxacin
and Oﬂoxacin. Rate of response (clinically and microbiologi-
cally) in patients of A & B groups were 95%.
Conclusion: Switch therapy shortens duration of hospitaliza-
tion, in which decreases costs and risk of nosocomial infections.
The data indicates a good possibility of using oﬂoxacin as a drug
of the treatment of UTIs.
P495
Community-acquired urinary tract infections by
extended-spectrum beta-lactamase-producing
Enterobacteriaceae in the Zenica-Doboj canton,
Bosnia and Herzegovina
S. Uzunovic-Kamberovic, D. Saric (Zenica, BIH)
Objectives: The presence of ESBL producing strains in outpa-
tient samples are at least underreported. The aim of this study
was to determine the incidence and antimicrobial resistance of
ESBL-producing strains in the community-acquired urinary
tract infections (CAUTIs), which is necessary for antimicrobial
therapy selection.
Methods: From January 2003 to September 2004, 4224 consecu-
tive, non-duplicate coliform isolates from CAUTIs analysed.
Antimicrobial susceptibility testing was performed by disc-
diffusion method to twenty three antimicrobials. Double-disk
synergy test with amoxicillin-clavulanat, cefotaxime, ceftazi-
dime, ceftriaxone and aztreonam (by NCCLS recommendation)
and Etest strips with PM/PML (AB Biodisk) were performed to
detect the ESBL producers.
Results: The overall incidence of ESBL producing strains was
2.6% (108 of 4224), signiﬁcantly higher in male, 7.9% (79 of 1006)
than in female, 1.5% (29 of 3218). The highest number ESBL
producers noted in oldest and youngest age group: 4.7% (52 of
114) and 2.6% (27 of 1051), respectively. There observed the
increase from 2.1% (52 of 2463) to 3.2% (56 of 1761), and shift
ESBL producers toward younger age group (1.6% and 3.8%,
respectively) in this period. The incidence of ESBL producing
strains among isolated Klebsiella spp. were 7.8% (83 of 1060),
E. coli 0.7% (18 of 2561), Citrobacter spp. 0.6% (1 of 156),
Enterobacter spp. 7.7% (3 of 39) and Proteus spp. 1.0% ( 3 of 297).
Among ESBL producing isolates Klebsiella predominated, 76.9%
(83 of 108), E. coli 16.7% (18), Enterobacter and Proteus 2.8% each
(3), and Citrobacter 0.9% (1). ESBL producing strains showed
signiﬁcantly higher resistance rates for all tested antibiotics
comparing to non-ESBL-producers, and they were in the range
60% to 90% (98% for ampicillin), except for imipenem, 1%. In
non-ESBL-producing isolates resistance rates were about 20%
for the most antibiotics tested, for cefotaxime and aztreonam less
than 10%, for imipenem, 0.1%, and for ampicillin, tetracycline,
co-trimoxasole and carbenicillin were in the range 40–70%.
Conclusions: It is worrying the increase and the shift toward
youngest age group of the ESBL producer incidences in the
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CAUTIs in this region. ESBL producers associated with multi-
drug resistance, thus, its surveillance appeared to be important
in the community-acquired infections. Further studies are
needed to detect ESBL types in the term of highly different
geographical dissemination of these isolates.
P496
Crystalline bacterial bioﬁlm formation on urinary
catheters by urease producing urinary tract
pathogens
R.J. Broomﬁeld, D.J. Stickler (Cardiff, UK)
Objective: Long-term bladder catheterisation inevitably results
in bacteriuria and the formation of bioﬁlms on the catheters.
Crystalline bioﬁlms form when urease-producing bacteria infect
the catheterised urinary tract, generate alkaline urine and cause
the crystallization of calcium and magnesium phosphates. The
objective of this study was to compare the abilities of various
urease-positive species to encrust and block catheters with
crystalline bioﬁlm.
Methods: Laboratory models of the catheterised bladder were
infected with clinical isolates of various urease-positive species
and suppliedwith urine for up to fourdays. ThepHof the urine in
the bladder chamber and the numbers of viable cells in the urine
were measured at 24 h intervals. Catheters were removed from
themodels after fourdays or at the time theyblocked. The catheter
bioﬁlms were examined by scanning electron microscopy.
Results: Catheters inmodels infectedwithureasepositive strains
of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Providencia
stuartii drained freely for the four day experimental period. In
each case the urine remained acidic (pH < 6.5) and electron
microscopy showed no evidence of crystal formation in the
catheter bioﬁlms. In models infected withMorganella morganii the
urine remained acidic for 72 h but by 96 h the pHhad reached 7.4.
The catheters did not block but electron microscopy revealed the
presence of crystals in the bioﬁlm. Proteus mirabilis, Proteus
vulgaris, and Providencia rettgeri all blocked the catheters within
48 h. The pH of the urine became alkaline (pH 8–9) and extensive
crystalline bioﬁlm was observed on the catheters.
Conclusions: Not all urease-positive urinary tract pathogens
are capable of forming crystalline bioﬁlms on urinary catheters.
Of those species that can induce rapid catheter encrustation, Pr.
mirabilis is by far the most commonly found in the catheterised
urinary tract and therefore should be the main target for
strategies to control the clinical problem.
P497
Parenteral human albumin leads to quicker
recovery in patients with acute pyelonephritis
and hypoalbuminaemia
H. Lydataki, P. Hager, T. Sdralias, A. Peppas, E. Tambakos,
S. Pappas, I. Diamantis (Athens, GR)
Objectives: Patients admitted to a hospital due to microbial
infection such as pyelonephritis or community-acquired pneu-
monia, have increased mortality and morbidity. Hypoalbu-
minaemia, which develops in the early stage of the disease, and
it is probably due to a decreased protein production by the liver,
seems to be a critical factor inﬂuencing the course of the
infection. The aim of this study was to investigate the role of
parenteral human albumin, given in the early stage of infection,
in improving the outcome of the disease. The clinical outcome
was determined using the temperature and the CRP levels.
Patients/Methods: From May 2003 to October 2004, 60 immu-
nocompetent adults were admitted to our hospital with acute
pyelonephritis and hypoalbuminaemia (admission albu-
min < 3.1 mg/dl). These patients were randomly separated in
two groups of 30. All 60 patients had a positive urine culture,
while 20 patients from ﬁrst and 21 from second group had also a
positive blood culture. Both groups had similar mean values of
age (67.97 ± 15.011 vs 71.17 ± 15.746), admission temperature
(38.487 ± 0.685 vs 38.49 ± 0.6838) , admission serum CRP
(288.17 ± 95.824 vs 311.57 ± 103.545) and admission serum
albumin (2.543 ± 0.4289 vs 2.413 ± 0.4425). Patients in the ﬁrst
group received antibiotics and additionally 100 ml/day paren-
teral solution of human albumin (inject. solution infusion 20%
250 mg/ml), starting within 24 hours from admission. Patients
in the second group received only antibiotics, During the 4th
day of hospitalization the patient’s temperature, serum CRP and
albumin levels were measured.
Results: During the 4th day of hospitalization the temperature of
the ﬁrst group was signiﬁcantly lower than that of the second
group (36.75 ± 0.601 vs 37.323 ± 0.715p = 0.0001). Likewise there
was a signiﬁcant reduction of serum CRP in the ﬁrst group
compared to the second group (73.30 ± 35.226 vs 140.83 ± 56.64
p = 0.009). The mean value of serum albumin during the 4th day
was signiﬁcantly higher in patientswho received human albumin
(3.42 ± 0.2285 vs 2.45 ± 0.4315 p = 0.003). The hospitalisation
time was signiﬁcantly shorter in patients who received albumin.
Conclusions: The level of serumalbumin represents a nutritional
marker for patients with an infectious disease. Administration of
human albumin in the early stage of infection increases the
albumin levels, improves the clinical outcomeand leads to shorter
hospitalization time in patients with acute pyelonephritis.
P498
Four-year survey and resistance trend analysis in
37,261 isolates causing community urinary tract
infections in Brazil
C.R. Kiffer, C. Oplustil, J.L. Sampaio, L. Kudo,
C.M. Mendes (Sao Paulo, BR)
Objectives: Assess the antimicrobial resistance pattern and
trends in pathogens responsible for urinary tract infections
(UTI) in community-based patients in Sa˜o Paulo, Brazil between
the years 2000 and 2003.
Methods: From January 2000 to December 2003, 266,692 urine
cultures from community-based patients were collected. All
positive cultures with one single pathogen and a colony
count ‡ 100,000 CFU/mL were selected for the analysis. Based
on these criteria, 37,261 (14%) positive cultures were analysed in
this survey. Chi-square for trend test (Altman, 1999) was
performed to evaluate resistance prevalence ordering in the
years surveyed (p value below 0.05 was considered signiﬁcant).
Results: Among the 37,261 positive cultures, 88.8% belonged to
female and 11.2% to male patients. Among the Gram-negative,
E. coli (71.6%) presented the highest prevalence, followed by
K. pneumoniae (6.4%) and P. mirabilis (6.1%). Among Gram
positive isolates, E. faecalis was the most prevalent (4.8%)
followed by S. saprophyticus (1.6%). Susceptibility tests were
performed in 31,716 cultures. Resistance rates to E. coli,
K. pneumoniae, P. mirabilis, P. aeruginosa, E. aerogenes, E. cloacae,
E. faecalis, and S. saprophyticus are presented. For E. coli,
ascending resistance trend in 4 years was observed for nalidixic
acid, norﬂoxacin and ciproﬂoxacin (p < 0.0001); descending
resistance for cephalothin and tetracycline (p < 0.0001); elevated
and stable resistance to ampicillin and trimeth-sulfa (p > 0.5);
low and stable resistance to nitrofurantoin (p > 0.5).
Conclusions: Elevated resistance rates to trimeth-sulfa (>15%)
among most prevalent pathogens preclude the use of this drug
in the population studied. Quinolones may be used as ﬁrst line
agents for community UTIs in Sa˜o Paulo; however, a trend for
Abstracts
130
increasing resistance was observed in E. coli for this therapeutic
class. Thus, this drug class should be used cautiously and, if
possible, with lab identiﬁcation and susceptibility test. Focused
and specialized surveillance studies may be an adequate
strategy for guiding empirical therapy in community settings
and for halting the spread of resistance.
P499
Spectrum of pathogens in community-acquired
urinary tract infections and their antimicrobial
resistance in a general Hospital
A. Kyratsa, E. Kalogeropoulou, E. Kontekaki, C. Mihas,
K. Zambou, E. Trikka-Graphakos (Athens, GR)
Objectives: The aim of the study was the etiology and antibiotic
resistance of clinical isolates from community acquired urinary
tract infections, in a General hospital.
Methods: Between January 1998–2004, a total of 10276 urine
specimens were obtained from outpatients. Urine cultures were
performed in laboratory according to conventional methods.
The identiﬁcation of urinary isolates was performed using the
API20E system (BioMerieux), while their susceptibility was
tested by Kirby–Bauer and M.I.C methods (Vitek II, Bio-
Merieux), according to NCCLS guidelines.
Results: 2320 out of 10276 urine samples (22.5%) fulﬁlled the
criteria for signiﬁcant bacteriuria. The most frequent isolates
were: E. coli 1688 (72.7%), Klebsiella spp.182 (7.8%), Proteus spp.
170 (7.3%), E. faecalis 91 (2.9%), Ps. aeruginosa 65 (2.8%), Candida
spp. 52 (2.2%), CNS 45 (1.9%), S. aureus 37 (1.6%). E. coli
resistance pattern was as follow: ampicillin 41.4%, amoxicillin –
clavulanic acid 6.5%, cephalothin 20.0%, cefuroxime 4.8%,
nitrofurantoin 5.3%, cotrimoxazole 30.8%, quinolones 7.7%.Six
point ﬁve per cent of Klebsiella spp., 2.3% of Proteus spp and 1.1%
of E.coli were ESBL producers. E.faecalis high level gentamycin
resistance was 20.1%. There was no resistance to glycopeptides
for Staphylococcus and Enterococcus spp. The resistance of CNS to
oxacillin was 35.2%, to gentamycin 16.2%,cotrimoxazole 33.1%,
quinolones 20.8% and nitrofurantoin 18.4 %.
Conclusions: E. coli, continuous to be the most common clinical
isolate in commumity acquired urinary tract infections. About
41.1% of E. coli isolates were resistant to ampicillin and 30.8% to
cotrimoxazole. Approximately 9.9% of Enterobacteriaceae
would be considered as ESBL producers.
P500
Community-acquired enterococcal urinary tract
infection
S. Maraki, M. Bitsori, M. Raissaki, A. Bakantaki,
E. Galanakis (Heraklion, GR)
Objectives: Urinary tract infections in childhood are mainly
caused by Gram-negative organisms of the intestinal ﬂora.
Enterococcal urinary tract infections are often considered to be
hospital- acquired and to affect children with predisposing
conditions. The aim of this study was to investigate the
frequency, susceptibility patterns, clinical characteristics, ima-
ging ﬁndings and outcome of otherwise well children with
community-acquired enterococcal urinary tract infections.
Methods: We reviewed the medical and microbiological
records of all the 272 cases of proven urinary tract infections
in children hospitalized in the Department of Pediatrics of a
General Hospital during the 5-year period 1998–2002, with
emphasis on patients with enterococcal urinary tract infections.
Results: Enterococcus faecalis was isolated in 14 episodes of
urinary tract infection in 13 children and was the third more
common uropathogen, accounting for 5.14% of urinary tract
infections. E. faecalis was the single pathogen isolated in 9
cultures, whereas in the remaining 5, E. coli was isolated as a
second pathogen. All strains were susceptible to ampicillin,
vancomycin and nitrofurantoin and resistant to cephalosporins
and quinolones and exhibited intrinsic, low-level aminoglyco-
side resistance. Intravenous ampicillin plus gentamicin was
administered in 7 children, ceftriaxone in 3 and amoxicillin-
clavulanic acid in the remaining 4 cases. Urine cultures obtained
under treatment were sterile in all cases.Imaging studies
revealed major urinary tract abnormalities in 9 children
Follow-up information was available for 11 children for a
period of 21 to 75 months. Four children (31%) suffered
recurrences, due to E. faecalis in one patient and to Gram-
negative organisms in the remaining three. Four children
underwent corrective surgery. Despite antibiotic prophylaxis,
which was given to all 13 children, 4 of them suffered break-
through infections and 3 developed renal scarring.
Conclusions: These ﬁndings suggest that children with com-
munity-acquired enterococcal UTI form a high-risk group,
characterised by considerable frequency of urinary tract abnor-
malities, recurrences, renal scarring, and need for surgical
intervention. Thus, special attention is required on appropriate
antibiotic regimens, early imaging investigation and prophylac-
tic antimicrobial treatment.
P501
Presence of difﬁcult-to-culture organisms in
urogenital specimens of healthy men
M. Sukhorukova, L. Stratchounski, B. Gvasalia,
O. Shipulina (Smolensk, Moscow, RUS)
Objectives: Chlamydia trachomatis,Mycoplasma hominis,Ureaplas-
ma urealyticum, Gardnerella vaginalis, Trichomonas vaginalis are
considered as the most common causative agents of nongonococ-
cal urethritis in men and have been reported to possibly cause
chronic prostatitis syndromes. The aim of this study was to
determine the frequency of isolation of C. trachomatis,M. hominis,
U. urealyticum, G. vaginalis, T. vaginalis from urethral swabs (US)
and expressed prostatic secretions (EPS) of healthy men.
Resistance rates to most commonly isolated pathogens in community urinary tract infections 2000 to 2003-Sa˜o Paulo, Brazil
% Resistant
N Nalidix acid Ampicillin Cephalothin Ceftriaxone Ciproﬂoxacin Gentamicin Nitrofurantoin Norﬂoxacin Trimeth-Sulfa Tetracycline
E. coli 22682 15.5 43.4 13.9 0.3 11.9 3 2.9 12 33.7 30.5
K. pneumoniae 2059 15.2 99.9 7.6 1.7 6 3.3 21.2 8.9 17.7 19.8
P. miratillis 1944 8.9 18.9 3.1 0.4 4.2 2.3 97.6 4 21.5 99.8
P. aeroginosa 605 40.3 40.7 39.8 85.1 62.8 47.9 42 57.4 98.3 41.3
E. aerogenes 510 9.6 99.2 98.6 2 5.1 2.2 21.2 5.5 7.8 6.9
E. cloacae 331 44.4 99.4 99.4 32.9 38.7 24.2 39.6 41.1 38.4 42.6
E. faecalis 1525 0.1 0.3 70.6 0.1 16.1 0 0.8 1.2 70.5 59.2
S. saprophyticus 531 0 79.1 7.5 0 1.3 2.1 0.6 0.6 7 15.8
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Methods: In 2003–2004 45 healthy volunteers without symp-
toms of urethritis, prostatitis and other urinary tract infections as
well as with the absence of white blood cells in EPS and who
had not taken antibiotics in previous month were included in
the study. The Meares–Stamey bacteriologic technique and
commercial PCRs (Amplisens, Russia) with primers speciﬁc for
C. trachomatis, M. hominis, U. urealyticum, G. vaginalis and
T. vaginalis on US and EPS were performed for each person.
Results: All healthy volunteers were negative by Meares–
Stamey technique in terms of the absence of culturable uro-
pathogens in EPS. According to PCR data, U. urealyticum have
been detected in 6 (13.3%) individuals, C. trachomatis–in 4
(8.89%), M. hominis–in 2 (4.4%), and G. vaginalis–in 1 (2.2%)
person. T. vaginalis have not been detected in the examined
healthy volunteers.
Conclusion: C. trachomatis, M. hominis, U. urealyticum, G. vag-
inalis are found in US of asymptomatic men. The most common
detectable microorganism was U. urealyticum. T. vaginalis have
not been revealed in the examined asymptomatic volunteers.
Frequent detection of difﬁcult-to-culture organisms in healthy
men requires further careful investigations of their causative
role in urinary tract infections.
P502
Role of Escherichia coli adhesins encoded by the
eae A, pap, and drae genes in urinary tract
infections related bacteraemia
G.M. Matar, R. Daou, G. Araj, M. Uwaydah (Beirut, LBN)
Objectives: The role of Escherichia coli genes in Urinary Tract
Infections (UTI) and blood stream infections remains to be well
elucidated. In this study we used PCR and RT-PCR for the
detection and expression of the eaeA, pap and drae genes,
encoding respectively the intimin, P ﬁmbriae and Dr-II adhesin,
in E.coli from patients UTI and or Bacteremia.
Methods: E. coli were isolated from patients with UTI (n = 10),
UTI related blood infection (n = 14), non UTI related blood
infection (n = 17) and control isolates from sputum and pus
(n = 5). Three reference strains harbouring the three genes were
used as positive controls. Strain identiﬁcation of all isolates was
done by Random ampliﬁed polymorphic DNA (RAPD)analysis.
Results: Our data have shown that the percentage of pap, eaeA,
drae genes detected by PCR and RT-PCR, respectively, was as
follows in the different study groups: patients with UTI
60%&0%, 100%&80%, 40%&20%; UTI associated blood stream
infection 100%&100%, 100%&76.5%, 100%&100%; non UTI
associated blood stream infection 100%&78.5%, 100%&35.7%,
100%&100%, and isolates from pus and sputum 0%&0%, 100%,
0%&0%. Genotyping data revealed 36 different RAPD patterns
among the 41 isolates, indicating the involvement of multistrains
in these infections.
Conclusion: The high prevalence of pap and drae genes in
isolates recovered from patients with UTI related and UTI non-
related bacteraemia, highlights the potential involvement of
these genes in this serious condition.
P503
Serum sensitivity of beta-lactamase-producing
Escherichia coli strains isolated from urine of
nonhospitalised patients
T.Marijan,A.Mlinaric-Dzepina, B.Matica, J. Vranes (Zagreb,HR)
Objectives: Extended-spectrum beta-lactamase (ESBL)-produ-
cing Escherichia coli has emerged in many hospitals worldwide,
increasing dissemination and long-term carriage of this
organism within community.Until recently, most infections
caused by ESBL-producing E.coli had mostly been described as
nosocomially acquired, or nursing home related. Some recent
data suggest that infections due to ESBL-producing organisms
might be an emergent problem in outpatients in different
countries, and that ESBL-producing E. coli is an emergent cause
of urinary tract infections in nonhospitalized patients. Better
characterization of these strains is needed. The aim of this study
was to determine the prevalence of ESBL-producing E. coli
among the strains isolated from urine of outpatients in Zagreb
region, and to assess the sensitivity of those strains to bacteri-
cidal action of normal human serum.
Methods: During the ﬁve-month study period (January to May
2004) a total of 2,451 E. coli strains were isolated from urine of
nonhospitalized patients with signiﬁcant bacteriuria. The iso-
lates were screened for ESBL production by a double disk
diffusion technique and 39 ESBL-producing strains were collec-
ted, as well as 45 randomly chosen non-ESBL-producing E. coli
strains. Antibiotic susceptibility was determined using a stand-
ard disk diffusion NCCLS procedure. Bacterial susceptibility to
serum killing was measured by assessing regrowth after
incubation in serum according to Schiller and Hatch method.
Results: The prevalence of ESBL-producing E. coli was 1.59%.
Statistically signiﬁcant difference in bacterial susceptibility to
serum killing was observed between two groups of strains
(p = 0.03). Out of 45 non-ESBL-producing strains tested, 25
(55.5%) were serum-resistant, while only 12 out of 39 (30.7%)
ESBL-producing strains were resistant to serum killing.
Conclusion: The decreased prevalence of serum resistance
among ESBL-producing isolates may be related to chronic
colonization or recurrent infection of urinary tract.
P504
Uncomplicated urinary tract infections in women:
cost-effectiveness of implementing national
guidelines in Finland
H. Koskinen, U.-M. Rautakorpi, H. Sintonen, M. Ma¨kela¨ On
behalf of the MIKSTRA Collaborative Study Group
Objectives: National, evidence-based guidelines for urinary
track infections (UTI) was introduced in Finland in 2000. The
aim of this study is to evaluate the cost-effectiveness of
implementing the guidelines in the treatment of uncomplicated
UTI (occasional lower urinary track infections with no predis-
posing factors to infection) in women. Cost-effectiveness com-
parison will also be done with a modelled situation, where
adherence to the implemented guidelines would have been even
more comprehensive.
Methods: A 5-year randomized trial was conducted in 30 health
centres around the country. All women between the ages of 15
and 55 diagnosed with uncomplicated UTI consulting the health
centres, for the ﬁrst time for this episode of illness, during a
1-week period in pooled years 1998–1999 (n = 293) and 2001–
2002 (n = 204) were included in this study. Total costs of an
infection period were estimated from a societal perspective. The
main outcome measures are the health beneﬁts, the costs and the
incremental cost-effectiveness ratio. Both direct and indirect
costs arising from the infection were prospectively monitored
for a period of two weeks. The measure of effectiveness is being
both symptom free and having had no health care re-visits or
re-medication for UTI during the follow-up period two weeks
after the initial consultation.Results:The cost of an uncompli-
cated UTI infection period stayed relatively similar before and
after implementing the guidelines while the percentage of
effectively treated patients increased from 65% to 78%, respect-
ively. At this point the modelled scenario seems to have
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moderate decreasing effects on the total costs while the
effectiveness of the treatment stays around the same level with
the actual situation after the implementation of the guidelines.
Conclusion: Implementing national, evidence-based guidelines
in the treatment of uncomplicated UTI had positive effects on
the treatment effectiveness with minor inﬂuence on total costs.
The focus of this study was on the short-term effects. Long-term
effects, including development of complications and resistant
strains, may have an effect the results.
P505
Management on the phone of acute
uncomplicated cystitis in women
M. Larosa, F. Marchetti (Verona, I)
Objectives: Acute uncomplicated cystitis (AUC) is a benign
illness with no long term medical sequelae, although signiﬁ-
cantly impacts on quality of life of women. Moreover, beha-
vioural and genetic risk factors can predispose to relapses.
European guidelines consider deep clinical history sufﬁcient for
AUC diagnosis; further diagnostic examinations are not sug-
gested in health young women. A 3 days antibiotic therapy with
cotrimoxazole or ﬂuoquinolones are recommended, according to
local bacterial resistance rate. There is evidence that young
women with no complicating factors and speciﬁc urinary
symptoms can be treated efﬁcaciously and safely over the
phone without ofﬁce visit. In the Italian context there is
incomplete compliance to AUC guidelines. Aim of this research
was to deﬁne a diagnostic, therapeutic algorithm to manage
AUC on the phone in order to optimize time consumption in GP
ambulatory practice, providing appropriateness and patient
satisfaction.
Methods: All literature on telephonic management of AUC
published between year 1995 and 2004 was critically reviewed:
Ovid MEDLINE database was used, with keywords ‘telephone
management and acute cystitis’.
Results: Six studies regarding telephonic management of AUC
in selected women (from 18 to 65 years) in the GP setting were
retrieved. The studies showed: standardization of proper pre-
scribing attitudes; clinical outcomes equivalent to the ambula-
tory practice; reduction of sanitary costs (i.e. ambulatory visit
and laboratory tests); higher satisfaction of patients. On this
basis an algorithm for telephone management of AUC by GPs in
Italy was designed including 4 steps: elegibility of patients (with
no complicating factors, for instance fever >38C, pregnancy,
history of relapses or diabetes); informed oral consent; therapy
indications; counselling (information regarding possible com-
plications during therapy and prevention of relapses).
Conclusion: Due to literature evidence and cost-efﬁcacy consid-
eration, AUC empirical management on the phone seems a
reasonable optionwithin the Italian ambulatory setting. This pro-
posal needs to be conﬁrmed by well designed studies comparing
AUC management on the phone with ambulatory practice.
Borrelia
P506
The prevalence of Lyme disease spirochete
Borrelia burgdorferi sensu lato in ticks (Ixodes
ricinus) collected in Lithuania
D. Ambrasiene, A. Paulauskas, R. Mikalauskas,
O. Rosef (Kaunas, Vilnius, LT; Bo, N)
The bacterium Borrelia burgdorferi belonging to the family
Spirochaetaceae is the etiological agent of human infectious
disease Lyme borreliosis. The pathogen can be transmitted to
humans and animals by various tick species of the genus Ixodes,
and in Europe by Ixodes ricinus. Lyme borreliosis is the most
common tick-borne infectious disease in humans and domestic
animals. In Europe, Lyme borreliosis is associated with three
genospecies: B. burgdorferi sensu stricto, B. garinii and B. afzelii.
These species can cause distinct clinical manifestations of Lyme
disease. B. burgdorferi s.s can cause arthritis, B. garinii serious
neurological manifestations and B. afzelii a distinctive skin
condition known as acrodermatitis chronica atrophicans. Each
of the three Borrelia species causes characteristic erythema
migrants. They cannot, however, be differentiated morpholog-
ically.
Objectives: The purpose of this study was to determine the
prevalence and genospecies of Borrelia burgdorferi s.l. in I. ricinus
ticks collected from different Lithuanian regions by molecular
genetic methods.
Methods: A total of 1559 ticks (151 nymphs, 777 females and
631 males), collected from 18 regions in Lithuania, were
examined for the presence of Borrelia burgdorferi s.l. All ticks
were analysed individually by the polymerase chain reaction
(PCR) with ﬂa gene speciﬁc primers. From total amount (1559)
the 243 ticks were analysed by multiplex PCRs using genospe-
cies-speciﬁc primers for B. burgdorferi s.s., B. garinii and B. afzelii.
Results: We found that 13.4% (209/1559) ticks were infected for
B. burgdorferi s.l. Females and males were more infected
(respectively 113 of 777, 14.5% and 81 of 631, 12.8%) than
nymphs (15 of 151, 9.9%). The prevalence in the 18 regions
varied from 1–32%. Borrelia genospecies identiﬁed were as
follows: 66% (25/38) B. afzelii, 31% (12/38) B. garinii and 3%
(1/38) B. burgdorferi s.s. Mixed infections were not detected.
Conclusions: The prevalence of B. burgdorferi sensu lato was
detected in ticks in all regions of Lithuania. The molecular tools
allow identifying three Borrelia genospecies which are import-
ant for pathogenesis, diagnostic and preventative implica-
tions.This study was supported by ENLINO (Environmental
Studies in Lithuania and Norway) and the Lithuanian State
Science and Studies Foundation.
P507
Detection of neuroborreliosis in patients from
Aarhus county, Denmark
J. Thorup, L. Svehag, L. Lemming, J.K. Møller (Aarhus, DK)
Objectives: To determine the incidence of Neuroborreliosis
(NB) in Aarhus County and to examine the relationship between
positive intrathecal synthesis of Borrelia burgdorferi antibodies
(BBAB) and elevated white blood cell count (WBC) in cerebro-
spinal ﬂuid (CSF). Furthermore to examine the extent of
retesting initially BBAB negative CSF in patients suspected of
having NB.
Methods: Detection of intrathecal BBAB by parallel CSF and
serum analysis using ELISA capture measuring optical density
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(OD) has been performed in our laboratory since 1994. The
index between the CSF and serum levels was calculated for IgG
and IgM respectively and indexes > 0.3 and/or individual IgG
or IgM levels in CSF OD > 1.0 were recorded as a positive test.
Data obtained from the computer systems used in Clinical
Microbiology (MADS) and Clinical Biochemistry (LABKA) was
analysed for all patients having had a test for NB.
Results: Since1997 test activity has been found to be stable with
an average of 370 patients tested each year. The positive rate was
also found to be stable at about 5% when excluding retesting of
knownpositive cases. About 18 new caseswere detected per year.
This corresponds to an incidence of 3/100,000/year. From 2001 to
2003 53 new cases were detected, 87% of these had biochemical
tests performed on CSF of which 96% showed elevated WBC in
CSF (median: 105 mill/L, range: 10–2790 mill/L). In 53 randomly
selected BBAB negative patients from the same period, 83% had
biochemical tests of CSF, of these 25% showed elevated WBC
(median 14 mill/L, range 6–139 mill/L). Of at total of 2842
patients with negative tests 55 (1.9%) were retested within
3 months. One of these was positive.
Conclusion: The incidence of NB in Aarhus County corresponds
to the expected national level. The absence of elevated WBC in
CSF is a strong predictor of not havingNB. Patients with elevated
WBC in CSF and negative intrathecal BBAB synthesis should be
retestedwithin 2–4 weeks if NB is still suspected. The current rate
of retesting BBAB negatives therefore seems insufﬁcient.
P508
Evaluation of a Bayesian decision support system
for diagnosis of Lyme disease
R.B. Dessau, J.M. Bangsborg, T. Ejlertsen, O.K. Hejlesen,
I. Beltoft, M. Trangeled (Næstved, Herlev, Aalborg, DK)
Objective: Evaluation of a Bayesian network constructed to
calculate the probability of Lyme disease, adjusted to individual
patient characteristics. The system is designed to give a
probability of Lyme disease, based on facts from the scientiﬁc
literature, local clinical prevalence and laboratory data.
Methods: A dataset of 100 Danish patients randomly extracted
from a larger survey of the clinical use of Lyme disease serology
was presented to two specialists in clinical microbiology on a
standardized form together with free text comments on some of
the patients. Each case of possible Lyme disease was scored on a
5-step ordinal scale and compared to the output from the
Bayesian decision support system. Furthermore a user evalua-
tion of the decision support system was conducted by two
general practitioners.
Results: The two experts had a high rate of agreement (92%
complete agreement or a difference of one score). 80% of the
patients were scored as having no or a low probability of Lyme
disease. The average score of the decision support system was in
agreement with the experts. But some patients were assessed
differently by the bayesian system, as the clinical expert may
consider additional more subtle clinical information (in this
setup the free text comment). In the user evaluation the general
practitioners were positive about the decision support system,
and suggested that it be used for educational purposes, as they
felt it impractical to use it in the daily routine.
Conclusion: The decision support system did perform quite
well on the average, but the ‘human’ experts add an individual
assessment, based on more subtle patient characteristics. How-
ever the system is only designed to calculate the average
probability of Lyme disease in subgroups of patients with
certain characteristics and thus support an evidence based
diagnostic decision. The ﬁnal diagnosis has to be made by the
clinician only after considering the complete history and
examination of the patient. There are very few studies pub-
lished on clinical evaluation of expert systems. The data from
the present study will be used for further development of the
expert system and prepare for a prospective clinical evaluation.
If an expert system is to be used in everyday busy clinical life,
integration into the electronic health care record is necessary.
As a stand-alone system it may be used for educational
purposes.
P509
Characteristics of children with clinical suspicion
of Lyme neuroborreliosis
R.B. Dessau, J.P. Glenthøj, I.-M. Nielsen (Næstved, DK)
Objectives: The clinical diagnosis Lyme neuroborreliosis and
the differential diagnosis of other neurological syndromes in
children is a challenge. The objective is to describe symptoms
suggestive of Lyme neuroborreliosis and testing for Borrelia
burgdorferi s.l. intrathecal speciﬁc antibody production (BbISAP).
Methods: Retrospective evaluation of the patient record: Group
1. All 29 patients tested for BbISAP (2001–2003) at the pediatric
department. Patients were scored by a specialist in Neuropedi-
atrics. Group 2. 44 patients selected with discharge diagnoses of
Lyme disease, Bells paresis or headache and who were tested for
BbISAP (1996 to 2001).
Main Results: Group 1. 29 patients (81%) did not have neuro-
borreliosis, 3(8%) had a deﬁnite diagnosis with positive BbSiap
and the remaining 4(11%) were scored as possible. Group 2.
Looking at the initial symptoms in the 17 patients with positive
BbISAP: facial paralysis 5, non speciﬁc symptoms (headache 5,
fever or tiredness 5), meningeal signs 1 and erythema migrans
with pain in one arm1 patient. 3 more developed facial paralysis
on admission. Concerning sequelae at follow up, 7 patients had
none, 3 had light signs of facial paralysis after 3, 6 and 12 months
respectively, 1 patient had irritability, speech problems and wrist
pain at 18 months. 6 patients were not seen after discharge. In
both groups patients with positive BbISAP had a mean leukocyte
count of 198 · 106/l (range 13–832)
Conclusion: All patients with positive BbISAP also had eleva-
ted leukocyte count in the spinal ﬂuid in both patient groups.
Non-speciﬁc symptoms as headache, fever and tiredness seem
to be common at the start of clinical neuroborreliosis. 4 of 17
(25%) patients had some remaining symptoms many months
after discharge.
P510
Contribution to post-Lyme syndrome: the
frequency of symptoms in long-term outcome of
patients with neuroborreliosis
D. Picha, L. Moravcova, V. Maresova, H. Rohacova (Prague, CZ)
Objective: The ‘post-lyme’ syndrome is a complex of symptoms
that can be found in patients after having adequately been
treated for Lyme borreliosis. The most frequent symptoms
include: fatigue, headaches, usually mild cognitive deﬁcit, joint
and ﬁbromyalgias and yet, nevertheless, the complaints can
persist for months to years, while typically no direct laboratory
hallmarks of infection can be found. Repeated antibiotic treat-
ment often does not result in clinical improvement. Because the
patients are repeatedly examined and treated by different
medical specialists the post-lyme syndrome creates a relative
consumptive medical problem.The long-term outcome of a
prospective organised study of patients with neuroborreliosis
was used to assess the incidence of possible post-lyme syn-
drome in this type of Lyme disease involvement.
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Methods: 88 patients with early forms of neuroborreliosis (diag-
nosis based on the typical neurological involvement and positiv-
ity of either antibody index CSF/serum or PCR in CSF) were
evaluated for late outcome (1–6 years; average 35 months). All
patients were treated intravenously by antibiotics in hospital.
Results: Subjective complaints of patients disappeared till
6 months after treatment in 42 patients (49%), till 1 year in the
next 10 (8%) and till 3 years in 3 (2.5%). 33 patients (37.5%) had
problems longer than 3 years. The most frequent symptoms in
this group were: headache (65 patients, 74%), psychic problems
(tensions, depression, psychic concentration disturbances in 61
patients, 69%), articular pains (33.38%), muscle pains (20.23%),
cognitive deﬁcit (14.17%). Notwithstanding the frequency and
duration of subjective troubles, the objective neurological
involvement disappeared substantially more quickly. Immedi-
ately after treatment neurological status was considered normal
in 49 patients (56%) whereas, after 6 months, neurological
normalisation was found in 72 of those tested (82%) and in
another 11 people only very mild residues existed.
Conclusion: The genesis of ‘post-lyme’ syndrome could be
expected in one third of patients with correctly treated neuro-
borreliosis. Because all patients connected their complaints with
their history of Lyme disease, better knowledge on the part of
medical staff is necessary and new diagnostic tools (DNA based)
are desirable. It is necessary to realise that repeated examination
and anti-infective treatment is expensive and less effective.
P511
Genospecies of Borrelia burgdorferi in patients
with erythema migrans
J. Niscigorska, B. Wodecka, I. Moranska, A. Boron-Kaczmarska,
B. Skotarczak (Szczecin, PL)
Objectives: Borrelia burgdorferi sensu lato(B.b.), a causative
agent of Lyme disease (L.d.) is a heterogeneous group of
spirochetes. Clinical manifestations of L.d. are genospecies
dependent, and the most common form of early localized L.d.
is erythema migrans (E.m). This study was performed to
determine genospecies of B.b.in patients with E.m.
Methods: Thirty two patients from West Pomerania region in
Poland with ﬁnal diagnosis of E.m. were admitted to study after
antibiotic treatment. Blood samples of patients were tested to
detect genospecies of B.b. using genospecies-speciﬁc primers for
DNA of Borrelia garinii, Borrelia afzeli and B.b. sensu stricto.
Results: The spirochetesDNAwere found in 25 blood specimens
(25/32, 78.1%), sevenwere negative. Among 25 positive samples,
ten contained B. garinii DNA (20/25, 40%), ﬁve-B. afzelii (5/25,
20%), four-B.b sensu stricto (4/25, 16%)and in six samples both
B.garinii and B. afzelii DNAwas present (6/25, 24%).
Conclusions: 1. DNA of B.b. can be detected in patients with
E.m. after antibiotic treatment. 2. The dominant genospecies of
B.b. among patients with E.m. from West Pomerania region is
B. garinii. 3. In patients with E.m. multi genospecies infection can
occur.
P512
Serological diagnosis of culture conﬁrmed early
Lyme disease (erythema migrans) by two
different EIAs and three Western Blot tests in an
Italian population
M. Sparacino, A. Marangoni, F. Cavrini, E. Storni, R. Cevenini,
V. Mondardini, V. Sambri (Bologna, I)
Objectives: To comparatively evaluate the performances of two
different EIA methods and three Western blot tests for the
diagnosis of Lyme borreliosis.
Methods: 60 sera were serially obtained from 30 Italian patients
suffering from acute culture conﬁrmed Lyme disease. All the
patients received antimicrobial therapy at the enrollment: the
follow up period was 1 month. 65 cross-reacting serum speci-
mens were also evaluated. The following EIAs were used: Anti-
Borrelia plus VlsE (Euroimmun) and Quick ELISA C6 (synthetic
peptide based from Immunetics). As conﬁrmatory methods,
three different Western blot (WB) tests were used: Euroline-WB
(Euroimmun), Qualicode B.burgdorferi WB (Immunetics) and a
multispecies ‘home made’ test.
Results: The highest sensitivity was found for Anti-Borrelia
plus VlsE IgG (56.6%) whereas the sensitivity of Quick C6 was
lower (33.3%). In addition, since 17 sera from the very early
disease were positive only for the IgM response when tested by
Anti-Borrelia plus VlsE IgM, this test performed as a whole
system with a sensitivity of 85.0%. The speciﬁcity of Anti-
Borrelia plus VlsE was 98.5% for the IgG and 78.5% for the IgM:
these values suggested the need of a conﬁrmatory testing by
WB. The three WB methods showed comparable performances
for the detection of the IgM. On the other hand, the WBs
performed differently for the IgG detection: the most sensitive
was the ‘home made’ method (71.7%), ranking at second place is
the Euroline-WB (68.3%). The Qualicode test was the least
sensitive (26.6%). The speciﬁcity of the ‘home made’ and of
Qualicode tests was 100%, whereas the Euroline WB IgG
identiﬁed 12 cross-reacting specimens as border line, giving a
speciﬁcity value of 80.0%.
Conclusion: The Anti-Borrelia plus VlsE ELISA showed to be a
better test than the Quick C6 but it still need to be followed by a
conﬁrmatory test in any case of positivity. The need of WB still
remains in Europe, where the etiology of Lyme disease is
complicated by more than one pathogenic genospecies.
P513
Low-avide IgG antibodies against the newly
discovered Borrelia main antigen VlsE correlate
to early stages of borreliosis
T. Scheper, W. Meyer, S. Krueger, W. Schlumberger,
W. Stoecker (Lubeck, D)
Objectives: In various infectious diseases, the detection of low-
avide IgG is used to differentiate early from late stages of the
disease. To date, such information for infections with borrelia is
limited. In the present study, the avidity of serum IgG
antibodies against the newly identiﬁed borrelia main antigen
VlsE was tested in recent and long-lasting borrelia infections.
Methods: The EUROIMMUN ‘Borrelia EUROLINE-WB’, a
combination of a western blot, containing a whole extract of
Borrelia afzelii plus a membrane chip with a printed line of
recombinant VlsE was used to incubate 28 clinically character-
ized sera from the CDC Lyme panel according to the standard
protocol (30 min serum, 3 · 5 min tris buffered saline (TBS), 30
min Anti-human IgG/alkaline phosphatase, 3 · 5 min TBS,
10 min substrate NBT/BCIP). In a parallel incubation, in the ﬁrst
of the three washing steps after the serum incubation, 8 M urea
was added to the TBS. Intensity of the VlsE band was
automatically evaluated using the computer programme EURO-
BlotScan. A relative avidity index (RAI) was calculated as
follows: RAI(%) = intensity VlsE band (urea)/intensity VlsE
band (without urea) · 100.
Results: In erythema migrans patients (early borreliosis,
n = 19), 79% of the sera displayed an RAI of 0–40%, 11%
exhibited an RAI in the range of 40–70%, and 10% an RAI higher
than 70%. In borrelia arthritis patients (late stage of borreliosis,
n = 9), no serum displayed an RAI of 0–40%, 44% showed an
RAI in the range of 40–70% and 56% had an RAI higher than
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70%. Two sera from patients with erythema migrans contained
high-avide antibodies, possibly caused by a reinfection.
Conclusions: Low-avide antibodies of class IgG against VlsE
appear in early borreliosis. In later stages, the antibodies mature
and the RAI increases. The EUROLINE-WB system enables the
diagnosis of fresh borrelia infections by identiﬁcation of low-
avide antibodies. In order to verify the signiﬁcance of avidity-
testing in borreliosis, larger, more representative serum panels
have to be analysed.
Acknowledgement: We thank Dr. Martin Schriefer from CDC
Atlanta for kindly providing the sera.
P514
Evaluation of an internally controlled real-time
PCR targeting the OspA gene for detection of
Borrelia burgdorferi (sensu lato) DNA in
cerebrospinal ﬂuid
J. Gooskens, K.E. Templeton, E.C.J. Claas,
A.P. Van Dam (Leiden, NL)
Objectives: PCR on skin biopsy specimens has a high sensitiv-
ity when used for the diagnosis of erythema migrans and Lyme
arthritis. In neuroborreliosis, however, the sensitivity of stand-
ard PCR tests on CSF samples is only 10–30%. The aim of the
study was to evaluate the sensitivity of the real-time PCR for
CSF samples.
Methods: An internally controlled real-time PCR targeting the
OspA gene was developed using Borrelia burgdorferi (sensu lato)
speciﬁc primers and Taqman probe. DNA from B. burgdorferi
and an internal control (Phocine herpes virus) were ampliﬁed
and detected simultaneously using probes labelled with
6-carboxy-ﬂuorescein (FAM) and indodicarbocyanine (Cy5)
respectively. Analytical sensitivity was evaluated on DNA
extracted from 33 B. burgdorferi sensu lato strains, including
B. burgdorferi sensu stricto (n = 6), B. garinii (n = 12), B. afzelii
(n = 9), B. valaisiana (n = 4), B. japonica (n = 1) and strain A14S.
Speciﬁcity was evaluated with DNA extracted from relapsing
fever (RF) Borrelia sp. (n = 4), belonging to all 3 phylogenetic
clusters, and on 31 viral, bacterial and fungal samples. Quan-
titative sensitivity was determined using limiting dilution series
of known DNA concentrations. Subsequently, cerebrospinal
ﬂuid (CSF) samples were spiked using limiting dilutions of
freshly cultured B. garinii. DNA was extracted from CSF
samples by QIAamp DNA mini blood kit columns. In addition,
three CSF samples from culture-positive patients as well as 13
samples from other patients with neuroborreliosis in which
culture was not done were tested in the assay.
Results: The real-time PCR detected DNA of all B. burgdorferi
(sensu lato) species and was negative for DNA from RF Borrelia
sp. and all other specimens. The sensitivity of the assay was 1–5
spirochetes. In spiked CSF samples the sensitivity was not
diminished. Two out of three culture-positive CSF samples were
positive in the PCR, whereas the third sample was inhibited.
Two out of 13 samples from other patients with neuroborreliosis
were positive in the PCR.
Conclusion: The real-time PCR assay developed in this study
provides sensitive and speciﬁc detection of all B. burgdorferi
sensu lato species tested. The QIAamp mini blood kit columns
are suitable to extract Borrelia DNA from CSF, and combination
with real-time PCR provides a sensitive assay. However, even
when using this assay the yield from CSF samples from patients
with neuroborreliosis is low.
P515
Impact of long-term antibiotic therapy on
symptoms evocative of chronic lyme disease
J. Clarissou, J. Salomon, D. Guillemot, C. Bernede, F. Ader,
L. Bernard, C.M. Perronne (Garches, Paris, F)
Objectives: chronic lyme disease (CLD) could be partly due to
the persistence of Borrelia. The aim of our study is to determine
the effect of long term antibiotic therapy on heterogeneous
symptoms evocative of CLD.
Methods: 100 patients (pts) (65% female, mean age 45 y) with a
diagnosis of CLD were included in an open study. A clinical
score was designed based on the following items: erythema
migrans (56% of cases), positive serology for Borrelia (51%), tick
bite (69%), combination of categories of signs or symptoms:
systemic (88%), neurologic (94%), articular (91%), cutaneous
(76%), psychiatric (77%), cardiorespiratory (73%) or muscular
(67%). Diagnosis was classiﬁed as very probable (67%), probable
(25%) or uncertain (8%), according to the clinical score. An
antibiotic therapy was given for 3 to 6 months (penicillin G,
ceftriaxone, amoxicillin, doxycycline or clarithromycin). The
number (No) of subjective symptoms (SS) and objective signs
(OS) was measured at day 0 (D0), month 3 (M3) and M6.
Results: The No of pts with 4 or more categories of signs or
symptoms was 82% at D0, 34% at M3 and 31% at M6. The mean
No of SS was 12 at D0, 6 at M3 and 5 at M6. The mean No of OS
was 2.7 at D0, 1.4 at M3 and 1 at M6. The differences were
signiﬁcant for very probable or probable cases (p < 0.001).
Conclusion: This study shows an important improvement of
the clinical conditions of pts with CLD treated with a prolonged
course of antibiotic. A controlled randomized trial with a strict
case deﬁnition and a follow up longer than 3 months is needed.
Antibiotic usage
P516
Antibiotic use and resistance in Gram-negative
hospital pathogens
K. Green, A. Jeffery, L. Dresser, M. Pitre, A. Kwan, D.E. Low,
A.McGeer for the Ontario Antibiotic Use and Resistance Study Group
Objectives: To determine the relationship between use of
different antibiotics and resistance patterns in hospital gram
negative pathogens.
Methods: In early fall, each hospital in Ontario was mailed a
survey requesting information about antibiotics included in
their formulary, their in-hospital use of speciﬁc antimicrobials
and their resistance rates in a number of hospital pathogens. A
representative from the pharmacy and microbiology laboratory
servicing each hospital was identiﬁed and served as the contact
for obtaining ethics approvals and collecting requested data.
Results: To date, 5 hospitals (3 acute care tertiary centres, 1
community hospital and 1 chronic care facility) have completed
the survey. The median DDDs/1000 patient days varied for each
drug between the reporting hospitals; ciproﬂoxacin 51.2 (range
11.2–107.6), ampicillin 24 (range 0–44.9), trimethoprim/sulfa-
methoxazole 7.8/39 (range 1.7/8.3–36.1/180.4), ceftriaxone 14.8
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(range 0.9–77.5). Four of the 5 hospitals reported antibiotic use
data for three years. In 2003, 2/4 reported an increase in
ceftriaxone use over that of 2001 (71.9 vs 77.5 and 0.4 vs 0.9
DDDs/1000 patient days), 2 reported a modest increase in
ciproﬂoxacin use (49.6 vs 51.2 and 11.7 vs 11.9 DDDs/1000
patient days). Only one facility reported an increase in more
than one type of antibiotic. Although the medians and ranges of
resistance rates varied (shown in table below), they did not
appear to correlate with the DDD use data reported for the
respective antibiotics.
Conclusions: Although antibiotic use and resistance varied
between the reporting hospitals, the sample was not adequate to
determine correlations between the two for the gram negative
hospital pathogens reported.
P517
Outpatient utilisation of antibiotics in Zagreb
(Croatia) 2001–2003
D. Stimac, I. Vukusic, J. Culig (Zagreb, HR)
Objective: To analyze outpatient utilization of antibiotics in
Zagreb during a 3-year period (2001–2003) using the Anatom-
ical-Therapeutic-Chemical (ATCD) drug classiﬁcation system
and deﬁned daily doses (DDD).
Method: Data on outpatient drug utilization were obtained
from Zagreb Municipal Pharmacy, its units accounting for 16%
of all city pharmacies, and extrapolated to total number of city
pharmacies. All drugs were classiﬁed according to ATC drug
classiﬁcation system. Utilization data on each individual drug
were expressed as the number and size of packages, and as the
cost expressed in HRK based on wholesale price. These data
were used to calculate the number of DDD and DDD per 1000
inhabitants per day (DDD/TID).
Results: From 2001 to 2003, the utilization of systemic antibac-
terials (J01) decreased by 18.18%(from 55 to 45.01 DDD/TID); in
all three years, the highest consumption was recorded for
penicillins (J01C), which accounted for a half of total antibiotic
utilization (25.4, 24.43 and 20.87 DDD/TID in 2001,2002 and
2003, respectively), showing a decline by 17.83%. Cephalospo-
rins (J01D) ranked second in all three years, showing a decline
by 33.46% from 2001 to 2003. Macrolides (J01F) ranked third;
from 2001 to 2003 their consumption decreased by 17.68%, from
6.9 to 5.68 DDD/TID; quinolones (J01M) ranked fourth and
showed a 7.22% increase (from 3.6 to 3.88 DDD/TID). In all
three study years, amoxicillin+clavulanic acid was the most
commonly prescribed antibiotic (14.7,17.25 and 14.64 DDD/TID
in 2001, 2002 and 2003)followed by amoxicillin (7.3, 6.84 and 5.93
DDD/TID in 2001, 2002 and 2003, respectively). Cefurohime
ranked third in 2002 and 2003 with 5.28 and 4.56 DDD/TID,
respectively, whereas in 2001 ceftibuten ranked third to decline
to seventh place according to utilization in 2002 and 2003. In all
three years, doxycycline ranked fourth, and azithromycin ﬁfth
according to utilization in Zagreb.
Conclusion: Utilization of antibiotics in Zagreb is uneconom-
ical, mostly due to the high use of amoxicillin+clavulanic acid,
which has no rational ground in professional guidelines. The
analysis showed expensive antibiotics to be largely prescribed in
Zagreb representing 50% of total national drug utilization and
pointing to the need of efﬁcient measures to make the utilization
of antibiotics in Croatia more rational.
P518
Antimicrobial prescribing pattern in primary
care: a comparison between general practitioners
and family physicians in Bahrain
K.A. Al Khaja, R. Sequeira, A. Damanhori, A. Ismaeel (Manama,
BH)
Objectives: The aim of this study was to determine antimicro-
bial prescribing pattern in primary care and to ﬁnd out whether
prescribing pattern is inﬂuenced by physicians’ training back-
ground.
Methods: A retrospective prescription-based study was carried
out in 17 out of 20 primary health care centres in Bahrain.
Prescriptions (n = 4367) were collected randomly during a
weekday in July 2003.
Results: Systemic antimicrobials ranked the fourth most com-
monly prescribed therapeutic classes of drugs. The top-ten most
commonly prescribed antimicrobials, in descending order, were
amoxycillin (14.3%), cephalexin (5.3%), erythromycin (1.1%),
cloxacillin (0.8%), metronidazole (0.8%), ciproﬂoxacin (0.5%),
cefadroxil (0.4%) cotrimoxazole (0.3%), tetracyclines (0.3%),
norﬂoxacin (0.1%) and procaine penicillin (0.02%). Amoxycillin,
cephalexin, erythromycin and cotrimoxazole were prescribed by
general practitioners (GPs) more often than by family physicians
(FPs) (p < 0.05). With respect to prescribing of other antimicro-
bials and anthelmintic mebendazole the differences between
GPs and FPs were nonsigniﬁcant. Topical antimicrobial prepara-
tions for ear and nose infections were prescribed by GPs in a rate
signiﬁcantly higher than by FPs (p < 0.05); of these topical
antimicrobials, chloramphenicol and locacorten vioform
(ﬂumethasone + clioquinol) ear drops and sulphacetamide eye
drops were more often prescribed by GPs (p < 0.05). There were
no signiﬁcant differences in prescribing patterns between GPs
and FPs as regards various topical antimicrobials used for
oropharyngeal, skin, and vulvo-vaginal infections.
Conclusion: Antimicrobial prescribing differences in primary
care were observed between GPs and FPs. The generalizability
of these ﬁndings is uncertain. Judicious use of antimicrobials
should be encouraged to reduce the dramatic increase in the
prevalence of resistant microorganisms worldwide.
P519
Antibiotic usage in a university hospital in a
country with a low prevalence of antimicrobial
drug resistance
J.K. Møller (Aarhus, DK)
Objectives: To describe the overall usage of antibiotics over two
decades in Aarhus University Hospital (AUH). To compare the
use of antibiotics with the patterns of antimicrobial drug
resistance in micro-organisms causing blood-stream infections
in AUH.
Methods: Data on micro-organisms causing blood-stream infec-
tions from 1981 to 2004 were compiled from the microbiological
computer system MADS at AUH. Data on antibiotics were
obtained from the hospital pharmacy. Three different blood
culture systems were used during the period, BacT/ALERT
since 1994. Sub-cultivation and identiﬁcationwas done according
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to standard methods. Unit of measurement for antibiotic use is
DDD (Deﬁned Daily Dose).
Results: At AUH the yearly use of antibiotics increased 30%
from 1981 to 2004. Expressed as DDD per bedday, however, the
use of antibiotics more than tripled during the period and
amounted to 0.55 DDD/bedday in 2004. For the periods 1981–
1985 and 2000–2004, the relative distribution of the usage in
DDD for the various antibiotics was penicillins (76% vs. 66%),
cephalosporins (3% vs. 14%), aminoglycosides (7% vs. 4%),
quinolones (0% vs. 9%), macrolides (6% vs. 7%), and glycopep-
tides (1% vs. <1%), respectively. Use of cephalosporins and
quinolones increased substantially in the ICU. MRSA was found
in <0.1% of blood-stream infections with S. aureus from 1981–
2000, but in about 3% for 2001–2004. Ampicillin resistance in
E. coli increased from 27% to 44 % during the period, whereas
gentamicin resistance was found in <2% of E. coli from 2000–
2004. Candida species in blood cultures increased more than 10
times over the years and ranked ﬁrst among micro-organisms
isolated in the ICU in 2003.
Conclusion: AUH is still a hospital with a modest prevalence of
drug resistance and use of antibiotics. Changes in relative
distribution of antibiotics (marked increase in use of quinolones
and cephalosporins) in the latter years seem to coincide
especially in the ICU not only with a selection of MRSA but
also in the distribution of micro-organisms causing blood-
stream infections. Monitoring drug resistance and use of
antimicrobial agents in the hospital is a prerequisite for choice
of adequate empiric treatment of blood-stream infections and
also for an evaluation of the antibiotic policy.
P520
Effect of aminoglycoside/beta-lactam
combination therapy versus beta lactam
monotherapy on the emergence of antimicrobial
resistance: a meta-analysis of randomised
controlled trials
I. Bliziotis, G. Samonis, K. Vardakas, S. Chrysanthopoulou,
M. Falagas (Athens, Iraklion, GR)
Background: The addition of an aminoglycoside to a beta-
lactam has been suggested to have a beneﬁcial effect in delaying
the development of antimicrobial resistance.
Objectives: To study the effect of aminoglycoside/beta-lactam
combination therapy versus beta-lactam monotherapy on the
emergence of resistance.
Design: Meta-analysis of randomized controlled trials (RCTs).
Data sources: Data for this meta-analysis were identiﬁed from
PubMed, Current Contents, Cochrane central register of con-
trolled trials, and references from relevant articles.
Study selection: RCTs comparing aminoglycoside/beta-lactam
combination therapy with beta-lactam monotherapy and report-
ing data regarding the emergence of resistance (primary
outcome) and/or development of superinfection, treatment
failure, treatment failure attributable to emergence of resistance,
treatment failure attributable to superinfection, all cause mor-
tality during treatment, and mortality due to infection.
Data extraction: Data for one primary and six secondary
outcomes were extracted by two investigators.
Data synthesis: A total of 9 RCTs were included in the analysis.
Beta-lactam monotherapy was not associated with more emer-
gence of resistance compared to the aminoglycoside/beta-
lactam combination (OR = 0.91; 95% CI 0.55–1.49). Actually,
beta-lactam monotherapy was associated with fewer superin-
fections (OR = 0.62; 95% CI 0.41–0.93) and less treatment failure
(OR = 0.65; 95% CI 0.49–0.86). Treatment failure attributable to
emergence of resistance (OR = 1.56; 95% CI 0.59–4.09), treatment
failure attributable to superinfection (OR = 0.72; 95% CI 0.31–
1.64), all cause mortality during treatment (OR = 0.70; 95% CI
0.40–1.25), and mortality due to infection (OR = 0.74; 95% CI
0.45–1.21) did not differ signiﬁcantly between the two regimens.
Conclusions: Compared to beta-lactam monotherapy, the ami-
noglycoside/beta-lactam combination was not associated with a
beneﬁcial effect on the development of resistance of initially
sensitive isolates.
P521
Cefuroxime as antibiotic prophylaxis in cardiac
surgery
I. Kriaras, A. Mastoraki, O. Daligarou , S. Mastoraki,
S. Geroulanos (Athens, GR)
Introduction: Infectious complications have a major impact on
the surgical patient and are associated with substantial morbid-
ity and mortality. For this reason, antibiotic prophylaxis is
widely used in cardiac surgery in order to reduce the postop-
erative infection rate.
Objectives: To elucidate the prophylactic efﬁcacy of a second
generation cephalosporin given as single dose for patients who
are submitted to Coronary Artery Bypass Grafting after 10 years
of constant use.Methods: Comparedwere two groups of patients.
The ﬁrst group consisted of 429 patients who underwent CABG
in 1994 and the second group of 803 patients whowere submitted
to CABG in 2003. All patients received cefuroxime intravenously
as single dose (3 gr) at the induction of anaesthesia. Patients with
pre-existing infection or receipt of antibiotics during the last
2 days before surgery, with hypersensitivity to cefuroxime or
pre-existing IABP were excluded from this study.
Results: The overall postoperative infection rate was 4.9% in
1994 (21/429) and 5.6% in 2003 (46/803). Respiratory tract
infections were 2.3%(n:10) in 1994 and 0.6%(n:5) in 2003 while
incisional or deep surgical site infections were 0.7%(n:3) in 1994
and 3.2%(n:26) in 2003. In 1994 catheter-related infections were
0.93%(n:4) vs. 0.87%(n:7) in 2003, urinary tract infections
0.47%(n:2) vs. 0.25%(n:2), infective endocarditis 0.23%(n:1) vs.
0.12%(n:1) and sepsis 0.23%(n:1) vs. 0.62%(n:5). In both periods
of time, the predominant pathogens were staphylococcus
species (aureus and epidermidis), Gram positive cocci, Gram
negative bacilli and fungi.
Conclusions: The increase in surgical site infections is due to a
more meticulous surveillance of postoperative infections in the
last years as only one case required a sternum revision and
debridement and the remaining patients had only a minor
infection of the sternal or donor site incision. A single-shot of
cefuroxime prophylaxis (3 gr IV) given just after the induction of
anaesthesia remains effective throughout the years, despite its
continuous use conﬁrming that single dose regimen with a
second generation cephalosporin is the method of choice.
P522
Evaluation of antibiotic consumption and
resistance patterns in a tertiary care surgical ICU
and a medical ICU
E. Hajdu, R. Benko, M. Matuz, Z. Peto, A. Molnar, L. Rudas,
I. Ver, G. Janosi, G. Soos, E. Nagy (Szeged, HUN)
Objectives: A continuous and critical analysis of antibiotic
consumption and a knowledge of resistance patterns are essential
for the control of health care expenses and microbial resistance,
and can additionally be of help in targeting the necessary
interventions. The aims of this work were to reveal the charac-
teristics and trends in parenteral, systemic antibiotic use and to
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gain an insight into themost important resistance patterns in a 12-
bedmedical ICUand a 6-bed surgical ICUbetween 1999 and 2003.
Methods: The annual quantities of antimicrobials delivered to
the units during the study period were determined retrospec-
tively from the central pharmacy’s database.Antibiotic usagewas
converted into grams andﬁnally expressed as deﬁneddaily doses
(DDD) per 100 bed-days. Microbiological data were screened for
duplicates and only relevant cultures were taken into account.
Results: Our results can be summarized in the following table:
Conclusions: As concerns the antibiotic consumption, positive
trends could be observed both in quantity and in quality in both
settings. Dangerous resistances have newly emerged (e.g.MRSA)
or increased in number (e.g. MRCNS). However, these ﬁndings
did not attain an alarming level. Local susceptibility patterns
should be taken into account in empiric antibiotic therapy.
P523
Self-medication with antibiotics in Poland
A. Olczak, P. Grzesiowski, W. Hryniewicz, F.M. Haaijer-
Ruskamp (Warsaw, PL; Groningen, NL)
Objectives: The study was undertaken as a part of the Self-
medication with antibiotics in Europe (SAR) founded by DG
SANCO and coordinated by the University Groningen, Nether-
lands. The aim of the study was to characterise utilisation of
antibiotics in Poland in order to evaluate the prevalence, reasons
of self-medication, sources and structure of antibiotics used for
self-medication.
Methods: The survey was conducted using a self-administered
postal questionnaire obtained from SAR coordinating centre.
The outcome measures were: reported use of antibiotics in the
last 12 months, prescribed or used for self-medication. Self-
medication assessment included intended use and storage of
antibiotics at home. Study population: adult population selected
from region with average age and sex distribution in a country.
The randomly selected sample consisted of 1500 individuals
from a middle size city (population between 150000 and 250000)
and 1500 from a rural area (population between 5000 and 10000),
both in northern part of Poland.
Results: The overall response rate was 31%, without signiﬁcant
difference between city and rural populations. Overall, 29% of
respondents indicated to use antibiotics in the last 12 months.
The most common reasons were: acute laryngitis/tracheitis,
acute bronchitis/bronchiolitis, teeth/gum symptom/complaint,
and cough, skin infection and urethritis. The most frequently
used antibiotics were: amoxicillin, amoxicillin/clavulanic acid,
doxycycline, clindamycin, sulfamethoxazole/trimethoprim.
Inspite of all antibiotics for systemic use in Poland being
currently available only on prescription, 12.5% of respondents
indicated its use as self-medication without prescription. The
main reasons for using antibiotics as self-medication were: sore
throat, runny nose/cold, cough and fever. The main sources of
antibiotics used for self-medication were: leftovers from previ-
ous illness available at home and antibiotics intended from
relatives or friends. Overall 18% of the respondents indicated to
keep antibiotics at home during the study period.
Conclusions: Although all antibiotics for systemic use are
available in Poland only with medical prescription, the self-
medication with antibiotics occurs in substantial proportion of
population. There is a need for community directed interventions
to limit the use of antibiotics without adequate medical attention.
P524
Antibiotic usage peculiarities in Lithuanian
hospitals revealed by national prevalence study
R. Valinteliene, J. Griskeviciene (Vilnius, LT)
Objectives: Study antibiotic usage in Lithuanian hospitals and
identify week points of antibiotic consumption monitoring
system. Monitoring antibiotic consumption is one of the key
activities in combating antimicrobial resistance. Lithuania is one
of the few countries in Europe that is just starting to obtain
antibiotic consumption data, primarily from hospitals.
Methods: Point prevalence study in representative number of
Lithuanian hospitals was performed. Data on current antibiotic
treatment (antibiotic name, route of admission, reason) as well as on
infections were collected for all hospitalized patients during bed
rounds. All antibiotics were recorded: those offered by hospital as
well as thoseprescribedbydoctorsbutboughtbypatients themselves
(last mentioned drugs are not included in ofﬁcial hospital’s con-
sumption data). The study included 10102 patients in 39 hospitals.
Results: One third of patients were given antibiotics (3140
patients, 31.1%) and in 77.9% of cases it was monotherapy. In
general, 3943antibioticswereprescribedandmostof them(74.8%,
2948) were prescribed for the treatment of infections while 24.8%
(979) as prophylaxis (unknown - 0.4%, 16). Most often used were
penicillin (23.4%), aminopenicillins (19.2%), aminoglycosides
(21.2) and cephalosporins (15.5%). When structure of antibiotic
was compared with antibiotic consumption data ofﬁcially
obtained from hospitals some differences were detected. During
our study it was determined that 6.2% of all used antibiotics were
obtained by patients themselves (these are not coming in ofﬁcial
consumption data). Great variations between hospitals and units
in this respect were observed. There were 5 hospitals wheremore
than 20% (up to 50%) of antibioticswere bought by patients.More
often patient’s own antibioticswereused in surgical departments:
orthopaedic/trauma (12.9%), general surgery (7.3%). It was
determined that antibiotics for prophylaxis (12.3%) are tend to
bemore often bought by patients than for treatment (4.0%). It also
was found out that patients more often are asked to buy certain
antibiotics: III–IV gen. cephalosporins (27.8%), quinolons (18.4%),
I–II gen. cephalosporins (13.7%).
Conclusion: Antibiotic consumption monitoring based only on
data from hospital pharmacies might be inaccurate, especially
for prophylactic usage, total consumption in surgical depart-
ments and some certain drugs (III–IV gen. cephalosporins,
quinolons).
DDD/100bed-days
Systemic
anti-
bacterial Penicillins
Cephalo-
sporins
Carba-
penems MLS
Ami-
nogly-
cosides
Quinolones Glyco-
peptides
1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2
1999 71.8 137.6 29.5 39.2 6.6 42.7 7.4 6.2 0.3 1.8 8.3 4.7 7.4 18.8 10.2 6.4
2000 69.3 133.7 19.9 44.0 8.9 30.8 9.4 7.4 1.2 5.0 4.5 4.2 6.5 16.9 15.6 12.1
2001 99.2 164.8 19.3 32.4 10.5 47.8 17.2 18.3 4.2 3.7 5.6 6.7 9.7 15.8 30.3 28.0
2002 99.5 153.5 22.6 30.4 7.9 32.9 14.3 25.3 1.6 2.5 5.3 10.4 14.5 13.4 32.6 31.1
2003 78.9 11.9 26.0 28.7 8.9 40.9 12.5 15.6 0.6 2.7 7.7 1.5 13.1 6.8 9.6 9.4
1. Medical ICU
2. Surgical ICU
S.aureus/
MRSA CNS/MRCNS
KES/3rd
generation
cephalosporin
R KES
P. aeruginosa/
imipenem R
P. aeruginosa
E. coli/
ciproﬂoxacin
R E.coli
1 2 1 2 1 2 1 2 1 2
1999 57/0 18/1 44/24 30/26 16/1 26/7 12/4 40/11 43/1 16/0
2000 61/1 19/0 54/30 17/11 24/1 26/1 21/4 25/1 65/5 26/3
2001 52/1 14/0 63/33 31/22 18/2 35/3 46/9 22/2 66/2 19/3
2002 62/0 39/0 89/47 47/34 19/1 40/5 43/2 34/9 63/14 24/1
2003 61/5 47/4 68/37 40/27 10/1 63/11 32/7 24/1 61/14 37/0
1. Medical ICU
2. Surgical ICU
VRE and MDR Acinetobacter was not found
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P525
An additional measure for quantifying antibiotic
use in hospitals
P.M.G. Filius, T.B.Y. Liem, P.D. van der Linden, R. Janknegt,
S. Natsch, A.G. Vulto, H.A. Verbrugh on behalf of the Working
Party on Antibiotic Policy (SWAB)
Objectives: The number of Deﬁned Daily Doses (DDD) per 100
patient days is often used as an indicator for the selection
pressure exerted by antibiotics in the hospital setting. This unit
of measurement does, however, not fully describe the selection
pressure and is sensitive to changes in hospital resource
indicators. Additional information is required to facilitate
interpretation of this indicator. The number of DDD per 100
admissions could be a valuable additional tool. The aim of this
study is to investigate the importance of units of measurement
in quantifying antibiotic use data with regards to antibiotic
resistance risks.
Methods: Trends in antibiotic use in acute care Dutch hospitals
between 1997–2001 were studied. Antibiotic use was expressed
in DDD per 100 patient days and in DDD per 100 admissions.
Results: From 1997 to 2001 total systemic antibiotic use signi-
ﬁcantly increased from 47.2 to 54.7 DDD per 100 patient days
whereas expressed in DDD per 100 admissions it remained
constant. For some individual antibiotics increases in DDD per
100 patient days were not accompanied by increases in DDD per
100 admissions and vice versa. The average length of stay and
the number of admissions decreased between 1997 and 2001.
Conclusions: Correction for variation in resource indicators and
additional expression of the data in DDD per 100 admissions is
imperative for a meaningful understanding of observed trends in
antibiotic use expressed in DDD per 100 patient days. Further
research is needed to determine the correlation between different
measures of antibiotic use and the level of antibiotic resistance.
P526
Antibiotic prescribing on general surgical wards
– room for considerable improvement
S.F. FitzGerald, L. Walsh, E. Thornton, M. Scally,
H. Humphreys, E.G. Smyth (Dublin, IRL)
Objectives: The inappropriate use of antibiotics leads to the
emergence of resistant organisms, causes unwanted adverse
effects and results in unnecessary costs for the health services.
Attempts to improve prescribing habits of doctors have been
largely unsuccessful. This study was undertaken to determine
what could be done to improve antibiotic prescribing habits in
our hospital.
Methods: An audit of current antibiotic prescriptions on three
general surgical wards was carried out over a four week period
in Beaumont Hospital, a tertiary referral 650-bedded teaching
hospital in Dublin. Prescriptions were deemed inappropriate if
the choice did not conform to hospital antibiotic guidelines for
empirical therapy; if duration of antibiotic treatment exceeded
guidelines; if dose or dosage interval was incorrect, or if an
alternative agent was indicated by available sensitivity results.
In each instance of inappropriate treatment, a recommendation
to change the prescription was made in the medical chart and
the surgical team was contacted with this advice. Whether or not
this advice was followed, was then documented.
Results: Treatment was inappropriate in 58% (100/171) of
prescriptions studied - the advised change was implemented
in half of these (49/100). Prolonged administration of peri-
operative prophylaxis (53/58) and the co-administration of
metronidazole with coamoxiclav (32/60) were the most common
inappropriate prescriptions.
Conclusions: This initiative was time-consuming (48 hours
over 4 weeks) and yielded only moderate results in terms of
compliance with our advice. However two major areas of
inappropriate antibiotic use were identiﬁed and interventions
have been implemented to try to effect change, including
enhanced education of prescribers, liaison with surgeons and
greater input by ward pharmacists. Re-audit is currently
underway.
P527
Antimicrobials usage in orphanages: results of
the unique prospective multicentre study
CORPUS
R.S. Kozlov, O.U. Stetsiouk, O.I. Kretchikova, L.P. Zharkova,
N.A. Petrochenkova, J.A. Poupard, L. Stratchounski (Smolensk,
RUS; Philadelphia, USA)
Objectives: Pattern of the use of antimicrobials has been shown
to be an independent risk factor for emergence and spread of
resistant microorganisms. It has been previously shown that
orphanages are considered to be reservoirs of resistant strains,
which spread to day-care centres and into clinical settings. A
special study was designed to evaluate patterns of use of
antimicrobials in children from different orphanages located in
geographically distinct Russian cities.
Methods: Analysis of the use of antimicrobials in previous
12 months was performed based upon reviews of medical
histories of 743 children < 7 years from 11 orphanages in 4 cities
of European Russia (Moscow, Saint-Petersburg, Smolensk,
Karachev).
Results: In general, prescription of antimicrobials varied from
0.31 courses per child/per year in infant orphanage No. 7 in
Saint-Petersburg to 3.63 courses per child/per year in Karachev.
In all orphanages, b-lactams were the most frequently pre-
scribed (55.3 to 100% of all antimicrobials). Among them,
predominant ones were (in order of frequency): ampicillin/
oxacillin (164 courses), amoxicillin/clavulanate (148), cefazoline
(128), cefotaxime (119) and ampicillin (103). In general, paren-
teral compounds were predominantly used in orphanages with
the proportion from 61.9 to 100%. Macrolides/lincosamides
were the second most frequently prescribed in 6 out of 11
orphanages, with azithromycin being prescribed more often (98
courses), exceeding sum of all macrolides: both co-trimoxazole
and aminoglycosides were the second in 2 out of 11 institutions.
Conclusions: There were substantial variations in frequency of
the antimicrobial prescriptions with no reﬂection of geographic
location, size of city or speciﬁc children population. It was a
tendency in all orphanages to prescribe parenteral antimicrobi-
als in spite of the presence of suitable oral alternatives.
Enforcement measures have been implemented in order to
prohibit unlicensed use of some antimicrobials in studied
populations.
P528
Two consecutive point prevalence studies on
indications for antibiotic use in selected Latvian
hospitals
E. Pujate, D. Vigante, E. Kvista, D. Pavlovska, A. Mironovska,
I. Lama, O. Nikitina, M. Kula, R. Snipe, L. Zeidaka, U. Dumpis
for the Latvian Nosocomial Infection Study Group
Objectives: The objective of these surveys was to test simple
surveillance system for the assessment of the prevalence of
nosocomial infection and use of antibiotics.
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Methods: Seven and nine Latvian hospitals were included in
years 2003 and 2004 respectively. One trained personnel in each
hospital has visited all clinical departments over the month
(May) period. All administered antimicrobials were recorded
according to the purpose of the administration: treatment of
community and hospital acquired infection, prophylaxis, or the
purpose was unclear to investigator. Data were double entered
and analysed by EpiData 3.02 and Epi Info 2000 software
packages.
Results: The number of patients treated with antibiotics was
855 (28.9% out of 3150 in 7 hospitals) and 988 (26.2% out of 3776
in 9 hospitals) in years 2003 and 2004 respectively. The
prevalence of patients treated for nosocomial infection was
3.6% in both 2003 and 2004. In 21% (2003) and 12% (2004) of
patients antibiotics were prescribed without clear clinical indi-
cations. Five most commonly used antibiotics were cefazolin
(26% of all antibiotics in 2003 and 22 % in 2004), gentamicin (11%
and 10%), ampicillin/amoxicillin (14% and 12%), metronidazole
(9% and 8%), and ciproﬂoxacin (9% and 7%). Ten different
antibiotics were used for surgical prophylaxis. Cefazolin
accounted for 58% and 63% from them in 2003 and 2004
respectively. For treatment of infection most commonly used
antibiotics were cefazolin (19% and 14%), ampicillin/amoxicillin
(15% and 14%), and gentamicin (12% and 11%).
Conclusions: Surveillance protocol was equally applicable for
all hospitals. The results of the study indicate the main problems
in antibiotic prescription: overuse of antibiotics, inconsistent
surgical prophylaxis, and different pattern of empirical choice in
various hospitals. It also gives an insight for the problem of
nosocomial infections in Latvian hospitals.
P529
Another white spot on the Europe map is gone:
ﬁrst results of the Russian monitoring of
antimicrobial consumption
L. Stratchounski, A. Bedenkov, A. Ishmukhametov,
M. Denisova, L. Abramenko, S. Gotovats (Smolensk,
Moscow, RUS)
Objectives: The joint project of the Institute of Antimicrobial
Chemotherapy and The Remedium Group of Companies
(TRGC) was established to monitor the patterns of antimicrobial
(AM) consumption in Russia with a long term aim to improve
prescription habits and reduce antimicrobial resistance.
Methods: Data on the use of AM in Russia were collected from
the national projects Retail Pharmaceutical Market Audit and
Hospital Audit that are conducted by TRGC since 2000. The
pharmacy and hospital audits are realized in 51 and 27 regions
of Russia, respectively. Imprecision of the data of both audits
does not exceed 10%. The ﬁnal reports contain products names,
Anatomical Therapeutic Chemical classiﬁcation codes, drug
forms, dosages and packages quantity. The use of AM was
expressed as the number of deﬁned daily doses (DDD) per 1000
inhabitants per day – DDD/1000 inhabitants/day (DID).
Results: The mean total consumption of AM for systemic use
(J01) in 2001–2002 in Russia was 11.9 DID (2001 – 12.0, 2002 –
11.8). The use of tetracyclines (J01A), amphenicols (J01B),
beta-lactams, penicillins (J01C), other beta-lactams (J01D), sul-
fonamides and trimethoprim (J01E), macrolides, lincosamides
and streptogramins (J01F), aminoglycosides (J01G), quinolones
(J01M), other antibacterials (J01X) was, respectively, in 2001 –
1.88, 0.38, 3.71, 0.30, 1.92, 1.03, 0.99, 1.00, 0.81 DID and in 2002 –
2.12, 0.47, 2.90, 0.41, 1.97, 1.04, 0.81, 1.14, 0.97 DID. Among J01C
group aminopenicillins were prescribed above all (57.4% in
2001, 63.4% in 2002) and their use in 2001 was 2.13 DID and in
2002 - 1.84 DID. From 2001 to 2002, the use of ampicillin
decreased from 1.67 to 1.10 DID. However, its oral form was
mainly prescribed (2001 – 1.3 DID, 76.5%, 2002 – 0.81 DID,
72.7%). Whereas, the consumption of amoxicillin increased from
0.46 DID in 2001 to 0.74 DID in 2002. Cephalosporins use
increased from 0.29 DID in 2001 to 0.40 DID in 2002. Between
J01F AM macrolides were the most often prescribed group with
0.84 DID in 2001 (81.6%) and 2002 (80.8%).
Conclusions: Data on antibiotic consumption on a country level
could be applied for improvement of the usage patterns.
P530
Evolution in antibiotics consumption in a Belgian
general hospital between 1996 and 2003
C. Sneessens, D. Govaerts, J. Douchamps (Montigny-le-Tilleul, B)
Objectives: The excessive and inadequate consumption of
antibiotics (ATBs) has serious consequences for public health,
such as the increase of bacterial resistance. Therefore, our
hospital evaluates trends in antimicrobial use since 1996.
Methods: A 666-bed general hospital in Belgium (186 235 bed-
days in 2003, including 65% acute beds). Antibiotic committee
was created in 1998 and has many missions like to develop
formalized treatment guidelines for commonly encountered
infectious diseases and control the consumption of extended-
spectrum (E-S) ATBs. The annual consumption of ATBs (Class
J01 in the ATC classiﬁcation from WHO 2004) in Deﬁned Daily
Doses (DDDs) and total patient days (PD) for 1996 through 2003
were determined from electronic capture of billing records. The
DDD/100 PD was calculated for each antimicrobial. The
microbiology laboratory provides the committee with data
about the frequency of various resistant pathogens (Sirscan
expert system).
Results: Total antimicrobial use (J01) between 1996 and 2003
was 30.80, 31.44, 31.79, 30.87, 30.20, 36.63, 42.95 and 45.5 DDD/
100PD, respectively. The most dispensed antimicrobials are the
combinations of penicillins, including beta-lactamase inhibitors
(J01CR) with an average DDD/100PD of 15.90. The cephalospo-
rins (J01DA) and the ﬂuoroquinolones (J01MA) have an average
DDD/100PD of 5.45 and 4.28, respectively. Incidences of
nosocomial Methicillin resistant Staphylococcus aureus (MRSA)
acquisition, methicillin resistance and glycopeptides consump-
tion were stable until 2001, then increase (+23.43% for the
resistance; +128.52% for the consumption) between 2001 and
2003.
Conclusion: Total consumption of ATBs has not changed
signiﬁcantly between 1996 and 2000, but in 2001 there is an
increase of almost all classes of ATBs. In 2003, a 72-hour stop
order system of prescribing was implemented to control the use
of E-S ATBs. This system, which is hoped to have an impact on
the epidemiology of nosocomial bacteria, is presently under
evaluation.
P531
Study of quinolone consumption in Greek
hospitals: results of a Hospital Network
M. Lelekis, C. Loupa, A. Provis, C. Anitsakis, K. Katsimpris,
V. Markos, G. Xylomenos, H. Antonopoulou, P. Gargalianos
(Athens, Zakynthos, Mytilini, Rhodes, GR)
Background: Resistance to quinolones is growing both in the
community and the hospitals of Greece. For this reason,
quinolone use is restricted in both settings.
Methods: We studied quinolone consumption in Greek hospi-
tals, through a network that we established and includes 5
hospitals located in different parts of Greece: ‘G. Gennimatas’
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General Hospital (GGH) of Athens (tertiary care, 700 beds),
‘A. Fleming’ General Hospital (AFH) of Athens (300 beds),
‘A. Papandreou’? General Hospital of Rhodes Island (RH,
Southeastern Greece, 335 beds), ‘Vostaneio’ General Hospital
of Lesvos Island (LH, Northeastern Greece, 225 beds) and
Zakynthos Island General Hospital (ZH, Western Greece, 125
beds). Antibiotic consumption for the year 2003 was calculated
in Deﬁned Daily Doses (DDDs) per 1000 patient days.
Results: Overall, RH had the greatest consumption (1403.3
DDDs /1000 patient days), followed by ZH (1300.1), LH
(1210.6), GGH (926.5) and AFH (851.3). In general, cephalospo-
rins and penicillins+inhibitors were the most popular antibiot-
ics. Quinolone consumption was very high in LH (275.5) ranked
2nd among all antibiotic groups. Furthermore, quinolones were
ranked 3rd in other 2 hospitals (240.1 DDDs in RH and 90.2 in
AFH,). Finally, their consumption was 106.9 DDDs in ZH
(ranked 5th) and 61.7 DDDs in GGH (ranked 4th). Considering
the ratio new (respiratory) quinolones/ all quinolones the
numbers were: 63.4% for RH, 44.4% for ZH, 22.7% for LH,
20.7% for GGH and 15.5% for AFH.
Conclusions: According to our data, quinolones are widely
used in Greek hospitals. Consumption of new (respiratory)
quinolones is greater in hospitals located far away from Athens.
It is obvious that there is need for the design and implemen-
tation of a new antibiotic policy, since the existing one is not
effective, especially in the hospitals of the periphery. Meanwhile
we are planning an audit of the use of these agents in order to
clarify the reasons for this prescribing behavior.
P532
Trends in antibiotic consumption and
antimicrobial resistance of major bacterial
pathogens over a 5-year period in a general
hospital in Athens, Greece
M. Lelekis, H. Antonopoulou, H. Papadaki, M. Tsimoraga,
V. Markos, K. Papaefstathiou, C. Loupa, G. Kouppari
(Athens, GR)
Methods: We recorded antibiotic consumption in our hospital,
a 300-bed General hospital, from 1999 to 2003 and correlated it
with the resistance rates of major Gram(-) and Gram (+)
pathogens isolated during the same period.
Results: Antibiotic consumption (DDDs/1000 patient days)
was 612.2, 687.5, 707.8, 722.9, 851.3, for the years 1999, 2000,
2001, 2002 and 2003 respectively (overall 39% increase). Con-
sumption of all major classes of antibiotics except penicillins
increased, especially that of macrolides (>100% increase),
quinolones (>200%) and glycopeptides (>600%). Furthermore,
penicillins + b-lactamase inhibitors (from 28.4% to 30%),
macrolides (from 6% to 9%), quinolones (from 4.8% to 11%)
and glycopeptides (from 0.2% to 1.2%) had a proportional
increase among antibiotic groups used. During the same period:
E. coli resistance rate increased for ampicillin (28.7% to 55.2%),
co-amoxiclav (22.7% to 27.6%), cefotaxime (0.7% to 5.5%),
ceftazidime (1% to 4.5%) and gentamicin (1.8% to 3.2%),
decreased for cotrimoxazole (33.2% to 22.4%) and ciproﬂoxacin
(2.2% to 1.8%) and remained 0 for imipenem. For P. aeruginosa,
resistance rates increased for imipenem (13.9% to 15.4%),
ceftazidime (12.8% to 17.6%), gentamicin (30.2% to 35.3%),
ciproﬂoxacin (16.8% to 28.6%) and decreased for amikacin
(27.9% to 25.7%), aztreonam (29.6% to 18.3%) and piperacillin/
tazobactam (19.3% to 13.2%). For K. pneumoniae resistance rates
increased for co-amoxiclav (20% to 25.2%), cefotaxime (7% to
10.1%), ceftazidime (5% to 9%), ciproﬂoxacin (2% to 4%),
imipenem (0 to 5.6%) and remained stable for cefoxitin (~8%)
and gentamicin (6%). For S. aureus resistance increased for
methicillin (24.6% to 35.2%) and ciproﬂoxacin (13% to 21.6%),
decreased for rifampicin (11.6 to 7.2%) and cotrimoxazole (18.8%
to 8%) and remained stable for gentamicin (~18%). For entero-
cocci, resistance increased for ampicillin (14.4% to 26.7%),
ciproﬂoxacin (50.5% to 83.6%) and rifampicin (18.3% to 40.5%).
Furthermore, Vancomycin-Resistant Enterococci (VRE) were
isolated for the ﬁrst time during 2001 and in 2003 4/116 strains
of enterococci were VRE.
Conclusions: During the study period, consumption increased
signiﬁcantly in our hospital for almost all major classes of
antibiotics and this was accompanied by an overall increase in
resistance for the major pathogens both Gram (+) and Gram ())
and the emergence of VRE. The existing antibiotic policy has to
be reinforced or possibly changed.
P533
Trends in antibiotic consumption and bacterial
isolation rate over a 5-year period in a general
hospital in Athens, Greece
M. Lelekis, H. Antonopoulou, M. Zoumberi, A. Karaitianou,
P. Fytili, S. Botsari, C. Loupa, G. Kouppari (Athens, GR)
Objectives: The aim of this retrospective study was to record
the antibiotic consumption in our hospital, a 300-bed General
Hospital over a ﬁve year period (1999–2003) and to try to
correlate it with the bacterial isolation rate of the same
period.
Results: During the study period, total antibiotic consumption
expressed in DDDs/1000 patient days was 612.2, 687.5, 707.8,
722.9, 851.3, for the years 1999, 2000, 2001, 2002 and 2003
respectively (overall 39% increase). Consumption of all major
classes of antibiotics except penicillins increased, especially
that of macrolides (>100% increase), quinolones (>200%) and
glycopeptides (>600%). Further analysis showed that penicil-
lins + b-lactamase inhibitors (from 28.4% to 30%), macrolides
(from 6% to 9%), quinolones (from 4.8% to 11%) and glyco-
peptides (from 0.2% to 1.2%) had a proportional increase
among antibiotic groups used, with penicillins + inhibitors and
cephalosporines being the leading groups in all years. During
the same period the ratio of Gram negative/ Gram positive
bacteria isolated in our hospital was 3.0, 2.5, 3.3, 1.8, 1.6 for the
years 1999, 2000, 2001, 2002 and 2003 respectively. A. Gram ()):
E. coli isolation rate among Gram ()) remained stable during
the study period (around 51%),while for P. aeruginosa the rate
declined (from 19.6% to 14.4%) and the same was true for
K. pneumoniae (from 11.4% to 10.5%) and A.bowmannii as well
(from 3.6% to 3.0%). At the same time isolation rate of E. cloacae
and P. mirabilis increased (from 3% to 5.5% and from 5.1% to
8.3% respectively). B. Gram (+): S. aureus isolation rate among
Gram(+) declined from 24% to 21.4% and the same was true
for enterococci as well (from 38.7% to 19.8%). On the other
hand, coagulase ()) staphylococci (CNS) showed a great
increase (from 37.3% to 58.8%).
Conclusions: During a 5 year period antibiotic consumption
increased signiﬁcantly in our hospital and this was true for
almost all major classes of antibiotics. At the same time changes
in bacterial isolation rate were observed, both among Gram(+)
and Gram()), with E. coli, however, still remaining ﬁrst among
all bacteria isolated, despite the striking increase in Gram(+)
isolation.
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P534
The role of inadequate prescribing for the
development of drug resistance in respiratory
infections in Russia
Y. Balabanova, I. Fedorin, S. Kuznetzov, R. Coker,
F. Drobniewski (Samara, RUS; London, UK)
Incorrect antimicrobial prescribing increases the risk of the
development of drug resistance in pathogen. There have been
few studies to detect levels of resistance in respiratory patho-
gens in Russia but a recent study in Samara Region of resistance
among M. tuberculosis strains showed very high levels of
resistance including multi-drug resistance.
Objectives: To determine the patterns of antimicrobial prescri-
bing for respiratory prescribing including tuberculosis (TB)
among Russian physicians in Samara Region and it’s possible
role in development of resistance.
Methods: 1) point-prevalence cross-sectional survey involving
28 primary care, general and TB institutions; in total 425
physicians took part in the questionnaire-based survey which
aimed to look at empirical management of patients with
respiratory diseases including the ‘common cold’. 2) Subse-
quently analysis of clinical notes of 491 consecutive patients
with respiratory diseases were reviewed to assess actual
prescribing habits.
Results: Only a small group of doctors (1.7%) said that they
would prescribe antibiotics for the simple ‘cold’. Review of
clinical cases showed that antibiotics (ABs) were prescribed for
20% of patients with a simple upper respiratory tract infection.
At least one AB was prescribed for the majority of patients
(90.8%) with acute bronchitis; 80.0% of patients with exacerba-
tion of chronic obstructive pulmonary diseases received one AB
and 18.0% received two. When there was no clear evidence base
for an AB in treatment of acute tonsillitis, Russian doctors
prescribed at least one AB for nearly all (98.9%) of these patients
and 18.0% received two ABs. Ciproﬂoxacin was widely but
inappropriately used. Eight out of twelve patients with suspec-
ted but unconﬁrmed tuberculosis received rifampicin mono-
therapy alone.
Conclusions: Current AB over prescribing in Russia may
contribute to the development of resistance in respiratory
pathogens. There remains a need to restrict the prescribing of
antibiotics by doctors in general and to provide further training.
Further studies are needed to assess the level of patients’
expectations in receiving an AB as well as the role of over-the-
counter prescribing and the true levels of resistance in TB and
other respiratory pathogens.
P535
Outpatient intravenous antibiotic therapy
A. Basterretxea (Baracaldo, E)
Introduction: Outpatient intravenous antibiotic therapy
(OIAT), has been proved to be both, safe and effective, on
patients with several infectious conditions who are discharged
for treatment and follow up at home. Yet there is an open debate
on whether we should maintain the antibiotic indicated in
hospital or use a different one more suitable for an outpatient
setting.
Objective and design: To review a long series of (OIAT)
indicated in our (OHD). A full recording of the clinical data
available from patients treated between 1996 and 2004 was done:
diagnosis, indicated therapy, duration of treatment and out-
come.
Results: 990 (OIAT) were indicated. A total of 824 patients were
treated with a mean age of 60. The mean duration of treatment
was 14.1 days.The infection diagnosis were: respiratory 47%
post surgery 11.5%, skin and soft tissues 7.7%, bacteriemias
9.9%, osteoarticular 5.5%. The most used antibiotics were:
ceftriaxone 25.8%, aminoglycosides14.9%, piperacilin-tazobac-
tam 9.7%, ceftazidime 9.3% teicoplanine 4.3%, ganciclovir 4.3%.
Intravenous infusion pump devices were used in 389 of the
treatments. 124 patients needed to be readmitted to hospital (34
secondary to therapy failure). Number of hospital inpatient
stays avoided: 11.963.
Conclusions: (OIAT) is both, safe and effective, with a low rate
of complications and admittances to hospital in a wide variety of
infections. We show in this review that it is not necessary to
change the antibiotic indicated during the inpatient treatment if
we use intravenous infusion pump devices that allow us to use
different antibiotics and regimens.
Antibiotic policy intervention
P536
Audit of antibiotic prescribing in primary
paediatric care for acute tonsillopharyngitis and
its progress
H. Hupkova, K. Banasova, A. Petrzalka,
M. Tavodova (Bratislava, Zvolen, SVK)
Backgrounds: Audits on the diagnosis and treatment of respir-
atory tract infections (RTIs) have been performed in primary
paediatric care in Slovakia for the past 5 years. Respiratory tract
infections are most often the reason for antibiotic indication in
ambulatory practice. One representative of RTIs is acute ton-
sillopharyngitis as clinically narrowly deﬁnite problem.
Objectives: The aim of the present study was to evaluate the
progress or changes of antibiotic prescribing for acute tonsillo-
pharyngitis in Bratislava and in Zvolen where paediatricians
have participated in the study frequently and possibly to
improve antibiotic prescribing for acute tonsillopharyngitis via
audit, feed back of results and educational activities.
Methods: Four weeks prospective studies in years 2002 and
2003 in two Slovak cities; Same protocols and methodology was
applied for multicentric study; the entrance of paediatricians to
diagnosis and antibiotic prescribing for acute tonsillopharyngitis
were monitored on the basis of resistance surveillance in
positive regions.
Results: Out of 1308 patients in February 2002 (whole study), to
1127 (86.2%) were indicated antibiotic treatment and in Novem-
ber 2003 out of 4480 patients (whole study), to 3303 (72.7%).
Positively after intervention the prescribing of macrolides
decreased in both cities. In Bratislava from 28% to 17% and in
Zvolen from 18% to 13%. Indication of penicillins to acute
tonsillitis had good tendency in Bratislava (from 45% to 51%)
but in Zvolen prescription of penicillins declined (from 63% to
57%). Although aminopenicillins and co-aminopenicillins are
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contra-indicated for acute tonsillopharyngitis, they are still more
often prescribing in both cities. Prescribing of cephalosporines
declined in Bratislava (from 18% to 9%) but in Zvolen increased
(from 6% to 10%).
Conclusions: Educational programmes with the aim to stop the
growth of antibiotic resistance, in this case macrolides resistance
of main pathogen Streptococcus pyogenes, shows that it is possible
to improve prescription habits of paediatricians by frequently
using the prescribing audit.It is important to support the
implementation of antibiotic prescribing and effective inter-
vention methods for improving antibiotic prescribing in the
regions.
P537
A controlled intervention study to improve
antibiotic use in a Russian paediatric hospital
D. Berild, T.G. Abrahamsen, S. Andresen, E. Bjørløw,
S. Mintchenko, I. Kossenko, O. Kubar, M. Lelek, M. Pyasetskaya,
S. Ringertz, G. Sysenko (Oslo, N; St. Petersburg, RUS)
Objectives: Antibiotic use is increasing in Eastern Europe
promoting antibiotic resistance. There have been few reports
on antibiotic use from Russian hospitals. We aimed to imple-
ment guidelines for rational antibiotic use in a Russian 600-bed
paediatric hospital.
Methods: We performed a prospective controlled intervention
study to improve antibiotic use. One dep. of gastroenterological
infections and one dep. of respiratory tract served as interven-
tion deps. One dep. of gastroenterological infection and one dep.
of respiratory tract infections served as control departments.
During October through December 2002 demographic data,
diagnoses, antibiotic allergy, bacteriological ﬁndings, antibiotic
use, duration of stay, costs, and outcome were recorded in all
patients. Thereafter we conducted repeated whole day meetings
where rational antibiotic policy was promoted. Written consen-
sus guidelines for rational antibiotic use based on the local
resistance pattern were developed and implemented. The same
data as in the baseline period were recorded during October
though December 2003.
Results: At the intervention department of gastroenterological
infections the percentage of patients treated with antibiotics
decreased from 96% to 50%. At the intervention department of
respiratory tract infections the percentage of patients receiving
antibiotics decreased from 91% to 69%. There was a slight
reduction in antibiotic use at one control dep. There was no
increase in mortality or duration of hospital stay.
Conclusion: There was a signiﬁcant decrease in antibiotic use
and costs at the intervention departments and a slight reduction
at one control department. The decrease of antibiotic use did not
compromise quality of patient care.
P538
Multidisciplinary interventions and system
orientated strategies do have an impact on
improving antimicrobial prescribing
R. Crowley, F. Fitzpatrick, D. Solanki, S.F. FitzGerald,
H. Humphreys, E. Smyth (Dublin, IRL)
Observations by the clinical microbiology team in our institution
suggested that patients were not receiving all doses of vanco-
mycin prescribed. A prospective month-long audit in September
2003 revealed that 160/1007 prescribed vancomycin doses (16%)
were withheld inappropriately. Much confusion existed among
healthcare professionals in ordering and interpreting vancomy-
cin therapeutic drug monitoring (TDM) levels. In order to avoid
generating a culture of blame between the various healthcare
professional groups involved in the TDM process, measures to
improve vancomycin administration focussed on system-
change. These included changes in computer ordering, replacing
various vancomycin TDM levels with a single ‘pre-dose’ level
and an agreement from the phlebotomy department to take
TDM levels rather than relying on medical staff. In addition,
multidisciplinary hospital-wide and ward based educational
sessions were undertaken. Following these changes, a second
monthly audit in February 2004 revealed that 150/1161
prescribed vancomycin doses (13%) were held inappropriately.
The main location of confusion appeared to be at ward level,
where both medical and nursing staff had difﬁculties in
ordering and interpreting vancomycin TDM levels. In order to
address this, a senior pharmacist undertook to coordinate ward-
based pharmacists in assisting staff interpret levels, stickers and
TDM interpretative charts were designed for the drug charts of
each patient receiving vancomycin and feedback by ward
pharmacists to our department was encouraged. Further multi-
disciplinary audit feedback sessions, including feedback to
hospital management and a plan for ongoing education were
undertaken. A third audit in September 2004, revealed a further
decrease: 78/782 (10%) prescribed doses were inappropriately
withheld. Overall our various interventions resulted in a 37.5%
reduction in inappropriately held vancomycin doses over a one-
year period. Whilst we feel that we have signiﬁcantly improved
vancomycin prescribing, 10% doses are still being held inap-
propriately. This study highlights the difﬁculties identifying
barriers to change and changing healthcare worker behaviour
despite multiple multidisciplinary system orientated interven-
tions.
P539
Two-year experience of cephalosporins rotation
in the cardiosurgery intensive care unit
N.V. Beloborodova, G.V. Lobatchova, T.Y. Vostrikova,
D.A. Popov (Moscow, RUS)
Objectives: Cephalosporins are the drugs of choice in cardio
surgery patients as agents with broad antibacterial spectrum
and high level of safety. Traditionally, antibiotic rotation means
to use the various classes of drugs. Different activity of
cephalosporins against some gram-negative bacteria, causing
nosocomial infections, gives the opportunity to rotate the drugs
within this class. We evaluated the results of two years
experience (2002–2003) of antibiotic rotation, based on monitor-
ing of acquired resistance proﬁle of gram-negative bacteria
isolated from prolonged ventilated (more than 72 h) adult
cardiosurgery patients in intensive care unit (ICU).
Methods: Before rotation ceftriaxon was used as a drug for
empirical treatment. The proposed antibiotic rotation scheme
was the 6-month cycles of cephalosporins: cefoperazon, then
ceftazidim, then cefepim, based on the results of preceding
microbiological monitoring. Additional antibiotics of other
groups were used when indicated. Total of 151 consecutive
nosocomial isolates of gram-negative enterobacteria and non-
fermenting bacteria were studied. According to NCCLS recom-
mendations, disc-diffusion test was used to determine bacterial
sensitivity. Level of infectious complications and additional use
of some reserve antibiotics were evaluated during each cycle.
Results: 2269 patients were admitted. The use of P. aeruginosa-
active cephalosporins of the III and IV generations resulted in
elimination of this pathogen from ICU. We registered the
decrease of the number of positive haemocultures from 38/221
(17.2%) before rotation to 16/164 (10.7%) by the 3th rotation
cycle. In parallel, the total rate of postoperative infectious
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complications also decreased (47/657 (7.2%) vs. 22/489 (4.5%),
p = 0.015). The need of carbapenems and vancomycin did not
increase. Antibiotic susceptibility of KES (Klebsiella, Enterob-
acter, Serratia), P. aeruginosa, A. baumannii during our study in
ICU is listed in the table (% of sensitive strains).
Conclusion: Cycling of cephalosporins under microbiological
monitoring in ICU is an effective method for the management of
nosocomial infections in cardiac surgery.
P540
Impact of infectious diseases division
interventions on hospital-acquired infections and
antimicrobial resistance in the neurosurgical
department of a Greek university hospital
S. Metallidis, P. Selviaridis, A. Tsona, E. Koumentaki, M.
Chatzidimitriou, P. Kollaras, P. Nikolaidis (Thessaloniki, GR)
Objective: The purpose of the present study was to estimate the
impact of Infectious Diseases Division interventions on the
incidence of Hospital Acquired Infections (HAIs) and antimo-
crobial resistance in the neurosurgical department of a Greek
University Hospital.
Methods: Data concerning the year 2002, 2003 were derived
from a database of HAIs in our hospital. Antimicrobial resistance
data were obtained from the microbiology department and
antibiotic consumption from the pharmacy, expressed as the
number of DDDs per 100 bed days. The interventions in year 2003
included quality rounds, close monitoring of antibiotic con-
sumption and strict guidelines for the prophylactic antibiotic.
The goal was to reduce the consumption of 3d generation
cephalosporins, carbapenems and vancomycin. Educational
meetings of the personnel regarding the hand hygiene took place.
Results: In year 2002, 1035 patients were hospitalized in the
neurosurgery department and 756 of them had at least one
operation. During that year 69 HAIs (6.6%) were detected (11
LRIs, 22 SSIs, 7 BSIs, 8UTIs, 5 shunt infections and 6 others). In year
2003, 1110 patients were hospitalized, 810 of them had at least one
operation. 44 HAIs (3.9%) were detected (7 LRIs, 9 SSIs, 9 BSIs, 5
UTIs, 2 shunt infections and 10 others). There was signiﬁcant
reduction especially in SSIs (p < 0.001). The antibiotic consumption
was decreased during 2003 from 53.68 DDDs/100 bed days to 42.6
with the exception of piperacillin/tazobactam (from 1.95 to 2.42)
and aminoglycosides (from 5.8 to 6.6). Penicillins in total were
reduced from15.81 to16.87, 3dgenerationcephalosporins from2.68
to 2, ﬂuoroquinolones from2.1 to 1.4, glycopeptides from1.86 to 1.4
and carbapenems from 1.9 to 1.6. The median duration of the
prophylactic antibiotic use in surgery was 4 days in 2002 and 1 in
2003. Antimicrobial resistance in Acinetobacter spp. was reduced
from 78% to 39% for piperacillin/taz and from 22% to 10% for
imipenem. Antimicrobial resistance in Pseudomonas aueroginosa
was reduced from 31% to 6% for piperacillin/taz, from 20% to 8%
for imipenem and from 25% to 10% for gentamycin.
Conclusion: The interventions of the Infectious Diseases Divi-
sion resulted in decrease of the number of HAIs, especially in
SSIs. Despite the small amount of species the study indicates
that the reduction of the antibiotic consumption might have an
impact on antimicrobial resistance.
P541
Impact of scheduled antibiotic change in the
intensive care unit of a tertiary referral hospital in
Malaysia
G Rajasekaran, S.D. Puthucheary, C.C Tan, L.C. Han,
S. Balan (Johor Bahru, Kuala Lumpur, MYS)
Introduction: Resistance to antimicrobial agents is driven by
the selective pressure of its usage in conﬁned areas such as the
Intensive Care Unit (ICU). Immunocompromised patients
receiving broad spectrum antibiotics and being cared for in a
conﬁned space by busy doctors from various disciplines act as a
conducive environment for organisms to develop resistance,
multiply and spread. Pathogens of concern at hospital Sultanah
Aminah, a tertiary referral hospital for the southern region of
Malaysia, include multiply resistant gram-negative organisms,
the most common being Klebsiella pneumoniae (22%), Acinetob-
acter spp. (20%) and Pseudomonas aeruginosa (18%). The inci-
dence of extended spectrum b lactamases among Klebsiella
pneumoniae was 41.1% while that of Escherichia coli was 29%. The
frequency of Pseudomonas aeruginosa hyper-producing AmpC –
cephalosporinase was 57%.
Objective: In view of the growing population of multiresistant
organisms in the ICU, a prospective study was carried out to
determine the impact of scheduled formulary change in the
antibiotic used for empiric treatment of suspected gram-negat-
ive bacterial infections.
Methods: During the pre-interventional period, ceftazidime
was used for empiric therapy, which was replaced with
cefepime during the one year study period, from January to
December 2003.
Results: The incidence of extended spectrum b lactamases
among Klebsiella pneumoniae was reduced from 41.1% to
36.45% (p > 0.05) while that of Escherichia coli from 29% to
19.2% (p > 0.05). Pseudomons aeruginosa which hyper-produced
AmpC –cephalosporinase was also reduced from 57% to 37.25%
(p > 0.05).
Conclusions: These data suggest that a scheduled change in the
antibiotic class, by restricting the use of third generation
cephalosporin in favor of a fourth generation cephalosporin,
resulted in a favorable reduction in the nosocomial bacteria
producing extended spectrum aˆ lactamases and the Richmond
and Sykes class 1 chromosomally mediated AmpC – b-lacta-
mases.
P542
The impact of prescription intervention on
antibiotic resistance patterns of K. pneumonia
and P. aeruginosa in a tertiary care hospital
G.L. Petrikkos, J. Papaparaskevas, G. Stephanakos,
A. Markogiannakis, A. Sarmi, G.L. Daikos, P.
Triantaphyllopoulou, N.P. Zissis, A. Avlami (Athens, GR)
Objective: To evaluate the impact of replacing third generation
cephalosporins (CEP) by piperacillin/tazobactam on antibiotic
resistance patterns of K. pneumoniae (K.p) and P. aeruginosa.
Methods: This was a prospective, open-label, observational,
antibiotic usage interventional study. Bacterial resistance data
and the antibiotic consumption rates were collected from the
internal medicine, the surgical wards and the ICU. There were
Drug KES (%) P.aeruginosa (%) A.baumannii (%)
1 cycle
(n = 26)
2 cycle
(n = 37)
3 cycle
(n = 20)
1 cycle
(n = 15)
2 cycle
(n = 18)
3 cycle
(n = 3)
1 cycle
(n = 9)
2 cycle
(n = 14)
3 cycle
(n = 9)
Ceftriaxone 19.2 10.8 5 0 0 0 0 0 0
Ceﬂazidime 77 54.1 30 73.3 77.8 100 22.2 42.8 0
Cefoperazone 11.6 10.8 5 13.3 44.5 33.3 0 0 0
Cefepime 80.8 78.4 55 80 83.3 100 66.7 85.8 55.5
Imipenem 100 100 100 33.4 55.5 66.7 100 100 100
Meropenem 100 100 100 33.4 55.5 66.7 100 100 100
Cefoperazone/
Sulbactam
– 67.6 70 – 94.5 100 – 100 89
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two periods. At the ﬁrst 3 month period, consumption data were
collected for piperacillin/tazobactam and CEP without any
intervention. At the second 12 month period an antibiotic
restriction policy was applied. Bacterial susceptibilities of
K. pneumoniae as well as the rate of ESBL+ K.p. and imipenem
resistant P. aeruginosa were determined. ESBL detection was
performed using the NCCLS 2003 guidelines.
Results: The consumption of CEP and speciﬁcally that of
ceftazidime (CAZ) was decreased from 79.9 DDD/100 bed-
days to 19.8 DDD/100 bed-days while that of piperacillin/
tazobactam was increased from 112.8 DDD/100 bed-days to
370.8 DDD/100 bed days respectively. The resistance levels of
CAZ to K. pneumoniae were decreased from 38.0% to 7.5% and
that of piperacillin/tazobactam decreased from 12.0% to 10.0%
for the respective periods (Fig 1). The rate of ESBL+ K.p.
dropped from 5.7% during the observation period to 0% during
the last 3 months of the study. Regarding the P. aeruginosa ImpR
there was a decrease in the incidence rate from 32.8% to 12.2%.
Conclusion: Antibiotic formulary intervention by restriction of
CEP and their replacement by piperacillin/tazobactam might be
useful for reducing high antibiotic resistance rates of
K. pneumoniae and the incidence of P. aeruginosa ImpR .
P543
Survival outcome by initial antimicrobial
appropriateness in severe infections of medical
patients: a pilot study
T. Peppas, I. Hager, H. Vlastari, A. Sotiropoulos,
I. Dimitrakopoulou, I. Kreatsoulas, M. Savvala,
S. Pappas (Piraeus, GR)
Objective: To estimate impact of initial antimicrobial regimen
(Rx) appropriateness (Appr) on survival of patients with severe
infection (SI).
Patients-Methods: Prospective entry of all demographic, clin-
ical and microbiology data entry of medical patients with severe
infection (3 or more SIRS criteria and/or evidence of organ
dysfunction). Most Rx based on currently accepted guidelines.
Only infections documented by bacteriology were evaluated.
Outcome endpoint: death during hospital stay. Period: March to
September 2004. Analysis in PC, by SPSS (Windows-XP)
programme. Sensitivity as by Kirby-Bauer.Results: Documented
SI pts were 46 (M: 19-F: 27) m.age 72.4 years. Chronic disease
present in 84%, and documented infections were 31 bacterae-
mias (many of urinary origin) and 15 urinary tract without
bacteraemia. More frequent pathogens were E. coli (17), S. aureus
(6) S. faecalis (5) and 3 each of Pseudomonas, Acinetobacter and
Candida sp. Mortality during stay was 8/46 [17.4%]. Appr Rx
was noted 34 pts (83%), 4 deaths in each arm (Appr and non
Appr. Rx) of bacteraemias (p = 0.02 by Fisher exact test) while
all urinary SI survived. A stronger correlation to mortality was
noted for co-morbidity, previous hospitalization and Rx history,
Gram+ cocci or Candida isolation.
Conclusions: The factor of initial Rx appropriateness is, rea-
sonably, important for the survival of patients with severe
infections, but only one of several parameters to be taken into
account for a multi-disciplinary approach for optimal manage-
ment, particularly upon pre-existing co-morbidity. An increased
number of pts will allow for more solid evidence.
P544
The impact of a sore throat score and a rapid
antigen test on clinical management in
streptococcal pharyngitis
C.S. Stingu, T. Turcu, S. Dimitriu (Iasi, RO)
Objective: To establish the impact of a sore throat score and a
rapid antigen test for group A streptococci on clinical manage-
ment of patients with acute pharyngitis focusing on reducing the
antibiotic prescription.
Methods: This study included 98 patients hospitalized in
Infectious Disease Hospital, Lasi, Romania. From each patient
we collected clinical data for the score and two pharyngeal
swabs: one for rapid antigen test (One Step Strep A Test
Cassette–AccuBioTech- a two side sandwich immunoassay) and
the second one for culture. Catalase negative, gram positive
cocci in chains were serogrouped using a latex-agglutination kit
(Slidex Strepto A – BioMerieux). All patients had no antibiotic
therapy prior examination and no other infectious diseases. We
compared physicians intent for prescribing antibiotics based on
clinical data with physicians practice after doing the score and
rapid antigen test. We have to state that the hospital standard
procedure for diagnosis of acute pharyngitis doesn’t include the
score and the rapid antigen test. The patients were hospitalized
5–7 days.
Results: Of 98 patients 32 (32.65%) had group A streptococcal
pharyngitis, and from 17 (17.34%) patients we isolated non
group A beta hemolytic streptococci. Combination of score and
rapid test didn’t miss any positive result (95%CI: 82.35%–
99.87%) and had a good speciﬁcity: 93.75% (95%CI: 69.77%–
99.84%). Based upon intent the physicians would have
prescribed antibiotics for 85 patients including 36 (73.46%)
with negative culture and all 17 patients with non group A beta
hemolytic streptococci. After doing the score and receiving the
results of the rapid antigen test the physicians prescribed
antibiotics only for 33 patients (reducing the overall prescription
for antibiotics with 67.17%).
Conclusions: The score higher than 3 and the rapid antigen test
improved the use of antibiotics as follows: 1. All patients with
group A streptococcal pharyngitis received the proper course of
antibiotics. 2. Only one patient received unnecessary therapy. 3.
The combination of score higher than 3 and rapid antigen test
reduced the prescription of unnecessary antibiotics with 98.11%
on a ﬁrst visit of a patient with sore throat. 4. The number of
hospitalization days would have been reduced from 5–7 to
2 days in 66.33% of cases.
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P545
An intervention programme to optimise the
levoﬂoxacin use
A. Del Arco, J.L. Prada, J. De La Torre, F. Moreno, J. Aguilar,
V. Faus, I. Lopez (Marbella, E)
Introduction: Levoﬂoxacin (LF) is a wide spectrum antibiotic
with an exceptional oral biodisponibility. It is used mainly in
respiratory infections and in other infections especially in
penicillin allergic patients. A quick switch from intravenous
(IV) to oral (OR) formulation is possible with this antibiotic. In a
former study we detected an important use of the IV formula-
tion with economic consequences because IV-LF is particularly
more expensive than OR-LF (a difference of 23.5 €/doses). In
order to optimize this therapy we thought of start of a
programme of early switch from IV to OR formulation.
Objectives: to evaluate the results of a new intervention
programme in order to manage an early switch to OR formu-
lation in patients treated with IV-LF.
Methods: An observation in the prescription order with the text
‘consider oral formulation by its qualiﬁed biodisponibility’ was
added in all the Costa del Sol in-patients with IV LF prescrip-
tion. We have analysed the LF consumption in two periods: ﬁrst
before the intervention programme (BI), from july 2002 to june
2003; second after the intervention (AI), from july 2003 to june
2004. Total study and by department analysis were performed.
Results: A total of 3619 doses were used in the BI period: 2514
(30%)wereORand 1105 (70%) IV formulation. InAI timeweused
3541 doses (79%) OR and 983 (21%) IV. Prescription fromGeneral
Internal Medicine (GIM) and Neumology formed 90% of total
prescriptions. The additional 10% were in other Medical Units,
Surgery and Traumatology. InGIM the lowering of IV doseswere
from 32% to 22% and inNeumology from 25% to 17%. In the other
services, although with lower consumption a reduction in IV
doses was observed too (Cardiology from 39% to 25%, Gastro-
enterology from 39% to 26%, Nephrology from 50% to 26% and
Traumatology from 50% to 35%). Altogether a reduction in IV
used from 31% to 22%was observed, thereforewe have estimated
a saving of 398 IV doses and this means a gain of 9610 €.
Conclusions: The initiation of a elementary, easy and quickly
intervention programme in antibiotic prescription can contrib-
ute to a more careful antimicrobial employ and to a best used of
economical resources in the public health system.
P546
MIKSTRA Programme – a ﬁve-year follow-up of
indication based antibiotic prescribing in
primary health care
U.-M. Rautakorpi, S. Huikko, P. Honkanen, T. Klaukka,
M. Ma¨kela¨, E. Palva, R. Roine, H. Sarkkinen, H. Varonen,
P. Huovinen for the MIKSTRA Collaborative Study Group
Objectives: To follow indication based antibiotic use in primary
care to see if prescribing practises change after implementing
new treatment guidelines.
Methods: A prospective, controlled before-after study. The data
was collected during one week in November each year from
1998 to 2002 in 30 health centres with a total population of 820
000. Twenty control health centres were recruited in 2002.
National guidelines for six major infections (otitis media,
sinusitis, throat infection, acute bronchitis, urinary tract infec-
tions and bacterial skin infections) were published and distri-
buted to all doctors between October 1999 and March 2000. An
intervention was carried out in study health centres by training
one of the doctors from each health centre to be a trainer at work
site and by producing educational and feedback material for
their use. Training at work site was carried out by the trained
doctor using either problem based learning-method or academic
detailing with feedback.
Results: The six most common infections under intervention,
together with common cold, comprised 80–85% of all infections
each year. The proportion of each infection was very stable over
the years. The proportion of patients, who were prescribed
antibiotics did not change signiﬁcantly or differ from that of
control health centres in any diagnosis. However, there were
changes towards the recommended in antibiotic choices in several
infections. Use of ﬁrst-line antibiotics as the antimicrobial chosen
at the ﬁrst consultation increased in all infections except throat
infection. The increasewas statistically signiﬁcant in sinusitis and
urinary tract infections. Also the percentage of antibiotic treat-
ments of recommended duration increased signiﬁcantly in all
infections under intervention except throat infections. The treat-
ment practises in throat infections were, however, well in
concordance with the guidelines already at the base-line. Results
of the study health centres did not differ statistically signiﬁcantly
from those of the controls in 2002. Therewerenodrop-outs among
health centres during the ﬁve year follow-up but over one third of
the doctors changed during the follow-up years.
Conclusions: Training intervention changed antibiotic choices
and duration of treatment towards recommended but did not
decrease prescribing in general. Changing professional practice
is not easy. It takes time, needs simple and targeted messages
and repetition.
P547
Use of symptomatic medication in acute otitis
media
J. Va¨lila¨, S. Huikko, U.-M. Rautakorpi, P. Honkanen, T. Klaukka,
M. Ma¨kela¨, E. Palva, R. Roine, H. Sarkkinen, H. Varonen,
P. Huovinen for the MIKSTRA Collaborative Study Group
Objectives: To study what kind of symptomatic medication is
used in acute otitis media in primary care and whether the use is
in accordance with national guidelines.
Methods: The data was collected in a ﬁve-year MIKSTRA
Programme in 30 primary health care centres throughout
Finland during one week in every November from 1998 to
2002. Physicians and nurses collected data about the diagnosis,
prescription-only medicines and over-the-counter medicines
prescribed or recommended for all patients with an infection
during the study weeks (www.mikstra.ﬁ).
Results: A total of 3229 patients were diagnosed as having ﬁrst
consultation for an episode of otitis media (14% of all patients
with ﬁrst consultation for an infectious disease). Of these only
the 3059 patients, who had the diagnosis of otitis media alone,
were included in this study. One third of the patients at the age
group older than 15 years and a quarter of those under 15 years
of age got some other medicine than a systemic antimicrobial
agent for otitis media. Symptomatic medication was prescribed
or recommended for 25% of the patients, who also had been
prescribed systemic antimicrobials (n = 2 880) and for 45% of
the patients, who had not got a systemic antimicrobial (n = 179).
Non-steroidal anti-inﬂammatory agents (NSAIDs) and painkill-
ers were the most commonly prescribed symptomatic medicines
(7% collectively). Antihistamines and topical eardrops with
analgesic-anti-infective combination for earache were prescribed
for 4% of the patients respectively. Compared to adults over
25 years of age, children under 2 years of age were recommen-
ded less systemic ﬂu medicines (9% vs. 4%), topical ear
medicines other than those for earache (14% vs. 1%) as well as
cough medicines (9% vs. 2%).
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Conclusion: According to the national treatment guidelines for
acute otitis media, medication, which relieves earache, should be
used as a supportive medication especially if prescription of
antibiotics is postponed. According to our results the use of
NSAIDs and painkillers as well as local analgesic eardrops
should be increased in acute otitis media. By improving the
symptomatic relieve of pain in acute otitis media the use of
watchful waiting-policy in the treatment of this infection could
become more acceptable and prescription of systemic antimi-
crobial agents could be decreased.
P548
Investigation of divergent piperacillin and
piperacillin/tazobactam activities to support
appropriate formulary decisions
M.E. Jones, C.L. Pearce, D.A. Styers, S.L. Tench, R.N. Master,
D.F. Sahm (Hilversum, NL; Herndon, USA)
Objectives: The use of generic antibiotics over branded ver-
sions can bring signiﬁcant costs savings. However, the use of a
cheaper generic compound in preference to a branded version of
the same compound in combination with an inhibitor, should be
carefully considered in the context of current susceptibility data,
ensuring appropriate antibiotic use. The use of generic pipera-
cillin (PI) instead of piperacillin combined with tazobactam (PT)
is a case in point. This investigation was done to establish the
extent to which the antimicrobial activity between PI and PT
diverge with respect to their in vitro activities against key gram-
negative bacilli.
Methods: The Surveillance Network (TSN) collects all routine
susceptibility data from >300 U.S. sites on a daily basis. The
majority of data is derived from Vitek and Microscan diagnostic
devices, approved by the FDA. Data from Jan 00–Feb 04 was
analysed to compare PI and PT activities against isolates of
C. freundii (CF)[n = 8.649], E. coli (EC) [n = 218.331], K. pneumo-
niae (KP) [n = 58.499], P. mirabilis (PM) [n = 31.489], P. aeruginosa
(PA) [n = 109.191], S. marcescens (SM) [n = 14.070], and Acine-
tobacter spp. (AB) [n = 9.925]. Only organisms tested at the
same time to the selected antibiotics using approved NCCLS
methodologies were included in this analysis.
Results: Overall resistance (R) rates for PI were consistently
higher than those observed for PT, respectively for: CF (22.2/
6.8%), EC (26.2/1.1%), KP (14.8/4.2%), PM (9.1/0.5%), PA (16.0/
10.1%), SM (8.2/4.3%) and AB (46.8/21.0%). During the same
time period: for enterics, 93.5–99.7% of PI-R isolates and 99.4–
100.0% of PI-I strains were susceptible to PT; for non-enterics,
83.1–90.0% of PI-R isolates and 99.8% of PI-I strains (AB only)
were PT-susceptible.
Conclusions: The superior in vitro activity of PT over PI, even
among PI-R strains, clearly demonstrates the crucial role played
by tazobactam to inhibit expressed beta- lactamases. These two
agents should not be considered ‘interchangeable’ in the face of
formulary decisions. Similar analyses must be undertaken when
evaluating the appropriate use of any antibiotic whose ‘off-
patent’ status revitalizes its potential formulary status.
Tuberculosis: diagnosis, resistance and immunology
P549
Rapid cultivation of Mycobacterium tuberculosis
and other mycobacterial species by using culture
supplements
I. Szpinda, I. Olsen, U. Dahle, T. Tønjum (Oslo, N)
Objectives: Rapid growth of mycobacteria and susceptibility
testing in liquid media has greatly reduced the time by which
the overall processing of culture-positive samples is completed.
This procedure has also reduced efforts invested in culture
negative samples. The detection of minimal growth at an early
stage combined with the use of nucleic acid-based tests for
mycobacterial species identiﬁcation and their drug susceptibility
markers provide a unique opportunity for rapid diagnostics.
However, the time required for growth and less than optimal
media are still limiting factors for the performance of culture
systems. Our aim is to improve the sensitivity and reduce the
time required for the detection of mycobacteria in clinical
specimens.
Methods: Clinical specimens investigated for the presence of
mycobacteria were cultivated in the BACTEC MGIT 960 culture
system. The specimens were cultivated in the regular BBLTM
Middlebrook 7H9 medium with and without the addition of
culture supplements. The Mycobacterium tuberculosis strains
isolated were typed by using RFLP typing.
Results: Among the eleven hundred clinical samples investi-
gated for the presence of mycobacteria, the culture supplements
improved the recovery of M. tuberculosis from patients and
increased the sensitivity of M. tuberculosis cultivation by 20%.
Furthermore, the mycobacterial culture supplements reduced
the time required for the detection of growth of M. tuberculosis
by 5.4 days from an average of 16.2 days without supplement
addition to an average of 10.8 days with supplement. IS6110-
based RFLP typing of M. tuberculosis demonstrated that the
isolates that grew quicker with supplements represented var-
ious RFLP types, and not only a sub-cluster of strains. The
sensitivity and rapidity of culture were also enhanced for the
detection of other mycobacterial species, but to a various extent
in the different entities isolated. M. avium isolates that grew
faster with culture supplements were found in neck abscesses in
children and sputum from immunocompromised patients.
Conclusion: Signiﬁcantly shorter cultivation time and 20%
higher sensitivity in M. tuberculosis cultivation was achieved
by adding culture supplements to liquid Middlebrook 7H9
medium. Also, a number of non-tuberculous mycobacterial
species grew faster with culture supplements addition than
without. This results hold promise for signiﬁcant improvements
in culture-based mycobacterial diagnostics.
P550
Evaluation of the Ampliﬁed Mycobacterium
Tuberculosis Direct test for direct detection of
Mycobacterium tuberculosis complex in
respiratory specimens
J. Lago, M. Silva, A. Reme´dios, A. Silva Grac¸a (Lisbon, P)
Objectives: Evaluation of the Ampliﬁed Mycobacterium Tuber-
culosis Direct (AMTD) test (Gen Probe Inc, bioMe´rieux) by
comparing the sensitivity, speciﬁcity and positive (PPV) and
negative (NPV) predictive values of the test with the acid fast
smear and the mycobacterial culture.
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Methods: We studied 147 respiratory specimens: sputum (98),
bronchoalveolar lavage (22) and bronchial aspirate (27), sub-
mitted to the microbiology laboratory from patients suspected
of pulmonary tuberculosis (TB). The AMTD results were
compared with acid fast smear, MB/Bact system liquid culture
(bioMe´rieux) and Lowenstein-Jensen solid medium (L J).All
samples were subjected to the Than-Thiam-Hok (bioMe´rieux)
staining for acid fast bacilli (AFB) detection, decontaminated
according to the NALC-NaOH method (N-acetyl-L-cysteine
and sodium hydroxide) using the commercial Mycoprep kit
(Becton Dickinson) and inoculated in parallel in the MB/Bact
system and in the L J medium. The mycobacteria isolated were
identiﬁed by DNA probes (Accuprobe, Gen Probe, bio-
Me´rieux).
Results: Based on mycobacterial culture and on the clinical
diagnosis, 70 samples were from patients with TB and 77 from
no TB patients. 57 specimens were culture positive (identiﬁed as
Mycobacterium tuberculosis complex -Mt), and 47 were smear
positive. 74 specimens were positive by AMTD. After resolution
of discrepancies, the sensitivity, speciﬁcity and PPV and NPV
for the AMTD test were 98.6%, 93.5%, 93.2% and 98.6%
respectively.
Conclusions: The results suggest that the AMTD test in
combination with AFB and culture is a fast and accurate test
for suspected TB patients.
P551
Comparison of a LightCycler real-time PCR
method and the BDProbeTec ET system for direct
detection of Mycobacterium tuberculosis complex
in respiratory specimens
S. Bernal, C. Freyre, M.J. Torres, I. Jesus de la Calle,
J.M. Rodrı´guez-Iglesias, J.C. Palomares, E. Martı´n-
Mazuelos (Seville, Ca´diz, E)
Objectives: Detection of micobacteria by culture takes between
one week and two months.To reduce the delay in tuberculosis
diagnosis, we compared a home-made LightCycler real-time
PCR method to the BDProbeTec ET system (Becton Dickinson,
Sparks, Md.), for direct detection ofMycobacterium tuberculosis in
60 clinical samples and to the conventional mycobacterial
culture.
Methods: The real-time assay ampliﬁes a region from the
IS6110 sequence and the BDProbe Tec ampliﬁes a region of the
mycobacterial 16S rDNA. Conventional mycobacterial culture
was performed with BACTEC MGIT 960 and Lowestein-Jensen
medium. Sixty respiratory specimens were used (36 sputa, 14
pleural ﬂuid and 10 BAL) from patient with negative smear
microscopy and a high probability of tuberculosis were assessed
by the three methods.
Results: Of 60 specimens, 10 grew MTBC (and in one culture
grew one M. avium-intracellulare). BDProbeTec ET detected 9 of
the 10 MTBC culture-positive specimens and gave a positive
result in one of the 49 negative cultures. LC real-time PCR
detected the same 9 MTBC culture-positive specimens and gave
a positive result in another – but different from that of the
BDProbeTec ET – of the 49 negative cultures. Thus, the
sensitivities of the real-time PCR method and SDA were similar
for respiratory specimens.
Conclusion: The data demonstrate that both LC real-time PCR
and BDProbeTec assays are highly sensitive and speciﬁc
techniques for the rapid detection of M. tuberculosis comples in
respiratory smear negative specimens.
P552
Comparative evaluation of different methods for
the identiﬁcation of mycobacteria other than
tuberculosis
Z. Gitti, S. Maraki, F. Kontos, V. Kafarakis, A. Georgiladakis,
Y. Tselentis (Heraklion, Heraklion, Crete, GR)
Rapid, easy and prompt identiﬁcation of mycobacteria to the
species level is of utmost importance, since treatment varies
according to the species.
Objective: To evaluate several techniques that allow the iden-
tiﬁcation of mycobacteria other than tuberculosis (MOTT).
Methods: A total of 70 clinical strains of MOTT isolated in
Lo¨wenstein-Jensen medium were included in the study. Iden-
tiﬁcation has been performed to species or to complexes level
using 1) Conventional methods, 2) Accuprobe (Gen-Probe), an
hybridization protection assay and chemiluminescent detection
of rRNA presented in living organisms, and 3) Genotype
(HAIN Lifescience), that consists of PCR ampliﬁcation, reverse
hybridization of PCR products to the strips and detection and
interpretation of the results according to the interpretation
chart.
Results: The 70 MOTT strains were identiﬁed as follows:
Conclusion: The differentiation of MOTT species by conven-
tional methods is difﬁcult, time consuming and many times
unreliable. The commercial tests of AccuProbe and Genotype
have replaced the conventional biochemical tests for identiﬁca-
tion of mycobacteria. The AccuProbe test has a limited number
of species that can be identiﬁed. The Genotype strip technology
detects simultaneously much more species and also gives the
opportunity of identiﬁcation of M. tuberculosis complex together
with MOTT strains. Although the new methods are more rapid
and accurate, all strains were not identiﬁed to complex or
species level. Seventeen per cent of the isolates would need to be
identiﬁed by sequencing.
P553
An insight into the evolution of Mycobacterium
tuberculosis complex using a novel molecular
technique – multiple interspersed repetitive units
A. Gibson, T. Brown, L. Baker, F. Drobniewski (London, UK)
Objectives: Many molecular techniques have been utilised in
an attempt to elucidate the phylogeny of Mycobacterium tuber-
culosis (M. tb). Despite these advances the evolution of this
Groups of MOTT
Conventional
methods AccuProbe Genotype
Scotochromogenes
M. gordonae 23 presumptive 23 23
M. scrofulaceum - - 1
Non chromogenes
M. avium–avium - 6 7
M. intracellulare
(avium complex)
- 3 2
Rapid growers
M. fortuitum 19 presumptive 19 type 1
M. peregrinum - - 6
M. chelonae 2 presumptive - 2
M. fortuitum–
chelonae complex
12 - -only band
number 10
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organism is still poorly understood. This study aimed to assess a
new molecular ampliﬁcation technique, Mycobacterial Inter-
spersed Repetitive Units (MIRU), to discover if the phylogeny of
M. tb complex could be deﬁned using this novel tool.
Methods: A deﬁned M. tuberculosis population of 316 isolates
indexed by neutral genetic variation was analysed using MIRU.
In addition, 50 M. bovis isolates were examined to determine if
they could be separated from M. tb by MIRU typing alone.
Results: Previously neutral genetic variation within the M. tb
complex genome demonstrated that M. tb could be divided into
four lineages with M. bovis clearly separated on another branch
of the tree. Analysis with MIRU established that each lineage
could in turn be deﬁned by a speciﬁc MIRU code made up of
only 2 or 3 loci. EachMIRU code could deﬁne between 85–98% of
isolates within their respective lineage. However, some markers
were not as conserved as others. A MIRU code for M. bovis was
determined which could deﬁne 83% of isolates. This code was
unique to M. bovis and not observed in any M. tb isolates.
Conclusions: MIRU can deﬁne evolutionary lineages within
M. tb andM. bovis populations without the need for sequencing.
M. bovis isolates can easily by differentiated from M. tb isolates
using this technique. MIRU is a valuable tool for phylogenetic
studies and could deﬁne an evolutionary uncharacterised
population of M. tuberculosis complex.
P554
Comparison of RFLP-IS6110 and MIRU-VNTR
typing of Mycobacterium tuberculosis strains
E. Fernandes, A. Macedo, I. Portugal, L. Brum (Lisbon, P)
Objectives: The discovery of insertion elements and other
repetitive DNA elements in the genome of Mycobacterium
tuberculosis has led to many methods for differentiating clinical
isolates, becoming an important tool in the epidemiology of
tuberculosis. The use of RFLP-IS6110 (restriction fragment
length polymorphism) method allows a high degree of
M. tuberculosis isolates discrimination and is considered the
gold standard. The introduction of MIRU-VNTR (variable
number tandem repeats of mycobacterial interspersed repetitive
units) has become an alternative to the classical method. More-
over, isolates having low copy numbers of IS6110 can not be
clustered precisely, and since MIRU-VNTR analysis detects
polymorphisms in 12 different loci, it would be a useful method
for subdivide this isolates. Theobjectiveof this study is to evaluate
the discrimination power of MIRU-VNTR technique analysing a
set ofM. tuberculosis strains isolated in Lisbon hospitals.
Methods: 53 M. tuberculosis isolates were typed using RFLP-
IS6110 and MIRU-VNTR techniques.
Results: Individually, the total of the 52 strains analysed by
RFLP-IS6110 produced 45 strains in previously deﬁned clusters
(4 strains in cluster R2; 3 strains in cluster R4; 2 strains in
cluster R7; 1 strain in cluster Lisboa2; 4 strains in cluster
Lisboa3; 1 strain in cluster Lisboa9; 3 strains in cluster T1; 2
strains in cluster T4; 3 strains in cluster F; 4 strains in cluster B;
1 strain in cluster I1; 1 strain in cluster I2; 1 strain in cluster X1;
1 strain in cluster Y; 1 strain in cluster Q; 1 strain in cluster K; 1
strain in cluster M; 1 strain in cluster L10; 1 strain in cluster J; 3
strains in cluster N2; 2 strains in cluster N3 and 4 strains in
cluster O1); 3 of these clusters had low (<5) copy numbers of
IS6110 (clusters N2, O1 and N3). MIRU-VNTR analysis of the
same isolates with more than 6 copies of IS6110 generated a
total of 19 different VNTR allele proﬁles which is in agreement
with the classical technique. However, the analysis of the
clusters with low IS6110 copy numbers produced 7 different
proﬁles suggesting a major discrimination power.
Conclusion: The results obtained show that the congruence
between genetic relationships inferred from MIRU-VNTR and
RFLP-IS6110 typing was highly signiﬁcant. Compared with
RFLP-IS6110, MIRU-VNTR typing has the advantages of being
fast and appropriate for all M. tuberculosis isolates, including
strains with a few IS6110 copies.
P555
Evaluation of novel tandem repeat loci as
potential Mycobacterium tuberculosis molecular
typing VNTR regions
N. Thorne, S. Gharbia, A. Underwood, C. Arnold (London, UK)
Objectives: The international community involvedwithmolecu-
lar typing of M. tuberculosis isolates has recently focussed on
Variable Number Tandem Repeat (VNTR) loci. VNTR-PCR
involves ampliﬁcation of the repeat region with primers in the
ﬂanking sequences. The number of repeat units is determined
from the size of theproduct on an agarose gel. Todate themajority
of investigations intoM. tuberculosisVNTRs have focussed on 40–
100 bp repeat-unit VNTRs. In this study we looked at a range
(3–78 bp repeats) including smaller repeat-unit VNTRs to investi-
gate allelic variation in our collection of isolates and determine
their usefulness in a molecular typing VNTR panel.
Methods: A collection of 23 isolates was used to investigate
repeat-number variation at novel VNTR loci ranging from 3 bp
to 78 bp in unit length. PCR of tandem repeat sequences were
performed using primers in the 5’ and 3’ ﬂanking regions.
Pyrosequencing technology, non-denaturing High Performance
Liquid Chromatography (non-dHPLC) and Beckman CEQ8000
fragment analysis were used to determine VNTR number for
these loci. Beckman capillary sequencing was used to conﬁrm
VNTR copy number from sequence for anomalous fragment
sizes and to further characterise the individual loci. VNTR copy
number was determined from these fragment sizes using a
simple calculation. These data were entered into Bionumerics
software for phylogenetic analysis of isolates.
Results: Several novel VNTR loci tested were found to vary in
copy number between strains in our isolate collection. The
number of alleles varied for several of the novel VNTR loci.
Certain loci were found to be useful to differentiate the ancient
genotypic group one isolates from the more recent groups two
and three. For example, all non-genogroup one isolates (n = 15)
had one copy of VNTR12, while genogroup one isolates (n = 8)
all had greater than one copy of this repeat. Further results
characterising each novel locus will be presented.
Conclusion: Results from this study indicate that other tandem
repeats, outside the 40–100 bp unit range, should be considered
for investigations into highly discriminative markers for
M. tuberculosis molecular typing. These investigations could
help augment the ﬁnal VNTR panel for an international strain-
typing of M. tuberculosis. Our results may indicate that certain
repeat loci within the genome could enable modelling of M.
tuberculosis evolution and better inform the role of these repeat
sequences in the chromosome.
P556
Sensitivity of PCR for IS2404 insertion sequence
of Mycobacterium ulcerans in diagnosis of Buruli
ulcer from punch biopsies
R. Phillips, C. Horsﬁeld, S. Kuijper, A. Lartey, S. Etuaful,
B. Nyamekye, P. Awuah, F. Osei-Sarpong, S. Lucas, A. Kolk,
M. Wansbrough-Jones (London, UK; Kumasi, Agroyesum, Nkawie,
Tepa, GH; Amsterdam, NL)
Objectives: Mycobacterium ulcerans disease (Buruli ulcer)
manifests as a nodule, papule, plaque or oedematous lesion
Abstracts
150
prior to ulceration and the usual form of treatment is surgery.
Clinical diagnosis can be conﬁrmed by histopathology, detection
of acid fast bacilli (AFB) and culture from surgically excised
lesions but if non-surgical treatment is planned an alternative
diagnostic technique is needed. In the present study 4 or 6 mm
punch biopsies were used to compare the sensitivity of detection
of AFB, culture for M. ulcerans, polymerase chain reaction (PCR)
for M. ulcerans and histopathology in making the diagnosis of
M. ulcerans disease in a ﬁeld setting.
Methods: 4 or 6 mm punch biopsies were taken before surgical
excision of 69 lesions suspected clinically to be due toM. ulcerans
disease. They were analysed by Ziehl- Neelsen stain (ZN) for
AFB, culture on Lo¨wenstein Jensen slopes, histology and PCR.
PCR for the insertion element IS2404 was modiﬁed to include
uracil-N-glycosylase and dUTP instead of dTTP to reduce the
risk of cross contamination.
Results: Out of 69 clinically diagnosed cases of M. ulcerans
disease, 50 were conﬁrmed on the basis of culture or histopa-
thology and all were PCR positive. Nine had negative culture
and AFB but histopathology was compatible with M. ulcerans
disease and all had positive PCR. Out of the remaining 10 cases
in which PCR was negative, AFB and culture were also negative
and histopathology was incompatible withM. ulcerans disease in
all but one case showed inﬂammation compatible with but not
diagnostic of M. ulcerans disease and the clinical presentation
was not typical. Therefore the modiﬁed PCR was 100% sensitive
and there was only one possible false negative result. The
sensitivities of microscopy, culture and histology were 42%, 50%
and 83% respectively. A 4 mm punch biopsy was preferred to a
6 mm biopsy since it was less likely to bleed and to need
stitching.
Conclusion: This ﬁeld study showed that PCR for IS2404 was
the most sensitive diagnostic test for M ulcerans disease, with
high speciﬁcity and it gave a rapid result. Given adequate
technical expertise and controls the PCR was viable in this
teaching hospital setting in Ghana and, in routine practice, we
would recommend ZN staining of biopsies to detect AFB,
followed by PCR in AFB negative cases only, in order to
minimise costs. Histology and culture remain important as
quality control tests, particularly in studies of treatment efﬁcacy.
P557
Reverse hybridisation as tool for the
identiﬁcation of mycobacteria other than
tuberculosis from clinical respiratory samples
I. Solino, I. Jesus de la Calle, C. Freyre, S. Perez-Ramos,
J.M. Rodriguez-Iglesias (Cadiz, E)
Objectives: To evaluate molecular methods for the identiﬁca-
tion of non-tuberculous mycobacteria (mycobacteria other than
tuberculosis, MOTT) isolated from clinical respiratory samples.
Methods: Nineteen MOTT strains were selected isolated from
respiratory clinical samples and cryopreserved at –80C. Previ-
ously decontaminated samples were cultivated in MGIT broth
and incubated in BACTECMGIT 960 system (Becton Dickinson).
The strains were identiﬁed by hybridization with speciﬁc
labelled probes (AccuProbe, GenProbe) or identiﬁed by Refer-
ence National Center in Madrid (CNM). The strains included in
the study were M. abscessus (1), M. alvei (1), M. avium (5),
M. avium complex (1),M. celatum (1),M. fortuitum (2),M. gordonae
(1) M. kansasii (2), M. mucogenicum (1), M. peregrinum (1),
M. senegalense (1), M. simiae (1), and M. terrae (1). The strains
were partially thawed and recovered in MGIT broth until to
obtain positive signal growth. DNA was extracted from 0.2 ml
and ampliﬁcation by PCR from rRNA 16S–23S spacer region
was done in PE-9600 thermocycler (Perkin Elmer). Ampliﬁed
product were visualized by electrophoresis agarose gel checking
a 400–550 bp band and positive samples were identiﬁed by
reverse hybridization with labelled probes ﬁxed to nitrocellulose
following manufacturer’s indications (InnoLipa Mycobacteria
v2, Innogenetics).
Results: Three strains (15.7%) cannot be recovered (M. alvei,
M. celatum and M. fortuitum). Other 3 strains were identiﬁed as
Genus Mycobacteria only (M. senegalense, M. mucogenicum and
M. terrae) due to not include speciﬁc probes for those species.
The rest of strains were identiﬁed as M. abscessus (1), M. avium
(5), M. avium complex (1), M. fortuitum–M. peregrinum complex
(2), M. gordonae (1), M. kansasii (2) and M. scrofulaceum (1).
Discussion: All ampliﬁed strains were correctly identiﬁed
except one (93.7%). Only M. simiae was identiﬁed incorrectly
as M. scrofulaceum by reverse hybridization. Innolipa is a
convenient and accuracy method for the identiﬁcation of
MOTT and is more versatility that AccuProbe due to have a
more complete probes collection.
P558
Rapid detection of multi-drug resistant
Mycobacterium tuberculosis by pyrosequencing
J. Ma¨kinen (Turku, FIN)
Objectives: After the introduction of effective antimycobacteri-
al drugs, tuberculosis (TB) was thought to be under control.
Today,Mycobacterium tuberculosis is still one of the most harmful
human pathogens worldwide, causing 8 million new cases and
between 2 and 3 million deaths each year. The upsurge of TB has
been accompanied by the emergence of drug-resistant strains of
M. tuberculosis. Primary multi-drug resistance (MDR), resistance
to at least isoniazid (INH) and rifampin (RMP), is an increasing
problem in both developed and developing countries. DNA-
sequencing studies have demonstrated that >95% of the RMP
resistantM. tuberculosis strains have a mutation within the 81-bp
hot-spot region of the gene encoding for the b subunit of DNA
dependent RNA polymerase (rpoB). INH resistance is most
frequently associated with a speciﬁc mutation in katG (codon
315) gene, that encodes the catalase-peroxidase enzyme in
M. tuberculosis. Since early diagnosis of the disease and the rapid
identiﬁcation of resistance to primary anti-TB agents are
essential for the efﬁcient treatment and control of MDR-TB,
rapid methods for early detection of resistant M. tuberculosis
isolates are required. The aim of this study was to develop a
rapid and reliable method for detection of MDR-TB, applicable
to both routine and research laboratory work.
Methods: Pyrosequencing is sequencing by synthesis, a simple
and rapid technique for accurate analysis of DNA sequences. A
pyrosequencing assay for the detection of rpoB and katG315
mutations causing rifampin and isoniazid resistance was devel-
oped. The method was evaluated using 42 clinicalM. tuberculosis
isolates. Pyrosequencing results were compared to the conven-
tional sequencing results and to the phenotypic susceptibility
test results.
Results: The concordance of the pyrosequencing and conven-
tional methods was 100% for rifampin resistance and 81% for
isoniazid resistance. Nine different rpoB mutations were detec-
ted, which all have been previously characterized. The
Ser531Leu was the most common mutation found in 16/27
RMP resistant isolates. None of the susceptible isolates were
found to contain mutations. The pyrosequencing results were
obtained in two days, compared to at least 5 days with the
conventional sequencing (in our laboratory settings).
Conclusion: The pyrosequencing method was found to be a
cost-effective, rapid and reliable method for detection of MDR-
TB.
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M. tuberculosis drug resistance and clinical
outcome in Greek and immigrant patients
S. Kanavaki, A. Papavassiliou, S. Karabela, I. Varonou,
A. Skroubellou, S. Anagnostou, A. Malgarinou,
S. Nikolaou (Athens, GR)
Objective: We studied Isoniazide (INH), Rifampicin (RIF) and
(MDR) resistance (INH+RIF) of M. tuberculosis strains derived
from Greek and immigrant patients of ‘Sotiria’ hospital, in the
years 1993–1995 and 2001–2003. We also studied the clinical
outcome in the same patients.
Methods: In 1993–95, 1391 M. tuberculosis strains were studied,
1209 from Greeks and 182 from immigrants, while in 2001–03,
1270 strains, 960 from Greeks and 306 from immigrants.
Cultures and susceptibility testing were performed, classically
and automatically, by Bactec 460 and MGIT 960 systems.
Results: In 1993–95, 81/1209 (6.7%)M. tuberculosis isolates from
Greeks and 26/182 (14.3%) from immigrants were resistant to
either INH or RIF. ‘Sotiria’ TB unit followed up 64 (79%) Greeks
and 24 (92.3%) immigrants. Successful therapy was for 50 (78%)
Greeks and 13 (54%) immigrants, while contact was lost with 14
(22%) Greeks and 11 (46%) immigrants. In 2001–03, 144/964
(14.9%) isolates fromGreeks and 103/306 (71%) from immigrants
were resistant to either INH or RIF. ‘Sotiria’ TB unit followed up
103/144 (71%) Greeks and 63/306 (85%) immigrants. Successful
therapy was for 72 (70%) Greeks and 51 (82%) immigrants, while
contactwas lostwith 31 (30%)Greeks and 12 (19%) immigrants. In
1993–95, 14/1209 (1.16%) Greeks and 4/182 (2.20%) immigrants
were MDR. TB unit followed up 11 (78.6%) Greeks and 4 (100%)
immigrants, with a successful outcome for 7 (63%) Greek and 2
(50%) immigrant patients and lost contact with 3 (27%) Greeks
and 2 (50%) immigrants. One Greek patient died. In 2001–03, 36
(3.73%) Greeks and 18 (5.88%) immigrants were MDR. TB unit
followedup 25 (69.4%)Greeks and17 (94.4%) immigrants and lost
contact with 5 (20%) Greeks and 3 (17.6%) immigrants. Successful
outcomewas for 13 (52%)Greeks and 8 (47%) immigrants,while 5
(20%) Greeks and 5 (29.4%) immigrants are still under therapy. 2
(8%) Greeks and 1 (6%) immigrants died.
Conclusion: There is a remarkable increase of M. tuberculosis
resistance to INH, RIF and MDR, both in Greeks and immi-
grants, but the per cent of successful clinical outcome remains
almost the same. Greek authorities should organize a modern
and functional TB monitoring system.
P560
Mycobacterium tuberculosis primary resistance
during 1995–2004 in a general universitary
hospital, Alicante, Spain
J. Plazas, R. Serrano, A. Sanchez, I. Vidal (Alicante, E)
Introduction: The treatment of tuberculosis as global emer-
gency of public health, fail by drug resistance, inadequate
regimen, or noncompliance with prescribed treatment. The
resistance to antituberculous agents is primary when it is
present before treatment has been started and secondary when it
happens during treatment course.
Objectives: To know the prevalence of resistant Mycobacterium
tuberculosis in primary infections during the period of time 1995–
2004.
Methods: The results of susceptibility tests in positive cultures
for M. tuberculosis were analysed. Cultures in solid medium
Lowestein-Jensen and liquid medium Middlebrook 7H12 were
made, and, drug susceptibility testing was done by using a
radiometric BACTEC 460 system (Becton Dickinson Diagnostic
Systems). The antituberculous drugs tested have been as
following: streptomycin, isoniazid, rifampicin, ethambutol and
pyrazinamide.
Results: In a total of 490 patients with diagnosis of tuberculosis
and positive culture, 89.8% (440) of cases shown sensibility to all
antituberculous agents, and 10.2% (50) of them were resistant at
least to one drug. The 76% (38) of cases in the resistant group
were just to one drug, and 24% (12) were resistant to more than
one agent. There were 1.4% of multidrug-resistant tuberculosis
(MDR-TB) (rifampicin and isoniazid resistance) and, of them, 3
cases were resistant also to a third or fourth drug, pyrazinamide,
streptomycin and/or ethambutol. In the period 1995–1997 we
have found two cases of MDR TB, another case in the period
1998–2000, and four cases in 2001–2004.
Conclusions: The resistance rate in our area was of 10.2%. The
antituberculous agent with higher number of resistances was
isoniazid (8.8%), followed by rifampicin (2%). Ethambutol and
streptomycin (0.6%) were found in a lowest percentage. The
global multidrug-resistant tuberculosis was 1.4%, inﬂuenced
mainly by increasing number of cases in last years.
P561
Prevalence of mutations associated with drug
resistance in Beijing and non-Beijing
Mycobacterium tuberculosis strains from the
Southern Ukraine
V. Nikolayevskyy, F. Drobniewski, Y. Bazhora, N. Levitska,
A. Asmolov (Odessa, UKR; London, UK)
Tuberculosis (TB) incidence in Ukraine has virtually doubled
since 1992, reaching 77.5/100 000 in 2003. Recent studies have
demonstrated that Beijing strains of Mycobacterium tuberculosis
dominate in certain regions of Russia and some countries of the
former Soviet Union (FSU). The spread of Beijing strains and
their strong association with high levels of drug resistance are
believed to be major factors contributing to the TB epidemic in
the FSU. Limited data regarding drug resistance rates are
available only for selected regions of Ukraine and the prevalence
of different genotypes and their contribution to the TB epidemic
in Ukraine is unknown.
Objective: To determine the prevalence of Beijing strains of
M. tuberculosis in two regions in the Southern Ukraine and their
association with drug resistance and to determine prevalence of
speciﬁc mutations associated with rifampicin and isoniazid
resistance.
Materials and methods: Total of 110 Mycobacterium tuberculosis
strains isolated from patients with pulmonary TB from Odessa
and Nikolaev oblasts were analysed. Beijing strains were
identiﬁed using spoligotyping. The prevalence of mutations in
rpoB, katG and inhA associated with rifampicin and isoniazid
resistance was evaluated using a dot-blot hybridization macro-
array based on reverse hybridization of biotin-labelled PCR
products to oligonucleotide probes immobilized on membranes.
Results: Spoligotyping of 110 M. tuberculosis strains yielded 12
clusters and 28 individual patterns with the largest cluster
consisting of 34 isolates. Forty (36.4%) strains were identiﬁed as
the Beijing strains. Six Beijing isolates had incomplete Beijing
spoligotyping proﬁles with spacers 37, 37–38, and 38–40 miss-
ing. Mutations conferring multidrug resistance were most
prevalent in Beijing strains (47.5% versus 22.9%). In rifampicin
resistant isolates mutations were seen in rpoB codons 512–519,
523–529, and 528–534 in 18.9%, 32.4%, and 51.4% respectively.
Mutations in codons 528–534 of rpoB were strongly associated
with Beijing strains. Previous evidence about association of
mutations in katG codon 315 with the Beijing genotype was not
supported in our study.
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Conclusions: Molecular genetic analysis shows relatively high
genetic diversity of strains circulating in the Southern Ukraine
compared with those seen in Russia. High rates of drug
resistance are likely to be associated with the spread of Beijing
strains and with exogenous infection.
P562
The pattern of drug resistance in hospitalised
patients with drug resistant tuberculosis in an
Iranian hospital
M. Amiri (Tehran, IR)
Introduction: Tuberculosis is a common infectious disease
these days; it has the highest mortality rate among all infectious
causes only after AIDS. The emergence of Tuberculosis bacillus
species resistant to multiple drugs has become a serious global
threat to the human race. Resistance is either primary, or it may
evolve in the course of treatment due to patient’s non-compli-
ance or an inadequately and inappropriately selected drug
regimen. This study has been done to evaluate drug resistance
and to determine the type of resistance in drug resistant
tuberculosis patients.
Methods: The ﬁles of patients hospitalized in Massih Danesh-
vari clinical mycobacteriology ward during the past 2.5 years
due to suspected drug resistance tuberculosis were evaluated.
Those who had a sputum antibiogram indicating resistance to at
least one anti-TB drug were included in the study. Data,
including demographic data, radiological ﬁndings, sputum
smear, sputum culture and antibiogram was recorded in a
speciﬁed questionnaire. Analysis was done for central indices
using the SPSS software.
Results: 43 cases met the inclusion criteria. 27 of them (63) were
male and 16 (37) were female. The youngest patient was 16 and
the oldest was 80 years old. The mean value was 36.9 years
(SD = 16.76). 30 cases (70%) were Afghans and 13 (30%) were
Iranian. Antibiograms of 38 patients (88%) showed resistance to
at least INH and RIF; these cases were considered to be MDR. In
24 cases (56%) the tubercles bacillus was resistant to all four
drugs (INH, RIF, STM, EMB). 36 patients (85%) had resistance to
STM at least, and 26 patients (60%) were at least resistant to
EMB. Bacillus drug sensitivity for PZA was not speciﬁed.
Conclusion: Most drug resistant cases of TB were seen among
Afghan emigrants. 95% of cases had a history of treatment at
least once, and the resistance was secondary. Despite discon-
tinuation of streptomycin usage as an anti-TB drug in Iran in
recent years, the most common type of resistance was related to
this drug, occurring in 85% of cases. Conﬁrming different
studies in other countries, the lowest resistance to ﬁrst line anti-
TB drugs was for EMB, detected in 56% of cases.
P563
Rapid drug sensitivity testing for M. tuberculosis
using slide culture
K. George, L. Nair, S. Jestus (Calicut, IND)
Objectives: MDR-TB has worsened the tuberculosis crisis in the
developing world. Lack of resources limits access to rapid drug
sensitivity tests like BACTEC. We conducted in a tertiary care
public sector hospital in South India, a study to compare drug
sensitivity testing of M. tuberculosis on LJ medium with the
Rapid Slide Culture (RSC) method using human blood medium
(HBM).
Methods: Isolates of M. tuberculosis grown on LJ medium were
subjected to sensitivity testing on LJ medium and by RSC
(Absolute Concentration Method). For RSC, citrated HBM
(antibiotics and antifungals added to prevent contamination)
was used. Outdated human bloodwas obtained from the hospital
blood bank. Antituberculous drugs – INH, Rifampicin, Etham-
butol and Streptomycin were added to HBM.Standardised inoc-
ula ofM. tuberculosiswere smeared on to the lower 1/3rd of sterile
glass slides, immersed in HBM and were incubated at 37C for
8 days. Presence of microcolonies were demonstrated by ZN
staining. Growth was graded according to the size of microcol-
onies and the drug sensitivity patterns were documented.
Results: 41 isolates were tested for drug sensitivity on LJ
medium.25/41 (60.9%) were sensitive to all 4 drugs, 6/41
(14.6%) resistant to a single drug and 10/41 (24.3%) resistant to
multiple drugs [6 resistant to all 4 and 4 to INH and Rifampicin].
Drug sensitivity was reported at 28 days. 37/41 isolates (90.2%)
were grown by RSC method. Results were read on 8th day. 26/
37 (70.2%) were sensitive to all 4 drugs, 3 resistant to single drug
(8.1%) and 8 resistant to multiple drugs (21.6%) [2 resistant to all
4 drugs, 3 to INH, Rifampicin and Ethambutol, 3 to INH and
Rifampicin]. Agreement between the 2 methods were calculated
by kappa statistics. Signiﬁcant agreement was shown for INH
(.871) , Rifampicin (.924) and Ethambutol (.874). Streptomycin
(.226) failed to show agreement.
Conclusion: 1. Rapid Slide Culture shows agreement with the
standard method for sensitivity testing of M. tuberculosis
especially for the clinically important drugs INH and Rifampi-
cin. 2. The results of drug sensitivity are obtained considerably
early than the standard. 3. This simple inexpensive technique
has potential for adaptation to developing economies lacking
sophisticated rapid drug sensitivity tests like BACTEC.
P564
LCD-array for molecular analysis of isoniazid
and rifampin resistance in Mycobacterium
tuberculosis
L.M. Arago´n, F. Navarro, M. Garrigo´, C. Moreno, V. Heiser,
P. Coll (Barcelona, E; Berlin, D)
Objective: To evaluate a Low Cost Density Array (LCD-Array;
Chipron, Berlin. Germany) for molecular analysis of isoniazid
and rifampin resistance in Mycobacterium tuberculosis.
Methods: A total of 44 M. tuberculosis isolates with a previously
characterised resistant mechanism were evaluated. One LCD-
Array contains eight identical microarrays, separated in pre-
structured reaction chambers. Each chamber is designed to
detect mutations within the 90 bp rpoB region, codon 315 in the
katG gene and mabA-inhA regulatory region. The capture
probes the sequence region of amino acid position 315 for the
katG gene span. One probe represents the wild type (wt) (315-
Ser) and two probes harbour the sequence for the mutations 315-
Thr and 315-Asp. The capture probes of the mabA-inhA
regulatory region have been designed for three point mutations
in the 5‘ non-coding region (-8T-C, -15C-T and –17G-T). One
capture probe spanning all three positions has been designed for
the wt. The capture probes for the rpoB gene cover a region
coding for amino acids 504–534. Six capture probes, represent-
ing the wt sequence, are included. Below there are 12 capture
probes for the most frequent mutations. A multiplex-PCR for
rpoB, katG and mabA-inhA was performed with 1 ll of DNA in
25 ll reaction volume. Hybridizations were performed accord-
ing to the manufacturer’s instructions.
Results: Of the 22 strains with a katG 315 mutation (20
Ser315Thr, 1 Ser315Arg and 1 Ser315Asn) all were correctly
identiﬁed by the LCD-Array except for the strain
with Ser315Asn which is not represented in the LCD-Array.
Nevertheless, this strain did not hybridise with the wt probe.
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Nineteen strains with alterations in the mabA-inhA regulatory
region (2 with-8T-C, 16 with -15C-T and 1 with –17G-T) were
included. The LCD-Array correctly identiﬁed 16 mutated
strains. Three strains (2 with -15C-T and 1 -8T-C) did hybridise
with both the wt and mutated capture probes. Thirteen out of 15
strains with mutations in the rpoB region were correctly
classiﬁed. One strain with an Asp516Phe did not hybridise
with the wt type probes for aminoacids 514–519 and the capture
probe for this rare mutation was not included in the panel.
Conclusion: LCD-Array is an easy, rapid and convenient
method to characterise codon 315 mutations in the katG gene
and rpoB region. Capture probes for the mabA-inhA regulatory
region should be optimised in order to suppress cross hybrid-
isation of wt with the -15C-T capture probe.
P565
Mutations in the rpoB, katG and inhA genes
leading to rifampicin and isoniazid resistance in
Mycobacterium tuberculosis isolates from Turkey
A. Sanic, C. Eroglu, M. Gunaydin, H. Leblebicioglu, E. Seber,
V. Avkan Oguz, M. Atasever, I. Uruk, I. Ceyhan, R. Durmaz,
A. Yaman, O. Tansel, A. Karadag, E. Ozturk, B. Durmaz,
S. Guneri, A. Yuce, G. Aslan (Samsun, Istanbul, Izmir, Ankara,
Malatya, Adana, Edirne, Duzce, Mersin, TR)
Objectives: This study was carried out to specify mutation
within subunit b of the rpoB gene in rifampin (RIF) resistant and
within katG and inhA gene in isoniazid (INH) resistant
M. tuberculosis isolated from TB patients in Turkey.
Methods: 227 RIF, 255 INH resistance strains were included in
this study. Strains were identiﬁed by standard biochemical tests
and molecular method, of PCR-RFLP. Rifampin resistance was
determined by proportion method using LJ medium. In order to
detect the presence of mutation, ampliﬁcation was performed
using primer rpo95-rpo397 for rpoB, TB86–TB87 for katG, TB92–
TB93 for inhA genes as described previously. The same primers
were used for DNA sequence analysis of both strands, using the
automated Applied Biosystems, ABI PRISM 310 Genetic Ana-
lyzer (Applied Biosystems, Foster City, Calif).
Results: In 227 RIF resistant M. tuberculosis isolates, twenty
different types of point mutation at eight different codons, two
deletions and one insertion were detected. The codon most
frequently involved in mutation were codon 531 (53.3%) and
codon 526 (18.5%). The most frequent allelic mutation was the
mutated codon TTG in position 531 (Ser Leu) (49.3%). The
other mutations were codon 516 (10.1%), 522 (3.5%), 533 (1.8%).
We couldn’t ﬁnd any mutation 11 (4.9%) isolates. A three
nucleotide deletion between codon 514 and 516 at two rifampin
resistant isolates, and a three nucleotide insertion between
codon 514 and 515 was found in one rifampin resistant isolates.
In 255 INH resistant M. tuberculosis isolates, seven different
types of point mutation at three different codons, one deletion
were identiﬁed. The codon most frequently involved in muta-
tion was codon 315 (66.7%). The most frequent allelic mutation
was the mutated codon ACC in position 315 (SerThr) (60.4%).
The other mutations were codon 314 (0.4%), 299 (0.8%). We
couldn’t ﬁnd any mutation 82 (32.2%) isolates. Four codons
deletion between codon 301 and 306 at one INH resistant isolate.
We studied inhA gene mutation on 113 of 255 INH resistant
M. tuberculosis. We found only one type point mutation codon
TGA in position 209 (Arg Stop)
Conclusion: The most frequently encountered mutation is at
codon TTG 531 for rpoB gene and at codon ACC 315 for katG
gene and at codon TGA 209 for inhA gene.(The project was
supported by Government Planning Organization, Turkey)
P566
Second-line antituberculous drugs: usefulness of
the E-test for susceptibility testing of multidrug-
resistant Mycobacterium tuberculosis
N. Garcı´a-Escribano, M.J. Ruiz-Serrano, S. Jime´nez,
O. Pe´rez-Olaso, A. Bla´zquez Abella´n, D. Garcı´a de Viedma,
E. Bouza (Madrid, E)
Objective: Tuberculosis caused by multidrug-resistant strains
represents a therapeutic challenge for the selection of appropri-
ate antimicrobial agents. Therefore is important to obtain results
of susceptibility to second-line antituberculous drugs earlier and
accurately. The aim of this study is to demonstrate the
usefulness of the E-test to obtain susceptibility to second-line
antituberculous drugs against M. tuberculosis multidrug-resist-
ant (MDR-TB) strains.
Methods: From 1992 to March 2004 we isolated 20 MDR-TB.
Second-line susceptibility testing was performed retrospectively
by the proportions method and for amikacin (AK), claritromycin
(CH), oﬂoxacin (OF) and rifabutin (RF) by BACTEC 460TB, as
reference methods (NCCLS M24-T2), and by E-test according to
the manufacturer’s recommendations. We tested isoniazid (IZ),
rifampin (R), streptomycin (SM), ethambutol (EB), AK, CH, and
OF by two methods. Levoﬂoxacin (LE), moxiﬂoxacin (MO), and
linezolid (LZ) was only tested by the E-test and RF only by the
reference method. We used M. tuberculosis H37Rv as a quality
control.
Results: Percentages of MTB strains resistance comparing
reference methods versus E-test were as follows: IZ (100% vs
100%), R (100% vs 100%), SM (27% vs 27%), EB (27% vs 33%),
AK (13% vs 20%), CH (67% vs 73%), OF (33% vs 40%), RF (87%),
LE (27%), MO (7%), and LZ (7%). These results were read after
21 days by reference method following NCCLS recommenda-
tions. Nevertheless, the E-test was read before 10 days.
Conclusions: The E-test is an easy and accurate method for the
rapid detection of resistance to second-line anti-TB drugs.
Linezolid and moxiﬂoxacin showed the best activity against all
MDR-TB. Therefore, E-test is a rapid and valid alternative for
susceptibility testing in a clinical laboratory routine.
P567
Temperature mediated heteroduplex analysis of
rpoB mutations in Mycobacterium tuberculosis
DNA: direct detection of rifampicin resistance in
clinical specimens
J. Evans, A. Parveen, K. Boese, X. Li, E. Smith, G. Hong,
P. Hawkey (Birmingham, UK; Omaha, USA)
Objectives: The frequency of resistance to rifampicin in some
countries can be as high as 23%. Rifampicin and isoniazid are
ﬁrst-line drugs, and up to 90% of rifampicin resistant isolates are
also isoniazid resistant, deﬁned as Multi-Drug Resistant TB.
(MDR-TB). 96% of rifampicin resistant isolates carry mutations
in a 81-bp region of the rpoB gene. Therefore, it is of clinical
importance to be able to rapidly detect rifampicin resistance in
patients that are at risk of MDR-TB. Mutations in the rpoB gene
of M. tuberculosis have been analysed by Temperature Mediated
Heteroduplex Analysis (TMHA) previously, however, we make
the ﬁrst report of direct detection of rpoB mutations from
clinical specimens.
Methods: 100 rifampicin resistant isolates and 100 rifampicin
sensitive isolates from the West Midlands, UK cultured in 2000–
2004 had DNA extracted using the QIAamp DNA Mini-Kit.
Primers were designed to amplify a 400 bp fragment of the
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M. tuberculosis rpoB gene that includes the 81-bp ‘hotspot’
region. Forward and reverse DNA sequencing deﬁned muta-
tions in the rpoB gene. From July 2004, all sputum samples that
were rifampicin resistant frozen at –70C and DNA was as
above. An equal number of rifampicin sensitive sputum samples
were also examined. To establish technique reproducibility each
individual mutation was analysed in triplicate. After PCR and
heteroduplexing, ı`L of each PCR reaction was loaded onto a
DNASep Cartridge in a WAVE DNA Fragment Analysis
System (Transgenomic Inc., Omaha, NE). The gradient for
separation was a 5.8-min gradient (400 bp) at a ﬂow rate of
0.9 ml/min at 68C.
Results: The 100 rifampicin resistant isolates possessed a range
of deﬁned rpoB mutations. The most common mutation was
S531L, with H526Y being the second most prevalent. Mutations
conferring rifampicin resistance in all of the 100 isolates were
readily detected by the WAVE System. No false positive results
were obtained when the 100 isolates with no resistance confer-
ring mutations were analysed by dHPLC on the WAVE
System. Mutation heteroduplexes were reproducible when
analysed in triplicate on the WAVE System. All mutations
deﬁned in cultured isolates from the Midlands were detected
directly in clinical sputum specimens.
Conclusion: Temperature mediated heteroduplex analysis of
rpoB mutations conferring resistance to rifampicin in
M. tuberculosis isolates and clinical specimens is an accurate,
sensitive, cost-effective and reproducible technique.
P568
Comparison of an ELISPOT assay based on the
RD1 selected peptides and intact proteins with
QF-TB gold assay in the surveillance of health
care workers
D. Goletti, D. Vincenti, S. Carrara, F. Bizzoni, O. Butera,
R. Sorrentino, B. Zerillo, S. Signorini, N. Magnavita,
M. Amicosante, E. Puro, E. Girardi (Rome, I)
Objective: To evaluate the usefulness of different immunologi-
cal tests for the diagnosis and surveillance of tuberculosis (TB)
infection among health care workers (HCW).
Methods: We enrolled 100 HCW coming from 3 hospitals
located in Roma, Italy. Among them, 57 came from wards at
high risk of exposure to patients with active TB (pneumology
and infectious disease wards). All HCW gave a written
informed consent. Samples were analysed by 1) a novel
ELISPOT assay based on RD1 selected non-overlapping pep-
tides, 2) an ELISPOT assay based on intact RD1 protein and, 3) a
whole blood commercial kit (QF-TB Gold; Cellestis, Australia)
which uses overlapping peptides spanning the whole length of
RD1 proteins. The results were then compared with tuberculin
skin test (TST) score and size; TST >5 mm was considered
positive.
Results: Overall, positive response to RD1 selected peptides
was 11/100, 2/11 were BCG-vaccinated and 7/11 had a TST
>10 mm. A positive response to RD1 proteins was found in 28/
100, 10/28 were BCG-vaccinated and 12/28 had a TST >10 mm.
A positive response to QF-TB was found in 23/100, 7/23 were
BCG-vaccinated and 12/23 had a TST >10 mm. Among those
QF-TB positive (assay that is going to be considered the gold
standard of TB infection), we identiﬁed 10 peptide positive and
13 peptide negative. Among those peptide positive 7/10 (70%)
had a TST >10 mm, whereas only 5/13 peptide negative (38%)
had a TST>10.
Conclusions: The results indicate that the response evaluated
by the QF-TB Gold (23/100), is similar to the response obtained
by ELISPOT assay with RD1 protein stimulation (28/100)
whereas the response to the selected peptides is found only in
a smaller group of the HCW (11/100) and it correlates with the
TST-size. Our study suggests that the RD1 peptides response
may have an higher speciﬁcity in identifying these HCW with
an higher risk of developing active TB during life time,
compared with other immunological in vitro tests.
P569
Lymphocyte subpopulations in patients with
active pulmonary tuberculosis
F. Deveci, H. Akbulut, I. Celik, M.H. Muz, F. Ilhan (Elazig, TR)
Objectives: Tuberculosis remains the leading causes of mortal-
ity among human infectious diseases in the world. B cells,
natural killer cells, CD4+ T cells, other T cell subsets such as,
gamma-delta, CD8+ and CD1 restricted T cells have roles in the
immune response to M. tuberculosis. How T cells help them
perform this task remains poorly understood. A study was
undertaken to evaluate the proﬁle of the CD4+, CD8+ T cells and
CD19+, CD (16 + 56)+ population in patients with active
pulmonary tuberculosis.
Methods: Forty-nine active (mean age 35.76 ± 15.8) and 13
inactive (mean age 43.23 ± 20.5) pulmonary tuberculosis cases
and 20 healthy subjects (mean age 38.20 ± 17.6), having no
disease and at the similar age range were evaluated. CD4+, CD8+
T cells and CD19+, CD (16+56)+ cells percentages were analysed
by using Coulter EPICS XL-MCL (Beckman Coulter U.S.A.) ﬂow
cytometry. Active tuberculosis patients were divided into three
groups according to the treatment and X-ray ﬁndings. So, the
results were analysed in the context of antituberculous treat-
ment stages and X-ray ﬁndings in patients with active pulmon-
ary tuberculosis.
Results: CD4+ cell percentages were signiﬁcantly lower in
active pulmonary tuberculosis patients than in healthy subjects
(p < 0.001). CD (16 + 56)+ cell percentages were signiﬁcantly
increased in patients with active pulmonary tuberculosis
compared with healthy controls (p < 0.01). CD8+ T cells were
signiﬁcantly decreased (p < 0.05), and CD (16 + 56)+ cell
percentages were signiﬁcantly increased (0.01) in inactive
pulmonary tuberculosis patients compared with healthy
controls. These parameters were not different statistically
when compared the active and inactive pulmonary tuberculosis
patients (Table). CD4+, CD8+, CD19+, CD (16 + 56)+ cells
percentages did not show difference at the different time of
the antituberculous regimen and X-ray ﬁndings of the three
different groups of active tuberculosis patients.
Conclusion: Active pulmonary tuberculosis patients have a
reduced number of circulating CD4+ cells and an increased
number of CD (16 + 56)+ cell compared with healthy individ-
uals. These cells could be played an important role in the
immune response to M. tuberculosis infection. Table: CD4+,
CD8+ T cells and CD19+, CD (16 + 56)+ cell percentages (means
of % ±SD) among active pulmonary tuberculosis (PT), inactive
pulmonary tuberculosis and healthy subjects
Active PT Inactive PT Healthy subjects
CD3+/CD4+ 35.48 ± 9.18 39.28 ± 8.17 43.36 ± 6.01
CD3+/CD8+ 25.72 ± 9.37 22.13 ± 5.75 27.16 ± 7.01
CD3)/CD19+ 11.76 ± 5.97 14.13 ± 4.10 11.86 ± 3.26
CD3)/CD(16+56)+ 16.56 ± 8.46 17.36 ± 7.48 11.03 ± 6.71
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P570
The serum/pleural IL-6 ratio in the differential
diagnosis of the tuberculous pleural effusion
A. Christopoulos, E. Fengou, I. Katsarou, E. Ikonomopoulou,
K. Papadopoulos, A. Rengli (Patras, Zakynthos, GR)
Introduction: Interleukin 6 (IL-6) is locally produced at the sites
of inﬂammation of the pleural space. Pleural IL-6 leaks to
circulation to cause its systematic effects. The amount of IL-6
produced in the pleural space as well as the amount that leaks to
circulation depends on the particular disease.
Objectives: To study the serum/pleural IL-6 ratio as a speciﬁc
marker in the diagnosis of tuberculous pleural effusion.
Method: Patients: IL-6 value was assessed in 77 serum/pleural
ﬂuid pair samples from patients with exudative pleural effu-
sions with Quantakine IL-6 Immunoassay (4.5 hour solid phase
ELISA).
Results: The serum/pleural IL-6 ratio was always £0.01 in
tuberculous, ‡0.1 in malignant (with exception mesotheliomas)
and ‡0.02 in parapneumonics pleural effusions. Pleural IL-6 was
>100 U/ml in all par pneumonic and <100 U/ml in all
malignant effusions.
Conclusion: Serum/pleural IL-6 ratio in association with pleu-
ral ﬂuid’s value is a speciﬁc and sensitive marker for the quick
diagnosis of the tuberculous pleural effusion.
P571
CD14 and IL-10 gene polymorphisms in relation
to tuberculosis
M. Druszczynska, D. Strapagiel, B. Sadowska, J. Karhukorpi,
R. Karttunen, S. Kwiatkowska, B. Rozalska, W. Rudnicka (Lodz,
PL; Oulu, FIN)
Objectives: Over 2 billion people are estimated to be infected
with virulent Mycobacterium tuberculosis but fewer than 10%
develop clinical tuberculosis within their lifetime. Resistance to
M. tuberculosis involves a complex interaction between the
bacteria and the host immune system. Genetic differences in
immune responses may affect susceptibility to mycobacterial
infection, but no speciﬁc genes have been implicated in humans.
The aim of this study was to evaluate whether polymorphisms
on CD14 or IL-10 genes might be involved in determining
human susceptibility to mycobacteria.
Methods: Eighty nine tuberculosis adult patients were recrui-
ted from Regional Center for Pulmonary Diseases in Lodz,
Poland. Active tuberculosis was detected by sputum smear
staining and culturing of mycobacteria. Control group consisted
of eighty six healthy adult volunteers, who have never had
tuberculosis. Genomic DNA was isolated from EDTA-anticoag-
ulated whole blood according to the QIAamp DNA Mini Kit
from Qiagen (Hilden, Germany). Genotype frequencies for
CD14 (-159C/T) and IL-10 (-1082G/A) polymorphisms were
analysed using allele speciﬁc PCR methods. The levels of serum
sCD14 were tested by ELISA (Quantikine TM sCD14, R&D, MN,
USA).
Results: The frequency of the CD14 genotypes (C/C, C/T and
T/T) in patients and controls was similar. About half of the
individuals were C/T heterozygous in both groups. The 34% TB
patients and 27% healthy controls were C/C homozygous. The
association between serum sCD14 levels and CD14 promoter
polymorphisms was noticed for neither controls nor patients.
We could see no signiﬁcant differences between sCD14 levels in
sera form C/C, C/T and T/T individuals, however we observed
signiﬁcantly higher levels of serum sCD14 in tuberculosis
patients (3178 ng/ml) compared with controls (1582 ng/ml).
The distribution of the IL-10 genotypes (A/A, A/G and G/G)
was similar in both groups being under the study. The 53% TB
patients and 43% controls were A/G heterozygous. A/A and G/
G genotypes were observed in about 30% and 20% tuberculosis
patients and controls respectively.
Conclusions: Our results suggest that genetic variants of CD14
and IL-10 genes may not be involved in determining the
susceptibility to tuberculosis. The increase of serum sCD14
levels in patients with tuberculosis has no genetic background,
but probably is a consequence of M. tuberculosis infection.
Supported by MNiI, Grant No. 3PO5B09124.
P572
Monitoring the efﬁcacy of anti-tuberculous
treatment by the expression of phagocyte Fcg
receptors
J.A. Bernal, M.A. Escobar, A.A. Garcia-Egido, F.J. Fernandez,
J.L. Puerto, C. Asencio, P. Ruiz, M. Rosety, S.P. Romero,
C. Rivera, F. Gomez (Cadiz, E)
Background: Receptors for IgG (FcgRs) on phagocytic cells are
important in host defence against infection.
Objectives: We have studied the expression of FcgRs by
peripheral blood monocytes (M), M cultured for 72 hours (M/
Mø), and granulocytes (G) in patients with active Tuberculosis
(TB), during anti-TB therapy (anti-TB-Rx) and, after completion
of anti-TB-Rx.
Methods: The expression of the three type of FcgRs, FcgRI,
FcgRII and FcgRIII, on M, M/Mø and G were analysed by ﬂow
cytometry in 87 HIV-negative patients with TB (59 men and 28
women), at diagnosis, and monthly thereafter until completion
of anti-TB-Rx. FcgRs expression was assessed on resting M, M/
Mø and G, and on these cells after stimulation by culture with
IFNg.
Results: The expression of FcgRI and FcgRIII by M, M/Mø and
G was enhanced in patients with active TB by: 42 ± 4% and
22 ± 2% for M, respectively (p < 0.001), 56 ± 6% and 41 ± 4% for
M/Mø, respectively (p < 0.001) and, 119 ± 9% and 37 ± 3% for
G, respectively (p < 0.001). The expression of FcgRIIA by M, M/
Mø and G was decreased by –31 ± 1% (p = 0.02), –46 ± 3%
(p < 0.001), and –23 ± 1% (p = 0.002), respectively. These altera-
tions of FcgRs expression normalized from the 8th week until
the end of effective anti-TB-Rx. The expression of FcgRI,
FcgRIIA and FcgRIII by M, M/Mø or G from patients with
active TB was signiﬁcantly increased by culture in the presence
of IFNg (p < 0.001), returning to normal after 8 wks of anti-TB-
Rx. Setting a cut-off value = 25% of the mean ﬂuorescence
intensity over controls for FcgRs surface expression and,
assuming a prevalence range of active TB between 25 and 80%
among patients undergoing conﬁrmatory tests, results in a range
of sensitivity, speciﬁcity, positive and, negative predictive
values of: 57%–96%, 48%–97%, 34%–74%, and 59%–98%,
respectively for M-FcgRIIA, 48%–73%, 51%–96%, 38%–74%
and 68%–97%, respectively for M-FcgRIII, 31%–58%, 64%–93%,
37%–79% and 69%–95%, respectively for G-FcgRI and, 52%–
71%, 88%–98%, 49%–77% and 81%–93%, respectively for
G-FcgRIIB.
Conclusions: Mø and G from patients with active TB exhibit an
altered expression of FcgRs that disappear after effective anti-
TB-Rx. Thus, Mø and G FcgRs expression may help in predicting
the response to anti-TB therapy.
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P573
Study of the Th1/Th2 response and IgG/IgE
isotypes in patients with tuberculosis in the
Warao indigenous population, Venezuela
F. Giampietro, Z. Araujo, C. Ferna´ndez de Larrea,
J. de Waard (Caracas, VE)
Objectives: Tuberculosis is an important health problem in
Venezuela. The Warao people of the Delta Amacuro State,
Venezuela, have the highest prevalence of adult TB (115 cases
per 100,000 habitants) in this country. We studied some
immunological factor that could explain that special suscepti-
bility, like the Th1/Th2 response (IL-4, IL-12 and gamma IFN)
and the isotypes IgE and IgG, in mononuclear cell culture and
serum respectively.
Methods: We evaluated 86 adults, 40 Warao patients (34
tuberculin skin test (TST) positive and 6 negative), 22 Creole
patients (11 TST positive), 12 Warao controls (11 TST positive)
and 12 Creole controls (10 TST positive). The antibodies and
cytokines were measured by ELISA.
Results: We found that Warao patients showed a high response
of IgG4 and IgE against H37Rv antigens in contrast to Creole
patients. On the other hand, Creole patients had the highest
percentage of positive individuals in IgG1 and IgG3 against PPD
antigen. This was correlate with higher levels of IL-4 in Warao
patients in 24-hour cell cultures in comparison to Creole
patients. IL-12 was found increased in Creole patients in 24
and 48-hour cultures. We could not ﬁnd any difference in
gamma IFN between both populations.
Conclusion: Warao patients showed a immune proﬁle charac-
terized by Th2 response. These differences between Creole and
Warao patients were found in humoral and cellular response.
P574
Comparative study of initial and acquired drug
resistance in pulmonary tuberculosis in a
national research institute of tuberculosis and
lung disease, Iran
S. Arami, D. Mansoori (London, UK; Tehran, IR)
Resistant to anti-tuberculosis agents particularly multiple drug
resistant (MDR) Mycobacterium tuberculosis is an important
obstacle in the treatment and control of tuberculosis in the
world. Between Sep. 1996 and March 2000 for 273 smear and
culture positive pulmonary tuberculosis patients (both
old = 86/273 and new = 187/273) pretreatment susceptibility
tests of isolated bacilli to INH, RIF, EMB and STM were
performed by standard proportional method and the results
were classiﬁed in three groups: i) Newly diagnosed without any
history of treatment; ii) Patients with history of treatment with
one course; iii) Patients with history of treatment for two or
more courses supposed to be MDR cases. The results were
collected for each drug individually and different combinations
of two, three and four medications. Resistance to single drug,
two drugs, three drugs and four drugs was signiﬁcantly
increased in group III in comparison to group II and I, also
signiﬁcantly increase in group II when compared to group I. We
observed a high rate of primary resistance to INH and STM in
group I and II and a high rate of MDR (INH and RIF resistance)
in groups II and III. The duration of bacilli exposure to anti-
tuberculosis agents in the past is a major factor in developing
resistance. In contrast to WHO’s guideline, due to high rate of
primary resistance especially to STM in our area, we don’t
recommend addition of STM for treatment of patients whose
initial four-drug regimens have been failed (group II).
P575
Evaluation of the BacT/ALERT 3D system for
susceptibility testing of Mycobacterium kansasii
to ﬁrst-line drugs: comparison with the
radiometric BACTEC 460TB system
E. Carden˜osa, F. Alcaide, B. Ferrer, R. Martı´n (Barcelona, E)
Objective: M. kansasii is one of the most frequent and patho-
genic nontuberculous mycobacteria isolated from human
beings. There is evidence that the in vitro susceptibility of
M. kansasii, based on the same interpretative criteria used with
M. tuberculosis, correlates adequately with clinical response. The
aim of this study was to evaluate the fully automated BacT/
ALERT 3D system for susceptibility testing of M. kansasii to four
major antimycobacterial drugs and to compare the results to
those obtained by the radiometric BACTEC 460TB system.
Methods: A total of 32 clinical isolates of M. kansasii (one per
patient) were tested for antimicrobial susceptibility by BacT/
ALERT 3D, and by BACTEC 460 as reference method.
M. kansasii ATCC 12478 and S. aureus ATCC 29213 were also
processed as quality control. Four antimycobacterial drugs were
studied at different critical concentrations: isoniazid (0.4, 1, and
5 mg/L), rifampicin (1 mg/L), streptomycin (1 mg/L with
BacT/ALERT 3D and 2 mg/L with BACTEC 460) and etham-
butol (5 mg/L).
Results: All isolates were identiﬁed as M. kansasii genotype I.
The data obtained with BACTEC 460 were as follows: 32
resistant to isoniazid at a concentration of 0.4 mg/L, 15 resistant
to isoniazid at a concentration of 1 mg/L, 3 resistant to isoniazid
at a concentration of 5 mg/L, 2 resistant to rifampicin and 2
resistant to ethambutol. The overall agreement between the two
systems was 76.6%. Forty-ﬁve discrepancies were detected: 2
major (false-resistant) errors (ME) for streptomycin, 25 very
major (false-susceptible) errors (VME) for isoniazid 0.4 mg/L, 12
VME and 1 ME for isoniazid 1 mg/L, 1 VME for isoniazid
5 mg/L, 1 VME and 1 ME for rifampicin and 2 VME for
ethambutol. When isolates with discordant results were tested
again, the overall agreement between the two systems was
78.1% and forty-two discrepancies were observed: 25 VME for
isoniazid 0.4 mg/L, 12 VME for isoniazid 1 mg/L, 1 VME for
isoniazid 5 mg/L, 1 VME and 1 ME for rifampicin, and 2 VME
for ethambutol. The contamination rate for BacT/ALERT 3D
was 0.5%, and results were obtained within an average rate of
6.4 days (range: 4 to 10 days).
Conclusions: A poor correlation between BacT/ALERT 3D and
BACTEC 460 for susceptibility testing of M. kansasii was
observed, specially, with the lower concentrations of isoniazid
studied. Therefore, the current protocol for susceptibility testing
of M. tuberculosis by the BacT/ALERT 3D seems not to be useful
for M. kansasii.
P576
NKT cells in the peripheral blood of patients
with active and inactive pulmonary tuberculosis
I. Celik, F. Ilhan, H. Akbulut, F. Deveci, T. Turgut (Elazig, TR)
Objectives: Cell mediated immunity is critical in Mycobacterium
tuberculosis infection. NKT cells are important in viral and
intracellular infection. In this study, it was aimed to investigate
whether a difference of NKT cells ratio between active and
inactive tuberculosis patient.
Methods: Forty-nine active and 13 inactive pulmonary tuber-
culosis patients and 20 healthy individuals, having no disease
and at the similar age range (35.76 ± 15.8, 43.23 ± 20.5 and
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38.20 ± 17.61 yrs, respectively) were included in the study.
Twenty-ﬁve of all active patients at pre-treatment period, 18 of
them were in 2nd month and six patients of them were at 6th
month of the treatment period. Two ml venous blood samples
were drawn from all patients and healthy subjects for studying
NKT cells. Total T cells and NKT cells [CD3+, and CD3+/
CD(16+56)+] were established from EDTA blood. The blood
cells were analysed by Coulter EPICS XL-MCL (Beckman
Coulter U.S.A.) ﬂow cytometry equipment.
Results: Percentages of total T cells were not different between
active and inactive pulmonary tuberculosis cases, but they were
signiﬁcantly lower than in controls (64.9 ± 9.6, 65.2 ± 5.4,
73.2 ± 7.1, respectively, p = 0.001 for active, p = 0.003 for inac-
tive patients compared with controls). NKT cells percentages
were not different statistically between active and inactive
patients. In addition, NKT percentages in active and inactive
patients did not differ statistically then healthy subjects
(5.25 ± 3.93, 5.11 ± 2.48, 5.91 ± 6.09 respectively).
Conclusion: Many studies showed NKT cells can play an
important role for protection from M. tuberculosis infections but
in this study, we could not ﬁnd any difference for NKT cells
among active, inactive tuberculosis and healthy controls.
P577
Investigation of T cell receptors in the peripheral
blood of patients with active pulmonary
tuberculosis
H. Akbulut, F. Deveci, I. Celik, T. Turgut, F. Ilhan (Elazig, TR)
Objectives: Human immune responses to M. tuberculosis are
characterized by activation of multiple T cell subsets including
CD4+, CD8+, and gamma-delta T cells, and the role of alpha-beta
TCR+ T cells in this response is poorly understood. In this study,
it was aimed to compare gamma/delta (gd) and alpha/beta T
cell receptors (ab TCR) at active and inactive period of patients
diagnosed as tuberculosis.
Methods: Forty-nine active and 13 inactive pulmonary tuber-
culosis patients and 20 healthy individuals, havingnodisease and
at the similar age range (35.76 ± 15.8, 43.23 ± 20.5 and 38.20 ±
17.61 yrs, respectively) were evaluated in the study. Gamma-
delta TCRandalpha-betaTCRpercentageswere analysedbyﬂow
cytometry (EPICS XL-MCL; Beckman Coulter U.S.A.). Active
tuberculosis patients were divided into three groups according to
the treatment and X-ray ﬁndings. So, the results were analysed in
the context of antituberculous treatment stages andX-rayﬁndings
in patients with active pulmonary tuberculosis.
Results: Percentages of CD3+ cells and CD3+/alpha-betaTCR+
were signiﬁcantly lower in both active and inactive pulmonary
tuberculosis than in healthy subjects. Percentages of CD3+/
gdTCR+ and CD3+/abTCR+ were not different statistically
between active and inactive patients of pulmonary tuberculosis.
In addition, CD3+/gdTCR+percentages in active and inactive
patients did not differ statistically than in healthy subjects
(Table).CD3+, CD3+/abTCR+, CD3+/gdTCR+ percentages did
not show difference at the different time of the antituberculous
regimen and X-ray ﬁndings of the three different groups of
active tuberculosis patients.
Conclusion: Recent studies have established that besides CD4+
abTCR+ cells, both CD8+ abTCR+ cells and gdTCR T cells have
a role in the cellular immune response to mycobacteria. On the
contrary, it was found no difference between active and
inactive pulmonary tuberculosis and healthy subjects in terms
of gdTCR T cells but abTCR T cells were lower at patients then
in healthy subjects in this study. It was concluded that abTCR+
T cells might have a protective role for tuberculosis infec-
tion.Table: Alpha-betaTCR, gamma-deltaTCR and CD3+ cell
percentages (means of % ±SD) among active pulmonary
tuberculosis (PT), inactive pulmonary tuberculosis and healthy
subjects.
P578
MB/BacT system and E-test versus standard
methods for drug susceptibility testing of
Mycobacterium tuberculosis
E. Demertzi, S. Smilakou, D. Fourkas, E. Tabouratzi, S. Nikolaou,
S. Anagnostou, A. Avlamis (Athens, GR)
Objectives: To evaluate the reliability of MB/BacT system
(Organon Teknika, USA) and E-test (AB BIODISK, Sweden)
for drug susceptibility testing (DST) of Mycobacterium tubercu-
losis (MTB).
Methods: Susceptibility testing for Isoniazide (INH), Strepto-
mycin (SM), Rifampin (RMP) and Ethambutol (ETB) using the
MB/BacT system was performed on 63 MTB strains isolated
from clinical specimens since 2000 in our laboratory. According
to the protocol used, ﬁnal drug concentrations were the
following: INH 0.1 lg/ml, SM 1 lg/ml, RMP 1 lg/ml, ETB
5 lg/ml. 20 strains of them, isolated last year, were also tested
by E-test. The inoculum turbidity was adjusted to McFarland 3.0
standard and Middle brook 7H11 agar plates were inoculated
and preincubated (37C, 7–10% CO2) for 24 h after which time,
the E-test strips were placed. MICs were easily read within 5 to
10 days of incubation. All the isolates were sent for conﬁrmation
to the National Mycobacterium Reference Laboratory where the
proportion method on L-J media was used.
Results: 48 out of 63 isolates were susceptible to all drugs tested
according to the reference method. 43 of these strains were also
detected as susceptible to the four drugs by MB/BacT system.
There were only 2 multi-resistant isolated strains. Full agree-
ment of DST between MB/BacT system and L-J media was
attained in 241/252 individual tests (95.6%) from 56/63 isolates
(88.9%). The sensitivity was 90%, 100%, 87.5% and 87.5% for the
detection of resistance to INH, SM, RMP and ETB respectively,
while speciﬁcity was 96.2%, 94.4%, 98.2% and 96.4%. There was
full agreement (100%) between E-test and the reference method
for all the 20 strains tested, while the discrepancy with the MB/
BacT system was 94%.
Conclusions: MB/BacT system is fully automated and it seems
to perform quite well in comparison to the media proportion
method. E-test was found to be rapid, accurate and reliable but
not so easy to perform. Both methods need further evaluation.
P579
Molecular characterisation of isoniazid and/or
rifampicin-resistant Mycobacterium tuberculosis
clinical strains isolated in Spain
L. Herrera-Leon, T. Molina Moreno, P. Saiz Vega, A. Valverde,
M.S. Jimenez Pajares (Majadahonda, E)
Isoniazid (INH) and rifampicin (RIF) represent the backbone of
short-course chemotherapy for Mycobacterium tuberculosis infec-
tion. Multidrug-resistant strains of M. tuberculosis (MDR-TB)
Active PT
(n = 49)
Inactive PT
(n = 13)
Healthy subjects
(n = 20)
Total Lymphocytes 24.86 ± 11.02 37.79 ± 7.23 30.13 ± 7.65
CD3+/ab TCR+ 58.49 ± 9.84a 59.02 ± 5.01d 67.73 ± 7.26a,d
CD3+/gd TCR+ 5.12 ± 2.71 5.18 ± 2.74 5.25 ± 1.45
T Cells 64.89 ± 9.59b 65.19 ± 5.45c 73.24 ± 7.14b,c
ap ¼ 0.001; bp ¼ 0.001; cp ¼ 0.003; dp ¼ 0.001
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deﬁned as resistant to INH and RIF have been increasing over
the years. Resistance to RIF has been shown to be caused by an
alteration of the B-subunit of RNA polymerase, encoded by the
rpoB gene. More than 95% of RIF-resistant strains are associated
with speciﬁc mutations, insertions and deletions in 81-bp region
of this gene termed the rifampicin-resistance determining region
(RRDR) and these mutations have been reported by several
authors in several countries. In contrast, resistance to INH is
more complicated as mutations in a different number of genes
can lead to drug resistance. In most INH resistant strains,
mutations have been found in the katG gene and the promoter
region of the mabA-inhA regulon. The molecular mechanism of
resistance is unknown in the 10–20% INH-resistant strains. In
this study, the objective was to characterize mutations in the
rpoB and katG genes just as in the mabA-inhA regulon of RIF
and INH Spanish resistant strains. We analysed a total of 278
RIF-resistant and 413 INH-resistant isolates (233 MDR). The
resistance to RIF was determined by automated DNA sequen-
cing whilst the resistance to isoniazid was determinated by
multiplex-PCR and DNA sequencing. The analysis revealed that
266 (96%) of the RIF-resistant had any mutation in the RRDR.
The codons most frequently involved in mutations were the
codon 531 (52%), the codon 526 (26%) and the codon 516 (11%).
Other codons involved in resistance to rifampicin were 511, 513,
522, 530 and 533. All of them showed point mutations. We
detected deletions of the codon 514, 515 and 519 and insertions
between the codon 512 and 513. The change of codon 531 (TCG
to TTG) was found with highest frequency (47%), the second in
frequency was the mutation of codon 526 (CAC to
TAC)(10%)followed by the mutation of codon 516 (GAC to
GTC) (9%). The prevalence of katG315 AGC > ACC allele and
inhAC-15T mutation is 48% and 23% respectively whist others
mutations in the 315 codon are found in 5% of the isoniazid
resistant strains. The 2% of the INH-resistant strains had
mutations in both genes. In 22% of the INH-resistant strains
the mechanism of resistance was unknown. The frequency of the
different changes was similar to other studies both the rifampi-
cin resistance and the isoniazid resistance.
Brucella
P580
Human brucellosis in Crete, Greece
D. Kofteridis, G. Milaki, D. Alegakis, E. Mazokopakis,
E. Christias, G. Samonis (Heraklion Crete, Athens, GR)
Background: Brucellosis is a zoonosis with a worldwide distri-
bution and may present with a variety of clinical manifestations
and complications. The aim of this study was to investigate the
epidemiological and clinical features, the complications and the
laboratory ﬁndings of brucellosis in adult patients during a
4-year period.
Methods: The medical records of 37 patients with brucellosis,
hospitalized between 1998 and 2001 were retrospectively
reviewed. The diagnosis was based on clinical symptoms,
cultures and serological tests. Hepatitis was deﬁned as elevated
liver transaminase enzymes 2 times over the upper normal value.
Results: The mean age of the patients was 41 (median 33, range
15–79). Twenty-nine (78%) were males. Occupational exposure
was mentioned by 54% while 64% had consumed unpasteurized
diary products. The most frequent symptom was fever,
observed in 34 (94%) with median duration 17 days (range
4–60). Other symptoms were sweating (66%), backache (45%),
and malaise (18%). Focal disease was present in 16 patients
(43%). The most common sites were spondilitis (24%) and
sacroilitis (19%), epididymoorchitis (5%), erythema nodosum
(5%) and meningitis (3%). Hepatitis was found in 6 patients
(16%). The mean CRP value was 2.3 + 1.3 mg/dL. Leucopenia
and thrombocytopenia were observed in 2 patients. Blood
cultures were positive for brucella spp. in 74%. The organism
was isolated from the cerebrospinal ﬂuid in one patient (3%). All
patients received combination treatment. Doxycycline and
rifampin was the most common regimen (19 patients; 51%).
Relapse occurred in 3 patients with osteoarticular disease who
responded to second line therapy.
Conclusion: Brucellosis is endemic in Crete and presents
mainly with fever, osteoarticular involvement and hepatitis.
The outcome was favorable in most of the patients. Relapse was
rare.
P581
Brucellar spondylitis: review of 24 cases and
compared to inpatients without spondylitis
A. Kalkan, M. Ozden, K. Demirdag, P. Yuce, S. Kilic (Elazig, TR)
Objective: Brucellosis has a worldwide distribution but in the
Mediterranean and Middle East countries it is still a major
public health problem. The frequency of osteoarticular involve-
ment of brucellosis is high and the most prevalent manifestation
is spondylitis. This study was carried out to describe the clinical
and laboratory evaluations, treatment combinations of 24
patients with brucellar spondylitis and compared with those of
patients with nonspondylitic brucellosis.
Methods: A total of 125 cases of brucellosis were diagnosed and
followed up prospectively between January 2002 and August
2003.
Results: Of these patients with brucellosis, 24 (19.2) were
diagnosed with spondylitis. In spondylitis patients, one had
servical involvement, two had thoracic, 20 had lumbosacral and
one had multiple involvement seen in MRI. Nine patients
(%37.5) had paravertebral abscess. Back pain (%100), fever and
sweating (%91.7), and arthralgia (%72.5) were the most common
symptoms for patients with spondylitis. The duration of
antimicrobial combination therapy for cases with spondylitis
was 60–365 days (median 156 day). Three of these patients
underwent surgical abscess drainage. Neurologic sequelae was
observed one of patients with spondylitis. No relapse was
observed in spondylitis patients. Patients with spondylitis were
more likely to have longer durations of symptoms (p < 0.05).
Cultures of blood specimens from 11 (%45.8) of patients with
spondylitis were positive Brucella spp. Erythrocyte sedimenta-
tion rates (ESR) and age were higher than those of patients with
brucellosis who did not have spondylitis (p < 0.05). Serum
transaminase levels were higher in nonspondylitis group than
spondylitis group (p < 0.05).
Conclusion: Our study has shown that brucellar spondylitis
affects predominantly the lumbosacral spine. Older age and
duration of symptoms before therapy are risk factors for
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brucellar spondylitis. Antibiotic treatment should be administered
for a long period in patients with brucellar spondylitis than in
systemic brucellosis without spondylitis.
P582
Human brucellosis on a Mediterranean island:
Crete, Greece
A. Christidou, A. Turkmani, E. Stylianoydaki, V. Kafarakis,
Y. Tselentis (Heraklion, GR)
Objective: Brucellosis is endemic in Mediterranean area. We
investigated the epidemiological characteristics of human bru-
cellosis in the island of Crete.
Methods: All cases of human brucellosis diagnosed from
January 1999 to October 2004 were included in this study.
Age, sex, animal contact, annual and monthly distribution,
phase and type of infection as well as the diagnostic methods
were studied.
Results: During this period, 67 (51 males) patients with brucel-
losis were detected. Mean age was 41.1 and the range was
8–80 years. Among them 50 were occupationally infected
(shepherds or goatherds, slaughters, laboratory technicians), 3
were visitors in the island, and 7 were children. Six of the
children lived in villages and their parents were farm-workers.
Regarding annual and monthly distribution, the higher inci-
dence was detected in 2000, and about half of the cases (31)
occurred during the spring months. Most patients (46) were
undergoing the acute phase of the disease, 11 the subacute, 3 the
chronic, and 7 were in relapse. About half of the patients (33/67)
presented a focal disease: bone-joins, 19; epididymo-orchitis, 10;
neurobrucellosis, 2; and chronic enteric disease, 2. Hepato-
splenomegaly was found in 2 patients, nodular erythema in 1,
and thrombocytopenia also in 1 patient. In 29 cases the diagnosis
was based on serological tests in association with clinical signs
and symptoms. A successful culture for brucella conﬁrmed the
diagnosis in 38 patients. Brucella was isolated from blood in 28
patients, from bone marrow in 2, from bone-joins in 2, from CSF
in1, from both blood and bone marrow in 3 patients, and from
both blood and bone-joins in 2. Unfortunately, in 13 cases no
samples for culture were obtained. Subsequently the sensitivity
of the culture was at 70%. All cultures were performed by BacT/
Alert blood culture system. Time to determination ranged from
43.2 h to 84 h with a mean value of 61.6 h. All isolates were
identiﬁed as B. melitensis.
Conclusion: Brucellosis remains a health problem in our region
mainly as an occupational disease caused by B. melitensis
exhibiting increasing during spring. Blood culture is a useful
tool in the diagnosis of human brucellosis.
P583
Human brucellosis in Northern Greece
E. Vasileiadou, F. Papalexi, A. Kalogirou, D. Chrysagis,
F. Kamaria, D. Kolokotroni (Thessaloniki, GR)
Objectives–Aims: To present the clinical and epidemiological
aspects of the disease at a specialized hospital, where most cases
of human brucellosis in Northern Greece are referred.
Material–Methods: 67 adult cases (43 men and 24 women,
mean age 45.1 {range 14–78} yrs-old) were analysed retrospec-
tively, admitted between 2000 and 2003. All of them were
hospitalized at ﬁrst, and had a follow-up period from 1 to 43
(range 15.9) months afterwards. Diagnosis was based on clinical
symptoms and conﬁrmed by serology and/or positive blood
cultures.
Results: Fifty two (77.6%) patients had acute, 7 (10.4%) sub-
acute and 8 (11.9%) chronic brucellosis. Forty one (61.2%) had an
occupational association with animals, 37 (55.2%) mentioned
consumption of diary products, since 30 (44.8%) had not evident
afﬁnity with animals or their products. All but two (97%) lived
or worked in rural areas. Fifty three (79.1) presented with typical
and 14 (20.9%) with atypical symptoms. Thirteen (19.4%)
suffered from serious complications, {5 (7.5%) from neurobru-
cellosis, 2 (3%) from endocarditis, 2 (3%) from spondylitis, 2
(3%) from orcheoepididymitis, 2 (3%) from compression}. Blood
cultures were positive at 35 (52.2%) cases (Brucella melitensis). A
combination of 3 antibiotics (an aminoglucoside plus doxycy-
cline plus rifampin/cotrimoxazol/quinolone) was administered
to all patients from the beginning, followed by a combination of
2 or 3 antibiotics (after the withdrawal of the aminoglucoside).
Mean duration of treatment was 11.5 (range 4–20) weeks in
uncomplicated cases. Relapses were observed in 12 (17.9%)
cases. Final, higher than 1/160 titre (range 1/320–1/800) of
standard tube Brucella agglutination test (SAT), was observed in
15 (22.4%) treated cases, after the follow-up period. No patient
had a fatal outcome.
Conclusions: Human brucellosis still remains a considerable
problem in Northern Greece. Atypical symptoms and serious
complications are not rare in endemic areas. Initial administra-
tion of a combination of more than 2 antibiotics in all cases and
duration of treatment longer than 8 weeks may reduce the
morbidity and mortality rate. High SAT ﬁnal levels don’t rule
out the successful management of the disease.
P584
Cytokine levels in patients with brucellosis and
their relations with the treatment
H. Akbulut, M. Ozden, I. Celik, A. Akbulut (Elazig, TR)
Objectives: Cytokines appear to have an important role in the
pathogenesis and outcome of brucellosis, and the Th1/Th2
balance may be involved in the susceptibility or resistance to the
disease. In vitro experiments demonstrated B. abortus induces
human and murine monocytes to secrete proinﬂammatory
cytokines such as TNF-alpha and IL-1 beta. The aim of this
study was to determine the serum levels of proinﬂammatory
and some Th1/Th2 cytokines in brucellosis and those alterations
with treatment and outcome.
Methods: This study was conducted in 28 acute and 7 subacute
brucellosis patients who had positive clinical ﬁndings, brucella
standard tube agglutination tests and/or positive blood culture
and 20 healthy volunteers who had any complaints. Eighteen
(51.4%) Brucella species were isolated in the blood cultures. All
patients were treated with combination of doxycycline or
tetracycline with one of the rifampin or streptomycin for
6 weeks. Cytokine levels of pre and post-treatment period
serum samples were measured by ELISA method according to
the protocol of the manufacturer.
Results: It was found that mean serum levels of IL-6, IFN-
gamma and TNF-alpha (mean ± SEM, 15.7 ± 2.7 pg/ml,
12.9 ± 2.9 pg/ml, and 53.3 ± 10.1 pg/ml, respectively) were
signiﬁcantly higher in acute brucellosis compared to the control
group (mean ± SEM, 1.1 ± 0.8 pg/ml, 6.9 ± 1.3 pg/ml, and
8.4 ± 1.2 pg/ml, respectively) (p < 0.05). Whereas, no signiﬁcant
differences were found between patient and control groups in
terms of IL-1beta, TGF-beta, IL-2, IL-4 and IL-8 levels. There was
a positive correlation between IFN-gamma, TNF-alpha and IL-6
levels with CRP levels. IL-6, IFN-gamma and TNF-alpha levels
measured after treatment were statistically signiﬁcantly lower
than pretreatment values (p < 0.001). No differences were found
in the levels of these cytokines between acute and subacute
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patients with brucellosis. Cytokine levels at patients with
positive blood cultures did not show statistically signiﬁcant
differences than the ones with negative.
Conclusion: It was concluded that IL-6, IFN-gamma and TNF-
alpha levels were higher in patients with brucellosis that is acute
or subacute. It was determined that the levels of these of
cytokines were decreased signiﬁcantly with effective and
adequate treatment. However, it was observed that these
increases did not correlate with the extent or activity of the
disease.
P585
Liver injury at brucellosis acuta
D. Galovska, D. Galovski, B. Sukarovska, E. Dimitrovska,
E. Pop Andonova (Bitola, MK)
Objectives: To present the frequency of liver injury among the
patients with brucellosis acuta one department.
Material and methods: 517 patients (33.7% female, 66.3% male)
were admitted to one hospital under diagnose of brucellosis
acuta. Among them 153 (29.6%) were afﬂicted by liver disease in
anamnestic sile. Patients were treated with concomitant antibi-
otic therapy associated with hepatoprotective therapy. We used
standard laboratory and biochemistry analysis, serological
investigations, ultrasonography and liver scanning.
Results: Liver injury comprised 153 (29.6%) of total cases with
brucellosis acuta. Slight hepotemegaly with hypodensity was
observed at 41/153 (27.3%) patients. Rise activity of amino-
transfer enzyme (about two times large) was found at 105/153
(68.7%) which has normalized for 3 weeks. Three times and
higher serum transaminase was found at 43/153 (28.3%), value
than retain 4–5 weeks. In 147/153 (93.3%) patients obvious
serum transaminase activity and liver ultrasonography
improvement were noted to the end of antibiotic therapy.
Conclusion: Liver injury is the part of immunopathology
mechanisms of brucellosis. Liver injury is not so rare in our
material (29.6%) and it is lightly and transitory. Liver injury is
not tightly related with severity of clinical signs. Also it is not
related with high levels of serologic values.
P586
Utility of Brucellacapt in the follow-up of
patients with acute brucellosis
A. Orduna, M.A. Mantecon, M.P. Zarzosa, B. Sanchez Borge,
M.P. Gutierrez, M.A. Bratos, A. Rodriguez Torres (Valladolid, E)
Objectives: The aim of these study is to know the utility of a
new serological test (immunecapture-agglutination test (Brucel-
lacapt@)) in the follow up of patients with acute Brucellosis. We
compare the evolution curves of the titres of the brucellosis
patients with clinical antecedents of previous brucellosis and
without these antecedents.
Methods: It has been studied that 258 sera from 51 patients with
acute brucellosis. From these 22 patients presented antecedents
of previous brucellosis at least 12 months before of the new
brucellosis process and 29 patients did not. The diagnosis of
brucellosis was based on CDC criterions. We consider acute
brucellosis when the patients did not have any brucellosis
symptom after 3 months of the beginning of speciﬁc treatment.
Sera were taken at the moment of ﬁrst clinical consultation
(baseline sera (BS)) and in the 2nd, 4th, 6th, 8th and 10th month
after have begun treatment (evolutive sera). All sera were tested
by agglutination test tube (SAW), Coombs test anti-Brucella, and
Brucellacapt@.
Results: The evolution curves of SAW, Coombs test and
Brucellacapt were very similar. From the 1st month till the 6th
month after the speciﬁc treatment was began, the titres were
decreasing in the patients with antecedents of previous brucel-
losis till 60% of the titres obtained by the baseline sera in all
techniques studied. In the patients with antecedents of previous
brucellosis the titres of the sera from the 2nd till the 10th month
were very similar to the titres of the baseline sera. The titres
from the patients with and without antecedents of previous
brucellosis presented statistical differences from the 2nd till the
10th month of evolution (SAW BS p = 0.35; 2nd month
p = 0.038; 6th month p = 0.03, 8th month p = 0.025) (Coombs
test BS p = 0.42; 2nd month p < 0.001; 4th month p = 0.042; 10th
month p = 0.028) (Brucellacapt@ BS p = 0.15; 2nd month
p = 0.004; 4th month p = 0.042; 6th month p = 0.004).
Conclusions: The patients with acute brucellosis and with
antecedents of previous brucellosis present titres statistically
higher than patients without antecedents between 2nd month
and the 10th month of evolution.
P587
Native and prosthetic valve endocarditis caused
by Brucella Spp.: evaluation of eight cases
F. Kocak, S. Simsek Yavuz (Istanbul, TR)
Objectives: Brucellosis and its complications are still a problem
in developing countries. Eight cases of infective endocarditis
caused by Brucella spp. were reported.
Material and methods: All cases of infective endocarditis were
recorded in previously prepared forms prospectively between
January 2000 and January 2004 by one of the authors. Duke
Criteria were used for the diagnosis of infective endocarditis.
BACTEC 9240 Becton Dickinson blood culture system were used
for the incubation of blood bottles. Identiﬁcation of microorgan-
ismsweredonewith classicalmethods andanti serawereused for
Brucella melitensis (Murex Biotech Lmtd. UK, Lot No: CM02).
Results: A total of 88 cases with infective endocarditis were
recorded and 8 of these (9%) patients were identiﬁed as having
endocarditis caused by Brucella spp. Six patients were male and
two were female. Median age was 44 (range) and median time
from the beginning of complaints to the admittance to the
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hospital was 17 days (range 5–60 days). Underlying heart
diseases were prosthetic valve in 5 patients and native valve
sequel secondary to acute rheumatic fever in 3. Splenomegali
and hepatomegali were found in 6 patients. Osler node and
janeway lesion were found in only one patient. Romatoid factor
were found to be positive in 3 patients. All of the patients had
positive results of Wright agglutination with titres greater than
1/1280. Brucella melitensis were isolated in blood cultures of 6
patients. Vegetation, abscess, corda rupture and new dehiscence
of prosthetic valve have been seen either TEE or TTE in 8, 5, 1
and 1 of 8 patients respectively. Although TTE were found to be
normal, TEE revealed vegetation in 4 (3 prosthetic, one native
valve) of 8 patients. Diagnosis of infective endocarditis was
deﬁnite in all of the cases. All of the patients were treated with
trimetoprim–sulfametaxazole, rifampicin and doxycyclin com-
bination for 12 months. Surgical intervention was done for 7
patients within a median of 18 days (range 7–45). All of the
patients were alive after 12 months of follow up.
Conclusions: Brucella spp. should be considered in patients
with infective endocarditis, especially in countries where the
disease still endemic. TEE should be done in case of normal TTE
ﬁndings. Early surgical intervention can reduce mortality.
P588
Laboratory diagnostics of Brucella infection – risk
of laboratory infection
M. Steinbakk, N. Evjen, T. Tjade, K.B. Hellum,
T.O. Jonassen (Lørenskog, N)
Objectives: Brucellosis is a rare disease inNorway. Brucellosis is
caused by Brucella, a small, non-motile, Gram-negative aerobic
coccobacillus. The genus Brucella comprises the six species
B. melitensis, B. abortus, B. suis, B. ovis, B. neotomae and B. canis.
Even though Brucella is divided in different species based on host
speciﬁcity and biochemical characteristics, they may be regarded
as one species based on DNA sequence information. Here we
present a case of laboratory-acquired brucellosis.
Methods: Brucella is oxydase- and catalase-positive, and how
fast they become urease-positive is used as a phenotypic
criterion of differentiation. Brucella grows slowly in Bactec
aerobic blood culture medium, but more than 95% of the
positive cultures are positive in less than seven days. In
subculture Brucella grows on blood agar in less than two
days. When conventional methods are insufﬁcient for identiﬁ-
cation of a bacterium, sequencing of the 16S rDNA will give the
correct genus and often also the species.
Results: Case 1 is a 54-year-old man who was admitted to the
Department of Neurology after one day of acute lumbago ultimo
July 2003. Seven days later the patient in addition to severe back
pain got fever and was transferred to the Department of
Infectious Diseases. After three days small Gram-negative rods
grew out in aerobic blood cultures. Themicrobe was identiﬁed as
Brucella sp based on standard bacteriological techniques and
sequencing of 16S rDNA. The patient had not been abroad the
last two years, and had no known exposure to Brucella. Case 2 is
a 30-year-old woman who had worked with the blood culture
isolate from case 1. From January 10th 2004 she had undulating
fever, initially regarded as an inﬂuenza-like illness. She was
admitted to the Department of Infectious Diseases ultimo
January 2004 under the diagnosis: ‘Fever of unknown origin,
Brucella?’ Aerobic blood culture taken at the time of admission
was positive after three days of incubation, and also in this case
Brucella sp was identiﬁed. The patient had no other risk of
brucellosis than her work in the laboratory ﬁve months earlier.
Conclusions: During bacteriological identiﬁcation of the blood
culture isolate from case 1, parts of the identiﬁcation work
(catalase reaction) was done on open bench. After the identiﬁ-
cation of this isolate as Brucella, all bacteriological diagnostic
work that can produce infectious aerosol, are done in biological
safety cabinets.
P589
Trends in the epidemiology of brucellosis in
Northern Greece 1994–2003
F Kamaria, P. Iliadou, M. Sidiropoulou, D. Chrisagis,
E. Vasiliadou, D. Kolokotroni, A. Kansouzidou
(Thessaloniki, GR)
Objectives: In 1994, the vaccination control programme with
Rev-1 vaccine against Brucella melitensis infection in sheep and
goats, was discontinued in Greece. Soon, the incidence of
brucellosis in animals and humans increased. Thus, in 1998 an
emergency mass-vaccination programme for animals with the
same vaccine was resumed. The aim of this study is to present
and analyse the cases of brucellosis attended to the adult
Department of Thessaloniki Infectious Diseases Hospital during
1994–2003. Our hospital attends patients from all Northern
Greece.
Methods: We reviewed retrospectively the brucellosis unit
archives of our Department and found the patients attended
as outpatients during this period, including the hospitalized
ones after their dismissal. Sex, age, year of ﬁrst diagnosis, mode
of infection and outcome of disease were included in the study.
Results: 947 patients were identiﬁed, 684 males, 263 females,
from 14 to 83 years old, mean age (x ± SD) 43 ± 16 years.
Between 1994–1998, 258 cases were identiﬁed, 27% of the sum
of study patients. Between 1998–2000 there was an increase in the
number of cases, 411 cases, 43% of the sum. The increase was
signiﬁcant (p < 0.001). Between 2001–2003 a decrease in the
number of cases was observed, 277 cases, 30% of the sum,
p < 0.001. The possible source of infection was identiﬁed in 660
cases. 499 patients (75%) had direct contact with animals (398
were farmers, 28 veterinarians and 73 had other occupational
exposure) and 161 (25%) patients had reported consumption of
unpasteurized dairy products. Concerning the complications, 112
patients (12%) had a focal or complicated illness. Osteoarticular
complicationswere themost frequent focal forms (50 patients had
spondylitis, 14 sacroiliitis and13 other formsof arthritis). 21males
(3% of all males) had orchiepididymitis. 10 patients (1%) had
neurobrucellosis and 4 (0.4%) patients had endocarditis.
Conclusion: A signiﬁcant increase of human brucellosis took
place in Greece from 1998 to 2000 due to the discontinuation of
animal vaccination. Once a new vaccination campaign had
started again, the incidence in humans decreased. Furthermore,
the main way of brucellosis transmission is occupational contact
and the most common type of complication is osteoarticular
P590
Pancytopenia in patients with Brucella melitensis
infection
A. Karakolios, T. Kallinikidis, F. Markou, G. Tsinopoulos,
G. Lazaridis, A. Garefas, M. Melikidis (Serres, GR)
We studied retrospectively the incidence of pancytopenia in
patients with Brucella melitensis infection in an endemic area of
Northern Greece. Nine out of 88 (10%) patients that were
diagnosed and treated at our Hospital over a period of 7 years
developed pancytopenia during the course of their disease.
Pancytopenia was mild in 7 patients and moderate/severe in 2
patients (Hb 7.4 g/dl, white cell count 1680/ll, neutrophils 900/
ll and platelets 48000/ll in the ﬁrst patient and Hb 8 g/dl,
Abstracts
162
white cell count 1800/ll neutrophils 1050/ll and platelets
51000/ll in the second patient. The majority of patients (51%)
developed mono- or bi-lineage cytopenias (41 and 10% respect-
ively). Anaemia was the commonest cytopenia (28 patients, i.e.,
32% of all patients), while leukopenia or thrombocytopenia
developed in 4% of patients. Concomitant anaemia and thromb-
ocytopenia were the commonest cytopenias (6%) in those
patients with bi-lineage cytopenias. The cytopenias were mild
in all cases except 3 patients in whom Hb was 7.3 g/dl, white
cell count 1180/ll (neutrophils 580/ll) and platelets 21000/ll.
In the vast majority of patients the cytopenias were not of
clinical signiﬁcance neither did they require speciﬁc treatment.
Blood counts promptly returned to normal upon commence-
ment of speciﬁc antibiotic treatment and response of the disease.
Conclusion: Pancytopenia is a relatively common complication
in patients with Brucellosis and it is usually mild and without
clinical signiﬁcance. However, it can cause diagnostic problems,
especially outside endemic areas.
P591
Sensorineural hearing loss in three cases with
neurobrucellosis
G. Sengoz, K.K. Yasar, D. Berzeg, F. Yildirim, S. Karabela,
S. Basturk, A. Sengoz (Istanbul, TR)
Objectives: Brucellosis is an endemic disease in our country. It
can be in acute, subacute or chronic form. Central nervous
system involvement (neurobrucellosis) in brucellosis is less than
5% of all cases. The most common complication is meningitis.
Methods and Results: In our study we evaluated three patients
whose main complaint were sensorineural hearing loss (SNHL)
among our neurobrucellosis (NB) patients. All of our patients
aged 39, 54 and 60 years old were males. Diagnosis of NB
depended on positive blood and cerebrospinal ﬂuid (CSF)
culture in the ﬁrst patient and by positive CSF culture in the 3rd
patient and by positive brucella agglutination titre in blood and
CSF and by positive Brucella IgG titre in CSF in the second
patient. In all of the cases the period between the beginning of
the complaints and the diagnosis exceeded 6 months. Involve-
ment of cranial nerves are rare complications reported as
sporadic cases in NB. In 2000’s among diagnostic criteria of
NB; ‘positive CSF culture for Brucella spp’ or ‘positive Brucella
IgG agglutination titre in CSF’ gained importance due to
isolation of responsible agent.
Conclusions: SNHL is a rare complication of NB which has not
attracted enough attention among known and reported mani-
festations May we suggest neurologists and otologists to be
aware of this evidence as much as we do? Because, necessity of a
multidisciplinary approach to diagnosis and therapy of NB is
inevitable.
Toxoplasmosis
P592
Genetic engineering of Toxoplasma gondii P30
(SAG1) antigen for improved antibody detection
in immunoassays
G. Maine, C. Patel, T. Bliese, S. Ginsburg, J.-M. Pinon, D. Aubert,
Reto Stricker, Rene Stricker (Abbott Park, USA; Reims, F; Geneve,
CH)
Objectives: To improve the immunoreactivity of the recombin-
ant T. gondii P30 (SAG1) immunodominant antigen in serologic
tests for the detection of human anti-Toxoplasma (Toxo) IgG
and IgM antibodies.
Methods: The immunodominant T. gondii P30 (SAG1) antigen
was expressed and puriﬁed from E. coli as a soluble fusion
protein to the E. coli Maltose Binding Protein (MBP-P30). A
series of MBP-P30 deletion mutants were constructed and
evaluated in a Toxo IgG and IgM immunoassay. Based on
these data, we completed total gene synthesis of the P30 gene
with a mixture of mutant oligonucleotides designed to replace
the non-essential cysteine residues with alanine, removal of the
signal peptide, and removal of C-terminal residues to improve
antigen immunoreactivity.
Results: The MBP-P30(52–300aa)Ala5 recombinant antigen con-
tains deletion of the signal peptide, deletion of 36 amino acid
residues at the C-terminus of P30 including one cysteine residue,
and substitution of the ﬁve remaining C-terminal cysteine
residues in P30 with alanine. The immunoreactivity of this
antigen was improved 2–3 fold over MBP-P30. The performance
of the MBP-P30(52–300aa)Ala5 antigen was evaluated in a
recombinant antigen based Toxo IgG (in combination with the
T. gondii P35 antigen(GRA8)) and Toxo IgM immunoassay
(alone) by testing a pregnant women patient population and
comparing the results to a commercial Toxo IgG and IgM
immunoassay which employs tachyzoite-derived antigen for
antibody detection. The relative sensitivity and speciﬁcity of the
recombinant Toxo IgG assay was 100% and the relative
sensitivity and speciﬁcity of the recombinant Toxo IgM assay
was 97.2% and 95.1%, respectively.
Conclusion: The MBP-P30(52–300aa)Ala5 can replace the tach-
yzoite antigen in an immunoassay for the detection of human
anti-Toxo IgG and IgM antibodies.
P593
Avidity of toxoplasma speciﬁc immunoglobulin
G: results of a new Vidas test on 603 sera
H. Fricker-Hidalgo, C. Saddoux, A.-S. Suchel-Jambon,
S. Romand, A. Foussadier, H. Pelloux, P. Thulliez
(Grenoble, Marcy L’Etoile, Paris, F)
Objectives: A new version of the serological test Vidas Toxo
IgG IV has been recently developed with antigens obtained from
tachyzoı¨tes cultured on cells and not on mice. Avidity of
Toxoplasma-speciﬁc IgG antibodies has been shown to be an
important tool for discrimination between recent and distant
infection. The aim of this study was to assess the value of the
determination of avidity on the new Vidas test on 553 sera
obtained from pregnant women whose dates of seroconversion
were known, and on 50 sera obtained from immunocompro-
mised patients.
Methods: A total of 603 sera (563 patients) were tested by the
Vidas Toxo IgG IV Avidity test. The datation of the seroconver-
sion was determinated between the date of two samples, the ﬁrst
negative one and the second positive, or before the ﬁrst sample
(positive IgM and negative or weakly positive IgG followed by a
twofold or greater increase). The sera of pregnant women and
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immunocompromised patients with past infection (more than
15 months) showed weakly positive IgG antibodies and negat-
ive IgM. The Vidas Toxo IgG IV Avidity test was performed by
the Vidas instrument that automatically produces results and
their interpretation. The avidity test was performed on sera with
positive Vidas Toxo IgG IV result (>6 IU/ml).
Results: In cases of infection occurring less than 4 months
before sampling, the avidity index was <0.3 (low and border-
line) on 266 among 267 sera. The serum with high avidity was
sampled one month after the infection and it concerned a patient
for who the avidity index performed on another serum sampled
two months after the infection was low. In the group of infection
occurring more than 15 months before sampling, the avidity
index was high for 44/46 sera. The avidity results of sequential
sera of 13 patients (3 sera per pregnant women) showed that the
increase of avidity index was slow and the rate of increase was
variable for the different patients. The avidity threshold of 0.3
was reached between 4 and 15 months after infection for 551
sera among 553. The avidity indexes were high for the 47
patients with different types of immunocompromission and past
toxoplasmic infection.
Conclusion: The new version of avidity test was helpful
primarily to rule out that a patient’s infection occurred within
the prior 4 months. An appropriate decision on how patients
with low- or high-avidity test result should be managed must be
made using also results of other serologic methods.
P594
AF146527 as target gene for detection of
Toxoplasma gondii by LightCycler PCR
B. Edvinsson, M. Lappalainen, B. Evenga˚rd for the ESGT
Objective: Early detection of toxoplasmosis by PCR in the
transplanted immunocompromised host is important to improve
the outcome of this patient group. We compare sensitivity and
accuracy for detection of Toxoplasma gondii when targeting two
different repetitive genes, the 35-fold repetitive B1gene and the
200–300-fold repetitive AF146527 gene, using the LightCycler
instrument. Further, an AF146527 TaqMan assay was tested with
two different internal ampliﬁcation control systems to investigate
their impact on PCR performance.
Methods: DNA was quantiﬁed and quality controlled with the
NanoDrop ND-1000 Spectrophotometer. Sensitivity and accu-
racy of similar B1 and AF146527 LightCycler SYBR green assays
were compared using ten-fold serial dilutions of T. gondii DNA.
Performance of the AF146527 TaqMan assay was tested using
two different internal ampliﬁcation control systems. One of the
internal ampliﬁcation control systems tested was ampliﬁed by
the primers used for detection of the parasite and the other by a
different set of primers.
Results: LightCycler PCR is more sensitive when targeting the
more repeated AF146527 gene compared to a similar assay
targeting the less repeated B1 gene. Performance of the AF146527
TaqMan assay with internal ampliﬁcation control is similar to the
corresponding AF146527 SYBR green assay without internal
ampliﬁcation control. Performance is not affected by an internal
ampliﬁcation control ampliﬁed by the same primers as used for
detection of T. gondii compared to an internal ampliﬁcation
control ampliﬁed by a different set of primers.
Conclusions: For increased sensitivity and accuracy when
using LightCycler PCR, our results suggest that the AF146527
gene is a preferred PCR target for detection of T. gondii. This
200–300-fold gene allows the use of an internal ampliﬁcation
control without loss of performance. However, the conserved
nature of this newly described gene still remains to be further
conﬁrmed analysis of additional strains of T. gondii.
P595
Seroepidemiology of toxoplasmosis in female
population in Greece
I. Glynou, M. Simou, K. Avdeliodi, S. Tzortzatou,
H. Kada (Athens, GR)
Objectives: The study of Toxoplasma gondii immunological
status in female population of reproductive age in Greece as
toxoplasmosis is a common and important cause of congenital
disease.
Methods: 3016 women who attended the Outpatient Dpt of our
Hospital from January 2003 to November 2004 were tested for
Toxoplasma IgM and IgG antibodies. Of 3016 women 1208 were
immigrants (40.05%) and 1808 were Greek. The detection of
Toxo IgM and IgG antibodies was performed by MEIA method
(AxSYM, Abbott) in 1779 samples and ELFA method (VIDAS,
BioMerieux) in 1327 samples. To the last 1327 samples (577
immigrants, 750 Greek), avidity test was performed for the Toxo
IgM/ IgG positive sera. All Toxo IgM positive women were
tested again after three weeks.
Results: In the total of 3016 women the percentage of Toxo IgG
positive women was 25.40% and Toxo IgM positive was 2.22%.
The percentage of Toxo IgG positive immigrants was 45.11%
and Toxo IgM positive was 2.89%. The percentage of Toxo IgG
positive Greek women was 12.22% and Toxo IgM positive
1.76%. Out of 1327 samples tested by ELFA method 35 (2.63%)
were Toxo IgM positive: a) 3 samples gave Toxo IgG negative
result (8.57% of the Toxo IgM positive) and avidity test has not
been performed, second test after three weeks showed serocon-
version (Toxo IgG positive). b) 6 samples (avidity <0.300)
showed recent infection (17.15%), second test after three weeks
showed an increase in Toxo IgG, decrease in Toxo IgM and
avidity test >0.300. c) 26 samples (avidity >0.300) (74.28%) were
probably excluded from recent infection. In 24/26 samples were
no signiﬁcant changes after the second test. In 2/26 samples test
by molecular method was recommended because the IgM/IgG
changes could not be sufﬁciently evaluated.
Conclusions: The seroprevalence of Toxoplasma gondii IgG is
25.40% in female population in Greece (Toxo IgM positive
2.22%). Prevalence is considerably higher in immigrants
(45.11%) than in Greek women (12.22%). As 74.6% of tested
women were seronegative, antenatal control should be recom-
mended in order to avoid intrauterine infection with consequent
congenital disorders.
P596
Handling toxoplasmosis in pregnancy:
the Verona experience
L. a Beccara, G. Nicolini, E. Tonolli, M.C. Danzi,
E. Concia (Verona, Vicenza, I)
Background: Assessing seroprevalence of the infection from
Toxoplasma gondii is of pivotal importance to estimate the risk for
mothers of becoming infected with toxoplasmosis during
pregnancy. Informing non-immune women about which behav-
iours should be avoided in order not to get infected is therefore
important. Even more important is to devise early diagnosis
techniques in order to treat the mother and possibly the foetus
and to monitor the newborn in the case of an infection: avoiding
risk behaviours is sometimes not sufﬁcient to avoid the
infection.
Objective: The aim of this study was to estimate: i) the
prevalence of antibodies against Toxoplasma gondii in pregnant
women in Verona; ii) the incidence of primary infection during
pregnancy; iii) the prevalence of congenital toxoplasmosis. By
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means of procedure we wanted to test: i) the validity of the pre-
birth monthly screening in women susceptible to infection as a
function of seroprevalence; ii) the feasibility of an early diagno-
sis; iii) the validity of the diagnostic-therapeutic iter for women
with an acute infection.
Methods: Seroprevalence was prospectively analysed in 1801
pregnant women visited at the general hospital during 2001:
assays were performed to detect immunoglobulins IgG, IgM,
IgA and IgG avidity antibodies. In case of positive IgM a second
serum sample was requested and processed in parallel with the
ﬁrst one. Determination of IgG avidity antibodies allowed us to
deﬁne three stages of infection: acute, possible and past.
Congenital infection was determined prenatally by PCR in
amniotic ﬂuid and/or postnatally by serology and clinic of the
newborn in 27 acute infection cases screened between 1999 and
October 2004.
Results: Seroprevalence of toxoplasmic infection in pregnant
women in Verona was 17.5%. The incidence of primary infection
in pregnancy was 4.7/1000 susceptible pregnant women. All
women with serological evidence of toxoplasmosis during
pregnancy were given spiramicin to stop placental infection.
Transmission was 7.4%. No children showed clinical signs of
congenital toxoplasmosis.
Discussion: Our seroprevalence ﬁgures (17.5%) are very low
and justify the screening of all pregnant women. Monthly
screening of susceptible pregnant women has allowed us to
early recognise an occurred infection in the mother. This way we
could put in action prevention and therapy strategies against the
foetus infection, which occurred only in the 7.4% of the studied
cases.
P597
Immunoreactivity of predicted antigenic
determinants of Toxoplasma gondii ROP 4 protein
T. Ulanova, V. Puzyrev, N. Savel’eva, T. Volkova, L. Loginova,
A. Burkov, A. Obriadina (Nizhniy Novgorod, RUS)
Objectives: The purpose of this study was to determinate and
evaluate diagnostic relevance of antigenic epitopes encoded by
open reading frame for Toxoplasma gondii ROP 4 protein (Serine/
Threonine protein kinases, catalyticdomain).
Methods: Four potential antigenic epitopes of Toxoplasma gondii
ROP 4 protein have been predicted by bioinformatics analysis.
Recombinant genes encoded selected amino acids sequences
have been constructed from synthetic oligonucleotides by using
PCR reaction. Proteins were expressed in E. coli as hybrid
protein with Glutathione S-transferase. To study antigenic
property of new proteins 25 well deﬁned positive (N = 15)
and negative (N = 10) serum samples were tested. All serum
samples were previously tested by three commercially available
assays for the detection of IgG anti Toxoplasma gondii. In absence
of known IgM positive samples and high discordance between
commercially available assays for the IgM detection the 3rd
International Standard for ANTI-TOXOPLASMA SERUM,
HUMAN (TOXM, NIBSC, UK) was used. Also 200 serum
specimens from normal blood donors were tested.
Results: Predicted antigenic determinants were located at
position 30–159 aa, 447–467 aa, 491–505 aa and 548–558 aa.
Gene encoded amino acid sequences of ROP 4 protein at
position 30–145 aa (RH2) and artiﬁcial mosaic gene encoded
amino acid sequences at position 447–467 aa, 491–505 aa, 548–
558 (RH1) aa were synthesized. The pure samples of two
recombinant proteins were obtained. All proteins were weak
immunoreactive with IgG antibody of anti Toxoplasma gondii
positive serum samples. When TOXM was tested RH1 and RH2
were able to detect 1. 6 preliminary units of IgM anti-toxoplasma
antibodies. None of specimens from normal blood donors were
tested as IgM positive with new recombinant proteins. Anti-
genic epitopes located at 30–159 aa was found as most
immunoreactive for the speciﬁc IgM detection.
Conclusion: The results indicated that 4 antigenic epitopes
have been predicted of the ROP 4 protein of Toxoplasma gondii.
All proteins used in this study demonstrated a signiﬁcant
diagnostic potential as candidates for the development of
diagnostic assays for the detection of anti-Toxoplasma gondii
IgM activity in serum specimens.
Clinical mycology
P598
An outbreak of Pichia anomala fungaemia
A.C. Pasqualotto, T.C.T. Sukiennik, I.G. Rocha, L.R. Martins,
S.M. Colares, A.L. Colombo, L.C. Severo (Porto Alegre, Sa˜o Paulo,
BR)
Objectives: To report an outbreak of Pichia anomala fungaemia
(formerly Hansenula anomala the perfect state of Candida
pelicullosa).
Methods: Report of an outbreak of fungaemia caused by a rare
yeast. Clinical investigation was supported by a case-control
study and by molecular studies.
Results: In the period comprising October 2002 to November
2003, 16 cases of fungaemia due to P. anomala occurred in a pediatric
intensive care unit (ICU) at Porto Alegre, Brazil. We performed a
case-control study to determine the potential risk factors for
P. anomala fungaemia, deﬁning cases (n = 16) as those patients in
whom P. anomalawas isolated from at least one blood culture, in
association with signs and symptoms of sepsis. Controls (n = 48)
were randomized among all patients hospitalized for at least
2 days in pediatric ICU during the outbreak period. During
these studies, multiple environmental cultures were also
obtained, as well as hand cultures of all health care workers.
Weekly surveillance swabs (mouth, rectum, umbilicus, and
groin) were done in all children admitted to ICU. Compared to
controls, cases had higher duration of stay in intensive care
(mean 16.9 versus 9.3 days, p < 0.01), and more days of
mechanical ventilation (13.4 versus 5.8, p < 0.01); they also
used more H2 blockers (93.8% versus 56.3%, p < 0.01), central
venous catheters (93.8% versus 56.3%, p < 0.01), and antibiotics
(mean 4.2 for 19.2 days, versus 3.1 for 13.4 days, p < 0.05), and
they were more frequently submitted to neurosurgery (25.0%
versus 6.3%, p < 0.05). Mortality rate was higher in cases then in
controls (43.8% versus 6.3%, p < 0.01). At multivariate analysis,
however, only the presence of central venous catheter was
associated with P. anomala fungaemia (p = 0.009, OR 17.1, CI
2.0–145.7). Despite the high rate of yeast colonization among
pediatric patients during surveillance study (>80%), P. anomala
was not found in these patients, in health care workers or from
environmental. Molecular studies showed that only one strain of
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P. anomala was responsible for the outbreak, and the outbreak
was controlled after institution of oral nystatin prophylaxis and
improvement of care of central venous catheters.
Conclusion: In accordance to previous studies, we reinforce
that P. anomala can be exogenously acquired.
P599
Nosocomial candidemia in patients using
antifungals (breakthrough): comparison to
non-breakthrough episodes
A.C. Pasqualotto, W.L. Nedel, T.S. Machado, L.C. Severo (Porto
Alegre, BR)
Objectives: To describe all consecutive cases of breakthrough
candidemia (BT) that occurred in a large Brazilian hospital, and
to compare risk factors, etiology, and the outcome of the
infection among patients with breakthrough (BT) and non-BT
candidemia.
Methods: Retrospective cohort study (1995–2003). BT candide-
mia was deﬁned as the occurrence of candidemia in a patient
receiving at least 3 days of systemic antifungal therapy.
Results: During the period of study, 20 patients had BT
candidemia. Major underlying diseases were solid tumors
(25.0%) and hematological malignancies (15.0%), and 60.0%
were in use of amphotericin B. Species other than C. albicans
caused 75% of candidemias in BT patients, mainly C. parapsilosis.
Comparing to non-BT patients with candidemia (n = 171), BT
patients had more frequently mucositis, longer stay in the
intensive care unit, and longer periods of hyperalimentation,
mechanical ventilation, urinary catheters and large spectrum
antibiotics. Candida isolation from sites other than blood
occurred more frequently in BT patients (p = 0.028), as well as
the Candida isolation from central venous catheters (p = 0.057).
Mortality rate and Candida species distribution were similar
among groups.
Conclusions: Based on these observations, it seems that the
source of BT candidemia can be not only endogenous, but also
exogenous.
P600
Correlation between zinc level of serum and
recurrent vulvovaginal candidiasis
M. Zangeneh, S. Ravani, M. Jamshidi, S. Omidi (Tehran, IR)
Objective: Alteration in cell-mediated immunity have been
seen in some patients suffering from recurrent vulvovaginal
candidiasis. Zinc, an essential trace element has been shown to
inﬂuence several cell-mediated immunologic mechanisms. Most
people in Iran suffer from zinc deﬁciency. We want to determine
whether zinc deﬁciency in serum is a risk factor for recurrent
vulvovaginal candidiasis.
Method: This is a cross-sectional controlled study on 100
women who had experienced at least three documented epi-
sodes of vulvovaginal candidiasis within the previous
12 months. 25 women of 100 cases who did not have any
other risk factors for recurrent vulvovaginal cadidiasis were
selected as case group and 50 matched women without
recurrent vulvovaginal candidiasis as a control group. Blood
samples were drawn for measurement of plasma zinc level. Zinc
level of serum determined by Flame Atomic Absorption Spec-
trophotometry.
Results: We found no signiﬁcant difference in the mean zinc
concentration of plasma between patient and the control group
(P value = 0/09).
Conclusion: It is well known that zinc not only has a major
impact on different immune function, but also participates in
growth and morphogenesis of Candida Albicans. In spite of, in
Iran zinc deﬁciency is common, our results could not conﬁrm
the previous hypothesis that zinc deﬁciency of serum is a risk
factor for recurrent vulvovaginal candidiasis. Supported by
Azad Islamic University.
P601
Emerging issues of HIV-associated cryptococcosis
after versus before the availability of highly
active antiretroviral therapy: an analysis of 72
disease episodes
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
Objective: Aim of our investigation is to compare the frequency
and clinical and mycological features of AIDS-related primary
and relapsing cryptococcosis, before and after the introduction
of highly active antiretroviral therapy (HAART).
Patients and Methods: The 58 disease episodes occurred at our
reference centre of Bologna (Italy) were compared with the 14
cases occurred since the year 1997.
Results: An abnormal clinical presentation, disease localiza-
tion(s), and evolution (which may involve the so-called ‘immune
reconstitution syndrome’) have been noticed since the HAART
era (p < 0.001 to p0.04). An early negative culture search and
direct microscopy, observed with higher frequency during the
HAART era (p < 0.03), led to a more extensive resort to
polysaccharide antigen testing as the apparently most sensitive
diagnostic assay, although a late positivization (after > 1 week
of disease) became more common in patients undergoing
HAART. Although disease recognition may be delayed, the
reduced severity of concurrent immunodeﬁciency and the
availability of an enhanced spectrum of potent antifungal
drugs, led to a signiﬁcant drop of mortality and relapse rates
during the HAART time (p < 0.0001).
Discussion: An elevated clinical suspicion for HIV-associated
cryptococcosis should be maintained in the HAART era too, to
obtain an early diagnosis in immunocompromised patients, or
in subjects who are beneﬁting of a rapid HAART-driven
immune recovery. In fact, cryptococcosis may occur with a
proportionally increased frequency in absence of an evident
neurological involvement, and positive microscopy and culture.
The large-scale introduction of HAART is probably responsible
for a signiﬁcant clinical and laboratory pathomorphism of AIDS-
associated cryptococcosis, parelleling the remarkable reduction
of absolute morbidity of this typical opportunistic disease,
compared with the pre-HAART era. The different clinical and
laboratory presentation of this fungal disease just in the HAART
era recommends to maintain an elevated attention when facing
patients at risk for impaired immune defences, or under initial
HAART.
P602
A retrospective study of fungal infections in
patients with haematologic malignancies
E. Michalis, K. Chitiroglou, P. Arseni, I. Tsourveloudis,
H. Karabatsaki, A. Galanopoulos, T. Marinakis, A. Zomas,
N. Anagnostopoulos (Athens, GR)
Invasive Fungal Infections (IFI) represent a signiﬁcant problem
for patients with haematologic malignancies undergoing inten-
sive chemotherapy. The incidence and severity of IFI vary and
result from the interaction of the following risk factors: previous
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fungal infection, state of immunosuppression and organ dys-
function.
Objectives: In this retrospective study we estimated the inci-
dence of fungal infections and the toxicity of antifungal
treatment.
Patients and methods: 77 patients of median age 66 years
admitted in our department between November 2001 and June
2003. The median time of hospitalization was 30 days. They
were stratiﬁed in nine groups: Acute myelogenous leukae-
mia:40, acute lymphoblastic leukaemia:8, myelodyspoastic syn-
drome:7, multiple myeloma:4, myeloproliferative disease:3, non
Hodgkin lymphoma:11, chronic myelogenous leukaemia:1,
aplastic anemia:1, Hodgkin’s disease:1. A fungal infection was
determined as deﬁnite, if biologic ﬂuids cultures or a lesion
tissue biopsy were positive for fungi, as probable if imagine
technique ﬁndings were indicative for fungal infection and
possible if patients became afebrile after empirical antifungal
treatment. The period of neutropenia was approximately
15 days. The antifungal medication included liposomal amph-
otericin in 38/77, amphotericin B lipid complex (ABLC) in 29/
77, voriconazole in 1/77 and caspofugin in 2/77.
Results: 18/77(24%) had a deﬁnite, 17/77(22%) a probable and
42/77(54%) a possible fungal infection. Blood cultures were
positive for Candida species in 8/77(10%). Positive urine cultures
were eliminated in 3/77(4%), sputum cultures in 5/77(6.5%),
whereas one patient had positive CSF culture for cryptococcus.
Aspergillus spp. was eliminated from the pleural cavity of a
patient with empyema during neutropenia period. A 6.5% of
patients had both bacterial and fungal infection. Computerized
scanning ﬁndings were suspicious of fungal infection in 14/
77(18.2%). Side effects: ABLC caused fever, renal dysfunction
and decreased potassium serum level in 73%, whereas liposomal
amphotericin in 63%. The incidence of side effects was not
statistically different between the two amphotericin arms
(p = 0.36). The mortality was 68% and 42% on ABLC and
liposomal amphotericin group respectively (p = 0.039).
Conclusions: Toxicity was more severe on ABLC arm and
Candida species were the most frequent eliminated fungi. The
duration of neutropenia and immunodeﬁciency seemed to be
important risk factors for fungal infections.
P603
Bioﬁlm production and the genotypes of Candida
parapsilosis recovered from bloodstream and
non-bloodstream sources
J.H. Shin, J.W. Song, D.H. Shin, S.I. Jung, D. Cho, S.J. Kee,
M.G. Shin, S.P. Suh, D.W. Ryang (Gwangju, KOR)
Objectives: Bioﬁlm production has been implicated as a poten-
tial virulence factor in C. parapsilosis causing catheter-related
bloodstream infections. In addition, the epidemiology of
C. parapsilosis candidemia is still undeﬁned and may involve
sources such as the hands of health care workers (HCWs). We
investigated the distribution of C. parapsilosis genotypes in
isolates from blood, all other sites from patients, and the hands
of medical personnel, and its relation to bioﬁlm production.
Methods: A total of 121 C. parapsilosis strains were analysed,
including 53 bloodstream isolates from catheter-related fungae-
mia, 39 clinical isolates from other body sites, and 29 isolates
from the hands of HCWs. Organisms were grown in Sabou-
raud’s dextrose broth containing a ﬁnal concentration of 8%
glucose to induce bioﬁlm formation, which was determined
using both visual and spectrophotometric methods. Electroph-
oretic karyotyping with pulsed-ﬁeld gel electrophoresis was
used to genotype the C. parapsilosis.
Results: Eighty-three per cent (44/53) of the blood isolates were
bioﬁlm positive, while only 46% (18/39) of the isolates from all
other sites were bioﬁlm positive (P < 0.01). Isolates from
medical personnel showed high bioﬁlm production (72%, 21/
29), like the blood isolates. Electrophoretic karyotyping differ-
entiated all the isolates into three (I, II, and III) genotypes. All
the isolates from the bloodstream or the hands of HCWs
belonged to genotype I, whereas the clinical isolates from other
body sites belonged to genotypes I (64%), II (20%), and III (15%).
Bioﬁlm positivity was observed in 78% (83/107) of genotype I
isolates versus 0% (0/14) of genotype II and III isolates. There
was no signiﬁcant difference in bioﬁlm production among the
genotype I isolates from blood (81%), other clinical specimens
(72%), or the hands of HCWs (73%).
Conclusion: This study found a difference in bioﬁlm production
among three genotypes of C. parapsilosis isolates. Most of the
C. parapsilosis isolates from thebloodstreamor the handsofHCWs
belonged to genotype I, which has the ability to produce a bioﬁlm
and is associated with catheter-related bloodstream infections.
P604
Cryptococcus neoformans infection in Hong Kong
– a three-year retrospective review
M. Hui, K.C. Chu, M.L. Chin, W.M. Lai (Shatin, HK)
Objectives: Cryptococcus neoformans is encapsulated yeast
capable of producing life threatening meningitis and dissemin-
ated infection. Its importance is widely recognized in patients
with immunosuppressive conditions such as AIDS. In geo-
graphical areas where the seroprevalence of HIV is low,
Cryptococcus infection is often not clinically suspected. This
may result in a delay in initiating appropriate antifungal
treatment. Therefore, we aimed to analyze the clinical charac-
teristics of Cryptococcus neoformans infections occurring in the
past three years.
Methods: A retrospective analysis was conducted on all
patients’ records with microbiological conﬁrmation of Crypto-
coccus neoformans infection in the Prince of Wales Hospital of
Hong Kong from Nov 2001 to Oct 2004.
Results: A total of 14 non-duplicate patients were diagnosed to
have Cryptococcus neoformans infection during the time period.
Meningitis was found in 7 patients (50%). The remaining patients
consisted of 4 blood stream infection, 2 pneumonia, and 1
retinits. The male to female ratio was 1:1. The mean age was
54.8 years old (range: 25–78 years; S.D. 16.5 years). Initial pres-
entation included headache (5/14), pneumonia (2/14), sepsis
syndrome (3/14), confusion (1/14), blurred vision (1/14), mania
(1/14), and gastrointestinal bleed (1/14). Among the 5 patients
presenting with headache, three had hydrocephalus requiring
neurosurgical intervention. Six patients had underlying diseases
including malignancies (3/14), systemic lupus erythematosus
(1/14), HIV infection (1/14) and ventricular septal defect with
concurrent infective endocarditis (1/14). In patients with men-
ingitis, cerebrospinal ﬂuid showed lymphocytosis in 6 out of 7
patients, and Indian Ink preparation revealed encapsulated yeast
cells in 5 of them. Cryptococcal antigen testing was positive in all
cases of meningitis (Range: 1:8–1:2048). Antigen testing was also
positive on sera from 6 patients with meningitis, and 1 patient
with pneumonia. Antifungal treatment was started in 10 out of
14 patients, the remaining 4 patients had the disease diagnosed
post-mortem. Crude mortality rate was 50%.
Conclusion: Cryptococcus neoformans infection is an important
disease with high mortality. A high index of suspicion with
simple appropriate investigation such as Indian Ink test on
cerebrospinal ﬂuid can often reveal the diagnosis, which will
allow timely initiation of appropriate antifungal therapy.
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The Finnish experience with caspofungin:
retrospective study of patients treated during
2001–2004
V-J. Anttila, J. Salonen, P. Ylipalosaari, I. Koivula,
P. Riikonen (Helsinki, Lahti, Oulu, Kuopio, FIN)
The aim of the study: To evaluate retrospectively the use of
caspofungin in treatment of conﬁrmed and suspected invasive
fungal infections in Finland.
Materials & Methods: All adult patients (=/>16 years) treated
with caspofungin in ﬁve Finnish hospitals between years 2001–
2004 were included in the study and a patient records were
reviewed.
Results: 78 patients were enrolled in the study. These ﬁve
centres used over 92( of nation wide use of caspofungin during
the study period. The median age of patients was 55 years.
Underlying disease was haematological malignancy in 37 (47%),
diabetes in 11 (14%), solid organ transplantation in6 (8%), HIV in
1 (1%) and other disease in 23 (30%) patients. 26 (33%) patients
were neutropenic. The risk factor for fungal infection was use of
broad-spectrum antibiotics in 66 (85%), central venous catheter
in 51 (65%), and prior surgery in 19 (24%) patients. 51 (65%)
patients had conﬁrmed invasive fungal infection and 27 (35%)
patients received empirical treatment. 20 (26%) patients had
invasive aspergillosis and 31 (40%) invasive candidiasis. 13 (17%)
patients received caspofungin as primary therapy. Of the
remaining patients 45 were refractory to and 14 intolerant of
previous medication. The mean duration of caspofungin therapy
was 32 days. Caspofungin was discontinued in 4 (5%) patients (3
patients had elevated liver enzymes and 1 neuropathy). Five
patients received concomitantly cyclosporine without any major
adverse events. The response rate was 45% in Aspergillosis and
77% in Candidiasis. At the end of the follow up 40 (51%) patients
were alive. 9 of 38 deaths were caused by fungal infection.
Conclusion: Caspofungin has been used successfully as salvage
therapy in Finland. The low incidence of adverse events and
interactions make it an important alternative in treatment of
conﬁrmed and suspected invasive fungal infection. Efﬁcacy
evaluation is difﬁcult in a retrospective study with heterogenous
underlying diseases and requires further controlled prospective
studies.
P606
Fungal burn wound infection
A. Nasrollahi Omran, J. Hashemi (Tonekabon, Tehran, IR)
Objective: Infection remains the major problem of the burn
patients. Most common infectious complication involving the
burn wound. Fungal burn infections occurs most often in
patients with extensive burn wound injury, that recently
emerged as a distinct clinicopathological entity, responsible for
both mortality and morbidity.
Materials and methods: During a 2 year September 2002 to
September 2004, of patients with thermal injury admitted to
hospital burn, Swab specimens were obtained from areas of the
burn wound suspected to be harbouring infection. Diagnosis of
fungal burn wound conﬁrmed by microscopic examination and
culture of the specimens on SDA medium with antibiotic
chloramphenicol. Fungi Sp. was cultured at any time during
their hospital cause were selected for study.
Results: 25% (250 case) of these patients had colonization with
fungi species one or more site during acutely hospitalized study,
although 10% of these patients had positive microscopy exam-
ination. Patients with fungal burn wound infections had age a
mean of 28 years and a mean burn size of 63% of the total body
surface area. A mean burn day was 10 day. Majority to have
third degree burn (75%) and majority of this patients were male
(70%). 2% (5 case) of the patients with fungal burn wound
infection died disseminated fungal disease. All of the patients
had culture positive been receiving broad spectrum antibiotics
with an average of 15 days. 40% (100 case) Candidia Sp, 30% (75
case) Aspergillus Sp. and 20% (50 case) Zygomycet Sp. were
organisms fungi most frequently responsible for clinical mycotic
burn wound infections. Candida albicans was predominant
species isolated, remained Aspergillus fumigatus, Candida
tropicalis, Phycomyces Sp., Fusarium Sp., Acromonium Sp.,
Malassezia Sp., Penicillum Sp., Geotrichum Sp. were aetiological
agent fungal burn wound infections.
Conclusion: In burn patients lose of the normal ﬂora of the
body impairment of immunity system, contribute to the
increased susceptibility to fungal burn wound infection.
Among the fungi candida albicans which is an opportunistic
microorganism and one the normal ﬂora to create more difﬁcult
burn patients. In conclusion although fungal infections
remained a signiﬁcant source of morbidity, it was associated
with a low rate of mortality, large areas of open wound and
exposure borad-spectrum antibiotic were associated with the
development of fungal burn wound infections.
P607
Factors associated with death in candiduria
N. Paul, E. Mathai, O.C. Abraham, J.S. Michael,
D. Mathai (Vellore, IND)
Background: Candida species are responsible for causing seri-
ous systemic infections among hospitalized patients. Although
mortality rates in candiduria range from 18–30%, no study has
thus far focused on identifying factors associated with this high
mortality.
Objectives: To identify factors associated with mortality among
hospitalized patients with candiduria at our centre.
Methods: We prospectively studied the microbiological and
clinical characteristics of 77 consecutive cases of candiduria
[‡10,000 colony forming units (cfu)/mL] hospitalized between
Jan and Aug 2003 [eight months]. Odds ratios [OR] for suspected
risk factors were calculated using the Mantel-Haenzel test.
Analysis was performed using the SPSS version 10.0 software.
Results: Among 77 patients, 20 [26%] died during their hospital
stay. Analysis showed the following factors to be signiﬁcantly
associated with mortality: use of urinary diversionary devices
[OR 8.8; 95% conﬁdence interval (CI) 1.1–70.5; p = 0.04]; use of
two or more classes of antibiotics [OR 4.1; 95% CI 1.2–13.9;
p = 0.02]; ICU admission [OR 3.3; 95% CI 1.1–9.3; p = 0.03]; and
renal failure [OR 2.9; 95% CI 1.1–8.2; p = 0.05]. Besides, the
following factors approached statistical signiﬁcance: fungal
colony counts ‡100,000 cfu/mL [OR 4.5; 95% CI 0.9–21.4;
p = 0.06]; acidosis (serum bicarbonate £17 meq/L) [OR 3.6;
95% CI 0.9–13.7; p = 0.06]; positive urine nitrite test [OR 3.2; 95%
CI 0.8–12.3; p = 0.09]; serum albumin £3 g/L [OR 3.2; 95% CI
0.8–12.9; p = 0.10]; absence of any treatment interventions for
candiduria [OR 2.9; 95% CI 0.9–9.0; p = 0.07]; age ‡ 65 years
[OR 2.8; 95% CI 0.9–8.5; p = 0.07]; and treatment with antibiotics
for >7 days prior to isolation [OR 2.5; 95% CI 0.9–7.1; p = 0.09].
Infection with non-albicans Candida and co-infection with
bacterial urinary pathogens was not associated with increased
mortality.
Conclusions: Factors associated with increased mortality in
candiduria are those that might be expected to occur in critically
ill patients. However, the associations with absence of treatment
interventions and higher colony counts in urine culture indicate
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that fungal virulence characteristics may be important determi-
nants of mortality. These factors might achieve statistical
signiﬁcance in larger case series of candiduria.
P608
Recurrent vaginal candidiasis: management of
the asymptomatic partner
S. Baka, E. Makrakis, D. Hassiakos, G. Kapparos,
E. Kouskouni (Athens, GR)
Objectives: Treatment of acute yeast infections results in relief
of symptoms and eradication of yeasts in the majority of cases.
Recurrence is not uncommon and is always a problem for
gynecologists all over the world. Treatment of symptomatic
partner is imperative while simultaneously treatment of symp-
tom-free men is controversial. The purpose of our study was to
assess the importance and usefulness of treatment of the
asymptomatic partner of women with diagnosed recurrent
vulvovaginal candidiasis.
Methods: One hundred and forty-eight married women of
reproductive age with a history of at least four or more episodes
of recurrent vulvovaginal candidiasis in the preceding year
presenting to our clinic with a new episode were enrolled in the
study together with their partners. All women were sympto-
matic while all men were asymptomatic. Vaginal cultures were
positive for Candida spp. in all cases. Identiﬁcation of strains and
antibiotic susceptibility testing were carried out using the
VITEK System, ATB Expression, Biomerieux, France. All
women were treated with itraconazole. Couples were randomly
allocated into two groups according to application of treatment
to male partner. Group A comprised those with treatment and
group B those with no treatment which served as controls. One
month after treatment cultures were obtained to assess the cure
rate and a follow-up was performed at 6 months.
Results: Candida albicans was the most frequently isolated yeast
(90.5%). One month after treatment the cure rate was 93.2% in
group A and 89.2% in group B. The persistent asymptomatic
positivity rate was 5.4% and 8.1%, respectively, while the clinical
recurrence rate was 1.4% and 2.7%, respectively. Six months after
treatment the recurrence rate was 35.1% and 32.4%, respectively.
Conclusion: Our data suggest that treatment of the symptom-
free partner might not be necessary and should be limited to
difﬁcult situations.
P609
Micafungin (FK463) versus ﬂuconazole in a
randomised, double-blind, multinational,
oesophageal candidiasis study
N.T.E. de Wet, J.J. Viljoen, A.J. Bester, E. Ticona-Chavez,
D. Buell, C. Fisco (Dundee, Bloemfontein, Port Elizabeth, ZA; Lima,
PE; Deerﬁeld, USA)
Objective: To determine the efﬁcacy and safety of intravenous
micafungin (FK463) 150 mg versus intravenous ﬂuconazole
200 mg in the treatment of patients with esophageal candidiasis.
Methods: A multicentre, multinational, two arm, double-blind,
randomized (1:1), parallel group, non-inferiority (10% delta),
comparative study of patients 16 years of age and older with
esophageal candidiasis conﬁrmed by endoscopy and documen-
ted by clinical signs and symptoms. Patients received daily
infusions of micafungin and ﬂuconazole for a minimum of
14 days or 7 days after clearing, whichever is longer. The
primary efﬁcacy endpoint was the comparative incidence of
success or endoscopic cure rate at end of treatment. Endoscopic
cure rate was deﬁned as clearing of esophageal lesions (mucosal
grade of zero). Successful clinical response was deﬁned as a total
symptom score = 0 (cleared) or reduction in total symptom
score from baseline by 2 or more grades and no increase in grade
for any individual symptom (improved). Safety was assessed for
all patients who received at least one dose of study medication
based on the incidence of adverse events and changes from
baseline in clinical laboratory proﬁle.
Results: A total of 518 patients took at least one dose of study
medication. Treatment groups were well balanced with respect
to age, gender, race, baseline conditions, underlying disease,
and severity of disease at baseline. Micafungin was found to be
as effective as ﬂuconazole in clearing esophageal lesions as
documented by endoscopy. Clinical responses were rapid and
similar in the two study groups. Relapse rates measured at post
treatment weeks 2 and 4 were also comparable to ﬂuconazole.
There were no statistically signiﬁcant differences between either
arm with respect to overall incidence of treatment emergent
adverse events (p = 0.156). The most common adverse events
(‡5% of patients) regardless of relationship included: fever
(13.1% micafungin vs. 8.5% ﬂuconazole), diarrhoea (10.4% vs.
11.2%), phlebitis (15.4% vs. 4.7%), nausea (7.7% vs. 8.9%),
headache (8.5% vs. 8.1%) and pneumonia (9.6% vs. 5.0%). No
clinically meaningful changes in mean or median values for any
laboratory parameters were noted.
Conclusion: Micafungin is as effective and is a safe alternative
in treating esophageal candidiasis patients when compared to
Fluconazole.
P610
Candidaemia: retrospective analysis of a
seven-year experience
A. Spiliopoulou, K. Katsarou, P. Voila, V. Stamouli,
M. Christoﬁdou, G. Dimitracopoulos (Patras, GR)
Objectives: To investigate the isolation and distribution rate of
Candida spp. in blood cultures and to evaluate the antifungal
susceptibility during a 7-year period (1997–2004) at a tertiary
care hospital.
Methods: Positive blood cultures (BacT/Alert, Organon Tekni-
ka) were examined microscopically directly for yeasts or
pseudohyphae and subcultured on Sabouraud agar (Difco).
Candida isolates were screened by germ tube test and identiﬁed
using API20CAUX (Biomerieux). Antifungal M.I.C was carried
out by E-test (Biodisk) on RPMI-2% glucose agar, for the
following antifungals: Amphotericin B (A), 5-ﬂuorocytocin (5F),
itraconazole (I), ketoconazole (K) and ﬂuconazole (F). The last
two years voriconazole (V) was also included in this study.
Results: During the study period there were 142 (2%) yeast
isolates from a total of 6937 patients exhibiting positive blood
culture. All patients with fungaemia were immunocompro-
mised. The causative species were: C. albicans–C.a 80 strains
Fluconazole
(n = 258)
Micafungin
(n = 260)
Endoscopic Cure Rate at ET 227 (88.0%) 228 (87.7%)
Clinical Response at ET 237 (91.9%) 239 (91.9%)
Relapse Rates during
Post Treatment
Week 2 25/225 (11.1%) 35/227 (15.4%)
Week 4 27/200 (13.5%) 24/192 (12.5%)
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
169
(57%), C. glabrata–C.g 16 (11%), C. tropicalis–C.t 14 (10%),
C. parapsilosis–C.p 13 (9%), C. lipolytica–C.l 6(4%), C. guillermon-
dii–C. guil 4 (3%), C. krusei–C.k 3 (2%), C. stellatoida–C.s 1 (1.5%),
C. humicola–C.h 3(2%). Both C. glabrata and C. krusei were
isolated for the ﬁrst time during 2001. Two patients had non
Candida fungaemia with Trichosporon spp. Candida spp. excibit-
ed different susceptibility proﬁle to antifungals agents. Sensi-
tivity rates (%) of C.a to A was 98, to 5-F 92, K 81, I 73, F 87, V 98.
Respective results of C.gwere A 81, 5-F 81, K 69, I 31, F 56, V 100
of G.tA 86, 5-F 78, K 86, I 64, F 78, V 100, of C.pA 92, 5-F 92, K 92,
I 85, F 85, V 100, of C.l A 100, 5-F 67, K 100, I 50, F 67, V 100, of
C. guil A 100, 5-F 100, K 100, I 100, F 75,V 100, of C.h A 100, 5-F
67, K 100, I 34, F 100, V 100, of C.k A 100, 5-F 34, K 34, I 67, F 34, V
100 and of C.s A 100, 5-F 100, K 100, I 100, F 100, V 100.
Conclusions: Candidemia is predominantly caused by C. albi-
cans (57%). The frequency of candidemia due to Candida non
albicans is quite high (43%). Candida glabrata although the data is
limited however was the second most frequent isolate followed
by C. tropicalis and C. parapsilosis. The highest degree of
resistance was observed to ketoconazole, itraconazole and
ﬂuconazole whereas voriconazole was very active against
Candida.
P611
Prognostic indices for death in ICU patients with
invasive aspergillosis
S. Blot, P. Depuydt, D. Benoit, J. Decruyenaere, J. De Waele,
E. Hoste, F. Colardyn, K. Vandewoude (Ghent, B)
Objective: In ICU patients invasive aspergillosis (IA) is associ-
ated with a grim prognosis. The objective of this study was to
identify risk factors for mortality in ICU patients with IA.
Methods: Retrospective cohort study (1997–2003). Deﬁnite IA
was deﬁned as: (1) positive microscopic examination with
septate hyphae and positive Aspergillus culture on tissue
biopsy, or (2) positive culture of a normally sterile site obtained
by aseptic invasive techniques. Probable IA is deﬁned as (1)
clinical symptoms of infection, (2) any positive culture from a
nonsterile site, (3) chest X-ray or CT of lungs suggestive for IA
and (4) either (a) positive results of microscopic examination
and culture of BAL ﬂuid or (b) predisposing host risk factors for
IA: (i) haematological/oncological malignancy treated with
cytotoxic agents, (ii) neutropenia, (iii) glucocorticoid treatment,
and (iv) congenital or acquired immunodeﬁciency. All criteria
must be fulﬁlled for the diagnosis of probable IA (1 + 2 + 3 +
either 4a or 4b). Mortality was deﬁned as in-hospital mortality.
Results: During the study period 83 ICU patients experienced
IA. The overall mortality was 77% (64/83). In univariate
analyses no differences between survivors and non-survivors
were observed in age (53 ± 16 years vs. 59 ± 14 years;
P = 0.125), APACHE II scores (28 ± 5 vs. 28 ± 10; P = 0.999),
delay in start of antifungal therapy (2.5 ± 1.9 days vs.
2.1 ± 2.9 days; P = 0.125), absence of antifungal therapy (0%
vs. 19%; P = 0.059), hematologic or oncologic disease (21% vs.
27%; P = 0.769), neutropenia (16% vs. 13%; P = 0.708), chronic
use of corticosteroids (37% vs. 53%; P = 0.297), need for renal
replacement therapy (37% vs. 41%; P = 0.999), need for mechan-
ical ventilation (95% vs. 97%; P = 0.547), and need for vasoactive
drugs (84% vs. 91%; P = 0.421). Survivors had a longer length of
ICU stay (44 ± 29 days vs. 16 ± 13 days; P < 0.001) and were
mechanically ventilated for a more extended period
(37 ± 24 days vs. 15 ± 13 days; P < 0.001). A logistic regression
model could not identify independent risk factors for mortality.
Conclusion: In ICUs, IA affects patients with a high index of
disease severity as assessed on basis of the APACHE II score. It
is also associated with a high rate of severe organ derangements.
Due to the high rate of severe comorbidities among survivors
and nonsurvivors, and the high overall mortality this study did
not have sufﬁcient discriminative power to identify independent
risk factors for death.
P612
An open-label comparison of oral voriconazole
and itraconazole for long-term treatment of
paracoccidioidomycosis
F. Queiroz-Telles, L.Z. Goldani, M.A. Shikanai-Yasuda,
J.M. Goodrich, H.T. Schlamm (Curitiba, Porto Alegre, Sao Paulo,
BR; Groton, New York, USA)
Objectives: Paracoccidioidomycosis, previously named South
American Blastomycosis, is a subacute to chronic systemic
mycosis caused by Paracoccidioides brasiliensis. The aim of this
study was to investigate the efﬁcacy, safety, and tolerability of
voriconazole in the long-term treatment of acute or chronic
paracoccidioidomycosis, with itraconazole as control treatment.
Methods: This was a randomized, multicentre, open-label,
comparative study conducted in Brazil in 2000–2002. Subjects
were randomized (2:1) to receive oral therapy with voriconazole
or itraconazole for up to 12 months. Satisfactory global response
(incorporating clinical, mycologic, radiologic, and serologic
assessments) at end of treatment (EOT) was compared for the
two treatment groups.
Results: Fifty-three subjects received at least one dose of study
drug: 35 received voriconazole and 18 received itraconazole. All
but 4 subjects with conﬁrmed paracoccidioidomycosis (3 on
voriconazole, 1 on itraconazole) received at least 6 months of
continuous study treatment. The response rates in these treat-
ment-evaluable patients were 100% for both treatment groups,
and there were no relapses after 8 weeks of follow-up in either
group. The majority of cases had lung involvement at baseline;
one case with both lung and CNS involvement responded well
to voriconazole. The most common treatment-related events
included abnormal vision, chromatopsia, rash, and headache in
the voriconazole group, and bradycardia, diarrhoea, and head-
ache in the itraconazole group. Two voriconazole subjects were
withdrawn prematurely, as required by the protocol, due to
study drug related elevated alkaline phosphatase and hepatic
enzymes (ALT, AST, and GGT). The frequency of liver function
test abnormalities was slightly higher in subjects receiving
voriconazole compared to itraconazole, but the median changes
in these parameters from baseline values were similar between
treatment groups. One voriconazole subject expired after
52 days because of a rupture of an aortic aneurysm: an autopsy
was performed and was negative for paracoccidioidomycosis.
Conclusions: This is the ﬁrst study to demonstrate that voric-
onazole is well tolerated and effective for the long-term
treatment of paracoccidioidomycosis.
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Clinical use of vaccines
P613
Immunogenicity and safety of the pneumococcal
conjugate vaccine in elderly patients: comparison
to the 23-valent polysaccharide vaccine
A. de Roux, A. Kuhnke, N. Ahlers, B. Thoma, D. Madore,
M. Schmidt-Ioanas, T. Welte, H. Lode (Berlin, Munich,
Hannover, D)
Background: Patients ‡70 years are a target population for
pneumococcal vaccination but immunogenicity of the 23-valent
polysaccharide vaccine (23vPS) in this age is limited. Pneumo-
coccal conjugate vaccines induce enhanced, T-cell mediated
immunity and have been shown to be safe and effective in infants.
Objective: To compare immunogenicity and safety of pneumo-
coccal conjugate vaccine (PnC) to 23vPS in patients ‡70 years.
Methods: 443 ambulatory elderly patients aged ‡70 years with-
out prior pneumococcal immunization were randomized in an
open label study to receive 23vPS, 7vPnC (Prevnar 2 lg
saccharide/dose, except 4 lg for 6B), or higher doses, achieved
by reconstituting 9vPnC with 7vPnC and giving 0.5 or 1.0 ml
respectively to produce formulations with 4 or 8 lg saccharide /
dose, (except 8 or 16 lg for 6B, 2 or 4 lg for types 1 and 5,
present in 9vPnC). Blood samples were obtained prior to
vaccination and one month later. Antibody responses were
measured by ELISA and OPA.
Results: Only data for the lowest PnC dose (7vPnC) and 23vPS
are presented in this abstract. Samples from 439 subjects were
analysed. Mean age was 79.9 years (range 69-–90); 56.4% were
male 43.6% females. Pre-immunisation antibody levels were
similar in all groups. One month after vaccination ELISA GMCs
of 7vPnC andOPAGMTswere 2–3 times higher than 23vPS, with
exception of 19F. GMCs of all three conjugate doseswere superior
to 23vPS. Pain at the injection site (7vPnC 38% vs. 23vPS 23%),
redness (7vPnC 32.4% vs. 23vPS 21%) and swelling (7vPnC 19.6%
vs. 23vPS 16%) were the most frequent local reactions. Fever over
38Cwas observed in n = 3 (23vPS) and n = 1 (7vPnC) vaccinees.
No vaccine related serious adverse events were observed.
Conclusion: The antibody response after PnC in elderly
patients ‡70 years of age was superior to 23vPS. Local reactog-
enicity for PnC was slightly more common than after 23vPS and
highest in the top level dose of PnC. These results support
further investigations.
P614
Genetic characterisation of pneumococcal surface
protein A
C. Heeg, C. Franken, M. van der Linden, A. Al-Lahham,
R.R. Reinert (Aachen, D)
Objectives: Streptococcus pneumoniae is an important pathogen
causing invasive diseases such as sepsis, meningitis and pneu-
monia. The dramatic increase of antibiotic resistance of pneu-
mococci has stressed the need for the development of an
effective vaccine. In recent years, several studies have shown
that pneumococcal surface protein A (PspA) is a possible
candidate for vaccine development. The aim of this work is to
map the genetic variability of PspA among representative
clinical isolates from Germany.
Methods: PspA genes of 40 clinical pneumococcal isolates were
sequenced using a primer set amplifying the central region of
the gene and analysed using the HUSAR Bioinformatics Plat-
form (Biocomputing Service Group, Heidelberg, Germany).
Strains were serotyped using the Neufeld Quellung Reaction.
Results: The serotype distribution of the strains was as follows:
4 (n = 3), 6B (5), 9V (2), 14 (8), 18C (6), 19F (5), 23F (6) and 7F (5).
The pspA genes of these strains could be assigned to two
families both containing 20 genes. Family I could be divided into
two clades, with 17 genes in clade 1 and 3 genes in clade 2.
Family II could be subdivided into three subgroups (clades 3–5)
containing 16, 3 and 1 sequence respectively. Clade 1 and clade 3
represent 82% of the genes. Serotypes were distributed evenly
over the clades and families.
Conclusions: The distribution of the pspA gene families in
Germany differs widely from that found in other countries such
as, the US and Sweden. An effective vaccine for Germany could
be based on conserved N-terminal regions found in both clade 1
and clade 3 sequences.
P615
Prevalence of pneumococcal serotypes in invasive
disease in children
A. Gil-Setas, L. Torroba, A. Mazo´n, A. Barricarte (Pamplona, E)
Objectives: The aim of this study was to the investigate the
prevalence of pneumococcal serotypes in invasive disease in
children.
Methods: Navarra is a province in northern Spain with a
population of 570,000 inhabitants. From September 2000 we
have been referring all pneumococcal isolates to the Centro
Nacional de Microbiologı´a in Majadahonda for serotyping.
Although the health authorities in the province have not
included the heptavalent pneumococcal vaccine in the ofﬁcial
vaccination schedule, this vaccine has been widely used by
paediatricians since late 2001. We have split the study period
into 4 seasons (from September to October).
Results: During the study period, 88 pneumococcal strains
were isolated, of which 86 were typable and two were non-
typable. 19 were recovered during the ﬁrst season, 22 in the
second, 22 in the third and 25 during the last season. During the
ﬁrst season the most frequent serotypes were: 1 (4 isolates), 6A
(3), and 19 (2 isolates, one 19A and one 19F); For the second
season: 6 (7 isolates, 4 6A and 3 6B), 14 (4) and 18C (2) and 19 (2
isolates, one 19A and one 19F); for the third season: 19 (13
isolates, 5 19A and 8 19F), 1 (2) and 7 (2), and for the fourth
season: 19 (9 isolates, 4 19A and 5 19F), 14 (5), 18C (2) and 24 (2).
11 of 19 isolates from the ﬁrst season were not included in the
heptavalent vaccine (57.9%), 6 (27.3%) from the second, 6
(27.3%) from the third and 8 (30%) from the fourth season.
Conclusion: Despite the use of pneumococcal vaccine, the
number of cases of invasive infection has not decreased in the
Navarra region. Moreover, some serotypes included in the vac-
cine (14, 19A and 19F) have become more prevalent. Changes in
circulating serotypes, incidence of cases between vaccinated and
non-vaccinated children and changes in the population (rapid
growth due to immigration) could explain the ﬁndings presen-
ted here.
ELISA GMC (lg/ml)
4 6B 9V 14 18C 19F 23F
7vPnc (2 lg) 3.1 8.2 10.1 17.5 13.4 5.6 12.5
23vPS 1.4 4.4 3.6 8.4 6.7 4.4 3.8
OPA GMT
7vPnc (2 lg) – 1380.7 2999.4 – 1389.5 188.7 1329
23vPS – 795.4 966 – 444.6 195.5 301.9
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P616
Safety, reactogenicity and immunogenicity/
priming following 2 vs.3 doses of a
meningococcal C conjugate vaccine given
concomitantly with DTaP-IPV-HBV/Hib vaccine
to infants
H.-J. Schmitt, B. Gro¨ndahl (Mainz, D)
Objectives: Meningococci are important pathogens in young
children. Fewer injections may increase compliance with exist-
ing infant vaccination schedules.
Methods: Healthy infants (241) in ten paediatric practices in
Germany were randomized to receive either two or three doses
of a MCC vaccine (Menjugate, Chiron Vaccines, Marburg,
Germany) at age 2, 3, 4 or 2 and 4 months, co-administered with
a DTaP-IPV-HBV/Hib combination vaccine (Infanrixhexa,
GSK, Mu¨nchen) at age 2, 3, 4 months. At 12 months a plain
meningococcal A/C polysaccharide challenge was given. Blood
samples were taken prior to the administration of the ﬁrst
vaccine dose, four weeks after the second or third dose, just
prior to the challenge vaccination and either 7 or 28 days
thereafter.
Results: There was no serious adverse event related to vaccin-
ation. Local reactions were similar to those with hexavalent
vaccine, systemic reactions occurred with a similar frequency in
both groups. One month after 2 or 3 MCC doses, GMTs
(bactericidal assay with human complement; hBCA) were 337
(95%CI: 260–437) and 445 (95%CI: 346–572), respectively. 98%
and 100% of vaccinees, respectively, showed hBCA >1:8 one
month after primary immunization. Two injections of MCC
given at 2 & 4 months induced immunological priming In
children primed with 2 MCC doses, there was an 19 fold hBCA
increase at 28 days following the Men A/C polysaccharide
challenge as compared to 1.09 fold increase in a group of
unprimed historical control children. Antibody concentrations
to hepatitis B were similar in both groups.
Conclusions: In this group of 241 children, the MCC vaccine
Menjugate was safe, well tolerated and highly immunogenic
following administration of either 2 or 3 doses in infants and
primed immunologic memory responses at 12 months.
P617
Antibiotic resistance, serotypes, and clonal
composition of Streptococcus pneumoniae in
clinical trials of acute otitis media pre- and post-
launch of the 7 valent pneumococcal conjugate
vaccine
H. Amrine-Madsen, B. Abraham-Van Parijs, L. Miller, S. Ondus,
J. Becker, M. Jacobs, M. Stanhope (Collegeville, Cleveland, USA)
Objectives: Streptococcus pneumoniae is among the most
common bacterial pathogens associated with acute otitis media
(AOM). Although high levels of efﬁcacy for the 7 valent
pneumococcal conjugate vaccine (PCV–7) have been reported
for invasive pneumococcal disease, the efﬁcacy with regards to
AOM is considerably less clear. Earlier studies involving three
prospective, multinational AOM clinical trials, reported on
penicillin resistance and serotypes of pre and post PCV-7
S. pneumoniae isolates. The present study expands the analysis of
these same samples to include genotyping of all 187 isolates for
which penicillin resistance and serotyping data were available.
Methods: The genotyping involves our expanded MLST
approach, in which all of the customary 7 MLST loci are
sequenced not only for the usual 500 bp internal fragment, but
for the entire locus, with the addition of several housekeeping
loci adjacent to MLST genes. The resulting data set includes
approximately 9000 base pairs of sequence data for each isolate,
including as a subset, the usual MLST sequence data. These data
provide us with high resolution clonal designation of the pre
and post PCV-7 samples, while also allowing us to correlate our
clonal composition data with the pneumococcal MLST database.
Results: In general, the same clones were present in the pre and
post PCV-7 samples; however, there tended to be a proportional
increase within clones of non-vaccine serotype in the post PCV-7
set (e.g. clones of serotype 11, 29, and 22 increased in propor-
tional representation in post vaccine years). The changes
associated with clones of vaccine or vaccine related serotype
were more variable, with some clones not changing in propor-
tional abundance (e.g. clones of 19F, 9V and the mixed serotype
clone known as Spain 23F-1), others decreasing (e.g. clones of
23F, 14, and 6A), and others increasing (e.g. one 19F clone). One
clone of particular interest was represented by 19A isolates pre
PCV-7, and in post PCV-7 years was, with the exception of a
single serotype 19A isolate, represented entirely by serotype 15B
(a serotype not present in the pre PCV-7 set of isolates).
Conclusions: Although it is difﬁcult to determine if the intro-
duction of PCV-7 directly caused the changes in the AOM clones
documented in this study, our results are consistent with a
mixture of clonal expansion of non-vaccine serotypes and
occasional serotype switching mediated by the selective pres-
sure of the vaccine.
P618
Effect of the 7-valent conjugate pneumococcal
vaccine on the serotype distribution of drug-
susceptible and drug-resistant Streptococcus
pneumoniae colonising healthy children
attending day-care centres in Lisbon
N. Fraza˜o, S. Nunes, N.G. Sousa, R. Sa´-Lea˜o, C. Simas,
R. Mato, A. Brito-Avoˆ, J. Saldanha, I. Santos-Sanches,
H. de Lencastre (Oeiras, Lisboa, P)
Objectives: Evaluate the impact of the 7-valent pneumococcal
conjugate vaccine on the serotype distribution among drug-
susceptible (DS) Streptococcus pneumoniae (Pn) and drug-resistant
(DR) Pn isolates colonizing children.
Methods: Nasopharyngeal samples were collected from chil-
dren under 6 years old attending 5 day-care centres in Lisbon,
Portugal. A total of 243 children were sampled before vaccin-
ation (May 2001-baseline period); and 127 samples from the
vaccinees were obtained afterwards (March 2003). All Pn strains
were characterized by antibiotype and serotype.
Results: Frequency of Pn carriage was 74% in the baseline
period and 64% after vaccination. Carriage of DSPn isolates with
vaccine serotypes (VT) decreased from 24% in the baseline to 5%
after vaccination, while carriage of DSPn with non-vaccine
serotypes (NVT) increased from 76% in the baseline to 95% after
vaccination. In the baseline period, we found six VT, among 23
DSPn isolates, being serotype 19F (39%) the most frequent one,
followed by serotypes 23F, 9V, 14, 18C and 6B in decreasing
order of prevalence. We also found 15 NVT among 74 DSPn
isolates, being serotype 11A (18%) the most frequent one; other
serotypes were: 16F, 15B, 23A, 6A, 19A, 7F, 10A, 35F, 33F, 3, 15C,
17, 18A, 34 and 3 non-typeable (NT). After vaccination, only two
VT were found: serotypes 19F (2 isolates) and 6B (1 isolate). In
addition, we found 14 NVT among 57 isolates: serotypes 6A and
11A were the most frequent ones - 18%, followed by 3, 10A, 15B,
16F, 15C, 21, 17, 9N, 19A, 23A, 34, 35F and 1 NT isolate. Carriage
of DRPn with VT decreased from 81% in the baseline to 5% after
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vaccination, and carriage of DRPn with NVT increased from
19% to 95% after vaccination. In the baseline period, we have
identiﬁed ﬁve VT among 64 DRPn, being serotype 6B (31%) the
most frequent one, and serotypes 23F, 14, 19F and 9V more
rarely found. Among 15 DRPn isolates we found four NVT
being serotype 15A (33%) the most prevalent, followed by
serotypes 6A, 15C, 33F and 5 NT isolates. After vaccination, only
one VT isolate was identiﬁed (9V). In addition, we found 20
NVT isolates, being serotype 19A (25%) the most frequent. The
other serotypes found were: 23A, 15A, 33F and 9 NT isolates.
Conclusions: Vaccination did not affect carriage of Pn, however
decreased carriage of DRPn and DSPn isolates with vaccine
serotypes and increased carriage of Pn populations of non-
vaccine serotypes. Serotype diversity in DSPn is higher than in
DRPn isolates and this trend is not affected by vaccination.
P619
Immune response in measles-mumps-rubella
of young adults aged 16–25 years vaccinated
with one or two doses of MMR vaccine
E. Balomenaki, F. Barabouti, A. Tsialla, V. Makri, E. Dana,
M. Christodoulaki, A. Vasiliadi, D. Athanasopoulos
(Chania, GR)
Objectives: Serologic evidence of immunity and immunization
status were evaluated in healthy adolescents and young adults
4–10y after completing their immunization for MMR.
Methods: Blood samples were collected from 286 healthy ado-
lescents and young adults aged 16–25y (47.7%) female; (52.3%)
male on April 2002 in the province of Chania. IgM and IgG
antibodies were detected using microparticle enzyme immuno-
assay, Pambio for measles and mumps and MEIA for rubella.
Results: 220 (80.7%) individuals had received the combined
vaccine for measles-mumps-rubella , whereas 40 (19.2%) indi-
viduals had received monovalent vaccines: 33 for measles, 22 for
rubella, 32 for mumps. In addition, 16 (5.6%) individuals were
unimmunized. Furthermore, the combined vaccine and the
monovalent vaccine were compared with regard to induced
serum antibody titres. Concerning measles, the mean antibody
level (positive > 11) was 11,394 after administration of the
monovalent vaccine, compared to 10,947 after administration of
the combined vaccine (not signiﬁcant difference). Concerning
rubella, the mean antibody level (positive > 0.5) was 69.8 after
administration of the monovalent vaccine, compared to 71,535
after administration of the combined vaccine (not signiﬁcant
difference). Finally, concerning mumps, the mean antibody level
was 0.6879 after administration of the monovalent vaccine,
compared to 0.777 after administration of the combined vaccine
(p < 0.001). The mean value of antibody titre after administrat-
ing a single dose (n = 122) compared to two doses (n = 107) of
the MMR-vaccine was as follows: concerning measles 11.09 and
10.74 (not signiﬁcant difference) respectively, concerning rubella
65.59 and 76,068 (not signiﬁcant difference), whereas concerning
mumps 0.712 and 0.851 (p < 0.001) respectively.
Conclusions: The mean values of antibody activities against
measles and rubella did not differ signiﬁcantly after vaccination
with monovalent or combined vaccine. However after vaccin-
ation with combined vaccine the mean antibody values were
signiﬁcantly higher against mumps. The administration of one
dose of the vaccine for measles and rubella produces similar
immune response compared to two doses of vaccination,
whereas concerning mumps two doses of MMR vaccine can
provide sufﬁcient seroconvertion. Adolescents with naturally
acquired immunity had signiﬁcantly higher titres than adoles-
cents with vaccine-induced titres.
P620
DNA vaccination fails to induce protective
immunity against herpes simplex virus type 1
in chronic morphine treatment mice
A. Jamali, M.H. Roostaie, T. Bamdad, H. Solimanjahi
(Tehran, IR)
Objective: Chronic morphine treatment has been shown to alter
a number of immune parameter including suppression of
cellular immunity. In this study, we compared protection
against lethal HSV-1 challenge following live virus immuniza-
tion(avirulent strain)with that following vaccination with a
plasmid encoding HSV-1 glycoprotein B (gB-DNA) in chronic
morphine treated mice.
Methods: HSV-1 was propagated on vero cell line. Mice
received (50 mg/kg) morphine s.c daily; on day 11 chronic
morphine treated group and control group (PBS treated)
immunized with one i.d. injection of HSV-1(KOS). For DNA
vaccination chronic morphine treated group and control group
(PBS treated) received 100 microgram of DNA vaccine and two
booster dose injections i.m. were one week apart. Neutralizing
anti body assayed two weeks after the second vaccination. Cell
mediated immunity (CMI) was evaluated by measuring footpad
immune response(DTH) to inactive HSV-1(KOS). All mice
challenged with 4MLD50 of virulent HSV-1 two weeks after
ﬁnal immunization. Survival rate was followed for 14 days.
Results: Chronic morphine treated mice, which immunized
with DNA vaccine impaired to induce enough neutralizing anti
body. CMI as measured by DTH response was also impaired in
the two types of vaccines in chronic morphine treated mice. The
protection rates of the vaccinated mice against the lethal i.p
challenge were shown as 1) KOS-morphine treated (57.14%)
control group(85.71%), 2) DNA vaccine-morphine treated
(16.66%) control group(66.66%). There were no survival of the
PBS vaccinated mice that treated with morphine or PBS.
Conclusion: The cellular requirements for induced immunity
against HSV-1 has been shown differ between the two types of
vaccines. The results showed chronic morphine treated mice
that immunized with DNA vaccine failed to induce protective
immunity, DTH and anti body response. However live virus
vaccination impairs DTH in mice, but it can induce protective
immunity against lethal HSV-1 challenge.
P621
Hepatitis B vaccine coverage among health care
workers in Malaysia
Z. Sekawi, H. Rashwan, T. Mohamed-Eusoff, A. Adnan,
I. Isahak (Kuala Lumpur, Shah Alam, MYS)
Due to the nature of work, health care workers (HCW) are at
great risk of acquiring blood borne infections such as hepatitis B
virus, hepatitis C virus and human immunodeﬁciency virus
from patients. Universal Precautions Policy guidelines were
introduced more than a decade ago to minimise exposure to
diseases spread by blood and certain body ﬂuids. This study
looked into one of the aspects of hepatitis B prevention among
HCW in Malaysian context.
Objective: To assess hepatitis B vaccine coverage among HCW
working in hospitals in Malaysia.
Methods: This is a cross sectional study involving pre-tested
questionnaires. The duration of the study is seven months, from
February 2001 to August 2001. Hospital staff working in wards
or diagnostic laboratories in Hospital Kuala Lumpur (HKL) and
Hospital Universiti Kebangsaan Malaysia (HUKM) as well as
Universiti Kebangsaan Malaysia (UKM) undergraduate
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students undergoing clinical attachments in HUKM were
randomly chosen. All subjects volunteered to participate in
this study. The hospital staff comprised nurses and medical
laboratory technologists while the students included student
nurses, medical students, biomedical students and dental
students.
Results: A total of 625 subjectswere enrolled and only 58.4% had
taken a complete hepatitis B vaccination. Majority of the last dose
taken by subjects was less than ﬁve years ago. However, 82.2%
have taken at least one dose of the hepatitis B vaccine and are
supposed to complete the schedule in due course. About 17.8%
HCW never received hepatitis B vaccination with the most
number from HKL (26.6% from the total staff in HKL). Approxi-
mately 22% admitted that anti-HBs test was done a month post
vaccination giving a desirable response rate of 84.8%.
Conclusion: Not all HCW are protected against hepatitis B.
Preventing hepatitis B in HCW should be one of the priorities of
the hospital management as it is deﬁnitely cheaper than
managing chronic hepatitis B cases.
P622
Factors affecting medical students’ participation
in measles-rubella immunisation campaign
in Iran
A. Etemadi, A. Keshtkar, R. Heshmat, S. Nejat, S. Asghari,
K. Holakouie Naieni (Tehran, IR)
Objectives: Immunization against measles and rubella can
prevent a remarkable part of morbidity and mortality. The
effect of these vaccines on public health depend largely on their
coverage. In Iran, the measles vaccine coverage has been above
95% in children under 5, while rubella immunization is not part
of the routine immunization programme. In December 2003, a
mass campaign was carried out with the aim of increasing
coverage for both vaccines. This study aimed at estimating the
participation of medical students (as one of the target groups for
the immunization campaign) and the factors affecting this
participation.
Methods: This was a cross-sectional study on 250 medical
students in Tehran University of Medical Sciences, Tehran, Iran.
The students completed a 25-item self-administered question-
naire about participation in MR mass immunization campaign,
demographic data, their knowledge (3 questions)and attitude (5
questions). A pilot study was done to assess the internal validity
of the questionnaire.
Results: Mean age of the students was 20.7 (SD: 2.4) years and
42% were female. 3% were married. Eighty-two per cent of the
students had participated in the mass campaign. The most
important source of their information regarding the campaign
were the radio and television (69.3%). Male sex (OR = 4.9; 95%
CI: 2.0–12.6) and living in private home (OR = 4.6; 95% CI: 1.7–
12.4) were the most important determinants of non-participa-
tion. Age and years spent at medical school did not affect
participation. There was no signiﬁcant association between
knowledge and participation in the mass campaign. The
participant’s attitude towards vaccination was signiﬁcantly
more positive than the non-participants. More participants,
rather than non-participants, believed that vaccination increased
immunity against the virus and improved public health.
Conclusion: Students who did not participate in the immun-
ization campaign had more negative attitude towards the
vaccine and the programme. Since medical students are instru-
mental in such public health activities, proper methods of
informing and training them (other than the mass media) are
necessary to increase their participation.
P623
The investigation of seroprevalance of vaccine
preventable diseases among medical students
H. Cabadak, D. Arman (Ankara, TR)
Objective: Medical students, like other healthcare workers,
often come into contact with patients and their infected
materials. They are therefore at risk for various infectious
diseases, some of which are preventable through vaccination.
There is insufﬁcient study indicating seroprevalance of these
infections among medical students in our country and there is
no vaccination programme. We aimed to detect the seropreval-
ance of vaccine-preventable diseases in the ﬁfth grade medical
students and emphasize the importance of immunization of
adults.
Methods: In this study HbsAg, antiHBs, antiHBcTotal, which
are serological indicators of HBV infection, and measles,
mumps, rubella, varicella, tetanus IgG and HAV total antibody
titres were investigated by ELISA method in students who were
in their ﬁfth year of medical school.
Results: HbsAg, antiHBs, antiHBcTotal, measles, rubella,
mumps, varicella, tetanus IgG and HAV Total were detected
as positive respectively, 2.8%, 67.2%, 41.2%, 56.5%, 96%, 92.1%,
56.5%, 80% and 74%. There was no correlation between illness
and vaccination history according to their student survey and
seropositivity.
Conclusion: This study indicated that a large proportion of the
students were at risk for measles, varicella, hepatitis A and B.
Susceptible students should be vaccinated. Medical students
should be tested serologically for these infections prior to
beginning their medical studies or at least prior to clinical
studies, and an immunization programme should be established
for all medical students lacking immunization to these infections
Molecular methods for respiratory bacterial pathogens
P624
porA sequencing for subtype characterisation of
Neisseria meningitidis group B
M.J. Simoes, M. Camoez, L. Brum on behalf of the Laboratory
Meningococcal Disease Network
Objectives: Meningococcal C conjugate vaccine is not part of
the national vaccination scheme, but volunteer vaccination of
children and adolescent occurs in large scale since the winter of
2003. This is the basis for the registered decrease of invasive
disease due to meningococcal group C, in Portugal. During the
epidemiological year of 2003–2004, Neisseria meningitidis group B
represented 71.7% of all strains that cause laboratory conﬁrmed
meningococcal disease (MD), according to the Portuguese
laboratory-based surveillance system for MD (VigLab DM).
The aim of this study is the fully characterization of the subtype
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of Neisseria meningitidis group B, by sequencing of porA.
Genosubtyping will be useful for epidemiological surveillance
as well as to predict the efﬁcacy of a future vaccine based on
meningococcal group B outer membrane vesicle.
Methods: We studied 78 strains of Neisseria meningitidis group
B, isolated from clinical samples during the epidemiological
year of 2003–2004. We ampliﬁed VR1 and VR2 of porA, and the
PCR products were sequenced.Nucleotide sequences were
analysed using the computer programme Bioedit and submitted
to the Neisseria meningitidis PorA Variable Regions Database
(http://neisseria.org) for subtype classiﬁcation in family and
variants.
Results: We found 39 different subtypes, the most frequent
being from family 14 and its variants (26 strains). VR2 could not
be ampliﬁed from 3 strains and VR1 was not ampliﬁed from one
strain. Two new nucleotide sequences from VR2 were submitted
to the PorA variable region database.
Conclusions: Considering the diversity of genosubtypes of the
studied strains and the geographic distribution of them, we did
not identify any focus or outbreak during the period of this
study. Sequencing of porA seems to be a good approach for
better characterization of N. meningitidis serogroup B, taking in
account the high number of nunsubtypable strains.
P625
New clone of Neisseria meningitidis Y causing
invasive meningococcal disease in the Czech
Republic
P. Kriz, J. Kalmusova, M. Musilek (Prague, CZ)
The serogroups of Neisseria meningitidis isolated from invasive
meningococcal disease (IMD) in the Czech Republic have been
investigated since 1970. For this period, the disease has been
caused mainly by serogroups B and C. Serogroup Y was not
isolated from IMD in the period 1970–1992 and since its ﬁrst
isolation from IMD in 1993 it has caused invasive disease very
rarely (1.1% of IMD). Serogroup Y is found among isolates from
healthy carriers and/or from respiratory disease at a higher
percentage than among isolates from IMD (4.1% and 4.2%
respectively). Since 1995 IMD caused by N. meningitidis Y has
shown an increasing annual incidence and the case fatality rate
(CFR) is the highest for IMD caused by N. meningitidis Y (27.8%)
compared to the total CFR (11.0%) and/or CFR caused by
serogroup B (8.1%) and serogroup C (12.7%). For this reason,
N. meningitidis Y was investigated using classical typing and
molecular microbiological methods to assess the clonality of this
agent. Serogrouping was performed by slide agglutination with
hyperimmune antisera and sero/subtyping by Whole Cell
ELISA with monoclonal antibodies. Electrophoretic types (ET)
were investigated by multilocus electrophoresis (MLEE) and
sequence types (ST) by multilocus sequence typing (MLST).
Among N. meningitidis Y isolates from IMD the prevalent
phenotype was Y:2c:P1.2,P1.5, which occurred in 1995, i.e. the
year after the annual incidence of IMD caused by N. meningitidis
Y started to increase in the Czech Republic. Clonal analysis by
MLEE and MLST showed that N. meningitidis Y:2c:P1.2,P1.5
belong to the ST–23/Cluster A3 clonal hyperinvasive complex.
Recent increased incidence of IMD caused by N. meningitidis Y
in the Czech Republic is in correlation with antigenic and
genetic shift of this strain. Our ﬁndings are in accord with a
similar situation found in Maryland (USA) recently. A new
clone of N. meningitidis Y caused an increase of invasive
meningococcal disease in the Czech Republic recently. The
availability of vaccine against N. meningitidis Y was recommen-
ded. This work was partially supported by research grants NI/
7109–3 and NJ/7458–3 of the Internal Grant Agency of Ministry
of Health of the Czech Republic and made use of the Multi
Locus Sequence Typing website (http://pubmlst.org/neisseria)
sited at the University of Oxford and funded by the Wellcome
Trust and European Union. We thank Dr. K. Jolley (University
of Oxford, UK) for kind editing of the text.
P626
Evaluation of touch-down real-time PCR based
on SYBR green I ﬂuorescent dye for the detection
of Neisseria meningitidis in clinical samples
G. Tzanakaki, K. Kesanopoulos, S. Levidiotou,
J. Kremastinou (Athens, Ioannina, GR)
Objectives: LightCycler (Roche) technology with the use of
SYBR Green I dye provides a convenient, high sensitive and
rapid way to detect any PCR ampliﬁed product. The present
study outlines the development and evaluation of a touch-down
real-time PCR for the detection of N. meningitidis in clinical
samples with the use of SYBR Green I dye and melting curve
analysis.
Methods: A total of 293 samples were obtained from 255
patients with conﬁrmed suspected or propable IMD over a
2 year period (2002 and 2003), were tested with both con-
ventional PCR (Robocycler, Stratagene) and Real-time PCR
(LightCycler. Roche). For the identiﬁcation of N. meningitidis
the crgA primers were used, and a 230 bp PCR fragment
was identiﬁed by both gel electrophoresis and melting curve
analysis.
Results: The sensitivity of both PCR assays for culture-con-
ﬁrmed cases was 93% and the speciﬁcity was 97.8%. Agreement
between the two PCR assays was 96%. The inter- and intra-assay
variations revealed a high variation of Tm values among the
different runs. Differences of 1.40C (mean Tm = 87.95C) were
observed. The inter-assay SD was equal to 0.36. In contrast, the
intra-assay SD was lower than 0.1 in experiments in which
2.5 pg of DNA were ampliﬁed in 3 different capillaries in the
same run.
Conclusions: Our results showed a good correlation between
the conventional PCR and the Real-time PCR. The use of SYBR
Green I dye, showed an excellent alternative for the rapid
and reliable diagnosis of menigococcal disease in biological
ﬂuids.
Table 1. Most frequent genosubtypes and its correspondent
phenotypes
Molecular
Characterization
Immunologic
Characterization
No. of
Strains Genosubtype
No. of
Strains
Phenotype
3 B:NT:P1.12
4 P1.12-L13-1 1 B:1:P1.12
1 B:2b:P1.14
2 B:1:P1.14
4 B:NT:P1.14
2 B:NT:NST
10 P1.22.14 1 Not done
5 B:NT:P1.14
2 B:NT:NST
8 P1.22-1.14 1 Not done
3 B:1:NST
1 B:14:NST
5 P1. 22,14-6 1 B:NT:NST
1 P1.7-2,14 1 B:NT:NST
1 B:NT:P1.14
2 P1. 18-1,14 1 B:NT:NST
5 P1.19,15 5 B:NT:P1.15
2 B:NT:P1.7
4 P1.7.16 2 B:NT:NST
2 P1. 17,16-3 2 B:NT:NST
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P627
Simultaneous detection of rifampicin resistant
and penicillin intermediate phenotypes in
Neisseria meningitidis by real-time multiplex PCR
P. Stefanelli, A. Neri, A. Carattoli, P. Mastrantonio (Rome, I)
Objectives: Detection of antibiotic resistance inNeisseria meningit-
idis is generally performedbyphenotypic assays,which require the
isolate to be cultured and tested against different drugs. This needs
time and bacterial culture may be negative when patients have
already started antibiotic treatment prior to specimen collection.
Rifampicin and penicillin are the two reference antibiotics for
prophylaxis and therapy, respectively, of meningococcal invasive
disease. In this study,we developed aReal-Timemultiplex PCR for
simultaneously detecting rifampicin resistant (RifR) and/or peni-
cillin intermediate (PenI)N. meningitidis strains.
Methods: The assay, developed on the LightCycler Real-Time
PCR platform (Roche Diagnostics), uses two primers and two
hybridization probe sets in the same reaction mixture. To
distinguish between ﬂuorescence emitted by each hybridization
probe set, two probes, detecting penA and rpoB genes respect-
ively, were labeled with a different ﬂuorophore (LC-Red640 or
LC-Red705, respectively) and read in two different channels.
The results were compared with those obtained by the E-test
and by sequencing the ampliﬁed genes.
Results: A total of 77 N. meningitidis strains, isolated from
patients with meningococcal invasive disease, and collected by
the Reference Laboratotory (RL) , were tested. Among them, 30
were PenI and 7 RifR; 1 strain was both PenI and RifR. RifR
strains showed a Tm of 49C compared to a Tm of 55C of RifS
strains by reading the emission of ﬂuorescence in the 705
channel. PenI strains showed a Tm of 55C and PenS strains a
Tm of 45.5C by reading the emission of ﬂuorescence in the 640
channel. The results were easy to be interpreted and always in
agreement with those obtained by E-test and by sequencing.
Conclusion: This molecular assay is able to distinguish RifR
and PenI meningococcal phenotypes in the same reaction tube.
The sensitivity and speciﬁcity of this assay make it suitable for
direct use on clinical samples to obtain a rapid result of the
antibiotic susceptibility.
P628
Quantitative detection of S. pneumoniae,
H. inﬂuenzae and M. catarrhalis in lower
respiratory tract samples by real-time PCR
M.Kais, C. Spindler,M.Kalin, A˚. O¨rtqvist, C. Giske (Stockholm, S)
Objectives: Quantitative lower respiratory tract culture is an
important diagnostic tool for bacterial respiratory tract infec-
tions, but is relatively insensitive and takes at least 24 h. Recently
the interest for a rapid and more sensitive diagnostic method has
lead to evaluation of the properties of PCR, but a consistent
problem has been distinguishing colonization from infection. To
our knowledge, the potential for overcoming this problem by
using quantitative PCR (Q-PCR) has not been investigated. We
have therefore evaluated the usefulness of Q-PCR for increasing
signiﬁcant pathogen detection in lower respiratory samples.
Methods: We investigated 203 (106 sputum, 51 bronchial brush,
46 BAL) consecutive respiratory tract samples collected at
Karolinska University Hospital, Solna. Following DNA extrac-
tion samples were subjected to Q-PCR, using primers targeting
the genes ply (S. pneumoniae), frdB (H. inﬂuenzae) and copB
(M. catarrhalis). DNA extracted from positive controls with
known CFU/mL was included in all PCR-runs, allowing later
estimation of CFU/mL for the test samples. In parallel, a blinded
assessment of quantitative cultures from all samples was
performed. Signiﬁcant pathogen ﬁnding by culture and Q-PCR
was deﬁned as ‡100.000 CFU/mL, for Q-PCR an estimate from
the amount of DNA present.
Results: Signiﬁcant pathogens were found in 45/203 (22.2%)
samples with culture and in 68/203 (33.5%) with Q-PCR. The
absolute increase in pathogen ﬁnding with Q-PCR was 23/203
(11.3%). The largest increase in signiﬁcant pathogen ﬁnding was
seen for H. inﬂuenzae, where a net increase of 13/203 (6.9%) was
observed with Q-PCR (19 additional, 6 missed). Signiﬁcant
culture and insigniﬁcant Q-PCR was only found in sputum
samples; in 2/203 (1.0%) samples with S. pneumoniae, in 6/203
(3.0%) samples with H. inﬂuenzae, and in 1/203 (0.5%) samples
with M. catarrhalis.
Conclusions: Q-PCR substantially improved signiﬁcant patho-
gen detection in the examined samples. The relative increase in
signiﬁcant pathogen ﬁnding with Q-PCR compared to culture
was 51.1%. Underestimation of CFU/mL with Q-PCR could be
due to inhibition of the PCR reaction or alternatively to
mutations in target genes leading to lower afﬁnity of the
primer. Q-PCR is a rapid method that can be implemented in
most laboratories. In an optimized setting, a Q-PCR result can be
achieved within 5 h after collecting the sample from a patient.
P629
Assessment of the MagNa pure compact system
for extraction of Neisseria meningitidis and
Streptococcus pneumoniae DNA from clinical CSF
and blood specimens
B. Ninet, I. Jan, G. Renzi, J. Schrenzel (Geneva, CH)
The use of molecular diagnostic tests in medical microbiology
has highlighted the need for a simple, rapid and efﬁcient
method of nucleic acids extraction. The evaluation of the new
MagNa pure compact system (Roche Diagnostic Ltd.) was
performed to detect bacterial DNA in CSF and blood samples.
The recovery of DNA of the two major pathogens causing
bacterial meningitis was analysed with an automatic extraction
and real-time PCR ampliﬁcation of the ctra gene (capsular
transport gene) for Neisseria meningitidis and ply gene (pneum-
olysin gene) for Streptococcus pneumoniae. CSF and whole blood
samples were spiked with a strain of Neisseria meningitidis 2711
and a strain of Streptococcus pneumoniae ATCC 6305 in order to
obtain dilutions of 10 000 to 1 bacteria per millilitre. Two
hundred microliters were directly extracted with the nucleic
acid isolation kit I and the blood protocol of the MagNa pure
compact system after a short pre-treatment of enzymatic and
buffer lysis. Fifty seven specimens of CSF samples were also
tested with the same protocol. For the two pathogens, the
sensitivity of DNA extraction was 100 bact/ml for CSF samples
and 1000 bact/ml for blood sample. This corresponds to 1–2 and
10 bacteria in our assay of CSF and blood, respectively. Among
the 57 CSF tested, 12 were PCR positive for Streptococcus
pneumoniae and 3 for Neisseria meningitidis. Cases positive by
culture (n = 10 for S. pneumoniae, n = 1 for N. menigitidis) were
all identiﬁed by our assay. Furthermore, we detected on
additional 3 cases of infection. No inhibition of ampliﬁcation
Signiﬁcant
Q-PCR ﬁndings
(n = 203)
Signiﬁcant culture ﬁndings (n = 203)
S. pneumoniae H. inﬂuenzae M. catarrhalis None of these
S. pneumoniae 12 (5.9%) – – 11 (5.4%)
H. inﬂuenzae – 16 (7.9%) – 19 (9.4%)
M. catarrhalis – – 8 (3.9%) 2 (1.0%)
None of these 2 (1.0%) 6 (3.0%) 1 (0.5%) 141 (69.5%)
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was recorded. The MagNa pure compact system allowed an
efﬁcient and reliable DNA extraction of both gram–positive and
gram-negative bacteria in about twenty minutes, provided a
pre-lysis step is included. Implementation of such strategy is
currently evaluated in our routine procedure.
P630
Analysis of mutations within quinolone
resistance determining regions of S. pneumoniae
clinical isolates collected from TARGET
surveillance during 2003
I. Morrissey, S. Buckridge, D.J. Farrell (London, UK)
Objectives: To compare ﬂuoroquinolone (FQ) susceptibilities
and determine the prevalence of QRDR mutations in recently
circulating S. pneumoniae (SP) strains.
Methods: SP were collected from centres within Europe, USA,
Mexico and South Africa. LEV, gatiﬂoxacin (GATI) and moxiﬂ-
oxacin (MXF) MICs were determined by microbroth dilution.
Approx. 20% of SP with LEV MIC of 1 mg/L and all SP with
LEV MIC of 2 and above were chosen for analysis. QRDR
regions for parC, parE, gyrA and gyrB were ampliﬁed by PCR
and DNA sequences determined.
Results: No isolate of intermediate susceptibility to LEV
(MIC = 4 mg/L) was found. Out of 3233 SP submitted 39 were
LEV resistant (res). Of these, 33 were res to GATI and 10 res to
MXF. QRDR amino acid changes are indicated in the Table.
[Key: 1 ParC-S79F, 2 ParC-S79Y, 3 ParC-S79R, 4 ParC-D83N, 5
ParC-D83Y, 6 ParE-D435N, 7 GyrA-S81F, 8 GyrA-S81Y, 9 GyrA-
E85A, 10 GyrA-E85G, 11 GyrA-E85K, ND not determined.]
Other QRDR changes were also found but these were not related
to FQ resistance (data not shown). Few isolates with LEV MIC of
1 mg/L possessed ‘silent’ mutations, but 42% of LEV MIC
2 mg/L did. These changes were mainly in the S79 residue of
ParC (1 SP carried a S81F GyrA change). These ‘silent’ SP are
only 1 step away from full LEV resistance. The mode GATI or
MXF MIC for these SP was 0.5 or 0.25, respectively. Most LEV-
res SP (MIC ‡ 8 mg/L) had 2 QRDR changes and those with
additional changes had higher LEV MICs.
Conclusions: A large proportion of borderline LEV-susceptible
isolates possessed silent parC mutations. These have the
potential to select full FQ resistance in the future. The use of
more potent FQs, such as MXF, that show less cross-resistance to
LEV than GATI may reduce the likelihood of this occurring.
P631
Non-haemolytic isolates of serotype 1
pneumococci
J.M.C. Jefferies, L. Kirkham, A. Smith, S.C. Clarke,
T.J. Mitchell (Glasgow, UK)
Introduction: The pneumococcus can be divided into over 90
different serotypes on the basis of capsular polysaccharide
which is one of the primary virulence factors of the organism.
Pneumococci can be carried asymptomatically in the human
nasopharynx and only rarely go on to cause invasive pneumo-
coccal disease (IPD). Pneumococci of serotypes 4, 9V, 14, 19F,
23F, 18C and 6B are more prevalent in IPD and are included in
the recent heptavalent conjugate vaccine. Serotype 1 is not
included in this vaccine. However serotype 1 pneumococci have
been linked to disease outbreaks, cause a high burden of disease
in developing nations and has been associated more with
disease than carriage. The cholesterol dependent cytolysin
pneumolysin (Ply) is an important multi-functional virulence
factor of the pneumococcus. The important activity of the toxin
in serotype 1 disease remains unclear as some invasive serotype
1 pneumococci express a non-haemolytic/very weakly haemo-
lytic version.
Objectives: To investigate variability in gene sequence protein
sequence, expression levels and activity of Ply from serotype 1
clinical isolates of S. pneumoniae. The gene sequences and
functional activities of Ply from 30 serotype 1 pneumococci were
investigated
Methods: MLST analysis to determine relatedness of isolates.
Ampliﬁcation of ply gene by PCR and DNA sequencing of
amplicons. Haemolytic Assays of cell lysates to determine in
vitro haemolytic activity. SDS PAGE, Western blot and Elisa to
determine in vitro expression levels.
Results: The 30 isolates were made up from four ST types; the
majority of isolates belonged to two related STs (ST306 and
ST227) and were considered part of the same clonal group. Over
half of the isolates were non-haemolytic despite producing high
titres of Ply. The majority of non-haemolytic isolates belonged to
ST306. We also identiﬁed an 8aa insertion from a non-haemo-
lytic ST227 isolate. Preliminary sequence analysis shows that
some serotype 1 Ply alleles differ from the 21 alleles observed
previously from clinical isolates in our laboratory and are
unique when compared to known Ply sequences.
Conclusions: Some serotype 1 pneumococci express novel Ply
alleles. Some serotype 1 pneumococci isolated from IPD produce
a non-haemolytic or very weakly haemolytic form of Ply. Non-
haemolytic forms of Ply are associated with ST306
P632
Phenotypic and genotypic characterisation
of ‘atypical’ Streptococcus pneumoniae isolates by
MLST
C. Heeg, C. Franken, M. van der Linden, A. Al-Lahham,
R.R. Reinert (Aachen, D)
Objectives: The aim of this study was to analyze the pheno-
typic and genotypic characteristics of Streptococcus pneumoniae
isolates presumptively identiﬁed as ‘atypical’ pneumococci and
the comparison with the novel species Streptococcus pseudopneu-
moniae. We describe the genetic relationships and critically
discuss the value of conventional identiﬁcation tests.
LEV MIC mg/L (N)
QRDR change 1 (508) 2 (57) 8 (18) 16 (16) 32 (4) 128 (1)
None 502 33 – – – –
1 1 12 – – – –
2 1 4 – – – –
3 – – – – – –
4 – 1 – – – –
5 – 1 – – – –
6 – 5 – – – –
7 – 1 1 – – –
1 & 7 – – 6 11 – –
1 & 9 – – 2 – – –
1 & 10 – – 4 1 – –
1 & 11 – – – 1 1 –
2 & 6 – – 1 – – –
2 & 7 – – 2 – – –
2 & 8 – – – 1 1 –
2 & 11 – – – – 1 –
3 & 8 – – – 1 – –
4 & 7 – – 1 – – –
6 & 7 – – 1 1 – –
1,7 & 5 – – – – 1 –
2,5,7 & 9 – – – – – 1
ND 4 – – – – –
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Methods: We analysed 12 atypical pneumococcal isolates from
patients with invasive diseases from Germany, Spain and
France. The following identiﬁcation procedures were per-
formed: optochin sensitivity (in 5% CO2 and ambient air), bile
solubility, capsular serotyping using the Neufeld Quellung
Reaction, DNA probe test (AccuProbe) and biotyping (API
Strep32). The analysis of the genotypic characteristics included
autolysin (lytA), pneumolysin (ply) and pneumococcal adhesin
A (psaA) detection by PCR, 16S rRNA sequencing and multi-
locus sequence typing using seven housekeeping genes (aroE,
gdh, gki, recP, spi, xpt, ddl).
Results: Nine isolates were positive by the DNA test. The
remaining three isolates showed typical pneumococcal charac-
teristics such as bile solubility, optochin sensitivity or positive
Quellung reaction. Interestingly, seven isolates showed optochin
susceptibility identical to S. pseudopneumoniae: they were resist-
ant after incubation in 5% CO2 and sensitive when they were
incubated in ambient atmosphere. Nearly all strains were
uncapsuled (rough); only three isolates were serotype 14.
Pneumococcal genotypic characteristics could be determined
as follows: ply (all isolates n = 12), lytA (n = 6) and psaA
(n = 2). MLST demonstrated all strains to belong to new
sequence types.
Conclusions: Differentiation of S. pneumoniae from certain other
‘viridans group’ and S. pseudopneumoniae remains difﬁcult. The
detection of pneumococcal virulence genes for ply or lytA seem
to be problematic because novel studies reported of their
presence in S. mitis or oralis. Especially the description and
classiﬁcation of ‘atypical’ pneumococci often leads to presump-
tive exact results which have to be regarded critically because of
the great DNA-similarity within the group of streptococci.
MLST is a useful tool for differentiation of ‘atypical’ pneumo-
cocci.
P633
Real-time PCR based on the ampliﬁcation of a
gene fragment of pneumococcal surface antigen A
in the identiﬁcation of Streptococcus pneumoniae
A. Saukkoriipi, T. Kaijalainen, L. Kuisma, M. Leinonen
(Oulu, FIN)
Objectives: It has recently been found that some alfa-hemolytic
streptococci other than pneumococci may harbour genes enco-
ding pneumococcal virulence factors, mainly pneumolysin (ply).
This could present a problem, as many PCR methods for
S. pneumoniae are based on detection of pneumolysin gene.
Pneumococcal surface antigen A (PsaA) has previously been
demonstrated in all of the 90 currently known serotypes of
S. pneumoniae (1). Our aim was to develop a real-time PCR
method for rapid detection of a fragment of PsaA encoding
gene, to analyse pneumococcal and nonpneumococcal strains
using the method and to compare results to those obtained
using our previously published ply real-time PCR method (2).
Methods: The forward primer used was adapted from Morri-
son et al. (1). A new reverse primer was designed using
VectorNTI Suite v6 (Informax). A hybridization probe pair was
designed and synthesized at TibMolbiol and at the same time
additional nucleotides were added to the 5’ end of the primers to
get a higher melting temperature of primers. Real-time PCR was
done using the LightCycler (Roche Diagnostics). Speciﬁcity of
the PsaA PCR method was studied by analysing 28 nonpneu-
mococcal bacterial strains, including DNA extracted from
freshly grown S. mutans (1 strain), S. mitis (2), S. agalactiae (2),
S. bovis (1), S. pyogenes (2) and S. sanguis (2), human DNA and
cytomegalovirus DNA. Additionally, 97 nasopharyngeal
alfa-hemolytic streptococcal strains were studied, among which
were 65 strains identiﬁed aspneumococci (optochin sensitive, bile
soluble) and 9 strains previously found difﬁcult to identify.
Results: The PsaA real-time PCR method was found to
speciﬁcally detect pneumococcus. None of the other DNA:s
tested were ampliﬁed and detected using the method. All 65
pneumococcal strains were positive by PsaA real-time PCR.
All 9 alfa-hemolytic streptococcal strains that had given
aberrant results in different identiﬁcation tests previously
(optochin test, bile solubility, ply PCR) were negative by PsaA
PCR.
Conclusions: PsaA real-time PCR is a rapid method for detect-
ing and identifying pneumococci. Since increasing numbers of
studies report that other alfa-hemolytic streptococci may har-
bour the ply gene, PsaA real-time PCR could be used for
conﬁrmation of pneumococci in samples that give a positive or
aberrant result in pneumolysin based PCR. Ref: (1) Morrison
et al. 2000, J Clin Microbiol 38:434–7. (2) Saukkoriipi et al. 2002,
Mol Cell Probes 16:385–90.
P634
Chlamydophila psittaci in fulmars on the Faroe
islands – a disease risk to humans?
B. Herrmann, H. Persson, J.-K. Jensen, H. Debes Joensen,
M. Klint, L. Chytraeus, B. Olsen (Uppsala, Kalmar, S; Nolsoy,
Torshavn, FO)
Background: Birds are natural hosts for Chlamydophila psittaci,
but also mammals and humans can be infected. In the 1930ties
C. psittaci caused severe epidemics with 20% fatality rate on the
Faroe Islands. The infections were associated to catching of the
seabird fulmar Fulmarus glacialis. The knowledge of the C. psittaci
prevalence among fulmars and its implication for risk of human
disease is scarce.
Objective: To investigate the prevalence of C. psittaci in fulmars
on the Faroe Islands and relate it to reported zoonotic infections.
Methods: Juvenile fulmars were caught on the sea surface in
the northern archipelago of the Faroe Islands. Fecal swab
samples were collected and after transportation to Sweden.
DNA was prepared and examined by real time PCR (DeGraves
et al, J Clin Microbiol 2003, 41:1726–9). DNA sequencing of
ompA was done by using terminator labeled cycle sequencing in
a modiﬁed version of a previous description (Herrmann et al
Appl Environ Microbiol 2000, 66:3654–6). Information about
human C. psittaci infections were obtained from The Chief
Medical Ofﬁce.
Results: Of 431 juvenile fulmars were 43 (10%) detected to be
infected by C. psittaci. The prevalence differed between 8% and
21% in different catchment areas, suggesting variation in
C. psittaci attack rate on different nesting rocks. Analysis of the
ompA gene from 29 C. psittaci cases resulted in identical
sequences that also was identical to the type strain 6BC, that was
isolated from a parakeet. Considering previously reported strain
variation of C. psittaci among birds, it was surprising that ompA
was conserved in fulmars and identical to the prototype strain
isolated 63 years ago. Catchment and preparation of juvenile
fulmars for domestic food implies heavy exposure to eventual
occurrene of C. psittaci. Nevertheless, on average only one case
per year (range 0–8) of psittacosis has been reported from the
Faroe Islands since 1954, and of these no case was fatal.
Conclusion: The risk for humans to acquire symptomatic
C. psittaci infection from fulmars, and probably from all wild
birds, is very low.
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P635
Suitability of a single throat swab specimen for
the detection of M. pneumoniae, C. pneumoniae
and Legionella spp. in respiratory specimens by
nucleic acid ampliﬁcation techniques
K. Loens, T. Beck, K. Dirven, D. Ursi, M. Overdijk, P. Sillekens,
H. Goossens, M. Ieven (Edegem, B)
Introduction: The advantage of nucleic acid ampliﬁcation
techniques (NAAT) is their extreme sensitivity and speciﬁcity
when compared to traditional techniques. Multiplex formats
might solve the practical shortcoming of detecting only the
infectious agent that is searched for. Real-time assays enable a
one-tube assay, reducing the assay time and limiting potential
contamination between samples. A comparison between differ-
ent NAAT is needed.
Objectives: To compare the sensitivity and speciﬁcity of con-
ventional nucleic acid sequence-based ampliﬁcation (cNASBA),
real-time (RT) mono- and multiplex NASBA, and mono-PCR for
the detection of M. pneumoniae (M. pn), C. pneumoniae (C. pn)
and Legionella spp. (Leg) on a single throat swab from hospit-
alized and outpatients with community-acquired pneumonia
(CAP).
Methods: 215 dry throat swab specimens from patients with
CAP, collected all over Europe, were investigated by in-house
mono PCR, conventional NASBA, RT mono-NASBA, and RT
multiplex NASBA, respectively. Deﬁnition of the expanded gold
standard used to calculate the sensitivities of the tests applied:
true positive if positive by at least two NAAT.
Results: 5/215 swabs were found to be positive for C. pn. by all
NAAT. Two additional specimens were found to be C. pn
positive by conventional NASBA. Leg was detected in 2, 1, 0, 0
swabs by PCR, cNASBA, RT mono- and multiplex NASBA
respectively. Total numbers of positives for C. pn. and Leg were
too low to calculate sensitivities and speciﬁcities. M. pn was
detected in 12, 16, 10, 8 swabs by PCR, cNASBA, RT mono- and
multiplex NASBA respectively The sensitivities of the different
techniques, compared to an expanded gold standard, were 69%,
100%, 63% and 50% for detection of M. pn by PCR, cNASBA, RT
mono- and multiplex NASBA respectively. If positive by any
method, the sensitivities were 71%, 94%, 59% and 50% for
detection of M. pn by PCR, cNASBA, RT mono- and multiplex
NASBA respectively.
Conclusions: Previously obtained results on sensitivity were
conﬁrmed: the slightly lower sensitivity of the multiplex assay
for the detection of M. pn and Leg when compared to the mono
real-time and conventional assay. Lower sensitivities of the
NASBA assays for the presence of M. pn and Leg species were
observed, which could be due to RNA degradation.
P636
Evaluation of the NucliSens mini MAG RNA
extraction and real-time NASBA applications for
the detection of M. pneumoniae and
C. pneumoniae in throat swabs
K. Loens, D. Ursi, M. Overdijk, P. Sillekens, H. Goossens,
M. Ieven (Edegem, B)
Introduction: A new nucleic acid isolation method, the Nucli-
Sens mini MAG (bioMe´rieux, The Netherlands), was developed
based on the Boom nucleic acid extraction method in combina-
tion with magnetic silica particles. Real-time NASBA applica-
tions have been developed for the detection of M. pneumoniae
and C. pneumoniae.
Objectives: To evaluate the performance of the mini MAG
combined with real-time NASBA applications for the detection
of M. pneumoniae and C. pneumoniae in a single throat swab from
hospitalized patients with community-acquired pneumonia
(CAP).
Methods: Nucleic acids were extracted from aliquots of 215
throat swab specimens from patients with CAP, collected all
over Europe, bymanual Boom extraction and, retrospectively, by
using the NucliSens mini MAG. Nucleic acid extracts from the
former were investigated by in-house real-time mono NASBA,
from the latter by real-time NASBA applications containing an
internal control RNA (bioMe´rieux). Real-time detection was
done on the NucliSens EasyQ Analyzer (bioMe´rieux).
Results: All ﬁve C. pneumoniae positive samples were positive
by all techniques used. No invalid results were reported. Fifteen
specimens were found to be M. pneumoniae positive: 4/15 swabs
were positive by all techniques used, 5/15 were positive by PCR
and the mini MAG in combination with the real-time NASBA
application, 4/15 were only positive by manual Boom extraction
and in house real-time NASBA and 1/15 was only positive by
PCR. When a truly positive was deﬁned by positivity in both
ampliﬁcation or extraction methods, sensitivities of PCR,
manual Boom extraction and minimag were 100%, 40% and
90% and speciﬁcities were 100%, 98.0% and 100%, respectively.
Fourteen samples (6.5%) gave an invalid M. pneumoniae result
due to the absence of the signal of the internal control when
using the M. pneumoniae real-time application.
Conclusions: The NucliSens mini MAG and the real-time
NASBA applications were successfully combined to detect
C. pneumoniae and M. pneumoniae RNA in throat swabs. This
combination is simple, easy and fast.
P637
Investigation of Chlamydia pneumoniae and
Mycoplasma spp. in clinical specimens from
patients with arthritis
C. Contini, S. Seraceni, M. Giuliodori, D. Segala, R. Cultrera,
M. Govoni, F. Trotta (Ferrara, I)
Objectives: Chlamydia-induced arthritis is the most frequent
form of reactive arthritis in Western countries. Recent advances
in the standardization of polymerase chain reaction techniques
has accounted for considerable progress in identiﬁcation of
Chlamydia. Although C. pneumoniae is often detected by
molecular assays, it is rarely investigated with a panel of
multiple genes in different human ﬂuids. We mainly focused in
the ampliﬁcation and detection of DNA and or mRNAs
fragments from Chlamydia and Mycoplasma genome.
Methods: PCR and RT-PCR were used to assess bacterial DNA
and mRNA transcripts on 40 specimens from 12 patients with
undeﬁned arthritis. Specimens including sinovial ﬂuid, PBMC
and serun samples, were analysed by either nested polymerase
chain reaction (n-PCR) or touchdown PCR for Mycoplasma and
C. pneumoniae with primer sets targeting the 16S-rRNA and
urease gene ofMycoplasma spp. andU. urealyticum and the major
outer membrane protein (MOMP), the 16S rRNA and the Heat
shock Protein 60–70 (Hsp-60–70) of C. pneumoniae. A molecular
study to evaluate genetic diversity among isolates of both
pathogens and to compare bacterial sequences was done.
Results: Five out 12 (41.6%) patients (10/33 specimens) were
found n-PCR positive for C. pneumoniae Momp (21.2%) or 16s
rRNA (24.4%); two patients (16.6%) did also show HsP-60 gene.
One C. pneumoniae negative specimen was found positive for
Mycoplasma hominis. Four specimen (including those HsP+)
were also positive by rt-PCR. Chart analysis revealed that
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C. pneumoniae positive specimens were from patients with
psoriatic arthropaty, atipic arthritis, rheumathic polymialgy
and reactive arthritis. The Mycoplasma hominis positive speci-
men was from a patient with psoriatic artrhopaty. Previous
serological analyses provided no evidence of recent exposure to
both pathogens.
Conclusion: Molecular biology not only has improved the
ability to detect Chlamydia in the joint for diagnostic purposes
but also has extended the current understanding of whether the
organism triggers or perpetuates disease. In two patients, the
detection of MOMP and 16s rRNA C. pneumoniae gene in either
blood or sinovial ﬂuid was together with the metabolic active
HsP-60 transcripts. This ﬁnding together with the genetic
background of the patients, may indicate an alternate state
used by Chlamydia to escape the immune system of the host
and cause worsening of disease.Grants of MIUR 04, CA.RI.FE.
and CA.RI.CE. Foundations
P638
Comparison of ﬁve PCR methods and culture in
detection of Chlamydia pneumoniae in mouse
lungs
L. Erkkila¨, N. Lehtonen, P. Saikku, M. Leinonen (Oulu, FIN)
Objectives: Chronic C. pneumoniae infection has been associated
with atherosclerosis and pulmonary diseases. The aim of this
study was to evaluate ﬁve PCR methods and culture in detection
of C. pneumoniae in the lungs of infected mice at different disease
stages.
Methods: NIH/S mice were infected intranasally with C. pneu-
moniae K6 or K7 isolates, and reinfected 56 days later. Samples
from the lungs were taken after both infections. Samples were
cultured in Vero cells, and DNA was extracted using QIAamp
Tissue Kit. Five PCR methods were used: 1) single-step hot start
PCR, 2) nested PCR, 3) hot start PCR-TRF (time-resolved ﬂuores-
cense), 4) and 5) Light Cycler real-time quantitative hot start PCR
with two different primer-probe –sets. In methods 1 and 2, PCR
products were visualized in agarose gel, and in methods 3 to 5,
liquid hybridisationwas used. StandardDNAwas obtained from
puriﬁed elementary bodies of isolate K7.
Results: With the puriﬁed C.pneumoniae DNA, the sensitivity
of all the ﬁve PCR methods was <2 genome equivalents. In the
mouse lung specimens taken on days 3–14 after primary
infection, the sensitivities of all methods were high. However,
at day 24 p.i., the sensitivities of PCR methods 1 and 2 and
culture were markedly lowered compared to the methods 3–5.
After reinfection, the decreased sensitivities of PCR methods 1
and 2 and culture compared to methods 3 to 5 became obvious
already at day 9 p.i., and after that, no positive ﬁndings were
obtained with methods 1 and 2 and culture. Among 20 samples
obtained at days 21 and 31 after reinfection, 11 were positive
with one, and 8 with at least two of the methods 3 to 5. As a
whole, the sensitivity of methods 3 to 5 was >90% in all culture-
positive, and 60 to 71% in culture-negative samples. The
sensitivity of methods 1 and 2 decreased below 90% when the
IFU counts in culture decreased below 1000–10000 IFU/sample,
and was only 2 to 7% in culture-negative samples. The
correlation between genome quantiﬁcation and IFU counts
was weaker after the reinfection than after the primary infection.
Conclusions: As a conclusion, the sensitivities of PCR methods
and culture correlated very well during the acute phase of
C. pneumoniae infection, but, along with decreased numbers of
viable chlamydia, the correlation decreased. In addition, the
selection of PCR method affects positive ﬁndings. This may also
demonstrate difﬁculties in detection of C. pneumoniae especially
in chronic infections.
P639
Real-time multiplex PCR for the detection of
Legionella species in respiratory samples
J.M. Bangsborg, B. Erlang, H. Vinner (Herlev, DK)
Objectives: Legionella species cause life-threatening pneumonia
and a fast diagnostic method is crucial for the correct treatment
and the survival of the patients. Since 1998, a conventional PCR
with agarose gel detection (LA-PCR) has been in use at our
laboratory for the detection of Legionella species in respiratory
samples. We sought to develop a real-time multiplex PCR with
an internal control using the SYBR Green format (LC-PCR) and
melting point analysis, with the advantage of even quicker, and
possibly, more speciﬁc results.
Methods: Sixty-two specimens from patients previously found
positive by the LA-PCR (positive reaction for L. pneumophila), of
which 37 were conﬁrmed by culture or other methods, 26
specimens with a positive reaction for Legionella species in the
LA-PCR, and 117 LA-PCR negative specimens were the study
material. Seven primers targeting the 5 S rDNA and the mip
genes were applied with the FastStart SYBR Green using the
LightCycler (Roche), together with an internal synthetic DNA
control (IPC), ampliﬁed by two of the primers. The IPC was
titrated to ensure minimal competition for the primers.
Results: The sensitivity of the LC-PCR was 50 genome copies.
Melting points for the 5 S rDNA product was 82.2 ± 0.6C for
the positive control and 82.0 ± 0.3C for the positive patient
samples. All specimens positive for L. pneumophila by the LA-
PCR were positive with the LC-PCR. Interestingly, only the
ampliﬁcation product representing the 5S rDNA target was
visualised in the ﬂuorescence plot, whereas an ensuing agarose
gel electrophoresis revealed both the 5 S rDNA and the mip
products. This is probably due to preferential binding of the
SYBR Green to the 5 S rDNA product rather than the mip
product (Giglio et al. 2003). Of the 26 samples positive for
Legionella species by the LA-PCR, only 11 (of which 8 were from
patients with conﬁrmed Legionella infection by other methods)
could be conﬁrmed by the LC-PCR.
Conclusion: A multiplex real-time PCR for the detection of
Legionella species was established. With the LC-PCR, response
time can be shortened by several hours, with a sensitivity
comparable to the LA-PCR and with a higher speciﬁcity.
P640
International pilot proﬁciency programme for the
molecular detection of Legionella pneumophila on
respiratory samples
R. De Mendonc¸a, N. Maes, M. Ieven, M.J. Struelens for the
QCMD Working Party on Respiratory Infections
Objectives: To assess the proﬁciency of laboratories performing
of nucleic acid ampliﬁcation technologies (NATs) for the
detection of L. pneumophila in European and other countries.
Methods: Bronchoalveolar lavage specimens (BAL) were
pooled from patients with other diagnosis than legionellosis.
Each specimen was individually tested negative by PCR and
cultured for Legionella before pooling. The presence of inhibitors
in the PCR was assessed. The test panel consisted of 10 heat-
inactivated BAL or phosphate buffered saline (PBS) samples,
composed of 6 samples spiked with 18, 1.8 · 103 or
1.8 · 105 cfu/ml of L. pneumophila sg 1 reference strain ATCC
33152 and four negative samples. The panels were distributed
by courier at room temperature. To compare performance, a
scoring system was applied: 2 points for a correct result, 1 point
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for an equivocal result and 0 point for an incorrect result. A
maximum score of 20 points was attainable.
Results: A total of 38 data sets were returned from 34
participant laboratories (85%). Fourteen countries were repre-
sented. The mean performance score was 15.6 and 13.0 for in-
house and commercial assay methods, respectively. Thirty-four
(89.5%) data sets reported qualitative results only and 4 (10.5%)
data sets reported both qualitative and quantitative results.
Correct results for the entire panel were reported in 3 (7.9%)
data sets, one incorrect or equivocal results was reported in 8
(21%) data sets and 27 (71.1%) data sets had two or more
incorrect or equivocal results. BAL samples were more fre-
quently identiﬁed correctly compared to PBS samples. False
negative results were reported in 68 (29.8%) of all tests
performed on positive samples. False positive results were
reported in 6 (4%) negative samples.
Conclusion: The mean performance score (15.6) was very
satisfactory, considering the inclusion of two challenging low
inoculum samples (18 cfu/ml). Higher performance scores (18–
19) were obtained if those samples are excluded. Twenty-seven
participant centres (71.1%) achieved a score of 16 or higher.
Single PCR showed a lack of sensitivity compared to real-time
PCR based assays.
P641
An in-ﬁeld hygiene-epidemiological
demonstration of the true relations between a
case of legionellosis and single spot exposure to
L. pneumophila from shower on board a
Norwegian seismic vessel in the Gulf of Mexico
C. Ahle´n, M. Aas (Trondheim, N)
Introduction: Legionellosis is a life-threathening illness which
to a high degree is shown to be caused by Legionella pneumo-
phila. Most well known are the outbreaks from air condition
systems, which regularly are seen from hotels and hospitals
around the world. Although outbreaks connected to showers
and bobble-pooles are discussed, speciﬁc demonstration of true
genetical relations between infection and speciﬁc exposure have
only infrequently been presented. In this paper we present a
case of legionellosis, occurring on board a ship in the Gulf of
Mexico, diagnosed at a hospital in Norway, epidemiologically
surveyed on board and identiﬁed as being connected to one
certain shower on board the ship.
Material and Methods: The hygiene-epidemiological surveys
were done by water samplings and swabs from showers in all
cabins on board (n = 39). In addition, swabs were taken from
each of the shower hoses and taps giving a total number of
samples of 136. The samplings were analysed by screening using
L. pneumophila-speciﬁc RealTime PCR (Roche), cultivation of the
positive RT-PCRs, serotyping (BioRad)of the live isolates and
further genotyping (PFGE).
Results and discussion: The RT-PCR screening revealed pos-
itive results of L. pneumophila genetic material from 18 of the 39
cabins (46%). Cultivation rendered live L. pneumophila from 22
spots and of these, 21 were L. pneumophila, serotype 1. The
epidemiological relations were determined by PFGE analyses
showing four different genotypes, of which one was dominant
in the environment. Among the other three genotypes, two were
found in more than one spot, while one of the genotypes only
was found in one spot. The latter was identical to the infection
genotype, and was not found in the shower of the cabin
belonging to the patient but from the shower in a guest cabin not
in ordinary use, but used in connection with sunbathing on
deck. In conclusion, use of screening investigations by of speciﬁc
L. pneumophila-PCR seem to be a good and rapid tool to indicate
speciﬁc exposure. By further analyses including cultivation,
serotyping and genotyping, the true source are possible to
identify also in environments which are strongly contaminated
with Legionella.
P642
Detection of Legionella spp by a multiplex real
time PCR based on the rnpB gene
M. Klint, S. Bernander, J. Etienne, M. Ullberg,
B. Herrmann (Uppsala, S; Lyon, F)
Objective: To develop a multiplex real time PCR for detection
of the most important species in the Legionella genus.
Methods: The rnpB gene, coding for the RNase P RNA, was
determined for 40 species speciﬁc reference strains of Legionella
and all 15 serogroups of L. pneumophila. A set of three primers
and a TaqMan probe for speciﬁc analysis of L. pneumophila was
designed. In addition seven primers and a group speciﬁc probe
were selected for detection of L. anisa, L. bozemanii, L. dumofﬁi,
L. feeleii, L. gormanii, L. longbeachae and L. micdadei. Species
identiﬁcation of non-pneumophila species was performed
by terminator labeled cycle sequencing of the ampliﬁcation
product.
Results: The rnpB gene had species speciﬁc sequences for 38
species, while identical sequences were found for L. micdadei and
L. maceachernii. For L. pneumophila 8 sequence variants were
found. In the real time PCR the detection limit for L. pneumophila
was 10 genome copies per reaction. For other Legionella spp the
sensitivity was typically between 10 and 60 copies when using a
mix of primers. In addition to the above mentioned species, nine
other Legionella spp of less medical importance were detected at
varying copy numbers. A sensitivity comparison between our
method and the ProbeTec assay for detection of L. pneumophila
(BectonDickinson) showed that our method could detect a 200
fold higher dilution of a DNA preparation from a reference
strain. To analyse the detection capacity of the real time PCR ﬁve
clinical isolates/reference strains of the above mentioned Leg-
ionella species and 20 strains of L. pneumophila were tested. All
strains were detected, except one strain of L. feelii. This strain
had no mismatching sequence in the primer/probe regions that
could explain this failure. The speciﬁcity was assessed by using
a panel of DNA from 12 representative bacteria species and the
PCR resulted in no ampliﬁcation. Our method was further
assessed by examination of a quality assurance panel from the
European Working Group of Legionella Infections and all 10
specimens of L. pneumophila were detected.Evaluation of the
method for detection of Legionella spp in clinical respiratory tract
samples and environmental water samples is ongoing.
Conclusion: We have developed a sensitive and speciﬁc mul-
tiplex real time PCR for detection of the most important
Legionella species in clinical diagnostics.
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Molecular methods for enteric pathogens
P643
Comparison of VNTR analysis with PFGE and
REP-PCR for genotyping of pathogenic Yersinia
enterocolitica
I. de Benito,M.E.Cano, J.M.Garcı´a-Lobo, J. Agu¨ero (Santander, E)
Objective: Analysis of variable-number tandem repeat (VNTR)
sequences has proved to be a useful tool for molecular
epidemiology studies in bacteria. Identiﬁcation of a VNTR
locus in the genome of Yersinia enterocolitica (located at the 3’
side of orf528) has recently been described. We have evaluated
the usefulness of this polimorphic region analysis in comparison
to other well-established methods such as pulsed-ﬁeld gel
electrophoresis (PFGE) or repetitive extragenic palindrome PCR
(REP-PCR) to genotype clinical isolates of Y. enterocolitica.
Methods: We studied a total of 51 clinical isolates of
Y. enterocolitica serobiotype O:3/4 with no evident epidemio-
logical relationship, collected from different patients over seven
years, and clustered by VNTR analysis in 8 different alleles
according to the number of CCAGCA repeats they contained: 14
repeats (n = 6), 13 (n = 14), 11 (n = 5), 9 (n = 3), 8 (n = 9), 7
(n = 8), 5 (n = 1) and 4 (n = 5). These were all analysed by REP-
PCR, and 16 isolates, representative of the different alleles, were
further characterized by PFGE (NotI restriction).
Results: REP-PCR did not identify separate clusters among the
Y. enterocolitica isolates, as all showed identical patterns. NotI
generated 4 different PFGE-patterns with minor differences
between them. The combination of PFGE and VNTR analysis
divided both of the two predominant PFGE types into ﬁve
subtypes, increasing discrimination.
Conclusions: REP-PCR does not discriminate among Y. entero-
colitica isolates of the same biotype. PFGE identiﬁes different
genotypes but less so than the analysis of the polimorphic VNTR
locus. VNTR analysis provides a method that notably increases
the discriminatory power of other typing methods.
P644
Evaluation of molecular markers (PFGE,
PCR-RFLP-ﬂaA, MLST and PCR-RFLP-LG)
in Spanish C. jejuni isolates
J.A. Lo´pez-Portole´s, J.V. Galiano, J.C. Sanz, C. Simon,
A. Echeita (Majadahonda, Madrid, Castellon, Madrid, E)
Campylobacter jejuni has been established as the microorganism
to be the major cause of acute diarrhoeal disease in humans.
Bacteria showed high polymorphism and molecular diversity.
Objectives: The aim of this study was to evaluate the discrim-
inatory power of different molecular methods in strains closely
related (three outbreaks) and between strains non related.
Methods: Forty two C. jejuni strains were studied (thirty three
non relate isolates and nine isolates from three outbreaks). All
strains were molecularly characterized by pulsed-ﬁeld gel
electrophoresis (PFGE) digested separately with SmaI and
KpnI, ﬂaA restriction fragment length polymorphism (PCR-
RFLP-ﬂaA) using Dde I as the restriction enzyme, multilocus
sequence typing (MLST) based on the DNA sequences of an
aproximate 450 bp size fragments of aspA, glnA, gltA, glyA,
pgm, tkt and uncA housekeeping genes and LPS genes (LG)
restriction fragment length polymorphism (PCR-RFLP-LG)
digested separately with DdeI and CfoI. Serotyping was per-
formed on strains with a passive hemagglutination technique
and non-absorbed antisera, using a set of 33 different antisera
produced by ourselves.
Results: PFGE provided 25 and 30 different types for SmaI and
KpnI respectively (DI: 0,968 and 0,990). Using PCR-RFLP-ﬂaA 19
types were obtained (DI: 0,941). MLST identiﬁed 21 different
sequence types (DI: 0,949). By means of PCR-RFLP-LG geno-
typing method isolates were grouped in 15 and 14 types with
the enzymes DdeI and CfoI respectively (DI: 0,905 and 0,877).
Ten serotypes were found (DI: 0,911), one isolate reacted with
two antisera, cross-reactions (1 + 44) and seven isolates were
untypeable. All related strains within each outbreak showed
identical types in all tested methods.
Conclusions: All genotyping methods showed high Discrimin-
ation Indexes being PFGE the methods with the most discrim-
inatory power. The unambiguous nature of MLST, based on
sequence data, represents a signiﬁcant advantage over PFGE
and other gel-based methods and it is very useful for longitud-
inal studies of population structure. The results obtained
suggest that the combine use of PCR-RFLP-ﬂaA and PFGE
(with KpnI digestion) methods could be a good option for
identifying identity among isolates.This work has been suppor-
ted by the I + D + I project MCYT n: AGL2002 - 04480- C03 - 02.
P645
Comparison of different isolation and
identiﬁcation methods for thermophilic
Campylobacter species
O. Darka, D. Gur, Y. Akyon (Samsun, Ankara, TR)
Objectives: In this study different culture methods were com-
pared in order to optimize the recovery of thermophilic
Campylobacter species those were accepted to be associated
with diarrhoea in human. After cultivation all isolates were
identiﬁed to the species level by conventional and molecular
methods for comparison.
Methods: Rectal swab samples taken from 514 children with
diarrhoea were examined. All samples were diluted in PBS and
inoculated on to two CAT agar plates and one non-selective agar
plate by using the membrane ﬁlter method. One of the CAT agar
plates was incubated at 42C, the other one was incubated at
37C with the non-selective agar plate. At the identiﬁcation
stage, performance of biochemical reactions and restriction
enzyme analysis (REA) were compared. Bacterial DNA was
extracted by CTAB (Cetyltrimethylammonium bromide)
method and PCR was performed by using the previously
described primer pair THERM 1 and THERM 4. Following PCR
ampliﬁcation products were cut by AluI and Tsp509I.
Results: Thirty six (7%) Campylobacter strains were isolated. The
sensitivities of the CAT agar at 42C, CAT agar at 37C,
membrane ﬁlter were calculated as 86.1, 58.3 and 52.8%
respectively. CAT agar at 42C was found signiﬁcantly more
effective than the others in recovering thermophilic Campylobac-
ter spp. But ﬁve (13.9%) isolates were recovered only by the
membrane ﬁlter method. One of these ﬁve isolates was
C. upsaliensis. Thirty two (88.9%) isolates were deﬁned by
biochemical reactions while all of the isolates were succesfully
identiﬁed to the species level by REA. REA was found reliable
and faster than the conventional biochemical reactions. The
isolation rates of the species were calculated as C. jejuni 83.3%,
C. coli 13.9% and C. upsaliensis 2.8%.
Conclusions: According to our ﬁndings we recommend the
usage of CAT agar at 42C and the ﬁlter method in combination.
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Conventinal methods for identiﬁcation of thermophilic Campy-
lobacter s to the species level are cumbersome but REA is an easy
method to set up in a routine laboratory and can shorten the
time required for diagnosis.
P646
Identiﬁcation of plasmids by PCR-based replicon
typing
A. Carattoli, A. Bertini, L. Villa, V. Falbo, K. Hopkins,
J. Threlfall (Rome, I; London, UK)
Objectives: The dissemination of antimicrobial resistance is
largely attributed to the acquisition of resistance genes by
horizontal transfer mediated by plasmids. Plasmids are usually
classiﬁed in incompatibility (Inc) groups. Incompatibility is a
manifestation of relatedness, relying on common replication
controls (replicons, rep) or equipartitioning elements. The
identiﬁcation of plasmid by rep typing could represent a very
useful method to trace the diffusion of plasmids conferring
antimicrobial resistance to unrelated bacterial strains, and to
follow the evolution and spread of emerging plasmids. How-
ever, plasmid characterization by incompatibility typing is
limited by the laborious and time-consuming methodology
required, based on conjugation, transformation or on multiple
hybridization experiments performed with low-speciﬁc inc/rep
probes. These methods cannot be easily applied on a large
number of strains.The necessity of tracing plasmids conferring
drug resistance prompted us to develop a PCR-based replicon
typing method.
Methods: In this method, 18 couples of primers were devised to
perform 5 multiplex- and 3 simplex-PCRs, recognizing the
repFIA, repFIB, repFIC, repHI1, repHI2, repI1, repL/M, repN,
repP, repW, repT, repA/C, repK, repB/O, repX, repY repF, and
repFII replicons.
Results: Eighteen different replicons were cloned and
sequenced and used as positive controls in the PCR-based
replicon typing. The speciﬁcity of the method was investigated
on a collection of 62 reference plasmids, belonging to known Inc
groups. The method was also applied to a collection of 25
multidrug resistant Salmonella enterica strains isolated from
animals in Italy, previously characterized respect to the resist-
ance genes. In 19 on 25 strains, plasmids of the A/C, I1, N, X and
HI2 were detected, demonstrating the circulation of prevalent
plasmids associated to speciﬁc resistance genes.
Conclusion: The PCR-based inc/rep typing could represent the
easiest way to perform a ﬁrst screening of a large number of
strains, or can be used to trace the diffusion of multi-drug
resistant plasmid. The application of this method could have a
great impact on epidemiological investigation of the horizontal
transfer of resistance genes in different bacterial strains.
P647
Simple sequence repeat analysis for Vibrio
cholerae strains typing
Y. Danin-Poleg, L. Cohen, H. Gancz, M. Broza, Y. Kashi (Haifa,
IL)
Background: One of the most dynamic components of bacterial
genomes are the Simple Sequence Repeats (SSR). SSRs, also
termed VNTR, are simple DNA motifs tandemly repeated at a
speciﬁc locus. A subgroup of SSRs are the mononucleotide
repeats (MNR). Being highly mutable, SSR provide a ready
source of genomic polymorphism used in bacterial typing.
However, to date, practical typing of Vibrio cholerae is mainly
serological and requires about 200 antisera. V. cholerae is the
etiological agent of cholera. The pathogenic and non-pathogenic
isolates are divided into different serological groups, of which
only O1 and O139 serogroups are associated with cholera
pandemics.
Objectives: Development of an SSR-based method that com-
bines the variation seen in highly mutable SSR loci, with that of
shorter, relatively more stable MNR loci , for accurate and rapid
typing of V. cholerae isolates. This approach will enable accurate
phylogenetic and evolutionary studies, as it offers the ability to
distinguish both far- and closely-related strains.
Methods: The complete genomic sequence of V. cholerae was
screened for perfect SSR (‡3). Two strategies were applied for
the identiﬁcation of SSR polymorphism: capillary fragment size
analysis for the SSR loci, and sequencing of the selected MNR
loci.
Results: In silico screen of the V. cholerae genome revealed
thousands of SSR tracts with an average frequency of one SSR
every 152 bp. The longest SSR and MNR loci were chosen for
further analysis. A panel of 32 V. cholerae strains, representing
both clinical and environmental isolates, was tested for poly-
morphism in SSR loci. All nine SSR loci were polymorphic,
displaying two to 13 alleles per locus. Also, sequence analysis of
nine MNR-containing loci provided information of both varia-
tions in the MNR tract itself, and single nucleotide polymorph-
ism (SNP) in their ﬂanking sequences. These multiple sequence
variations presented high levels of polymorphism, with four to
eleven distinct sequence-types per locus. Phylogenetic analysis
of the combined SSR data showed a clear discrimination
between the clinical strains belonging to O1 and O139 sero-
groups, and the environmental isolates. Furthermore, discrim-
ination between most of the strains was achieved.
Conclusion: Results suggest that SSR-based typing methods,
which combine both SSR length polymorphism and MNR multi-
locus sequence typing (MNR-MLST) could be efﬁciently applied
for V. cholerae typing.
Serotype (CtxA) Source of isolation
O140 Z56B (-) Env3, Zanzibar
Env3, Zanzibar
Env3, Zanzibar
Env3, Zanzibar
Env3, Zanzibar
Env3, Zanzibar
Env3, WSP3 Israel
Env3, WSP3 Israel
Arakawna et al. 2000
Arakawna et al. 2000
Arakawna et al. 2000
Arakawn et al. 2000
Arakawn et al. 2000
Clinical, Rwanda
Clinical, Isreal1
Clinical, Israel1
Clinical, Calcutta
Clinical, Israel
Clinical, Isreal1
Clinical, Maryland1
Clinical, Maryland1
Clinical, IMH1
Clinical, IMH1
Clinical, IMH1
Clinical, IMH1
Arakawn et al. 2000
Env3, WSP3 Israel
Env3, WSP3 Israel
Env3, WSP3 Kenya
Env3, Israel
Env3, Israel
Env3, Japan
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(-)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
(+)
O140 Zc33
O79 B145
O79 T145
O2 EB116
O37 Zc5a
O10 Zc22
O10 Zc22b
O139 470-00
O9
O2 k2
O2 B27
O2 K183
O22
O141 475-00
O1 lnaba 35-A-3
O1 lnaba -6-11-61
O1 Ogawa 41
O1 Inaba ET155314
O1 Inaba
O1 Ogawa ET4
O1 Inaba 390-93
O1 Inaba 384157
O139 58-99
O139
O1 Ogawa ET
O1 Inaba 391-93
O1 Ogawa
O1 Ogawa ET185
O1 Ogawa ET20
O141 849-95
O37 Zc32e
0.4 0.3 0.2
Genetic Distance
0.1 0.0
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P648
Identiﬁcation of potential faecal contamination
markers of coliforms and thermotolerant
coliforms isolated from chicken feed using
tRNA intergenic length polymorphism analysis
(tDNA-PCR)
T. Pedersen, M. Vaneechoutte, M. Bisgaard,
J. Olsen (Frederiksberg, DK; Ghent, B)
As part of a National Salmonella Programme, raw material and
processed feed from feed mills producing poultry feed in
Denmark are regularly tested for coliforms (Gram-negative and
lactose-positive bacteria) as a measure of possible faecal con-
tamination of the feed. However, no further identiﬁcation of the
bacteria contained in this group of coliforms is performed. In
this study the species distribution for coliforms and thermotol-
erant coliforms (TTC) used as indicators for faecal contamin-
ation were investigated. Coliforms were isolated together with
TTC’s (coliforms grown at 44C) that increase the speciﬁcity of
faecal contaminants. Application of classical phenotyping meth-
ods alone was not sufﬁcient to identify species within the
coliforms and TTC’s in the raw material and feed. Therefore,
intergenic length polymorphism analysis (tDNA-PCR) was
employed as a reliable and rapid method to allow ﬁnal
speciation. A total of 290 isolates were identiﬁed representing
110 coliforms and 180 TTC’s, with only 23 (21%) and 67 (37%) of
the isolates were identiﬁed as E. coli, respectively. Other
coliforms represented Enterobacter spp. (44%), Klebsiella spp.
(26%) and Citrobacter spp. (5%), whereas TTC’s constituted
Enterobacter spp. (29%), Klebsiella spp. (23%) and Citrobacter spp.
(4%). Among the coliforms and TTC’s, 8 isolates could not be
identiﬁed using tDNA-PCR. 16S rRNA sequence analysis will
establish whether these constitute a new taxon under the family
of Enterobacteriaceae. The present investigation showed that
tDNA-PCR represents a quick and reliable method for identi-
ﬁcation of coliforms and TTC’s obtained from feed and feed raw
materials. In addition, the heterogeneity of taxa identiﬁed as
TTC’s seems to indicate that TTC’s should not be used as an
indicator of faecal contamination of feed and feed ingredients.
P649
Improved PCR detection and subtyping
of CTX-M-beta-lactamase-encoding genes
M. Edelstein, M. Pimkin (Smolensk, RUS)
Background: Rapid detection and differentiation of CTX-M
beta-lactamases is of need in many laboratories as this family of
ESBLs is rapidly disseminating. PCR has been used widely to
detect blaCTX-M genes but detection of all the known variants
usually required multiple reactions with speciﬁc primers for
different CTX-M subtypes. Consensus primers have also been
described but the recent emergence of new CTX-M variants (e.g.
CTX-M-25, -26) made them no longer versatile. In this study we
describe a novel real-time PCR technique for detection of all
CTX-Ms and a single-enzyme post-PCR restriction analysis for
differentiation between the 5 CTX-M genetic clusters.
Methods: A pair of primers matching conserved sequences at
positions 205 to 227 and 724 to 706 with respect to the CTX-M
translational starting point was designed to amplify a 519-bp
fragment of all the known blaCTX-M genes using a real-time
approach with SYBR Green product detection. A computer
analysis was used to identify BseDI as a restriction endonuclease
capable of distinguishing the subtypes of blaCTX-M genes. PCR
products were digested with BseDI and digests analysed by
agarose gel electrophoresis. Bacterial strains producing known
beta-lactamases (CTX-M-2, -3, -4, -5, -9, -15; TEM-1; SHV-1;
KluA) were used for quality control and assessment of specif-
icity of PCR and discriminative power of the restriction analysis.
Results: A single DNA fragment of the expected size was
ampliﬁed in all CTX-M-positive control strains. Melting curve
peaks were detected at 85, 86.5 and 88C for CTX-M-2, -3 and
CTX-M-9 genetic subtypes, respectively. No increase in ﬂuores-
cence was detected for CTX-M-negative isolates. Further restric-
tion analysis produced the predicted restriction patterns and,
therefore, allowed to distinguish different CTX-M subtypes.
Conclusions: The proposed real-time PCR is a versatile and
speciﬁc tool for rapid detection of CTX-M beta-lactamases.
When needed, the post-PCR restriction analysis may be used to
conﬁrm differentiation of CTX-M genetic subtypes.
P650
Detection of extended-spectrum and plasmid-
mediated AmpC beta-lactamase in cefoxitin
resistant Klebsiella pneumoniae clinical isolates
S.G. Hong, S.K. Hong, S.Y. Chong, M.S. Kang (Gyeonggi-do,
KOR)
Objectives: Clinical isolates of Klebsiella pneumoniae are often
multi-resistant and the major hosts for extended-spectrum beta-
lactamases (ESBLs) and plasmid-mediated AmpC beta-lacta-
mases (PABLs). Many clinical laboratories have problems for
ESBL detection in the presence of an AmpC beta-lactamase.
Nonetheless, identiﬁcation of ESBLs is important, since the
activity of the extended-spectrum cephalosporins (ESCs) in vivo
may not be accurately predicted by susceptibility tests using the
traditional National Committee for Clinical Laboratory Stand-
ards (NCCLS) breakpoints. This study was conducted to
evaluate two phenotypic conﬁrmatory tests for the detection of
ESBLs and to identify families of PABL genes in clinical isolates
of cefoxitin-nonsusceptible K. pneumoniae.
Methods: A total of 55 clinical isolates of K. pneumoniae at the
Bundang CHA Hospital that were non susceptible to cefoxitin
were collected between June 2004 and September 2004. Suscep-
tibility testing was performed by Vitek GNS card. To detect ESBL
and AmpC production, double disk synergy test (DDS), NCCLS
ESBL phenotypic conﬁrmatory test, and mHodge test with some
modiﬁcation were performed. ampC mutiplex PCR developed
by Perez-Perez and Hanson was performed (JCM, 2002).
Results: According to the susceptibility for ESCs and result of
ESBL by automated Vitek system, isolates were categorized to
three groups. By phenotypic ESBL conﬁrmatory test, 37 of the 40
ESC-non susceptible (NS) and Vitek ESBL()) and all of the 10
ESC-NS and Vitek ESBL(+) isolates, but none of the 5 ESC-
susceptible (S) and ESBL()) isolates, produced ESBL. DDS was
more excellent than NCCLS conﬁrmatory test. Thirty-six of the
40 ESC-NS and Vitek ESBL()), all of the 5 ESC-S and Vitek
ESBL()), and 2 of the 10 ESC-NS and ESBL(+) isolates were
shown to contained ampC-type genes by PCR. Of the 43 PABL
producing isolates, 39 (90.7%), 2 (4.7%), 2 (4.7%), and 1 (2.3%),
respectively, demonstrated DHA, CIT, EBC, and MOX bands.
One isolate demonstrated CIT and DHA bands. The results of
mHodge test with some modiﬁcation were well correlated with
that of PCR
Conclusions: Among the K. pneumoniae isolates with decreased
cefoxitin susceptibility, PABL-producing strains were prevalent.
In the case of Vitek ESBL(+) and cefoxitin non susceptible, only a
few strains contained ampC genes. The most common type of
family-speciﬁc AmpC beta-lactamase genes within K. pneumo-
niae at our institution in Korea was DHA group.
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P651
Pulsed ﬁeld gel electrophoresis of Salmonella
enterica subspecies enterica: the presence of
plasmid DNA has implications for the
interpretation of PFGE data
D.J. Brown, A. Murray, H. Mather, J.E. Coia (Glasgow, UK)
Objectives: Pulsed ﬁeld gel electrophoresis (PFGE) is currently
regarded as the ‘Gold Standard’ for the typing and strain
identiﬁcation of isolates of Salmonella enterica subspecies enterica
and other organisms. Plasmid proﬁling, on the other hand, has
been used previously in epidemiological investigations but is
not now in common use. This study examines the contribution
of plasmid DNA to the PFGE patterns obtained and assesses the
signiﬁcance of plasmids for the interpretation of PFGE data for
Salmonella.
Methods: All isolates of Sal. enterica from human infection in
Scotland are submitted to the reference laboratory. Isolates are
serotyped and, where applicable, phage typed. Since the
beginning of 2003, all isolates have been examined for the
presence of plasmid DNA and subjected to PFGE following
chromosomal digestion with Xba1. Analysis utilised BioNume-
rics software (Applied Maths, Belgium). Plasmid sizes were
calculated and stored in a database. PFGE patterns were
analysed (excluding fragments below 30 kbp in size), PFGE
types were assigned to each isolate and stored in a database
together with plasmid proﬁles.
Results: Plasmid and PFGE data has been collated on over 1800
isolates. Plasmid DNAwas detected in 1525 (about 85%) of these
isolates, ranging in size from 1.9 to 180 kbp. It was generally
observed that bands arising from smaller plasmids (<30 kbp)
were not visible on the PFGE gels. Larger plasmids could be
observed as bands on the PFGE pattern. The virulence plasmids
of serotypes Typhimurium, Enteritidis and Dublin appeared as
bands of the expected size. However, some other plasmids were
found to contribute bands of lower molecular weight than
expected, or no observable band, probably dependent on the
number of restriction sites present on the plasmid. During an
outbreak of serotype Saintpaul, PFGE differences of up to 4
bands were observed as the result of the presence/absence of
different plasmids.
Conclusion: PFGE is widely used as an epidemiological tool
and is rightly regarded as the ‘Gold Standard’ for outbreak
investigation of Salmonella. Correlation of plasmid proﬁle with
PFGE typing results has indicated that plasmids can make a
signiﬁcant contribution to the banding patterns obtained with
PFGE. Plasmid proﬁling should be considered as a relatively
easy and inexpensive addition to PFGE in order to simplify the
interpretation of PFGE results in the identiﬁcation of outbreaks
and strain relatedness.
P652
Molecular characterisation of Salmonella by
multilocus sequence typing, pulsed-ﬁeld gel
electrophoresis and ampliﬁed fragment length
polymorphism
M. Torpdahl, M.N. Skov, D. Sandvang,
D.L. Baggesen (Copenhagen, Odense, DK)
Objectives: The variability of Salmonella enterica strains were
studied using three genotypic typing techniques and the
discriminatory ability, reproducibility and ease of analysis
were compared.
Methods: Three molecular typing methods were used to char-
acterize 110 Salmonella enterica strains that had been isolated
from human or veterinary sources in Denmark between 1995
and 2001. All strains were genotyped by multilocus sequence
typing (MLST) using the genes aroC, dnaN, hemD, hisD, purE,
sucA and thrA, pulsed-ﬁeld gel electrophoresis (PFGE) with
XbaI and ampliﬁed fragment length polymorphism (AFLP) with
BglII and BspDI.
Results: The number of alleles for the seven housekeeping
genes ranged from 15 to 22. Sequence types (ST) were assigned
based on the allelic proﬁle and in total 43 STs were identiﬁed.
Most of the strains with the same serotype had the same ST or
only one isolate accounted for an additional ST. Eleven of the
strains could not be typed with the conventional PFGE method
because of DNA degradation and were given the PFGE type,
NT. The last 99 isolates generated ﬁngerprints with between 11
and 22 bands and 73 unique PFGE types were identiﬁed. The
proﬁles were used to generate an UPGMA tree using the dice
similarity coefﬁcient, and in most cases isolates with the same
serotype clustered together. The 110 AFLP ﬁngerprints gener-
ated between 80 and 100 bands and in total 78 AFLP types were
assigned. When making an UPGMA tree using the dice
similarity coefﬁcient, isolates with the same serotype clustered
in the same lineage of the tree supported by bootstrap values
above 70%.
Conclusion: When making genetic trees, all three methods
resulted in similar clustering which in most cases corresponded
with serotype. Of the three techniques, MLST was the easiest to
interpret and compare between laboratories. The MLST genes
used here lacked diversity and the ability to discriminate
between isolates were higher with both AFLP and PFGE. The
discriminatory ability of AFLP and PFGE were similar but PFGE
ﬁngerprints were both easier to reproduce, interpret and less
time consuming to analyze when compared to AFLP.
P653
Characterisation of Salmonella enterica serovar
Typhimurium DT104 strains isolated in the
Slovak Republic
V Majta´n, M. Szabo´ova´, L. Majta´nova´ (Bratislava, SVK)
Objectives: Multidrug-resistant S. enterica serovar Typhimurium
(S. Typhimurium) deﬁnitive phage type (DT) 104 is now
acknowledged as an internationally distributed zoonotic patho-
gen. In the SR this phage type has been isolated for the ﬁrst time
in 1997 and in 2003 predominated among the S. Typhimurium
strains. The aim of this study were both molecular and
biological analysis of 70 DT104 strains isolated from sporadic
human cases.
Methods: The all isolates were tested by the disc diffusion
method for susceptibility to ten antimicrobial drugs, according
to standard procedure of NCCLS (1997). The plasmid DNA was
isolated by the alkaline lysis technique of Birnboim and Doly
(1979). PCR with speciﬁc primers for integron detection was
performed as described by Lovesque et al. (1995). PCR technique
was also used for detection of virulence genes. The hydrophob-
icity was determined on the basis of bacterial adherence to
hydrocarbon-xylene (BATH) and salt aggregation test with
ammonium sulphate. The assay of motility was performed on
the semisolid agar medium and the bioﬁlm formation was
examined in the tube test (Bonafonte, 2000).
Results: The majority of DT104 strains were isolated from
patients of age 0–18. However, fourty-nine strains were multi-
drug-resistant, the dominant resistance type was ACSSuT
(58.6%). The analysis of plasmid DNA revealed that 69 (98.6%)
strains possessed 90 kb serovar speciﬁc virulence plasmid.
Fourty-four DT104 strains contained integrons of 1000 and
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1200 bp and 40 of they exhibited the ACSSuT phenotype. Two
strains with the same multiresistance contained only integron of
1200 bp. All studied strains were positive for presence of
virulence genes stn and iroB. Adhesion was found to be high
in 48 (68.6%) strains. Motility of 55 (78.0%) strains was high. The
bioﬁlm after cultivation in a starvation medium was formed by
63 (90.0%) strains.
Conclusion: The results involving the multidrug-resistance, the
content of the class 1 integrons as well as the high virulent
potential of studied strains suggest the rapid spread of DT104-
ACSSuT phenotype strains in recent time in the SR. They
possess a signiﬁcant threat for possible the horizontal transfer of
resistance determinants to other pathogens of importance to
human health.
Acknowledgements: This work was supported by Science and
Technology Assistance Agency under the contract No. APVT-
21–052602.
P654
Ampliﬁed intergenic locus polymorphism as a
basis for bacterial typing of Listeria spp. and
Escherichia coli
L. Somer, Y. Danin-Poleg, E. Diamant, Y. Kashi (Haifa, IL)
Objectives: Identiﬁcation and typing of microorganisms have
become major objectives over the past decade in microbiology.
Recent advances in molecular biology have resulted in the
development of numerous DNA-based methods for discrimin-
ation among bacterial strains. The high number of polymor-
phic sites present among closely related bacterial genomes is
the basis for the presented method. The method identiﬁes
multi-locus genomic polymorphisms in intergenic regions
termed AILP – Ampliﬁed Intergenic Locus Polymorphism.
The experiments described here were carried out to evaluate
the potential of this new strain typing methodology for
representative gram positive and gram-negative bacterial
species, Listeria and E. coli.
Methods: For each locus, a pair of unique PCR primers was
designed to amplify an intergenic sequence from one ORF to the
adjacent ORF. Presence, absence and size variation of the
ampliﬁcation products analysed by gel electrophoresis were
identiﬁed, and used as genetic markers for rapidly differenti-
ating among strains.
Results: Polymorphism was evaluated using eighteen AILP
sites among 28 strains of Listeria monocytogenes and six strains
of Listeria spp., and 30 AILP markers among 27 strains of
Escherichia coli. Up to four alleles per locus were identiﬁed
among Listeria strains and up to six among E. coli strains. In both
species, more than half of the AILP sites revealed intra-species
polymorphism. The AILP data were applied to phylogenetic
analysis among Listeria and E. coli strains. A clear distinction
between L. monocytogenes and Listeria spp. was demonstrated.
In addition, the method separated L. monocytogenes into the
three known Lineages and discriminated the most common
virulent serotypic group 4b. In E. coli AILP analysis separated
the known groups as well as the virulent O157:H7 isolates.
These ﬁndings for both Listeria and E. coli are in agreement with
other phylogenetic studies using molecular markers.In conclu-
sion, the AILP method provides a rapid and simple initial
identiﬁcation of isolates as a basis for epidemiological investi-
gation, clearly discriminating between different strains or
revealing similarities that can be further tested using high
discriminatory power typing methods. Thus, the AILP should
be a useful addition to the available methodologies for rapid
initial microbial strain typing.
P655
Detection of quinolone resistance mutations in
gyrA, gyrB, parC and parE by denaturing high
performance liquid chromatography using
standard HPLC equipment
L.P. Randall, N.G. Coldham, M.J. Woodward (New Haw, UK)
Objectives: Denaturing high performance liquid chromatogra-
phy (DHPLC) has become widely used in recent years as a
method of detecting single nucleotide polymorphisms (SNPs).
As such, DHPLC can be used for the detection of mutations that
confer quinolone resistance, e.g. mutations in DNA gyrase
(gyrA, gyrB) or DNA topoisomerase IV (parC, parE). Dedicated
machines for DHPLC are available but expensive and many
laboratories have existing HPLC equipment. In this study the
use of a standard HPLC machine (Agilent A1100) and a
generally available column (Varian HelixTM DNA column)
was investigated for detection of mutations in the gyrA, gyrB,
parC and parE genes of Salmonella enterica.
Methods: A panel of Salmonella strains with known different
mutations in gyrA (n = 9), gyrB (n = 2), parC (n = 2) and parE
(n = 1) were assembled. Wild type (WT) Salmonella enterica
serovar Typhimurium NCTC 74 was used as control strain. The
DNA of respective strains was ampliﬁed by PCR using Opti-
mase proofreading DNA polymerase and prepared for DHPLC
as previously described. Duplex DNA samples (5 ll) were
analysed using an Agilent A100 HPLC system with a HelixTM
DNA column (Varian) and Varian buffers A and B according to
the manufactures recommendations. DHPLC analysis was
performed at temperatures of both 61C and 63C to detect
mutations in gyrA and gyrB and at both 62C and 64C to detect
mutations in parC and parE.
Results: Using the A1100 HPLC system mutations in gyrA,
gyrB, parC and parE were readily detected by comparison with
control chromatograms although in some cases this required
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Figure 1 shows the effect of increasing temperature on the peaks
observed for an Asp87-Asn mutation in gyrA.
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Figure 2 shows the peaks at 61C for wild type DNA and for WT
and mutant DNA from strains with mutations in the following
regions of gyrA - Ser83-Phe + Asp144-Asp (A), Asp114-Asp (B),
Asp 87-Asn (C), Ser 83-Phe (D), Ser 83-Tyr (E), Asp 87-Gly (F),
Asp87-Gly + Asp144-Asp (G), Asp 87-Tyr (H), Asp82-Asn (I).
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analysis at two temperatures. In most cases the strains with
different mutations gave unique proﬁles from each other.
Conclusion: The results showed that it is possible to use
standard HPLC equipment and readily available columns for
detection of mutations in gyrA, gyrB, parC and parE. However,
interpretation of results can be subjective when only small
differences between WT and mutant or between mutants and
mutant are seen and appropriate controls should always be used.
P656
Replicon typing of emerging plasmids conferring
resistance to ceftriaxone and carbapenems
L. Villa, V. Miriagou, A. Loli, C. Colinon, A. Bertini,
G.M. Rossolini, A. Carattoli (Rome, I; Athens, GR; Siena, I)
Objectives: A resistance gene that has emerged on a plasmid
may be transferred to other strains and species, enabling it to
penetrate into niches not accessible to its original host strain.
This implies that plasmid-mediated antimicrobial resistance is a
global problem that does not respect any boundaries, among
bacterial species and genera. The replicon typing of plasmids is
a potent tool to classify plasmids into families on the basis of
their replication controls. However, this approach has been
limited by the laborious and time-consuming methodology
required. We have developed a replicon typing method to
screen and classify plasmids by PCR. In this study the method
was applied to well characterized plasmids, belonging to the
collections of resistant Gram-negative bacteria isolated in USA,
Greece and Italy. The aim of this study was to verify the
sensitivity of the method when applied to plasmids circulating
among human pathogens, conferring resistance to antimicrobi-
als of relevance for human therapy.
Methods: The PCR-based inc/rep typing method recognizes 18
different replicons (rep) and has been applied to 31 previously
characterized plasmids from our collections of multi-drug
resistant Enterobacteriacae and Pseudomonas, showing resist-
ance to extended-spectrum cephalosporines or carbapenems by
the presence of the blacmy-2, blacmy-4, blacmy-13, blavim-1,
blavim-2, blavim-4 or blaimp-12 genes.
Results: The repA/C and repI1 were identiﬁed on the highly
diffused blacmy-2-plasmids isolated from ceftriaxone resistant
Salmonella enterica and Escherichia coli in USA. Three repA/C
plasmids, carrying the blacmy-4 and blavim-4 genes have been
also identiﬁed in clinical isolates of Klebsiella pneumoniae and
Enterobacter cloacae from Italy, suggesting a wider diffusion of
these kind of plasmids. Nine blavim-1-carrying plasmids,
identiﬁed in Enterobacteriacae recently isolated in ﬁve hospitals
of Athens, were all positive to the repN replicon. This informa-
tion represents a new tool to monitoring the spread of these
plasmids. However, the method failed in identifying three
plasmids from Pseudomonas spp. isolated in Italy, suggesting
that additional replicon sequences should be analysed to
increase the sensitivity of the method.
Conclusion: The possibility to trace plasmids by PCR may
extend the knowledge of the mechanisms of horizontal gene
transfer of antimicrobial resistance, facilitating the development
of control strategies against this phenomena.
P657
A role for rmoA in IncF plasmid mediated bioﬁlm
formation in E. coli K12
M. Nuk, A. Reisner, M. Neuwirth, E. Zechner (Graz, A)
Objectives: Bacterial bioﬁlms cause serious health problems
because these sessile cells can withstand immune response and
show an increased resistance to antimicrobial agents. Non
pathogenic E. coli have a limited ability to form bioﬁlms, but
carriage and transmission of conjugative plasmids enhance
bioﬁlm formation. We are interested in understanding the role
plasmids play in promoting bioﬁlm formation and the molecu-
lar mechanisms behind these effects.
Methods: To create mutations in bioﬁlm associated genes
random transposon mutagenesis of IncF plasmid R1–16 was
performed using miniTn5 transposition. To exclude mutations
in transfer genes, a selection screen requiring conjugative
transfer of mutant plasmids was employed. Interrupted genes
were identiﬁed using arbitrary PCR and DNA sequencing.
Strains harbouring mutant plasmid derivatives were tested for
bioﬁlm forming ability in microtiter format. This in vitro model
of bioﬁlm formation that relies on removal of planktonic cells
and quantiﬁcation of surface attached bacterial mass by crystal
violet staining. Subsequent speciﬁc inactivation of the rmoA
gene in R1–16 was performed using the lambda Red system of
bacteriophage lambda. To obtain information about the expres-
sion of the gene of interest Northern Blot analysis and Reverse
Transcriptase PCR were performed.
Results: As a result of the transposon mutagenesis rmoA was
found to be important for bioﬁlm formation. E. coli strains
carrying R1–16 with a deletion of rmoA showed a 5-fold
decrease in bioﬁlm formation compared to wildtype R1–16. This
effect was observed in full and in minimal media. Kinetic
experiments of bioﬁlm formation revealed that the rmoA
phenotype is already developed in an early stage of bioﬁlm
formation. Northern Blot analysis and Reverse Transcriptase
PCR indicate that rmoA is transcribed as part of an operon.
Conclusions: Genes homologous to rmoA are present in Yer-
sinia enterolitica, Salmonella typhimurium, and on many
plasmids including plasmids of pathogenic E. coli, Shigella
ﬂexneri and Salmonella typhi. The amino acid sequence of
RmoA shows strong homology to the Hha protein of Escherichia
coli and the YmoA of Yersinia enterolitica, which are modulators
of bacterial gene expression in response to environmental
stimuli. Thus, RmoA may act to regulate plasmid or host
genes that are important to bacterial bioﬁlm formation.
P658
Subtyping of Esherichia coli verocytotoxin 1:
ﬁrst report of VT1d subtype in humans
K.E.P. Olsen, S. Persson (Copenhagen, DK)
Objectives: Verocytotoxins are highly potent cytotoxins and are
important virulence factors of verocytotoxin producing Escheri-
chia coli. Two major types of toxins are known: verocytotoxin 1
(VT1) and verocytotoxin 2 (VT2). Several variants of VT2 have
been identiﬁed, whereas the VT1 type appears to be more
homogenous with only one variant VT1c, besides the VT1.
However, in 2003 a new variant of VT1 of bovine origin was
identiﬁed and named VT1d.358 vtx1 positive strains, isolated
from 1983–2003 from Danish patients with diarrhoea, were vtx1
subtyped. The vtx1 subtypes were corre-lated to clinical man-
ifestations such as diarrhoea, bloody diarrhoea, fever, vomiting,
HC and HUS.
Methods: A PCR-RFLP assay was used to distinguish the vtx1
and vtx1c subtypes. PCR products obtained with Gannon F and
R primers were independently digested with cfoI and rsaI. The
vtx1d subtype was revealed by sequencing.
Results: The vtx1c subtype was found in 54 strains, predom-
inantly those without the eae gene (see table). The vtx1c positive
VTEC strains belonged to 17 different O-serogroups, the
predominant serotypes were O146: H21 (25.9%) and
O128ab:H2 (18.5%). Only one O157:H- was found. Moreover,
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vtx1c was most frequently associated with the vtx2d subtype.
Vtx1c strains (without vtx2) were less associated with fever
(P = 0.0275) and had a higher incidence amongst women
(P = 0.0020). We found that the vtx1c subtype in combination
with vtx2 had a protective effect on bloody diarrhoea
(P = 0.0084). We found 8 strains, isolated from 1998–2003,
containing the vtx1d subtype. The vtx1d strains belonged to
ﬁve different O-serogroups (O64, O41, O79, O84 and O154). The
vtx1d subtype was signiﬁcantly associated to vomiting
(P = 0.0249).
Table. Distribution of VT1 subtypes according to the virulence
proﬁle
Conclusion: This is the ﬁrst reported ﬁnding of the vtx1d
variant in humans. Transmission of the vtx1d, probably from the
bovine reservoir, is not a new phenomenon; since we found this
variant from strains isolated already in 1998. This study
emphasizes the need to develop easy screening methods that
take vtx1 variants into account and the need for more know-
ledge of the clinical signiﬁcance of vtx1 variants.
P659
Rapid detection and characterisation of extended-
spectrum beta-lactamases by PyrosequencingTM
B.S. Timmerbeil, E. Stu¨renburg, P. Heisig (Hamburg, D)
Objectives: Since the ﬁrst detection of extended-spectrum beta-
lactamases (ESBLs) two decades ago this group of beta-lactam
hydrolysing enzymes has become a major problem in the usage
of cephalosporins. ESBLs are mainly found in Escherichia coli and
Klebsiella pneumoniae and are able to hydrolyse and inactivate
most beta-lactams including aztreonam and third generation
cephalosporins. So far, there are about 340 different ESBLs
described whereas the most common and clinical relevant ones
are the TEM and SHV beta-lactamases. Different techniques are
in use for the detection of ESBLs like Etest, Vitek, PCR-RFLP,
and sequencing to mention the most relevant ones. However, all
these methods are either time consuming or cost intensive which
makes them unattractive for high throughput screening and
characterisation. Thus, the goal of the present study was to
develop a fast and cost-efﬁcient method for the detection and
characterisation of ESBLs. Pyrosequencing is a novel non-
electrophoretic sequencing method for the detection of single
nucleotide polymorphisms (SNPs) by rapid sequencing of short
sequences of DNA. All TEMs and SHVs show very high
homology with differences in only a few distinct nucleotides.
With Pyrosequencing 96 different SNPs can be detected within
10 min. The costs for one sample are between 0.2–1$. The built-
in quality control allows the exact and easy conﬁrmation of the
quality of the obtained data.
Methods: Plasmid preparation followed by phenol/chloro-
forme-extraction; PCR with biotinylated primers; gelelectropho-
resis; puriﬁcation of PCR products (Streptavidin);
pyrosequencing reaction
Results: Different polymorphic sites (SHV: amino acids Leu-31,
Arg-201, Gly-234 and Glu-235; TEM: amino acids Gln-37, Glu-
102, Arg-162, Met-180, Gly-236) were chosen for identiﬁcation of
SHV-1, -2a, -3, -4, -5 and TEM-1, -2, -6, -7, -10, -20, -21 and -52.
Representative results are shown for the characaterisation of
SHV-4 (table 1).
Conclusion: Pyrosequencing has been demonstrated to be a
suitable and cost-saving technique for the rapid an accurate
identiﬁcation of clinically relevant SHV and TEM beta-lacta-
mases. Further work will include the implementation of multi-
plexed assays for PCR and pyrosequencing to increase cost and
time efﬁciency. Pyrosequencing has proven to be a very cost
efﬁcient and reliable method for the detection and characteri-
sation of TEMs and SHVs.
P660
Identiﬁcation of major pathogenic markers
in shigatoxigenic Escherichia coli by the use
of multiplex PCR in beef meat
M. Weiner, J. Osek (Pulawy, PL)
Shiga toxin-producing E. coli (STEC) are a very important cause
of gastrointestinal diseases in humans, often with severe
complicating problems that include bloody diarrhoea, haemor-
rhagic colitis (HC)and haemolytic uraemic syndrome (HUS).
Cattle appear to be the main reservoir of STEC which are
transmitted to humans through food (especially raw beef)
contaminated with faecal material. Moreover, transmission of
STEC by person-to–person contact, drinking water or unpaster-
urised milk has also been described.
Objectives: The aim of the present study was to develop and
evaluate two multiplex PCRs (mPCR) systems for rapid and
speciﬁc identiﬁcation of major virulence genes (stx1, stx2, eaeA,
hlyA) of STEC detected in raw beef meat samples.
Methods: The 25 g raw beef samples were inoculated with
different numbers of E. coli of reference strain EDL 933. Thus,
they were added into 225 ml of TSB broth and incubated at 37C
for 18 h with shaking (150 rpm). The ﬁrst mPCR test (mPCR-1)
was established to identify Shiga toxin 1 and 2 genes and, as an
internal control of ampliﬁcation, the speciﬁc for E. coli 16S rRNA
gene. The second mPCR assay (mPCR-2) allowed the identiﬁ-
cation of two STEC-associated virulence marker genes encoding
intimin (eaeA) and enterohaemolysin (ehlyA). Each PCR ampli-
ﬁcation was performed in PCR mixture consisting of DNA
template, 1 X Taq buffer, 2 U Taq DNA polymerase (MBI,
Lithuania), dNTPs, 5 mM of Mg+, speciﬁc primers and water to
the ﬁnal volume of 50 ul. All ampliﬁcations were run in a
thermocycler (PTC-100, MJ Research, USA), under the following
conditions: initial DNA denaturation at 94C for 5 min followed
by 30 cycles of 94C for 1 min, 53C for 1 min and 72C for
1 min. The ﬁnal extension step was performed at 53C. The
ampliﬁed PCR products were visualized in 1.5% agarose gel.
Results: The ﬁrst mPCR resulted in different ampliﬁcation
products (348 bp for stx1 gene, 584 bp for stx2 gene and 798 bp
for 16S rRNA gene), which could be readily distinguished in
agarose gels. In the second test (mPCR-2), which uses the
primers speciﬁc for intimin and enterohemolysin and the E. coli
16S rRNA, the amplicons of 837 bp, 534 bp and 401 bp,
respectively, were generated.
Conclusion: The obtained results demonstrate the high specif-
icity of the mPCR systems developed and their possibility for
rapid and speciﬁc identiﬁcation of the major virulence factor
genes in STEC originated from raw beef meat samples.
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P661
Commensal and uropathogenic Escherichia coli
strains: do they have differences in the presence
of pathogenicity islands?
M. Sabate´, A. Andreu, E. Moreno, T. Pe´rez, G. Prats
(Barcelona, E)
Objectives: To detect the different PAI markers in commensal
and uropathogenic E. coli strains and to stablish the relationship
between PAIs and the ECOR phylogenetic group.
Methods: 50 different E. coli commensal strains from feces of
healthy women and 100 uropathogenic E. coli (UPEC) strains (50
from pyelonefritis and 50 from urinary sepsis), were studied.
Molecular typing by ERIC-PCR was used to assess the clonal
relationships among the commensal strains. The PAIs (I, II, III
and IV) described in UPEC 536, PAI I and II in UPEC J96 and
PAI I and II in UPEC CFT073 were detected by PCR using
speciﬁc primers. The resolution of the phylogenetic group was
done by PCR. The results were analysed statistically using the
SPSS 10X software.
Results: E. coli commensal strains showed a signiﬁcant presence
of PAIs (42%), but lower than UPEC strains (91%). The eight
different PAI markers detected showed the same distribution in
commensal and UPEC strains, being lower in the commensal
group. PAI IV536 was the most frequently found in 38% of
commensal vs 88% of UPEC strains, followed by PAI ICFT073
(26% vs 73%), PAI IICFT073 (14% vs 45%), PAI IIJ96 (8% vs
34%), PAI I536 (8% vs 33%) and PAI II536 (4% vs 20%). PAI
III536 was only detected in 2% of the UPEC strains and PAI IJ96
was never detected. The distribution of the phylogenetic group
was antagonic, being group B2 the less frequent in commensal
strains (18%) and B1 the majority (34%), whereas in UPEC
strains the group B2 was the most common (67%) and B1 the
minority one (18%). From a total of 49 PAIs detected in
commensal E. coli strains, the 74.4% were harboured in strains
from group B2, 14.3% group D, 8.2% group A, and 6.1% group
B1. From a total of 295 PAIs observed in UPEC strains, the 84.4%
were exhibited in strains from group B2, 9.2% group D, 4.4%
group A, and 2.0% group B1. In both groups, commensal and
UPEC strains, B2 showed association to the presence of PAIs
(P < 0.001). The average number of PAIs accumulated per strain
was 0.98 in commensal and 2.95 in UPEC strains; nevertheless
the comparison of PAIs per cell in the different phylogenetic
groups, showed that B2 group had 3.9 in commensal vs 3.7 in
UPEC strains, while in the remaining phylogenetic groups was
lower than 1.6 in both commensal and UPEC strains.
Conclusion: Although group B2 E. coli strains were uncommon
in commensal ﬂora, they are highly virulent and represent a
potential reservoire for strains that cause urinary tract infection.
P662
Different virulence factors in pathogenic
enterohaemorrhagic Escherichia coli O157 and
non-O157 isolated from humans compared to
isolates from cattle
C. Welinder-Olsson, E. Eriksson, B. Kaijser (Go¨teborg, Uppsala, S)
Objectives: Verocytotoxin producing E. coli can cause bloody
diarrhoea and haemolytic-uremic syndrome among humans
and especially children. Additional traits besides the verocyto-
toxin production seem however to increase the virulence.
Intimin is an adhesin that enables some isolates of EHEC to
tightly attach to epithelial cells of the intestine. EHEC-hemolysin
is plasmid encoded, and the hemolysin lyses erytrocytes and
provides hemoglobin as a source of iron. The objectives of the
present study were to study additional, possible virulence
factors in verocytotoxin producing E. coli.
Methods: In the present study, we have used PCR with primers
detecting four additionally adhesin genes other than the intimin
gene and two other genes than E-hly supporting the bacterial
access of iron. Isolates of different clonality according to PFGE of
both human and cattle origin have been studied.
Results: We found that E. coli possibly compensate the absence
of the eaeA gene coding for intimin by another adhesin gene
coding for type 1 ﬁmbriae and that the absence of EHEC-
hemolysin may be compensated by the gene coding for a
siderophore aerobactin or the usually chromosomally encoded
gene coding for alfa-hemolysin. Interestingly, verocytotoxin
producing E. coli isolated from cattle, the main source of human
infection, do not have the genes coding for aerobactin or
hemolysin to the same extent as human isolates.
Conclusion: We propose that this difference concerning pres-
ence of the genes coding for intimin, aerobactin and alfa-
hemolysin might be the reason for the relatively low incidence
of symptomatic EHEC infections among humans in relation to
the high number of verocytotoxin producing E. coli among
cattle. Verocytotoxin as well as intimin, aerobactin and
a-hemolysin seem to be important virulence factors for EHEC.
P663
Phylogenetic origin of the uropathogenic
Escherichia coli resistant and susceptible to
ﬂuoroquinolone and trimethoprim-
sulfamethoxazole
E. Moreno, M. Sabate´, A.M. Planes, I. Planells, G. Prats,
A. Andreu (Barcelona, E)
Objectives: To assess the role that the relationships between
resistance and virulence may play in the uropathogenic E. coli,
we compared E. coli strains resistant to ﬂuoroquinolone (FQ)
and trimethoprim-sulfamethoxazole (TMP-SMZ) with the sus-
ceptible ones.
Methods: A total of 150 E. coli uropathogenic strains (50 from
cystitis, 50 from pyelonephritis and 50 from urinary bacterae-
mia) were analysed for virulence factors genes: papA, papGI,
papGII, papGIII, ﬁmH, afa/draBC, sfa/focDE, hlyA, cnf1, iutA,
fyuA, kpsMTII, ibeA, traT, malX; ECOR phylogenetic groups: A,
B1, B2 and D by PCR. O antigens associated to UTI (O1, O2, O4,
O6, O7, O18 and O83) were determined using a agglutination
microtechnique. Antimicrobial susceptibility to FQ and TMP-
SMZ by standard disc-diffusion techniques.
Results: From the 150 E. coli, 12% were resistant to FQ and 29%
to TMP-SMZ. FQ and TMP-SMZ susceptible and resistant E. coli
were equally distributed among the 3 clinical syndromes.
Phylogenetic group B2 was associated to FQ susceptible (76%
vs 28% in resistant, P < 0.001) and TMP-SMZ susceptible
isolates (80% vs 45% in resistant, P < 0.001), in contrast group
B1 was associated to FQ resistance (11% vs 6%, P < 0.001) and
TMP-SMZ resistance (14% vs 4%, P < 0.001), and group D to
TMP-SMZ resistant (25% vs 7%, P < 0.001). E. coli susceptible
strains were associated to high virulence score (mean of 7.3
virulent traits for FQ susceptible strains vs 3.94 for resistant
strains, P < 0.001; and 7.90 virulent traits for TMP-SMZ
susceptible strains vs 6.45 for resistant strains, P < 0.05). malX,
papA, papGII, ﬁmH, afa/draBC, sfa/focDE, kpsMII, hlyA, cnf1,
fyuA and UTI-O antigens were statically associated to FQ
susceptible E. coli (P < 0.05) and malX, sfa/focDE, kpsMII, fyuA
and UTI-O antigens to TMP-SMZ susceptible strains (P < 0.05).
Conclusions: E. coli isolates susceptible to FQ or TMP-SMZ
belonged predominantly to ECOR phylogenetic group B2,
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harbouring a great number of virulent traits and consequently
showed a high virulence score. On the contrary, strains resistant
to these antibiotics belonged predominantly to B1, possesses a
little number of virulent traits and consequently showed a lower
virulence score. Our results suggest that resistant strain prob-
ably are not the consequence of the acquisition of the resistance
elements by a susceptible strain, but come from others phylo-
genetic origins.
P664
Virulence factors and antibiotic resistance
in uropathogenic Escherichia coli
S. Puglisi, R. Musumeci, C. Cocuzza, G. Blandino, F. Caccamo,
D. Nicolosi, M. Pisano, C. Torrisi, A. Speciale (Catania, Monza, I)
Objectives: To use multiplex polymerase chain reaction (PCR)
to screen a large number of Escherichia coli clinical isolates for
virulence factor genes and to ﬁnd, if present, a correlation
between pathogenicity and antibiotic resistance in these strains.
As some in vitro studies have recently suggested that decreased
pathogenicity of E. coli is associated with the acquisition of
quinolone resistance, our study aimed to investigate, in partic-
ular, the virulence factors in ﬂuoroquinolone-resistant, com-
pared with ﬂuoroquinolone-susceptible, uropathogenic E. coli
strains.
Methods: In two hundred and twenty-four E. coli isolates from
the urine of patients with urinary tract infections the sensitivity
to ﬂuoroquinolones (ciproﬂoxacin, levoﬂoxacin and norﬂoxa-
cin), beta-lactams (ampicillin, amoxicillin-clavulanic acid, cefac-
lor and ceftazidime) and co-trimoxazole was investigated by a
microdilution technique according to the recommendations of
the National Committee for Clinical Laboratory Standards
(NCCLS). ESBL production was investigated by the double-
disk synergy test. On the basis of antibiotic susceptibility
pattern, one hundred and twenty of the tested strains were
chosen and screened for type 1 ﬁmbriae, P ﬁmbriae, hemolysin,
aerobactin and cytotoxic necrotizing factor 1 genes by multiplex
PCR. Hemolysin production was tested on sheep-blood agar
plates. The presence of type 1 ﬁmbriae was determined on the
basis of mannose-sensitive agglutination of Saccharomyces
cerevisiae.
Results: Type 1 ﬁmbriae were present in more than 90% of the
strains; the gene for aerobactin was present in approximately
two thirds of the isolates; genes for P ﬁmbriae, hemolysin or
cytotoxic necrotizing factor 1 were present in approximately one
fourth of the strains. But these last three genes were present in a
very small percentage or absent in the ﬂuoroquinolone-resistant
strains.
Conclusion: Our results suggest that resistance to ﬂuoroquino-
lones is associated with a great decrease in the presence or the
expression of some virulence factors in uropathogenic E. coli,
while resistance to beta-lactams is not. Where phenotypic
information was available, it was consistent with the genotypes
identiﬁed by PCR.
HIV
P665
HIV-proviral DNA and plasma-RNA sequencing
for detection of drug resistance mutations
in antiretroviral naive patients
S.G. Parisi, M. Zazzi, F. Dal Bello, V. Manfrin, G. Carolo,
G. Nicolini, F. Gatti, C. Boldrin, E. Franchin, G. Palu` (Padua,
Siena, Vicenza, Legnago, Schio, Verona, I)
Objectives: Genotypic antiretroviral resistance testing is com-
monly used in drug naive HIV-patients (pts). Plasma-RNA is
taken as representative of the actively replicating viral popula-
tion. However, in the absence of drug pressure, resistant
variants may revert to or be outcompeted by more ﬁt wild
type viruses. We tested if DNA obtained from peripheral blood
mononuclear cells (PBMC) provides better or complementary
informations than plasma (PL) about drug resistance mutations
(DRM) transmitted or superinfections in naive pts.
Methods: PL and PBMCs from 34 pts diagnosed in 2004 as HIV-
infected were analysed. The protease (PR) and aa 1–240 of the
reverse transcriptase (RT) were sequenced by in-house method,
compared for the presence of DRM as deﬁned by IAS, and
analysed for drug susceptibility proﬁle by the Stanford HIVdb
algorithm.
Results: In 29 pts both genotype and subtype were concordant
(Cpt); 4 Cpts had non-B subtype (CRF01_AG subtype in 1,
CRF02_AG in 1, F in 1, C in 1), B in the others; several DRMs
were detected, conferring resistance to NRTI (2 pts), to
NRTI + NNRTI (1 pt), PI (2 pts). 5 pts showed substantial
differences between PL-virus and PBMCs-virus (Dpt). While
only 2 Dpts showed RT primary DRMs and resistance to NRTI
(1 pt) and NNRTI (1 pt) in PL, in PBMCs-DNA of these Dpts also
PR-primary DRMs were found, conferring PI-resistance too;
other 3 Dpts revealed in PBMCs both RT and PR primary DRMs,
and related broad range of NRTI and PI-resistance, with drug
sensitive viruses in PL. 3 out of these 5 Dpts had a CRF01_AG
subtype in PBMC, and B subtype in PL. A Dpt had a concordant
B wild type in a blood sample stored 7 months before.
Conclusions: We found resistance to antiretroviral drugs in 10
out of 34 naive-pts (29.4%), but only in 7 pts, 5 Cpts and 2 Dpts,
(20.5%) this resistance was at least partially evident with
conventional Plasma analysis. A substantially different virus,
often with another subtype alignment, was found in PBMCs of 5
Dpts, revealing a recent superinfection by a resistant virus, or a
reversion of an originally infecting resistant virus, with the
storage of the less ﬁt variant, still detectable as transient
prevalent population in the PBMC-archive. A longitudinal
analysis will allow to clarify these ﬁndings, but we suggest
that a periodical analysis of PBMCs is useful in naive pts to
detect drug resistant variants that may be stored and may
compromise future therapy options.
P666
HIV-1 DNA load in naive and successful
antiretroviral treated patients
S.G. Parisi, E. Nicastri, R. Mazzi, F. Gatti, E. Concia, C. Boldrin,
M. Biasolo, G. Palu`, M. Andreoni (Padua, Rome, Verona, I)
Objectives: In antiretroviral treated patients the size of the HIV
DNA reservoir in PBMCs is associated with disease progression.
This parameter can be relevant for treatment maintenance,
simpliﬁcation or discontinuation in patients with viro-immuno-
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logical success after several years on highly active antiretroviral
therapy (HAART). We evaluated the association between HIV-
DNA load and viro-immunologic and clinical parameters in
antiretroviral naive (NPts) and in treated (TrPts) patients,
selected for successful long term HAART.
Methods: This cross-sectional study was performed on 31 NPts
and 49 TrPts selected on the basis of plasma RNA load (50 cp/
ml within 6 months of starting their ﬁrst regimen, without either
replication (blips) or treatment interruption, and a (12 months
treatment period. To quantify the HIV-DNA integrated copy
number in PBMC, we used a real time PCR in-house protocol
performed on ABI-PRISM 7000 (App. Bios.), with a detection
limit of 20 cp/106 CD4.
Results: Considering NPts stratiﬁed according to the median
HIV-DNA level of 27299 cp/106 CD4 (range 189–525675),
subjects with lower DNA level had more frequently higher
CD4 (p = 0.042), and higher CD4 percentage (p = 0.13). No
statistically signiﬁcant association with plasma RNA levels was
found. After a median of 30 months of HAART (12–93 months),
6 out of 49 (12.2%) patients had undetectable DNA level.
Considering TrPts stratiﬁed according to the median DNA level
(1908 cp/106 CD4), no statistically signiﬁcant differences in
terms of age, gender, risk factors for HIV, pre-HAART HIV-
RNA level, PI- or NNRTI-based HAART, duration of HAART
were found. Conversely, subjects with lower HIV-DNA level
had more frequently higher pre-HAART CD4 cell count and
percentage, higher CD4 cell count and percentage at last follow
up (p < 0.001 for all assays). Considering TrPts by CD4 count
strata (<200, 201–350, >350), the distribution of HIV-DNA load
was statistically correlated in these groups (p < 0.001). After
adjusting for epidemiological and other confounding variables,
only pre-HAART CD4 cell count (OR 0.1, 95% CI 0.01–0.92,
p < 0.001) was found to be independently associated to low
DNA values.
Conclusions: In NPts HIV-DNA load was inversely correlated
with immunological status, but not with RNA load. Patients
with persistently undetectable RNA load during HAART have a
wide range of proviral DNA (<20–13142 cp/106 PBMC). Low
DNA level was independently associated with high pre-HAART
CD4 cell count.
P667
Prevalence of HIV-1 drug resistance-associated
mutations in multi-treated infected patients
A. Sua´rez, C. Sa´nchez, E. Va´zquez, J.J. Picazo (Madrid, E)
Objectives: Drug resistance mutations in the human immuno-
deﬁciency virus type 1(HIV-1) Reverse Transcriptase (RT) and
Protease genes lead to lower sensitivity to antiretroviral agents
and are an important cause of drug failure. We evaluate the
presence of mutations in antiretroviral multi-treated patients.
Methods: The plasma of 527 HIV-1 infected patients previously
treated with different therapeutic regimens were analysed. Most
patients were males (72%), mean age 41 years (range 73–21).
Plasma of patients were collected for genotyping analysis to
identify resistance mutations in RT and Protease regions using
ABI ViroSeq HIV-1 Genotyping System (Applied Biosystem).
Changes in susceptibility were assessed by a computer
programme that interprets drug resistance: Standford database
(http:/hivdb.standford.edu/hiv/).
Results: On the HIV-1 Reverse Transcriptase region 1730
mutations were detected, 1076 (62.2%) of them were primary
mutations correlated with high level of drug resistance. 470
mutations were implied in the resistance to the non nucleoside
analogues of the reverse transcriptase inhibitors (NNRTIs). On
the Protease gene 1669 mutations were found, 1239 (74.2%) of
them were secondary mutations. Mutations al codons 184, 215
and 103 were most frequent in the RT region. L63P was the most
prevalent Protease mutation. Multi-drug resistant mutation
Q151M was observed in 10 patients. Wild type sequence was
detected in 29 cases. Genotyping was not available because not
enough cDNA were obtained in 59 (11.2%) samples. Presence of
mutations related with high-level of resistance to Zidovudine
were detected in 39% of the patients, 39% to Lamivudine, 51% to
NNRTIs and 69% to Protease Inhibitors (Nelﬁnavir presented
the high-level of resistance 25%).
Conclusion: The detection of key mutations associated with
HIV-1 antiretroviral resistance is very useful because it enhances
clinical management and permits to chose the optimal thera-
peutic regimens in treatment-experienced patients.
P668
Thymic size and CD4+ cell recovery in
HIV-infected patients during long-term highly
active antiretroviral therapy
L. Kolte, A. Lerbæk, A.K. Ersbøll, C. Strandberg, J.O. Nielsen,
S.D. Nielsen (Hvidovre, Frederiksberg, DK)
Objectives: Thehuman thymus is suggested tobe contributing to
de novo T cell synthesis even late in life. Such synthesis can be
assessedby analyzing thymic outputmarkers such as thymic size.
In HIV-infected patients reconstitution in the peripheral CD4+
cell pool during the ﬁrst phase of highly active antiretroviral
therapy (HAART) seems to be thymic-associated. To investigate
whether this is a prolonged effect 25 HIV-infected patients in
steady state HAART and with known thymic size were followed
prospectively with CD4 counts and HIV-RNA measurements
every third month in a follow-up period of 12 months.
Methods: Thymic size was determined by computer tomogra-
phy (CT) at inclusion in the study and T-cell subpopulations
were determined at follow-up by ﬂow cytometry.
Results: The correlation between thymic size and CD4 counts
was signiﬁcant at inclusion in the study (r = 0.498; P = 0.011)
and remained almost unaltered at 3, 6 and 9 months of follow-
up (r = 0.449, P = 0.036 after 3 months, r = 0.517, P = 0.012 after
6 months, r = 0.478, P = 0.021 after 9 months). However, with
regard to CD4 increase no difference was found between
patients with minimal and abundant thymic tissue, respectively,
at any time of follow-up.
Conclusions: The measurement of thymic size at baseline may
be of importance regarding the initial increase in CD4+ cells in
HIV-infected patients receiving HAART, but does not seem
important to a continued increase in CD4+ cells during long-
term HAART in a follow-up period of 12 months. Whether
thymic size is important to a continued increase in CD4+ recent
thymic emigrants estimated by measuring other thymic output
markers such as naı¨ve CD4+ cells and TREC-containing CD4+
cells is still not known. The included patients in this study are
still followed and the abovementioned measurements at follow-
up will be performed.
P669
Immune reconstitution syndrome in HIV patients
J. De La Torre, A. Del Arco, J.L. Prada, J. Aguilar, F. Moreno,
N. Montiel, M.C. Luque, A.B. Flores (Marbella, E)
Introduction: immune reconstitution syndrome (IRS) is an
inﬂammatory process which happen from few days to months
after beginning of antirretroviral treatment (ART). IRS give rise
to a variable clinical picture from only fever and malaise to fatal
outcome.
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Objectives: To describe the clinical feature of patients suffering
from HIV infection and IRS.
Method: We have compiled all the patients suffering from HIV
infection and IRS attended in our Hospital from August-2003 to
August-2004. Diagnosis Criteria of French (AIDS 2004; 18: 1615–
1627) were used. We have describe the clinical and immunolo-
gical status, the probable cause of IRS and the outcome.
Results: In the study-time 108 patients began initial or rescue
ART. 7 were diagnosed of IRS. 6 were infected when used
intravenous drug (all were co-infected by hepatitis C virus) and
the other by sexual transmission. Mean age was 37 years and the
time from HIV diagnosis was 10 years. The number of previous
ART and the drug patterns at this time were variable. Mainly
CD4 were less than 50 and viral load (VL) were high. Clinical
data appeared between weeks 2 and 8 from the ART beginning,
mainly with good tolerated fever. VL decrease and CD4 increase
were observed. In 3 cases the associated infections was dissem-
inated tuberculosis, 1 lymph node tuberculosis, 1 disseminated
MAI, 1 pneumonia by P. carinii and 1 liver necrosis by hepatitis
B virus. All of them required treatment as in-patients. Steroid
therapy was indicated in 4 cases with satisfactory outcome and 3
cases were no treated and treated only with non-steroidal anti-
inﬂammatories.
Conclusions: 6.4% of patients who start initial or rescue ART
suffered from IRS, mainly related with mycobacterial infection.
Symptoms appear between weeks 2 and 8 from de ART
beginning with good response to therapy with steroids or non-
steroidal anti-inﬂammatories.
P670
Hyperlactateamia during highly active
antiretroviral therapy. Frequency and
clinical-therapeutic consequences in a
prospective case-control study
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
Introduction: Notwithstanding the increased frequency of
HAART-associated hyperlactataemia, causes, pathogenesis,
management, and consequences on HIV disease course remain
uncertain.
Methods: A case-control study was conducted on 1027 HIV-
infected patients (p) referring to our centre, to prospectically
assess the frequency and features of hyperlactataemia. Among p
taking HAART with adherence levels (90%, p with serum lactic
acid levels (18 mg/mL were compared with p with normal
lactatemia, on the basis of a wide series of variables.
Results: Of 755 evaluable p, 272 (36%) had (1 event of
hyperlactatemia (mean value, 24.7 mg/mL). Two or more
subsequent alterations were found in only 56 p (7.4%), with
progressively worsening values in 73.2% of cases, while a grade
4 (<39.6 mg/dL) hyperlactataemia was found in 5 p only (0.7%).
Comparing the 272 p with elevated lactatemia with the 483
controls, no signiﬁcant differences as to age, gender, risk for
HIV, duration and stage of HIV disease, CD4+ count, HIV
viraemia, as well as prior or present nucleoside analogue (NA)
treatment and its duration. P with hyperlactataemia experienced
a signiﬁcantly longer anti-HIV therapy (p < 0.004), and a more
elevated frequency of lipodystrophy (p < 0.005), hypertriglyc-
eridaemia (p < 0.02), and altered serum skeletal muscle
enzymes (p < 0.02 for CPK, and p < 0.001 for aldolase). The
prevalence of clinical signs and symptoms (nausea, vomiting,
abdominal pain, fatigue, myalgia) was limited to 2–3%, and
comparable in the two study groups, and therefore difﬁcult to be
related to hyperlactataemia. Elevated serum lactic acid levels
never was responsible for HAART interruption, while regimen
modiﬁcation was precautionarily modiﬁed in <5% of p.
Discussion: While hyperlactatemia may involve ~20 of
HAART-treated p, according to the literature the development
of lactic acidosis is an exceedingly more rare event (1.7–25.2
cases per 1000 treated p-year), and usually interested p receiving
NA (d4T, followed by ZDV, ddI, 3TC, ddC, and ABV). In our
experience, asymptomatic hyperlactatemia emerged as a fre-
quent HAART complication, although acidosis was never
observed. An association with a more prolonged HAART
duration and other adverse events like lipodystrophy, dyslip-
idaemia, and skeletal muscle toxicity, was noticed. When facing
a metabolic acidosis, ventilatory assistance may become needed,
as well as prompt ﬂuid, bicarbonate, and vitamin and coenzyme
administration. NA should be replaced with same-class drugs
borne by a lower risk of acidosis, such as tenofovir, 3TC and
ABV.
P671
Do oestrogen receptors have a role in the
pathogenesis of HIV-associated lipodystrophy?
L. Barzon, M. Pacenti, G. Milan, M. Zamboni, R. Vettor,
G. Palu` (Padua, Verona, I)
Objective: Epidemiological data of increased risk of HIV-
associated lipodystrophy in women and reports of sex hormone
abnormalities in patients receiving highly active antiretroviral
therapy (HAART) led us to investigate whether sex steroid
hormone receptors were involved in this syndrome.
Methods: 14 male HIV-positive patients were evaluated, inclu-
ding 6 naive patients who were starting a HAART protocol
(group 1) and 8 who were switching from a HAART regimen
including PIs to a PI-free treatment (group 2). Five patients of
group 2 had lipodystrophy. Patients underwent a thorough
endocrine and metabolic examination and were submitted to a
needle biopsy of abdominal subcutaneous fat before starting
HAART therapy (group 1) or before switching from PIs (group
2) and 6 months after the ﬁrst evaluation. Expression of genes
encoding sex steroid hormone receptors, aromatase, and factors
produced by adipose tissue and involved in adipogenesis was
evaluated by real-time RT-PCR.
Results: Anthropometric evaluation showed that lipodystroph-
ic patients had lower BMI, total and subcutaneous thigh adipose
tissue, but higher WHR and visceral adipose tissue than non-
lipodystrophic patients. However, 6 months HAART adminis-
tration in group 1 naive subjects and PI switch in group 2 did
not substantially modify fat mass and fat distribution. Endocrine
evaluation demonstrated that lipodystrophy patients had sim-
ilar hormone proﬁle than non-lipodystrophic subjects and that
HAART did not signiﬁcantly modify hormone levels. Analysis
of transcript levels in adipose tissue showed that oestrogen
receptor beta expression was signiﬁcantly reduced in the
subcutaneous adipose tissue of HIV-infected lipodystrophic
patients, down-regulated by HAART regimens including pro-
tease inhibitors (group 1), and restored following switch from
protease inhibitors (group 2). Regarding adipose tissue marker
genes, adiponectin mRNA levels in lipodystrophic patients were
signiﬁcantly lower than in non-lipodystrophic subjects, but not
modiﬁed by HAART.
Conclusions: This study introduces oestrogen receptor beta
as a new player in the scenario of HIV-associated lipodys-
trophy, opening perspectives for the investigation of selective
oestrogen receptor modiﬁers for the management of this
syndrome.
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Effect of HAART on HIV-related hospital
admissions and morbidity
J.A. Bernal, M.A. Escobar, A.A. Garcia-Egido, F.J. Fernandez,
S.P. Romero, E. de la Hoz, J.M. Aparicio, A. Romero,
B. Dominguez, J. Gonzalez-Outon, F. Gomez (Cadiz, E)
Background: AIDS related hospital admissions and morbidity
have decreased after the introduction of HAART.
Objective: To assess the changes in hospital admissions and
morbidity with the improvement of HARRT.
Methods: We studied the hospital admissions and morbidity
over three different periods pre-HAART (January 1992 to
December 1994), early-HAART (January 1995 to December
1998) and post-HAART (January 1999 to October 2004), in HIV
infected patients followed at our centre. Results are expressed
for periods pre-HAART, early HAART, and post-HAART
respectively. Mean (SD) CD4/mL were: 16 ± 5, 37 ± 11 and
118 ± 33 (p < 0.0001). Undetectable plasma viral load (%) were:
0, 16 and 43 (p < 0.0001). Patients with a prior diagnosis of AIDS
were: 91%, 68% and 36% (p < 0.001). The rate (%) of women/
heterosexuals was: 6/2, 11/5 and 21/11 (p < 0.01) and, that of
IVDA (%) was: 96, 88 and 75 (p = 0.03). Hospital admissions due
to AIDS-deﬁning illnesses decreased (p < 0.001) with a signiﬁ-
cant increase in the rate of respiratory tract infections (p < 0.005),
digestive tract (p < 0.01) and liver diseases (p < 0.001). The
proportion of AIDS-deﬁning illnesses decreased after HAART
(p < 0.01),whereas the rate of liver diseases increased (p < 0.001).
Conclusions: The HAART era has been associated with a
progressive decrease in hospital admissions due to AIDS-
deﬁning conditions, and a steady enhancement of the spectrum
of admissions by non-AIDS-deﬁning conditions has increased.
P673
Persistence of chronic premature priming for
apoptosisin HIV-infected individuals during
HAART and short structured interruption
A. Amendola, G. D’Ofﬁzi, F. Ciccosanti, P. Narciso,
M.R. Capobianchi, F. Poccia, G. Ippolito, M. Piacentini (Rome, I)
Objectives: Despite the beneﬁts produced by HAART, persist-
ent apoptosis in HIV-infected patients receiving efﬁcient anti-
retroviral therapy occurs. Aim of this study was to assess
priming for apoptosis and susceptibility to undergo sponta-
neous apoptosis in PBMC from HIV-1 infected patients. More-
over, the inﬂuence of continuous HAART and short structured
therapy interruption (STI) have been investigated.
Methods: In-vivo priming for apoptosis was detected in freshly
isolated PBMC by analysis of ‘tissue’ transglutaminase protein
synthesis and the phosphatidylserine exposure on plasma
membrane. The susceptibility of PBMC to undergo spontaneous
apoptosis was analysed ex-vivo, after 48 h of in-vitro culture in
absence of growth factors, by quantiﬁcation cells showing DNA
fragmentation. In addition, the anti-apoptotic Bcl-2 down-
modulation and caspases 8 and -9 activation were monitored,
to identify the main apoptotic pathway prematurely initiated.
The relationship between priming and spontaneous apoptosis
markers and antiretroviral treatment or stopping was investi-
gated in two groups of HIV-infected patients: a group of 15 HIV-
infected patients, naı¨ve for HAART (with CD4 cell counts
(500 cells/mmc and plasma HIV-1 RNA levels (10,000 copies/
ml), at baseline and during 6 months of HAART; and a second
group of 20 HIV-infected patients during a short period of STI
and reintroduction of therapy.
Results: Our ﬁndings highlight that a non-physiological per-
sistent priming for apoptosis is induced in PBMC of HIV-1
infected individuals. Introduction of efﬁcient antiretroviral ther-
apy in naı¨ve patients does not modify the quote of PBMC primed
for apoptosis, that remains almost unchanged and statistically
not inﬂuenced from the modiﬁcation of viral load. Neither
successful HAART associated with short STI can modify this
situation. By contrast, the susceptibility of primed cells to
undergo spontaneous apoptosis closely correlates with viral
load. The accumulation of caspase-8 suggests that the non-
physiological chronic priming for apoptosis may be sustained by
death receptors signalling, likely mediated by viral components.
Conclusions: Further studies on priming for apoptosis in HIV-
infected PBMC may be relevant for the deﬁnition of alternative
immune intervention targets aimed to prevent the premature
priming for apoptosis of immune cells, rather than the inhibition
of activation of programmed cell death, should be planned and
analysed.
P674
Polymerase chain reaction detection of
Leishmania from blood in HIV-infected patients.
What does it mean?
V. Moreno, I. Cruz, M.E. Valencia, C. Can˜avate, J. Alvar,
J. Gonzalez-Lahoz (Madrid, E)
Objectives: Interpretation of Polymerase Chain Reaction (PCR)
of Leishmania in blood samples from asynthomatic HIV infected
patients
Patients and methods: PCR for Leishmania detection in blood
and urine, latex agglutination test and serology was done in 250
HIV infected outpatients. LnPCR was performed following
author’s instructions and consists in two ampliﬁcation reactions:
the ﬁrst includes primers R221 and R332 speciﬁc for kineto-
plastida and the second consists on the reampliﬁcation of the
ﬁrst PCR product with a new set of Leishmania-speciﬁc primers,
R223 and R333. KAtex detects antigen present in a urine sample
by agglutination.
Results: We studied 250 HIV infected patients. None of them
had history of recent or past visceral leishmaniasis and all
subjects were asympthomatic. Mean age was 35 years and 184
(73.6%) were men. Blood PCR was positive in 46 patients
(18.4%); 8 subjects (3.2%), all with blood PCR positive, had urine
PCR positive and 6 (2.4%), also with blood PCR positive, had
positive the determination of LATEX in urine. None of the 42
patients had positive serology for Leishmania. All patients were
controlled for, at least, 2 years and none of them had suspected
or conﬁrmed visceral leishmaniasis. During the study, a second
strange was obtained only in 17 subjects and only one of them
maintained positive blood PCR without clinical manifestations
of visceral leishmaniasis.
Conclusions: These data suggest that isolated positive PCR for
Leishmania can not be associated with active visceral leishmani-
asis. According to our data positive PCR cannot predict
developing visceral leishmaniasis, at least, during study
period. More studies are necessary for knowing the real
meaning of positive PCR for Leishmania.
P675
Cryptococcaemia: aetiological agent and clinical
outcome
A.C. Pasqualotto, C.B. Severo, F.M. Oliveira, L.C. Severo (Porto
Alegre, BR)
Objectives: To report the underlying diseases, the type of
etiologic agent involved, severity and outcome of the disease of
patients with cryptococcal fungaemia.
Clinical Microbiology and Infection, Volume 11, Supplement 2, 2005
193
Methods: Between April 1995 and November 2002, we retro-
spectively studied all patients with at least one positive blood
cultures for C. neoformans at Mycology Laboratory, Santa Casa
ComplexoHospitalar, Brazil. The clinical records of these patients
were reviewed, and the clinical outcome was based on the report
of hospital discharge or death of the patient while hospitalized.
Disease severity was estimated using APACHE II score.
Results: During the period of study, 28 patients with cryptococ-
cemia were included in this study. These patients were mainly
white (89.3%) andmale (78.6%), and their mean age was 36 years
old. With the exception of one immunocompetent patient, the
remaining patients had the following underlying diseases: AIDS
(89.3%), lung transplantation (3.6%) and liver cirrhosis (3.6%).
The CD4 cells mean count was 49 cells/mm3. The varieties of
C. neoformans isolated from these patients were identiﬁed as
variety grubii in 26 patients (92.8%) and variety gattii in the
remaining two patients (7.1%). With one exception, C. neoformans
var. grubii infected 25 patients with AIDS. C. neoformans variety
gattii was recovered from an immunocompetent patient and
from a lung transplanted patient. Besides blood cultures,
C. neoformans was also isolated from the following body sites:
cerebrospinal ﬂuid (89.3%), respiratory tract (35.7%), urine
(35.7%), skin lesions (3.6%) and prostate (3.6%). Systemic anti-
fungal therapy was initiated within 24 hours after positive blood
culture in 95% of the patients. There were a strong association
between APACHE II >14 and mortality (p < 0.01).
Conclusions: The majority patients with cryptococcaemia in
our study (89.3%) had AIDS, supporting previous epidemiolog-
ical studies involving variety grubii as the etiologic agent. The
high mortality rate among patients with cryptococcaemia in our
study (41%) showed strong association with the APACHE II
score (p < 0.01).
P676
Outcome of HIV-associated tuberculosis in the
early- and late-HAART era
F. Palmieri, D. Goletti, P. DeMori, E. Busi Rizzi, R. Maddaluno,
M. DeMarco, R. Licordari, A. Rianda, E. Girardi (Rome, I)
Objectives: To assess outcome of pulmonary tuberculosis (TB)
diagnosed in HIV-infected patients in the early and late time
period of the widespread introduction in clinical practice of
highly active antiretroviral therapy (HAART) in Italy (during
1996).
Methods: We reviewed clinical charts of 121 HIV-infected
patients with culture-conﬁrmed pulmonary TB hospitalized at
National Institute for Infectious Diseases ‘‘L. Spallanzani’’, Rome
from January 1996 to December 2002. 42 patients diagnosed in
1996–1998 (early-HAART patients) were compared to 79
patients diagnosed in 1999–2002 (late-HAART patients). Differ-
ences in categorical variables were analysed with the use of the 2
test or Fisher’s exact test, as appropriate. The Kaplan–Meier
method was used to estimate survival. In univariate analysis,
survival differences between the two groups of patients were
assessed using the log-rank test.
Results: At onset, patients diagnosed in 1999–2002 were more
likely to be foreign born (39% vs 21%, p < 0.05), and less likely to
be injection drug user (54% vs 74%, p < 0.05). Late-HAART
patients had a higher CD4+ median count (155 vs 113/mm3).
Moreover, 1999–2002 patients had more frequently started an
HAART regimen at least 3 months before TB diagnosis (43% vs
21%, p < 0.05), and were less frequently on prior Nucleoside
Reverse Transcriptase Inhibitors (NRTI) therapy before starting
an HAART regimen (6% vs 48%, p < 0.001). By the end of the
study period (December 31, 2003) 12 patients had died (15%) in
1999–02 period and 17 patients (40%) in 1996–98 period
(p < 0.005). The survival proportion at 6, 12 and 24 months was
95%, 93% and 89% in patients diagnosed in 1999–2002, while it
was 83%, 76% and 66% respectively in 1996–1998 patients
(p = 0.016, log-rank). Compared to patients who started
HAARTwhen antiretroviral naive risk of death was signiﬁcantly
increased in patients who started HAART after NRTI therapy or
did not take HAART at all (p < 0.001 for both comparison).
Conclusions: We found that patients diagnosed in the late-
HAART era had a signiﬁcantly longer survival. Our data
suggest that the increasing use of HAART has continued to
modify the survival of patients with HIV-associated TB, prob-
ably because of the increased proportion of patients starting
HAART when antiretroviral naive in the late-HAART era.
P677
Screening for tuberculosis infection using a new
blood test in a population of HIV-positive
individuals
I. Brock, M. Ruhwald, B. Lundgren, H. West, P. Ravn (Hvidovre,
DK)
The tuberculin skin test (TST) used to detect Mycobacterium
tuberculosis infection has many drawbacks, and a new diagnostic
test for latent tuberculosis (QuantiFERON-TB GOLD) has
recently been introduced. This test measures the production of
IFN-g in whole blood upon stimulationwith the antigens ESAT-6
and CFP-10, which are not present in BCG vaccine strains or the
vast majority of nontuberculous mycobacteria. This test over-
comes some of the drawbacks of the TST including lowered
speciﬁcity in BCG vaccinated individuals. The test has been
reported to perform with speciﬁcity of 98.1% and a sensitivity of
89.0% when tested in a population of 216 BCG-vaccinated
Japanese adults and 118 patients with culture-conﬁrmed
M. tuberculosis infection. Another study reported a test perform-
ance with sensitivity at the level of TST and an excellent
agreement between the two tests of 94%, (kappa value 0.866) in
a population of BCG unvaccinated young Danish individuals. As
the QuantiFERON-TB GOLD test is based on cellular immune
responses, the test is believed to have impaired performance
when used on individuals with immune suppression, as seen in
HIV infected. However, this group is in particular risk of
developing tuberculosis and a test to detect latent as well as
active TB would be of particular interest in this group. We
therefore designed a study involving HIV positive individuals
attending an outpatient unit at a department of infectious disease
in Copenhagen. Blood samples from 250 HIV positive individ-
uals has been collected and tested with the 3. generation of the
QuantiFERON TB technology; the QuantiFERON-TB Gold in
tube test (in tube QFT). This test uses the addition of a third TB
speciﬁc antigen to ESAT-6 and CFP-10 and blood is drawn
directly into antigen coated collection tubes, which can be
incubated immediately. Because of the study group under
investigation we also added mitogen (PHA) as a positive control
in order to reveal individuals with a degree of impaired cellular
immune response that would make the test inadequate.
P678
Altered phagocyte Fcg receptors expression in
HIV-infected patients with active tuberculosis
J.A. Bernal, A.A. Garcia-Egido, M.A. Escobar, F.J. Fernandez,
M. Rosety, F. Bricen˜o, A. Michan, P. Ruiz, C. Rivera,
F. Gomez (Cadiz, E)
Background: Phagocyte receptors for IgG (FcgRs) are important
in host defence against infection.
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Objectives: We have studied the expression of FcgRs by
peripheral blood monocytes (M), monocytes cultured for
72 hours (M/Mø), and granulocytes (G) in HIV infected patients
with active Tuberculosis (TB), during anti-tuberculous therapy
(anti-TB-Rx) and, after completion of anti-TB-Rx.
Methods: The expression of FcgRI, FcgRII and FcgRIII, on M,
M/Mø and G (resting and cultured with IFNg) were analysed
by ﬂow cytometry in 51 HIV infected patients with active TB (45
men and 6 women), at diagnosis of TB, and monthly thereafter
until completion of anti-TB-Rx.
Results: The expression of FcgRI and FcgRIII by M, M/Mø and
G was enhanced in HIV infected patients with active TB by:
34 ± 4% and 19 ± 3% for M, respectively (p < 0.001), 43 ± 6%
and 29 ± 3% for M/Mø, respectively (p < 0.001) and, 54 ± 6%
and 21 ± 3% for G, respectively (p < 0.001). The expression of
FcgRIIB by M, M/Mø and G was decreased by )24 ± 3%
(p = 0.02), )33 ± 4% and, )19 ± 2% (p < 0.005), respectively.
These alterations of FcgRs expression normalized from week
12th until the end of effective anti-TB-Rx. The expression FcgRI,
FcgRIIA and FcgRIII by M, M/Mø and G from HIV patients
with TB was signiﬁcantly enhanced by culture with IFNg
(p < 0.005). Setting a cut-off value = 25% of the mean ﬂuores-
cence intensity over controls for FcgRs surface expression and,
assuming a prevalence range of active TB between 25 and 80%
among HIV patients undergoing conﬁrmatory tests, results in a
range of sensitivity, speciﬁcity, positive and, negative predictive
values of: 61–86%, 58–96%, 64–89%, and 57–90%, respectively
for M-FcgRIIA, 56–84%, 63–91%, 58–79% and 68–97%, respect-
ively for M-FcgRIII, 61–88%, 54–87%, 44–87% and 69–91%,
respectively for G-FcgRI and, 42–75%, 88–98%, 49–77% and 86–
98%, respectively for G-FcgRIIB.
Conclusions: Our results suggest that, the alterations of Mø and
G Fcg receptors expression in HIV infected patients with active
TB can be used to predict the response to anti-tuberculous
therapy.
P679
High prevalence of admission for AIDS-
associated opportunistic infections in a Brazilian
teaching hospital
D.A. Kliemann, P.R.P. Behar, A. Ziegler, M. Prestes,
A.C. Pasqualotto (Porto Alegre, BR)
Objectives: The aim of this study was to describe the proﬁle of
patients admitted in an Infectious Diseases ward of a large
Brazilian tertiary hospital during the period comprising Decem-
ber 2002 to December 2003.
Methods: Retrospective observational study.
Results: During the period of study, 125 patients were admitted
to the Infectious Diseases ward of Santa Casa Complexo
Hospitalar, Brazil. Most of these patients were male (68.0%)
and mean age was 39.4 years old. Most of the patients (57.6%)
were in their ﬁrst hospital admission. During hospitalization,
the diagnosis of AIDS was performed in 76.8% of patients. Mean
CD4 count was 134 cells/mm3 and mean HIV-1 viral load was
671,267 copies/mL. Previous HIV serologic status was known
by 50.0% of those HIV patients admitted for the ﬁrst time.
Tuberculosis was the main diagnosis in patients admitted to the
Infectious Diseases ward (20.0%), and 92.0% of these patients
had HIV co-infection. Tuberculosis was also the main cause of
death (36.0% of deaths); all the patients who died had HIV
co-infection. However, cryptococcal meningitis was the more
lethal disease (lethality rate of 57.1%). Other co-infections
presented in patients with HIV infection were hepatitis C
virus (28.0%), hepatitis B virus (6.4%), HTLV (2.4%), and Chagas
disease (0.8%).
Conclusions: Despite the policy of providing free antiretroviral
in Brazil, AIDS is still a frequent cause of hospital admissions,
mainly in those patients who were unaware of their HIV
serological status and in those who had the diagnosis in late
stages of the disease. Tuberculosis continues to be a important
diseases for these patients.
P680
Pneumococcal disease in HIV-infected patients:
vaccination an unresolved issue
J. Guardiola, L. Matas, S. Herrera, M. Mateo, A. Lacal,
H. Corominas, A. Mauri, J. Montiel, M. Puig, M. Gurgui,
S. Benito, P. Domingo (Barcelona, E)
Background: Pneumococcal disease is preventable in HIV-
infected patients but the efﬁcacy of pneumococcal vaccine in
this population remains controversial. The aim of this study was
to describe the characteristics of pneumococcal disease and
analyze the vaccine response in a population of HIV patients.
Methods: In a retrospective study of the clinical records and
microbiological database we analysed the incidence of pneu-
mococcal infection in patients visited at the HIV Unit of our
hospital over a 9-year period (1996–2003). Vaccine use and
immunological and virological status were assessed in all
patients. The study was carried out in a universitary tertiary
hospital.
Results: A total of 74 (4.9%) pneumococcal episodes were
recorded in 65 of 1502 HIV-infected patients. Mean age was
40 + 9 years (18–79), 53 males (71.6%), 55% IDU, 39.2% were C3
and 16.3% were B2-B3 stages, and mean of HIV infection was
135 months. Baseline CD4 count was 276 cell/mm3 and viral
load was 251,240 cop/ml. Streptococcus pneumoniae was isolated
from respiratory specimens in 40 patients (54.1%) and 29 (39.2%)
patients had pneumococcal bacteraemia. Mean CD4 during the
infectious process was 289 cell/mm3 and viral load was
369,000 cop/m3. Only 35 (47.3%) patients received 23 valent
pneumococcal vaccine. Mean basal CD4 count for vaccinated
and no vaccinated patients were 362 and 206 cell/mm3, respect-
ively (p < 0.04). Mean CD4 counts and HIV RNA viral loads at
vaccination and 3 months after vaccination were 362 and
368 cell/mm3 and 41,791 and 72,996, respectively (p < 0.7
and 0.1). In 17/35 (57.1%) patients the episode was diag-
nosed after a mean of 799 (55–2582) days of vaccination. The
CD4 at vaccination was 343 cell/mm3. Patients without pneu-
mococcal episode after vaccination showed a mean CD4 of 313
(p < 0.5).
Conclusions: Prevalence of Streptococcus pneumoniae infections
in our HIV population was 4.9%. Less than half of patients had
been vaccinated, mainly due to low CD4 count. Vaccination did
not signiﬁcantly modify CD4 count or HIV RNA viral load.
However, pneumococcal disease developed in 57% of those
previously vaccinated.
P681
Neoplasia associated with HIV infection in the
HAART era
J.A. Bernal, M.A. Escobar, A.A. Garcia-Egido, A. Romero,
B. Dominguez, C. Asencio, J.L. Puerto, J. Gonzalez-Outon,
D. Garcia-Gil, M. Rosety, F. Gomez (Cadiz, E)
Background: Surveillance data indicate that, the incidence and
type of HIV related neoplasias has changed after the introduc-
tion of HAART.
Objective: To determine the incidence and types of cancers in
the pre-HAART and post-HAART eras, and the differences
between women and men.
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Methods: Retrospective record review of HIV infected patients
with cancer from January 1991 to December 2003 at a teaching
hospital.
Results: A total of 192 HIV patients with cancer were identiﬁed,
158 men (age: 38 ± 11 years, CD4: 123 ± 39/lL) and 34 women
(age: 44 ± 16 years, CD4: 68 ± 27/lL), of them 90 were detected
in the pre-HAART (47%) and 102 in the post-HAART era (53%,
p = n/s). AIDS deﬁning cancers (Total: 139, 72.4%; of them 108,
77.7% in men vs. 31, 22.3% in women) were more frequent pre-
HAART (Total: 76, 54.7%; of them 60, 43% in men vs. 16, 11.5%
in women) than post-HAART (Total: 63, 45.3%; of them 48,
34.5% in men vs. 15, 10.8% in women). Non AIDS deﬁning
cancers (Total: 53, 27.6%; of them 34, 64% in men vs. 19, 36% in
women) were less frequent pre-HAART (Total: 14, 26.4%; of
them 9, 17% in men vs. 5, 5.3% in women) than post-HAART
(Total: 39, 73.6%; of them 25, 47.2% in men vs. 14, 26.4% in
women). Total cancer related mortality was higher pre-HAART
(61% vs 52%, p < 0.05) and in women (60% vs 55%, p = n/s)
than post-HAART (Total: 53, 27.6%; of them 36, 18.8% in men vs.
17, 8.9% in women). AIDS deﬁning cancer related mortality was
higher pre-HAART (65.8% vs 36.5%, p < 0.01) in both sexes
(p < 0.01), while non AIDS deﬁning cancer related mortality was
higher post-HAART (76.9% vs 35.7%, p < 0.01) in both sexes
(p < 0.01).
Conclusions: The incidence of non AIDS deﬁning cancer
increased, although the total incidence of HIV related neoplasia
has not changed after HAART. Total cancer related mortality is
higher pre-HAART and in women. Both sexes have a higher
mortality by AIDS deﬁning cancer pre-HAART and, by non
AIDS deﬁning cancer post-HAART.
P682
Genotyping HIV-1 non-B subtypes in Ireland:
comparison of env and pol methods
L. Goins, S. Coughlan, F. Fitzpatrick, C. Bergin, F. Mulcahy,
G. Sheehan, W.W. Hall (Dublin, IRL)
Characterisation of HIV-1 subtypes provides important epide-
miological information and also has a potential impact on
diagnosis, and therapy. The dominant HIV-1 strain in Ireland is
subtype B, however other strains have also been identiﬁed. Most
subtyping in our institution is performed using pol nucleotide
sequence analysis.
Aims: To establish methods for ampliﬁcation and subtyping of
HIV-1 env (V3 region) gene and to compare pol and env
genotypes in non subtype B HIV-1 samples.
Methods: HIV-1 viral pol sequences of stored samples were
obtained and an approximate subtype assigned using the online
HIV-1 Genotyping Tool (http://www.ncbi.nlm.nih.gov/
projects/genotyping/formpage.cgi). 25 samples (viral loads
440–500,000 copies/ml) containing non subtype B viral pol
regions were chosen for further analysis. Viral RNA from the
env region of each sample was ampliﬁed and nucleotide
sequences generated. The env and pol sequences were inputted
into the above online genotyping tool, sequences were aligned
using ClustalW and a neighbor-joining phylogenetic tree was
created. (Joe Feldstein, http://evolution.genetics.washington.
edu/phylip.html).
Results: 15 subtype categories were deﬁned by pol genotyping.
When compared to env genotyping, four samples (16%) had the
same, fourteen (56%) similar and seven (28%) samples possessed
divergent env and pol genotypes.
Conclusion: We have developed a feasible method for obtain-
ing env V3 region sequence and subtype data. Only 16% of
samples tested possessed truly the ‘same’ subtype. Overall, data
presented in this study illustrates that subtyping based on
simply the pol or env region may overlook interesting nuances
of subtype variation and recombination and therefore efﬁcient
and effective methods for rapid subtyping of both regions, must
continue to be developed. Larger studies may provide a clearer
picture of the similarity between pol and env region genotypes.
Such data could prove to be a helpful tool for more thorough
and comprehensive analyses of patient subtype distributions.
P683
CD27+ (memory) B cell reduction as
an independent marker of progression
in HIV-1-infected patients
O. Beran, M. Holub, J. Hnykova, H. Rozsypal, J. Spala (Prague,
CZ)
Objectives: Dysregulation of B cells and their decreased ability
to respond to HIV-1 antigen are likely to contribute to the
increase in bacterial infections observed in advanced HIV
disease in adults. However, the mechanisms of B cell dysfunc-
tion during HIV-1 infection are poorly understood. The aim of
this study was to determine the phenotype of peripheral B cells
in drug-naive HIV-1 positive patients. In addition, the relation-
ship between B cell subsets, quantity of CD4+ T cells, regulatory
T cells and plasma viral load was examined.
Methods: A group of 32 drug-naive patients with newly
diagnosed HIV-1 infection was investigated. Phenotyping of B
and T cells was performed in the peripheral blood by three-color
ﬂow cytometry (FACSCalibur, Becton-Dickinson, USA). B cells
were characterized using monoclonal antibodies (mAb) anti-
CD19 (FITC), anti-CD27 (PE), anti-CD38 (PerCP). CD27+ B cells
were recognized as memory B cells. T cells were analysed using
mAb anti-CD3 (FITC), anti-CD4 (PE), anti-CD25 (PerCP) (all
Becton-Dickinson, Germany). Plasma HIV RNA viral load was
detected by PCR (Roche Diagnostic Systems, Switzerland).
Results: We observed a positive correlation between CD4+
T-cell count and the percentage of CD27+/CD38( B cells (r = 0.49,
p < 0.01). Also, the percentage of CD27+/CD38- B cells negat-
ively correlated with plasma viral load (r = (0.501, p < 0.01).
Additionally, we found no correlation between the levels of
B cell subsets and the percentage of CD25+ regulatory T cells.
Conclusions: These ﬁndings suggest that HIV-1 infection indu-
ces a remarkable phenotypic alteration of B cells. Additionally,
CD27+ B cell reduction is associated with the decrease of CD4+ T
cells, as well as the increase of plasma viral load. This indicates
that defects of humoral immunity during HIV-1 infection may
play a role in disease progression. Therefore, further study to
investigate of these phenotypic alterations after the reduction of
HIV-1 loads by effective antiretroviral therapy is required.
Acknowledgement: The study was supported by the grant
7513–3/2003 from the IGA MZ of the Czech Republic.
P684
Immune activation markers in HIV-1 infected
patients from India
S. Kaushik, M. Vajpayee, N. Wig, A. Biswas, P. Seth (New Delhi,
IND)
Objectives: The dynamic interaction between the human
immune system and HIV-1 leads to the altered expression of
T-cell surface markers, reﬂecting the various aspects of HIV
immunopathogenesis. We studied the changes in the T-cell
surface expression of peripheral blood lymphocyte subpopula-
tions in HIV-1 subtype C infected Indian patients.
Methods: Blood samples were collected from 78 ART naı¨ve
HIV-1 seropositive and 25 seronegative individuals. Samples
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were processed by standard FACS Lyse/Wash method and
stained for three-color ﬂowcytometry with panels of CD3, CD4,
CD8, CD45RA, CD45RO, CD62L, CD38 and HLA-DR antibod-
ies. Appropriate leucogate and isotype controls were included
and samples were acquired on a BD FACSCalibur instrument
using Cell Quest software. The mean, median and SD values
were determined and expression levels of T-cell subsets were
compared using the nonparametric Mann–Whitney test.
Results: CD4 and CD8 absolute counts and percentages varied
signiﬁcantly between the HIV-1 infected individuals and healthy
controls (p < 0.000). The CD4:CD8 ratio was inverted in HIV-1
infected individuals as compared to healthy controls (p < 0.001).
The distribution of naı¨ve CD4+ T cell subset (CD45RA+CD45RO-
CD4+) and memory CD4+T cell subset (CD45RO+CD45RA-
CD4+) was signiﬁcantly decreased in HIV infected as compared
toHIV seronegative individuals (p < 0.000). However, both naı¨ve
and memory CD8+ T cell expression was signiﬁcantly higher in
HIV-1 infected individuals. The homing receptor expression on
naı¨ve CD8+ T-cell subset (CD62L+CD45RA+) was signiﬁcantly
reduced as compared to CD4+ T-cell subset (p < 0.004).
Co-expression of activation markers HLA-DR and CD38 was
signiﬁcantly elevated on CD4+ and CD8+ T cells in HIV infected
individuals as compared to healthy individuals (p < 0.000).
Expression of CD38 on CD8+ T cells was found to be augmented
in HIV-1 infected patients (p < 0.000).
Conclusion: The results suggest extensive immune alterations in
lymphocyte subpopulations in HIV-1 subtype C infected Indian
population similarly to the data reported for other subtypes.
P685
Rape and deﬁlement as a cause of AIDS and HIV
infection
A. Mayengo (Kampala, UG)
Objectives: High rate of deﬁlement and rape has greatly
increased the spread of AIDS among the young girls in Uganda.
Methods: There is a very high rate of AIDS and HIV infection in
Uganda as a result of school girls being raped. Methods used
include: teachers have become a great menace to their students.
Infected teachers have resorted to the young girls without any
protection. However, the Ministry of Education has resorted to
moving around the schools sensitizing both the students as well
as the teachers on the effects of such actions. This it has done by
showing ﬁlms on related topics and how one can easily fall in
such traps, teaching the students different dramas to be acted
out by them so that a practical picture of the disease is given.
The Government has also made laws whereby the people who
commit such crimes like deﬁling children are charged in the
courts of law. Parents have also been sensitised on the dangers
of making their children get close to the male teachers because
such closeness can lead to rape and ﬁnally to the spread of
AIDS. The media has also played a great role in ﬁghting the
spread of AIDS and HIV infection. The media has come up with
material targeting the young ones in school. This has played a
great role in the ﬁght against such. With such they have taught
the young ones defensive measures once they are found in such
situations like avoiding being with the opposite sex in isolated
places alone. The young ones have been advised to conﬁde in
their parents in case of anything. This greatly brings about
transparency and avoids doing things secretly.
Results: Children have picked up the messages being passed on
to them and have greatly reduced the high levels of HIV
infection. They have started talking to their parents and
contributing to articles in the media.
Conclusion: With the help of the Ministry of Education, Non
Government Organisations, Media, Reading materials, Drama in
schools, Ministry of Health and the parents/guardians, AIDS
and HIV infections have greatly reduced in Uganda.
P686
Who wishes to be tested for HIV?
B. Kotnik-Kevorkijan, K. Ekart-Koren, J. Rejc-Marko,
J. Rebersˇek-Gorisˇek (Maribor, SVN)
Objectives: Slovenia is a country with a low incidence of HIV
infections. Since 1988 Maribor Teaching Hospital offers the
possibility of free examination, counseling and testing for HIV
infection in the so-called AIDS OPC for all who do not wish to
visit their family doctor. Here the testing is done either by name,
conﬁdentially or anonymously. In our prospective study we
included all patients who visited the OPC between 1 January
1998 and 31 December 2003.
Methods: Using an inquiry form we followed sex, age, profes-
sion, marital status, risk factors, the reason for testing, eventual
contacts with HIV-infected persons, the general condition. Blood
screening was carried out by two different ELISA methods, and
in case of suspected infection additional conﬁrmative tests were
done – Western blot, Immuno blot and PCR.
Results: The men:women ratio of our patients was equal, most
of them were from the age group of 21–30 years, students or
persons with a high level of education. Only 4% wished to be
tested anonymously, 8% had HIV-positive acquaintances. In
more than half of the patients the stated reason for the visit of
the OPC was changing of sexual partners and prostitution, one
third had no risk factor and were tested as a preventive
measure, 9% were IV drug addicts. Only 5% of patients were
either homo- or bisexual. 75% of patients had no permanent
sexual partner, 16% were either married or in a permanent
relationship. 6% of patients stated feelings of ill-health, 11% had
enlarged lymph nodes. From among 396 tested patients, 4 cases
of HIV infection were revealed.
Conclusions: Among our patients we discovered only 4 HIV-
positive, all belonging in high-risk groups. The majority of HIV-
positive cases are still discovered due to clinical diseases. The
majority of tested patients are educated persons coming for
examination and testing on account of general concern and
when changing sexual partners. Despite the possibility of
anonymous testing, most decide on testing by full name,
nevertheless they do wish to avoid their family doctor.
P687
The utility of cytomegalovirus (CMV)
quantitative polymerase chain reaction in
diagnosis of CMV disease in patients with AIDS
A.B. Brantsæter, A.K. Goplen, M. Holberg-Petersen, S. Jeansson,
J.N. Bruun (Oslo, N)
Objective: HIV infected individuals on no or failing antiretro-
viral therapy are at risk of CMV disease. Reliable diagnostic tests
are important to identify patients at risk, to diagnose manifest
disease and to monitor therapy. Studies have shown various
capacities of diagnostic tests and have often been limited by lack
of autopsy, important because CMV disease is often ﬁrst
diagnosed after death. The objective of this study was to explore
the diagnostic utility of CMV quantitative PCR in AIDS patients
who died and had a subsequent autopsy.
Methods: Patients included in this retrospective study were
HIV and CMV seropositive and died during the period 1991–
2002 during follow-up at Ullevaal University Hospital, Oslo.
A full autopsy including neuropathological examination was
required for inclusion. Parafﬁn-embedded sections were rou-
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tinely stained with haematoxylin–eosin and immunohistochem-
istry for CMV was performed in a few cases of doubt to conﬁrm
CMV disease. In the case of CMV retinitis, ante-mortem
diagnosis was based on typical ophthalmoscopic ﬁndings.
Otherwise, characteristic histopathological features of cytomeg-
alocytes with inclusions were required for diagnosis of CMV
disease. The last one or two stored plasma samples (according to
availability) either before diagnosis of CMV alive or before death
were analysed by COBAS AMPLICOR CMV Monitor (Roche).
Results: A total of 125 patients were included. 55 patients were
diagnosedwith CMVdisease, of which 39 were ﬁrst diagnosed at
autopsy. 70 patients did not have CMV disease. A total of 85
plasma samples were tested before diagnosis in patients with
cytomegalovirus disease and 117 samples were analysed from
patients without CMV disease. Median time between the last
sample and diagnosis for patients with andwithout CMVdisease
were 69 and 74 days, respectively. Geometric mean virus titre in
the last sample in patients with viraemia with and without CMV
disease were 5894 (median 3140) and 1850 (median 1860) copies/
ml, respectively. Results of sensitivity, speciﬁcity, positive and
negative predictive values of the test are presented in table 1.
Conclusion: CMV disease continues to occur in HIV infected
individuals even at a time of widespread use of HAART. In this
retrospective autopsy based study quantitative PCR had high
speciﬁcity andpositivepredictivevalue inpatientswithhighviral
load or recurring viraemia butwas limited bypoor sensitivity and
negative predictive value.
P688
ICU admission in patients infected with the
human immunodeﬁciency virus over ten years
J. De La Torre, J. Aguilar, F. Moreno, A. Del Arco, J.L. Prada,
E. Perea (Marbella, E)
Objective: To describe the proﬁle of patients with infection HIV
who enter in the intensive cares unit (ICU) throughout 10 years
and to evaluate the potential impact of highly active antirretro-
viral therapy (HAART) of in the admission patterns and survival
Methods: Data were recorded all HIV-infected patients admit-
ted to our ICU since January 1994 to December 2003, to a general
ICU located in Marbella (south of Spain). We analyze age, sex,
epidemiologic dates of HIV infection, HAART, diagnosis in ICU,
mortality and use mechanical ventilation.
Results: To total of 41 HIV-related admissions were included.
Average age 40 ± 11, average stay 9 ± 9. Half was not previ-
ously known diagnose VIH. In the known cases, the average
time of diagnose of infection HIV was of 28 months and were
naive to the ART 65%. Only 15% were in HAART. The medium
one of CD4 was of 198 and the VL of 234.000. The reason for
entrance in ICU in 50% was respiratory insufﬁciency, (65%
PCP), followed of sepsis in 25%. More than 75% required
mechanical ventilation. Mortality was of 50%. When analyzing
mortality no signiﬁcant differences were found in the different
years neither in the reason for entrance nor in the virolo´gica and
immunological situation nor in if they were with HAART.
Conclusions: The HIV patients who enter in ICU do not know
infection HIV in half of the cases, usually they are not in ART
and the most frequent reason for the entrance is respiratory
insufﬁciency with use of mechanical ventilation. No signiﬁcance
difference in the last 10 years mortality was found in spite of the
HAART introduction.
P689
Management of lower respiratory tract infections
in HIV-infected adults
S. Erscoiu, O. Dorobat, M. Nica, G. Pelichet, P. Calistru,
E. Ceausu (Bucharest, RO)
Objectives: To asses the causative organisms and efﬁcacy of
antibiotic treatment of bacterial lower respiratory tract infections
(LRTI) in HIV infected patients.
Methods: Retrospective study of 113 patients diagnosed with
LRTI from January 2002 through December 2003, the suscepti-
bility to antibiotics of microorganisms isolated from sputum
samples and the management of the illness.
Results: We included 56 males (78% smokers) and 46 females
(70% smokers), with median age 35 years old (limits: 18–72 years
old). After clinical ﬁndings, chest radiographs and bacteriological
results, we diagnosed 44 pneumonia (P), 31 acute exacerbation of
chronic bronchitis (AECB), 28 episodes of super infection of
bronchectasis (B) and 5 pulmonary abscesses (PA). Bacteremia
was more common in P. The CD+ lymphocytes count was low
(median 110/mmc). The length of hospital stay was longer in
patientswithAP (median 18 days) comparedwith the other LRTI
(median 10 days). We isolated 152 strains, the most common
pathogen being Haemophilus Inﬂuenzae (63 admissions), followed
by Streptococcus pneumonia (30 admissions), Staphilococcus.aureu
(12 admissions), Klebsiella pneumoniae (14 admissions), E. coli (8
admissions), 7 admissions of each Ps.aeruginosa and Acinetobacter
spp, Enterobacter (5 admissions), Proteus mirabilis (3 admissions)
and 1 admission for each Citrobacter and Comamonas testosteroni.
Amoxicillin/clavulanate represented empirical treatment inmost
of cases (67 patients). Ciproﬂoxacin and third generation cepha-
losporin were the most administrated therapy after the suscep-
tibility tests. Bacteriological cure was obtained in 110 patients, 3
patients expired (1 Klebsiella spp. bacteraemia, 1 Ps. aeruginosa PA
and 1 Streptococcus pneumoniae bacteraemia).
Conclusions: LRTI are frequent causes of admission in HIV
infected patients. TMP-SMX prophylaxis is not useful for LRTI
in most of cases. A rapid diagnosis and the use of an susceptible
antibiotic can be the key of success, even in immunocompro-
mised patients.
P690
Prevalence of HIV infection and other sexually
transmitted diseases in gay saunas in Taiwan
H.C. Lee, N.Y. Ko, J.L. Chang, M.P. Lee, W.C. Ko (Tainan,
Kaohsiung, Taichung, TW)
Objectives: Gay bathhouses have been described as public
venues for transmitting human immunodeﬁciency virus (HIV)
and sexually transmitted diseases (STDs). This study aimed to
Table 1. Sensitivity, speciﬁcity, Positive and negative predictive
value for CMV disease by changing viraemia cut-off, time of
sampling and number of positive tests.
Quantitative
PCR result
Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
Positive
predictive
value (95% CI)
Negative
predictive
value (95% CI)
Any viraemia 0.51 (0,38-0,64) 0.87 (0,77-0,93) 0.76 (0,60-0,87) 0.69 (0,59-0,78)
Viraemia> 2 000
copies/ml
0,29 (0,19-0,42) 0,96 (0,88-0,99) 0,84 (0,62-0,95) 0,63 (0,54-0,78)
Vireamia> 10 000
copies/ml
0,16 (0,09-0,28) 1,00 (0,95-1,00) 1,00(0,70-1,00) 0,60 (0,51-0,68)
Sample < 30 daysab 0,50 (0,29-0,71) 0,87(0,53-0,98) 0,90 (0,60-0,98) 0,44 (0.23-0,67)
One of two tests
positivea
0,58 (0,38-0,73) 0,84 (0,72-0,91) 0,65 (0,46-0,80) 0,78 (0,66-0,87)
Two of two tests
positivea
0,23 (0,12-0,41) 1,00 (0,94-1,00) 1,00(0,65-1,00) 0,71 (0,60-0,80)
CI ¼ Conﬁdence interval
a Any viraemia.
b Patients with samples taken within 30 days of either CMV diagnosis Calive or post-mortem or before
death.
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investigate (1) the prevalence of HIV infection, syphilis, hepatitis
A, hepatitis B, amoebiasis, gonorrhoea, and chlamydial infection,
and (2) risky sexual behaviors for STDs acquisitions among men
who have sex with men (MSM) attending gay saunas in Taiwan.
Methods: An ongoing cross-sectional study has been conducted
in six gay saunas since September 2004. Men visiting bathhouses
who agreed to participate in this study were invited to complete
a one-page, anonymous questionnaire and to receive STDs
screening tests. Serology studies were tested for HIV, syphilis,
hepatitis A, hepatitis B, amoebiasis and urine specimens were
tested for Chlamydia trachomatis and Neisseria gonorrhoeae by
polymerase chain reaction (PCR).
Results: One hundred and sixty MSM were enrolled, including
138 (86.3%) questionnaires, 158 (98.8%) blood tests, and 69 (66.7%)
urine tests. The mean age (±SD) of 138 participates was 30.2
(±8.7) years (range: 18–74). Seropositivity for HIV antibody (Ab)
was 7.9% (12/152). Reactivity rate for Treponellma pallidum
hemagglutinin (TPHA) test with a 160-fold or higher dilution
was 21.3% (32/150), in which 14 (45.2%) of 31 men also tested for
rapid plasma reagin showing reactive with a 4-fold or higher
dilution. Seroprevalence for hepatitis A and B Ab, hepatitis B
antigen, and amoebiasis [IHA titre (1:128)] were 57.6% (57/144),
59.6% (87/146), 20.5% (30/146), and 4.8% (7/146), respectively.
Prevalence rates of Chlamydia and gonorrhoea infection were
7.2% (5/69) and 4.3% (3/69). In univariate analysis, seroreactivity
for TPHA (P = 0.001, odds ratio, 6.5; 95% conﬁdence interval,
1.99–22.34) and using party drugs (P = 0.001, odds ratio, 7.1; 95%
conﬁdence interval, 1.89–26.36) were associated with the risk for
HIV infection. Men with TPHA reactivity reported having more
unprotected oral sex partners than men who were seronegative
for syphilis (2.36 vs. 1.27, t = 0.23, P = 0.03).
Conclusions: The preliminary results showed that high preval-
ence rate of syphilis among MSM and the association between
syphilis, using party drugs and HIV infection. Unprotected oral
sex was associated with TPHA reactivity.
P691
The introduction of highly active antiretroviral
therapy paradoxically increased a late diagnosis
of HIV infection, often coinciding with
full-blown AIDS
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
Introduction: Notwithstanding the availability of HAART since
1996,AIDS notiﬁcations continue to occur, with increasing
frequency among patients (p) who were not aware of their
condition, or neglected speciﬁc monitoring and treatment.
Patients and Methods: All cases of AIDS newly diagnosed
since 2001 at our centre were compared with all AIDS episodes
observed in the decade preceding HAART introduction (1986–
1995),on the ground of a broad spectrum of epidemiological and
clinical variables.
Results: Comparedwith thepre-HAARTera, the expecteddropof
frequency of overall AIDS cases were seen: from a mean of ~58 p
from 1986 to 1995, to ~17 p per year since 2001 (p < 0.001). An
increased mean age at diagnosis (p < 0.003), a more frequent
involvement of women (p < 0.02), an increased sexual exposure vs
i.v. drug abuse (p < 0.001), and a higher proportion of foreign p
(p < 0.04),were found. After HAART introduction, the most
evident drop of incidence of AIDS-associated opportunism
involved all diseases linked to a very deep immunodeﬁciency (as
expressed by a CD4 count (50–100 cells/lL), while a proportional
increase of lymphomas, tuberculosis, and bacterial pneumonia
occurred. Both examined periods were characterised by the
persistence of Candida esophagitis and pneumocystosis as the
most frequent AIDS-deﬁning diseases, followed by neurotoxopla-
mosis, wasting syndrome, and AIDS dementia. Both absolute
number andproportionofpwithmultiple concurrentAIDS-related
disordershadaparadoxical increase just during theHAARTera, as
well as AIDS diagnoses notiﬁed at death (p < 0.001), while AIDS-
associated immunodeﬁciency did not change signiﬁcantly. Sur-
prisingly, a prior use of antiretrovirals was more common among
AIDS p until 1995, vs p diagnosed since 2001 (p < 0.001), since
during recent years an AIDS diagnosis tends to be made concur-
rently with the ﬁrst positivity of HIV serology.
Discussion: When facing p with suspected opportunistic ill-
nessess, the Clinician should maintain an elevated clinical
suspicion for an advanced, but occult and untreated HIV
disease. An increased attention to this emerging problem may
allow a more rapid recognition of suspected p, and an
appropriate therapy of p who could not beneﬁt from HAART,
since they were unaware of their disease, or ‘removed’ their
problem (when p lost to follow-up or p who previously refused
follow-up and cure, are of concern).
P692
Basic clinical-applied pharmacoeconomic
features of antiretroviral therapy. A pilot
single-centre study performed on around 1000
HIV-infected individuals receiving combined
antiretroviral treatment
R. Manfredi, S. Sabbatani, C. Biagetti, F. Chiodo (Bologna, I)
Objective: Aim of our study is to assess the frequency and
composition of prescriptions taken by 990 HIV-infected patients
(p) followed in a reference centre of Northern Italy during the
last 15 months.
Methods: All drugs are directly distributed at monthly interval.
Antiretrovirals administered for the longest period to each
single p were considered, for our 15-month assessment. Physi-
cians in charge of HIV-infected p evaluated all anti-HIV
treatments on the ground of internationally-recognized efﬁc-
acy-safety parameters, but not pharmacoeconomic issues. Upda-
ted pharmacy expenses were linked to the 24 most commonly
used therapeutic plans, covering 80.1% of prescriptions.
Results: AZT-3TC-efavirenzwas themostprescribedcombination
(7.3%), followed by AZT-3TC-nevirapine (7.1%), 3TC-d4T (6.2%),
and AZT-3TC-lopinavir (5.2%). Mean daily costs of treatment
started fromaminimumofdual 3TC-d4Tassociation (10.7 ª), up toa
maximum of 25.8 a/d (+241.1%) for AZT-3TC-lopinavir. After
excluding dual nucleoside analogues (accounting for 9.8% of
prescriptions), regimensbasedonaNNRTIusuallyhada lowercost
vs the majority of those including 1–2 PI. The increased expense of
each combination is compared with the cheapest selection, and
costs of all triple associations were compared.
Discussion: NNRTI-based regimens accounted for 29.3% of
treatment administered to our p cohort (with nevirapine at
15.1% and efavirenz at 14.2%),while PI were used in 37.3% of
cases: lopinavir–ritonavir 13.6%, nelﬁnavir 9.9%, indinavir 9.2%.
Triple nucleoside/nucleotide analogues accounted for 4.1% of
regimens. Dual nucleoside analogues had the lowest expense
(10.7–11.6 a/d), while triple nucleoside/nucleotide analogues
costed 18.5–20.4 a/d. Among NNRTI, nevirapine-based combi-
nations costed 18.3–18.7 a/d, while efavirenz is 10% more costly
(19.2–20.l a/d). A broad range of associations and related prices
was found with PI-based HAART, but apart indinavir and
saquinavir combinations (15.7–21.7 a/d), all other regimens had
greater costs, ranging from 23.4–24.3 a/d for nelﬁnavir associa-
tions, up to 24.9–25.8 a/d for lopinavir. Considering nelﬁnavir-
and lopinavir-containing therapies, the difference with NNRTI
vary from 11.6% between efavirenz and nelﬁnavir, up to 41%
when nevirapine and lopinavir are compared.
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P693
Effectiveness and durability of tenofovir and
didanosine as backbones in anti-retroviral naive
patients
W. Jordan, R. Jefferson, F. Yemoﬁo, J. James, R. Green
(Los Angeles, USA)
Objective: To determine the durability and effectiveness of the
anti-HIV combination of didanosine (ddI) 250mg once daily
given with tenofovir (TDF) 300 mg once daily plus a protease
inhibitor or NNRTI in HIV+ anti-retroviral naive patients over a
3-year period
Method: Charts of all patients receiving ddI/TDF as a once
daily regimen were reviewed. Parameters to be measured
included (1) the total number started on this regimen; (2) the
per cent reaching viral suppression as measured by PCR-RNA;
(3) the per cent remaining on the regimen for 2 years or more; (4)
side-effect proﬁle
Results: 66 patients were identiﬁed. 7 were lost in follow-up: 2
were incarcerated and their regimen switched; 2 moved out of
state and 3 are lost to follow up. Of the 59 remaining, 47 have
been on the regimen over 36 months and 17 for 30 months. All
remain undetectable with viral loads less than 50 as measured by
PCR. CD4 counts increased by 53 with a range from (110 to 215.
Discussion: This differs from data recently reported by BMS
that was done by Podzamczer et al and JM Gtell. In our patient
population adherence was apparently good or better and clients
tolerated this regimen over a long period regardless if the
anchor drug was atazanavir, efaverinz, or niverapine. There was
no evidence of lactic acidosis or other complications. It is our
feeling that this is a strong backbone to give with a protease or
NNRTI in naive patients.
P694
Study on the effect of prolonged treatment
with zidovudine, lamivudine and abacavir
on a T-lymphoblastoid cell line
O. Turriziani, P. Pagnotti, A. Pierangeli, A. Mazzamurro,
A. Alberelli, G. Forte, P. Di Marco, M. Gentile, G. Antonelli
(Rome, I)
Objective: Cellular factors, such as altered activation and/or
decreased accumulation of drugs has been associated to a
decrease of the antiretroviral activity of several drugs. The aim
of this study was to determine whether the prolonged in vitro
treatment of cell culture with zidovudine (ZDV), lamivudine
(3TC) and abacavir (ABC) may select cellular factors able to
reduce the intracellular concentrations of drugs.
Methods: CEM T-cell line was treated with increasing concen-
trations of ZDV, 3TC and ABC. After 6 months of culture, we
obtained a cell line, here called CEMZLA. The antiviral activity
of drugs was evaluated by measuring p24 viral antigens.
Enzymatic assays, western blot assays and real-time PCR
analysis were used through the study to identify the mechan-
ism/s underlying the phenomenon of cellular resistance.
Results: CEMZLA were markedly resistant to the antiviral
activity of ZDV (25-fold), moderately resistant to the antiviral
activity of 3TC (5-fold) and fully sensitive to ABC. Parallel
experiments showed that ABC, alone or in combination, is not
able to select cells with a resistant phenotype. Assays, per-
formed to evaluate thymidine kinase (TK) and deoxycytidine
kinase (dCK) activities indicated that CEMZLA exhibits an
approx. 60-fold decrease in TK activity compared with the
parental line. On the contrary dCK activity from CEMZLA was
not decreased compared with the parental CEM cells. The lower
TK activity in CEMZLA correlates with a lower amount of TK
protein and to a decrease in the intracellular concentration of
ZDV-TP, being ZDV-TP levels 20-fold lower in CEMZLA than in
CEM. Interestingly, TK mRNA levels were unchanged in
CEMZLA when compared to parental line, suggesting that the
reduced activity of TK was not due to an alteration in the
transcription process. To explore whether an ABC transporter
protein played a role in the resistance to 3TC in CEMZLA, we
evaluated the expression of MDR1, MRP1, MRP4, MRP5 mRNA
levels in CEM and CEMZLA. No signiﬁcant differences were
observed in the expression of these mRNA in CEM and
CEMZLA.
Conclusions: The prolonged treatment with ZDV, 3TC and
ABC leads to a selection of cells highly resistant to ZDV (due a
defect of TK activity), moderately resistant to 3TC (the mech-
anism is still under study) and fully sensitive to ABC. Prolonged
treatment with ABC does not lead to the expression of cellular
factors involved in the decrease of the antiviral activity of the
drug.
HCV: risk factors, diagnosis, clinical presentation and treatment
P695
Hepatitis C exposure and the health care worker
in New Zealand. A review of 10 years of blood
and body ﬂuid exposure reports
M.I. Schousboe (Christchurch, NZ)
Objective: Evaluate the risk of Hepatitis C infection in the
Health Care Worker (HCW)Who had sustained a Blood or Body
Fluid (BBF) exposure, where the source BBF was Hepatitis C
positive or the source was of unknown.
Methods: Blood and Body ﬂuid Exposure Reports submitted
during the period 1993–2003 were reviewed. Source: The person
whose blood or body ﬂuid was involved in the injury HCW: The
injured person. Testing of the source person’s blood for evidence
of Hepatitis C antibodies was introduced in 1993. The BBE
exposure reports containing evidence that the source was
Hepatitis C positive or unknown were analysed for the follow-
ing factors: Exposure type: A: Needle stick or other sharp injury
B: Mucous membrane exposure C: Contamination of fresh
wounds D: Bite, scratches Employment Group Serological
testing of HCW and Source:
Results: 3302 BBF reports from staff were received during the
10–year period.510 were selected for review. 349 (68.4%) were
from blood or body ﬂuid exposure where no source was
identiﬁed. 161(31.6%) had an identiﬁable Hepatitis C positive
source. Exposure type A was reported in 395(77%) was,
however only 84(17%) had a documented Hepatitis C source.
Exposure type B was reported in 65(13%)and Exposure type C
and D 30 and 20 respectively. 51(10%) of the HCW s had left
employment prior to follow up. 17 of these had documented
Hepatitis C exposure. All had received information of the
exposure risk at time of injury and the need Hepatitis C serology
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6 months post injury. No communication regarding Hepatitis C
infection has been received from that group No Seroconversion
to Hepatitis C was recorded at 6 months follow up.
Conclusion: All Health Care Workers who sustain an BBF
exposure are concerned that they might get infected with an
blood borne virus one of which are Hepatitis C. The risk of
acquiring Hepatitis C is probably a rare event. 10 Years of
monitoring BBF exposures in a District Health Board with 6000
employees failed to document any seroconversion event.
P696
Striking changes in the prevalence of hepatitis C
virus genotypes in Greece in the last ﬁve years
E.S. Hadziyannis, S. Savvas, J. Koskinas,
S.J. Hadziyannis (Athens, GR)
Objectives: To estimate the relative frequency of Hepatitis C
Virus (HCV) genotypes in Greece over the last 5-year period in
comparison to their respective prevalence in the 1990’s and to
investigate for possible associations with epidemiological,
demographic and other variables.
Methods: 1090 consecutive patients with chronic HCV infection
and detectable HCV RNA, referred to the Hepatitis Research
Laboratory of Athens University over the last ﬁve years, were
included in this study. Sera were ﬁrst subjected to HCV RNA
ampliﬁcation by PCR (Amplicor-Cobas, Roche) and the PCR
product was then genotyped by a line probe assay (Innolipa,
Versant, Bayer) according to themanufacturer’s instructions. The
results were analysed by age, sex, duration of infection, intraven-
ous drug abuse (IVDU), other modes of transmision and other
variables.Resultswere also compared topreviously reporteddata
on the prevalence of HCV genotypes in Greece in the 1990’s.
Results: The overall prevalence of HCV genotype 1 was 43%, of
genotype 2 9%, genotype 3 29% and genotype 4 19%. The
prevalence rates in the 1990’s of genotypes 1, 2, 3 and 4 were
54%, 9%, 22% and 11% respectively. Among HCV-infected
individuals born after 1955, genotype 1 was detected in 36% and
genotype 3 in 44% of them, compared to 65% and 7%
respectively, in those born before 1955. There was no correlation
between HCV genotype and the sex of the patients. Genotype 3
accounted approximately for three quarters of HCV infections
among intravenous drug users. These secular changes of HCV
genotypes in Greece appeared to be related to alterations in
prevailing modes of HCV transmission as well as to increased
immigration and extensive population mix.
Conclusions: The distribution of HCV genotypes is in continu-
ous temporal change in Greece. The prevalence of HCV
genotypes 3 and 4 is progressively increasing, genotype 1
decreasing and contrary to most European countries and USA,
HCV genotype 3 is becoming the predominant type accounting
for almost half of new HCV infections and for their majority
among intravenous drug users. These results are of clinical,
epidemiological and particularly of therapeutic relevance.
P697
Hepatitis C virus infection among dialysis
patients in Tunisia: prevalence and molecular
evidence for nosocomial transmission
F. Hmaied, M. Ben Mamou-Ben Halima, K. Saune-Sandres,
L. Rostaing, A. Slim, Z. Arrouji, S. Ben Redjeb, J. Izopet (Tunis,
TN; Toulouse, F)
Objectives: In order to give evidence for nosocomial transmis-
sion of hepatitis C virus (HCV) in Tunisian haemodialysis
patients, 431 patients from 11 haemodialysis units were enrolled
in a prospective study between November 2001 and November
2003.
Methods: HCV serological and virological statute was initially
determined, respectively using third generation ELISA test and
RT-PCR qualitative assay. Anti-HCV negative haemodialysis
patients were followed monthly with measurements of alanine
aminotransferases (ALT). Every rise in ALT value led to the
screening for HCV-RNA in order to detect potential de novo
infection. In case of conﬁrmation of recent contamination, the
genotype of the HCV isolate was determined by sequencing
NS5B region. The issue of nosocomial transmission was
addressed by sequencing the HVR-1 region of the E2 gene.
Results: The overall prevalence of HCV antibodies in investi-
gated haemodialysis patients was 19%; HCV RNA was detected
in 72% of the anti-HCV-positive patients. Two cases of de novo
HCV infection were identiﬁed during the virological follow up
(incidence = 0.84%) with a signiﬁcant increase in ALT and a
seroconversion during the second sampling round. The ﬁrst
novel HCV-positive case (anti-HCV-negative patient, HCV RNA
positive)belonged to HCV genotype 1b, unlike isolates from
already infected dialysis patients in the same unit. In the second
case, the new case like other HCV positive patients were
infected with the same genotype 1b; the sequencing of the HVR-
1 region of the E2 gene provided strong evidence that the isolate
from newly infected patient and an other isolate from already
infected dialysis patients were closely related (bootstrap value
100%).
Conclusion: Molecular tools and phylogenetic analysis allowed
to exclude nosocomial transmission in the ﬁrst case and to
conﬁrm it in the second one. Epidemiological investigation
exhibited that these two patients were dialysed on the same day,
on the same shift but in different areas, suggesting nosocomial
transmission intermediating medical staff and/or nursing and
emphasizing on strict adhesion to universal hygiene standards
and routines in dialysis units.
P698
Sources of infection in patients with chronic
hepatitis C virus
L. Mendizabal, M. Basaras, J. Bilbao, E. Arrese,
R. Cisterna (Bilbao, E)
Since the discovery of hepatitis C virus (HCV), much has been
learned about its epidemiology and risk factors for infection.
The aim of this study was to evaluate risk factors for hepatitis C
virus infection, and to obtain a predictive value between some
factors and ﬁbrosis and hepatocellular carcinoma.
Subjects and methods: The study included 755 persons with
chronic hepatitis C virus infection. Screening for HCV antibod-
ies was carried out on serum samples using a third-generation
enzyme-linked immunoassay and conﬁrmed by third-genera-
tion line immunoblot assay. Samples were also tested for
hepatitis B virus surface antigen using ELISA and all positive
samples were conﬁrmed by Access-HBsAg. Anti-HIV antibodies
were sought by ELISA and positives were conﬁrmed byWestern
blot. For statistical analysis, Chi-square test was used. P-values
of <0.05 were considered statistically signiﬁcant.
Results: The global population was divided into drug users and
non drug users. In the drug users group, 431 were intravenous
drug users (IVDU) and 60 had high alcohol intake. Viral
coinfection with HBV and HIV was higher for IVDU than for the
other group (65.9% vs 15% for HBV; 63.6% vs 10% for HIV).
When alcohol intake was elevated, GOT value was signiﬁcantly
higher than GPT value (65% vs 35%). However, IVDU presented
GPT value higher than GOT value.In the non drug users group,
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the risk factors were: iatrogenic sources (41.6%), blood transfu-
sion (33.3%), high-risk sexual behavior (5.54%), hemodialysis
(3.78%), had lived in endemic countries (3.03%), tattooing
(2.65%), needle stick accidents (1.13%), transplants (1.13%) and
unknown (8.7%). This group was older than drug users group.
In the iatrogenic sources, digestive surgery and endoscopic
exploration had elevated values of viral transmission. HCV
infection by blood transfusion had an elevated HBV coinfection.
When the risk factor as unknown, they had HIV viral coinfection
rate higher than the rest of non drug users group (8.7% vs 4.5%).
Conclusion: In the drug users group, the multivariate analysis
showed a strong association between alcohol intake, hepatocel-
lular carcinoma, GOT value, ﬁbrosis and inﬂammation, and non
viral coinfection. On the other hand, HIV and HBV positive,
GPT value and non hepatocellular carcinoma items were
strongly associated. However, in the non drug users, the
multivariate analysis showed a strong association between
GOT value, ﬁbrosis and inﬂammation, and viral coinfection.
P699
HCV infection and pregnancy. Prospective series
of 29,260 consecutive cases
E. Minola, G. Rizzo, C. Passerini Tosi, M. Arosio, F. Suter,
A. Goglio (Bergamo, I)
In 29,260 consecutive pregnant women we evaluated the
prevalence of HCV chronic infection, its course during preg-
nancy and the rate of HCV vertical transmission.
Patients and methods: Anti-HCV was tested by EIA III and
conﬁrmed by RIBA III. ALT, anti-HIV and HCV-RNA were
tested at enrollment, at delivery and six months after. The same
determinations were also performed in all new-borns of anti
HCV positive mothers, at birth (on cord blood only during the
initial 36 months of the study) and at 6-month intervals up to
24 months.
Results: Anti-HCV positivity was found in 767 cases (2.6%),
65% of whom were HCV-RNA positive. The proportion of those
hypertransaminasemic decreased from 48% before pregnancy to
4% in the last trimester and increased again after delivery (49%
at 6 months) without concomitant changes in the proportion of
viremic ones. Twenty-two new-borns were HCV-RNA positive
but 20 negativized and nineteen others became positive within
6 months; thus the proportion of anti-HCV and HCV-RNA
positive new-borns was 4.5% at 1 years (19/418), all with the
same genotype of the mother. Type of delivery and feeding and
maternal HIV status did not inﬂuence the rate of HCV
transmission.
Comments: This series conﬁrm, on a large scale, previous data
concerning the prevalence of HCV infection in pregnant women
and strongly support a favourable (possibly immuno-mediated)
effect of pregnancy on liver cell necrosis in anti HCV positive
women. Data from new-borns also indicate that cord blood test
for HCV RNA is not advisable due to its negligible positive
predictive value.
P700
Evaluation of a new kinetic ampliﬁcation based
assay for quantiﬁcation of hepatitis C virus
(HCV) RNA
T.R. Battersby, M.L. Abraham, J.D. Ahle, E.J. Brooks,
M.J. Friesenhahn, L. Grewal, J. Jiang, D. Sherman,
C. Wang (Berkeley, USA)
Objectives: The authors are developing an automated kinetic
ampliﬁcation assay targeting the 5¢-UTR for quantiﬁcation of
HCV RNA. Analytical performance characteristics of this assay
were evaluated, including: sensitivity, linearity, the ability to
detect genotypes 1–6, and speciﬁcity.
Methods: Viral RNA was extracted from panels and donor
samples using an automated method with magnetic silica beads.
Reverse transcription, ampliﬁcation, and detection were subse-
quently performed. Analytical performance of the assay, cur-
rently in development, was evaluated to determine sensitivity,
dynamic range, speciﬁcity, and equivalence of genotype quan-
tiﬁcation. Linearity and limit of detection were evaluated with
HCV 1a viral panels. Additionally, HCV 1a transcript quantiﬁed
by phosphate analysis and A260 was used to evaluate linearity
over an extended range. Transcripts representing HCV subtypes
were similarly quantiﬁed and used to evaluate genotype
detection. Speciﬁcity was evaluated using serum from HCV
antibody negative donors.
Results: The assay was linear over the range tested (25–
5 · 108 copies/reaction) with subtype 1a transcripts as target.
HCV 1a virus panels were detected >95% of the time at 20 IU/
mL with a 0.5 mL sample volume. Preliminary experiments
with transcripts representing genotypes 1–6 demonstrated
equivalent quantiﬁcation. Assay speciﬁcity was >99% using
negative donor serum samples.
Conclusions: The new automated HCV viral load assay under
development has been demonstrated to detect HCV RNA at
very low concentration. The assay displays a wide dynamic
range with excellent speciﬁcity.
P701
Evaluation of the total hepatitis C virus core
antigen in children born to HCV positive mothers
C. Pitart, R. Benito, J. Gil, J. Castillo, M.C. Rubio (Zaragoza, E)
Objectives: The aim of this study was to evaluate an immuno-
enzymatic assay for the detection and quantiﬁcation of HCV
core antigen (HCV core Ag) and examine the time course and
pattern of HCV antibody response and viral load in infants born
to HCV positive mothers. We also studied the correlation
between viral load and HCV core Ag levels.
Methods: We studied 67 blood samples collected from 22
children born to a HCV positive mothers group, between birth
and more than 24 months, in the period August 2000–July
2004. Samples were stored frozen at –80C. Specimens were
tested for the presence of anti-HCV antibodies using a third
generation screening assay, Abbott AxSYM HCV 3.0. Cobas
Amplicor Test (Roche Diagnostics) was used to detect and
quantify HCV RNA in patients serum samples. Detection and
quantiﬁcation HCV core Ag was measured by track-C assay
(ORTHO). All assays were carried out following manufacturer
instructions.
Results: All children except ﬁve were anti-HCV negative after
24 months of birth. Fifty-ﬁve samples showed agreement with
PCR (83.6%), twenty-three were PCR and HCV core antigen
positive and thirty-three were negative in both markers. The
correlation coefﬁcients (r) observed between HCV core Ag
(pg/ml) and HCV RNA (UI/ml) was 0.72. Eleven sera
showed disagreement between HCV core Ag (signiﬁcantly
higher than in disagreement proﬁles (622 ± 0 UI/ml) (p <
0.001). However, among agreement proﬁles there is no
signiﬁcantly difference of viral load between Anti-VHC
negative patients (389190 ± 272974 UI/ml) and positive patient-
s(411241 ± 293342 UI/ml). On the other hand, mean VHC core
Ag concentration in agreement proﬁles 92 ± 105 pg/ml)is also
signiﬁcantly higher than in disagreement proﬁles (17 ± 24 pg/
ml) (p < 0.001).
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Conclusion: The HCV Ag core quantiﬁcation is useful to
identify viraemia in anti-VHC negative and positive and antigen
levels correlated with quantitative HCV RNA levels. However,
track C could fail to detect viraemia in patients with very low
HCV core Ag concentrations.
P702
A new anti-HCV EIA based on recombinant
antigens derived from different sequence
variants of hepatitis C virus
T. Ulanova, V. Puzyrev, L. Kulikova, G. Bochkova, I. Golubeva,
A. Obriadina, A. Burkov (Nizhniy Novgorod, RUS)
Objective: The purpose of this study is the development of a
new anti-HCV EIA by using recombinant antigens derived from
different sequence variants of different HCV virus genotypes.
Methods: The 9 sequence variants of recombinant antigens
comprising major epitopes from core, NS3, NS4 and NS5 HCV
proteins have been selected for the anti-HCV assay develop-
ment. This new EIA was evaluated using serum specimens (n ¼
511) obtained from patients infected with different HCV
genotypes from different parts of the world. The HCV status
of these specimens was conﬁrmed using RIBA HCV 3.0
(ORTHO Diagnostic Systems Inc., USA), and Cobas Amplicor
HCV Test, v.2.0 (Roche Diagnostics, USA). 376 samples were
conﬁrmed as anti-HCV positive, 57 samples were tested anti-
HCV ‘Indeterminate’, and 78 serawere tested anti-HCVnegative.
Among anti-HCVRIBA negative specimens 3 sampleswereHCV
RNA positive. Additionally, anti-HCV Mixed Titer performance
Panel PHV 205, anti-HCV Low Titer Performance Panel PHV 103
(BBI Inc., USA) and 15 anti-HCV seroconversion panels (BioCl-
nical Partners, Inc., USA) were tested. The anti-HCV negative
panel was composed of 200 specimens (BBI Inc., USA).
Results: New EIA detected anti-HCV activity in 100% of
specimens tested anti-HCV positive or/and anti-HCV indeter-
minate by RIBA HCV 3.0 and HCV RNA positive. 92% of RIBA
‘indeterminate" samples were immunoreactive with more than
one antigen used for the development of the new anti-HCV EIA.
Moreover, three anti-HCV negative but HCV RNA positive
samples were immunoreactive with NS3 antigens used in this
new EIA. Additionally, the EIAwas able to detect seroconversion
point earlier in 3 anti-HCV seroconversion panels than commer-
cially available anti-HCV EIA. Two anti-NS4 HCV negative but
anti-core, anti-NS3 and anti-NS5 positive specimens from PHV
103 and PHV 205 were found anti-NS4 positive by using the NS4
antigen from the new EIA. None of the used anti-HCV negative
specimens were tested as positive with new anti-HCV EIA.
Conclusion: A new highly sensitive and speciﬁc anti-HCV
detection assay was developed using various sequence variants
of HCV antigens. This assay may be used for screening sera
from patients infected with different HCV genotypes with
almost equal efﬁciencies.
P703
Seroprevalence of HIV, HBV, HCV and CMV
infection among Polish orthopaedic surgeons
M. Ganczak (Szczecin, PL)
Background: Orthopedic surgeons are at risk for occupationally
acquired infections with blood borne pathogens.
Objective: to estimate the prevalence of infection with hepatitis
B and C viruses (HBV, HCV), cytomegalovirus and human
immunodeﬁciency virus (HIV) among orthopaedic surgeons
and correlate the results with occupational and nonoccupational
risk factors.
Design: A voluntary, anonymous serosurvey at an annual
meeting of Polish Asso-ciation of Orthopedic Surgeons held in
Szczecin, Poland in September 2004. Serum samples were tested
for HIV antibody, for CMV IgG antibody, for HCV antibody and
for markers of HBV infection: hepatitis B surface antigen and
total antibody to hepatitis B antigen.
Results: Of 1000 eligible orthopaedic surgeons at the annual
meeting, 101 (10%) participated. 76 (75.2%) reported a percuta-
neous blood contact in the previous month. Among participants
without reported nonoccupational risk factors for HIV infection
none was positive for HIV (0%; 95%CI: 0–3.7%). One participant
(1%), 26 years in profession, had anti-HCV. There was evidence
of infection with hepatitis B in 10 of 74 (13.5%) participants who
had reported having no nonoccupational risk factors and in 5
participants with such risk factors. None of them developed a
chronic infection. From 15 doctors infected with HBV, 5 knew
their serological status (3 immunized themselves against hepa-
titis B despite such knowledge), 10 did not know the fact and
had been immunized with hepatitis B vaccine, 4 revaccinated.
The immunization rate in our study was 79%. The prevalence of
infection with HBV was not associated with number of proce-
dures and of percutaneous contacts with blood in the past
month (p > 0.94 and p > 0.14 respectively) and the use of
protective barriers (p > 0.01), but was associated with the age
(p < 0.02) and the participation in the training sessions on
occupational infections (p < 0.05). The seroprevalence for CMV
was 63/98 (62%); it decreased with age (p < 0.0003).
Conclusions: 1. Although these ﬁndings may not be generaliz-
able to all orthopaedic surgeons, we found that despite infection
control precautions and availability of hepatitis B vaccine,
orthopaedic surgeons remain at risk for acquiring bloodborne
viral infection. CMV posed the highest risk, followed by HBV
and HCV. 2. As the vast majority of HBV infected doctors did
not know their serological status and underwent immunization
with hepatitis B vaccine, testing for HBc antigen before every
vaccination remains crucial.
P704
Insertion of a new V3-like domain in
nonstructural 5A protein of hepatitis C virus
genotype 1b
P. Veillon, F. Lunel, J. Redureau, B. Coefﬁc, J.F. Subra, X. Causse,
P. Dubois, C. Gaudy, C. Payan (Angers, Orle´ans, Tours, F)
Objectives: Hepatitis C virus (HCV) nonstructural 5A (NS5A)
protein has been disputably implicated in the resistance of HCV
to interferon therapy in both Japanese and European clinical
studies, particularly for HCV genotype 1b. Many interactions
have been reported between NS5A and cellular proteins, but its
function in the life cycle of HCV is unknown despite an
interaction with NS5B. Some authors have reported insertions–
deletions of small sequences, from 1–12 nucleotides long, in
different regions of the viral genome, 5¢ UTR, HVR1, ISDR. In
this study, we report on a novel insertion in the HCV genome in
the V3 region of NS5A protein.
Methods: We ampliﬁed the second half of the NS5A gene
including ISDR and V3 domains in 131 patients with HCV
genotype 1b (n ¼ 113) and mixed genotype 1, 1a-1b or 1b-4a
(n ¼ 18).
Results: Among these patients, we found ﬁve (3.81%), infected
by HCV-1b, with an insertion in the V3 region of the NS5A gene
without disruption of the open reading frame. Two sizes of
inserts were found: four patients had an insert of 31 amino acids
and one patient had an insert of 27 amino acids. The 31 amino
acid insert was very similar to the V3 domain (2353–2379) but it
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was not the same sequence in the ﬁve cases (homology from
54.8–71%).
Conclusion: The consequences of this duplication on protein
function are not yet clear. The NS5A protein needs further study
to understand its implication in replication, transcription acti-
vation, or resistance to treatment of HCV.
P705
Serological proﬁle and virological evaluation of
hepatitis B and hepatitis C virus infection among
HIV-infected patients in Greece
I.S. Elefsiniotis, V. Paparizos, C. Mpotsi, K.D. Pantazis,
A. Katsambas (Athens, GR)
Objectives: To evaluate the prevalence of serological markers of
HBV and HCV infections among a large cohort of HIV-infected
patients and to examine the serum levels of HBV-DNA and
HCV-RNA in a subgroup of HIV/HBV and HIV/HCV coin-
fected patients respectively.
Methods: We retrospectively analysed 737 HIV-infected
patients followed-up at the Department of Infectious Diseases,
‘Andreas Sygros’ University Hospital of Athens, Greece, since
1995, for the presence of serological markers of HBV and HCV
infection. Virological evaluation (HBV-DNA, HCV-RNA) and
HCV genotyping, before the initiation of ART, was available in a
subgroup of HIV/HBV and HIV/HCV coinfected patients.
Results: Overall 88.6% (653/737) of the study population were
men and 11.4% (84/727) women whereas the vast majority of
them (453/737, 61.5%) were homosexual (HOM) men. Thirty-
nine of 737 patients (5.3%) reported intravenous drug use
(IVDU) and 17 of them were both HOM/IVDU. Among the 737
HIV-infected patients 89 (12.1%) were HBsAg(+) and the
majority of them (54/89, 60.7%) were HBeAg(+) whereas 33.7%
(30/89) of HBsAg(+)/HIV(+) patients were HBeAg())/anti-
HBeAg(+). Anti-HBc seropositivity was detected in 48.1% (355/
737) of the study population. The serum levels of HBV-DNA
in this subpopulation with available virological data were
5.75 ± 1.66 ()log10 copies/ml) and HBeAg(+) HIV/HBV coin-
fected patients had signiﬁcantly higher baseline serum
HBV-DNA levels than HBeAg())/AntiHBe(+) coinfected ones
(7.40 ± 0.64 vs 4.59 ± 1.01, )log10 copies/ml, respectively,
p < 0.001). Fifty-one of 625 HIV-infected patients, of which
anti-HCV test was available, were anti-HCV positive (8.2%).
Quantitative calculation of HCV-RNA and HCV genotyping
were available in 28 HIV(+)/anti-HCV(+) patients. The vast
majority of them (24/28, 85.7%) had HCV-RNA levels more
than 700.000 IU/L and the most common HCV-genotype was
genotype-1 (12/28, 42.9%) followed by genotype-3 (10/28,
35.7%), genotype-4 (4/28, 14.3%) and genotype-2 (2/28, 7.1%).
Five patients (0.68% of the total study population) exhibited
triple infection (HIV/HCV/HBV).
Conclusion: HIV/HBV coinfection is observed in a signiﬁcant
proportion of HIV-infected patients in Greece and the majority of
them areHBeAg (+), exhibiting extremely highHBV-DNA levels,
in contrast to general Greek population. Genotype-1 and high
HCV-RNA levels are the most common ﬁndings in HIV/HCV
coinfected patients, characterizing a difﬁcult to treat population.
P706
Acute transverse myelitis and hepatitis C virus
M. Marroni, P. Annunziata, D. Francisci, G. Stagni (Perugia,
Siena, I)
Objectives: We report a case of acute transverse myelitis
developing 4 years after documented HCV seropositivity, asso-
ciated with intrathecal anti-HCV protein IgG synthesis.
Case report: A 60-year-old woman, seropositive for HCV since
1996, was admitted to the hospital in July 2000 with persistent
fever and acute transverse myelitis. Blood parameters were
normal but serum antibodies against HCV and HCV-RNA
(genotyping 1) were tested positive. Cerebrospinal ﬂuid (CSF)
analysis showed mild lymphocytic pleocytosis (40/mmc) with
increase of total proteins (116 mg/dl); and isoelectrofocusing
(IEF) evidence of oligoclonal bands not found in serum.
Neurotropic virus RNA and DNA were not found. The patient
was treated with ampicillin, gentamicin and acyclovir for
3 weeks. Leg weakness slightly improved and was discharged.
In November 2001, she was admitted to the hospital with
worsening of leg weakness. She was treated with intravenous
methylprednisolone (1 g for 3 days) responding with slight
improvement in clinical parameters. In July 2002, due to
renewed worsening of clinical parameters, a lumbar puncture
was performed. CSF analysis showed normal protein levels and
no pleocytosis but IEF conﬁrmed several oligoclonal bands. PCR
testing for HCV-RNA was negative but antibodies against HCV
c22–3 protein were found by immunoblot assay. Further
treatment with intravenous methylprednisolone was underta-
ken. The patient is currently unable to walk and shows
hyperreﬂexia with Babinski sign and moderate urinary urgency.
In order to test for an intrathecal immune response to HCV, we
performed IEF of the ﬁrst and last serum and CSF specimens of
the patient and a multiple sclerosis (MS) patient as control,
before and after immunoabsorption with recombinant structural
and non structural HCV proteins immobilized on nitrocellulose
strips (Chiron, CA, USA). Identical patterns of oligoclonal IgG
were found in the ﬁrst and last CSF sample of our patient. After
immunoabsorption with recombinant HCV proteins, some IgG
bands disappeared or became markedly faint in the last CSF
sample, whereas no change was observed in IgG oligoclonal
pattern of CSF from the MS patient
Conclusion: To our knowledge, this is the ﬁrst report of acute
myelitis developing some years after demonstration of HCV
seropositivity and associated with intrathecal immune response
against HCV proteins.
P707
Prevalence of chemokine receptor
polymorphisms in HIV/HCV co-infected subjects
F. Roman, K. Hawotte, J.Y. Servais, V. Arendt, R. Hemmer,
T. Staub, J.C. Schmit (Luxembourg, LUX)
Objective: The protective role of chemokine receptor polymor-
phisms has been well established in HIV infection. Still under
debate is the association between the CCR5-delta32 allele and
the acquisition, natural evolution or treatment response in
chronic HCV infection. To date, the prevalence of chemokine
receptor polymorphisms in the context of HIV/HCV-coinfection
has not been extensively studied. Our objective was to deter-
mine the prevalence of 5 chemokine receptor polymorphisms in
HIV/HCV-coinfected patients, in comparison with HIV-infected
patients and uninfected, healthy volunteers.
Methods: The respective allele frequencies of CCR5-delta32,
CCR2–64I, SDF1–3¢A, and genotype distributions of CCR5–
59029 and CX3CR1 were determined for 43 HIV/HCV-coinfect-
ed patients, 245 HIV-infected patients, and 158 uninfected
volunteers using PCR-restriction fragment length polymorph-
ism(RFLP)-based methods.
Results: Compared to controls and HIV-infected patients, HIV/
HCV-coinfected patients did not show any difference in terms of
prevalence of CCR5-delta32, CCR2–64I and SDF1–3¢A alleles
(respective p-values in comparison with controls (0.27; 0.24 and
1 and respective p-values in comparison with HIV-infected (0.62;
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0.63 and 1). The distribution of CCR5–59029 and CX3CR1
genotypes was comparable in each group (respective p-values
in comparison with controls ( 0.88 and 0.35 and respective
p-values in comparison with HIV infected ( 0.28 and 0.121). The
Hardy–Weinberg Equilibrium was respected for all polymor-
phisms in the HIV/HCV-coinfected group.
Conclusion: The chemokine polymorphisms investigated in
this study are not positive selection factors for the HIV/HCV-
coinfection status.
P708
Is it justiﬁable to withhold treatment for
HCV-chronic hepatitis from drug addicts?
M. Bonasso, D.A. Zeme, G. Oroﬁno, E. De Vivo, D. Artuso,
P. Cerrato, D. Pini, T. Marmo (Turin, Moncalieri, Orbassano, I)
Objectives: Current therapies for HCV-chronic hepatitis have a
low success rate and are not well tolerated in drug addicts. In
fact literature data show that 20% of these patients drop out vs.
7% of patients from general population. Our purpose was to
improve adherence to therapy and to closely evaluate side-
effects in our patients, particularly depression.
Methods: Patients attending addiction treatment clinics have
been evaluated for HCV serology and then for their family and
job stability. Furthermore, an assessment of depression was
made through Beck test. Then the patients could be enrolled and
treated with pegylated interferon 2b (PEG-IFN 2b) and ribavirin
for 24 or 48 weeks, according to the genotype. Periodic haem-
atological tests were performed to investigate blood abnormal-
ities and virological response; Beck test was repeated every
3 months.
Results: Seven addiction treatment units of our area took part
to the study and 41 patients were enrolled (39 males and 2
females). The population mean age was 32 (20–52) years old. The
mean HCV infection duration was 7.5 years and the mean
duration of addiction was 10 years. HCV genotypes distribution
was as follows: genotype 1 ¼ 8 pts, genotype 2 ¼ 1 pt, genotype
3 ¼ 30 pts, genotype 4 ¼ 2 pts. Ten patients had undergone
previous treatment with IFN. Up to now 20 patients (49%) have
reached an end- of- treatment response (ETR), 14 pts (34%) are
on treatment and 7 pts (17%) have stopped the therapy, of
whom 5 pts (12%) because of adverse events and only 2 pts (5%)
have dropped out. Seventeen out of 41 patients (41.5%)
presented adverse events (someone had more than one): 7 pts
weight loss, 3 pts nausea, 2 pts rashes, 4 pts fatigue, and 5 pts
reported other symptoms (mialgyas, dizziness, panic attacks
and insomnia). In 4 patients (9.8%) there was evidence of blood
abnormalities (3 pts showed anemia and 1 pt reduction of
platelets number).
Conclusions: In our experience, the low rate of drop-outs in our
population (5%) vs 20% reported in literature is both due to a
careful selection of patients and to a close clinical and psycho-
logical follow-up.
P709
Erythema multiforme related to pegylated
interferon alpha 2a plus ribavirin treatment
for chronic hepatitis C
N. Erben, G. Usluer, I. Ozgunes, H. Colak (Eskisehir, TR)
Objectives: Pegylated interferon and ribavirin combination
therapy is effective and safe for chronic hepatitis C infection.
Adverse affects are similar to interferon alpha and a variety of
rashes including erythema multiforme have been noted. We
report a case of erythema multiforme related to pegylated
interferon alpha 2a plus ribavirin treatment for chronic hepatitis
C virus infection.
Case: In May 2004 a 56-year-old woman was admitted to
hospital because of anti-HCV positivity. The ALT and AST
levels were found in normal range. HCV RNA level was found
as 616619 copy/mL. Histopathological examination of biopsy
material was showed chronic hepatitis by a Knodell score 9.
Pegylated interferon alpha 2a 180 microgram/week and ribavi-
rin 1200 mg/day combination therapy was started. Flu like
syndrome was seen after the ﬁrst dose of interferon. The patient
was readmitted because of fever and rashes on thigh with
pruritis 3–4 hours after the second dose of interferon. In
physical examination multiple maculopapular lesions in various
sizes were seen on thigh and leg bilaterally. WBC, platelet, ESR,
IgE, ALT, AST, TFT, ANA, Anti-DNA, ASMA, AMA, cryoglob-
ulin, thyroglobulin, anti-thyroglobulin. anti-TPO were searched
and found in normal range. Skin biopsy was performed and
erythema multiforme was conﬁrmed by histopathological exam-
ination. The treatment was started with oral antihistaminic
(fexofenadine hydrochloride 180 mg/day) and topical cortico-
steroid (Fluticasone propionate 0.005%). Skin lesions were
regressed in 10 days.
Conclusion: Interferon alpha have been widely used to treat
chronic hepatitis C virus infection and pegylated interferons are
novel agents in this area. Side effects are common; they are
usually minor but are problematic for a signiﬁcant proportion of
patients. Major adverse events can occur, but life-threatening
adverse events have been rare in large surveys. Erythema
multiforme can be seen after or during various infections and
with administration of various drugs. In this case report,
erythema multiforme probably belong to pegylated interferon
alpha 2a was reported.
Bacteriology: role of selective media and identiﬁcation systems
P710
Evaluation of selective culture media for
Lactobacillus, Biﬁdobacterium and Bacteroides to
study the intestinal ﬂora
C. Vael, A. De Coninck, C. Lammens, K. Desager,
H. Goossens (Antwerp, B)
Objectives: False positivity rates of selective culture media to
study Lactobacillus (Lac) and Biﬁdobacterium (Bif) in the intestinal
ﬂora, range from 9–85% and 29–50% respectively. The aim of
our study is to evaluate sensitivity and speciﬁcity of established
and recently described selective culture media used for enu-
meration of Lac, Bif and Bacteroides (Bac) from faecal samples.
Methods: For Lac 8 selective media (LAMVAB, Sorbitol agar, 2
Rogosa variants and 4 MRS variants) were studied with 24 Lac
strains and 14 faecal (non-Lac) strains. For Bif 3 selective media
(NPNL, MTPY and RB) were studied with 22 Bif strains and 44
faecal (non-Bif) strains. For Bac 2 selective media (BBE and
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Schaedler ( VN) were evaluated with 31 faecal (non-Bac) strains.
All plates were incubated anaerobically at 37C for 72 h.
Results: The MRS medium, most widely used for enumeration
of Lac from faecal samples, is not selective (speciﬁcity = 0%) but
sustains the growth of all Lac strains tested (sensitivity = 100%).
MRS with aerobic incubation improves speciﬁcity of the
medium (67%) but reduces sensitivity (90%). Similar data were
obtained for Rogosa medium: high sensitivity (100%) but low
speciﬁcity (7%), which was increased to 50% by the addition of
metronidazole. LAMVAB medium, recently described by Harte-
mink et al. (J. Microbiol. Meth., 1999) has the highest speciﬁcity
(100%) with acceptable sensitivity (83%). The L. acidophilus
group is not detected using this medium. NPNL, the reference
medium for selective enumeration of Bif has a sensitivity of
100% but a speciﬁcity of only 32%. RB medium showed similar
results. MPTY medium, recently described by Rada et al.
(J. Microbiol. Meth., 2000) demonstrated a sensitivity of 95%
and a speciﬁcity of 100%. Out of the selective media for Bac, BBE
showed the highest speciﬁcity (100%) compared to only 48% for
Schaedler (VN. BBE detects only the B. fragilis group.
Conclusions: Several media used for the selective enumeration
of Lac, Bif and Bac allow the growth of faecal contaminants,
leading to an insufﬁcient speciﬁcity. LAMVAB is the optimal
medium for Lac. MTPY is the optimal medium for Bif and BBE
is the medium of choice for selective enumeration of Bac.
P711
Comparative evaluation of a new biochemical test
kit for the presumptive identiﬁcation of Candida
albicans
T. Baalham, A. Brown, R. Dunsmuir, G.S. Shankland,
M. Blackman (Basingstoke, Glasgow, UK)
Objectives: Conventional methods for the presumptive identi-
ﬁcation of Candida albicans such as the germ tube test (GT)
requires expertise, a microscope and is time consuming to
perform. In this study a direct comparison was made between
the GT and the new Oxoid OBIS albicans test. OBIS albicans is a
rapid card-based chromogenic test that detects the presence of
two enzymes speciﬁc to C. albicans and C. dubliniensis: b-galac-
tosaminidase and L-proline aminopeptidase. OBIS albicans uses
non-carcinogenic substrates and does not require the use of UV
light sources.
Methods: A total of 219 fully characterised clinical strains were
blind tested, comprising: C. albicans, including control strain
ATCC 10231, C. dubliniensis, other Candida spp., Saccharomyces
cerevisiae, Blastoschizomyces capitus, Geotrichum candidum and
Rhodotorula rubra. All organisms were grown on Sabouraud
Dextrose Agar for 48 hours at 30C. Material equivalent to three
to ﬁve 1-mm colonies was removed from the agar plates using a
paddle pastette and spread across the surface of the test area.
One 50 ll drop of OBIS Rehydrating Solution was added to each
test area. The cards were placed in a plastic sleeve and incubated
at 37C for 60 min. Following incubation, 50 ll of OBIS NaOH
Developer was added to each test area and the reaction noted.
Formation of a distinct yellow colour at the point of inoculum
indicated the presence of b-galactosaminidase and was therefore
a positive result. 50 ll of OBIS DMAC Developer was then
added to each test area and the reaction noted. A distinct
magenta colour indicated presence of L-proline aminopeptidase
and was therefore a positive result. A positive reaction for both
enzymes provided presumptive identiﬁcation of C. albicans. A
negative reaction for either one or both enzymes indicated that
the organism was not C. albicans. All organisms were also tested
by the germ tube test.
Results: Sensitivity and speciﬁcity of OBIS albicans was 100%.
Candida albicans and C. dubliniensis are phenotypically similar
and both species produce the target enzymes and form germ
tubes.
Conclusion: OBIS albicans performed equivalently to the germ
tube test in differentiating C. albicans/dubliniensis from other
Candida spp.
P712
Evaluation of chromogenic Candida agar
T. Baalham, B. de Caux, C. Alexander, L. Brown, R. Dunsmuir,
G.S. Shankland, M. Blackman (Basingstoke, Glasgow, UK)
Objectives: Several chromogenic Candida media have been
developed to aid differentiation and identiﬁcation of yeast
cultures in clinical specimens, in particular, C. albicans,
C. tropicalis and C. krusei. Differentiation is based upon reactions
with chromogenic substrates and colonial morphology on the
medium. In this study, direct comparison was made of a new
medium, Oxoid Chromogenic Candida Agar (OCCA), CHROM-
agar Candida (CHROM) and Candida ID (CID).
Method: 214 fully characterised clinical cultures were tested
blind, comprising strains of: C. albicans, C. krusei, C. kefyr,
C. parapsilosis, C. tropicalis, C. glabrata, C. lusitaniae, C. dublinien-
sis, C. guilliermondii and other yeast species. Mixed cultures
comprising C. albicans mixed with one other Candida spp. were
also tested. Using the diminishing streak technique, each pure
and mixed culture was plated onto OCCA, CHROM and CID.
The plates were incubated for a minimum of 24 h and a
maximum of 48 h at 30C. Plates were examined for growth and
morphology at both time intervals.
Results: After 24 h OCCA revealed a sensitivity and speciﬁcity
of 100% and 97.8% respectively for C. albicans (n = 64), com-
pared to 98.4% and 98.5% for CHROM and 100% and 96.3% for
CID. All media yielded false positive results with C. dubliniensis.
Sensitivities for C. tropicalis (n = 30) after 48 h incubation for
OCCA and CHROM were 100%. Speciﬁcities were 100% and
94.7% respectively. Candida glabrata, C. dubliniensis and Saccharo-
myces cerevisiae yielded false positive C. tropicalis results on
CHROM. Grouped sensitivity and speciﬁcity for C. tropicalis,
C. guilliermondii, C. kefyr and C. lusitaniae on CID was 100% and
98% respectively. CID yielded 3 false positives in this group
including S. cerevisiae, C. famata and Rhodotorula rubra. The
sensitivity and speciﬁcity for C. krusei (n = 30) after 48 h on
OCCA was 96.7% and 100% respectively, with 1 false negative,
compared to 100% for both on CHROM. The grouped sensitivity
and speciﬁcity for other yeast species on CID after 48 h was
90.7% and 98.3% respectively, yielding 8 false negatives and 2
false positives.
Conclusion: The new Oxoid Chromogenic Candida Agar
(OCCA) is recommended for the differentiation and presump-
tive identiﬁcation of clinically important Candida spp. After 24 h
incubation, OCCA detected and differentiated C. albicans more
reliably than CHROM. After 48 h incubation, both OCCA and
CHROM were more speciﬁc than CID.
P713
Usefulness of selective media for isolation of
Aeromonas spp. from stool samples
A. Andelova, E. Durnova, I. Porazilova (Ostrava, CZ)
Objectives: Convincing evidence suggests that some aeromon-
ads do cause gastroenteritis. Seriousness vary from acute watery
diarrhoea up to chronic problems. Diarrhoea caused by Aero-
monas spp. are located principally in warmer regions, where
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aeromonads are accounted among the major enteric pathogens.
Nevertheless it still remains unclear, how far aeromonads could
be involved in diarrhoeal disease in our region. Isolation from
stool samples is difﬁcult and successfulness of isolation depends
on the cultivation method used. Use of an appropriate selective
media for isolation of aeromonads is necessary.
Methods: All Aeromonas isolates were obtained from stool
samples during a routine survey in 2003–2004. Two cultivation
methods were compared. Beside Deoxycholate Citrate agar, the
common medium for isolation of enteric pathogens, CIN agar
(Cefsulodin Irgasan Novobiocin) was included in the routine
processing of stool samples in 2003. In 2004 Aeromonas agar (Bile
Salt Irgasan Brilliant Green), on which also aeromonads sus-
ceptible to ampicilin are able to growth, was added.
Results: Two years of microbiological examination of stool
samples from patients suffering from acute gastroenteritis
proved, that Aeromonas isolates are not so rare. 49 aeromonads
were isolated from 11 371 stool samples in 2003, whereas in 2004
already 116 aeromonads were obtained from 11 695 stool
samples. From all bacteriologically positive stool samples (any
diarrhoeal agent) aeromonads were detected in 2.2% (2003) resp.
4.5%(2004) cases. Aeromonas agar was more efﬁcient and
considered to be better selective medium than CIN agar.
Unlike CIN agar, detection of positive oxidase reaction was
possible directly from Aeromonas agar. In comparison with
aeromonads other enteric pathogens as Salmonella, Campylobacter
and Yersinia were more frequent. On the other hand only in 29%
cases aeromonads were isolated together with another enteric
pathogens mentioned above.
Conclusion: Very young children or old people were often
predisposed to an acute gastroenteritis due to aeromonads. We
noticed, that aeromonads were repeatedly isolated from
patients, who had been treated for dyspepsia before (10% of
Aeromonas isolates). Change of the use of selective media for
aeromonads signiﬁcantly increased the number of isolates and
thus it contributed to the clariﬁcation of cases of unknown
diarrhoea. Our project is being supported by IGA of Ministry of
Health of the Czech Republic, Id.code: NR/8011–2.
P714
Identiﬁcation of Gram-negative bacilli in BD
PhoenixTM using the new low inoculum mode
J. Salomon, E. Smith, T. Hansen, V. White, T. Gresock,
W. Williams, J. Reuben (Sparks, USA)
Objectives: Identiﬁcation of gram-negative bacilli using auto-
mated microbiology systems has been a common and accepted
laboratory practice for many years. The systems that provide
rapid results typically require the user to make an inoculum
concentration that is equivalent to a 0.5 McFarland standard.
Occasionally, due to an insufﬁcient number of colonies on the
primary isolation media, this inoculum requirement is not
readily achieved . In order to address these cases, a low
inoculum mode has been developed for The BD PhoenixTM
Automated Microbiology System (BD Diagnostics). The low
inoculum mode utilizes the same panels as the regular system,
but contains new databases and only requires an inoculum
density equivalent to a 0.25 McFarland standard. This study
investigates identiﬁcation accuracy of the Phoenix System, set to
low inoculum mode, for frequently encountered and clinically
signiﬁcant gram-negative bacilli.
Methods: A total of 866 gram-negative bacilli, comprised of 15
genera, were tested in the BD Phoenix System set on low
inoculum mode (PSLI). The majority of strains had been
biochemically referenced using classical methods, while a
small portion were run in parallel using the BD Phoenix
System on regular mode (PSRM) as the reference. The PSRM
was set up according to the users manual and the PSLI was set
up using the new BD PhoenixSpec nephelometer at an inoculum
density ranging from 0.2 to 0.3 McFarland units.
Results: Of the total 866 isolates tested, the PSLI correctly
identiﬁed 839 (96.9%) to the species level and 851 (98.3%) to the
genus level. There were 15 cases (1.7%) which listed 2 or 3
choices under instrument ID requiring a supplemental test to
produce a ﬁnal ID. The PSLI yielded 18 (2.1%) incorrect results
to the species level and 6 (0.7%) to the genus level, while 9 (1.0%)
strains resulted in no identiﬁcation. Average time to results
came out as 4.58 hours for the 839 strains that produced a
correct ID to species level.
Conclusion: The newly developed low inoculum mode of the
BD Phoenix System provides acceptable performance for the
identiﬁcation of routine and clinically signiﬁcant gram-negative
bacilli while using half of the normal inoculum density.
P715
Performance of BD PhoenixTM in low inoculum
mode for the identiﬁcation of frequently isolated
Gram-positive cocci
T. Dunk, K. Landerkin, G. Gao, A. Patel, M. Young, J. Sinha,
J. Salomon (Sparks, USA)
Objectives: Gram-positive cocci from the genera Staphylococ-
cus, Enterococcus, and Streptococcus, make up a signiﬁcant
portion of the frequently isolated bacteria to be identiﬁed in
the clinical microbiology laboratory. Because the colonies that
these organisms form on a primary isolation plate are often
few and small, it is not unusual to subculture for next day
testing. This is done to ensure enough growth is present to
make a suspension equivalent to a 0.5 McFarland standard –
generally the minimum required for ID systems. Utilizing a
newly developed low inoculum mode, and databases, the BD
PhoenixTM Automated Microbiology System (BD Diagnostics)
provides the user with an option of running isolates at an
inoculum density equivalent to a 0.25 McFarland standard. The
panels that are used with the low inoculum mode are the same
as those used with the regular system. This study examines
identiﬁcation accuracy of frequently isolated gram-positive
cocci using the BD Phoenix System conﬁgured to low inoculum
mode.
Methods: Using the new BD PhoenixSpec nephelometer, 730
gram-positive cocci were set up in Phoenix GP panels at an
inoculum density of 0.2–0.3 McFarland units and tested in low
inoculum mode (PSLI). The isolates were comprised of 14
species which were referenced by a combination of conventional
testing and the BD Phoenix System set at regular mode (PSRM).
Results: Accuracy of identiﬁcation with PSLI was determined
to be 97.1% (709/730) to the species level and 99.6% (727/730)
to the genus level for the isolates tested. Incorrect identiﬁca-
tion rates were found to be 2.6% (19/730) to species level and
0.1% (1/730) to genus level. For 1.0% (7/730) of the isolates
the PSLI did not give a ﬁnal ID but required a supplemental
test to separate 2 or 3 organisms listed under instrument ID,
and for 0.3% (2/730) of the isolates no identiﬁcation was
obtained.
Conclusion: Frequently isolated gram-positive cocci, tested at
low inoculum density, were accurately identiﬁed in the
BD Phoenix System run in the newly developed low inoculum
mode.
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P716
Evaluation of the new Gram-negative
identiﬁcation card for the VITEK 2
C. Brosnikoff, R. Rennie, S. Shokoples, L. Turnbull, S. Graff,
D.F. Sahm, S. Mirrett, L.B. Reller (Edmonton, CAN; Herndon,
Durham, USA)
Objective: The objective of this study was to evaluate the new
Gram-negative identiﬁcation card (GN) for the VITEK 2 with
API 20E and API 20NE as the reference method. The three
components of the study were reproducibility and Quality
Control (QC) testing, challenge testing, and clinical and stock
isolate testing. The performance criteria for the challenge and
clinical isolates with the GN cardwere set at >96% overall correct
identiﬁcation, >11% low discrimination, >2% incorrect identiﬁ-
cation, and>4%unidentiﬁedorganismswithina>95%conﬁdence
interval. The evaluation was performed at three laboratory sites.
Methods: Ninety-four (94) challenge and 562 clinical and stock
isolates were included in this study. The same challenge organ-
isms were tested once at all three sites. Reproducibility testing
included 7 different strains that were tested for 10 days, and QC
was performed for 20 days with 7 ATCC species. All microor-
ganisms were inoculated to the GN card and either an API 20E
and API 20NE strip, depending on the suspected identiﬁcation
of themicroorganism.AppropriateQCwas performed on theGN
card and the reference methods according to the manufacturer’s
package insert. Identiﬁcationwas assessed to be correct when the
microorganism was identiﬁed by the GN card as the single ﬁrst
choice identiﬁcation to the genus and species level, or to one of
two closely related species of the samegenus, orwhen theneed for
supplemental tests was speciﬁed owing to low discrimination.
Results: The challenge microorganism testing with the GN card
showed 98% overall correct identiﬁcation, 2.5% low discrimin-
ation ID, 2.0% incorrect ID and 0% unidentiﬁed organisms with
the GN card. The clinical strains demonstrated 96.8% overall
correct ID, 6.4% low discrimination ID, 3.0% incorrect ID and
0.2% unidentiﬁed microorganisms. Of the 3% (17/562) clinical
isolates that were deﬁned as giving incorrect ID only 3 strains
were incorrect at the genus level. All QC testing yielded
expected results within a 95% conﬁdence interval except for
three microorganism and biochemical combinations.
Conclusions: The results of the reproducibility, challenge and
clinical isolates tested indicate that the GN card meets all
performance criteria within a >95% conﬁdence interval.
P717
Analysis of the comparative work-ﬂow and
accuracy of the VITEK2 Compact and the ATB
Expression system
V. Blanc, P. Brugel, L. Lerousseau, M.C. Mourier, A. Blandin,
M.F. Raynaud (Antibes, F)
Objectives: The aim of this study was to analyse the impact of
introducing into our routine microbiology laboratory the
VITEK2 Compact (V2C), bioMe´rieux France, a new automated
identiﬁcation (ID) and susceptibility testing system (AST).
Primary focus was to measure potential gains in laboratory
productivity and operating costs. Secondary focus was to
evaluate the quality of ID/AST results analysed by the system
test validation softwares.
Methods: The evaluation took place in our 532-bed hospital
from Sept to Oct 2004. 400 routine isolates, except fastidious
bacteria: 57% Gram-negative, 40% Gram-positive and 3% yeasts
were tested using our in-house method, ATB Expression
(ATBEx) in parallel with the V2C. This represented 91% of
laboratory activity, from 370 various clinical samples. Data were
collected on 4 parameters:
Productivity: Independent analysis and chronometric time
measurement of the general work process: from specimen
reception, ID/AST set-up to result validation.
Cost: The total ID/AST cost including technician time (cost per
hour) was calculated.
ID Accuracy: Tests were performed in parallel and discordant
results were tested by molecular technique.
AST Conﬁdence: Comparison was made of ATBEx Expert
software and V2C Advanced Expert SystemTM (AES) for result
agreement. The Medical microbiologist expertise provided ﬁnal
results on any discordant results.
Results: The global process time gain with the V2C was 12 hrs
due to a) the more rapid ID/AST result reporting time (mean
detection of 6 hrs for V2C and 18 hrs for ATBEx), b) the faster
manipulation time (1.5 min vs 5.5 min), c) the faster AES vali-
dation. The overall operating cost was reduced by 15% with
V2C.The overall ID agreement between the systems was 94%.
Global agreement with AST expertise was more than 95% with
both systems.
Conclusions: We underline the beneﬁts of the V2C in the setting
of a medium sized microbiology laboratory. V2C compared well
to our robust ATBEx overnight method and provided time and
cost gains. The V2C AES validation tool allowed technicians to
perform ﬁrst level ID/AST validation conﬁdently before biolo-
gist ﬁnal approval. Further investigations are planned to study
clinical impact of rapid ID/AST reporting with this innovative
instrument in a unit of our hospital.
P718
Comparison of the identiﬁcation performance of
the VITEK 2 system to the PHOENIXTM system
under laboratory conditions
T. Schu¨lin, P. Cuppen, A. Voss (Nijmegen, NL)
Objectives: It is essential to obtain fast and reliable identiﬁca-
tion of clinical isolates to adjust patient drug treatment. To reach
this goal, different automated systems are now available on the
market. Two of them were evaluated in our routine laboratory:
the VITEK 2 system, equipped with the new colorimetric menu,
and the PHOENIXTM system.
Material and methods: In total, 501 clinical isolates were tested;
247 were Gram-positive and 254 Gram-negative. Half consisted
of fresh clinical isolates and the rest, stock collection strains. All
were subcultured on Columbia Blood Agar and tested in
parallel. In case of result discrepancies, the strains were retested
on both systems. If the discrepancy remained, supplemental
tests were performed including molecular identiﬁcation meth-
ods to deﬁne the reference identiﬁcation. In the analysis, the
repeats were also considered for the performance calculation.
Results: The performance including repeat results is shown in
the table. Overall, 81 (16%) strains were repeated due to discrep-
ant results at theﬁrst test: 13 (16%)due to incorrect answeronboth
systems, 9 (11%) and 59 (73%) due to VITEK 2 and PHOENIX
systems, respectively. A higher level of discrepancies with the
PHOENIX system was observed for the identiﬁcation of Gram-
positive and stock collection isolates at the ﬁrst test.
Method Total Correct ID Mis Identiﬁcation No Identiﬁcation
# # % # % # %
GP VITEK 2 247 236 95.6 4 1.6 4 1.6
PHOENIX 247 232 93.9 13 5.3 2 0.8
GN VITEK 2 254 243 95.7 10 3.9 0 0.0
PHOENIX 254 237 93.3 15 5.9 1 0.4
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Conclusion: Overall, the VITEK2 system using the new color-
imetric menu gives better correct identiﬁcation than the PHOE-
NIXTM system after the ﬁrst test. With regard to Gram-positive
and stock collection isolates, its performance was clearly
superior.
P719
The performance of the new streptococci panel
for BD PhoenixTM
T. Schu¨lin, E. Bochem, A. Voss (Nijmegen, NL)
Introduction: Identiﬁcation of streptococci (beta-hemolytic and
viridans streptococci) can cause problems with conventional
biochemical test or identiﬁcation kits. We investigated the
performance of a new streptococci identiﬁcation panel for the
automated system BD Phoenix.
Methods: Ninety-two clinical isolates of streptococci from
sterile body sites were investigated. Thirty-nine were beta-
hemolytic streptococci (Lanceﬁeld group A, B, C, G), 17
pneumococci, and 36 viridans streptococci. Reference methods
were latex agglutination for beta-hemolytic streptococci, opto-
chine susceptibility and bile-solubility for pneumococci and 16S
sRNA and sequencing for all other streptococci, including some
pneumococci. The Phoenix panels were inoculated from a fresh
culture and processed as advised by the manufacturer.
Results: Seventy-seven (84%) strains were identiﬁed correctly,
including all beta-hemolytic streptococci, 12 (13%) strains were
identiﬁed incorrectly, and 3 (3%) strains could not be identiﬁed
at all by the system. Only one third (4/12) of the S. mitis strains,
which is an important pathogen in hematological patients, were
identiﬁed correctly.
Conclusion: Beta-hemolytic streptococci and pneumococci
were reliably identiﬁed by the automated system. Identiﬁcation
of viridans streptococci esp. S. mitis is less reliable. Therefore
further attention is needed to better identify viridans strepto-
cocci.
P720
Evaluation of LIAISON treponema screen, a
novel recombinant antigen-based
chemiluminescence immunoassay for the
diagnosis of syphilis
A. Marangoni, A. Moroni, E. Della Bella, F. Cavrini, E. Storni,
V. Sambri, R. Cevenini (Bologna, I)
Objectives: The laboratory diagnosis of syphilis is a crucial
point in the epidemiological and diagnostic evaluation of the
disease. In this study we compared the performances of a new
chemiluminescent assay, LIAISON Treponema Screen, with
those obtained by ELISA, TPHA and WB methods.
Methods: Study group. 2500 serum samples were obtained
from two blood banks in France (Tours and Lille). 131 serum
samples were from patients attending the STD outpatients clinic
of the St Orsola Hospital in Bologna, Italy, and suffering from
different stages of syphilis.Commercial serologic tests. The
following tests were used: Syphilis screening EIA, (Radim,
Pomezia, Italy), and TPHA (AlfaWasserman, Milan, Italy).
Testing was performed following the manufacturer’s instruc-
tions and all the specimens showing an equivocal result were
tested twice. WB. A native ‘home made’ WB was used. An IgG
test was considered positive when at least three out of the four
following T. pallidum antigens were present: TpN15, TpN17,
TmpA and TpN47. LIAISON Treponema Screen. LIAISON
Treponema Screen (DiaSorin, Saluggia, Italy) is a qualitative
fully automated method for determination of speciﬁc antibodies
to T. pallidum in human serum or plasma. This new method is a
one step sandwich chemiluminescence immunoassay (CLIA).
Results: Blood donors serum samples. All the blood donors
samples were screened by CLIA: 2 sera showed a border-line
result. These 2 samples were further analysed by all the others
methods and they were scored as negative. The speciﬁcity of the
CLIA was 99.92% (95% CI: 99.71–99.99%). Syphilis serum
samples.128 out of 131 samples were identiﬁed as positive by
the CLIA test; 2 samples showed a border-line result and 1
sample was negative by the chemiluminescent assay. ELISA test
showed the following performance: 125 sera were positive, and
6 samples were scored as border-line. Finally, all the 131
samples were WB positive, whereas TPHA identiﬁed 124
positive specimens. The concordance between CLIA and
ELISA was 99.24% (95% CI: 95.82–99.98%).
Conclusions: The LIAISON Treponema Screen assay showed
to be a very sensitive and speciﬁc method for the laboratory
diagnosis of syphilis and it can be considered a good alternative
to the conventional tests.
P721
Evaluation of the BINAX-Now urinary antigen
test for establishment of pneumococcal aetiology
of adult community-acquired pneumonia with
bacteraemia
S. Ocan˜a, J. Valverde, M. Velasco, J. Ferna´ndez, A. Espinosa,
J. Losa, A. Delgado-Iribarren (Madrid, E)
Objectives: Community-acquired pneumonia (CAP) is a seri-
ous problem and Streptococcus pneumoniae is the leading cause.
Recently recommended strategies include optimization of
etiological diagnosis because of emerging resistance. For this
purpose the development of tests that can rapidly and reliably
identify the causative agent has been encouraged. The aim of
the present study was to evaluate the use BINAX-Now
urinary antigen test (BNUAT) in clinical practice of a general
hospital.
Material and methods: From November of 2001 through
October of 2004, 1161 patients with suspected CAP were
analysed with BNUAT; this test was solicitated according to
clinician criteria of results were compared with isolation of
Streptococcus pneumoniae from blood culture (77% of the
patients).
Results: BNUAT was positive in 174 cases (15%), negative in
982 (84.6%) and not conclusive (weak reactivity) in 5 (0.4%). We
do not evaluate the speciﬁcity of the technique because we have
not a valid gold standard, specially in patients ongoing
antibiotic therapy. The sensibility of the method: of the 894
Stage of syphilis ELISA CLIA TPHA WB
Primary (n = 7) 4
3 border-line
6
1 border-line
3 7
Secondary (n=31) 31 31 31 31
Latent (n = 77) 74
3 border-line
75
1 border-line
74 77
Tertiary (cardiovascular) (n = 5) 5 5 5 5
Tertiary (neurological) (n = 6) 6 6 6 6
Congenial syphilis (n = 5) 5 5 5 5
Total number (n = 131) 125
6 border line
128
2 border-line
124 131
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patients with blood culture was of 70% (Streptococcus pneumoniae
was isolated in 26 patients, having positive antigen 18 of them).
In the same period of time Streptococcus pneumoniae was isolated
from blood cultures of other 54 patients with pneumonia that
had not been requested BNUAT.
Conclusions: Although recently it has been recommended
strategies for CAP diagnosis include rapid urinary antigen
tests we believe that the sensitivity is not high in bateremic
patients; also it is not clear in which patients this assay is
needed. In our experience BNUAT was only solicitated in 26 out
of 80 patients (32.5%) with pneumococcal bacteraemia. In
addition cost-effectiveness analysis is needed.
P722
Evaluation of the combined use of Statens Serum
Institut enteric agar and the LOUIS test screening
protocol in a Scottish microbiology laboratory
G. Wilson (Stirling, UK)
Objectives: Statens Serum Institut (SSI) enteric agar has
previously been reported as a suitable single plate agar for
the isolation of enteric pathogens except Campylobacter spp
and anaerobic bacteria. This study sought to compare the
combined use of SSI enteric agar and the LOUIS test
screening protocol with that of a more traditional 3-plate
system, for the detection of Salmonella and Shigella, employed
in the microbiology laboratory of a Scottish District General
Hospital.
Methods: Over a 6-month period 780 outpatient stool samples
were compared by both methods.The traditional method
consisted of direct plating of faecal material onto MacConkey
and DCLS agars and after overnight selenite enrichment on to
XLD agar (all Oxoid, UK). Suspect colonies were identiﬁed
using overnight API 20E identiﬁcation strips (bioMerieux,
France). For the SSI method 10 microlitres of a faecal suspen-
sion was inoculated onto SSI agar (Statens Serum Institut,
Denmark) and after selenite enrichment 10 microlitres to a
further SSI plate. Suspect colonies were screened by the 3 h
LOUIS test protocol. The API rapid ID32E gallery (bioMerieux,
France) was used for full identiﬁcation. Polyvalent and group
speciﬁc sera (Murex, England) were used for serological
identiﬁcation.
Results: The traditional method resulted in a total of 205
identiﬁcations. Duplicate identiﬁcations from MacConkey and
DCLS were counted as one for purposes of analysis. The SSI
method resulted in 149 identiﬁcations. The difference was
statistically signiﬁcant (p < 0.001). Both methods detected 31
Salmonella strains after enrichment but differed signiﬁcantly
(p = 0.027) on direct detection (SSI = 20, traditional = 12). One
isolate of Shigella sonnei was detected by both methods and in
addition the SSI agar allowed the isolation of a Vibrio
parahaemolyticus and a Yersinnia enterocolitica without the
need for additional agars. The application of the LOUIS test
protocol on SSI isolates enabled 20 Salmonella and 1 Shigella
sonnei to be presumptively reported 3 h after direct isolation
and a further 11 Salmonella after enrichment. Only 2 false
positive Shigella isolates required full identiﬁcation after
LOUIS test screening.
Conclusions: The use of SSI enteric media can signiﬁcantly
reduce the amount of false positive workload. The combined use
with the LOUIS test protocol can effectively screen out false
positives and allow presumptive reporting of most enteric
pathogens 3 h after isolation.
P723
Matrix assisted laser desorption/ionisation time-
of-ﬂight mass spectrometry provides fast and
reliable identiﬁcation of Staphylococcus
haemolyticus
P.B. Nielsen, D. Dare, M. McLachlan, H. Sutton, H. Shah,
M. Lunt, A. Sismey (Middlesex, Manchester, Peterborough, London,
UK)
Objective: Staphylococcus haemolyticus is an emerging pathogen
more resistant to antibiotics than most MRSA. It causes
symptoms indistinguishable from Staphylococcus aureus infec-
tions and is responsible for some outbreaks in orthopaedic and
neonatal wards mimicking MRSA infection. Analysis of these
isolates can mistakenly be perceived and identiﬁed as low-grade
pathogenic coagulase negative staphylococci. However, a fast
and reliable identiﬁcation is needed in order to institute
appropriate antibiotic therapy. To achieve this we have success-
fully used the ‘‘Peterborough Collection’’ of clinical isolates to
establish a MALDI-TOF MS database for Staphylococcus haemo-
lyticus.
Method: Intact Staphylococcus haemolyticus cells are transferred
from a culture plate to a MALDI target plate and overlaid with
the MALDI matrix 5-Chloro-2-mercaptobenzothiazole. The
co-crystallised sample is then irradiated with a N2 laser and
the resulting plume of positive ions separated using time-
of-ﬂight mass spectrometry. This produces a characteristic mass
spectral ﬁngerprint pattern, which forms the basis of identiﬁca-
tion against a database containing representative spectra of the
species. The MALDI-TOF MS technique also allows for high
sample throughput and rapid identiﬁcation of isolates, since the
collection and analysis of spectral data against a substantial
database requires ~1.5 hours for a 96 well MALDI target plate.
Results: In this study 71 (93.4%) of the 76 clinical strains of
Staphylococcus haemolyticus were identiﬁed correctly against a
database of more than 3600 spectral entries representing over
500 different bacterial species, Figure 1. Furthermore conclusive
identiﬁcation was conﬁrmed for the majority of these strains
since all 8 top matches were correct to species. Comparison of
three misidentiﬁed test spectra with their corresponding spec-
tral matches demonstrated unique high mass ions exclusive to
the matching S. haemolyticus spectra. Therefore ﬁltering the
matches for these ions it is possible to correctly identify 74
(97.4%) of the 76 clinical strains to species level.
Conclusion: MALDI-TOF MS has successfully identiﬁed 97.4%
clinical isolates of S. haemolyticus, demonstrating the techniques
provides fast reliable identiﬁcation of this emerging pathogen.
Abstracts
210
P724
External quality assessment for microbiology – a
review of participant performance with
coryneform bacteria
C. Walton (London, UK)
Objectives: To assess the results from clinical diagnostic labor-
atories taking part in the United Kingdom National Quality
Assessment Service general bacteriology scheme with EQA
specimens containing coryneform and other Gram positive
bacteria increasingly associated with infections in the immuno-
compromised, and to compare performance with repeat spec-
imens.
Methods: Quality assessment of general bacteriology (n = 781;
301 UK, 480 overseas) for the isolation and identiﬁcation of
bacterial pathogens, was performed on isolates including Erysi-
pelothrix, Rhodococcus, Bacillus, Arcanobacterium, Rothia and
Nocardia.
Results: The overall level of performance since 1990 with
specimens containing coryneform bacteria was 71% of partici-
pants’ reporting a correct result; which compares with 94% for
all identiﬁcation specimens in the general bacteriology scheme
over the same period. A correct result was assigned where
participants’ had reported identiﬁcation to at least genus level.
Over a series of specimens, participants’ identiﬁcation to species
level was met with varying success. Erysipelothrix were fully
identiﬁed by participants with an average success rate of 63%
(range 72–88%); Rhodococcus, 69% (range 59–79%); Arcanobacte-
rium, 62% (range 58–66%); and Nocardia, 17% (range 11–24%).
For organisms distributed only once, the percentage of partic-
ipants fully identifying a Bacillus cereus was 52% and a Rothia
mucilaginosa, 47%.
Conclusions: These data provide an interesting insight into
overall performance with the coryneform bacteria in diagnostic
microbiology laboratories. The level of performance seen with
isolates such as Erysipelothrix was generally better than with
others, such as Nocardia spp. or Rothia mucilaginosa. Performance
over time with repeat specimens was variable however, a
signiﬁcant improvement was seen with Arcanobacterium. More
unusual organisms including coryneform bacteria are increas-
ingly implicated in infections of the immunocompromised
patient. The Gram stain and other simple phenotypic tests are
critical in differentiating these organisms, before a commercial
identiﬁcation system is considered, and laboratories need to be
aware of some of the pitfalls in identiﬁcation. EQA has an
important role as an educational tool available to participating
laboratories, highlighting some of the common problems faced
in routine diagnostic testing and where appropriate, providing
some practical advice.
P725
Evaluation of the ATB STREP 5 and ATB
ENTEROC 5 tests for Gram-positive pathogens
antimicrobial susceptibility determination
E. Stefaniuk, A. Mrowka, W. Hryniewicz (Warsaw, PL)
Objectives: The aim of this study was to evaluate ATB STREP 5
and ATB ENTEROC 5 tests (bioMerieux) for antimicrobial
susceptibility determination of streptococci and enterococci.
Methods: A total of 200 clinically signiﬁcant Gram-positive
bacterial pathogens were included in the study. The isolates
belonged to two Streptococcus species (S. pneumoniae n = 79 and
S. pyogenes n = 21) and two species of Enterococcus (E. faecalis
n = 7, E. faecium n = 93) collected from patients in different
medical centres in Poland. The results of the analyses were
compared with those obtained by reference microbiological
methods in accordance with the NCCLS guidelines. The entero-
coccal isolates were tested for the presence of the HLAR
phenotype using the agar screening method. Vancomycin-
resistant enterococci were identiﬁed by agar screening proce-
dure and positive results of the test were conﬁrmed by PCR
detection of vanA and vanB genes. Penicillin-resistant S.
pneumoniae strains were identiﬁed by two methods: the oxacillin
disc and broth dilution methods. The E-tests were used for
determination of penicillin and cefotaxime MICs to S. pneumo-
niae. Characteristic parameters of the automatic methods of drug
susceptibility determination were deﬁned. E. faecalis ATCC
29212, E. faecalis ATCC 51299, S. pneumoniae ATCC 49619 strains
were used as reference strains.
Results: A high correlation was found between the results
obtained by the ATB STREP 5 and ATB ENTEROC 5 and by the
dilution reference methods. The total concordance of resistance
categories was 99% for streptococci and 98.5% for enterococci.
The concordance of MICs values for S. pneumoniae determined
by ATB STREP 5 and E-tests was 98.7% for penicillin and 97.4%
for cefotaxime. For enterococci 98% accuracy, 100% sensitivity
and 97.8% speciﬁcity was achieved for HLAR, 100% accuracy,
speciﬁcity and sensitivity for VanA and 97% accuracy, 98.8%
sensitivity and 96.3% speciﬁcity for VanB.
Conclusion: The ATB STERP 5 and ATB ENTEROC 5 tests
represent an accurate and acceptable means for antimicrobial
susceptibility testing of clinically relevant Gram-positive cocci.
P726
Evaluation of a new chromogenic agar medium
for isolation and identiﬁcation of group B
streptococci from clinical samples
J.D. Perry, M. Oliver, F.K. Gould (Newcastle upon Tyne, UK)
Objectives: Isolation procedures for Streptococcus agalactiae
(Haemolytic streptococcus Group B) are routinely performed
in many clinical laboratories. S. agalactiae is particularly sought
in genital samples from ante-natal patients due to the risk of
transmission to the neonate during delivery. The aim of this
study was to evaluate the effectiveness of a new chromogenic
medium for isolation of S. agalactiae from genital samples.
Methods: Culture plates of a new chromogenic medium,
Strepto B ID, were kindly provided by bioMe´rieux. A total of
134 swabs routinely referred to our department for ante-natal
screening were tested. All swabs were either high vaginal or
endocervical swabs from pregnant women. Each swab was
emulsiﬁed in 1 ml of sterile physiological saline and a 100 ll
sample of the resulting suspension was then inoculated onto
both Columbia blood agar and Strepto B ID. Cultures on Blood
agar were incubated for 20 h anaerobically at 37C and cultures
on Strepto B ID were incubated for 20 h in air at 37C. 112 of the
134 swabs were also enriched overnight in selective Todd
Hewitt broth and cultured onto the same media under the same
conditions. Haemolytic colonies on Blood agar and red colonies
on Strepto B ID medium were identiﬁed using latex agglutin-
ation and standard biochemical tests.
Results: A total of 20 strains of Group B streptococci were
recovered in this study using any medium (19 on direct culture
and one strain via enrichment). All of these strains were isolated
as red colonies on Strepto B ID. Of the 20 strains, 19 strains were
isolated using Blood agar. A total of 24 additional haemolytic
colonies required further investigation on Blood agar but were
shown to be species other than Group B streptococci. In contrast
only one false positive strain, Streptococcus equisimilis, generated
red colonies on Strepto B ID.
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Conclusions: Strepto B ID was more sensitive and more speciﬁc
than Blood agar for isolation of Group B streptococci. All strains
of Group B streptococci formed distinct red colonies that were
very easy to differentiate from other ﬂora.
P727
Accelerated blood culture diagnostic using the
bioMe´rieux Vitek 2TM
J. Wu¨llenweber, M. Herrmann (Homburg/Saar, D)
Objectives: Identiﬁcation (ID) and antimicrobial susceptibility
testing (AST) from positive blood cultures normally require
overnight culture. We evaluated a method to obtain ID and AST
within 1 day.
Methods: After detection of bacterial growth, 10 ml of each
blood culture bottle (Becton Dickinson BactecTM) was centri-
fuged thrice (10 min 500 g to remove erythrocytes, 2 · 5 min
2500 g to remove the supernatant). A suspension with 0.9
McFarland was then inoculated into the bioMe´rieux Vitek 2.
Results of direct ID and AST were compared to those obtained
from agar cultures according to manufacturers guidelines.
Results: 346 bottles containing 198 gram-positive cocci and 148
gram-negative rods were investigated during a period
from December 2003 to July 2004. Identiﬁcation and AST were
excellent for gram-negative rods and enterococci, whereas direct
identiﬁcation of staphylococci required conﬁrmation by other
rapid tests (e.g. slide agglutination for clumping factor). AST
results showed major discrepancies for 0.2% (gram-negative
rods) to 1.2% (gram-positive cocci) of all tested antibiotics.
Conclusion: This method is suitable for same day ID and AST
of typical blood cultures isolates. While gram-negative bacilli
and enterococci were determined with high accuracy, differen-
tiation between S. aureus and coagulase-negative staphylococci
requires complementation by additional techniques.
16S rRNA
P728
Evaluation of QIAamp DNA min kit for
removing of inhibitors in detection of
Cryptosporidium parvum oocysts in water
samples by a nested PCR assay
M. Nikaeen, K. Makimura, A. Mesdaghinia (Esfahan, IR; Tokyo,
JP; Tehran, IR)
In recent years, there has been a dramatic increase in the
occurrence of waterborne disease outbreaks caused by the
Cryptosporidium parvum, and presence of this protozoan parasite
in drinking water supplies is a signiﬁcant health problem faced
by the water industry. Therefore regulatory agencies are urging
that source and ﬁnished water be screened for this organism. A
new strategy for detection of Cryptosporidium parvum oocysts in
water samples is PCR–based techniques. In this study a nested–
PCR assay was designed for the speciﬁc ampliﬁcation of a
199 bp DNA fragment of the gene encoding the hsp70 of
Cryptosporidium parvum oocysts. In order to prevent the inhibi-
tion of PCR ampliﬁcation by substances contained in water
samples, three DNA puriﬁcation methods including QIAamp
DNA min kit, InstaGene Matrix and MagExtractor–Genome
were compared in concentrates of tap water samples spiked
with the oocysts. After determining the most efﬁcient puriﬁca-
tion technique, the efﬁciency of QIAamp and immunomagnetic
separation for nested–PCR assay of various environmental
water samples was compared. The results show that QIAamp
provide a useful and rapid mean for removing PCR inhibitors to
facilitate screening clean water samples (turbidity < 2 NTU) to
detection Cryptosporidium parvum oocysts, by nested-PCR. It
seems that QIAamp puriﬁcation- nested PCR assay is a
sensitive, rapid and cost effective method for detection of
Cryptosporidium parvum oocysts in clean water samples.
P729
Ampliﬁcation of conserved 16S rDNA sequences
in the diagnosis of subdural empyema
complicating sinusitis
H. Sprecher, R. Shalginov (Haifa, IL)
Objectives: To demonstrate the usefulness of broad-range PCR
ampliﬁcation and sequencing of 16S rDNA in the diagnosis of
culture-negative subdural empyema (SDE), complicating sinus-
itis.
Methods: DNA was extracted from sinus discharge and SDE
samples. Broad-range ampliﬁcation of bacterial DNA was
carried out using primers aimed at the 16S rRNA gene. PCR
amplicons were directly sequenced and resulting sequences
were analysed using BLAST analysis.
Results: Case1: a 12-year-old male child was admitted to the
pediatric ward because of severe headache accompanied by
fever (400C) and vomiting. Bilateral ethmoid and maxillary
sinusitis was demonstrated by CAT scan without brain involve-
ment. After 6 days of treatment with intravenous ceftriaxone
and metronidazole, he developed hemiplegia, aphasia and
disorientation. CAT scan demonstrated SDE. The SDE and
sinuses were drained. Subsequent course was uneventful. Case
2: a 15-year-old male, presented with headache, fever and nasal
discharge. He had been treated with oral amoxicillin-clavulanic
acid for several days before admission. CAT scan demonstrated
pansinusitis. He received intravenous ceftriaxone and metroni-
dazole. Three days later the patient developed focal convulsions.
CAT scan demonstrated a large SDE. The empyema and sinuses
were drained. No pathogens were demonstrated by Gram stain
and aerobic and anaerobic cultures obtained from both patients.
Broad-range 16S rDNA PCR resulted in positive amplicons in
both patients’ SDE samples. Direct sequencing of the positive
amplicons identiﬁed nucleotide sequences speciﬁc to S. interme-
dius in case 1, and to S. Pyogenes in case 2.
Conclusion: Intracranial infections complicating sinusitis are
not common, but may be devastating. Microbiological diagnosis
is complicated by a wide range of causative pathogens and
jeopardized by the fact that many patients are already treated
with antibiotics at presentation. Broad range PCR sequencing
provides a rapid and accurate methodological solution in cases
of partially-treated bacterial infections of unknown etiology,
giving clues to the etiologic agents and probably better guide
antimicrobial therapy.
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P730
Application of 16S rRNA PCR and DGGE to
demonstrate differences in local bacterial
colonisation within a single chronic venous leg
ulcer
A. Andersen, K.E. Hill, P. Stephens, D.W. Thomas, B. Jorgensen,
K.A. Krogfelt (Copenhagen, DK; Cardiff, UK)
Objectives: Chronic wounds represent an enormous, but often
neglected health care problem. Pressure sores, venous leg ulcers
and diabetic foot wounds require long-term professional care
and are associated with a signiﬁcant socio-economic impact. It is
estimated that around 50–60 thousand patients in Denmark
suffer from wounds needing professional treatment, with
annual costs to the Danish healthcare sector of £100–200
million. Wound healing represents an extremely complex
physiological process, which is often detrimentally inﬂuenced
by the presence of colonizing bacteria (even in clinically non-
infected wounds). Moreover, in polymicrobial wounds they may
act synergistically to the further detriment of wound healing.
The purpose of this study was to investigate local differences in
bacterial colonisation within a chronic wound.
Methods: In this investigation, multiple biopsy and swab
samples were obtained as part of skin graft operations per-
formed on chronic venous leg ulcers in order to study microbial
diversity. The wound was sampled prior to excision of the
whole wound bed. Sampling was undertaken at multiple
locations across the wound and at the wound edge. Swab
samples and biopsies were subjected to standard culture
analysis and 16S rRNA PCR, denaturing gradient gel electro-
phoresis (DGGE) and sequencing.
Results: Within the wound samples DGGE identiﬁed the major
wound microﬂora components and established the extent of
local differences in bacterial diversity. Conﬁrmatory sequence
analysis demonstrated that Staphylococcus aureus was main-
tained across the wound area, but differences in the occurrence
of catalase-negative Staphylococcus species an Escherichia coli
were detected.
Conclusion: This ongoing investigation has veriﬁed DGGE as a
powerful, novel tool for use in the elucidation of the clinical
microbiology of a chronic disease state.
P731
Ribosomal DNA sequencing: experiences from
use in the Danish national reference laboratory
for identiﬁcation of bacteria
J.J Christensen, K. Andresen, T. Justesen, M. Kemp (Copenhagen,
Hillerød, DK)
Objectives: Diagnostic tools for identiﬁcation have increased
dramatically in the last decade. Sequencing of genes coding for
rRNA have revolutionized the insight in phylogeny and taxon-
omy of bacteria as it has put new demands for the service given
by national reference laboratories for identiﬁcation of bacteria.
Experiences relating to phenotypical as well as 16S rDNA
sequencing of the ﬁrst 175 strains examined are presented.
Methods: Submitted, clinically important, bacterial strains,
from the years 2002 and 2003, difﬁcult to species designate
were, in addition to phenotypic characterization, examined by
partial 16S rDNA sequencing. Phenotypic characterization of
strains were based on internationally accepted guidelines. For
molecular analysis, DNA was extracted from strains and
analysed by real-time PCR of part of the 16SrRNA gene.
Amplicons produced were DNA sequenced and a BLAST
search in the NCBI GenBank was done. Obtained results were
compared.
Results: Of the 175 strains examined, approximately 2/3 were
Gram-positive and 1/3 Gram-negative, respectively. One ﬁfth of
strains were anaerobes, while 4/5 were either facultative
anaerobic or aerobic strains. Most strains showed methodologi-
cal agreement at species or genus level. Methodological disa-
greements were relatively rare. In 1/6 of strains valuable
information was obtained from sequencing results, while for
some strains identiﬁcation was based primarily on the pheno-
typic results. Only few strains could not be clearly identiﬁed by
either method. A very large number of strains representing
taxons ranging from facultative anaerobic to aerobic and
anaerobic species and genera, as well Gram-positive as Gram-
negative, were successfully examined. Of the submitted strains
many have only rarely been encountered as human pathogens.
Conclusion: Thus, genotypic identiﬁcation may result in recog-
nition of hitherto seldomly or unrecognized bacteria as human
pathogens, which will lead to a deeper understanding of the
nature of human infections. It is evident to focus on slowly
growing, fastidious or suspected troublesome organisms when
using sequencing for national reference purposes. Short
sequences (450–650 base pair) seem sufﬁcient for most identi-
ﬁcations. There is no doubt that in the future molecular bacterial
identiﬁcation will be a powerful tool for national reference
laboratories enhancing both the speed and validity of performed
examinations.
P732
Using polymerase chain reaction for evaluation of
positive results of two automated blood culture
systems which remain negative by smear and
subcultures
Z.C. Karahan, I. Mumcuoglu, D. Tamer, H. Guriz, N. Balaban,
D. Aysev, N. Akar (Ankara, TR)
Objectives: Automated blood culture systems have improved
the detection rate of blood-borne pathogens. False positivity of
these systems is between 1–10%. In this study we aimed to
evaluate whether smear and subculture-negative positivities
observed in two automated blood culture systems (BacTAlert
(Biome´rieux) and Bactec (Becton Dickinson)) were due to real
microbial growth or false positive signalling.
Methods: Microbial DNA was extracted from 90 aerobic BacT-
Alert and 65 aerobic Bactec blood culture bottles which gave
positive signals but smear and sub-cultures were sterile. Each
bottle belonged to a different patient. Eubacterial 16SrDNA and
fungal ITS region directed PCR were performed to determine
the presence of microorganisms in these samples. Positive
results were subjected to automated sequence analysis and
nucleotide sequences were matched from the GeneBank.
Results: None of the bottles gave positive results by fungal
PCR. Only 10 BacTAlert bottles gave positive results by
eubacterial PCR. These bottles gave positive signals between
2nd and 5th days of incubation (mean 3.5 days). Sequence
analysis results were as follows: Pasteurella multocida (1),
S.epidermidis (2), S.hominis (1), Micrococcus spp (1), S.pneumoniae
(1), Corynebacterium spp (2), Brachibacterium spp (1), Arthrobacter/
Rothia spp. (1).
Conclusions: P. multocida was determined from a patient who
had undergone surgery and S. pneumoniae was from a patient
who was admitted to emergency department. In other patients
there were underlying diseases such as hematological malig-
nancies or solid tumors. Although most of the determined
bacteria were the inhabitants of the skin ﬂora, characteristics of
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the host make them medically important for diagnosis. As these
bacteria are easy to grow on laboratory media, their inability to
grow on subculture may be due to their low number, or the
antibiotic usage of the patient. Incubating these bottles for
longer periods may increase the number of microorganisms and
subcultures may become positive. In patients with underlying
diseases, molecular methods can be used for quick identiﬁcation
of the microorganisms.
P733
Detection of bacterial pathogens by polymerase
chain reaction in case of endophthalmitis, by
using universal eubacterial primers
M. Pietras-Trzpiel, M. Koziol-Montewka, M. Gerkowicz,
A. Szczepanik, E. Kosior-Jarecka (Lublin, PL)
Infectious endophthalmitis, despite its being relatively rare, is
potentially one of the most devastating ocular infections.
Therefore, the most effective treatment is based on rapid
diagnosis of the disease and the identiﬁcation of a causative
agent. The most common bacteria that cause acute endopht-
halmitis are Staphylococcus epidermidis, Staphylococcus aureus and
Streptococcus spp. Delayed postoperative endophthalmitis is
caused by microorganism such as Propioniobacterium acne,
Actinomyces israelli, or Corynebacterium spp. The tests for pres-
ence of these bacteria in classic culture of aqueous humor (AH)
and vitreous ﬂuid (VF) are often negative, between 24–80% of
which, lead to a clinical dilemma over the cause of the
inﬂammation. A rational approach to the use of antibiotics
and steroids necessitates determining, whether the inﬂamma-
tion is infectious or sterile. The evolution of new molecular
techniques adapted to the ﬁeld of medical microbiology is a
promising tools, for the rapid and sensitive identiﬁcation of
bacterial pathogens.
Purpose: The goal of this study is to determine the usefulness of
the PCR method in the diagnosis of endophthalmitis.
Materials and methods: 30 clinical specimens 19 AH and 11 VF
were obtained from 20 eyes with the clinical diagnosis of
endophthalmitis. These included: 14 cases after cataract surgery,
1 case post trabeculectomy, 2 cases after penetrating traumas,
and 3 cases after endogenous endophthalmitis. The same
samples were analysed using 2 different methods: 1. conven-
tional microbiological techniques (microscopy and diagnostic
culture) and 2. PCR directed at 16S rDNA using universal
primers.
Results: In the aqueous humor the causative pathogen was
identiﬁed in 1 case (5.2%) by using diagnostic culture compared
with 7 cases (36%) by using PCR methods. In the vitreous
samples the pathogen was identiﬁed in 1 case (9%) by using
conventional method compared with 5 cases (45.4%) by using
PCR. Microscopic preparation was difﬁcult to evaluate in all
samples.
Conclusions: PCR performed on aqueous humor and vitreous
ﬂuid is a reliable tool for diagnosis of causative organism
particularly in smear and culture negative specimens. By using
universal primers we are able to detect the presence of pathogen
in case of endophthalmitis. This plays the main role in a
successful therapy.
P734
Detection of Tropheryma whipplei in Portuguese
patients by molecular methods
L. Monteiro, A. Santos, A. Pelerito, L. Brum (Lisbon, P)
Tropheryma whipplei is the causative agent of Whipple’s disease,
a rare multisystemic bacterial infection with variable clinical
manifestations. The diagnosis of this disease is usually based on
histopathological study of the infected tissues by periodic acid-
schiff staining (PAS). More recently, molecular identiﬁcation
methods were developed based on PCR ampliﬁcation of a
intergenic region between the 16s and 23s ribossomal DNA.
Objective: Detection of T.whipplei in clinical samples of patients
with suspicion of Whipple’s disease, from different Portuguese
hospitals.
Patients: Different clinical samples of 6 hospitalized patients
were tested. From patients 1 and 2, serum and cerebrospinal
ﬂuid were collected, from patient 3 serum and urine, from
patient 4 only serum and from patients 5 and 6 a duodenal
biopsy.
Methods: DNA of all samples was obtained by using the Qiamp
DNA mini Kit (Qiagen, Izasa, Portugal) and ampliﬁed by
Nested-PCR, with primers Tws 1F/2R in ﬁrst ampliﬁcation and
Tws 3F/4R in the second ampliﬁcation. The same DNA was also
ampliﬁed using the Real-Time PCR (by the tecnique of Faststart
DNA Master Sybr Green–Roche Farmaceˆutica Quı´mica, Portu-
gal) using the primers Tws 3F/4R, followed by sequence of
positive samples. The sequences obtained were then compared
to the T. whipplei reference sequence in NCBI Blast.
Results: In 3 of the 6 patients, DNA of T.whipplei was detected.
Two of the 3 positive results were only positive by Real-Time
PCR. Complete sequence homogeneity was found between the 3
positive results and the reference sequence for T. whipplei.
Conclusion: For the ﬁrst time in Portugal the diagnosis of
Whipple’s disease was conﬁrmed by the presence of T. whipplei
in clinical samples by molecular methods. Until now, the
detection of it’s presence was made by histopathological study
(PAS-positive) of the infected tissues or by exclusion with other
disease when the histological analysis was inconclusive. The
molecular identiﬁcation methods made possible the conﬁrma-
tion of positive results of PAS and the detection of T. whipplei in
patients were histopathology analysis was not possible or
inconclusive. The Real-Time PCR is a very important tool for
detection of intracellular and fastidious microrganism which are
very difﬁcult to detect by classical diagnosis methods of
microbiology.
P735
Evaluation of universal PCR assay and
endonuclease digestion for rapid direct
identiﬁcation from positive blood cultures
S.-Y. Lee, J. Lu (Taipei, TW)
From Sep/2003 to Apr/2004, positive BacT/Alert blood culture
bottles were collected for evaluating the accuracy of a direct
universal PCR assay and endonuclesae digestion method to
achieve rapid bacterial identiﬁcation at Tri-Service General
Hospital. A total of 168 clinical relevant samples including 104
gram-negative and 64 gram-positive bacteria were evaluated.
Results of the rapid PCR method were compared with conven-
tional identiﬁcation systems used in our clinical microbiology
laboratory. Overall, 135 (80.4%) were correctly identiﬁed to
species level. Thirty-three (19.6%) strains could not be identiﬁed
due to reasons of new or identical patterns. The rapid universal
PCR method proved more accurate for identiﬁcation of Gram-
negative bacteria (91%; 95/104) than that of Gram positive ones
(63%; 40/64). Most discordances corresponded to identical
patterns (17.2%; 3.5% for Gram-negative and 13.7% for Gram-
positive bacteria) while new patterns (database not included in
reference study) were found in 2.4% (1.8% and 0.6% for Gram-
negative and Gram-positive bacteria, respectively).The universal
PCR method is a directly reliable method for identiﬁcation of
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Gram-negative but not for Gram-positive organisms. Compared
with conventional methods that require 1 or 2 days, this method
can make same-day reporting possible so that it may permit
better patient management.
P736
Two possibly novel Alistipes species isolated
from clinical specimens of human origin
S. Finegold, Y. Song, C. Liu, M. Bolanos, M. McTeague (Los
Angeles, USA)
Objectives: In this study, two groups of unusual bacteria,
which phenotypically resemble members of Alistipes, but phy-
logenetically display ‡ 3% 16S rRNA sequence divergence with
their mostly closely related species, Alistipes ﬁnegoldii were fully
characterized.
Methods: The 7 isolates (4 for group I and 3 for group II) were
biochemically characterized by using a combination of conven-
tional tests as described in the Wadsworth and VPI anaerobic
manuals plus the API ZYM, rapid ID 32, and Rapid ANA II
systems. The 16S rRNA genes of the isolates were sequenced by
an automatic 373A DNA sequencer. Sequence data was ana-
lysed by using the programmes FASTA and DNATools.
Results: Phylogenetically and phenotypically, the unidentiﬁed
bacteria displayed a relatively close association with each other.
However, a 16S rRNA gene sequence divergence of approxi-
mately 4% between the two unknown bacteria, as well as
distinguishable biochemical characteristics such as different
activities of b-glucosidase, a-arabinosidase and p-nitrophenyl-
phosphatase, demonstrate that these organisms are genotypi-
cally and phenotypically distinct and each group represents a
previously unknown sub-line within the Alistipes phylogenetic
cluster. The closest described species to both of them is
A. ﬁnegoldii (approximate 97% similarity), but group I can be
differentiated from A. ﬁnegoldii by positive b-glucosidase reac-
tion, and group II can be distinguished from A. ﬁnegoldii by
being a-arabinosidase positive.
Conclusion: Additional studies are in progress, but based on
the phenotypic and phylogenetic ﬁndings to date, it appears that
these two groups may represent two novel species in the genus
Alistipes.
P737
Evaluation of molecular diagnostics of bacteria in
culture-negative human infections
M. Kemp, K. Andresen, J.J. Christensen (Copenhagen, DK)
Objectives: In this study universal bacterial PCR and subse-
quent DNA sequencing was evaluated for demonstration and
identiﬁcation of bacteria in culture-negative human infections.
As no ‘golden standard’ is available for comparison when
culture is negative, the performance of the molecular analyses
was estimated by 1) Ability to detect bacterial DNA in culture-
negative and culture-positive clinical samples from normally
sterile sites 2) Agreement between bacterial identities obtained
by the molecular methods and phenotypic identiﬁcation
3) Conﬁrmation of results by other laboratory tests in culture-
negative samples.
Methods: Clinical sample material from normally sterile sites
was examined by microscopy and culture. DNA extracted from
the specimens was analysed by real-time PCR of part of the 16S
rRNA gene. Bacterial identities were established by DNA
sequencing of amplicons. 1) Results of PCR were evaluated in
culture-negative and –positive samples. 2) DNA sequence based
bacterial identities were compared to those reported from
culture. 3) In cases of molecular bacterial identiﬁcation in
culture-negative samples, efforts were done to seek conﬁrmation
of the obtained identities by other laboratory tests.
Results: 1) Bacterial DNA could not be detected in unselected
culture-negative samples, but PCR was positive in two thirds of
microscopy-negative samples with monobacterial growth.
2) Generally, culture and DNA sequencing resulted in the
same bacterial identities. Species identiﬁcation was obtained by
DNA sequencing for bacteria that are only identiﬁed to the
genus level by routine culture, 3) In many culture-negative
cases, bacterial identities obtained by DNA sequencing could by
conﬁrmed by culture of the same organism from other sites or at
other times, by species-speciﬁc PCR, or by pressence of antigens
or antibodies.
Conclusions: Few data are available on the reliability of DNA
sequencing for diagnosis of culture-negative bacterial infec-
tions. The results show that: 1) The technique may be useful in
culture negative samples when there is particular suspicion of
bacterial infection, also when microscopy is negative, but its
routine application on unselected samples is futile. 2) Bacterial
identities obtained by culture-independent DNA sequencing
are highly reliable, and may be more accurate than culture.
3)DNA sequence based identiﬁcation of bacteria in culture-
negative samples can often be conﬁrmed by other laboratory
tests.
P738
Correlation between biochemical tests and 16S
rRNA gene sequencing to identify bacteria
J. Sa´nchez-Ce´spedes, C. Regata, D. Alamo, V. Dimova,
M. Almela, J. Vila (Barcelona, E)
Objectives: The objective of this work was to analyse the use of
PCR ampliﬁcation and DNA sequencing of the 16S rRNA gene
to identify clinical isolates which are difﬁcult to identify by
conventional biochemical tests.
Methods: Twenty-three bacteria isolated from blood were
analysed. PCR ampliﬁcation of the 16S rRNA gene was carried
out using 8F and 806R primers which ampliﬁed a region of
798 pb. The reaction was performed with 30 cycles of denatur-
ation at 95C for 1 min, annealing at 55C for 1 min, and
extension at 72C for 1 min. Ampliﬁed DNA products were
resolved by electrophoresis in agarose gels (2%, w/v) containing
0.5 mg/L of ethidium bromide. PCR products were recovered
directly from the agarose gel and puriﬁed. The DNA obtained
was sequenced and identiﬁed by comparison in the GeneBank.
Results: After DNA sequencing 11 (48%) out of the 23 bacteria
showed DNA homology ranging from 98% to 100% and 12
(52%) demonstrated homology ranging from 91% (only one
strain) to 97% with 16S rRNA sequences found in the GeneBank.
Biochemical methods allowed identiﬁcation of 12 (52%) of these
23 isolates at a species level. Among these 12 isolates, 4 showed
the same species with 16S rRNA (concordance of 33.3%). Five
out of the remaining 11 isolates were identiﬁed at a genus level
with biochemical tests and 6 isolates were not. Among the 5
isolates identiﬁed at a genus level 3 were identiﬁed with 16S
rRNA (concordance of 60%). The most difﬁcult species to
identify by biochemical testing were Nocardia sp. and Capno-
cytophaga sp. as well as anaerobes such as Fusobacterium sp.
Conclusions: This study shows that 16S rRNA gene sequencing
can be a useful and rapid technique to identify fastidious and
some anaerobic bacteria which are difﬁcult to identify by
biochemical methods.
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P739
Catabacter hongkongensis gen. nov. sp. nov., a
novel anaerobic Gram-positive bacillus
associated with bacteraemia
S.K.P. Lau, P.C.Y. Woo, G.K.S. Woo, A.M.Y. Fung,
K.-Y. Yuen (Hong Kong, HK)
Objectives: To characterize a novel anaerobic Gram-positive
bacillus, Catabacter hongkongnesis gen. nov. sp. nov., isolated from
patients with bacteraemia.
Methods: We isolated two strains of an unidentiﬁed anaerobic
Gram-positive bacillus from the blood cultures of two patients.
The isolates were characterized phenotypically by conventional
phenotypic tests, commercial identiﬁcation systems and scan-
ning electron microscopy; and genotypically by ampliﬁcation
and sequencing of their 16S ribosomal RNA genes and study of
their G + C contents.
Results: Two strains of an anaerobic, non-sporulating, gram-
positive bacillus was isolated from the blood cultures of two
patients, a 48-year-old man with intestinal obstruction and
secondary sepsis (strain HKU16T) and a 39-year-old man with
acute appendicitis (strain HKU17). Both isolates are unidentiﬁed
by conventional phenotypic tests and commercial identiﬁcation
systems. They produce catalase and are motile with a tuft of
ﬂagellae inserted on one side. Bacterial cells are coccobacilli
tapered at both ends on electron microscopy. 16S ribosomal
RNA gene sequence analysis showed more than 16% nucleotide
difference between the sequences of both isolates and those of
the most closely related bacteria. The G + C content of strain
HKU16T is 40.2 ± 2.2%.
Conclusion: Based on their phylogenetic position, unique
G + C content and phenotypic characteristics, we propose a
new genus and species, Catabacter hongkongensis gen. nov. sp.
nov., to describe the bacterium. The gastrointestinal tract may
have been the source in both patients. The isolation of a catalase-
postiive, motile, non-sporulating anaerobicGram-positive bacil-
lus in clinical laboratories should raise the possibility of
C. hongkongensis.
Clinical mycology: case reports
P740
Severe disseminated fusariosis in a leukaemic
child successfully treated with posaconazole and
white blood cell transfusions
C. Dheu, N. Entz-Werle, R. Campagni, V. Letscher-Bru,
J. Waller, C. Waller, R. Herbrecht, P. Lutz (Strasbourg, F)
Objective: Fusarium infections are an increasing threat to
patients with severe neutropenia. Mortality rates exceed 70%
in patients with disseminated disease. posaconazole (POS) is an
investigational extended-spectrum azole antifungal agent that is
active against Aspergillus spp and various other moulds, inclu-
ding Fusarium spp. We report the clinical outcome of a child
with leukaemia who underwent white blood cell (WBC) trans-
fusions and POS therapy for disseminated fusariosis after
conventional antifungal therapies failed.
Case Report: A 14-year-old girl with high-risk lymphoblastic
leukaemia began induction chemotherapy and prophylactic
antimicrobial therapy with oral amphotericin B (AMB) and
cotrimoxazole. An episode of Escherichia coli bacteraemia was
successfully managed; however, on Day 39 of chemotherapy
while still neutropenic, the patient became febrile. Multiple
ecchymotic skin nodules developed, and a large area at the
catheter insertion site became inﬂamed. Liposomal AMB and
caspofungin therapy was initiated empirically, but the patient’s
condition continued to deteriorate. Existing skin nodules wor-
sened, new lesions appeared, and 2 nodules became necrotic.
Cultures of specimens from skin biopsy, catheter insertion site,
sputum, stool, and blood all grew Fusarium moniliforme. Chest
radiography showed 2 condensations in the right lung consis-
tent with fungal pneumonia. Therapy was changed to POS oral
suspension (200 mg qid) and the patient received WBC trans-
fusions 24 and 48 hours later. The central venous catheter was
replaced; cultures of the ﬁrst catheter also grew F. moniliforme.
Subsequently, the patient’s condition rapidly improved. Cul-
tures of all blood samples drawn after the start of POS therapy
were negative, and no new skin lesions appeared. Fever and
neutropenia resolved, and existing skin lesions gradually
improved. One pulmonary lesion disappeared, and the second
evolved into a cavitation with an air-crescent sign. POS was
administered for 10 months, with concomitant consolidation
chemotherapy. POS was well tolerated with no drug-related
adverse events. The patient is alive, is in remission from
leukaemia, and has no residual fungal lesions except for a
thin-walled cavity in the right lung.
Conclusion: POS, in conjunction with WBC transfusions, resul-
ted in rapid clinical improvement in a child with leukaemia who
had an extensive Fusarium infection. As suggested by other
reports of successful outcomes, POS appears promising for the
treatment of invasive fusariosis.
P741
Successful combination therapy with
posaconazole and amphotericin B for multifocal
disseminated zygomycosis in a patient with
relapsed acute lymphoblastic leukaemia
K. Knapp, K. Allison, J. Franklin (Memphis, Amarillo, USA)
Objectives: Few therapeutic options exist for zygomycosis, a
rare but life-threatening fungal infection that affects immuno-
compromised patients. Posaconazole (POS), an investigational,
extended-spectrum triazole antifungal, has in vitro activity
against various Zygomycetes. We report the efﬁcacy of POS and
liposomal amphotericin B (LAMB) in a patient with multifocal
disseminated zygomycosis.
Case Report: A 22–year-old man underwent induction chemo-
therapy for relapsed acute lymphoblastic leukaemia. One week
after initiation of chemotherapy, the patient was febrile, had
throat, neck, and chest pain, and was noted to have hyperthy-
roidism. Vomiting and weight loss developed, and chest
radiography showed evidence of a right upper lobe inﬁltrate.
Caspofungin 50 mg qd was initiated. Chest/abdomen compu-
ted tomography revealed multiple bilateral pulmonary lesions,
an area of consolidation, multiple thyroid nodules, and a large
left renal infarct. Invasive pulmonary aspergillosis was suspec-
ted, and therapy with LAMB (7.5 mg/kg/d) and voriconazole
(4–6 mg/kg bid) was added. Culture of a biopsy specimen from
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the lung grew Mucor species. Voriconazole and caspofungin
were discontinued due to their limited activity against Zyg-
omycetes. Surgical resection of affected tissues was not per-
formed due to the extent of dissemination. The patient was
enrolled in an open-label clinical trial and received POS oral
suspension 800 mg/d in divided doses. Therapy with LAMB
was continued, but the dose was increased to 10 mg/kg/d.
Signs and symptoms improved over the next 3 months and the
LAMB dose was eventually reduced to 5–7.5 mg/kg/d, depend-
ing on renal function. Eight months after diagnosis of zygomy-
cosis, the patient underwent successful autologous stem cell
transplantation (SCT) without recurrence or worsening signs or
symptoms of zygomycosis. LAMB therapy was discontinued
after 11 months because of renal insufﬁciency. The patient was
considered to have had a partial response to POS and has not
required hospitalization since SCT. To date, the patient has
received POS for 18 months and continues to tolerate it well.
Conclusion: This is the ﬁrst reported case of successful POS/
LAMB combination treatment for multifocal disseminated zyg-
omycosis. Importantly, POS was well tolerated during long-term
treatment and allowed the patient to undergo SCT without
aggravating zygomycosis. Treatment outcome suggests that POS
may be an effective alternative treatment for zygomycosis.
P742
Effects of posaconazole salvage therapy in ﬁve
patients with zygomycosis
B. Dupont, P. Weinbreck, O. Brugiere, C. Winter, R. Lahoulou,
O. Lortholary (Paris, Limoges, Clichy, Montreuil sous Bois, F)
Objectives: Zygomycosis is a severe, life-threatening disease
that can occur in immunocompromised or debilitated patients,
including those with diabetes and acquired immunodeﬁciency
syndrome (AIDS). We describe our experience in treating
zygomycosis with posaconazole (POS), a potent, extended-
spectrum, investigational azole antifungal that has shown
promising in vitro activity against various Zygomycetes.
Methods: Patients with proven or probable invasive fungal
infections were enrolled in a multicentre, open-label trial in
which participants received monotherapy with POS oral sus-
pension 800 mg daily in divided doses after failing other
therapy or becoming intolerant to their therapy.
Results: Three men and 2 women (age range: 46–62 years) were
treated with POS for proven zygomycosis at our institution.
Underlying conditions included diabetes (n = 2); diabetes,
AIDS, and liver cirrhosis (n = 1); idiopathic pulmonary ﬁbrosis
treated with lung transplantation (n = 1); and lung cancer with
neutropenia (n = 1). Sites of primary infection were the sinuses
(n = 3, 1 with brain involvement) and lungs (n = 2). Treatment
with amphotericin B (deoxycholate and lipid formulations)
(n = 5) and voriconazole (n = 1) (median, 24 days; range, 10–
150 days), alone or in combination with surgical debridement
(n = 3), failed to produce sustained clinical improvement.
Additionally, 3 patients became intolerant to amphotericin B.
POS therapy was administered to the 5 patients for a median of
169 days (range: 77–214 days). Extensive surgery for rhino-
sinusal mucormycosis was carried out during POS treatment in
1 patient and before and during POS treatment in 2 patients.
Successful outcomes were seen in all 5 patients: 4 achieved a
complete response and 1 had a partial response. The 2 patients
with lung infection died; however, both deaths were considered
related to underlying conditions, not to the mycosis or to POS.
POS was generally well tolerated. Patients’ overall safety
proﬁles reﬂected their underlying disease, with no occurrence
of treatment-related adverse events.
Conclusion: POS demonstrated promising activity in patients
with refractory zygomycosis or intolerance to therapy and
produced successful outcomes in all 5 patients treated. It is
important to note that POS was well tolerated during long-term
treatment (up to 214 days), even in patients who were intolerant
of other therapies.
P743
Efﬁcacy of posaconazole for chronic refractory
Alternaria infection
L. Proia (Chicago, USA)
Objectives: Alternaria, a dematiaceous fungus and common
plant saprophyte, may cause invasive disease in immunocom-
promised human hosts, but invasive alternariosis in healthy
persons is rare. We describe a case of an immunocompetent
woman with a 25–year history of invasive Alternaria infection in
whom conventional antifungal and surgical therapy failed. The
disease subsequently responded to treatment with posaconazole
(POS), a new extended-spectrum triazole antifungal.
Case Report: In 1978, a 22–year-old immunocompetent woman
developed a painful ulcer of the hard palate after root canal.
Biopsy revealed maxillary osteomyelitis with fungal hyphae and
culture grew Alternaria spp. Despite treatment with amphoter-
icin B deoxycholate (AMB), the palatal ulcer recurred 1 year
later; culture grew Alternaria. Retreatment with AMB produced
an initial response, but the disease relapsed with bony destruc-
tion of the maxilla and nasal cartilage. During the next
18–20 years, multiple courses of ketoconazole, terbinaﬁne, ﬂuc-
onazole, AMB lipid complex, liposomal AMB, and itraconazole
(ITR) were given, but the disease eventually relapsed. In vitro
susceptibility testing showed voriconazole (VOR) MIC of
0.5 lg/mL and VOR was initiated. Clinical resolution was
achieved and biopsies were negative after 16 months. After
21 months of VOR treatment, she developed recurrent nasal
skin nodules, rhinorrhea, and pansinusitis. Sinus biopsy and
maxillary bone cultures revealed Alternaria and an increased
VOR MIC (8 lg/mL). Combination treatment with caspofungin
and liposomal AMB led to clinical remission after 8 months of
treatment, but sinus and bone biopsies continued to show fungal
hyphae despite negative cultures. Signs and symptoms returned
and the disease relapsed again. Because in vitro susceptibility
testing showed a POS MIC of 0.5 lg/mL, POS oral suspension
(400 mg Q12 hr) was begun. After 1 month all symptoms and
signs of infection resolved. Multiple skin and sinus biopsies
were negative on histopathologic examination and culture. POS
therapy was stopped after 18 months (August 2004). Currently,
the patient has shown no evidence of recurrent infection.
Conclusion: POS resolved all symptoms and signs of disease in
a patient with chronic alternariosis that was refractory to all
available antifungal therapies, including VOR. The successful
outcome suggests POS may be an alternative option for
refractory Alternaria infection, including those that do not
respond to other azoles.
P744
Efﬁcacy of posaconazole salvage therapy in
paediatric subjects with invasive fungal
infections
J. Blumer, R. Hare, G. Krishna, L. Pedicone, I. Raad (Cleveland,
Kenilworth, Houston, USA)
Objectives: We report the efﬁcacy of posaconazole (POS), an
extended-spectrum, investigational triazole antifungal, against
invasive fungal infections (IFIs) in pediatric subjects.
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Methods: Subjects ‡13 years of age with IFIs were enrolled in a
multicentre, open-label clinical trial in which participants were
administered POS oral suspension 800 mg daily in divided
doses after becoming intolerant of, or developing disease
refractory to, other antifungal therapy. Complete or partial
response was considered a successful outcome; stable disease or
treatment failure was considered a nonsuccessful outcome.
Results: Of the 330 subjects who were treated in the study, 11
were <18 years of age (range: 8–17 years). Six were boys and 5
were girls. Underlying diseases included haematological malig-
nancies (n = 9), bone marrow transplantation (n = 4), and
inherited immunodeﬁciency (n = 1). Previous antifungal ther-
apy included amphotericin B (n = 11, deoxycholate and lipid
formulations), itraconazole (n = 4), and other antifungal medi-
cations (n = 4). Successful outcomes were observed in 5 subjects
with IFIs caused by Aspergillus spp (n = 3), Candida spp (n = 1),
and Coccidioides immitis (n = 1). The remaining 6 subjects, who
had nonsuccessful outcomes, had IFIs caused by Aspergillus spp
(1), Candida spp (n = 2), Zygomycetes (1), and Fusarium spp
(n = 2). Mean POS plasma concentrations in pediatric subjects
were similar to those in adults (776 ng/mL and 817 ng/mL,
respectively). Occurrence of treatment-emergent adverse events
(AEs) was similar in pediatric and adult subjects; the most
commonly reported AEs were gastrointestinal events, fever, and
headache.
Conclusion: Treatment with POS resulted in successful out-
comes in 45% (5 of 11) of pediatric subjects. This rate of success
was similar to that seen in the overall population (50%).
Pediatric subjects who received POS had similar steady-state
plasma concentrations, comparable success rates, and similarly
favorable AE proﬁles to those of adults. Although the number of
subjects in this analysis is small, these data suggest that POS
may have clinical utility in the treatment of refractory IFIs in
pediatric subjects.
P745
Difﬁcult-to-treat central nervous system HIV-
unrelated cryptococcoma cured with voriconazole
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, I)
Introduction: When considering cryptococcosis in a setting
other than HIV disease,very few episodes are documented,and
CNS cryptococcoma is an absolutely rare event.
Case report: The authors describe an exceptional cerebral
cryptococcoma occurred in a chronic nephropathic HIV-negat-
ive patient (p) suffering from homocystinuria, favorably cured
with combined neurosurgery and voriconazole, after a limited
response to high-dose ﬂuconazole. In our case, after surgical
intervention conﬁrming a diagnosis of cryptococcoma, a ﬁrst
treatment line carried out with iv ﬂuconazole did not lead to a
sustained improvement, as the new antimycotic derivative
voriconazole did at 400 mg/day, later in the disease course.
After patient’s death due to a underlying progressive renal-
vascular disease,necropsy examination excluded any sign of
inﬁltration due to Cryptococcus neoformans; voriconazole admin-
istration can be therefore considered eradicating.
Discussion: When clinicians face an expansive cerebral mass,
before starting therapy it is mandatory to establish an early
presumptive diagnosis, in order to target antimicrobials and
recommend eventual surgical drainage. Among a broad spec-
trum of infectious etiologies, it is suggested to take into
consideration also of a fungal abscess, whose evolution would
certainly be disadvantaged by symptomatic steroids (like
happened in our p before that a speciﬁc diagnosis was
conﬁrmed), and/or antibacterial agents. In our case, both
surgical and medical therapy of a brain cryptococcoma in a
non-HIV-infected p have been performed: the surgical manage-
ment helped to remove the majority of the brain abscess and to
formulate the diagnosis, as well as to release an initial hydro-
cephalus. Also in HIV-infected p, cryptococcoma is a relatively
rare feature, and it hardly appears isolated,and not associated
with a meningeal cryptococcosis. As far as we know, there are
no prior reports of primary cryptococcomas in chronic nephro-
patic, HIV-negative p, as well as in p with homocystinuria.
Although being a rare occurrence, cerebral cryptococcoma may
represent an emerging issue in the next future, because of its
relationship with a broadening range of risk factors, including
malignancies, neutropenia, end-organ failure, bone marrow and
solid organ transplantation, and multiple primary-secondary
immunodeﬁciency. With the mounting increase in the frequency
of p with end-organ kidney disease,it is possible that also
cryptococcosis may emerge as a more frequent complication.
P746
Voriconazole proves effective in the management
of a brain cryptococcoma apparently resistant to
ﬂuconazole
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, I)
Introduction: The yeast Cryptococcus neoformans shows an
apparently homogeneous in vitro response to ﬂuconazole, but
particular sites of infection and prolonged disease may be
difﬁcult to treat. A rare case of cerebral cryptococcoma occurred
in a HIV-negative patient (p) suffering from chronic kidney
failure and pancytopenia is reported, since fungal clearance was
obtained only after voriconazole treatment, despite previous
surgery and long-term high-dose ﬂuconazole use.
Case report: A brain cryptococcoma was diagnosed in a 54–
year-old p after brain surgery, histopathological examination,
and culture. Despite i.v. ﬂuconazole treatment at 600–1000 mg/
day, the clinical and neuroradiological course was progressively
worsening, so that i.v. voriconazole (400 mg/day), was intro-
duced. The concurrent renal failure contraindicated amphoter-
icin B administration. After obtaining a certain diagnosis of this
rare fungal complication in a non-HIV-infected p, the ﬁrst-line
high-dose ﬂuconazole administration did not obtain a signiﬁ-
cant ameliorement, while the subsequent 50–day voriconazole
therapy led to negative neuroradiological, scintigraphic and
microbiological examinations associated with signiﬁcant clinical
improvement. After patient’s death occurred 7 months later due
to the progression of kidney failure and overwhelming cardio-
vascular events, the necropsy examination of the brain and other
organs excluded C. neoformans lesions, thus conﬁrming deﬁnit-
ively the eradicating efﬁcacy of voriconazole therapy.
Discussion: Although brain cryptococcoma remains a rare
occurrence, especially in the absence of HIV infection, this
shifty pathology may represent an emerging infection in the
next future. Its pathogenesis is supported by a broad variety of
risk factors, including malignancies, neutropenia, severe end-
organ failure, bone marrow and solid organ transplantation,and
other primary or secondary (i.e. iatrogenic) immunodeﬁciency.
When facing a cerebral mass, an early diagnosis is needed to
start an appropriate medical and/or surgical therapy. In the
broad spectrum of etiologies of brain abscesses the role of fungi
cannot be underestimated to avoid empiric steroid administra-
tion and proceed with an adequate antimycotic treatment. The
novel antifungal voriconazole combines an enhanced spectrum
with an increased intrinsic potency with a favorable cerebral
concentration which allows the treatment of difﬁcult-to-treat
brain fungal infections.
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P747
Cutaneous and disseminated histoplasmosis of
autochthonous origin in Italy
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
Introduction: Histoplasma capsulatum is a dimorphic fungal
pathogen involved in self-limited respiratory infection of the
immunocompetent host, while it may be responsible for severe
airway or disseminated disease when immunodeﬁciency is of
concern. Outside the endemic areas of America, Africa, and
South-Eastern Asia, it is a very rare, typically ‘imported’
pathogen. However, anecdotal reports of unequivocal autochth-
onous histoplasmosis suggest the possible existence of favorable
environmental conditions in our continent, and in Italy too (Po
river valley).
Case report: An Italian i.v. drug addict with advanced HIV
disease (as expressed by a CD4+ lymphocyte of 70 cells/lK) and
a negative history for travels outside our country), came to our
attention owing to an irregular hyperpyrexia, weight loss, chest
pain, pancytopenia, and hepato-splenomegaly persisting since
2 weeks. Plain radiological and CT studies of the chest detected
diffuse nodular inﬁltrates and a prominent mediastinal lymph-
adenopathy. One week later, multiple papulous-ulcerate skin
lesions of the face allowed the histopathological recognition of
the typical H. capsulatum blastoconidia, either intra- or extra-
cellular in site, with respect to phagocyte cells. A 5–week course
of i.v. liposomal amphotericin B at 5 mg/Kg and oral itracon-
azole achieved a complete clinical and mycological resolution of
this rare disseminated and cutaneous opportunistic mycosis.
Conclusions: Our patient represents the seventh case of auto-
chthonous AIDS-related histoplasmosis observed in Italy.
Epidemilological and environmental studies of habitats sup-
porting the growth of H. capsulatum in Italy and Europe could be
of particular interest, given the increased risk of opportunism
encountered in the immunocompromised host. Notwithstand-
ing its rare occurrence, this fungal infection causing a broad
spectrum of clinical presentations, cannot be disregarded in the
differential diagnosis of opportunistic disorders related to
advanced HIV disease.
P748
Reversible dilated cardiomyopathy associated
with amphotericin B treatment
I. Moyssakis, N.V. Sipsas, T. Vassilakopoulos, A. Perakis,
A. Petrou, N. Kosmas, G. Pangalis (Athens, GR)
Objectives: We report two patients who developed reversible
dilated cardiomyopathy secondary to amphotericin B (AmB)
treatment
Case series: Patient 1: A 64–year-old man with a history of
mild hypertension was treated with 6 cycles of rituximab –
chemotherapy for non-Hodgkin’s lymphoma (CHOP). The
cumulative dose of doxorubicine was 300 mg/m2. A baseline
transthoracic echocardiogram (TTE) was normal with an
ejection fraction (EF) of 59%. After the last cycle he was
treated with liposomal AmB (5 mg/kg, total 350 mg qd) for
febrile neutropenia. Seven days later he developed congestive
heart failure and a new TTE revealed dilated cardiomyopathy
(severe global impairment of the left ventricular (LV) systolic
function (EF = 13%) with LV end-diastolic diameter 61 mm
and end-systolic diameter 54 mm). Antifungal treatment was
discontinued and the patient was treated with inotropic
agents and diuretics. Within 24 hours vital signs were
improved and EF returned to 30%. One year later he had a
normal EF (56%).
Patient 2: A 23–year-old woman was admitted because of
pulmonary empyema. She had a history of mild systemic lupus
erythematosus (SLE) and she reported use of intravenous drugs.
A baseline TTE was normal. She was started on liposomal AmB
4 mg/kg (250 mg qd) for candiduria and 8 days later she
developed dyspnea and pulmonary oedema. A TTE revealed a
dilated LV with end diastolic diameter 59 cm, end systolic
diameter 47 cm and an EF of 35%. Diuretics were administered
and AmB was discontinued. Her vital signs were improved and
EF was increased to 48% ﬁve days later. One month later the EF
was 50%.For both patients, other causes of heart failure such as
septicaemia, viral myocarditis, valvular disease, or acute coron-
ary syndrome were excluded on the basis of negative blood
cultures, viral serology, and biochemical, and echocardiographic
ﬁndings. Doxorubicin cardiotoxicity, is unlikely due to the low
cumulative dose of the drug, the rapid evolution and the
reversibility of this condition.
Medline search: there are only 2 reports describing dilated
cardiomyopathy as side effect of AmB. In both reports the
patients were treated with AmB deoxycholate for coccidioid-
omycosis. All four reported patients (including ours) had
comorbid cardiac conditions such as coccidioidomycosis, che-
motherapy with anthracyclines, SLE and use of illicit drugs.
Conclusion: AmB might be cardiotoxic in patients with other
concurrent factors causing cardiac dysfunction.
P749
Caspofungin treatment in two infants with
persistent fungaemia due to Candida lipolytica
N. Belet, E. C¸iftc¸i, E. Ince, N. Dalgic¸, S. O¨ncel, H. Gu¨riz,
A. Yagmurlu, H. Dindar, D. Aysev, U¨. Dogru (Ankara, TR)
Caspofungin has been used successfully in adults with invasive
candidiasis. There is limited experience with caspofungin in
pediatric patients. We report two infants with persistent can-
didemia unresponsive to traditional antifungal therapy who
were successfully treated with amphotericin B and caspofungin.
Case 1. Ten day-old male patient underwent intestinal resection
with anastomosis due to jejunal stenosis. On 10th postoperative
day, the patient became febrile associated with elevated white
blood cell counts and CRP levels. Broad spectrum antibiotics
and ﬂuconazole were initiated. Because of positive blood
cultures for Candida albicans and Candida lipolytica, central
venous catheter of patient was removed and ﬂuconazole therapy
was replaced with conventional amphotericin B. However,
blood cultures continued to be positive for C. lipolytica. After
the possibility of a focal infection, such as endocarditis, was
excluded caspofungin was initiated with a dose of 1.6 mg/kg/
day. Following addition of caspofungin all blood cultures have
remained negative.
Case 2. A 4–month-old female with gastroesophageal reﬂux,
unresponsive to medical therapy was, admitted to the pediatric
surgery service. She was treated for nosocomial pneumonia due
to methicillin-resistant Staphylococcus aureus. On the follow up,
her temperature was elevated. Broad spectrum antibiotics and
ﬂuconazole were initiated. Because of positive blood cultures for
Candida albicans and Candida lipolytica, central venous catheter of
patient was removed and ﬂuconazole therapy was changed to
conventional amphotericin B. Focal infection could not be
demonstrated, however, blood cultures continued to be positive
for Candida lipolytica, then treatment changed to liposomal
amphotericin B. Due to persistence of positive blood cultures,
caspofungin was also initiated with a dose of 1.6 mg/kg/day.
The patient have since remained afebrile, and blood cultures
have remained negative. Caspofungin may be considered in
infants with persistent candidemia that are not responsive to
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standard therapy. Carefully controlled in vivo studies and well-
designed randomized clinical trials investigating dosage and
duration of the treatment with caspofungin, and investigation of
its pharmacokinetics, interactions and potential toxicities are
necessary before caspofungin is routinely recommended in
children.
P750
Paracoccidioidomycosis in the breast: case report
in a fertile female patient
A.C. Pasqualotto, L.C. Severo (Porto Alegre, BR)
Objectives: To report the case of a fertile female patient with
disseminated paracoccidioidomycosis involving the breast.
Methods and Results: A 32–year-old smoker female patient
was admitted to treat a breast abscess. Four years before, she
was admitted in other hospital to evaluate hoarseness – in that
occasion, she had the diagnosis of a vegentant lesion in the
larynx caused by Paracoccidioides brasiliensis. She had received
treatment with ketoconazole, but she abandoned treatment. Six
months before admission she went to the emergency room to
have an abscess in her left breast drained. Two months later, she
returned to the hospital because of the same problem. At
admission, she complained of weight lost (4 kg), productive
cough, and purulent sputum. She denied fever. An abscess was
drained in the left breast, and culture revealed Paracoccidioides
brasiliensis. Painful left axillary lymphadenopathy was observed
(~1.5 cm), and there was no oral lesions neither hepatospleno-
megaly. Chest radiography showed a bilateral interstitial inﬁl-
trate, with small nodules and cavities. P. brasiliensis grew in
sputum culture. Osteolytic lesions were seen in the 5th, 6th, and
7th left ribs. HIV serology tests were negative, and fasting
glucose was normal. This patient has 4 children, and normal
menstrual cycles. Her oestrogen levels were normal. Paracoc-
cidioidomycosis was effectively treated with itraconazole.
Conclusions: Women seem to be protected from paracoccidi-
oidomycosis, and most of cases occur in patients in the post-
menopause period. It has been suggested that the marked
gender difference seen in adults could be explained by the
inhibitory action of oestrogens on the conidia or mycelium-to-
yeast transition. Genital paracoccidioidomycosis is a very rare
event, mainly in fertile female patients.
P751
Successful treatment of Trichosporon mucoides
infection with lipid complex amphotericin B and
5–ﬂuorocytosine
E. C¸iftc¸i, T. Kendirli, E. Ince, N. Dalgic¸, S. O¨ncel, H. Gu¨riz,
E. U¨nal, U¨. Dogru (Ankara, TR)
Disseminated infection due to Trichosporon species is one of the
emerging mycoses in immunocompromised children. In this
report, a child with disseminated Trichosporon mucoides infection
who was successfully treated with lipid complex amphotericin B
and 5–ﬂuorocytosine are presented.
Case Report: A 15–year-old boy with acute lymphoblastic
leukaemia was admitted to the pediatric intensive care unit
because of fever, respiratory failure, and recurrent seizures. He
had been operated for cardiac thrombosis due to double-lumen
catheter two days before admission. His neurological ﬁndings
were attributed to hypoxia developed during the operation. On
physical examination, his body temperature was 39.2C, he was
unconscious, and he had left hemiplegia. Cracking rales were
also detected on the right hemithorax. Laboratory investigations
revealed that his hemoglobin was 10.5 g/dL, white blood cell
count was 3200/mm3, absolute neutrophil count was 1100/
mm3, and CRP was 9.7 mg/dL. Chest X-ray examination
revealed diffuse inﬁltration at the lower zone of the right lung.
The diagnoses of sepsis and pneumonia were established and
vancomycin and meropenem were initiated. On the follow up,
he developed pericardial effusion which was treated with
pericardial tube drainage. Because of persistent fever, ﬂuconaz-
ole was initiated on the 5th day of hospitalization. His blood
cultures were positive for Trichosporon mucoides. Because this
strain was resistant to ﬂuconazole and itraconazole but suscept-
ible to 5–ﬂuorocytosine and amphotericin B, ﬂuconazole treat-
ment was discontinued and lipid complex amphotericin B
(5 mg/kg/day) and 5–ﬂuorocytosine (100 mg/kg/day) were
initiated. Patient’s fever was resolved on the 5th day of new
antifungal regime. Pneumonia was also gradually resolved and
antifungal therapy was discontinued at the end of 8th week of
therapy. The patient was discharged with almost no neurolog-
ical sequel.
Conclusion: Trichosporon mucoides must be considered as an
etiological agent in patients with immunocompromised and/or
recently operated. Although optimal therapy of serious Tricho-
sporon infections remains poorly deﬁned, amphotericin B in
combination with 5–ﬂuorocytosine may be suitable.
P752
Successful treatment of ulcerating keratitis due to
Acremonium recifei with voriconazole
M.A. Horstkotte, J. Weißmann, K. Engelmann, J.-C. Gantier,
I. Sobottka (Hamburg, Dresden, D; Paris, F)
Objectives: Fungal keratitis is a common, potentially sight-
threatening ocular infection. The majority of cases occur after
corneal injury, usually by fungus-contaminated plant material.
Occasionally, contact lens wear is complicated by fungal
keratitis. A broad spectrum of fungal species has been identiﬁed
as etiologic agents. Until now, only a single ocular infection due
to Acremonium recifei has been described in a 48–year-old man
who developed corneal ulcer after a piece of coconut ﬂew into
his eye while cracking it. He was treated successfully with
keratoplasty, local and intravenous miconazole as well as oral
ketoconazole.
Methods: A previously healthy 38–year-old woman was admit-
ted for severe, ulcerating keratitis. She had worn hard contact
lenses since the age of 12 without complications. Despite topical,
subconjunctival, intracameral and systemic broad-spectrum
antibiotics, amphotericin B and itraconazole, as well as acanth-
amoebal therapy, the infection deteriorated. After seven weeks
there were satelliting inﬁltrations of the corneal stroma and a
severe anterior chamber reaction with hypopyon. A perforating
keratoplasty was performed.
Results: Microscopy of the corneal specimen detected fungal
elements. Culture of cornea and aqueous ﬂuid both yielded pure
growth of A. recifei. Using E-Test (AB Biodisk, Solna, Sweden)
the isolate exhibited resistance as indicated by minimal inhib-
itory concentration (MIC, expressed in lg/ml) to: itraconazole:
16, and amphotericin B: 2. Microdilution testing according to
NCCLS revealed the following MIC: ﬂuconazole: >64, itracon-
azole >8, voriconazole: 8, amphotericin B: 1, and ﬂucytosine:
>64. Because of the lacking clinical response and the discrepant
susceptibility results for amphotericin B, therapy with voricon-
azole was started. The vigorous local, intracameral and systemic
therapy with voriconazole was tolerated well and resulted in a
sustained resolution of the infection. Subsequently, due to
corneal haziness and vascularization corneal graft transplanta-
tion had to be repeated.
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Conclusion: We describe the ﬁrst case of an ulcerating keratitis
due to A. recifei associated with contact lens wear which was
treated successfully with voriconazole. Voriconazole is a new,
highly potent triazole with broad spectrum activity against
fungi, including moulds. The present case highlights the
potential of voriconazole in the treatment of severe ocular
infections even due to rarely encountered fungal species.
P753
Expression of alpha-defensin–1 in chronic
hyperplastic candidosis
A. Ali Vantaa, FIN
Background/Objectives: Candida yeasts are common commen-
sals of the normal oral microbial ﬂora. They may also penetrate
into underlying tissues and cause opportunistic infections.
Chronic hyperplastic candidosis (CHC) represents a chronic
opportunistic candida infection of the oral cavity. The aim of the
present study was to clarify the presence, tissue localization and
participation of a-defensin–1 in the host response against
chronic candidal stimulus.
Methods: Biopsies from ten patients with CHC lesions were
examined by immunohistochemistry using a-defensin–1 speciﬁc
polyclonal antibody. Ten samples from patients with leukopl-
akia of idiopathic origin (LP) were used as candida negative
controls. Sections were also stained with periodic acid-Schiff
(PAS).
Results: In CHC lesions, a-defensin–1 was detected intravascu-
larly in neutrophils, interstitially in lamina propria and, in
particular, intraepithelially in neutrophils, in part forming
intraepithelial microabscesses. In the CHC samples the staining
intensity of the individual neutrophils varied in the epithelium
and cellular staining was associated with peri- and extracellular
staining, in particular in the superﬁcial epithelial cell layers. In
contrast, only very few and homogeneously staining a-defensin–
1 immunoreactive neutrophils could be detected in the LP
samples, mostly intravascularly in lamina propria. No extracel-
lular a-defensin–1 deposits could be discerned in the LP
epithelia.
Conclusion: Alpha-defensin–1 containing neutrophils are
recruited from the intravascular pool, from where they trans-
migrate through lamina propria to Candida hyphen containing
epithelium. Neutrophils form microabscesses and respond to
Candida by activation and release of a-defensin–1 to peri- and
extracellular matrix. This together with the epithelial cell
migration from the basal layer to epithelial surface leads to
a-defensin–1 rich protective shield in the most superﬁcial
epithelial cell layers.
Enterococci: epidemiology and resistance
P754
The antimicrobial susceptibility of bacteraemia
isolates of Enterococcus faecalis and E. faecium in
a London hospital, 1990–2002
A. King, I. Phillips (London, UK)
Objectives: Enterococci are common in faecal ﬂora and can
cause serious infection in humans. We wished relate the
antibiotic susceptibility of enterococci from bacteraemic patients
to changes in human and animal use of antibiotics.
Methods: The antibiotic susceptibility of all enterococci isolated
from the blood of bacteraemic patients in St Thomas’ Hospital,
London, between 1990 and 2002 was determined either by broth
microdilution or by agar dilution. We noted local changes in
clinical services, and thus of antibiotic use (related to the union
of two hospitals), as well as published information on the use of
growth-promoting antibiotics in food animals.
Results: We isolated 392 E. faecalis and 147 E. faecium during the
12 years. The annual isolation rate of both species increased
markedly from 9 E. faecalis and 3 E. faecium in 1990 to a peak of
60 and 42 respectively in 2000. All isolates of E. faecalis were
ampicillin susceptible but 89% of E. faecium were resistant.
Resistance rates for other antibiotics for E. faecalis and E. faecium
were erythromycin 83% and 99% respectively, vancomycin 5%
and 26%, teicoplanin 3% and 22%, chloramphenicol 33% and
12%, ciproﬂoxacin 60% and 89%, gentamicin (high-level) 44%
and 39% and tetracycline 75% and 38%. In addition, 0.5% of
E. faecaliswere linezolid resistant and 2% of E. faeciumwere Q/D
resistant. When the years 1990–1996 (use of growth-promoting
antibiotics in food animals) and 1997–2002 (relocations of
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clinical services) were compared, resistance rates for erythro-
mycin, glycopeptides, ciproﬂoxacin, and aminoglycosides
increased for both species, and for ampicillin, tetracycline, and
Q/D for E. faecium. However, resistance to Q/D and linezolid
was negligible.
Conclusions: The two species of enterococci became more
common and more resistant largely in relation to relocation of
clinical services commonly associated with high-level antibiotic
use. Use of avoparcin and virginiamycin in animals before 1996,
had minimal or no potential effect on resistance, since resistance
appeared after their animal use had been discontinued, but
when local use of their counterparts in human medicine had
markedly increased or, in the case of Q/D, begun. Despite the
occasional use of Q/D and later linezolid, resistance to these two
antibacterials remained rare. Fortunately, newer antibiotics,
such as daptomycin, are active against all isolates, including
those resistant to virtually all other antibiotics.
P755
Wide dissemination of enterococci highly
resistant to aminoglicosides among poultry and
healthy humans from Portugal
C. Novais, J.C. Sousa, T.M. Coque, L.V. Peixe (Porto,
P; Madrid, E)
Objectives: To characterize enterococcal isolates highly resist-
ant (HLR) to aminoglycosides (AG) from human and poultry
samples from Portugal and to establish clonal relatedness
among them.
Methods: Fecal samples from 99 healthy human volunteers
(HV) and 99 skin or meat samples from poultry (P) were
collected in North and Center of Portugal (1999–2001). MICs for
gentamicin (Gm), streptomycin (Sm) and kanamycin (Km) were
determined by the agar dilution method (NCCLS). Species
identiﬁcation and presence of AG resistance genes [aac(6’)-Ie-
aph(2’’)-Ia, aph(2’’)-Ib, aph(2’’)-Ic, aph(2’’)-Id and aph(3’)-IIIa]
were determined by PCR. Clonal relatedness among HLRGm
enterococci was established by PFGE.
Results: 765 isolates [E. faecalis (n = 307), E. faecium (n = 301),
E. gallinarum (n = 68) and Enterococcus spp (n = 89)] were
identiﬁed. Resistance to Sm, Km, or Gm was observed in 72%,
53%, 39%, and 80%, 68%, 13% of P and HV samples, respectively.
All HLRGm enterococci contained aac(6’)-Ie-aph(2’’)-Ia: 53 iso-
lates (46 P and 7 HV) had only this gene and 31 isolates (20 P and
11 HV) had aac6-aph2 plus aph(3’)-IIIa. HLRKm but not to
HLRGmwas found in 180 isolates (70 P and 110 HV), aph(3’)-IIIa
being present in 90% of P and 85% of HV isolates. Two HLRGm
enterococcal PFGE types were found in both P and HV samples:
one E. faecalis (4 P and 1 HV) and one E. faecium (2 P and 1 HV).
Conclusion: HLRAG enterococci is widely spread among P
products and HV from Portugal, aac(6’)-Ie-aph(2’’)-Ia and
aph(3’)-IIIa being responsible of HLRGm and HLRKm. Our
results conﬁrm that poultry used for human consumption might
be an important source for the diffusion of HLRAG enterococci
strains and/or their respective resistance genetic elements.
P756
Molecular characterisation of vancomycin-
resistant Enterococcus faecium from Portuguese
hospitals
C. Novais, J.C. Sousa, T.M. Coque, L.V. Peixe on behalf of the
Portuguese Resistance Study Group
Objectives: To analyse the clonal relationship and the presence
of antibiotic resistance and virulence traits among vancomycin
resistant E. faecium (VREF) clinical isolates from hospitals of 3
different Portuguese cities.
Methods: 103 VREF isolates from different patients (1996–2003)
were studied. Susceptibility to 12 antibiotics was performed by
the agar dilution method (NCCLS). Isolates were searched for
genes coding for resistance to glycopeptides, macrolides, and
aminoglycosides. Tn1546 characterization was done by an
overlapping PCR strategy in 53 selected VREF isolates. Clonal
relatedness was established by PFGE. Presence of virulence
traits (Esp, Gel, Hyl, Cyl, Agg) was investigated by multiplex
PCR.
Results: VREF (102 vanA and 1 vanB2) were mostly resistant to
ampicillin, erythromycin, ciproﬂoxacin and HLR-kanamycin
(98, 98, 95, and 67%, respectively). Genes coding resistance to
macrolides or aminoglicosides were erm(B), aac6-aph2, and
aph3´-IIIa. Fifty-one PFGE types were identiﬁed, some of them
successfully spread among two (5 clones) or three (one clone)
hospitals in distinct years, and wards. Sixteen variants of Tn1546
were found; some of them were observed in different hospitals
(PP-2, PP-5), in different dates (PP-2, PP-4, PP-5, PP-13) and
different clones (PP-2, PP-4, PP-5, PP-9, PP-13). PP-4, PP-5 and
PP-24 contain an ISEf1 which we previously found to be
predominant among clinical Portuguese VRE faecalis strains.
Different combinations of virulence factors were detected, esp
being detected in 32% (n = 33/103) of VREF isolates, all resistant
to ampicillin.
Conclusions: VREF were frequently found in the institutions
studied. The presence of speciﬁc and persistent both VREF
clones and Tn1546 types might contribute to the wide spread of
VRE in the Portuguese hospital environment. The dissemination
and establishment of successful VREF clones in the hospital
setting amplifying particular Tn1546 types available in local
metagenomes, might inﬂuence different evolutionary events.
P757
Distribution of enterococci infections and
antibiotic resistance patterns in a Greek hospital
F. Markou, A. Poulou, P. Rozi (Serres, GR)
Objectives: Enterococci constitute a major problem due to the
increasing incidence of enteroccocal infections and the nosoco-
mial spread of strains resistant to multiple antimicrobials
including the threat of VRE strains. The purpose of this study
is to assess the prevalence and resistance patterns of enterococci
isolates among the patients of our hospital.
Methods: During a 3-year period 350 enterococci strains were
isolated from various clinical specimens obtained from 144
(41.2%) outpatients, 59 (16.8%) ICU patients and 147(42%)
patients hospitalized in other units. The identiﬁcation of the
isolates and the determination of the antimicrobial resistance to
penicillin (P), ampicillin (Am), ciproﬂoxacin (Cip), high dosage
gentamycin, vancomycin (Va), teicoplanin (Tei), and linezolid
(Lin) was performed by Auto Scan of D. Behring while the disk
diffusion method was used as a conﬁrmatory test.
Results: Among the 350 isolated enterococci, 203(58%) strains
derived from urine specimens, 31 (8.8%) from lower respiratory
tract, 30 (8.6%) from wounds, 20 (5.7%) from blood cultures and
66 (18%) from other sources. 298 (85.2%) strains were identiﬁed
as E. faecalis, 47 (13.4%) as E. faecium and 5 (1.4%) as Eterococcus
spp. The resistance rates of E. faecalis isolated from outpatients,
ICU patients and patients of other units were as follows: to Am
(0/26/2%), P (5/34/12%), Cip (20/70/30%), Va (0/9/2%), and
Tei (0/8/0%) while the antimicrobial resistance for the same
groups of patients for E. faecium were to Am (0/86/2%), P
(75/86/10%), Cip (75/86/78%), Va (0/14/0%) and Tei (0/14/
0%) respectively. A total of 18 (5.1%) enterococci isolates
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predominately derived from ICU and comprised of 9 strains of
E. faecalis (3%) and 9 strains of E. faecium (19%), were found to be
high level Gentamicin resistant. No strains resistant to linezolid
were observed.
Conclusions: Enterococcus spp. is the causative pathogen for
many urinary, lower respiratory tract and blood infections.
E. faecium shows higher antimicrobial resistance compared to
E. faecalis. It was observed that isolates from outpatients show a
moderate resistance to quinolones, while ICU isolates were
highly resistant to penicillin, quinolones and high level Genta-
mycin. For the present all VRE strains are susceptible to
oxazolidinone. The high incidence of resistant enterococci
strains to tested antibiotics, especially in ICU, highlighted the
need for continual surveillance and rational use of antimicrobial
compounds against enterococci.
P758
Vancomycin-resistant enterococci in Greece: a
multicentre prevalence study on intestinal
colonisation
A. Christidou, P. Nikolaidis, A. Skoutelis, S. Kartali, E. Maltezos,
S. Levidiotou, J. Kioumis, J. Pediaditis, G. Haliotis, S. Dima,
E. Scoulica, M. Roumbelaki, E. Kritsotakis, A. Gikas,
Y. Tselentis (Heraklion, Thessaloniki, Patras, Alexandroupolis,
Ioanina, Halkis, Chania, GR)
Objective: To estimate the prevalence rates of fecal carriage
with vancomycin resistant enterococci (VRE) in Greek hospitals
and investigate the risk factors.
Methods: Thirteen hospitals (5 university and 8 regional)
scattered in all Greek territory participated in the study and
1246 patients were tested. The survey took place on November
1, 2002. The same methodology was exactly performed in every
hospital. Fecal specimens were cultured in enterococci broth
with 6 lg/ml vancomycin and subcultured on bile esculin azide
agar with 6 lg/ml vancomycin. Enterococci were identiﬁed by
conventional methods and vancomycin resistance was detected
by disk diffusion method and E-test. All isolates were sent to a
reference centre for further investigation. Van gene characteri-
zation was performed by a multiplex polymerase chain reaction
(PCR), which also conﬁrmed the identiﬁcation. Clone distribu-
tion was tested by pulsed-ﬁeld gel electrophoresis (PFGE).
Results: VRE were detected in all except 1 regional hospital and
266 strains were isolated from 255 (20.5%) of 1246 patients.
Overall, 79 (29.7%) isolates were E. faecium, 12 (4.5%) E. faecalis,
153 (57.5%) E. gallinarum, 16 (6%) E. casseliﬂavus, 4 (1.5%)
E. avium, and 2 (0.8%) E. hirae. Among 266 isolates, 82 (30.8%)
presented vanA, 17 (6.4%) vanB, 152 (57.1%) vanC1, and 15
(5.6%) vanC2/C3 resistance type. When the inducible types
(vanA, van B) were separately considered 93 (7.5%) patients
were carriers. Van-A type was detected in all university and in 4
of the 8 regional hospitals, while van-B in 1 university and 3
regional hospitals. The percentages of vanA and vanB were
signiﬁcantly higher in university compared to regional hospi-
tals. At the ward level, university hospitals exhibited signiﬁ-
cantly higher rates for renal and surgical wards, whereas in ICU
and medical wards no difference was observed. PFGE analysis
revealed the presence of multiple clones. Age, presence of
cancer, chronic renal failure, length (days) of hospitalization, use
of monobactams and carbapenems and previous ERCP were
identiﬁed as risk factors independently associated with
increased risk of VRE (VanA or VanB) colonization.
Conclusion: This study revealed high VRE colonization rates
among Greek hospitalized patients. Van-A appeared as the
predominant inducible type. Cancer, chronic renal failure,
length (days) of hospitalization, use of monobactams and
carbapenems, and previous ERCP were identiﬁed as risk factors.
P759
Ampicillin resistant Enterococcus faecium: a
rapidly increasing problem in hospitals in a
Danish region
T. Ejlertsen, R. Nielsen (Aalborg, DK)
Objectives: In 2000, clusters of epidemic spread of ampicillin
resistant enterococci (ARE) were registered in two wards and
their afﬁliated intensive care units (ICU). In order to determine
the size and dynamics of nosocomial infection with ARE, the
study investigates the overall isolation of ARE during an 9-year
period in a Danish region. Molecular examination of the ARE
strains was used to disclose clonal spread within hospitals.
Methods: The Department of Clinical Microbiology, Aalborg
Hospital provides diagnostic bacteriology to the County of
North Jutland (approximately 500,000 inhabitants) and serves
around 300 general practitioners (GP) and 7 hospitals. The
department also undertakes surveillance of nosocomial infec-
tions in the county. Enterococci were identiﬁed by conventional
methods (1), and examined with pulsed-ﬁeld gel electrophoresis
(PFGE). Molecular bands were judged visually according to
previous described methods (2). Clinical data was retrieved
from the case records. Retrospective data regarding ARE strains
were retrieved from the department’s laboratory information
system (ADBakt, Autonik, Sweden).
Results: The number of ARE strains was: 1996 (2), 1997 (11),
1998 (7), 1999 (5), 2000 (18), 2001 (26), 2002 (44), 2003 (73),
January to October 2004 (127). ARE was isolated from various
sources including blood cultures, surgical wounds and abdom-
inal abscesses. Fourteen isolates (4.5%) came from GP’s and 299
isolates (95,5%) from hospitals. Forty-eight ARE strains isolated
locally during 1997–2004 and 8 E. faecium and 6 E. faecalis strains
from a neighbouring county were compared by PFGE. All
strains from the neighbouring county were distinct from local
strains. Many unique strains were identiﬁed both in the
community and in hospitals. Clonal spread of ARE strains was
disclosed in one department of abdominal surgery and one
department of nephrology as well as their afﬁliated ICUs.
Conclusions: ARE has emerged and become a nosocomial
problem in North Jutland County, Denmark. ARE strains
seems to be prevalent in the community and following intro-
duction into the hospital setting they may give rise to clonal
spread and nosocomial infections.
References
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P760
A Nordic study of antibiotic susceptibility of
enterococci at different ward levels
C. Claesson, M. Nilsson, A. Ha¨llgren, H. Hanberger,
L.E. Nilsson on behalf of the SCOPE Study Group
Objectives: To study the antibiotic susceptibility of enterococci
at different ward levels.
Methods: Initial isolates of enterococci from patients at primary
care centres (PCC) (N = 220), general hospital wards (GHW)
(N = 215) and intensive care units (ICU) (N = 176) at 16
hospitals and counties, in Denmark, Finland, Norway and
Sweden, were collected during 1999–2000. Minimal Inhibitory
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Concentrations (MICs) were determined using Etest (AB Bio-
disk). Species related MIC breakpoints of the Swedish Reference
Group for Antibiotics were used for all antibiotics except for
moxiﬂoxacin and levoﬂoxacin. For these two antibiotics the
European Committee on Antimicrobial Susceptibility testing
nonspecies related clinical breakpoints were used.
Results: There were signiﬁcant differences in the frequency of
E. faecium among the enterococci at the PCC (7.3%), GHW (13%)
and the ICUs (28%) (p < 0.05). A total of 0.8% of the E. faecalis
isolates and 2.7% of the E. faecium isolates were low level (MIC
8–16 mg/l) vancomycin resistant (VRE) but teicoplanin suscept-
ible. High level gentamicin resistance (HLGR) was seen among a
total of 13% and 17% of the E. faecalis and the E. faecium isolates,
respectively. There were signiﬁcant higher frequency of HLGR
among the E. faecalis isolates at both the GHW (20/%) and the
ICUs (17%) compared to the PCCs (5.9%) (p < 0.05). The E.
faecalis isolates showed a signiﬁcant difference in susceptibility
to imipenem, moxiﬂoxacin, and vancomycin at the ICUs
compared to the PCCs (p < 0.05). A signiﬁcant difference in
susceptibility between the GHW and PCC was only seen for
moxiﬂoxacin. The E. faecium isolates showed no difference in
susceptibility between the ward levels.
Conclusion: There were signiﬁcant differences in the frequency
of E. faecium at the different ward levels, E. faecalis showed a
high susceptibility against all the tested antibiotics except for
imipenem, the quinolones and gentamicin (HLGR). These
antibiotics showed a signiﬁcant difference in susceptibility
between the ward levels. Vancomycin and teicoplanin were
the only antibiotics that showed high susceptibility against most
E. faecium at all ward levels.
P761
ESPAR: variation of antibiotic resistance in
Enterococcus spp. isolates
M. Lindgren, P. Huovinen, C. Edlund, J. Jalava and ESPAR
Group
Objectives: The idea of ESPAR project was to study emergence,
spread and persistence of antibiotic resistance in normal
microbiota during 2-year period. The main objective was to
follow the variation of antibiotic resistance, caused by a short
antibiotic treatment in Enterococcus isolates, and to study the
evolution of the resistant Enterococcus strains.
Methods: Enterococcus spp. isolates were collected from 4
healthy subjects, treated with clindamycin for 7 days. Faecal
samples were serially collected in nine different time points;
Before administration of antibiotic, right after it and then after
21 days, 3, 6, 9, 12, 18 and 24 months. Enterococcae were also
isolated from faecal samples, serially collected from 4 control
subjects during 6 months. Antibiotic susceptibility testing was
done by agar dilution method on Mu¨ller–Hinton II medium,
according to NCCLS. MIC values were tested against erythro-
mycin, clindamycin, ciproﬂoxacin, ampicillin, gentamicin,
vancomycin and tetracycline. Multiplex-PCR was used for
studying macrolide resistant genes, erm (B), erm (TR) and mef
(A). Species variation was studied with pyrosequencing method.
Results: When comparing all four subjects, there were no clear
correlation between clindamycin treatment and antibiotic resist-
ance. However, results from two subjects showed that clindamycin
probably had inﬂuence, because there were no resistant strains in
0-sample, but after 7 days resistance rose substantially. The amount
of resistant strains in 7 days samples was at least threefold
comparing to 0-sample, and the amount of resistant Enterococcus
strains was largest between 7 and 21 days. In control group there
were no clear correlation between resistance and time.
Conclusion: Results showed that due to the clindamycin
treatment, the amount of resistant Enterococcus strains rose
substantially and resistance returns very slowly, if not at all,
back to the normal level. However, normal variation in antibi-
otic resistance in Enterococcus isolates makes it more difﬁcult to
analyse the real inﬂuence of the clindamycin treatment.
P762
Diversity among high-level gentamicin resistant
Enterococcus faecium in the south east of Sweden
B. Saeedi, M. Ta¨rnberg, C. Claesson, L.E. Nilsson,
H. Hanberger (Linko¨ping, S)
Objectives: The aim of this study was to investigate genetic
relatedness of Enterococcus faecium with high-level gentamicin
resistance (HLGR) among clinical isolates from patients with
clinical indications admitted to three hospitals in the south east
of Sweden during a period of nine and a half months.
Methods: High-level gentamicin resistant E. faecium isolates
obtained from routine clinical specimens submitted to the
Clinical Microbiology Laboratory between November 2003 and
August 2004 were included in this study. No zone around a disc
with 30 lg gentamicin (Oxoid Ltd) was deﬁned as HLGR
according to SRGA, the Swedish Reference Group of Antibiotics
(www.srga.org). Genetic relatedness was studied among 20
none-replicate E. faecium with HLGR and control strains with no
HLGR (n = 20). The control strains were matched when possible
by year and unit with the HLGR-isolates. Detection of related
clones was performed using PFGE of SmaI DNA restriction
fragments. S. aureusNCTC 8325 was included as control/ladder.
The isolates were subjected to PCR for detection of the aac(6¢)Ie-
aph(2¢¢)Ia gene. E. faecalis ATCC 51299 was included as positive
control and E. faecalis ATCC 29212 as negative control.
Results: Thirteen of 20 E. faecium with HLGR belonged to the
same clone according to the PFGE patterns. There was similarity
between one of the HLGR-isolates and two of the control strains.
19 of 20 isolates with HLGR and the positive control carried the
aac(6¢)Ie-aph(2¢¢)Ia gene. The gene was not present in the
negative control and non-HLGR control strains of E. faecium.
Conclusion: Genetic relatedness was seen among 65% of the
E. faecium isolates with HLGR indicating a clonal spread of these
isolates among patients admitted to hospitals in the south east of
Sweden. Almost all HLGR isolates harboured the aac(6¢)Ie-
aph(2¢¢)Ia gene.
P763
Temporal changes in enterococcal species in the
human intestine, and persistence of Enterococcus
faecium SF68 following its administration to
healthy volunteers
V. Vankerckhoven, C. Lammens, H. Goossens (Wilrijk, B)
Objectives: To investigate the temporal changes in enterococcal
species in the human intestine, and the persistence of the
probiotic strain, Enterococcus faecium SF68, a human volunteer
study was conducted.
Susceptibility PCC/GHW/ICU (%)
Antibiotic E. faecalis E. faecium
Ampicillin 100/100/98 6.0/19/29
Imipenem 90/88/83 –
Levoﬂoxacin 11/6.2/7.1 6.0/2.7/84
Moxiﬂoxacin 89/78/74 12/11/19
Teicoplanin 100/100/100 100/100/100
Vancomycin 100/100/98 100/97/98
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Methods: A total of 13 healthy volunteers were enrolled in the
study. Seven subjects received 2 capsules of Entercoccus faecium
SF68 (108 CFU/caps.) thrice daily for 5 days, while 6 subjects
formed the control group. Faecal samples from all subjects were
collected before E. faecium SF68 administration (day 0) and on
days 4, 10, 20, weeks 5, 7, 9, 11, and months 6, 8, 12. Pre-probiotic
administration, stools were screened for enterococcal species
and their clonality for all volunteers and further on, only for the
control group. Faecal samples were plated on Enterococcal agar
and after 48 h of incubation, 10 esculin hydrolysing colonies
were followed further. PYR was used for genus identiﬁcation,
while species identiﬁcation was studied by RAPD-PCR using
primer D11344, and in case of inconclusive results, by SDS-
PAGE of whole-cell proteins. Clonality was investigated by
RAPD-PCR using primers D11344 and D14307, and in case of
discordant results between the 2 primer sets, by PFGE using
SmaI.
Results: From 127 enterococci isolated on day 0, a total of 5
different species were identiﬁed: E. faecium (47%), E. faecalis
(39%), E. durans (11%), E. hirae (2%) and E. gallinarum (<1%).
From day 4 to month 12, 744 enterococci were isolated from the
control group and identiﬁed as: E. faecium (59%), E. faecalis
(26%), E. durans (7%), E. hirae (3%); other species (E. casseliﬂavus,
E. avium, E. mundtii) were <2%. Distribution of clonal types,
especially in E. faecium and E. faecalis, varied among the control
group. During the study period clonal types in E. faecalis varied
from 1 to 6 and in E. faecium between 8 to 14 types, which was on
an average twice the number of types/isolation day compared
to E. faecalis. Post-administration, E. faecium SF68 was detected in
all 7 subjects on day 4. At week 9, only a single volunteer
showed the presence of E. faecium SF68 and at week 11 none of
the volunteers were found to carry the probiotic strain.
Conclusions: The composition of the commensal enterococcal
faecal ﬂora was found to ﬂuctuate over the study period of
1 year with E. faecium and E. faecalis being the predominate
species. This is the ﬁrst study showing the persistence of
colonisation by a probiotic strain in the intestine for such a
prolonged period.
P764
Vancomycin-resistant enterococci, colonising the
intestinal tract of hospitalised patients in a
university hospital in Greece
S. Metallidis, P. Nikolaidis, M. Chatzidimitriou, A. Basiklis,
A. Tsona, G. Lazaraki, E. Koumentaki, A. Gikas, S.
Alexiou-Daniel (Thessaloniki, Heraklion, GR)
Objectives: To explore the prevalence of Vancomycin-resistant
Enterococci (VRE) colonizing the intestinal tract of hospitalized
patients and to deﬁne risk factors.
Patients and Methods: A point prevalence survey of VRE fecal
carriage was carried out among patients admitted to a 600-bed
teaching hospital for at least 2 days. Resistance to vancomycin
was detected by the E-test method. Epidemiological data were
recorded for all patients included in the study and were used for
the risk factor analysis.
Results: A total of 128 patients hospitalized for at least 2 days
were enrolled in this investigation. Thirty-nine patients (30.5%)
were colonized with vancomycin-resistant enterococci. Twenty-
three of the 39 strains were identiﬁed as Enterococcus faecium, 13
were identiﬁed as Enterococcus gallinarum and 3 strains as
Enterococcus casseliﬂavus. The risk factors that were signiﬁcantly
associated with VRE colonization included length of hospital
stay (13.2 days vs. 8.6 days), age (60.7 years vs. 47.7 years) and
the presence of underlying malignancies (28.2% vs. 11.2%).
Association was found between VRE colonization and use of
antimicrobials with anaerobic activity such as metronidazole,
piperacillin/tazobactam and imipenem. The use of vancomycin
was associated with VRE colonization in ICU.
Conclusions: VRE colonization must be monitored and risk
factors should be determined because they are useful for
screening hospitalized patients for VRE colonization in order
to establish prevention and control measures.
P765
Persistent single VRE strain is responsible for
two outbreaks in an ICU
F. Huenger, P. Ruland, H. Haefner, S. Klik, V. Krizanovic,
H. Heisel, R. Lu¨tticken, S.W. Lemmen (Aachen, D)
Background: Colonisation and infection with vancomycin-
resistant Enterococci (VRE) are problems in hospitals world-
wide. In October and November 2003 VRE were detected in
clinical specimens of ﬁve patients on a surgical ICU of our
University Hospital with a VRE prevalence of less than 0.7%. In
order to prevent further transmission standard isolation proce-
dures were initiated and no additional cases were found.
Combined with routine MRSA screening a screening for VRE
colonisation was started in March 2004.
Materials and Methods: VRE screening was performed on this
ICU with 4 subunits and 28 beds for a 6-month period. 114
patients who stayed for more than 5 days were included and
screened weekly. A rectal swab was taken and examined by
direct culture on bile esculin azide agar plates containing 6 mg/l
of vancomycin. Suspicious colonies were identiﬁed to species
level using routine criteria and API Rapid ID 32 Strep system.
The MIC of vancomycin and teicoplanin was determined by
E-test method. In case of VRE detection standard isolation
practices were started. Molecular typing was performed by
pulsed ﬁeld gel electrophoresis (PFGE) to determine relatedness
of isolates.
Results: End of May 2004 one case of VRE wound infection
occurred, rectal screening was negative. During June and July
nine patients were found to be VRE positive, eight cases were
revealed by rectal screening, one by clinical specimen only. Five
of these nine patients developed VRE infection. All isolates were
E. faecium with vancomycin and teicoplanin resistance. PFGE
conﬁrmed a single VRE strain was responsible for both VRE
outbreaks. Since August 2004 no additional VRE cases were
detected on this ICU.
Conclusions: Probable a single VRE strain can persist undetec-
ted for at least 6 month in an ICU setting. Our routine VRE
screening seems to be efﬁcient for the detection of colonised
patients but did not prevent a second outbreak. Colonised
patients are at risk for VRE infection and represent a source for
further transmission. VRE outbreaks can be controlled by
intervention strategies.
P766
Clonal outbreak of vancomycin and ampicillin
resistant Enterococcus faecium (VRE) in the
haematological unit of a Belgian hospital
A. Deplano, I. Dom, O. Denis, R. De Ryck, C. Nonhoff, F. Rost,
B. Byl, M.J. Struelens (Brussels, B)
Background: Outbreaks of VRE nosocomial infection have been
described in high risk units but remain rare in Belgium. We
investigated a cluster of vancomycin resistant Enterococcus
faecium infection in our hematological unit.
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Methods: Case deﬁnition was a patient admitted to Erasme
Hospital hematological unit and colonized/infected with
vancomycin and ampicillin resistant E. faecium (VRE) during
2003–2004. Enterococci were identiﬁed by Rapid ID-Strep and
mobility at 35C. Susceptibility to ampicillin, gentamicin, strep-
tomycin, clindamycin and doxycycline was determined using
the disk-diffusion method. Vancomycin resistance was tested on
vancomycin screen agar (6 lg/ml) according to NCCLS. Resist-
ance to glycopeptides and ampicillin were conﬁrmed by E-test
method and by PCR for detection of vanA, vanB and vanC
genes. SmaI macrorestriction analysis resolved by pulsed ﬁeld
gel electrophoresis (PFGE) was performed. Weekly rectal
screening for VRE was undertaken in patients hospitalized in
the haematological unit by inoculation on Enterococcosel agar
supplemented with vancomycin (10 lg/ml) and with/without
enrichment broth with 7.5% NaCl.
Results: From January to June 2004, the incidence of infection
with VRE in patients admitted to hematological unit was 0.9%
(4/466) as compared to 0% (0/956) (p < 0.005) in the previous
12 months. Infections included bacteraemia (n = 2), anchiocho-
litis (n = 1) and soft tissue abscess (n = 1). At the end of June,
outbreak investigation and control measures were implemented
combined to weekly rectal screening. Contact precautions
(wearing of gloves and gown) and environmental disinfection
were implemented for the care of VRE infected/colonized
patients. After infection control implementation, no further case
of VRE infection was occurred but 7/134 (5%) screened patients
were colonized with VRE over a 5-month period. All strains
were resistant to ampicillin (MIC > 256 lg/ml), vancomycin
(MIC > 256 lg/ml) and teicoplanin (MIC > 16 lg/ml),
harbored the vanA gene and belonged to the same PFGE type.
Conclusions: This clonal outbreak of VRE in an hematological
ward over a 10-month period was associated with signiﬁcant
morbidity. Early detection of carriers and use of contact
precaution have not led to full control of the epidemic as
asymptomatic cross colonization still occurred. Active surveil-
lance culture of carriers will be continued to enforce isolation of
colonized patients.
P767
First nosocomial outbreak of Enterococcus
faecium expressing heterogenous vancomycin-
resistance at a French university hospital
T. Naas, N. Fortineau, R. Snanoudj, C. Spicq, A. Durrbach,
B. Charpentier, P. Nordmann (Kremlin-Bicetre, F)
Objectives: Vancomycin-resistant enterococci (VRE) are wide-
spread worldwide. Despite growing concern about VRE as
nosocomial pathogens, especially in the United States, they are
rarely isolated in French hospitals. We report the molecular
characterization of the ﬁrst nosocomial outbreak of VRE at a
French University Hospital.
Methods: Strains correspond to either clinical samples or rectal
swab specimens for analyzing carriage. Identiﬁcation, suscepti-
bility testing, molecular characterization and molecular com-
parison of the strains [pulse ﬁeld gel electrophoresis (PFGE)]
were performed according to standard techniques.
Results: VRE were isolated from 18 patients between August
and November 2004, of whom 17 were hospitalized at the
department of Nephrology and one at the department of
Internal Medicine. Twelve patients were only carriers and six
patients had true VRE infections: one bacteraemia, two perito-
nitis and three urinary tract infections. All of these isolates were
E. faecium and expressed heterogenous glycopeptide resistance
(MIC for vancomycin: 12–256 mg/L and for teicoplanin:
6–16 mg/L). These strains were also resistant to ampicillin,
levoﬂoxacin, clindamycin, erythromycin and displayed high-
level resistance to gentamicin, kanamycin and streptomycin, but
remained susceptible to linezolid and tetracycline. PFGE
revealed that these 18 E. faecium isolates were undistinguishable
or clonally related. They were all of vanA genotype with a
genetic organization identical to that described for Tn1546 in the
VanA prototype strain E. faecium BM4147, except for the
presence of IS16 inserted into the vanY gene. Implementation
of stringent hand disinfection and environmental disinfection
policies, as well as measures for patient isolation contained this
outbreak of VRE, but currently did not eradicate totally the
vanA E. faecium strains from the unit.
Conclusions: This work reports the emergence of VRE in a
French University Hospital with very heterogenous glycopep-
tide expression, thus making their detection very difﬁcult.
P768
The ﬁrst recorded outbreak of VRE in Hungary
involving vanB carrying E. faecium isolates from
clinical samples and from the hospital
environment
B. Libisch, M. Gacs, T. Tirczka, J. Pa´szti, K. Glatz, M. Bogna´r,
M. Major, M. Konkoly-Thege, M. Fu¨zi (Budapest, HUN)
Objective: The aim of this study was to investigate and conﬁrm
by phenotypic and molecular methods the ﬁrst reported
outbreak of vancomycin resistant enterococci (VRE) in Hungary
and to uncover the epidemiological relationship between the
outbreak isolates.
Methods: The isolates were screened on a 6 mg/l vancomycin-
BHI plate as recommended by NCCLS. Vancomycin and
teicoplanin MIC values were determined for the screen-positive
isolates by the E-test. Identiﬁcation was achieved by basic
biochemical tests, motility in SIM medium, the Crystal GP
system and by PCR ampliﬁcation of the ddl and vanC genes.
vanA and vanB genes were detected by PCR. Clonal relationship
between the VRE isolates was determined by PFGE.
Results: The outbreak strains were isolated at a hematology
unit in Budapest during 2003 and 2004. The initial investigation
conﬁrmed vanB positive E. faecium isolates from six blood
cultures, one urine sample, eight faecal samples and three
environmental samples. All these isolates were found to be
epidemiologically related to each-other by macrorestriction
(PFGE) analysis but unrelated to vanB negative E. faecium
isolates obtained from the same hospital. One vanA carrying
E. faecium was also isolated from the faecal sample of a hospital
administrator which was clearly unrelated to the outbreak
strains. VRE carriage was not detected for any other member of
the hospital staff, however, a comparatively high percentage of
the carriage of vanC positive isolates (E. casseliﬂavus and
E. gallinarum) was observed.
Conclusions: This is the ﬁrst report of vanB carrying VRE from
Hungary and also the ﬁrst report of an outbreak caused by VRE.
These results suggest that a screening and monitoring system
has to be implemented to prevent the further dissemination of
VRE in the country.
P769
Genetic relationship, occurrence of esp and
antibiotic resistance among blood-culture derived
Enterococcus faecium isolates
H. Billstro¨m, A˚. Sullivan, B. Lund (Stockholm, S)
Background: Enterococci have during the last three decades
emerged as a signiﬁcant cause of nosocomial infections. The
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durable nature of enterococci combined with dissemination of
antibiotic resistant Enterococcus faecium and Enterococcus faecalis
in hospital settings is an increasing problem since treatment of
these infections can be challenging. Enterococcal surface protein
(Esp), a virulence factor encoded by the esp-gene, has been
associated with immune evasion, bioﬁlm formation and adhe-
sion. Isolates of infectious origin have been found to be enriched
with the esp-gene.
Objectives: To characterize E. faecium infectious isolates from a
Swedish blood-culture collection in terms of antibiotic resist-
ance, occurrence of esp, genetic relationship and to determine if
cross-infection of E. faecium had occurred between patients.
Methods: A total of 82 E. faecium strains isolated from different
patients with bacteraemia during a 3-year period at the
Karolinska University Hospital, Huddinge, Sweden were ana-
lysed. The strains were scanned for presence of the esp-gene by
PCR. Minimal inhibition concentration against ampicillin, ci-
proﬂoxacin, gentamicin, imipenem, linezolide and vancomycin
was determined by the agar diffusion method according to
NCCLS. For determination of genetic relationship between the
isolates and detection of possible cross-infection between
patients pulsed-ﬁeld gel electrophoresis was used.
Results: About half of all isolates were shown to be esp-
positive. The esp-positive strains were less genetically diverse
and had higher frequencies of antibiotic resistance compared to
the esp-negative ones. Resistance towards ampicillin, imipenem
and ciproﬂoxacin was common while vancomycin resistance
was rare. All isolates were susceptible to linezolid. E. faecium
isolates, identical according to PFGE, were detected from
different patients.
Conclusions: Presence of esp seems to be common among the
E. faecium blood-culture isolates. Dissemination of antibiotic
resistant, esp-positive E. faecium strains between patients seems
to occur in the hospital. The esp-positive E. faecium strains seem
to have a less diverse genetic origin compared to the esp-
negative ones.
P770
Molecular epidemiology of glycopeptide-
resistant enterococci isolated in a university
hospital, Italy (2003–2004)
C. Boldrin, M. Erdenizmenli, T. Tommasini, S.G. Parisi,
A. Grossato (Padua, I; Izmir, TR)
Objectives: Recently Enterococcus spp has emerged as a major
nosocomial pathogen because of its resistance to multiple
antibiotics, including glycopeptides. Actually severe enterococ-
cal infections create therapeutic problems difﬁcult to solve. The
aim of the present study was to determine antimicrobial
susceptibility pattern and genotypic characteristics of glycopep-
tide-resistant enterococci (GRE) isolated in Padua Hospital, one
of the largest in Northeastern Italy, and to explore the genetic
relationship among them.
Methods: In two-year period, 21 GRE were isolated principally
from patients who were undergone liver transplantation, hos-
pitalized in different wards. Strains were identiﬁed by API 20
Strep (BioMe´rieux). Minimal inhibitory concentrations (MICs)
were determined by broth-microdilution method according to
NCCLS guidelines with cation-adjusted Mueller-Hinton broth.
The presence of van genes (vanA and vanB) was analysed by
PCR assays and molecular analysis was performed by pulsed-
ﬁeld gel electrophoresis (PFGE) after restriction with SmaI
enzyme. The presence of esp genes was also investigated by
PCR assays.
Results: Of all GRE isolates, 92% were Enterococcus faecium. All
strains were vanA- positive and resistant to all traditional
antibiotics: ampicillin, cefalosporins, tetracycline, ciproﬂoxacin,
gentamycin (high resistance level). Assays to demonstrate the
surface protein Esp, recently identiﬁed as a marker of clones
prevalent among hospitalized patients, were negative for all
strains. Genotype analysis by PFGE identiﬁed three major
patterns (A–C) suggesting patient-to-patient clonal dissemin-
ation or presence of colonized residents who serve as a reservoir
for GRE.
Conclusions: The molecular typing is fundamental for epide-
miological studies which represent the ﬁrst step to establish
control measures directed to contain spreading of multidrug-
resistant bacteria responsible of severe infections.
P771
Low prevalence of vancomycin resistant
enterococci colonisation in intensive care patients
in a Brazilian teaching hospital
L.G.O. Cardoso, G.V. Castilho, P. Trabasso, S.R.P.E. Dantas,
A.T. Tresoldi (Campinas, BR)
Objective: To determine the prevalence of vancomycin resistant
enterococci (VRE) colonization in intensive care units patients in
a 400-bed tertiary care teaching hospital, and correlate with
vancomycin consumption.
Methods: Anal swab cultures were collected from patients in
adult and pediatric intensive care units (ICU) between October-
2003 and October-2004. Samples were collected from patients
with more than 5 days of admission in these units, and repeated
every 7 days until their exits, and incubated in a bile esculine
agar with vancomycin (6 mcg/ml) to search for Enterococcus sp
growth. Strains were then reincubated in a blood agar medium,
identiﬁed by Vitek and susceptibility to vancomycin and
teicoplanin tested by an E-test. Minimal inhibitory concentra-
tions (MIC) over than 8 lg/ml were reported like resistant.
Medical charts and use of antimicrobial were recovered. Deﬁned
daily dose (DDD) consumption of vancomycin in entire hospital
was also recovered using an informatized supply control
programme.
Results: In pediatric and adult ICU were collected 249 samples
from 112 patients, media of 2.22 samples per patient (ranging
from 1 to 12 cultures), of them 141 in the pediatric ICU (47
patients) and 108 in the adult ICU (65 patients). Vancomycin
resistant Enterococcus sp grew in 9 patients, 4 from pediatric and
5 from adult ICU, being 5 cases of Enterococcus gallinarum and 2
cases of Enterococcus casseliﬂavus, both possibly with no trans-
missible VanC phenotype. Only 2 patients were colonized by
Enterococcus faecalis vancomycin resistant. First, a woman with
acute intermittent porphyria with a length of stay in the ICU
longer than 3 months receiving broad-spectrum antimicrobials
(cefepime, vancomycin, anfotericin B and later piperacilin –
tazobactam). Another case was a child with an acute fulminant
hepatitis A with a prolonged stay in another hospital before his
admission, dying in the further 6th day waiting for a liver
transplantation. Both patients did not have documented infec-
tion by these strains, and in both the VRE were susceptible to
ampicilin and also resistant to teicoplanin. Consumption of
vancomycin was less than 50 DDD/1000 patients-day in this
period.
Conclusion: VRE is not a major concern in our ICUs, despite
the literature report. Furthermore, there was not any case of VRE
faecium colonization. Of note, both strains were susceptible to
ampicillin. These ﬁndings may correlate with a restrictive use of
vancomycin.
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P772
Glycopeptide-resistant Enterococcus faecium in
Spain with vanA genotype and apparent
teicoplanin susceptibility
M.V. Francia, J. Calvo, C. Garcı´a, E. Ugalde, I. Monteagudo,
A.B. Campo-Esquisabel, M.E. Cano, J. Agu¨ero, L. Martı´nez-
Martı´nez (Santander, E)
Objectives: Nosocomial glycopeptide-resistance Enterococcus
faecium (GREF) is unusual in Spain, however GREF have been
isolated in our institution since September 2002. The objectives
of this study were to determine the clonal relationship, the
phenotype of glycopeptide resistance and the involved genotype
and its association with conjugative elements in GREF isolated
in our hospital.
Methods: Identiﬁcation and preliminary susceptibility testing
were done with the Walk-Away System. MICs of vancomycin
(VAN), teicoplanin (TEI), ampicillin (AMP), erythromycin
(ERY), tetracycline (TET), chloramphenicol (CLO), HLR-gen-
tamicin (GEN), HLR-streptomycin (STR), linezolid (LNZ), and
quinupristin-dalfopristin (Q/D) were determined by microdilu-
tion (MD, NCCLS). MICs of VAN and TEI were also determined
with E-test strips. Clonal relationship was determined by both
REP-PCR and PFGE (SmaI restriction). VAN-resistance was
transferred by conjugation to E. faecium BM4105SS. Plasmids
were obtained by the alkaline lysis method. The glycopeptide-
resistance determinant was identiﬁed by multiplex-PCR and
PCR with vanA-speciﬁc primers.
Results: Between September 2002 and April 2004, 31 GREF
were isolated from 28 patients from wound (n = 13), blood
(n = 3), or other samples (n = 15). MICs (mg/l) of VAN for a
majority of isolates (n = 29) were >256 (MD and E-test). MICs of
TEI by MD and E-test were 4–8 and 32–256, respectively, for a
majority of isolates (n = 21). The percentages of resistance were:
HLR-GEN (77), HLR-STR (23), AMP (100), ERY (100), TET (6),
CLO (3), LNZ (0), Q/D (52). Three REP-PCR patterns (25, 5, and
1 isolates) and two PFGE patterns (26 and 5 isolates) were
obtained. VAN-resistance was transferred in all cases to
E. faecium BM4105SS (being the transfer frequencies 10)4 for 29
isolates and 10)6 for the remainder 2). Several conjugative
plasmids were involved in the transfer. MICs (mg/L) of VAN
and TEI against transconjugants were >128 and 8–64, respect-
ively. The vanA determinant was identiﬁed in all parental
isolates and transconjugants.
Conclusions: We have identiﬁed two clones of GREF transfer-
ring vanA at a high frequency. In our isolates, the E-test was
more reliable than MD for detecting the VanA phenotype.
P773
Comparative analysis of virulence factors in
enterococci isolated from hospitals
M. Filipova, E. Dworniczek, A. Seniuk, L. Wojciech,
H. Bujdakova (Bratislava, SVK; Wroclaw, PL)
Objectives: This work presents comparative evaluation of the
occurrence of potential virulence factors as hemolysin (Hly),
gelatinase (Gel), lipase (Lip), DNAse; esp gene and their
association with formation of bioﬁlm among enterococcal
clinical samples in Slovakia and Poland.
Methods: Total 225 clinical isolates E. faecalis and E. faecium
with different resistance determinants were involved in this
study (109 isolates from Slovakia and 116 isolates from Poland).
Antimicrobial susceptibility was determined by the disk-diffu-
sion method according to NCCLS standards. The presence of
Hly, Gel, Lip and DNase activities were investigated on TSA
with 5% horse blood, BHI agar with gelatine (40 g/l), Spirit Blue
agar and DNAse agar. For detection of esp gene PCR with
speciﬁc primer set was used. The ability to produce bioﬁlm was
tested in a microtiter assay.
Results: The occurrence of the respective virulence factors was
as follows (Slovak isolates vs. Polish isolates) cytolysin 16.5 vs.
11.2%, gelatinase 47.7 vs. 6.9%, DNAse 16.5 vs. 5.2%, lipase 5.5
vs. 25.9%, esp 55 vs. 53.5%. Both, esp-positive and esp-negative
isolates expressed competence for adherence in bioﬁlm experi-
ments; however intensity of bioﬁlm formation was different. The
Slovak/Polish enterococcal isolates were also screened for
resistance to 4 selected antibiotics with results: gentamicin
100/57.8%, streptomycin 10.1/59.5%, vankomycin 0/5.2% and
teicoplanin 0/0.8%.
Conclusion: Distributions of respective virulence factors which
may play an important role in enterococcal pathogenesis among
strains from Slovakia and Poland was estimated to be diverse.
Bacterial adherence to polystyrene surface was proved to be
independent with any of studied virulence factors, but seems to
be associated with antibiotic resistance.
P774
Occurrence of vancomycin-resistant and high
level aminoglycoside-resistant Enterococcus spp.
isolated in an Italian hospital, Bari, southern Italy
R. Monno, C. De Carlo, A. Lapata, F. Coscia, D. De Vito,
C. Rizzo (Bari, I)
Glycopeptide-resistant enterococci have become a focus of
concern in many countries because options for antimicrobial
therapy are limited. It is well known that the use of a cell wall
active such as penicillin or a glycopeptide with an aminogly-
coside results in synergistic bacterial activity against severe
infections due to Enterococcus. The efﬁcacy of this bactericidal
treatmen is limited by the emergence of high level gentamy-
cin, kanamycin and streptomycin resistance. The aim of this
study was to evaluate the occurrence of glycopeptide resist-
ance and high-level aminoglycoside resistance in 1169 strains
of Enterococcus spp isolated from several anatomic sites of
patients admitted to Policlinico Hospital, Bari, Italy. E. faecalis
and E. faecium represent the 82.6% and 15.8% of isolates,
respectively. The most common sites of isolation were in the
order: urinary tract (64.8%), pus (21.4%), blood (6.3%), CVC
(2.1%), materials from genital tract (3.2%) and rectal swab
(0.5%). We have identiﬁed 19 strains (1.6%) of Enterococcus spp
resistant to both vancomycin and teicoplanin (GRE). E. faecalis
represent the 0.7%, whereas E. faecium represent the 6.5%.
MIC90 to vancomycin was for E. faecalis 0.5 and 4 mg/L for
E. faecium. Corresponding values for teicoplanin were 2 mg/L
for E. faecalis and 0.25 mg/L for E. faecium. GRE represent the
1.6% of Enterococcus isolated and this value reﬂect those found
in Europe. GRE were isolated mainly from urine, pus, blood
and CVC, and essentially from service of Medicine, Surgery
and ICU. High-level resistance to gentamycin and kanamycin
were tested by diffusion agar screen method. HLR to
gentamycin were detected in the 33.2% of E. faecalis and in
the 31.3% of E. faecium. HLR to kanamycin was found in the
68.5% of E. faecalis and in the 81.1% of E. faecium. HLR to
aminoglycoside were found in isolates from urina, pus, blood
and CVC. Data on HLR to gentamycin are in according to that
found in other countries of Europe, whereas high percentage
of HLR was found for kanamycin. These data indicate a
potential for further improvement of antibiotic policies in our
hospital.
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P775
Mucoid Enterococcus faecalis, an emerging
phenotype?
C. Marne, A. Betra´n, A.I. Lo´pez, A. Hurtado,
M.J. Revillo (Zaragoza, E)
Objectives: The prospective evaluation of the isolation of
encapsulated Enterococcus spp. with mucoid phenotype, due to
the increase of this unusual type of strains.
Methods: Over a 4-year period (July 2000/June 2004) 116487
urine specimens from hospital and community patients were
cultured.
Results: 27054 (23.2%) specimens had positive results. Entero-
coccus spp. was recovered from 2744 of them (10.1%) samples.
After 24 h. of incubation in cultures from 8 patients, strains of
slow growth were isolated, with small colonies on blood agar
and pinpoint colonies on cled agar. After 48 h. nonhaemolytic
conﬂuent colonies with highly mucoid aspect, resembled that of
Gram-negative bacilli. Gram stain corresponded to ovoid Gram-
positive cocci arranged in pairs, with a distinctive halo around
the cells. Urine sediment showed good quality of the samples,
with abundant leukocytes and Gram-positive cocci. All 8 isolates
were identiﬁed as E. faecalis, without atypical reactions. By
microdilution, strains were susceptible to ampicillin, amoxicil-
lin-clavulanic, nitrofurantoin, norﬂoxacin and vancomycin and
presented variable results to fosfomycin, gentamicin and cotri-
mazole. Mucoid aspect persisted after repeated subcultures and
after frozen storage. All 8 patients were community patients.
Ages were 72, 77, 92, 57, 72, 71, 75 and 39 years and had cronic
urinary tract infections, although not previously caused by
E. faecalis. The only patient with relevant risk factors was the ﬁrst
one, with cystectomy for bladder neoplasia. Evolution was
favorable, with negative post-treatment controls in 6 cases. In
two patients mucoid E. faecalis was reisolated repeatedly despite
correct therapy.
Conclusions: 1. In our patients mucoid E. faecalis urinary
infections were community-acquired.
2. The possibility of initial misidentiﬁcation with gram-negative
bacilli, can delay the microbiological diagnostic.
3. Antimicrobial susceptibility results not expected with a
mucoid strain, must orientate to the isolation of encapsulated
E. faecalis.
4. Routine Gram stain of slow growing strains will help in early
detection of these kind of strains.
P776
Detection of high-level gentamicin resistance and
genes encoding gentamicin resistance in invasive
enterococci in Denmark
C.H. Lester, M. Kaltoft, H.C. Schønheyder, J.O. Jarløv,
A. Friis-Møller, D.S. Hansen, J.J. Christensen, T.G. Jensen,
A.M. Hammerum (Copenhagen, Aalborg, Herlev, Hvidovre,
Hillerød, Odense, DK)
Objectives: Enterococcal infections are often treated with a
combination of an aminoglycoside and a cell-wall-active agent
such as penicillin or a glycopeptide. In Denmark vancomycin
resistant enterococci still have a very low prevalence, whereas
high-level resistance to gentamicin (MIC > 500 mg/l) seems to
be more common. In the other Nordic countries is high-level
gentamicin resistancemost frequently detected in E. faecalis. Four
genes, aac(6’)-Ie-aph(2’’)-Ia, aph(2’’)-Ib, aph(2’’)-Ic and aph(2’’)-
Id, are known to encode gentamicin resistance in enterococci.
This study investigates the prevalence of high-level gentamicin
resistance and the distribution of the different gentamicin
resistance genes in invasive enterococci.
Methods: A total of 159 invasive (mainly blood) enterococci
were collected between January 2004 and September 2004. Only
one isolate from each patient was included in this study, except
in two cases where both an E. faecium and an E. faecalis were
obtained from the same patient. The strains were collected at six
Danish Departments of Clinical Microbiology (Aalborg, Odense,
Hvidovre, Herlev, Hillerød, and SSI) and sent to National
Center for Antimicrobials and Infection Control at SSI. All 159
strains were identiﬁed to species level by PCR. Susceptibility to
gentamicin (128–2048 mg/l) was determined by the micro broth
dilution method. Gentamicin resistant enterococci were inves-
tigated for the presence of the aac(6’)-Ie-aph(2’’)-Ia, aph(2’’)-Ib,
aph(2’’)-Ic, and aph(2’’)-Id genes by PCR.
Results: Of the 159 isolates were 97 (61%) E. faecalis and 62
(39%) E. faecium. In total were 59 (37%) of all the invasive
enterococci resistant to gentamicin, divided into 36 (61%)
E. faecium and 23 (39%) E. faecalis. All gentamicin resistant
isolates contained aac(6’)-Ie-aph(2’’)-Ia. None of the other
resistance genes were detected in any of the isolates.
Conclusion: In total 38% of the collected invasive strains were
gentamicin resis-tant and 61% of these resistant strains were
E. faecium. This indicates that gentamicin resistance is common
in Denmark especially in E. faecium. The resistance was
mediated by the aac(6’)-Ie-aph(2’’)-Ia gene, which was the only
gene detected in the resistant strains.
P777
An unusual resistance phenotype in nosocomial
strains of Enterococcus species in a Greek
hospital
E. Metzidie, S. Pournaras, D. Soﬁanou (Thessaloniki,
Larissa, GR)
Objectives: Enterococcus faecalis is a common nosocomial agent
and usually demonstrates susceptibility to ampicillin, penicillin
G and amoxicillin/clavulanicate, while Enterococcus faecium is
commonly resistant to the above mentioned antimicrobial
agents. The aim of our study is the presentation of an unusual
resistance phenotype that was recently identiﬁed in a Greek
tertiary hospital among A. faecalis and E. faecium, exhibiting
resistance to penicillin and susceptibility to ampicillin and
amoxicillin/clavulanate.
Methods: A total of 35 non-repetitive enterococcal strains were
collected from various hospital infection samples. Identiﬁcation
and susceptibility testing were performed by using the Vitek 2
automated system (Biomerieux, Marcy l’ Etoile, France). The
MICs for penicillin G, ampicillin and amoxicillin/clavulanic
acid were determined using E-test. The production of beta-
lactamase was evaluated using the ceﬁnase test.
Results: Among 35 isolates, 33 were identiﬁed as E. faecalis and
2 as E. faecium. All isolates were susceptible to ampicillin and
amoxicillin/clavulanic acid with MIC ranging from 0.38 to
1.50 mg/L respectively but they were resistant to penicillin
(MIC > 32 mg/L). Using the ceﬁnase test they were found to be
negative for beta-lactamase production. PFGE analysis revealed
various unrelated clonal patterns.
Conclusions: A spread of this unusual resistance phenotype
would affect the usefulness of penicillin that generally retains
activity against E. faecalis. The aetiology of this phenotype is an
object of study.
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P778
Low diversity of integrons among non-
Escherichia coli Enterobacteriaceae clinical
isolates producing extended-spectrum
beta-lactamases from Spain
E. Machado, R. Canto´n, J. Ferreira, A. Novais, F. Baquero,
L.V. Peixe, T.M. Coque (Porto, P; Madrid, E)
Objectives: To analyse the overall prevalence and diversity of
integrons among ESBL-producing non-Escherichia coli Entero-
bacteriaceae, NEC-ESBL(+), from Hospital Ramo´n y Cajal (1987–
2000).
Methods: Sixty-six PFGE clonal types of NEC-ESBL(+) corres-
ponding to 34 Klebsiella pneumoniae (KP), 7 Klebsiella oxytoca (KO),
14 Enterobacter cloacae (ECL), 3 Enterobacter aerogenes (EA), 1
Enterobacter gergoviae, 4 Salmonella enterica, and 3 Citrobacter spp.
were studied. Fifty-two ESBL-producing E. coli, EC-ESBL(+), and
43 EC-ESBL()), recovered in the same institution were used as a
control group. Class 1 and 2 integrons were detected by PCR,
typed by RFLP using AluI and HaeIII as restriction enzymes,
respectively, and identiﬁed by sequencing (one per RFLP type).
Class 3 integrons were determined by dot-blot hybridization.
Results: ESBL among NEC-ESBL(+) were identiﬁed as 17 TEM,
15 SHV, 3 CTX-M-9, and 31 CTX-M-10 and among EC-ESBL (+)
as 16 TEM, 9 SHV, 22 CTX-M-9, 1 CTX-M-14, and 4 CTX-M-10.
Class 1 integrons were detected in the 30% of the NEC-ESBL(+)
isolates studied, being more common among KP (13/34, 38%)
than among all other different enterobacterial species (7/32,
22%). The presence of these integrons among NEC-ESBL(+) was
lower than among EC-ESBL(+) or EC-ESBL()) from the same
hospital (30%, 67% and 40%, respectively). Eight RFLP types
(size ranged from 0.9 to 2.2 kb) were detected. The most
common ones were those identiﬁed as aadA1 (7/19, found in
KP and ECL species), and dfrA16aadA2 (2/19 found in KP and
ECL species). Three other types were detected in KP and one
type in EA. Four of these six types were also present in E. coli.
Two types were only found in ECL and Salmonella isolates,
respectively. Five isolates contained two class 1 integron types of
different size. Class 2 or class 3 integrons were not found.
Conclusions: The lower prevalence of integrons among NEC-
ESBL(+) than among EC-ESBL(+), could be related with differ-
ent content in ESBL genes (CTXM-9, more prevalent in EC, is
associated to In6 class 1 integron). The presence of most of the
class 1 integron types among different enterobacterial species
during the same time period suggests dissemination of common
elements (plasmids or transposons) in which integrons are
located.
P779
Diversity of integrons and sulfonamide
resistance genes among ESBL and non-ESBL
Enterobacteriaceae recovered from Portuguese
hospitals
E. Machado, R. Canto´n, F. Baquero, T.M. Coque,
L.V. Peixe (Porto, P; Madrid, E)
Objectives: To analyse the overall distribution of class 1 and
class 2 integrons, and sul1, sul2, and sul3 genes among ESBL
and non-ESBL Enterobacteriaceae isolates from different Portu-
guese nosocomial environments.
Methods: We studied 83 Enterobacteriaceae clinical isolates
recovered from patients attending at Portuguese hospitals
(October 2002 to May 2004): (i) 50 ESBL-producing clinical
isolates corresponding to 21 Klebsiella pneumoniae, 2 Klebsiella
oxytoca, 12 Escherichia coli, 4 Enterobacter aerogenes, 4 Enterobacter
cloacae, 4 Proteus mirabilis, and 3 Serratia marcescens; and (ii) 33
non-ESBL-producing isolates (4 K. pneumoniae, 4 E. coli, 4
E. aerogenes, 2 E. cloacae, 13 S. marcescens, 2 P. mirabilis, 2 C.
freundii, 1 M. morganii, and 1 P. stuartii). Bacterial identiﬁcation
was performed by the Vitek System. Antibiotic susceptibility
was performed by the standard disk diffusion method. Presence
of class 1 and 2 integrons, and sul1, sul2 and sul3 genes, were
searched by PCR using primers previously described.
Results: Class 1 integrons were most prevalent than class 2
integrons (61% vs 5%). Presence of class 1 integrons was higher
among ESBL(+) than among ESBL()) strains (36/50, 72% vs
19/33, 58%) but class 2 were more common among ESBL())
isolates (3/33, 9% vs 1/50, 2%). Resistance to sulfonamides was
found in 77% (64/83) of the isolates, sul1 being more commonly
found than sul2 or sul3 genes (55/83, 66%; 35/83, 42%; 4/83,
5%). The recently described sul3 gene was detected in four
ESBL-producing K. pneumoniae isolates from two hospitals. A
high number of strains contained simultaneously sul1 and sul2
(n = 29), sul1 and sul3 (n = 4) or sul1, sul2 and sul3 (n = 3)
genes.
Conclusion: Class 1 integrons and sul1 and sul2 genes are
widely distributed among Enterobacteriaceae clinical isolates
from Portugal. The frequent presence of class 1 integrons among
ESBL(+) isolates carrying sul genes might contribute to the
persistence of these genes in the nosocomial setting. Although
described recently in different enterobacterial species, this is the
ﬁrst report of sul3 genes in K. pneumoniae.
P780
High diversity of genetic elements associated
with CTX-M-9-producing Enterobacteriaceae
clinical isolates from Spain
A. Novais, R. Canto´n, J.C. Gala´n, A. Valverde, E. Machado,
F. Baquero, T.M. Coque (Madrid, E)
Objectives: To analyze the clonal relatedness and diversity of
the genetic environments among all CTX-M-9 producing
enterobacterial clinical isolates recovered in our institution
since ﬁrst description in 1996.
Methods: Seventy CTX-M-9-producing isolates (69 Escherichia
coli (EC) and 1 Klebsiella pneumoniae) from 45 different patients
were collected from 1996 to 2002. Forty-ﬁve isolates (one per
patient) were included in the study. ESBL characterization was
performed by isoelectric focusing, PCR and sequencing. Anti-
biotic susceptibility was determined by the disk diffusion and
microdilution methods. Conjugation experiments were done by
broth and ﬁlter matings Whole plasmid proﬁle was determined
in both wild type and transconjugant strains by the Birnboim
Doly method. Clonal relatedness was established by XbaI-PFGE
and EC phylogenetic groups were determined by a multiplex
PCR assay. Characterization of blaCTX-M-9 genetic environ-
ment was performed by a PCR overlapping assay based on In60
sequence (GenBank AF174129), an In6-like class 1 integron in
which blaCTX-M-9 has been previously reported.
Results: All but one CTX-M-9-producing isolate were identiﬁed
as E. coli. The isolates showed a high clonal diversity (41 PFGE
types/45 isolates) and belonged to phylogenetic groups D (54%),
B1 (20%) A (15%) and B2 (10%). All isolates were resistant to
streptomycin, trimethoprim, sulfonamide, and ciproﬂoxacin.
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Plasmid content of wild type strains varied from 1 to 7 (2 to
>65 kb). Transfer of blaCTX-M-9 was achieved in 80% of the
cases. Size of plasmids carrying blaCTX-M-9 ranged from 7 to
65 kb, 45% of the transconjugants showed more than one
plasmid. In all cases, blaCTX-M-9 was located in In6-like class I
integron structures that were divided in four types: (I) similar to
that of In60 (n = 30), (II) showing differences in the region
located downstream blaCTX-M-9, (IS3000) (n = 5); (III) showing
different gene cassette content in the ﬁrst 5CS¢-3CS¢ (aadA1 vs
dhfrA16-aadA2) (n = 4); IV) lacking the ﬁrst 5CS¢-3CS¢ (n = 2).
Conclusions: CTX-M-9 producing isolates were mainly associ-
ated to E. coli species belonging to a wide variety of clonal types
and phylogenetic groups. Variations in the genetic environment
of blaCTX-M-9 suggest a high recombination rate of this
structure. The location of In60 elements on different conjugative
plasmids might contribute to increase the dissemination of
blaCTX-M-9 in our environment.
P781
Characterisation of class1 integrons carrying
blaVIM genes in Enterobacteriaceae from Greece
E. Koratzanis, I. Galani, M. Souli, Z. Chryssouli,
H. Giamarellou (Chaidari, GR)
Objectives: The emergence of VIM-producing Enterobacteria-
ceae in Greece is a worrisome phenomenon which incited the
present study aiming to investigate whether and to what extend
the horizontal transfer of metallo-b-lactamase (MBL) genes
contributes to the acquisition of these genes by pathogenic
bacteria. The blaVIM gene is carried on mobile gene cassettes
inserted into class 1 integrons having the potential to move from
one bacterium to another.
Methods: Two Escherichia coli [bronchial secretions-BS (1) and
urine-U (2)], one Klebsiella pneumoniae (U), one Proteus mirabilis
(CSF), two Enterobacter cloacae [blood-B(1) and U(2)], two
E. aerogenes [B(1) and stool carriage-SC(2)] and one Citrobacter
freundii (SC) were studied. Antibiotic susceptibility testing and
EDTA-disk synergy tests, were carried out to screen for MBL-
producing phenotype. PCR and sequence analysis were used to
identify and analyse the blaVIM-containing integrons.
Results: All isolates had reduced susceptibility to imipenem
(0.5–2 lg/ml) and demonstrated a positive EDTA-disk synergy
test. Sequence analysis of PCR products detected the presence of
the MBL gene blaVIM-1 as part of class 1 integron to all but one
isolates. E. coli (1) isolate from BS harboured a class 1 integron
that contained only a blaVIM-2 gene cassette. Preliminary PCR-
based experiments and RFLP analysis revealed the presence of
the same integron carrying blaVIM-1, dhfrI and aadA in three of
the strains [E. coli (2), P. mirabilis and E. aerogenes (2)] isolated at
different tetriary hospitals in Athens at different periods.
E. cloacae (1) and C. freundii isolated from two not epidemiolog-
ically related patients of our hospital carried the same integron
containing blaVIM-1 and aac(6’)-IIc genes. E. cloacae (2),
C. freundii and K. pneumoniae isolates from the same patient
hospitalised in the ICU of our hospital harboured different to
each other class I integrons with blaVIM-1 gene cassette.
Conclusions: MBLs of the VIM-type represent an emerging
threat in Greek hospitals. All of the blaVIM-carrying isolates of
our study harboured class 1 integrons. We observed: 1) the
diversity of blaVIM-containing integrons in different isolates of
the same patient and 2) the integration of the same class 1
integrons in genetically unrelated nosocomial isolates. More
research is needed for understanding the way these mobile
genetic elements are transferred between bacteria and how
they incorporate and disseminate antibiotic resistance gene
cassettes.
P782
Rectal carriage of extended-spectrum beta-
lactamase producing Gram-negative bacilli in
patients admitted to intensive care units
F. M’Zali, M. Wilcox, C. Rodrigues, S. Elliot, A. Bodenham,
J. Dave, M. Denton (Leeds, UK)
Objectives: To ascertain the rate of rectal carriage of extended-
spectrum beta-lactamase (ESBL) – producing Gram-negative
bacilli in patients admitted to two different intensive care units
(ICUs).
Methods: Rectal swabs were obtained from all patients within
24 h of admission (and every third day thereafter) to either an
adult general medical and surgical ICU (MSICU) or an adult
neurosurgical ICU (NICU). Swabs were cultured on Maconkey
agar at 37C in air for 48 h. Presumptive Gram-negative bacilli
were identiﬁed to species level using API 20E. Screening for
ESBLs was conducted using MAST DD and positive isolates
were screened further using published molecular methods.
Susceptibility was determined using the BSAC disk diffusion
method. Demographic details were recorded for all patients in a
prospective manner during the study.
Results: Ninety-two patients (median age 61 yr, range 18–88; 47
male) were entered into the study (52 MSICU, 40 NICU).
Median length of stay was 4 days (range 1–24 days). ESBL-
producing Gram-negative bacilli were isolated from 13/52 (25%)
of MSICU and 3/40 (7.5%) NICU patients on rectal screening at
admission. A further eight patients (3 MSICU, 5 NICU) became
positive after admission. Ten (62%) of 16 patients ESBL+ on
admission were admitted to the ICU within 48 h of admission to
hospital. Molecular characterization identiﬁed ESBLs from the
TEM-, SHV- and CTX-M classes.
Conclusions: Rectal carriage of ESBL-producing Gram-negative
bacilli was common in this study, particularly on the MSICU.
Prior hospitalization was not a reliable indicator of carriage with
some ESBL+ patients being admitted direct from the commu-
nity. These ﬁndings may inﬂuence the selection of antibiotics for
empirical treatment of sepsis in the ICU setting.
P783
First description of bla-ctx-m-2 producing isolate
in Spain and characterisation of its genetic
environment
A. Valverde, R. Canton, J.C. Galan, A. Novais, F. Baquero,
T.M. Coque (Madrid, E)
Objectives: To characterize the genetic environment of the ﬁrst
CTX-M-2-producing Escherichia coli isolate described in Spain.
Materials and methods: E. coli VS27, a fecal isolate collected in
2003 as part of a surveillance study from a healthy volunteer
without hospital or antibiotic exposure in the previous 3 months
to the sample collection, was analysed. ESBL characterization
was carried out by IEF, PCR, and further sequencing. Antibiotic
susceptibility was performed by disk diffusion and microdilu-
tion (NCCLS). Transfer of blaCTX-M-2 was searched by broth
and ﬁlter mating methods. Whole plasmid proﬁle was deter-
mined by the Kado and Liu technique. To characterize the
genetic environment of blaCTX-M-2, an overlapping PCR assay
based on the sequence of In35 (GenBank AY079169), an In6-like
class 1 integron in which blaCTX-M-2 has been previously
reported, was designed. All PCR products were sequenced and
further compared to sequences in the GeneBank databases by
BLASTN.
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Results: E. coli VS27 showing resistance to streptomycin,
sulfonamide, tetracycline, ciproﬂoxacin and nalidixic acid,
produced an ESBL of pI = 8.1. The strain contained 6 plasmids
(three <3 kb, 5, 40 and 70 kb) but broth or ﬁlter mating did not
achieve transfer of cefotaxime resistance. blaCTX-M-2 was
located in a In6-like class I integron that show 100% homology
with the In35 sequence except for the gene cassette content of the
ﬁrst 5CS-3CS (sat-aadA1) which has not been previously
associated with this element.
Conclusions: Presence of blaCTX-M–2 in Spain is of concern
since increases the diversity of blaCTX-M genes in our area,
already epidemic for those of clusters CTX-M-1 (blaCTXM-10)
and CTX-M-9 (blaCTXM-9, blaCTXM-14). The genetic environ-
ment of blaCTX-M-2 in isolates from different continents
(showing diversity of the ﬁrst 5’CS-3’CS and 100% homology
with the rest of In35 sequence) suggests recent emergence of this
structure and a high recombination rate of the 5’CS-3’CS part of
this integron.
P784
Great diversity of ESBL-producing
Enterobacteriaceae in a Birmingham hospital,
United Kingdom
W. Liu, L. Xu, V. Ensor, C. Munday, S. Gossain, P. Hawkey,
S. Ahmed, K. Nye (Hunan, RC; Birmingham, UK)
Objective: To ascertain the diversity of ESBLs present in
Birmingham Heartlands Hospital.
Method: Isolates from clinical specimens submitted from Octo-
ber 2003 to February 2004 which were resistant to any of
cefotaxime, ceftazidime, cefpodoxime were screened using the
double disk diffusion (DDD) method. Faeces from the same
period from hospitalised and community patients with diar-
rhoea were plated on CAT campylobacter medium which has
8 mg/L cefoperazone and subsequent colonies screened using
the DDD test. Positive isolates were identiﬁed and primers to
amplify blaTEM, bla SHV, bla OXA and bla CTX-M used to
generate amplicons, blaTEM/SHV were sequenced. For CTX-M
positive isolates, dHPLC heteroduplex analysis was used to
identify the CTX-M types. A proportion of these isolates were
also sequenced to conﬁrm the accuracy of the heteroduplex
analysis.
Results: For clinical specimens, 41 E. coli were isolated (29
carrying CTX-M-15, 31 TEM-1, 29 OXA and 1 SHV-12); Klebsiella
21 isolates (19 producing OXA, 14, SHV-11, 3 SHV-12, 1 SHV-28,
1 SHV-1, 18 TEM-1 and16 CTX-M-15); Enterobacter 11 isolates (9
SHV-12, 8 OXA and 7 TEM-1). In the case of faecal isolates: 12 E.
coli (12 CTX-M-15, 10 TEM-1 and 5 OXA); Klebsiella 14 isolates
(13 CTX-M-15, 13 SHV-11, 5 OXA and 1 SHV-12); Enterobacter 13
isolates (13 SHV-12 and 5 TEM-1).
Conclusion: The striking ﬁnding is that the SHV-11 and –12
ESBL genes are extensively distributed amongst both commu-
nity and hospital isolates of Klebsiella and Enterobacter. A single
hospital isolate of E. coli was found to carry SHV-12, perhaps
representing spread from Klebsiella, conversely Klebsiella were
also found to carry high levels of CTX-M-15 in both hospital and
community isolates. In contrast, E. coli isolates almost only
carried CTX-M-15. CTX-M-15 is more widely distributed
amongst bacterial species than suggested by the most recent
survey in the UK and ESBLs of the SHV type are also highly
signiﬁcant causes of resistance to third generation cephalospo-
rins.
P785
Investigation of a possible outbreak of extended
spectrum B-lactamase producing Enterobacter
cloacae using ERIC-PCR
S.V. Smith, F.M. MacKenzie, K.E. Milne, I.M. Gould (Aberdeen,
UK)
Objective: Over the course of 2003 there was a marked increase
in the number of extended sprctrum B-lactamase (ESBL)-
producing isolates of Enterobacter cloacae from clinical specimens
submitted to the microbiology laboratory in Aberdeen, Scotland.
The molecular epidemiology of these isolates was investigated.
Methods: 59 isolates from 47 patients were investigated. They
had previously been identiﬁed phenotypically as Enterobacter
species using the API 20E system and their ESBL activity
conﬁrmed by double-disc testing and/or combination disc
testing according to NCCLS guidelines. Enterobacterial-repetit-
ive-intergenic-consensus (ERIC)-PCR was used to retrospec-
tively type these isolates of ESBL-producing Enterobacter.
Results: 31 isolates were from Aberdeen Royal Inﬁrmary (ARI,
tertiary referral hospital for the region), 7 were from Woodend
Hospital (acute and long-stay geriatrics), 1 from Roxburghe
House (hospital for the terminally ill), 1 from Cornhill Hospital
(psychiatric), 1 from the Neonatal Unit at Aberdeen Maternity
Hospital and 4 from three community hospitals. 14 samples
were from general practices in the region. The isolates originated
from a wide variety of clinical specimens including urine (35
samples), wound swabs (8), blood (4), sputum (3), faeces (3),
other swabs (2) pus (1), tissue (1), line tip (1) and pleural ﬂuid
(1). Six different banding patterns were identiﬁed, designated
types A to F. It was found that 79% of the isolates typed were
type A, and that this percentage rose to 84% when only ARI
isolates were considered. The type A isolates from ARI had
come from 14 different wards. The remaining ﬁve types (B to F)
that were identiﬁed each accounted for only a small number of
isolates. Type B was found in ARI (1 isolate) and a GP specimen
(1). Type C was found in ARI (1), Woodend (1) and a GP
specimen (1). Type D also came from ARI (1) and Woodend (1).
Type E was only found in ARI (1) and type F in a GP specimen
(1) and the neonatal unit (1).
Conclusion: A clonal outbreak of ESBL-producing Ent. cloacae
was identiﬁed. The clone is widespread, being found in a large
number of wards throughout the hospital and in the commu-
nity.
P786
Detection of a novel CMY-type beta-lactamase in
Italian isolates of Proteus mirabilis
M.M. D’Andrea, T. Giani, E. Nucleo, F. Luzzaro, F. Vailati,
V. Kroumova, L. Pagani, G.M. Rossolini (Siena, Pavia, Varese,
Bergamo, Novara, I)
Background and objectives: Plasmid-mediated AmpC-type
beta-lactamases (CBLs) are emerging resistance determinants
of increasing clinical importance in Enterobacteriaceae. They
confer resistance to expanded-spectrum cephalosporins and
cephamycins and are poorly susceptible to beta-lactamase
inhibitors. In Italy, reports of these enzymes have been exceed-
ingly rare. In this work we report on the detection of a novel
CBL of the CMY/LAT lineage, named CMY-16, in clinical
isolates of Proteus mirabilis from northern Italy.
Methods: Bacterial identiﬁcation and susceptibility testing were
carried out following standard procedures. Beta-lactamase pro-
ductionwas analysedby isoelectric focusing (IEF). Beta-lactamase
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genesweredetected bya customDNAmicroarray, and their exact
nature was determined by PCR and sequencing.
Results: Eight nonreplicate isolates of P. mirabilis showing a
unusual beta-lactam resistance phenotype (resistance to: amp-
icillin, amoxicillin-clavulanate, cefotaxime, ceftazidime and
cefoxitin; susceptibility to: cefepime, aztreonam, piperacillin/
tazobactam and carbapenems) were obtained from patients from
4 different hospitals in Northern Italy (Novara, Varese, Bergamo
and Abbiategrasso) during the period Aug. 2003 to Jun. 2004.
Most isolates were from the urinary tract, from inpatients in
long-term-care facilities, but one isolate was from an outpatient.
Double-disk synergy test with extended-spectrum cephalospo-
rins (ESC) yielded negative results with clavulanate but positive
results with some ESC and tazobactam. IEF analysis revealed
the presence of beta-lactamases of pI 5.4 and >8.4. Microarray
analysis revealed the presence of CMY/LAT- and TEM-
type genes. Sequencing showed the presence, in all isolates, of
a novel CMY/LAT-type gene encoding an enzyme, named
CMY-16, different from CMY-2 by two (A171S and W221R) and
from CMY-12 by one (N363S) aminoacid substitutions, respect-
ively. Transferability of the CBL gene by conjugation was not
detected.
Conclusions: A novel CBL of the CMY/LAT lineage, CMY-16,
was found in P. mirabilis isolates resistant to cefotaxime,
ceftazidime and cephamycins circulating in northern Italy.
Present ﬁndings underscore the emerging role of these resist-
ance determinants also in our Country.
P787
Cephalosporin-resistance in Enterobacteriaceae: a
new plague?
A. Ghafur, A. Bose, I. Balakrishnan (London, UK)
Objectives: To study the prevalence, resistance mechanisms
and antibiotic susceptibility proﬁles of third generation cepha-
losporin resistant Enterobacteriaceae. To study the efﬁcacies of
different detection techniques (Phoenix methodology and com-
bination discs) for extended-spectrum Beta-lactamases (ESBLs)
and AmpC enzymes.
Methods: All Enterobacteriaceae isolates were subjected to
identiﬁcation and susceptibility testing using Phoenix methodo-
logy. All isolates found to exhibit resistance to 3rd generation
cephalosporins and/or ESBL production were subjected to
conﬁrmatory testing by the combination disc method using
cefpodoxime + cefpodoxime/clavulanate, and cefpirome +
cefpirome/clavulanate.
Results: ESBL producing Enterobacteriaceae were isolated from
71 patients, 73% of whom were in-patients. Fifty-six per cent of
isolates were from urine samples, 14% from respiratory tract
samples and 8% from blood cultures. The remaining 15
specimens comprised mainly abdominal drain ﬂuids and
wound swabs. Sixty per cent of these isolates were E. coli and
30% were K. pneumonia. There were 3 isolates of E. cloacae, 2
isolates of K. oxytoca and 1 isolate of C. freundii. All isolates were
sensitive to meropenem. Whereas 96% retained sensitivity to
amikacin, only 56% were sensitive to piperacillin-tazobactam,
40% to cefepime, 48% to gentamicin and 24% to ciproﬂoxacin.
Several of these isolates appear to be producing AmpC enzymes
as well as ESBLs. The prevalence of this dual resistance
mechanism was surprisingly high in E. coli. Results produced
by the different methodologies were largely consistent for ESBL
detection. AmpC production could not be conﬁrmed using
Phoenix methodology, but was detectable using combination
disc methodology, which was also able to detect ESBL and
AmpC dual resistance.
Conclusion: Cephalosporin resistance is becoming increasingly
common in Enterobacteriaceae, with increasingly diverse and
complex mechanisms. Laboratories should therefore have a low
threshold for conﬁrmatory testing of ESBL and AmpC produc-
tion. Phoenix and combination disc methodologies are both
reliable for ESBL detection. However, the latter are better for
AmpC detection, particularly when co-produced with ESBLs.
The carbapenems are now the only reliable agents against ESBL
producing Enterobacteriaceae. Amikacin provides an effective
alternative in the vast majority of cases.
P788
Widespread detection of VEB-1-type extended-
spectrum beta-lactamases among nosocomial
Pseudomonas aeruginosa isolates in Bulgaria: a
nationwide multicentre study
A. Bachvarova, T. Velinov, M. Petrov, T. Kantardjiev,
V. Levterova, I. Ivanov (Soﬁa, BG)
During the last few years Pseudomonas aeruginosa has become
one of the most common nosocomial pathogens in Bulgaria.
Recently, some isolates that are resistant to all available
antimicrobial agents including carbapenems have emerged.
We studied the prevalence and molecular epidemiology of
VEB-1-type beta-lactamases among Pseudomonas aeruginosa
strains, isolated since 1998 in more than 20 hospitals from
distinct regions of Bulgaria. The producers of VEB-1-type
enzyme were highly resistant to ceftazidime, aminoglycosides
and quinolones, and moderately susceptible to imipenem and
meropenem. Identiﬁcation was conﬁrmed with VITEK automa-
ted system. Resistance to ceftazidime was detected by disk
diffusion method of the National Committee for Clinical
Laboratory Standards and minimal inhibitory concentrations
were determined by E-test. All ceftazidime-resistant strains
were additionally tested by double disk diffusion method with
carbapenem disk and 3/4 generation cephalosporin disk for
presence of synergism. A total of 117 ceftazidime-resistant non-
repetitive P. aeruginosa isolates were studied during this period.
The presence of blaVEB-1 was determined with polymerase
chain reaction. We detected VEB-1-type beta-lactamases in
36.8% (43/117) of P. aeruginosa strains. All strains that express
synergism with double disk diffusion method were conﬁrmed to
be blaVEB-1 carriers. VEB-1 is widespread mostly in Asia and is
rarely detected in European countries. Nevertheless it appears
to have a signiﬁcant presence among P. aeruginosa isolates in
Bulgarian hospitals and causes serious impediments in anti-
microbial treatment and difﬁculties in limiting its dissemination
in our country.
P789
Occurrence in 2000 of epidemic CTX-M-15
producing Enterobacteriaceae before the
UK-wide outbreak was recognised
V. Ensor, L. Xu, M. Hastings, P. Hawkey (Birmingham, UK)
Objective: To screen isolates of presumptive ESBL-producing
Enterobacteriaceae made during 2000 and 2001 from the
University Hospital, Birmingham, for the early appearance of
CTX-M-15 producing Enterobacteriaceae.
Method: Sensitivity testing was carried out on the VITEK 1
system and presumptive ESBL isolates were stored at )70C.
Isolates were screened for the presence of blaCTX-M using a
PCR generated probe and dot blotting. Primers, which had
previously been shown to speciﬁcally amplify all groups of
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blaCTX-M genes, were applied. For probe positive isolates,
DHPLC heteroduplex analysis was employed to identify the
CTX-M speciﬁc gene. A total of 28 isolates of E. coli and 5 other
Enterobacteriaceae were obtained in 2000, and 58 and 18
respectively in 2001.
Results: Only E. coli were found to caryy blaCTX-M and no
isolates were found before July 2000. 19/28 E. coli in 2000 and
12/40 in 2001 were blaCTX-M positive.
Conclusion: We have discovered that CTX-M-15 appeared
very suddenly in Birmingham (within the Midlands) in July
2000, nearly 2 years before the UK-wide outbreak was
recognized. Interestingly the gene was only found in E. coli
and probably represents the spread of a highly successful
clone which subsequently has caused a large-scale and
persistent outbreak in a hospital in Shrewsbury (also within
the Midlands) starting in late 2002. As CTX-M-15 was ﬁrst
described in the South Asian region and Birmingham has a
very large South Asian community, the CTX-M-15 gene may
have been introduced in patients returning from India and
Pakistan.
P790
Distribution of beta-lactamases in clinical
isolates of enterobacteriaceae and nonfermenters
from a region of central Italy
F. De Santis, B. Caporale, G. Celenza, M. Fiore, C. Pellegrini,
M. Perilli, J.D. Docquier, G.M. Rossolini,
G. Amicosante (L’Aquila, Siena, I)
Objectives: In the last decade metallo-b-lactamases (MBL)
have widely spread in Italian Hospitals. MBL represent a
heterogeneous group of enzymes that have the common
feature of hydrolyzing extended-spectrum cephalosporins
and carbapenems. The aim of this work was that to investigate
the distribution of resistance genes to b-lactams in clinical
isolates of Enterobacteriaceae, Pseudomonas aeruginosa and
other gram-negative nonfermenters from Abruzzo, a region
of central Italy.
Methods: Nonreplicate isolates of Enterobacteriaceae (n = 25)
P. aeruginosa (n = 50) and other gram-negative nonfermenters
(n = 5) resistant to carbapenems were collected from 4 regional
hospitals (L’Aquila, Pescara, Atri, Avezzano) in Abruzzo (Cen-
tral Italy). Isolates were from the respiratory or the urinary tract.
MBL determinants were screened by colony blot hybridization
using DNA probes for blaVIM-1, blaGOB-1, and blaIMP-1 genes.
Hybridization-positive colonies were analysed by PCR using
speciﬁc primers, and the PCR products were sequenced to
conﬁrm identiﬁcation of the gene.
Results: MBL of the VIM and IMP types were detected in 30
P. aeruginosa isolates from three of four hospitals. A different
distribution was observed for different types: VIM-4 producers
were circulating in L’Aquila hospital (located in the internal
part of the region), while IMP-13 producers were circulating in
Atri and Pescara hospitals (both located on the coast). No MBL
were detected in clinical isolates of Enterobacteriaceae or of
Acinetobacter spp. Genetic analysis of the blaIMP and blaVIM
determinants revealed features typical of integron-associated
genes.
Conclusion: This report indicates that MBL are widespread in
nosocomial isolates of P. aeruginosa from our region, although
signiﬁcant geographical differences were observed for different
enzyme types. MBL genes have apparently not yet diffused in
Enterobacteriaceae or Acinetobacter, in this area. Continuous
surveillance is of paramount importance to control these
important emerging resistance determinants.
P791
ESBL-strains of E. coli and K. pneumoniae in
GENARS hospitals
K. Huppertz, J. Beer, I. Noll, W. Pﬁster, T. Pietzcker, S. Schubert,
T.A. Wichelhaus, S. Ziesing, B. Wiedemann (Bonn, Leipzig, Jena,
Ulm, Kiel, Frankfurt, Hannover, D)
Objectives: The increasing resistance of Enterobacteriaceae to
mono-bactams and oxyimino-cephalosporines like cefotaxime,
ceftazidime, ceftriaxone and cefpodoxime is due to an increasing
spread of strains expressing extended spectrum B-lactamases
(ESBL). ESBL rates of more than 50% have already been reported
for southern European countries. For Germany, Austria and
Switzerland a multicentre study of the Paul Ehrlich Society
(PEG) in 2001 detected ESBL-rates of 0.8% and 8.2% for E. coli
and K. pneumoniae, respectively. More recent and detailed
information about the occurrence of ESBL phenotypes in
Germany is provided by the GENARS project which is funded
by the German Federal Ministry of Health and Social Security.
Methods: All laboratories involved determine antimicrobial
susceptibility by testing the Minimal Inhibitory Concentration
(MIC) in the laboratory routine for about 25 different antibiotics.
According to NCCLS guidelines, some of these antibiotics
tested, could be used as indicators for an ESBL screening
(cefotaxime, ceftazidime, cefpodoxime). The ratio of cefpodox-
ime and cefpodoxime/clavulanic acid was used for phenotyp-
ical conﬁrmation.
Results: In the ﬁrst half of 2004, the percentage of strains with a
positive ESBL-screening amounts to 4.3% and to 10.5% for E. coli
(n = 1944) and K. pneumoniae (n = 382), respectively. Phenotyp-
ically conﬁrmed as ESBL are 1.7% of all E. coli strains and 7.1%
of all K. pneumoniae strains. In both species strains were detected
in which ESBL‘s are phenotypically conﬁrmed, but where
NCCLS parameters for initial screening failed. Strains with a
MIC for cefpodoxime of ‡ 8 mg/L which can not be reduced by
clavulanic acid are identiﬁed as AmpC expressing strains (E. coli
1.1%; K. pneumoniae 1.8%). Focused on the departments and the
kind of wards in GENARS hospitals the epidemiological
situation concerning ESBL producing strains can be assessed.
In GENARS hospitals the difference of ESBL rates between
departments can be considerable (E. coli: 0.7–6.1%; K. pneumo-
niae: 2.7–18.1%). For both E. coli and K. pneumoniae, ESBL rates
are highest in ICU‘s.
Conclusion: To prevent spread in hospitals, cities and coun-
tries, a detailed surveillance of ESBL-strains is necessary. To
reach this goal an improvement of our epidemiological know-
ledge about the occurrence and spread of ESBL-strains is
needed. In Germany the MIC-determination as demonstrated
for GENARS hospitals allows a correct detection of ESBL
producing strains.
P792
SARI: distribution of extended-spectrum
beta-lactamases in German ICUs
D. Jonas, E. Meyer, F. Schwab, K. Biehler, H. Ru¨den,
F.D. Daschner (Freiburg, Berlin, D)
Objectives: The aims of this study were to determine the
frequency of ESBL-positive (ESBL+) strains and the occurrence
of blaCTX-M encoded CTX-M enzymes in isolates obtained from
34 German ICUs participating in the project ‘Surveillance on
antibiotic use and bacterial resistance in ICUs’ (SARI). These
ﬁndings were investigated for an association with ICU-based
antimicrobial consumption data measured as ‘Antimicrobial use
density’ (AD).
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Methods: Within the German SARI project, 323 non-duplicate,
mainly ciproﬂoxacin- or cephalosporin-resistant isolates of
E. coli and Klebsiella spp. were obtained from 34 ICUs, together
with ICU - based antimicrobial consumption data. Additionally,
for one month the participating ICUs collected 169 isolates of
these species irrespective of their antimicrobial susceptibility for
determination of ESBL-prevalence.
Results: Eighty isolates were obtained from 15 ICUs tested
positive for ESBL. However, 52 strains of K. pneumoniae
originated from two ICUs. Genotyping conﬁrmed the continu-
ous spread of three ESBL+ clones. In 17 strains from seven ICUs
blaCTX-M genes related to the TOHO-1, CTX-M-1 and CTX-M-
15 families were detected. Antimicrobial consumption was
analysed in 20 ICUs, which had contributed at least 10 isolates
of E. coli or Klebsiella spp. for testing. Comparison of the
characteristics of 10 ICUs each with and without detectable
ESBL+ strains revealed signiﬁcant differences (P < 0.05) in the
average combined antimicrobial usage of cefotaxime and ceftri-
axone (AD 91.7 vs. 60.1). Contrarily, usage of other broad
spectrum antibiotics like ﬂuoroquinolones and carbapenems did
not reveal signiﬁcant differences.
Conclusions: The frequency of ESBL in 34 German ICUs was
estimated at 5% with a considerable variation in prevalence
between different ICUs and different blaCTX-M types spreading
throughout Germany. This study provides ﬁrst data on ESBL in
German ICUs and the possible inﬂuence of infection control and
antibiotic use.
P793
The ﬁrst incidence of PER-1 ESBL-producing
Pseudomonas aeruginosa in Poland and
identiﬁcation of a novel OXA beta-lactamase
variant
J. Empel, K. Filczak, A. Mrowka, W. Hryniewicz,
M. Gniadkowski (Warsaw, PL)
Objectives: To analyse an outbreak caused by ESBL-producing
P. aeruginosa in one of Warsaw hospitals.
Methods: Thirty-eight ESBL-producing P. aeruginosa isolates
were collected between September 2003 and May 2004 from
patients in different wards of a Warsaw hospital. The ESBL
production was conﬁrmed by the double-disc test. MICs of 14
antibiotics were determined by the NCCLS agar dilution
method. Molecular typing was performed by the PFGE analysis
of the XbaI-digested bacterial DNA. Beta-lactamases of the
isolates were visualised by isoelectric focusing (IEF) of whole-
cell extracts. Genes coding for the enzymes were identiﬁed by
PCR and sequencing of the resulting amplicons.
Results: The susceptibility testing revealed that the P. aeruginosa
isolates were multiresistant, demonstrating resistance to beta-
lactams, aminoglycosides and ciproﬂoxacin. Their patterns of
resistance to beta-lactams were typical for ESBL producers
except for the fact that all but 5 isolates were susceptible to
piperacillin. The PFGE analysis classiﬁed the isolates into two
different types; 35 isolates represented PFGE type A and the
remaining 3 isolates belonged to type B. The PFGE type A
isolates were characterised by beta-lactamase IEF patterns
consisting of enzymes with pIs of 5.3, 7.7 and 8.2 (33 isolates),
or 5.3 and 8.2 (2 isolates). The PFGE type B isolates produced
beta-lactamases with pIs of 5.3, 6.5, 7.7 and 8.2. Of the enzymes
observed in the all isolates, the one with the pI of 8.2
corresponded to the species-speciﬁc AmpC cephalosporinase,
whereas that with the pI of 5.3 was identiﬁed as the PER-1 ESBL.
The pI 7.7 and 6.5 IEF bands were assigned to OXA-2 and OXA-
74 beta-lactamases, respectively. OXA-74, produced exclusively
by the PFGE type B isolates, is a novel variant of OXA-10-related
oxacillinases. Although no other bands were observed in the IEF
analysis, PCR amplicons speciﬁc for the blaOXA-50 gene, which
naturally occurs in P. aeruginosa, were generated for the all
isolates.
Conclusions: PER-1-producing P. aeruginosa was identiﬁed for
the ﬁrst time in Poland. It caused a highly clonal outbreak in one
of Warsaw hospitals. It is possible that a blaPER-1 gene-
containing determinant was transmitted between two separate
clones of the organism observed during the outbreak.
P794
Detection of extended spectrum beta-lactamases
in Escherichia coli strains isolated from clinical
specimens and their antimicrobial susceptibility
N. Erben, I. Ozgunes, A. Kiremitci (Eskisehir, TR)
Objectives: Extended-spectrum beta-lactamases (ESBLs) confer
resistance to newer cephalosporins and penicillin with expan-
ded-spectrum activity. ESBLs are mostly plasmid-mediated
enzymes. ESBLs were ﬁrst described in 1983. ESBLs can be
detected by double disk synergy (DDS), modiﬁed DDS (MDDS)
and E test methods. It is important for clinicians for appropriate
antimicrobial treatment to ﬁnd ESBL.
Methods: In this study the presence of ESBL was investigated
by DDS and MDDS methods in 100 E. coli strains isolated from
clinical specimens such as urine (75), blood (8), wound (7) and
other sites (10). E. coli strains were also tested for susceptibility
to aztreonam, cefotaxime, ceftazidime, cefoperazone, cefoxitin
and imipenem. Demographic and clinical data of patients were
also collected and evaluated.
Results: The presence of ESBL was detected in 12% of isolates
by MDDS method. 94.6% of the ESBL negative and 4 of 12 ESBL
positive strains were isolated from urine specimens. 8 of 12
ESBL positive strains were isolated from blood (2), surgical site
(4) and respiratory tract (2) specimens. The 96.4% of out patient
E. coli strains was ESBL negative, but 10 of 12 ESBL positive
strains were isolated from hospitalized patients. Intravascular
catheters, surgical procedures and mechanical ventilation ratios
were statistically higher in ESBL positive group. Intermediate
susceptible isolates were classiﬁed as resistant. In-vitro suscep-
tibilities of 88 non ESBL producing E. coli strains were found as
73.9% for aztreonam, 96.6% for cefotaxime, 98.9% for ceftazi-
dime, 96.6% for cefoperazone, 98.9% for cefoxitin and 100% for
imipenem. In-vitro susceptibilities of 12 ESBL producing E. coli
strains to these antibiotics found as 0/12 for aztreonam, 0/12 for
cefotaxime, 1/12 for ceftazidime, 1/12 for cefoperazone, 6/12
for cefoxitin and 12/12 for imipenem.
Conclusion: ESBL producing pathogen bacteria was a clinical
problem especially in hospitalized patients. ESBL producing
strains must be suggested not only for Klebsiella spp. but also for
hospital acquired E. coli strains.
P795
Risk factors and treatment outcome of
bloodstream infections caused by Proteus
mirabilis isolates producing extended-spectrum
beta-lactamases
A. Endimiani, F. Luzzaro, G. Brigante, M. Perilli, G. Lombardi,
G. Amicosante, G.M. Rossolini, A. Toniolo (Varese, L’Aquila,
Siena, I)
Objectives: Bloodstream infection (BSI) caused by Proteus
mirabilis is a relatively uncommon clinical entity. Clinical
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signiﬁcance and diagnostic aspects have received little attention.
This study was initiated to evaluate risk factors and treatment
outcome of BSI episodes caused by P. mirabilis strains.
Methods: From January 1997 to June 2004, 25 BSI caused by
P. mirabilis strains occurred at the Ospedale di Circolo of Varese
(Northern Italy). Isolates were evaluated by phenotypic and
molecular methods in order to assess their ability of producing
extended-spectrum beta-lactamases (ESBLs). Clinical records of
BSI-patients were examined retrospectively. Demographic data,
underlying diseases (according to McCabe and Jackson classi-
ﬁcation scheme and Charlson weighted index), risk factors,
antimicrobial therapy, and treatment outcome were investigated
by comparing cases due to ESBL-positive to those due to ESBL-
negative P. mirabilis strains. Student’s unpaired t-test and the
Mann–Whitney U-test were used to compare continuous and
not normally distributed continuous variables, respectively.
V-square test was used to evaluate the treatment outcome.
Results: Eleven isolates were found to express ESBLs, either the
TEM-52 or TEM-92 enzyme. The remaining 14 isolates were
ESBL-negative and were uniformly susceptible to extended-
spectrum cephalosporins and monobactams. Comparison of the
two groups showed that previous hospitalization in nursing
homes (P = 0.04) and use of bladder catheter (P = 0.01) were
signiﬁcant risk factors for infections due to ESBL-positive
strains. In addition, cases due to ESBL-producing strains
showed a signiﬁcantly higher mortality attributable to BSI
(P = 0.04). BSI cases due to ESBL-negative isolates uniformly
responded to therapy, whereas 5/11 cases due to ESBL-positive
isolates failed to respond (P < 0.01). Use of carbapenems was
uniformly associated with complete response independently of
ESBL production.
Conclusion: Therapeutic failure and mortality may occur in BSI
episodes caused by P. mirabilis. Recognition of ESBL-positive
strains appears critical for the clinical management of patients
with systemic P. mirabilis infections.
P796
Community and hospital-acquired extended-
spectrum beta-lactamase (CTX-m-15)-producing
enterobacteriaceae in Lebanon
C. Moubareck, Z. Daoud, N. Hakime´, M. Hamze´, N. Mangeney,
H. Matta, J. Mokhbat, R. Rohban, D. Karam-Sarkis,
F. Doucet-Populaire (Paris, F; Beirut, Tripoli, LBN)
Introduction and objective: Extended-spectrum beta-lacta-
mases (ESBLs) are enzymes that encode resistance to broad-
spectrum beta-lactam antibiotics. This prospective multicentric
point-prevalence study was carried out to detect the presence of
ESBL-producing strains within the faecal ﬂora of community-
and hospital-based patients and health workers in Lebanon.
Methods: 1500 fecal samples were collected from patients and
staff of the intensive care units of six tertiary care general
hospitals located in different areas of Lebanon between January
and March 2003 and 382 from healthy subjects between April
and June 2003. These samples were screened for potential ESBL
producers by culture on trypticase soy-5% sheep blood agar
containing vancomycin (6 lg/ml), amphotericin (2 lg/ml),
ceftazidime (2 lg/ml) and clindamycin (1 lg/ml). Patients
were checked for ESBL producing strains upon admission,
72 h later and at weekly intervals over a 3-months period. Other
participants were checked once. ESBL producing strains were
detected by antimicrobial susceptibility testing and were then
identiﬁed by the API 20E system. The ESBLs produced were
characterized by PCR analysis of bla genes, DNA sequencing
and isoelectric focusing experiments. The genome of ESBL
producing strains was analysed using pulsed-ﬁeld gel electro-
phoresis.
Results: A total of 118 strains including 102 Escherichia coli, 9
Klebsiella pneumoniae, 6 Enterobacter cloacae and 1 Citrobacter
freundii collected from 61 patients, 2 health workers and 9
healthy subjects were found to produce ESBLs. The character-
ization of one representative strain by subject (n = 72) revealed
that the majority (83%) express CTX-M-15 ESBL (pI 8.6). The
remaining isolates produced SHV-5a ESBL (pI 8.2). DNA
macrorestriction presented 38 different genotypes revealing
the absence of clonal link among E. coli strains. In addition to
the fact that this study is the ﬁrst in Lebanon to investigate the
carriage of ESBL producing strains, it represents the ﬁrst report
of a SHV-5a producing C. freundii.
Conclusion: CTX-M-15 type ESBLs are capable of spreading in
both hospital and community settings in Lebanon. The high
degree of diversity of strains suggested that horizontal transfer
of plasmids was likely the main mechanism of CTX-M-15 ESBL
spread. The dissemination of plasmids was probably preceded
by inter and intra spread in the hospital and the community of
several strains
P797
Accurate, rapid genotyping of CTX-M beta-
lactamase by denaturing high-performance liquid
chromatography
L. Xu, T. Ling, K. Boese, V. Ensor, W. Liu, C. Munday, J. Evans,
B.A. Oppenheim, G. Hong, P. Hawkey (Birmingham, UK; Hong
Kong, HK; Omaha, USA)
Objective: To develop a sensitive, rapid and high-throughput
method using DHPLC (Wave Nucleic-Acid Fragment Analysis
System, Transgenomic) for genotyping CTX-Mproducing ESBLs.
Method: Primers were designed to amplify group speciﬁc
fragments (250–400 bp) of the ORF of all three groups of
blaCTX-M that have been identiﬁed in the UK and China.
Heteroduplex PCR products were formed using a speciﬁc
reference strain and the unknown ﬁeld isolate. The PCR
products were then screened using temperature-mediated
heteroduplex analysis by DHPLC on the Wave Nucleic-Acid
Fragment Analysis System. 101 isolates were tested blind,
having ﬁrst had the blaCTX-M identiﬁed by DNA sequencing.
Results: Unique proﬁles were obtained for all 5 blaCTX-M
types. Characteristic proﬁles were obtained for each blaCTX-M
type for all 101 isolates with a genotyping accuracy of 100%. The
distribution of CTX-M types for UK was: CTX-M-15 (61), -26 (8)
and China – 14 (28), -3 (9), -1 (3).
Conclusion: This is the ﬁrst report of the use of DHPLC
technology for beta-lactamase genotyping, it offers a highly
speciﬁc, sensitive, economical and high-throughput approach to
screen known, and identify new, CTX-M genotypes in large
numbers of clinical isolates. It has great potential for the
surveillance and epidemiological monitoring of CTX-M type
ESBLs.
P798
Outbreak of multiresistant Klebsiella pneumoniae
producing CMY-2 beta-lactamase in a neonatal
intensive care unit in Spain
M.E. Cano, J. Agu¨ero, C. Garcı´a, M.V. Francia, J. Calvo,
R. Galva´n, L. Martı´nez-Martı´nez (Santander, E)
Objectives: The aims of this study were to investigate the
presence of plasmid-mediated AmpC-type beta-lactamases
Abstracts
236
(PACBL) and of class 1 integrons in multiresistant K. pneumoniae
isolates from a neonatal intensive care unit and to determine
their clonal relationship.
Methods: Identiﬁcation and susceptibility testing were per-
formed with the Microscan Walkaway System (Dade Behring).
PACBL production was inferred from resistance (R) to penicil-
lins, penicillin-beta-lactamase inhibitor combinations, cefoxitin,
cefotaxime and ceftazidime; no synergism between cefotaxime
or ceftazidime and clavulanic acid; and susceptibility to both
cefepime and imipenem. Resistance to cefoxitin was transferred
by conjugation to rifampin-R E. coli J53. Plasmids were extracted
by the lysis-alkaline method. A PACBL was detected by
multiplex-PCR and identiﬁed by PCR with speciﬁc primers
and sequencing. Class 1 integrons were investigated by PCR and
sequencing. Clonal relationship of isolates was determined by
pulsed-ﬁeld gel electrophoresis (PFGE, XbaI restriction).
Results: Between January and October 2003, 35 neonates were
infected or colonized by multiresistant K. pneumoniae isolated
from urine (n = 16), blood (n = 5) or respiratory samples
(n = 14). All isolates were resistant to tobramycin and gentam-
icin and susceptible to amikacin, with MICs of ciproﬂoxacin of
0.5–1 mg/L. Eight isolates were selected for further evaluation:
these all presented the same PFGE-pattern and transferred
resistance to cefoxitin, tobramycin and gentamicin to E. coli by
conjugation (transfer frequency: ca. 10)3). A > 80 kb plasmid
was observed in all transconjugants. All parental isolates and
transconjugants produced a PACBL identiﬁed as CMY-2 and
carried a class 1 integron with aadB, ORF1 and cmlA gene
cassettes (but not blaCMY-2).
Conclusions: We have conﬁrmed the presence of an outbreak in
a neonatal intensive care unit caused by a multiresistant
K. pneumoniae producing CMY-2 and containing an integron
with the aadB gene cassette.
P799
Ascertainment of ESBL-producing E. coli
infections in 2002 and 2003 – survey of English
microbiology laboratories
A.D. Glasswell, A.D. Pearson, E.A. McKeown, D.M. Livermore,
A.J. Lee-Duggal (London, UK)
Objectives: Infections caused by Escherichia coli with extended-
spectrum CTX-M beta-lactamases are a rapidly growing prob-
lem in the UK. A survey of English microbiology laboratories
was carried out to audit the methodology used to detect ESBL-
producing E. coli, to identify the extent of community-acquired
urinary tract or bloodstream infections with ESBL producers,
and to establish the extent of any public health investigation.
Methods: Questionnaires were sent to all clinical microbiology
laboratories across England in January 2004. Analysis of the
responses was undertaken.
Results: A total of 142 laboratories returned completed ques-
tionnaires. A standard method for detecting ESBLs was used by
72% of the responders though the precise methods varied
among sites (16% of responders did not know whether or not
they used a standard method, or did not answer the question).
ESBL-producing E. coli was detected from blood cultures in
hospitalised patients by 44% of responders (27% did not know).
Fourteen responders (10%) had detected ESBL-producing E. coli
from blood cultures from community patients or samples (30%
did not know). ESBL-producing E. coli had been detected in
urine samples by 42% of responders from hospitalised patients
(32% did not know) whilst 37% reported that they had detected
producers in community patients or samples (35% did not
know). Thirty-two responders (23%) reported that there had
been a local investigation of multi-drug resistant infections
caused by ESBL-producing E. coli (3% did not know) in the
preceding 24 months.
Conclusions: The survey revealed numerous detections and
several investigations into potential outbreaks of ESBL-produ-
cing E. coli across England during 2002 and 2003. These ﬁndings
support the view, based on routine surveillance and reference
submissions, that ESBL-producing E. coli are an emerging
problem, also that they are occurring in community as well as
hospitalised patients. Most laboratories had methods for ESBL
detection, but standardised national guidance has recently been
published by the Health Protection Agency (http://
www.hpa.org.uk). A follow-up questionnaire is due to be sent
out early in 2005.
P800
Frequency of extended spectrum beta lactamase
producing Escherichia coli strains isolated from
central venous catheter related infections
quantiﬁed by three laboratory methods
M. Balotescu, V. Lazar, C. Larion, O. Banu, D. Bulai,
R. Cernat (Bucharest, RO)
Objectives: The purpose of this study was the ESBL screening
of clinical isolates of Escherichia coli isolated from patients with
central venous catheter related infections, by automatic methods
(VITEK system), double-disk synergy test and E-test ESBL.
Methods: The study was carried out on 51 E. coli strains
recovered in 2004 from patients admitted for cardiovascular
surgery at the Cardiovascular Disease Institute of Bucharest,
Romania. The strains identiﬁcation was performed using the
VITEK system. The strains were subsequently tested for antibi-
otic susceptibility by standard disk diffusion method and the
strains suspected of ESBL production were comparatively tested
by double disk diffusion conﬁrmatory test using clavulanic acid
and the standard E-test strips, containing of two gradients
aligned in opposing directions, one side of the strip cefotaxime
(CT) MIC range of 0.5–32 mcg/ml and the other a cefotaxime
MIC range of 0.125–8 mcg/ml overlaid with a constant level of
4 mcg/ml clavulanic acid (CTL). MIC ratios of CT/CTL (MIC
ratio >8) have been used as a discriminative criteria for the
presence or absence of ESBLs.
Results: Out of the total number of strains, 17.64% were given
ESBL positive by VITEK system. The results of antimicrobial
resistance testing by standard disk diffusion method showed
that 35.29% exhibited beta-lactamase pattern, with high resist-
ance levels to ampicillin and low or high resistance to 1st
generation cephalosporins and 17.64% of the tested strains were
suspected of ESBL production showing decreased sensitivity to
cephtazidime and cefotaxime. ESBL screening of strains by
double disk diffusion test showed that 5 strains (9.8%) demon-
strated clavulanic acid inhibitory effect in the phenotypic
conﬁrmatory test. The E-test results conﬁrmed the presence of
ESBL only in 4 strains of the suspected of ESBL production
(7.84%), the rest being not determinable, probably due to MICs
values exceeding the concentration range, or to the overlapping
of other beta-lactamases (e.g. AmpCs and inhibitor-resistant
TEMs (IRTs) masking the ESBL pattern.
Conclusion: Our results showed that different methods used
for the detection of ESBL producing E. coli strains gave variable
results and showed different sensitivity levels in detecting ESBL
strains. These data suggest that clinical microbiology laborator-
ies should not rely on one single method for the screening ESBL
producers, complementary tests being necessary for incidence
studies.
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